0001493152-24-008230.txt : 20240228 0001493152-24-008230.hdr.sgml : 20240228 20240228173326 ACCESSION NUMBER: 0001493152-24-008230 CONFORMED SUBMISSION TYPE: F-1 PUBLIC DOCUMENT COUNT: 122 FILED AS OF DATE: 20240228 DATE AS OF CHANGE: 20240228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SMX (Security Matters) Public Ltd Co CENTRAL INDEX KEY: 0001940674 STANDARD INDUSTRIAL CLASSIFICATION: MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT [3590] ORGANIZATION NAME: 06 Technology IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: F-1 SEC ACT: 1933 Act SEC FILE NUMBER: 333-277482 FILM NUMBER: 24697363 BUSINESS ADDRESS: STREET 1: MESPIL BUSINESS CENTRE, MESPIL HOUSE STREET 2: SUSSEX ROAD CITY: DUBLIN 4 STATE: L2 ZIP: D04 T4A6 BUSINESS PHONE: 353 1 920 1000 MAIL ADDRESS: STREET 1: MESPIL BUSINESS CENTRE, MESPIL HOUSE STREET 2: SUSSEX ROAD CITY: DUBLIN 4 STATE: L2 ZIP: D04 T4A6 FORMER COMPANY: FORMER CONFORMED NAME: Empatan Public Ltd Co DATE OF NAME CHANGE: 20220801 F-1 1 formf-1.htm
false 0001940674 false 0001940674 P6M P2Y 0001940674 2023-01-01 2023-06-30 0001940674 dei:BusinessContactMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember 2022-07-01 0001940674 2023-06-30 0001940674 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember 2020-01-01 2020-12-31 0001940674 2022-01-01 2022-06-30 0001940674 ifrs-full:IssuedCapitalMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:AdditionalPaidinCapitalMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:ForeignCurrencyTranslationMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:RetainedEarningsMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:IssuedCapitalMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 ifrs-full:AdditionalPaidinCapitalMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 SMX:ForeignCurrencyTranslationMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 ifrs-full:RetainedEarningsMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 ifrs-full:IssuedCapitalMember SMX:SecurityMattersLimitedMember 2019-12-31 0001940674 ifrs-full:AdditionalPaidinCapitalMember SMX:SecurityMattersLimitedMember 2019-12-31 0001940674 SMX:ForeignCurrencyTranslationMember SMX:SecurityMattersLimitedMember 2019-12-31 0001940674 ifrs-full:RetainedEarningsMember SMX:SecurityMattersLimitedMember 2019-12-31 0001940674 SMX:SecurityMattersLimitedMember 2019-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2022-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2022-12-31 0001940674 ifrs-full:RetainedEarningsMember 2022-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2021-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2021-12-31 0001940674 ifrs-full:RetainedEarningsMember 2021-12-31 0001940674 2021-12-31 0001940674 ifrs-full:IssuedCapitalMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:AdditionalPaidinCapitalMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:ForeignCurrencyTranslationMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:RetainedEarningsMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:IssuedCapitalMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:AdditionalPaidinCapitalMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:ForeignCurrencyTranslationMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:RetainedEarningsMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:IssuedCapitalMember SMX:SecurityMattersLimitedMember 2020-01-01 2020-12-31 0001940674 ifrs-full:AdditionalPaidinCapitalMember SMX:SecurityMattersLimitedMember 2020-01-01 2020-12-31 0001940674 SMX:ForeignCurrencyTranslationMember SMX:SecurityMattersLimitedMember 2020-01-01 2020-12-31 0001940674 ifrs-full:RetainedEarningsMember SMX:SecurityMattersLimitedMember 2020-01-01 2020-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2023-01-01 2023-06-30 0001940674 ifrs-full:RetainedEarningsMember 2023-01-01 2023-06-30 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2022-01-01 2022-06-30 0001940674 ifrs-full:RetainedEarningsMember 2022-01-01 2022-06-30 0001940674 ifrs-full:IssuedCapitalMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:AdditionalPaidinCapitalMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:ForeignCurrencyTranslationMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:RetainedEarningsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2023-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2023-06-30 0001940674 ifrs-full:RetainedEarningsMember 2023-06-30 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2022-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2022-06-30 0001940674 ifrs-full:RetainedEarningsMember 2022-06-30 0001940674 2022-06-30 0001940674 2022-01-01 2022-12-31 0001940674 SMX:LionheartMember SMX:BusinessCombinationAgreementMember SMX:SecurityMattersLimitedMember 2022-07-26 2022-07-26 0001940674 ifrs-full:OrdinarySharesMember SMX:SecurityMattersPTYLtdMember 2022-07-26 0001940674 SMX:LionheartMember SMX:BusinessCombinationAgreementMember 2022-07-26 2022-07-26 0001940674 SMX:EquityLineAgreementMember 2023-01-01 2023-06-30 0001940674 SMX:EquityLineAgreementMember 2023-06-30 0001940674 ifrs-full:ComputerEquipmentMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:MachineryMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:SpecialPurposeAcquisitionCompanyMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:MachineryMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:ComputerEquipmentMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:RightofuseAssetsMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:MachineryMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:ComputerEquipmentMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:RightofuseAssetsMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:MachineryMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:ComputerEquipmentMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:RightofuseAssetsMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:MachineryMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:ComputerEquipmentMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:RightofuseAssetsMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:MachineryMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:ComputerEquipmentMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:RightofuseAssetsMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:MachineryMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:ComputerEquipmentMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:RightofuseAssetsMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:MachineryMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:ComputerEquipmentMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:RightofuseAssetsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 ifrs-full:MachineryMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 ifrs-full:ComputerEquipmentMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 ifrs-full:RightofuseAssetsMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:MachineryMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:ComputerEquipmentMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:RightofuseAssetsMember ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:GrossCarryingAmountMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 ifrs-full:MachineryMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 ifrs-full:ComputerEquipmentMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 ifrs-full:RightofuseAssetsMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:MachineryMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:ComputerEquipmentMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:RightofuseAssetsMember SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:AccumulatedDepreciationMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:LeaseholdImprovementsMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:MachineryMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:FurnitureAndOfficeEquipmentMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:ComputerEquipmentMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:RightofuseAssetsMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember 2022-05-01 2022-05-31 0001940674 SMX:SecurityMattersLimitedMember 2022-05-31 0001940674 SMX:ConvertibleNotesAgreementsMember SMX:SecurityMattersLimitedMember 2022-07-31 0001940674 ifrs-full:MajorOrdinaryShareTransactionsMember SMX:SecurityMattersLimitedMember 2023-03-07 0001940674 SMX:ConvertibleNotesMember 2023-01-24 2023-01-25 0001940674 SMX:ConvertibleNotesMember 2023-01-25 0001940674 ifrs-full:OrdinarySharesMember 2023-01-25 0001940674 SMX:ConvertibleNoteAgreementsMember SMX:BonusWarrantsMember 2023-01-24 2023-01-25 0001940674 SMX:ConvertibleNoteAgreementsMember SMX:RedeemableWarrantsMember 2023-01-24 2023-01-25 0001940674 SMX:ConvertibleNoteAgreementsMember SMX:RedeemableWarrantsMember 2023-01-25 0001940674 SMX:ConvertibleNotesMember 2023-01-01 2023-06-30 0001940674 SMX:RedeemableWarrantsMember 2023-01-01 2023-06-30 0001940674 SMX:YahalomaTechnologiesIncMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:YahalomaTechnologiesIncMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:SMXBeveragesPtyLtdMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:SMXBeveragesPtyLtdMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:SMXBeveragesPtyLtdMember SMX:SecurityMattersLimitedMember 2021-12-23 2021-12-24 0001940674 SMX:SMXBeveragesPtyLtdMember SMX:SecurityMattersLimitedMember 2021-12-24 0001940674 SMX:GlobalBevCoPtyLtdMember SMX:ConsultingAgreementMember SMX:SecurityMattersLimitedMember 2021-12-23 2021-12-24 0001940674 SMX:SecurityMattersLimitedMember SMX:SecurityMattersLimitedsShareOfNetAssetsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SecurityMattersLimitedsShareOfNetAssetsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SecurityMattersLimitedsShareOfNetAssetsMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:CompanysShareInNetProfitsLossesOfAssociatedCompaniesMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:CompanysShareInNetProfitsLossesOfAssociatedCompaniesMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:CompanysShareInNetProfitsLossesOfAssociatedCompaniesMember 2020-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:CapitalisedDevelopmentExpenditureMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:LicencesMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:CapitalisedDevelopmentExpenditureMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:OtherIntangibleAssetsMember SMX:SMXBeveragesPtyLtdMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:OtherIntangibleAssetsMember SMX:SMXBeveragesPtyLtdMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:OfficeEquipmentMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:MotorVehiclesMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:OfficeEquipmentMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:MotorVehiclesMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:OfficeEquipmentMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:MotorVehiclesMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember 2015-01-01 2015-12-31 0001940674 SMX:LenderTwoMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember 2022-08-01 2022-08-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:BonusWarrantsMember SMX:SecurityMattersLimitedMember 2022-10-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:BonusWarrantsMember SMX:BlackAndScholesModelMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember SMX:SecurityMattersLimitedMember 2022-10-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember SMX:ThirdAnniversaryMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember SMX:ThirdAnniversaryMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember SMX:FourthAnniversaryMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember SMX:FourthAnniversaryMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeOneMember SMX:MonteCarloSimulationModelMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeTwoMember SMX:SecurityMattersLimitedMember 2022-10-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeTwoMember SMX:FirstAnniversaryMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeTwoMember SMX:FirstAnniversaryMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeTwoMember SMX:SecondAnniversaryMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeTwoMember SMX:SecondAnniversaryMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeTwoMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsTypeTwoMember SMX:MonteCarloSimulationModelMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:ThreeValuationModelsMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:ElevenLendersMember 2022-08-01 2023-01-31 0001940674 ifrs-full:TopOfRangeMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:BonusWarrantsMember 2022-08-01 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsMember 2022-08-01 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsMember 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember ifrs-full:TopOfRangeMember 2023-06-30 0001940674 SMX:BridgeLoanAgreementsMember 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsMember 2023-06-30 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsMember 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-01-01 2023-06-30 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-03-01 2023-03-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-03-31 0001940674 2022-07-01 0001940674 SMX:DeferredSharesMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember 2022-08-31 0001940674 SMX:SecurityMattersLimitedMember 2021-10-01 2021-10-31 0001940674 SMX:SecurityMattersLimitedMember 2021-10-31 0001940674 SMX:SecurityMattersLimitedMember 2021-05-31 0001940674 SMX:SecurityMattersLimitedMember 2021-05-01 2021-05-31 0001940674 SMX:EmployeesMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:ConsultantsMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:BottomOfRangeMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 ifrs-full:TopOfRangeMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:EmployeesMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:ConsultantsMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:BottomOfRangeMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 ifrs-full:TopOfRangeMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:EmployeesMember SMX:SecurityMattersLimitedMember 2020-01-01 2020-12-31 0001940674 SMX:ConsultantsMember SMX:SecurityMattersLimitedMember 2020-01-01 2020-12-31 0001940674 SMX:BoardMembersMember SMX:SecurityMattersLimitedMember 2020-01-01 2020-12-31 0001940674 ifrs-full:BottomOfRangeMember SMX:SecurityMattersLimitedMember 2020-01-01 2020-12-31 0001940674 ifrs-full:TopOfRangeMember SMX:SecurityMattersLimitedMember 2020-01-01 2020-12-31 0001940674 SMX:BoardMembersMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:BoardMembersMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:BoardMembersMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:BoardMembersMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:BlackScholesPricingModelMember ifrs-full:BottomOfRangeMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:BlackScholesPricingModelMember ifrs-full:TopOfRangeMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:BlackScholesPricingModelMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:TwoExecutiveDirectorMember SMX:SecurityMattersLimitedMember 2018-08-01 2018-08-31 0001940674 SMX:ExecutiveDirectorMember SMX:SecurityMattersLimitedMember 2021-08-01 2021-08-31 0001940674 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember SMX:SecurityMattersLimitedMember 2021-08-01 2021-08-31 0001940674 SMX:SecurityMattersLimitedMember 2021-08-01 2021-08-31 0001940674 SMX:SecurityMattersLimitedMember 2021-07-01 2021-07-31 0001940674 SMX:SecurityMattersLimitedMember 2021-07-31 0001940674 SMX:SecurityMattersLimitedMember 2022-07-01 2022-07-31 0001940674 ifrs-full:BottomOfRangeMember SMX:SecurityMattersLimitedMember 2022-06-01 2022-06-30 0001940674 ifrs-full:TopOfRangeMember SMX:SecurityMattersLimitedMember 2022-06-01 2022-06-30 0001940674 SMX:SecurityMattersLimitedMember 2022-07-31 0001940674 SMX:SecurityMattersLimitedMember 2022-06-01 2022-06-30 0001940674 SMX:SecurityMattersLimitedMember 2022-06-30 0001940674 2023-03-07 0001940674 2023-03-07 2023-03-07 0001940674 ifrs-full:WarrantsMember 2023-03-07 2023-03-07 0001940674 ifrs-full:WarrantsMember 2023-03-07 0001940674 ifrs-full:OrdinarySharesMember 2023-03-07 0001940674 SMX:PrivateWarrantsMember 2023-07-03 0001940674 SMX:PublicWarrantsMember 2023-03-07 0001940674 ifrs-full:WarrantsMember 2023-06-27 0001940674 SMX:OrdinarySharesTwoMember 2023-03-07 0001940674 SMX:OrdinarySharesTwoMember 2023-03-07 2023-03-07 0001940674 SMX:BridgeLoansMember 2023-03-07 0001940674 SMX:RedeemableWarrantsMember 2023-03-07 2023-03-07 0001940674 SMX:RedeemableWarrantsMember 2023-03-07 0001940674 SMX:YorkvilleMember 2023-05-31 0001940674 SMX:YorkvilleMember 2023-06-30 0001940674 SMX:YorkvilleMember 2023-05-01 2023-05-31 0001940674 SMX:YorkvilleMember 2023-06-01 2023-06-30 0001940674 2023-06-01 2023-06-30 0001940674 SMX:UnderwritingAgreementMember 2023-06-30 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantAMember 2023-06-30 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantBMember 2023-06-30 0001940674 SMX:IncentiveEquityPlanMember 2023-04-25 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-06-30 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember ifrs-full:BottomOfRangeMember 2023-01-01 2023-06-30 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember ifrs-full:TopOfRangeMember 2023-01-01 2023-06-30 0001940674 SMX:EmployeesMember 2023-01-01 2023-06-30 0001940674 ifrs-full:BottomOfRangeMember SMX:EmployeesMember 2023-06-30 0001940674 ifrs-full:TopOfRangeMember SMX:EmployeesMember 2023-06-30 0001940674 SMX:EmployeesMember 2023-06-30 0001940674 SMX:OptionsOutstandingOneMember ifrs-full:BottomOfRangeMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:OptionsOutstandingOneMember ifrs-full:TopOfRangeMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:OptionsOutstandingOneMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:OptionsOutstandingOneMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:OptionsOutstandingTwoMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:OptionsOutstandingTwoMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:OptionsOutstandingThreeMember ifrs-full:BottomOfRangeMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:OptionsOutstandingThreeMember ifrs-full:TopOfRangeMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:OptionsOutstandingThreeMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:OptionsOutstandingThreeMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:OptionsOutstandingFourMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:OptionsOutstandingFourMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:OptionsOutstandingFiveMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:OptionsOutstandingFiveMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:OptionsOutstandingOneMember ifrs-full:BottomOfRangeMember 2023-06-30 0001940674 SMX:OptionsOutstandingOneMember ifrs-full:TopOfRangeMember 2023-06-30 0001940674 SMX:OptionsOutstandingOneMember 2023-06-30 0001940674 SMX:OptionsOutstandingOneMember 2023-01-01 2023-06-30 0001940674 SMX:OptionsOutstandingTwoMember ifrs-full:BottomOfRangeMember 2023-06-30 0001940674 SMX:OptionsOutstandingTwoMember ifrs-full:TopOfRangeMember 2023-06-30 0001940674 SMX:OptionsOutstandingTwoMember 2023-06-30 0001940674 SMX:OptionsOutstandingTwoMember 2023-01-01 2023-06-30 0001940674 SMX:OptionsOutstandingThreeMember ifrs-full:BottomOfRangeMember 2023-06-30 0001940674 SMX:OptionsOutstandingThreeMember ifrs-full:TopOfRangeMember 2023-06-30 0001940674 SMX:OptionsOutstandingThreeMember 2023-06-30 0001940674 SMX:OptionsOutstandingThreeMember 2023-01-01 2023-06-30 0001940674 SMX:OptionsOutstandingFourMember 2023-06-30 0001940674 SMX:OptionsOutstandingFourMember 2023-01-01 2023-06-30 0001940674 SMX:OptionsOutstandingFiveMember 2023-06-30 0001940674 SMX:OptionsOutstandingFiveMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersLimitedMember SMX:ResearchAndDevelopmentExpensesMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ResearchAndDevelopmentExpensesMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ResearchAndDevelopmentExpensesMember 2020-01-01 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:GeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:GeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:GeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001940674 SMX:GeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001940674 SMX:GeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001940674 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:KeyManagementPersonnelOfEntityOrParentMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:DirectorsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:DirectorsMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:ShareholdersMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:ShareholdersMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:JointVenturesMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:JointVenturesMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:RelatedPartiesMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:RelatedPartiesMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:SecurityMattersLtdMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLtdMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersCanadaLtdMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersCanadaLtdMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersFranceLtdMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersFranceLtdMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:SMXBeveragesPtyLtdMember SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:SMXBeveragesPtyLtdMember SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember 2015-01-31 0001940674 SMX:NonadjustingEventMember SMX:SecurityMattersLimitedMember 2023-01-30 0001940674 SMX:NonadjustingEventMember SMX:SecurityMattersLimitedMember 2023-01-29 2023-01-30 0001940674 SMX:UnitedStatesDollarMember ifrs-full:CurrencyRiskMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:UnitedStatesDollarMember ifrs-full:CurrencyRiskMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:EURMember ifrs-full:CurrencyRiskMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:EURMember ifrs-full:CurrencyRiskMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:CurrencyRiskMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:CurrencyRiskMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:CreditRiskMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:CreditRiskMember 2021-12-31 0001940674 SMX:TradeAndOtherPayablesMember ifrs-full:NotLaterThanOneYearMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:TradeAndOtherPayablesMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:TradeAndOtherPayablesMember ifrs-full:LaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:BridgeLoansMember ifrs-full:NotLaterThanOneYearMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:BridgeLoansMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:BridgeLoansMember ifrs-full:LaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:GovernmentGrantsMember ifrs-full:NotLaterThanOneYearMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:GovernmentGrantsMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:GovernmentGrantsMember ifrs-full:LaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember ifrs-full:NotLaterThanOneYearMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:BorrowingMember ifrs-full:NotLaterThanOneYearMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:BorrowingMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:BorrowingMember ifrs-full:LaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:TradeAndOtherPayablesMember ifrs-full:NotLaterThanOneYearMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:TradeAndOtherPayablesMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:TradeAndOtherPayablesMember ifrs-full:LaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember ifrs-full:NotLaterThanOneYearMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:BorrowingMember ifrs-full:NotLaterThanOneYearMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:BorrowingMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:LaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:NotLaterThanOneYearMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:BorrowingMember ifrs-full:LaterThanFiveYearsMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:DerivativesMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:DerivativesMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:DerivativesMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:DerivativesMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:Level1OfFairValueHierarchyMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:Level2OfFairValueHierarchyMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:Level3OfFairValueHierarchyMember SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 ifrs-full:Level1OfFairValueHierarchyMember ifrs-full:DerivativesMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:Level2OfFairValueHierarchyMember ifrs-full:DerivativesMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:Level3OfFairValueHierarchyMember ifrs-full:DerivativesMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:DerivativesMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:Level1OfFairValueHierarchyMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:Level2OfFairValueHierarchyMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 ifrs-full:Level3OfFairValueHierarchyMember SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:NonadjustingEventMember SMX:ConvertibleNotesMember SMX:SecurityMattersLimitedMember 2023-01-25 0001940674 SMX:NonadjustingEventMember SMX:ConvertibleNotesMember SMX:SecurityMattersLimitedMember 2023-01-24 2023-01-25 0001940674 SMX:NonadjustingEventMember SMX:IsoradLtdMember SMX:SecurityMattersLimitedMember 2023-01-31 0001940674 SMX:NonadjustingEventMember SMX:BlackScholesPricingModelMember SMX:IsoradLtdMember SMX:SecurityMattersLimitedMember 2023-01-01 2023-01-31 0001940674 SMX:NonadjustingEventMember SMX:IsoradLtdMember SMX:SecurityMattersLimitedMember 2023-01-01 2023-01-31 0001940674 SMX:NonadjustingEventMember SMX:SMXPublicLimitedCompanyMember SMX:SecurityMattersLimitedMember 2023-02-28 0001940674 SMX:NonadjustingEventMember SMX:SMXPublicLimitedCompanyMember SMX:SecurityMattersLimitedMember 2023-02-01 2023-02-28 0001940674 SMX:NonadjustingEventMember SMX:SMXPublicLimitedCompanyMember ifrs-full:BottomOfRangeMember SMX:SecurityMattersLimitedMember 2023-02-01 2023-02-28 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember SMX:SecurityMattersLimitedMember 2023-01-01 2023-12-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember SMX:SecurityMattersLimitedMember 2023-12-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember SMX:ConvertibleNotesMember SMX:SecurityMattersLimitedMember 2023-03-01 2023-03-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember SMX:ConvertibleNotesMember SMX:SecurityMattersLimitedMember 2023-03-06 2023-03-07 0001940674 SMX:NonadjustingEventMember 2023-02-28 0001940674 SMX:NonadjustingEventMember 2023-02-01 2023-02-28 0001940674 SMX:NonadjustingEventMember ifrs-full:BottomOfRangeMember 2023-02-01 2023-02-28 0001940674 SMX:NonadjustingEventMember SMX:ConvertibleNotesMember 2023-01-25 0001940674 SMX:NonadjustingEventMember SMX:ConvertibleNotesMember 2023-01-24 2023-01-25 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember SMX:ElevenLendersMember 2022-08-01 2023-01-31 0001940674 SMX:NonadjustingEventMember ifrs-full:TopOfRangeMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-01-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember SMX:BonusWarrantsMember 2022-08-01 2023-01-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsMember 2022-08-01 2023-01-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsMember 2023-01-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember SMX:ConvertibleNotesMember 2023-03-01 2023-03-31 0001940674 SMX:NonadjustingEventMember 2023-04-25 2023-04-25 0001940674 SMX:NonadjustingEventMember 2023-04-25 0001940674 SMX:NonadjustingEventMember 2023-07-27 0001940674 SMX:NonadjustingEventMember 2023-07-27 2023-07-27 0001940674 SMX:NonadjustingEventMember SMX:PrePaidAdvanceAgreementMember 2023-07-27 0001940674 SMX:NonadjustingEventMember SMX:PrePaidAdvanceAgreementMember 2023-07-27 2023-07-27 0001940674 SMX:NonadjustingEventMember SMX:PrePaidAdvanceAgreementMember 2023-09-30 2023-09-30 0001940674 SMX:NonadjustingEventMember SMX:SecuritiesPurchaseAgreementMember 2023-09-06 2023-09-06 0001940674 SMX:NonadjustingEventMember SMX:SecuritiesPurchaseAgreementMember 2023-09-06 0001940674 SMX:NonadjustingEventMember SMX:BenchmarkInvestmentsLLCMember 2023-09-15 2023-09-15 0001940674 SMX:NonadjustingEventMember SMX:BenchmarkInvestmentsLLCMember 2023-09-15 0001940674 SMX:NonadjustingEventMember SMX:LoanAgreementMember 2023-09-19 0001940674 SMX:NonadjustingEventMember SMX:LoanAgreementsMember 2023-09-19 0001940674 SMX:TrueGoldConsortiumPtyLtdMember SMX:NonadjustingEventMember 2023-10-03 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-06-30 0001940674 SMX:TrueGoldConsortiumPtyLtdMember ifrs-full:BottomOfRangeMember 2021-10-01 2021-10-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember ifrs-full:TopOfRangeMember 2021-10-01 2021-10-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2021-10-01 2021-10-31 0001940674 SMX:SecurityMattersPTYLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersPTYLtdMember 2022-01-01 2022-12-31 0001940674 SMX:LionheartIIICorpMember 2023-01-01 2023-06-30 0001940674 SMX:LionheartIIICorpMember 2022-01-01 2022-12-31 0001940674 SMX:SMXCircularEconomyPlatformPTELtdMember 2023-01-01 2023-06-30 0001940674 SMX:SMXCircularEconomyPlatformPTELtdMember 2022-01-01 2022-12-31 0001940674 SMX:SMXIrelandLimitedMember 2023-01-01 2023-06-30 0001940674 SMX:SMXIrelandLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:SMXIsraelLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SMXIsraelLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersCanadaLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersCanadaLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersFranceLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersFranceLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SMXBeveragesPtyLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SMXBeveragesPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:YahalomaTechnologiesIncMember 2023-01-01 2023-06-30 0001940674 SMX:YahalomaTechnologiesIncMember 2022-01-01 2022-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-01-01 2023-06-30 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-02-28 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-02-01 2023-02-28 0001940674 SMX:StandbyEquityPurchaseAgreementMember SMX:FirstInstallmentMember 2023-02-28 0001940674 SMX:StandbyEquityPurchaseAgreementMember SMX:SecondInstallmentMember 2023-02-28 0001940674 2023-07-27 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-07-27 2023-07-27 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-07-01 2023-07-31 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-07-31 0001940674 SMX:UnderwritingAgreementMember SMX:EFHuttonLLCMember ifrs-full:OrdinarySharesMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantAMember SMX:EFHuttonLLCMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantBMember SMX:EFHuttonLLCMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantAMember ifrs-full:OrdinarySharesMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:PublicOfferingMember 2023-06-22 2023-06-22 0001940674 SMX:UnderwritingAgreementMember ifrs-full:OrdinarySharesMember SMX:PublicOfferingMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:PrefundedWarrantMember SMX:PublicOfferingMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantAMember SMX:PublicOfferingMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantBMember SMX:PublicOfferingMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember 2023-06-22 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantAMember 2023-06-22 2023-06-22 0001940674 SMX:UnderwritingAgreementMember ifrs-full:OrdinarySharesMember 2023-06-22 0001940674 SMX:WarrantBMember 2023-06-30 0001940674 ifrs-full:WarrantsMember 2023-01-01 2023-06-30 0001940674 SMX:UnderwriterWarrantMember 2023-06-30 0001940674 SMX:UnderwriterWarrantMember 2023-01-01 2023-06-30 0001940674 2023-01-31 0001940674 2023-01-01 2023-01-31 0001940674 ifrs-full:TechnologybasedIntangibleAssetsMember 2023-01-31 0001940674 ifrs-full:OrdinarySharesMember 2023-06-30 0001940674 ifrs-full:PreferenceSharesMember 2023-06-30 0001940674 ifrs-full:OrdinarySharesMember 2022-12-31 0001940674 ifrs-full:PreferenceSharesMember 2022-12-31 0001940674 SMX:DeferredSharesMember 2023-06-30 0001940674 SMX:DeferredSharesMember 2022-12-31 0001940674 ifrs-full:RestrictedShareUnitsMember SMX:EmployeesDirectorsAndServiceMember 2022-12-31 0001940674 ifrs-full:RestrictedShareUnitsMember SMX:EmployeesDirectorsAndServiceMember 2021-12-31 0001940674 ifrs-full:RestrictedShareUnitsMember SMX:EmployeesDirectorsAndServiceMember 2022-01-01 2022-06-30 0001940674 ifrs-full:RestrictedShareUnitsMember SMX:EmployeesDirectorsAndServiceMember 2023-06-30 0001940674 ifrs-full:RestrictedShareUnitsMember SMX:EmployeesDirectorsAndServiceMember 2022-06-30 0001940674 ifrs-full:OrdinarySharesMember 2023-01-01 2023-06-30 0001940674 ifrs-full:OrdinarySharesMember 2022-01-01 2022-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure SMX:Integer iso4217:AUD iso4217:ILS iso4217:AUD xbrli:shares iso4217:EUR iso4217:EUR xbrli:shares

 

As filed with the Securities and Exchange Commission on February 28, 2024

 

Registration Statement No. 333-

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM F-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

SMX (Security Matters) Public Limited Company

(Exact name of registrant as specified in its charter)

 

Ireland   3590   N/A

(State or other jurisdiction of

incorporation or organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification Number)

 

+353-1-920-1000

Mespil Business Centre, Mespil House, Sussex Road, Dublin 4, Ireland

(Address and telephone number of registrant’s principal executive offices)

 

Puglisi & Associates

850 Library Avenue, Suite 204

Newark, DE 19711

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to:

 

Stephen E. Fox, Esq.

Samantha Guido, Esq.

Ruskin Moscou Faltischek P.C.

1425 RXR Plaza

East Tower, 15th Floor

Uniondale, NY 11556

Tel: (516) 663-6580

 

Doron Afik Adv.

Afik & Co.

103 Hahashmonaim Street

Tel Aviv, Israel 6120101

Tel: +972.3.6093609

 

Connor Manning

Arthur Cox

Ten Earlsfort Terrace

Dublin 2

D02 T380

 

Approximate date of commencement of proposed sale to the public: From time to time after the date this registration statement becomes effective.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: ☒

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

 

Emerging growth company

 

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities Act. 

 

The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

 

The Registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

 

 

 

 
 

 

The information in this prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

 

Subject to Completion dated February 28, 2024

 

Preliminary Prospectus

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

 

Issuance of up to 4,000,000 Ordinary Shares

 

This prospectus relates to the resale, from time to time of up to 4,000,000 ordinary shares of the Company, $0.0022 par value per share, by YA II PN, LTD, a Cayman Islands exempt limited partnership (“Yorkville”). The ordinary shares included in this prospectus consist of ordinary shares that we may, in our discretion, elect to issue and sell to Yorkville, from time to time after the date of this prospectus, pursuant to a Reciprocal Standby Equity Purchase Agreement we entered into with Yorkville on February 23, 2023 and became effective on March 7, 2023, as amended (the “SEPA”), in which Yorkville has committed to purchase from us up to $25,000,000 of our ordinary shares, subject to the terms and conditions specified in the SEPA. As of the date of this prospectus, we have not issued any ordinary shares to Yorkville pursuant to an Advance (as defined below), although we have borrowed an aggregate of $3.5 million from Yorkville under the SEPA evidenced by promissory notes, of which approximately $3.0 million principal amount of such promissory notes have been repaid either in cash or as a result of conversions in accordance with the terms of the promissory notes. See the section entitled, “Committed Equity Financing” for a description of the SEPA and the section entitled, “Selling Shareholder” for additional information regarding Yorkville.

 

Subject to the terms and conditions of the SEPA, we have the right from time to time at our discretion until April 1, 2026 (or earlier in the event Yorkville shall have made payment of $25 million in Advances), to direct Yorkville to purchase a specified amount of our ordinary shares (each such sale, an “Advance”) by delivering written notice to Yorkville (each, an “Advance Notice”). While there is no mandatory minimum amount for any Advance, it may not exceed the lesser of (i) an amount equal to 100% of the average of the daily traded amount (as defined in the SEPA) during the five consecutive trading days immediately preceding an Advance Notice, or (ii) 1 million ordinary shares. The Ordinary Shares will be purchased at a price equal to (i) 96% of the daily volume weighted average price (“VWAP”) of our ordinary shares during the period commencing upon receipt by us of written confirmation of acceptance of the Advance Notice by Yorkville, and ending on 4:00 p.m. New York City time on the applicable Advance Notice date, subject to a volume threshold as described in the SEPA or (ii) 97% of the lowest daily VWAP of the ordinary shares during the three consecutive trading days commencing on the Advance Notice Date; provided, however, that with respect to any clause (ii) Advance, we may establish a minimum acceptable price in each Advance Notice below which we will not be obligated to make any sales to Yorkville.

 

We will control the timing and amount of any sales of ordinary shares to Yorkville, except with respect to conversions of the Pre-Paid Advances. Actual sales of our ordinary shares to Yorkville as an Advance under the SEPA will depend on a variety of factors to be determined by us from time to time, which may include, among other things, market conditions, the trading price of our ordinary shares and determinations by us as to the appropriate sources of funding for our business and operations. In addition, at any time during the term of the SEPA, provided that there is a balance remaining outstanding under any of the promissory notes referred to above, Yorkville may cause an Advance Notice to be deemed delivered to us and the issuance and sale of our ordinary shares to Yorkville pursuant to an Advance, in accordance with the terms and subject to the limitations set forth in the SEPA.

 

Our registration of the securities covered by this prospectus does not mean that Yorkville will offer or sell any of the ordinary shares. Yorkville may offer, sell or distribute all or a portion of their ordinary shares publicly or through private transactions at prevailing market prices or at negotiated prices. We will not receive any proceeds from the sale of ordinary shares by Yorkville pursuant to this prospectus. However, we may receive up to $25,000,000 in aggregate gross proceeds from sales of our ordinary shares to Yorkville that we may, in our discretion, elect to make, from time to time after the date of this prospectus, pursuant to the SEPA. We provide more information about how Yorkville may sell or otherwise dispose of our ordinary shares in the section entitled, “Plan of Distribution.” Yorkville is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended.

 

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. This prospectus complies with the requirements that apply to an issuer that is an emerging growth company.

 

We are a “foreign private issuer” as defined under applicable Securities and Exchange Commission (“SEC”) rules and an “emerging growth company” as that term is defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) and are eligible for reduced public company disclosure requirements.

 

Our Ordinary Shares are listed on The Nasdaq Capital Market (“Nasdaq”) under the symbol “SMX” and our public warrants are listed on The Nasdaq Capital Market under the symbol “SMXWW”. On February 26, 2024, the closing price of our Ordinary Shares was $0.2659.

 

You should read this prospectus and any prospectus supplement or amendment carefully before you invest in our securities. Investing in the Company’s securities involves risks. See “Risk Factorsbeginning on page 19 of this prospectus.

 

Neither the SEC nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

 

Prospectus dated               , 2024

 

 
 

 

TABLE OF CONTENTS

 

ABOUT THE PROSPECTUS 1
IMPORTANT INFORMATION ABOUT IFRS AND NON-IFRS FINANCIAL MEASURES 1
INDUSTRY AND MARKET DATA 2
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS 2
PROSPECTUS SUMMARY 4
THE OFFERING 17
RISK FACTORS 19
COMMITTED EQUITY FINANCING 42
USE OF PROCEEDS 47
DIVIDEND POLICY 47
BUSINESS 48
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 69
BOARD OF DIRECTORS AND EXECUTIVE MANAGEMENT 81
DESCRIPTION OF SECURITIES 90
CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 105
BENEFICIAL OWNERSHIP OF SECURITIES 108
SELLING STOCKHOLDERS 110
CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS 111
CERTAIN MATERIAL IRISH TAX CONSIDERATIONS TO NON-IRISH HOLDERS 118
PLAN OF DISTRIBUTION 123
EXPENSES RELATED TO THE OFFERING 125
SERVICE OF PROCESS AND ENFORCEMENT OF CIVIL LIABILITIES UNDER U.S. SECURITIES LAWS 125
LEGAL MATTERS 125
EXPERTS 125
WHERE YOU CAN FIND MORE INFORMATION 125
INDEX TO FINANCIAL STATEMENTS F-1

 

i

 

 

ABOUT THE PROSPECTUS

 

You should rely only on the information contained in this prospectus, any amendment or supplement to this prospectus or any free writing prospectus prepared by us or on our behalf. Any amendment or supplement may also add, update or change information included in this prospectus. Any statement contained in this prospectus will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in such amendment or supplement modifies or supersedes such statement. Any statement so modified will be deemed to constitute a part of this prospectus only as so modified, and any statement so superseded will be deemed not to constitute a part of this prospectus. See “Where You Can Find More Information.”

 

Neither we nor Yorkville have authorized any other person to provide you with different or additional information. Neither we nor Yorkville take responsibility for, nor can we provide assurance as to the reliability of, any other information that others may provide. The information contained in this prospectus is accurate only as of the date of this prospectus or such other date stated in this prospectus, and our business, financial condition, results of operations and/or prospects may have changed since those dates. This prospectus contains summaries of certain provisions contained in some of the documents described in this prospectus, but reference is made to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to in this prospectus have been filed, will be filed, or will be incorporated by reference as exhibits to the registration statement of which this prospectus is a part, any you may obtain copies of those documents as described under “Where You Can Find More Information.”

 

Neither we nor Yorkville are making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. Except as otherwise set forth in this prospectus, neither we nor Yorkville have taken any action to permit a public offering of these securities outside the United States or to permit the possession or distribution of this prospectus outside the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about and observe any restrictions relating to the offering of these securities and the distribution of this prospectus outside the United States.

 

This prospectus contains references to our trademarks and to trademarks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this prospectus, including logos, artwork and other visual displays may appear without the ® or symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend our use or display of other companies’ trade name or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.

 

Certain amounts that appear in this prospectus may not sum due to rounding.

 

IMPORTANT INFORMATION ABOUT IFRS AND NON-IFRS FINANCIAL MEASURES

 

SMX (Security Matters) Public Limited Company’s (“Company”) financial statements are prepared in accordance with international financing reporting standards, as adopted by the International Accounting Standards Board (“IFRS”). Security Matter PTY’s historical consolidated financial statements are prepared in accordance with IFRS. Security Matters PTY (formerly, Security Matters Limited, an Australian public company with Australian Company Number (ACN) 626 192 998 listed on the Australian Stock Exchange through March 7, 2023) is currently a private, wholly-owned subsidiary of the Company, whose name was changed to Security Matters PTY Ltd. in June 2023 (“Security Matters PTY”).

 

Certain of the measures included in this prospectus may be considered non-IFRS financial measures. Non-IFRS financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with IFRS, and non-IFRS financial measures as used by Security Matters PTY may not be comparable to similarly titled amounts used by other companies.

 

1
 

 

INDUSTRY AND MARKET DATA

 

Unless otherwise indicated, information contained in this prospectus concerning our industry and the regions in which we operate, including our general expectations and market position, market opportunity, market share and other management estimates, is based on information obtained from various independent publicly available sources and other industry publications, surveys and forecasts, which we believe to be reliable based upon our management’s knowledge of the industry. We have not independently verified the accuracy and completeness of such third-party information to the extent included in this prospectus. Such assumptions and estimates of our future performance and growth objectives and the future performance of our industry and the markets in which we operate are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those discussed under the headings “Risk Factors,” “Cautionary Statement Regarding Forward-Looking Statements and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this prospectus.

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

Certain statements in this prospectus may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this prospectus may include, for example, statements about:

 

the benefits of the transactions contemplated by the Business Combination Agreement, dated as of July 26, 2022, by and among the Company, Security Matters PTY, Lionheart III Corp., a Delaware corporation (“Lionheart”) and Aryeh Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”) (the “BCA”) and the scheme implementation deed, dated as of July 26, 2022, by and among the Company, Security Matters PTY, Lionheart and Merger Sub (“SID”) (collectively, the “Business Combination”);
   
the Company’s financial performance following the Business Combination;
   
the ability to maintain the listing of the Ordinary Shares on Nasdaq;
   
changes in the Company’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans;
   
the Company’s ability to develop and launch new products and services;
   
the Company’s ability to successfully and efficiently integrate future expansion plans and opportunities;
   
the Company’s ability to grow its business in a cost-effective manner;
   
the Company’s product development timeline and estimated research and development costs;

 

2
 

 

the implementation, market acceptance and success of the Company’s business model;
   
developments and projections relating to the Company’s competitors and industry;
   
the Company’s approach and goals with respect to technology;
   
the Company’s expectations regarding its ability to obtain and maintain intellectual property protection and not infringe on the rights of others;
   
the impact of war, terror threats, the COVID-19 pandemic or other adverse public health developments on the Company’s business;
   
changes in applicable laws or regulations; and
   
the outcome of any known and unknown litigation and regulatory proceedings.

 

These forward-looking statements are based on information available as of the date of this prospectus, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

 

As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include:

 

the outcome of any legal proceedings that may be instituted against the Company;
   
the ability to maintain the listing of the Ordinary Shares on Nasdaq;
   
changes in applicable laws or regulations;
   
the lingering effects of the COVID-19 pandemic on the Company’s business;
   
the ability to implement business plans, forecasts, and other expectations after the completion of the proposed transaction, and identify and realize additional opportunities;
   
the risk of downturns and the possibility of rapid change in the highly competitive industry in which the Company operates;
   
the risk that the Company and its current and future collaborators are unable to successfully develop and commercialize its products or services, or experience significant delays in doing so;
   
the risk that the Company may never achieve or sustain profitability;
   
the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all;
   
the risk that the Company experiences difficulties in managing its growth and expanding operations;
   
the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations;
   
the risk that the Company is unable to secure or protect its intellectual property;
   
the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; and
   
other risks and uncertainties described in this prospectus, including those under the section entitled “Risk Factors.”

 

3
 

 

PROSPECTUS SUMMARY

 

This summary highlights selected information contained elsewhere, or incorporated by reference, in this prospectus. This summary does not contain all the information that you should consider before investing in our securities. Before making an investment decision, you should read this entire prospectus carefully, especially “Risk Factors” and the financial statements and related notes thereto, and the other documents to which this prospectus refers. Some of the statements in this prospectus constitute forward-looking statements that involve risks and uncertainties. See “Cautionary Statement Regarding Forward-Looking Statements” for more information.

 

Our Company

 

We envision our self as the next generation solution provider of brand protection, authentication and track and trace technology for the anti-counterfeit market. Our vision is to build confidence in the era of the digital economy, enabling parties to maintain trust in physical assets and processes. Our transformative solution aims at building on the principles of The United Nations’ Sustainability Development Goals, particularly Goal 12: “Ensure sustainable consumption and production patterns” that can create value for participants in the circular economy. As an increasing number of industries and sectors are committing to using recycled material and realizing the broader strategic vision of net zero carbon emissions, we believe our solution is the next generation for sustainability and the circular economy.

 

For more information about the Company, see the sections entitled “Business” and “Management’s Discussion and Analysis of Financial Condition and Results of Operation.”

 

Business Combination

 

On March 7, 2023 (the “Closing Date”), the Company consummated its previously announced business combination pursuant to the BCA and its previously announced SID.

 

Beginning on the day immediately prior to the Closing Date and finishing on the day immediately after the Closing Date, the following transactions occurred pursuant to the terms of the BCA:

 

Under the SID, Security Matters PTY proposed a scheme of arrangement under Part 5.1 of the Corporations Act 2001 (Cth) (“Corporations Act”) (“Scheme”) and the equal reduction of capital under section 256B of the Corporations Act pursuant to which all ordinary shares of Security Matters PTY were cancelled in accordance with the terms of the resolution of the shareholders of Security Matters PTY whereby the shareholders approved the capital reduction (“Capital Reduction”) which resulted in all shares in Security Matters PTY being cancelled in return for the issuance of ordinary shares of the Company, with the Company being issued one share in Security Matters PTY (this resulted in Security Matters PTY becoming a wholly owned subsidiary of the Company);

 

4
 

 

Under the SID, Security Matters PTY proposed an option scheme of arrangement under Part 5.1 of the Corporations Act (“Option Scheme”), which resulted in the Security Matters PTY options held by participants in the Option Scheme being subject to a cashless exercise based on a Black-Scholes valuation, in exchange for SMX Shares. Under the Scheme those shares were cancelled and the participants received Ordinary Shares on the basis of the Scheme consideration;
   
Security Matters PTY shareholders received consideration under the Scheme of one Ordinary Share per 10.3624 Security Matters Shares having an implied value of $10.00 per Ordinary Share and the Company became the holder of all of the issued shares in Security Matters PTY and Lionheart, with Security Matters PTY being delisted from the Australian Stock Exchange;
   
Merger Sub merged with and into Lionheart, with Lionheart surviving the merger as a wholly owned subsidiary of the Company; and
   
Existing Lionheart stockholders received Ordinary Shares in exchange for their existing Lionheart shares and existing Lionheart warrant holders had their warrants automatically adjusted to become exercisable in respect of Ordinary Shares instead of Lionheart shares.

 

Committed Equity Financing

 

On February 23, 2023, we entered into the Reciprocal Standby Equity Purchase Agreement which became effective on March 7, 2023 (“SEPA”) with Yorkville pursuant to which we have the right to sell to Yorkville up to $25,000,000 of our Ordinary Shares, subject to certain limitations and conditions set forth in the SEPA, from time to time during the term of the SEPA. All references to sales of our Ordinary Shares by us to Yorkville in this section relate to Yorkville subscribing, on the terms described in this section, for newly issued Ordinary Shares in the Company and all references to “sales” or “sell” shall be construed accordingly. Sales of Ordinary Shares to Yorkville under the SEPA, and the timing of any such sales, are at our option, and we are under no obligation to sell any securities to Yorkville under the SEPA. In accordance with our obligations under the SEPA, we have filed:

 

A Registration Statement on Form F-1 (Registration No. 333-272503), as supplemented, which registered under the Securities Act the resale by Yorkville of up to 4,516,464 Ordinary Shares that were issued and sold to Yorkville, under the SEPA (the “Initial Yorkville Registration Statement”);
A Registration Statement on Form F-1 (Registration No. 333-274378), as supplemented, which registered under the Securities Act the resale by Yorkville of up to 1,406,853 Ordinary Shares that were issued and sold to Yorkville, under the SEPA (the “Second Yorkville Registration Statement”);
A Registration Statement on Form F-1 (Registration No. 333-276258), as supplemented, which registered under the Securities Act the resale by Yorkville of up to 1,400,000 Ordinary Shares that were issued and sold to Yorkville, under the SEPA (the “Third Yorkville Registration Statement”); and
The registration statement that includes this prospectus with the SEC to register under the Securities Act the resale by Yorkville of up to an additional 4,000,000 Ordinary Shares that we may elect, in our sole discretion, to issue and sell to Yorkville, under the SEPA.

 

Upon the satisfaction of the conditions to Yorkville’s purchase obligation set forth in the SEPA, including that the registration statement of which this prospectus forms a part be declared effective by the SEC and the final form of this prospectus is filed with the SEC, we will have the right, but not the obligation, from time to time at our discretion until the first day of the month following the 36-month period after the date of the SEPA, to direct Yorkville to purchase a specified amount of Ordinary Shares (each such sale, an “Advance”) by delivering written notice to Yorkville (each, an “Advance Notice”). While there is no mandatory minimum amount for any Advance, it may not exceed the lesser of (i) an amount equal to one hundred percent (100%) of the average of the Daily Traded Amount during the five consecutive trading days immediately preceding an Advance Notice, or (ii) 1 million Common Shares.

 

5
 

 

The Ordinary Shares purchased pursuant to an Advance will be purchased at a price equal to (i) 96% of the VWAP of the Ordinary Shares during the period commencing upon receipt by the Company of written confirmation of acceptance of such Advance Notice by the Investor, and which confirmation shall specify such commencement time, and ending on 4:00 p.m. New York City time on the applicable Advance Notice Date, subject to a 30% volume threshold as described in the SEPA or (ii) 97% of the lowest daily VWAP of the Ordinary Shares during the three consecutive trading days commencing on the Advance Notice Date; provided, however, that with respect to any clause (ii) Advance the Company may establish a minimum acceptable price in each Advance Notice below which the Company will not be obligated to make any sales to the Investor. Other than such minimum acceptable price in a clause (ii) Advance, there is no pricing floor with respect to the Advances. “VWAP” means, for any trading day, the daily volume weighted average price of the Ordinary Shares for such trading day on the Nasdaq Stock Market during regular trading hours as reported by Bloomberg L.P.

 

Accordingly, as may otherwise be limited by Yorkville’s 4.99% beneficial ownership limitation and by the 30% volume threshold described below and in the SEPA, assuming we elect option (i) above (i.e., 96% of VWAP) for all Advances and there are no fluctuations in our Ordinary Shares’ trading price, assuming a stock price of $0.2659 (the closing price on February 26, 2024), we would receive gross proceeds per share of approximately $0.2553 per share, or approximately $1,021,200 if all of the Ordinary Shares registered pursuant to the Registration Statement on Form F-1 of which this prospectus forms a part, are sold. In such event, Yorkville would receive a profit of approximately $0.0106 per share, or approximately $42,400, if it sold all of such shares at the closing price of $0.2659 per share.

 

Similarly, as may otherwise be limited by Yorkville’s 4.99% beneficial ownership limitation and by the “minimum acceptable price” we may indicate with respect to each Advance, assuming we elect option (ii) above (i.e., 97% of average VWAP) for all Advances and there are no fluctuations in our Ordinary Shares’ trading price, assuming a stock price of $0.2659 (the closing price on February 26, 2024), we would receive gross proceeds per share of approximately $0.2579 per share, or approximately $1,031,600 if all of the Ordinary Shares registered pursuant to the Registration Statement on Form F-1 of which this prospectus forms a part, are sold. In such event, Yorkville would receive a profit of approximately $0.008 per share, or approximately $32,000, if it sold all of such shares at the closing price of $0.2659 per share.

 

In connection with the SEPA, and subject to the condition set forth therein, Yorkville advanced to the Company in the form of convertible promissory notes in an aggregate principal amount of $3.5 million (the “Pre-Paid Advance”). The Pre-Paid Advance was disbursed in two separate installments, the first for $1.5 million at the closing of the Business Combination, which was funded on March 9, 2023 and the second, as subsequently amended, for $2 million upon the effectiveness of the Initial Yorkville Registration Statement. The purchase price for the Pre-Paid Advance is 92.0% of the Pre-Paid Advance. Such Pre-Paid Advances will be offset upon the issuance of Ordinary Shares to Yorkville at a price per share equal to the lower of (a) 100% of the daily VWAP of the Ordinary Shares on The Nasdaq Stock Market as of the trading day immediately prior to the date of the disbursement of the Pre-Paid Advance (the “Fixed Price”) (in the case of the first Pre-Paid Advance, $3.65), or (b) 93.0% of the lowest daily VWAP of the Ordinary Shares on Nasdaq during the seven trading days immediately prior to each purchase (the “Variable Price” and the lower of the Fixed Price and the Variable Price shall be referred to as the “Purchase Price”); however, in no event shall the Purchase Price be less than $1.10 (the “Floor Price”). On July 27, 2023, we amended the promissory note evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (as adjusted for reverse stock split which occurred on August 21, 2023), after we were required to repay in cash $500,000 of principal as a result of our stock price being below the original Floor Price as discussed further below. For example, with a Floor Price of $1.10 per share, the remaining outstanding Pre-Paid Advance of $470,334 are converted in full at such price may be converted into a maximum of over 427,576 shares, although that amount will be limited by the limitations set forth in the SEPA, such as the 4.99% beneficial ownership limitation and, accordingly, it is unlikely that the Company will be required to issue all such shares, even assuming all of such shares are registered by the Company for resale. Interest shall accrue on the outstanding balance of any Pre-Paid Advance at an annual rate equal to 0%, subject to an increase to 15% upon an event of default as described in the applicable promissory note. The maturity date will be 12-months after the initial closing of the Pre-Paid Advance. In July 2023, we repaid in full the first Pre-Paid Advance in the amount of $1.5 million, through a combination of cash and issuance of our Ordinary Shares upon conversion of the convertible note evidencing such first Pre-Paid Advance in accordance with its terms. Accordingly, as of the date of this prospectus, we have outstanding Pre-Paid Advances of $470,334 which are subject to conversion or repayment.

 

6
 

 

If, any time after a Pre-Paid Advance is issued, the daily VWAP is less than the Floor Price for five Trading Days during a period of 7 consecutive Trading Days (a “Floor Price Trigger”), or (ii) the Company has issued in excess of 95% of the Ordinary Shares available under the Exchange Cap (an “Exchange Cap Trigger”) (the last such day of each such occurrence, a “Trigger Date”) (a “Trigger Event”), the Company shall make monthly payments beginning on the 10th trading day after the Trigger Date and continuing on the same day of each successive calendar month, unless waived by Yorkville in its sole discretion. Each monthly payment shall be in an amount equal to the sum of (i) $500,000 of Principal in the aggregate among all promissory notes issued to the Investor (or the outstanding principal if less than such amount) (the “Triggered Principal Amount”), plus (ii) a payment premium of 7% in respect of such Triggered Principal Amount, and (iii) accrued and unpaid interest hereunder as of each payment date. The obligation of the Company to make monthly prepayments shall cease (with respect to any payment that has not yet come due) if any time after the Trigger Date (A) the daily VWAP is greater than the 110% of the Floor Price a period of five consecutive Trading Days in the event of a Floor Price Trigger, or (B) the date the Company has obtained stockholder approval to increase the number of Common Stock under the Exchange Cap and/or the Exchange Cap no longer applies, in the event of an Exchange Cap Trigger, unless a subsequent Trigger Event occurs. As stated above, in July 2023, the Floor Price Trigger was tripped and we paid one month of the Triggered Principal Amount plus the 7% payment premium. We amended the Floor Price to decrease it from $0.20506 to $1.10 (after adjustment) to conserve our cash resources and cease such Floor Price Trigger.

 

Based on the 18,186,028 Ordinary Shares issued and outstanding as of the date of February 26, 2024, and assuming no sale of any Ordinary Shares purchased by Yorkville pursuant to one or more Advances, Yorkville would be able to purchase an aggregate of 907,482 Ordinary Shares before it is limited by the 4.99% beneficial ownership limitation set forth in the SEPA. Any subsequent sales of our Ordinary Shares by Yorkville would reduce the number of Ordinary Shares owned by it and permit it to purchase more Ordinary Shares pursuant to Advances without hitting any of the ownership limitations to the extent of such reductions. Additionally, any decrease in our stock price would result in more of our Ordinary Shares being sold to Yorkville for the same amount of proceeds, and any of the ownership or registration limitations described in this section could prevent us from raising a portion of the capital available under the SEPA.

 

We will control the timing and amount of any sales of Ordinary Shares to Yorkville, except with respect to conversions of the Pre-Paid Advances. Actual sales of our Ordinary Shares to Yorkville as an Advance under the SEPA will depend on a variety of factors to be determined by us from time to time, which may include, among other things, market conditions, the trading price of our Ordinary Shares and determinations by us as to the appropriate sources of funding for our business and operations.

 

In addition, at any time during the term of the SEPA, provided that there is a balance remaining outstanding under a promissory note evidencing a Pre-Paid Advance (as described above, and further below under “Committed Equity Financing-Advances of Ordinary Shares Under the SEPA-Pre-Paid Advance”), Yorkville may cause an Advance Notice to be deemed delivered to the Company and the issuance and sale of the Company’s ordinary shares to Yorkville pursuant to an Advance, in accordance with the terms and subject to the limitations set forth in the SEPA.

 

The net proceeds under the SEPA to us will depend on the frequency and prices at which we sell Ordinary Shares to Yorkville. We expect that any proceeds received by us from such sales to Yorkville will be used for working capital and general corporate purposes.

 

While Yorkville may experience a positive rate of return based on the current trading price of our Ordinary Shares, our public securityholders may not experience a similar rate of return on the ordinary shares they purchased due to differences in the purchase prices and the then-current trading price at the time of any sale.

 

Yorkville has agreed that it and its affiliates will not engage in any short sales of the Ordinary Shares nor enter into any transaction that establishes a net short position in the Ordinary Shares during the term of the SEPA.

 

The SEPA will automatically terminate on the earliest to occur of (i) the first day of the month next following the 36-month anniversary of the date of the SEPA or (ii) the date on which Yorkville shall have made payment of Advances pursuant to the SEPA for Ordinary Shares equal to $25,000,000. We have the right to terminate the SEPA at no cost or penalty upon five (5) trading days’ prior written notice to Yorkville, provided that there are no outstanding Advance Notices for which Ordinary Shares need to be issued and SMX has paid all amounts owed to Yorkville pursuant to the SEPA. We and Yorkville may also agree to terminate the SEPA by mutual written consent. Neither we nor Yorkville may assign or transfer our respective rights and obligations under the SEPA, and no provision of the SEPA may be modified or waived by us or Yorkville other than by an instrument in writing signed by both parties.

 

7
 

 

As consideration for Yorkville’s commitment to purchase Ordinary Shares at our direction upon the terms and subject to the conditions set forth in the SEPA, we paid Yorkville, (i) a due diligence fee in the amount of $15,000 and (ii) a commitment fee equal to 92,315 Ordinary Shares.

 

The SEPA contains customary representations, warranties, conditions and indemnification obligations of the parties. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.

 

We do not know what the purchase price for our Ordinary Shares will be and therefore cannot be certain as to the number of shares we might issue to Yorkville under the SEPA. As of February 26, 2024, there were 18,186,028 Ordinary Shares outstanding. Although the SEPA provides that we may sell up to $25,000,000 of our Ordinary Shares to Yorkville, 4,516,464 (prior to taking into consideration the Reverse Stock Split) Ordinary Shares were registered for resale under the Initial Yorkville Registration Statement (all of which have been sold thereunder by Yorkville as of the date of this prospectus), 1,406,853 Ordinary Shares (post-Reverse Stock Split) were registered for resale under the Second Yorkville Registration Statement (all of which have been sold thereunder by Yorkville as of the date of this prospectus), 1,400,000 Ordinary Shares were registered for resale under the Third Yorkville Registration Statement (of which 1,125,604 have been sold thereunder by Yorkville as of the date of this prospectus), and 4,000,000 Ordinary Shares are being registered for resale under the registration statement that includes this prospectus.

 

If and when we elect to issue and sell shares to Yorkville, we may need to register for resale under the Securities Act additional Ordinary Shares in order to receive aggregate gross proceeds equal to the $25,000,000 available to us under the SEPA, depending on market prices for our Ordinary Shares. If all of the 4,000,000 shares offered by Yorkville for resale under the registration statement that includes this prospectus were issued and outstanding as of the date hereof, such shares would represent approximately 18.03% of the total number of Ordinary Shares outstanding as of February 26, 2024. If we elect to issue and sell more than the 4,000,000 Ordinary Shares offered under this prospectus to Yorkville, we must first register for resale under the Securities Act any such additional shares, which could cause additional dilution to our shareholders. The number of shares ultimately offered for resale by Yorkville is dependent upon the number of Ordinary Shares we may elect to sell to Yorkville under the SEPA.

 

There are substantial risks to our shareholders as a result of the sale and issuance of Ordinary Shares to Yorkville under the SEPA. These risks include the potential for substantial dilution and significant declines in our share price. See the section entitled “Risk Factors.” Issuances of our Ordinary Shares in this offering will not affect the rights or privileges of our existing shareholders, except that the economic and voting interests of each of our existing shareholders will be diluted as a result of any such issuance. Although the number of Ordinary Shares that our existing shareholders own will not decrease as a result of sales, if any, under the SEPA, the shares owned by our existing shareholders will represent a smaller percentage of our total outstanding shares after any such issuance to Yorkville.

 

For more detailed information regarding the SEPA, see the section entitled “Committed Equity Financing.

 

Recent Developments

 

$2,910,000 Offering

 

On February 20, 2024, the Company closed an underwritten public offering of securities for gross proceeds of approximately $2.9 million, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company. The offering was pursuant to an underwriting agreement with EF Hutton LLC relating to the public offering of 12,124,666 Ordinary Shares at a subscription price per share of $0.24. Additionally, to the extent that the purchase of such shares would cause the beneficial ownership of a purchaser in the offering, together with its affiliates and certain related parties, to exceed 4.99% of the Ordinary Shares, the Company agrees to issue the Underwriter, for delivery to such purchasers, at the election of the purchasers, a number of Pre-Funded Warrants which are initially convertible on a 1-for-1 basis into Ordinary Shares, at a price per Pre-Funded Warrant of $0.2378 (100% of the public offering price allocated to each Firm Share less $0.0022).

 

8
 

 

The net proceeds to the Company upon the closing of the Offering, after deducting the underwriting commissions and estimated offering expenses payable by the Company, were approximately $2.66 million. The Company used the net proceeds from the Offering for (i) sales and marketing; (ii) payment of certain outstanding liabilities and working capital; and (iii) digital branding consulting services. The Company entered into various agreements with consultants to provide the marketing and digital branding consulting services, effective as of the closing of the Offering.

 

Pursuant to the underwriting agreement, the Company paid the Underwriter a cash fee equal to 2.5% of the gross proceeds of the Offering, and also paid $100,000 of expenses of the underwriter in connection with the offering.

 

Transfer to Nasdaq Capital Market

 

On January 3, 2024, the Company received notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), stating that the Nasdaq staff has approved the Company’s application to transfer the listing of its Ordinary Shares from the Nasdaq Global Market to the Nasdaq Capital Market. The Ordinary Shares were transferred to the Nasdaq Capital Market at the opening of business on January 8, 2024.

 

The Ordinary Shares will continue to trade under the symbol “SMX,” and trading of the Ordinary Shares will be unaffected by the transfer. The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market.

 

As a result, the Company’s previously disclosed outstanding Nasdaq Global Market non-compliance notices are deemed to be resolved as a result of the Company’s transfer to the Nasdaq Capital Market.

 

Sales Cooperation Agreement

 

On July 25, 2023, the Company entered into a Sales Cooperation Agreement with Data Vault Holdings, Inc., which acts in the area of Web 3.0 technologies, crypto anchors and data software as a service, pursuant to which each party on a non-exclusive basis will effect introductions of potential clients to the other. Pursuant to the agreement, any transaction between a party and an introduced client shall entitle the introducing party to a commission on income received in the transaction for 48 months. In addition to entering into the Sales Cooperation Agreement, the companies intend to collaborate to advance Data Vault’s Web 3.0 strategies for data visualization, inventory tracking and laboratory automation, using the Company’s digital blockchain platform enhanced with a physical marker.

 

Reverse Stock Split

 

On August 8, 2023, the Extraordinary General Meeting of Shareholders (the “General Meeting”) of the Company, which was originally scheduled for August 1, 2023, was held and the Company’s shareholders voted in favor of consolidating every twenty-two ordinary shares in the authorized but unissued and in the authorized and issued share capital of the Company into one ordinary share (the “Reverse Stock Split”).

 

The Reverse Stock Split reduced the number of outstanding shares of the Company from approximately 48.8 million to approximately 2.2 million and affected all outstanding ordinary shares. No fractional shares were issued in connection with the reverse stock split. Instead, the Company aggregated the fractional entitlements of shareholders who otherwise would have been entitled to receive fractional shares because they held a number of ordinary shares not evenly divisible by twenty-two ordinary shares pursuant to the Reverse Stock Split or they held less than the number of ordinary shares which should be consolidated into one ordinary share pursuant to the reverse stock split and, to the extent possible, sell such aggregated fractional ordinary shares on the basis of prevailing market prices at such time. The par value of the ordinary shares was increased from $0.0001 to $0.0022.

 

After the Reverse Stock Split, all outstanding Company options, warrants and other applicable convertible securities, including the Company’s warrants listed on the Nasdaq Capital Market under the symbol SMXWW which retained its existing CUSIP number, were proportionately adjusted in accordance with their respective terms.

 

9
 

 

In connection with the Reverse Stock Split, the Company amended the Public Limited Company Constitution of SMX (Security Matters) Public Limited Company Memorandum of Association (“Amended Constitution”) to reflect the adjustment of the par value and increase in the total authorized ordinary shares of the Company.

 

Successful Marking of rPET Granule Raw Material

 

On August 21, 2023, the Company announced that, alongside Indorama Ventures, it successfully marked rPET granule raw material for textile production. Through successfully marking and detecting the uniformly dispersed SMX Technology within granulated rPET, Indorama Ventures is evaluating the patented non-destructive technology’s potential to authenticate premium rPET grades through its network of subcontractors and suppliers. The SMX Technology was successfully detected within the granules after the granulation process, within the dope dyed POY and DTY polyester filament yarns and within the undyed, dyed and dope dyed fabrics, regardless of color and the process methods.

 

Note and Warrant Offering

 

On September 6, 2023, we consummated the transactions pursuant to a Securities Purchase Agreement dated as of September 5, 2023 (the “Securities Purchase Agreement”) and issued and sold to an institutional investor a convertible promissory note and warrants, for gross proceeds to SMX of approximately US$2.5 million, before deducting fees and other offering expenses payable by the Company.

 

The note was in the principal amount of $4,290,000, all of which had been converted into Ordinary Shares as of the date of this prospectus. The actual amount loaned by the investor pursuant to the note was $2,574,000 after a 40% original issue discount. The maturity date of the note is the 12-month anniversary of the effective date, and is the date upon which any remaining accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of 12% per year and shall be payable on the maturity date or upon acceleration or by prepayment or otherwise.

 

The investor has the right, at any time, to convert all or any portion of the then outstanding and unpaid principal amount and interest (including any costs, fees and charges) into Ordinary Shares, at a fixed conversion price of $1.6378 per share, subject to customary adjustments and limitations as provided in the note including for fundamental transactions. Additionally, the Company has the right to convert in whole or in part the note into Ordinary Shares, subject to a beneficial ownership limitation.

 

The note contains customary events of default for transactions similar to the transactions contemplated by the Securities Purchase Agreement and the note, which entitle the investor, among other things, to accelerate the due date of the unpaid principal amount of, and all accrued and unpaid interest on, the note. Any principal amount or interest on the note which is not paid when due shall bear interest at the rate of the lesser of (i) 24.5% per annum and (ii) the maximum amount permitted by law during the event of default. Upon the occurrence of any event of default, the principal amount then outstanding plus accrued interest (including any costs, fees and charges) increases to 120% of such amount through the date of full repayment multiplied by 150%, as well as all costs of collection.

 

As of February 26, 2024, the investor has converted all of the principal of the note into an aggregate of 2,619,377 Ordinary Shares.

 

As part of the transaction, we issued two warrants to the investor, an “A” Warrant and a “B” Warrant. The A Warrant for 3,929,051 Ordinary Shares has an exercise price of $0.0022 per share, subject to customary adjustments, and may be exercised at any time until the five year anniversary of the A Warrant. The B Warrant for 2,619,367 Ordinary Shares has an exercise price of $1.6378 per share, subject to customary adjustments, and may be exercised at any time until the five year anniversary of the B Warrant. As of February 26, 2024, the investor exercised the Warrant A for 653,595 Ordinary Shares. Subsequent to February 26, 2024, the investor exercised the Warrant A for 736,274 Ordinary Shares.

 

10
 

 

Loan Agreement

 

On September 19, 2023, the Company amended the (a) loan agreement dated September 7, 2015 (as amended to date, the “Degania Agreement”), by and between SMX Security Matters Ltd. (Israel Corporate Number 515125771) (“SMX Israel”), Degania A. Business AGSHAH Ltd. and Kibbutz Degania and Kamea-the United Kibbutz Movement Ltd. (public benefit company) (“Kamea”) and (b) loan agreement dated September 7, 2015 (as amended to date, “Ketura Agreement” and, with the Degania Agreement, the “Loan Agreements”), by and between SMX Israel, Ketura International Energy AGSHAH Ltd. and Kibbutz Ketura.

 

Pursuant to the amendment to the Loan Agreements, among other things, Kamea agreed to convert $657,203 of indebtedness (the “Indebtedness Amount”) under the Loan Agreements into 487,281 Ordinary Shares of the Company as payment in full for such indebtedness; provided however, that in the event the proceeds received from Kamea with respect to any sales of the Ordinary Shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount.

 

EF Hutton Indebtedness

 

On September 15, 2023, the Company paid $250,000 to EF Hutton LLC (then known as EF Hutton, division of Benchmark Investments, LLC), pursuant to a Satisfaction and Discharge of Indebtedness Pursuant to Promissory Note Dated March 7, 2023 (the “Satisfaction and Discharge Agreement”). Upon paying such amount, the promissory note dated March 7, 2023 (the “Note”) in the principal sum of $900,000 was deemed fully paid and satisfied and the Note was thereafter canceled, discharged and no longer of any further force or effect.

 

Joint Project with Domaine des Massifs

 

On September 27, 2023, the Company announced it launched a collaborative project with Domaine des Massifs, an industry leader in leather sourcing, aiming to offer and establish a comprehensive system for their clients, achieving full traceability, verification, and certification of the origin of raw materials from farm to finished products.

 

Investment Agreement

 

On October 3, 2023, Security Matters PTY entered into an Investment Agreement (the “Investment Agreement”) with True Gold Consortium Pty Ltd (“True Gold”), of which Security Matters PTY is a shareholder.

 

Pursuant to the Investment Agreement, the AUD475,000 of indebtedness as of June 30, 2023 True Gold owes to Security Matters PTY was waived by Security Matters PTY in exchange for the issuance of additional shares of True Gold (the “True Gold Shares”) such that Security Matters PTY’s holdings in True Gold shall be increased to 51.9% of the total issued and outstanding shares of True Gold, making Security Matters PTY the majority owner of True Gold. Additionally, the existing license agreement as between Security Matters PTY and True Gold was amended to include additional intellectual property of Security Matters PTY to be licensed to True Gold thereunder. Security Matters PTY shall further supply to True Gold a credit line for research and development work by its employees of up to AUD1,000,000, free of interest and collateral.

 

Pursuant to the Investment Agreement, True Gold shall have the right, within 12 months of the issuance of the True Gold Shares to Security Matters PTY, to purchase the True Gold Shares from Security Matters PTY for a purchase price to be decided by an external valuator.

 

Plastic Cycle Token

 

On November 28, 2023, the Company announced the planned launch of a plastic cycle token, scheduled for release in Q2 2024. The initiative is being designed to present a reliable, ethical digital credit platform, aiming to capitalize on billions of dollars in recyclable plastics credits in a newly created market.

 

The tradeable plastic cycle token is being designed to enable companies to transition towards sustainable practices, encouraging entities within and outside the plastic ecosystem, including oil producers and waste management firms, to increase recycled content utilization.

 

This initiative is also expected to position the SMX Plastic Cycle Token as a next-generation alternative to carbon credits, creating a new paradigm in the Impact ESG investment landscape. Each token is being designed to represent a quantifiable amount of recycled plastic using the Company’s technology to physically mark the plastics, potentially offering a tangible impact on environmental circularity.

 

11
 

 

Warrant Reset Offer

 

On December 8, 2023, the Company consummated an inducement offer letter agreement with certain holders of the Company’s outstanding Warrant Bs to purchase Ordinary Shares of the Company. The Warrant Bs were issued on June 27, 2022 and had an exercise price of $5.28 per share (after taking into account the Company’s 1:22 reverse share split).

 

Pursuant to the inducement letter, the holders agreed to exercise for cash their Warrant Bs to purchase an aggregate of 606,060 Ordinary Shares at a reduced exercise price of $1.15 per share in consideration for the Company’s agreement to issue new warrants to purchase, in the aggregate, up to 909,090 of the Company’s Ordinary Shares at an exercise price of either (i) $0.0022 per share in an amount not to exceed 75% of the new warrant shares, or (ii) $1.15 per share, in the discretion of the warrantholders. The Company received aggregate gross proceeds, before payment of transaction fees and expenses, of approximately $697,000 from the exercise of the Warrant Bs by the holders. In January 2024, the holders of such reset warrants exercised 454,544 warrants pursuant to the option described above under clause (i), and as a result we issued an aggregate of 454,544 ordinary shares.

 

Agreement with R&I Trading of New York

 

On January 12, 2024, the Company announced that it entered into a $5 million contract with R&I Trading of New York (“R&I Trading”). The agreement with R&I Trading aims to set new standards in brand protection, authentication, ethical sourcing, and origination, specifically for the Fast-Moving Consumer Goods (FMCG) sector, including Beverage and Pharmaceutical industries.

 

Conversion and Exchange or Notes and Warrants

 

On or about January 12, 2024, the Company issued an aggregate of 4,032,256 Ordinary Shares and warrants to purchase an aggregate of 4,032,256 ordinary shares, to holders (the “Note Holders”) of existing convertible notes (the “Existing Notes”) and Redeemable Warrants (the “Redeemable Warrants”), in exchange for the cancellation of an aggregate of (a) approximately $750,000 owed to the Note Holders under the Existing Notes and (b) $1,450,000 cash value of Redeemable Warrants. The Company also issued 457,682 Ordinary Shares to a service provider (the “Service Provider”) as payment in full for $260,000 worth of services previously provided to the Company by the Service Provider. Such transactions were evidenced by a series of substantially similar Conversion and Exchange Rights Agreements executed as of December 31, 2023.

 

Notice of Failure to Satisfy a Continued Listing Rule

 

On January 26, 2024, the Company received a deficiency letter from the Listing Qualifications Department (the “Staff”) of Nasdaq, notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) for continued listing on the Nasdaq Capital Market, as the bid price of the Company’s ordinary shares on the Nasdaq Capital Market was below $1.00 for 30 consecutive business days, from December 11, 2023 to January 25, 2024.

 

In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”), the Company has a period of 180 calendar days, or until July 24, 2024 (the “Compliance Date”), to regain compliance with the Minimum Bid Price Requirement. If, at any time before the Compliance Date, the closing bid price of the Company’s ordinary shares is at least $1.00 for a minimum of ten consecutive business days, the Staff will provide a written confirmation to the Company that it has regained compliance with the Minimum Bid Price Requirement.

 

If the Company does not regain compliance with the Minimum Bid Price Requirement by the Compliance Date, the Company may be eligible for additional time. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company meets these requirements, Nasdaq will inform the Company that it has been granted an additional 180 calendar days. However, if it appears to Nasdaq that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that its securities will be subject to delisting. At that time, the Company may appeal the Staff’s delisting determination to a Nasdaq Listing Qualifications Panel (the “Panel”) pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. However, there can be no assurance that, if the Company receives a delisting notice and appeals the delisting determination by the Staff to the Panel, such appeal would be successful.

 

12
 

 

Additionally, there can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement, or will otherwise be compliant with other Nasdaq Listing Rules.

 

Letter Agreement with YA II PN, Ltd.

 

On February 2, 2024, the Company entered into a Letter Agreement with YA II PN, Ltd., a Cayman Islands exempt limited partnership (“Yorkville”) dated February 1, 2024 (the “Letter Agreement”), which amends and supplements the Standby Equity Purchase Agreement dated February 23, 2023, by and between the Company and Yorkville (the “SEPA”) pursuant to which, among other things, Yorkville advanced to the Company Pre-Paid Advances in the aggregate of $2,000,000 evidenced by a convertible promissory note issued to Yorkville dated May 23, 2023 as amended by that Letter Agreement dated July 27, 2023 (the “May Pre-Paid Advance”).

 

Pursuant to the Letter Agreement, the Company agreed to make payments to Yorkville, which may include proceeds of Advances (as defined in the SEPA) under the SEPA, to repay the amounts outstanding under the May Pre-Paid Advance plus Payment Premium (as defined in the SEPA), until all such amounts are fully repaid, and shall use commercially reasonable best efforts to do so by April 1, 2024. The Letter Agreement further provided that any proceeds from any capital raise after April 1, 2024, other than Advances under the SEPA, will be utilized to pay down outstanding principal, outstanding default interest and Payment Premium under the May Pre-Paid Advance. As a result, subsequent to the effective date of the Letter Agreement, the Company issued an aggregate of 1,000,000 Ordinary Shares as advances, the proceeds of which were applied to pay the first $100,000 fee described below and the remainder to repay a portion of the principal and interest outstanding under the convertible promissory note evidencing the remaining Pre-paid Advance.

 

The Company agreed to pay a fee to Yorkville equal to $200,000, of which $100,000 shall be payable from the next Advance after the date of the Letter Agreement and $100,000 shall be payable by April 1, 2024 (the “Second Tranche Fee”); provided, that the Second Tranche Fee will not be due if the total amount due and outstanding under the May Pre-Paid Advance is paid in full by April 1, 2024.

 

The Company further agreed to issue to Yorkville a 5-year warrant to purchase 250,000 ordinary shares of the Company at an exercise price of $0.0022 per share (the “Warrant”). Such ordinary shares issuable upon exercise of the Warrant have demand registration rights, and the Company further agreed to register additional ordinary shares that may be issued pursuant to the SEPA as provided in the Letter Agreement.

 

The Company also agreed to file a registration statement to register additional Registrable Securities (defined in the SEPA) and the Ordinary Shares issuable upon exercise of the warrant no later than thirty (30) calendar days from the date of the Letter Agreement and to file a registration statement to register additional Registrable Securities any time the Registrable Securities are less than 500,000 Ordinary Shares.

 

Implications of Being an “Emerging Growth Company” and a “Foreign Private Issuer”

 

The Company qualifies as an “emerging growth company” as defined in the JOBS Act. As an “emerging growth company,” the Company may take advantage of certain exemptions from specified disclosure and other requirements that are otherwise generally applicable to public companies. These exemptions include:

 

not being required to comply with the auditor attestation requirements for the assessment of our internal control over financial reporting provided by Section 404 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”);

 

13
 

 

reduced disclosure obligations regarding executive compensation; and
   
not being required to hold a nonbinding advisory vote on executive compensation or seek shareholder approval of any golden parachute payments not previously approved.

 

The Company may take advantage of these reporting exemptions until it is no longer an “emerging growth company.”

 

The Company is also considered a “foreign private issuer” and will report under the Exchange Act as a non-U.S. company with “foreign private issuer” status. This means that, even after the Company no longer qualifies as an “emerging growth company,” as long as it qualifies as a “foreign private issuer” under the Exchange Act, it will be exempt from certain provisions of the Exchange Act that are applicable to U.S. public companies, including:

 

the sections of the Securities Exchange Act of 1934, as amended (“Exchange Act”) regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act;

 

the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and
   
the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial and other specified information, or current reports on Form 8-K, upon the occurrence of specified significant events

 

The Company may take advantage of these reporting exemptions until such time that it is no longer a “foreign private issuer.” The Company could lose its status as a “foreign private issuer” under current SEC rules and regulations if more than 50% of the Company’s outstanding voting securities become directly or indirectly held of record by U.S. holders and any one of the following is true: (i) the majority of the Company’s directors or executive officers are U.S. citizens or residents; (ii) more than 50% of the Company’s assets are located in the United States; or (iii) the Company’s business is administered principally in the United States.

 

The Company may choose to take advantage of some but not all of these reduced burdens. The Company has taken advantage of reduced reporting requirements in this prospectus. Accordingly, the information contained in this prospectus may be different from the information you receive from the Company’s competitors that are public companies, or other public companies in which you have made an investment.

 

As a foreign private issuer, the Company is also be permitted to follow certain home country corporate governance practices instead of those otherwise required under the applicable rules of Nasdaq for domestic U.S. issuers. In order to rely on this exception, the Company is required to disclose each Nasdaq rule that it does not intend to follow and describe the home country practice that it will follow in lieu thereof. The Company currently follows the following Irish corporate governance practices in lieu of Nasdaq corporate governance rules: The Company has elected to (a) amend its 2022 Equity Incentive Plan to increase the number of shares authorized under the plan without stockholder approval, (b) follow home country practice in lieu of the requirements under Nasdaq Rule 5635(d) to seek shareholder approval in connection with certain transactions involving the sale, issuance and potential issuance of its Ordinary Shares (or securities convertible into or exercisable for its Ordinary Shares) at a price less than certain referenced prices, if such shares equal 20% or more of the Company’s Ordinary Shares or voting power outstanding before the issuance, and (c) follow home country practice in lieu of the requirements under Nasdaq Rule 5635(c) to seek shareholder approval in connection with the establishment or material amendment of a stock option or purchase plan or arrangement pursuant to which stock may be acquired by officers, directors, employees or consultants.

 

14
 

 

Summary Risk Factors

 

Investing in our securities entails a high degree of risk as more fully described under “Risk Factors.” You should carefully consider such risks before deciding to invest in our securities. These risks include, among others:

 

Risks Related to Ownership of the Ordinary Shares

 

A market for our securities may not continue, which would adversely affect the liquidity and price of our securities.
If securities or industry analysts do not publish or cease publishing research or reports about the Company, its business, or its market, or if they change their recommendations regarding the Ordinary Shares adversely, then the price and trading volume of the Ordinary Shares could decline.

 

Risks Related to Our Legal and Regulatory Environment

 

Changes in laws, regulations or rules, and a failure to comply with any laws, regulations and standards, may adversely affect our financial and operating performance and profitability.

 

Risks related to the business and operations of the Company

 

We are a rapidly growing company with a relatively limited operating history, which may result in increased risks, uncertainties, expenses and difficulties, and it may be difficult to evaluate our future prospects.
If we fail to effectively manage our growth, our business, financial condition, and results of operations could be adversely affected.
The industry in which we operate is competitive, and if we fail to compete effectively, we could experience price reductions, reduced margins or loss of revenues.
We will need in the future to raise additional funds, inter alia, by equity, debt, or convertible debt financings, to support our growth, and those funds may be unavailable on acceptable terms, or at all. As a result, we may be unable to meet our future capital needs, which may limit our ability to grow and jeopardize our ability to continue our business.

 

Risks Related to Technology, Intellectual Property and Data

 

We may be unable to, and it may be difficult and costly to, obtain, maintain, protect, or enforce our intellectual property and other proprietary rights sufficiently.

 

Risks Related to Our Operations in Israel

 

Conditions in Israel and relations between Israel and other countries could adversely affect our business.

 

Risks related to Tax

 

The enactment of legislation implementing changes in taxation of international business activities, the adoption of other corporate tax reform policies, or changes in tax legislation or policies could impact our future financial position and results of operations.
   
U.S. holders that directly or indirectly own 10% or more of our equity interests may be subject to adverse U.S. federal income tax consequences under rules applicable to U.S. shareholders of “controlled foreign corporations.”
   
Our U.S. shareholders may suffer adverse tax consequences if we are classified as a “passive foreign investment company.”
   
The Internal Revenue Service may not agree that the Company should be treated as a non-U.S. corporation for U.S. federal income tax purposes.
   
Unanticipated changes in effective tax rates or adverse outcomes resulting from examination of our income or other tax returns could adversely affect our financial condition and results of operations.
   
Future changes in U.S. and foreign tax laws could adversely affect the Company.

 

15
 

 

Risks related to Irish Law

 

The Company does not intend to pay dividends for the foreseeable future.
   
Provisions in the Company’s Amended and Restated Memorandum and Articles of Association (“Amended and Restated Memorandum and Articles of Association”) and under Irish law could make an acquisition of the Company more difficult, may limit attempts by the Company shareholders to replace or remove the Company’s management, may limit shareholders’ ability to obtain a favorable judicial forum for disputes with the Company or the Company’s directors, officers, or employees, and may limit the market price of the Ordinary Shares, the warrants to acquire one Ordinary Share at an exercise price of $253.00 per share (“Public Warrants”) and/or other securities issued by the Company.

 

General Risks

 

The Company will incur significant costs and devote substantial management time as a result of being subject to reporting requirements in the United States, which may adversely affect the operating results of the Company in the future.
   
The stock price of the Ordinary Shares may be volatile.
   
The Company may issue additional Ordinary Shares or other equity securities without seeking approval of its shareholders, which would dilute your ownership interests and may depress the market price of the Ordinary Shares.
   

The Company may lose its foreign private issuer status in the future, which could result in significant additional costs and expenses. This would subject the Company to generally accepted accounting principles, as in effect in the United States from time to time (“GAAP”) reporting requirements which may be difficult for it to comply with.

 

The Company is an “emerging growth company” and it cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make the Ordinary Shares less attractive to investors.

 

The Company will incur significant costs and devote substantial management time as a result of being subject to reporting requirements in the United States, which may adversely affect the operating results of the Company in the future.
   
The Company’s management has limited experience in operating a public company in the United States.
   
There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq. If we are not able to comply with the applicable continued listing requirements or standards of the Nasdaq Capital Markets, Nasdaq could delist our Ordinary Shares and Public Warrants.

 

In addition, we face other risks and uncertainties that may materially affect our business prospects, financial condition, and results of operations. You should consider the risks discussed in “Risk Factors” and elsewhere in this prospectus before investing in our securities.

 

Corporate Structure

 

The Company has six wholly owned subsidiaries: Lionheart, Security Matters PTY, SMX Circular Economy Platform PTE, Ltd. (Singapore), TrueSilver SMX Platform Ltd. (Canada), SMX Fashion and Luxury (France) and SMX (Security Matters) Ireland Limited (Ireland). Security Matters PTY has two wholly-owned subsidiaries: Security Matters Ltd. (Israel), and SMX Beverages Pty Ltd. (Australia), along with being the record holder of 50% of Yahaloma Technologies Inc. (Canada) and 51.9% of trueGold Consortium Pty Ltd. (Australia).

 

Corporate Information

 

The Company is a public limited company organized and existing under the laws of Ireland. The Company was formed on July 1, 2022 as a public limited company incorporated in Ireland under the name “Empatan Public Limited Company”. The Company changed its name to SMX (Security Matters) Public Limited Company on February 17, 2023. Its affairs are governed by its Amended and Restated Memorandum and Articles of Association, the ICA, and the laws of Ireland.

 

The Company’s principal website is https://smx.tech. We do not incorporate the information thereon, or accessible through, our website into this prospectus, and you should not consider it a part of this prospectus.

 

16
 

 

THE OFFERING

 

The summary below described the principal terms of the offering. The “Description of Securities” section of this prospectus contains a more detailed description of the Company’s Ordinary Shares.

 

Any investment in the securities offered hereby is speculative and involves a high degree of risk. You should carefully consider the information set forth under “Risk Factors” on page 19 of this prospectus.

 

Issuer   SMX (Security Matters) Public Limited Company
     
Ordinary Shares offered by Yorkville   4,000,000 Ordinary Shares we may elect, in our discretion, to issue and sell to Yorkville under the SEPA from time to time.
     
Ordinary Shares Outstanding Prior to Offering   18,186,028, as of February 26, 2024 (1)
     
Ordinary Shares to be Outstanding after the offering   22,186,028, based on our issued and outstanding Ordinary Shares as of February 26, 2024.
     
Use of Proceeds  

We will not receive any proceeds from the resale of Ordinary Shares included in this prospectus by Yorkville. However, we may receive up to $25,000,000 in aggregate gross proceeds under the SEPA from sales of Ordinary Shares that we may elect to make to Yorkville pursuant to the SEPA, if any, from time to time in our discretion (which includes the $3.5 million in Pre-Funded Advances made under the SEPA prior to the date of this prospectus). We expect to use the net proceeds that we receive from sales of our Ordinary Shares to Yorkville, if any, under the SEPA, after repayment of any remaing amounts under the Pre-Funded Advances, for working capital and general corporate purposes. See the section entitled “Use of Proceeds.

     
Market for Ordinary Shares   Our Ordinary Shares are listed on The Nasdaq Stock Market LLC under the symbol “SMX”.
     
Risk Factors   See the section entitled “Risk Factors” and other information included in this prospectus for a discussion of factors you should consider before investing in our securities.

 

(1) Excludes the following:

 

90,910 (adjusted pursuant to the Reverse Stock Split) Ordinary Shares issuable upon exercise of the Warrant B warrants‌, at an exercise price per share of $5.28;
   
6,273 (adjusted pursuant to the Reverse Stock Split) Ordinary Shares issuable upon exercise of the Warrant A warrants, at an exercise price per share of $5.28 (or, if exercised on a cashless basis, 3,137 Ordinary Shares);
   
30,303 (adjusted pursuant to the Reverse Stock Split) Ordinary Shares issuable upon exercise of underwriter warrants issued in June 2023, at an exercise price per share of ‌$5.808;
   
284,091 (adjusted pursuant to the Reverse Stock Split) Ordinary Shares issuable upon conversion of our Public Warrants;

 

17
 

 

4,295 (adjusted pursuant to the Reverse Stock Split) Ordinary Shares issuable upon exercise of outstanding redeemable 5-year warrants, at an exercise price per share of $253.00;
   
7,182 (adjusted pursuant to the Reverse Stock Split) Ordinary Shares issuable upon exercise of outstanding 5-year warrants, at an exercise price per share of $253.00;
   
100,000 (adjusted pursuant to the Reverse Stock Split) Ordinary Shares issuable upon exercise of outstanding warrants issued to Lionheart Equities, LLC, a Delaware limited liability company (“Sponsor”) or its affiliates;
   
60,307 (adjusted pursuant to the Reverse Stock Split) Ordinary Shares reserved for future issuance under options originally granted under Security Matters PTY’s 2018 Share Option Plan and that were assumed by us as a result of the Business Combination;
   
1,731,019 (adjusted pursuant to the Reverse Stock Split) Ordinary Shares reserved for issuance under our 2022 Incentive Equity Plan, of which (i) an aggregate of 197,042 are restricted stock units issued or to be issued to our employees and consultants, which vest from time to time through March 2027, and (ii) an aggregate of 32,138 5-year options were granted to employees, services providers and advisory board members, at exercise prices per share ranging from $78.54 to $88.00;
   
Ordinary shares that may be issued from time to time to Yorkville pursuant to the SEPA, including upon conversion of the outstanding convertible promissory note in the remaining principal amount of $0.5 million held by Yorkville as pre-advances under the SEPA;
   
Ordinary Shares issuable upon the conversion of accrued interest under a promissory note dated September 5, 2023;
   
3,275,456 Ordinary Shares being issuable upon exercise of an outstanding 5-year “A” warrant, at an exercise price per share of $0.0022, of which 736,274 were issued upon the exercise of Warrant A subsequent to February 26, 2024;
   
2,619,367 Ordinary Shares issuable upon exercise of an outstanding 5-year “B” warrant, at an exercise price per share of $1.6378.
   
457,682 Ordinary Shares issuable upon exercise of outstanding 5-year warrants at an exercise price of $1.17 per share;
   
227,273 Ordinary Shares issuable upon exercise of outstanding 5-year reset warrants at an exercise price of $1.15 per share;
   
227,273 Ordinary Shares issuable upon exercise of outstanding 5-year reset warrants at an exercise price of $0.0022 per share; and
   
250,000 Ordinary Shares issuable upon exercise of an outstanding 5-year warrant held by Yorkville at an exercise price of $0.0022 per share.

 

18
 

 

RISK FACTORS

 

An investment in our securities is highly speculative, involves a high degree of risk and should be made only by investors who can afford a complete loss. If any of the following risks actually occurs, then our business, financial condition or results of operations could be materially adversely affected, the trading of our Ordinary Share and warrants could decline, and you may lose all or part of your investment therein. In addition to the risks outlined below, risks and uncertainties not presently known to us or that we currently consider immaterial may also impair our business operations. Potential risks and uncertainties that could affect our operating results and financial condition include, without limitation, the following:

 

Risks Related to Ownership of the Ordinary Shares

 

A market for our securities may not continue, which would adversely affect the liquidity and price of our securities.

 

The price of our securities may fluctuate significantly due to general market and economic conditions. An active trading market for our securities may never develop or, if developed, it may not be sustained. In addition, the price of our securities can vary due to general economic conditions and forecasts, our general business condition and the release of our financial reports. Additionally, if our securities become delisted from Nasdaq for any reason, and are quoted on the OTC Bulletin Board, an inter-dealer automated quotation system for equity securities that is not a national securities exchange, the liquidity and price of our securities may be more limited than if we were quoted or listed on Nasdaq or another national securities exchange. You may be unable to sell your securities unless a market can be established or sustained.

 

The trading price of our securities could be volatile and subject to wide fluctuations.

 

The trading price of our securities could be volatile and subject to wide fluctuations in response to various factors, some of which are beyond our control. Any of the factors listed below could have a material adverse effect on your investment in our securities and our securities may trade at prices significantly below the price you paid for them. In such circumstances, the trading price of our securities may not recover and may experience a further decline.

 

Broad market and industry factors may materially harm the market price of our securities irrespective of our operating performance. The stock market in general and Nasdaq have experienced price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of the particular companies affected. The trading prices and valuations of these stocks, and of our securities, may not be predictable. A loss of investor confidence in the market for the stocks of other companies that investors perceive to be similar to the Company could depress our stock price regardless of our business, prospects, financial conditions or results of operations. A decline in the market price of our securities also could adversely affect our ability to issue additional securities and our ability to obtain additional financing in the future.

 

In the past, securities class action litigation has often been initiated against companies following periods of volatility in their stock price. This type of litigation could result in substantial costs and divert our management’s attention and resources and could also require us to make substantial payments to satisfy judgments or to settle litigation.

 

If securities or industry analysts do not publish or cease publishing research or reports about the Company, its business, or its market, or if they change their recommendations regarding the Ordinary Shares adversely, then the price and trading volume of the Ordinary Shares could decline.

 

The trading market for our Ordinary Shares will be influenced by the research and reports that industry or securities analysts may publish about us, our business, our market, or our competitors. Securities and industry analysts do not currently, and may never, publish research on the Company. If no securities or industry analysts commence coverage of the Company, our stock price and trading volume would likely be negatively impacted. If any of the analysts who may cover the Company change their recommendation regarding our stock adversely, or provide more favorable relative recommendations about our competitors, the price of our Ordinary Shares would likely decline. If any analyst who may cover the Company were to cease coverage or fail to regularly publish reports on it, we could lose visibility in the financial markets, which could cause our stock price or trading volume to decline.

 

19
 

 

Risks related to the business and operations of the Company

 

We are a rapidly growing company with a relatively limited operating history, which may result in increased risks, uncertainties, expenses and difficulties, and it may be difficult to evaluate our future prospects.

 

We have experienced rapid growth in recent years in the markets we serve, including hiring additional employees, running multiple projects concurrently and expanding into new fields, and we plan to continue to expand into new markets. Our limited operating history may make it difficult to make accurate predictions about our future performance. Assessing our business and future prospects may also be difficult because of the risks and difficulties we face. These risks and difficulties include our ability to:

 

enter into new relationships and maintain existing relationships with clients and business partners;

 

maintain cost-effective access to capital;
   
expand the use and applicability of our technology;
   
successfully build our brand and protect our reputation from negative publicity;

 

successfully adjust our proprietary technology, products and services in a timely manner in response to changing market conditions;
   
successfully compete with companies that are currently in, or may in the future enter, the business of providing traceability solutions;
   
enter into new markets and introduce new products and services based on our technology;
   
comply with and successfully adapt to complex and evolving legal and regulatory environments in our existing markets and ones we may enter in the future;
   
attract, integrate and retain qualified employees and independent contractors; and
   
effectively manage, scale and expand the capabilities of our teams, outsourcing relationships, third-party service providers, operating infrastructure and other business operations.

 

If we are not able to timely and effectively address these risks and difficulties as well as those described elsewhere in this “Risk Factors” section, our business, financial condition and results of operations may be adversely affected.

 

If we fail to effectively manage our growth, our business, financial condition, and results of operations could be adversely affected.

 

As described above, over the last several years, we have experienced rapid growth in our business and number of employees, and we expect to continue to experience growth in the future. This rapid growth has placed, and may continue to place, significant demands on our management, processes, systems and operational, technological and financial resources. Our ability to manage our growth effectively, integrate new employees, independent contractors and technologies into our existing business and attract new business partners and maintain relationships with existing business partners will require us to continue to retain, attract, train, motivate and manage employees and independent contractors and expand our operational, technological and financial infrastructure. Continued growth could strain our ability to develop and improve our operational, technological, financial and management controls, reporting systems and procedures, recruit, train and retain highly skilled personnel and maintain business partners’ and their customers’ satisfaction.

 

We may not have sufficient manufacturing capabilities for our markers and readers to satisfy demand for our products, including due to the Eastern-European issues, world politics, COVID-19 related issues, international freight issues, costs of goods and other external financial or political issues. We may be unable to control the availability or cost of producing such products.

 

20
 

 

Our current manufacturing capabilities may not reach the required production levels necessary in order to meet growing demands for any products we may commission or future products we may develop. There can be no assurance that our commissioned products can be manufactured at the desired commercial quantities, in compliance with our requirements and at an acceptable cost. Any such failure could delay or prevent us from shipping said products and marketing the technologies in accordance with our target growth strategies.

 

While we were able to date to find new employees, when required, Israeli (and other) high-tech employment atmosphere (including due to the post-COVID-19 pandemic and lack of available professionals) is making it harder and harder to find and retain new employees. Thus, risk exists that we will not be able to hire all the employees we seek to hire, in the timeframe required and anticipated, which may slow down our growth, cause increased costs and reduced profits or hinder our ability to duly and timely fulfill all tasks and growth plans.

 

We note that due to such employment atmosphere we may need to extend additional resources, including issuance of shares and options, and financial measures in order to create retention plans for key personnel.

 

Part of our products are in the field of sustainability and circular economy and part of our growth engine is the upcoming world-wide legislation and regulations demanding sustainability and circular economy and carbon-free environment. While we are not relying on such upcoming legislation or regulations, slow legislation or promulgation process and changes in priorities (including due to the COVID-19 epidemic or the Eastern-European issues) may slow our growth.

 

Due to the fact that we aim our sales efforts at large international market-maker conglomerates, our sales cycle is relatively slow and there is a larger risk that at any time, due to many reasons that are beyond our control, the sales cycle will be broken and all efforts will be lost.

 

Any of the foregoing factors could negatively affect our business, financial condition and results of operations.

 

If the Isorad Licence Agreement is terminated, our business, financial condition and results of operations may be harmed.

 

In January 2015, SMX Israel entered a license agreement with Isorad Ltd (a company wholly owned by the State of Israel with rights to exclusively commercialize the Soreq Nuclear Research Center technology for civilian uses) (“Isorad”) to license the initial technology of tracking and tracing materials by observing and identifying markers (“Source IP”) and commercialize and develop the technology further (“Isorad Licence Agreement”). Under the Isorad Licence Agreement, the Source IP can be utilized in almost any industry and with any product. The Source IP has been the cornerstone for our technological developments. Since entering into the Isorad Licence Agreement, we filed over a hundred additional patent applications worldwide (most of which are irrelated to the Source IP).

 

Specifically as to Yahaloma, the royalty rate on gross sales of Yahaloma, to be paid by Yahaloma, are 4.2% (and not 2.2% that applies solely to Security Matters PTY, its other affiliates and to other sublicensees). Upon the occurrence of an M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of Yahaloma and similar event), Isorad is entitled to a fee equal to 1% of the total consideration paid to, received by, or distributed to, Yahaloma and/or its shareholders and/or its affiliates in connection with the event, including, without limitation, all cash, securities or other property which is received by Yahaloma and/or its shareholders in connection with such event of two such events (i.e. twice) at its choice.

 

The Isorad License Agreement will continue in full force and effect in perpetuity unless terminated. If either party does not remedy a material breach of its obligations within 180 days of notice of the material breach, the non-defaulting party may terminate the Isorad License Agreement immediately. Isorad may terminate the agreement by providing 30 days prior written notice if the royalties payable to Isorad are nil in any semi-annual report or if we breach other certain obligations (such as a failure to maintain a patent or patent application in the previous semi-annual review period). If the Isorad License Agreement is terminated, our business, financial condition and results of operations may be harmed.

 

21
 

 

If we fail to penetrate the full value chain manufacturing eco-system effectively, our business, financial condition, and results of operations could be adversely affected.

 

Value based pricing may be necessary to enable roll-out across clients, creating challenges in full value capture and effective customer segmentation. Some end-markets (e.g. plastics) require high levels of penetration to support our full value proposition. A broad range of potential end-markets and clients with different value propositions and price sensitivities will require a substantial, high performing, commercial organization.

 

In order to maintain continuous growth there is a need to onboard more and more players from different parts of the value chain manufacturing eco-system with the final view of covering all links in the value chain manufacturing eco-system. This may be time and cost consuming and will require funding and personnel and we may not be able to achieve the full value chain penetration due to failure to attain funding or personnel or due to external circumstances, which may hinder our growth.

 

The COVID-19 pandemic has adversely affected, and may continue to affect, our business, financial condition, liquidity and results of operations.

 

The COVID-19 pandemic has resulted in a widespread health crisis that has adversely affected businesses, economies and financial markets worldwide, placed constraints on the operations of businesses, decreased consumer mobility and activity, and caused significant economic volatility in the United States, Israel, Australia and international capital markets. We have followed guidance issued from time to time by the Australian and Israeli governments and the other local governments in territories in which we operate to protect our employees. As such, we have implemented work from home where possible, minimized face-to-face meetings and utilized video conference as much as possible and adhered to social distancing rules at our facilities while eliminating international travel, which required us to use local representatives to handle presentations and demonstrations for oversees customers. As a result, we have experienced some difficulties in employee ability to efficiently collaborate to meet our customer needs, a difficulty in our efforts to recruit and hire qualified personnel during this time, and have recorded a minor decrease in expected growth in 2020 and 2021, both due to the lockdown and restrictions, and our customers postponing or being hesitant of making future financial, or other, commitments due to the need to put response to the pandemic at the forefront, hesitations that may continue, or reoccur, in the future. Although some of these limitations have been lifted as the pandemic has receded, many of the resulting difficulties have remained in varying degrees.

 

We cannot predict the other future potential, direct or indirect, impacts of the COVID-19 pandemic on our business or operations, and there is no guarantee that any near-term trends in our results of operations will continue, particularly if the COVID-19 pandemic and the adverse consequences thereof worsen. Additional waves of infections, a continuation of the current environment, or any further adverse impacts caused by the COVID-19 pandemic could further impact employment rates, supply chains, priorities and the economy, affecting our customer base and divert customers’ discretionary spend to other uses, including for essential items. These events could impact our cash flows, results of operations and financial conditions and heighten many of the other risks described in this prospectus.

 

Our operations in foreign jurisdictions will subject us to risks associated with operating in those jurisdictions and may adversely affect our business, cash flows, financial condition and results of operations.

 

As we operate in foreign jurisdictions (such as Ireland, Israel, Australia, Singapore, France and Canada), we will be subject to those risks associated with operating in foreign jurisdictions. Such risks may include economic, social or political instability or change, hyperinflation, currency non-convertibility or instability and changes of laws affecting foreign ownership, government participation, taxation, working conditions, rates of exchange, exchange control, licensing, repatriation of income or return of capital, consumer health and safety or labor relations. While the jurisdictions in which we currently operate are economically stable, there is no certainty that political and economic conditions will remain stable. Any deterioration in political or economic conditions, including hostilities or terrorist activity may adversely affect our operations and profitability. There is a risk that the government of any such jurisdiction may change its policies regarding foreign investment, apply new or different taxes and levies, or make any other change which may have an adverse impact on our profitability. See the risk factors under “Risks Related to Our Operations in Israel.”

 

Prior to the Russian-Ukrainian dispute, Security Matters PTY was cooperating with a Ukrainian entity in parallel with its activities in Israel and European entities for research and development for its readers. Security Matters PTY was also reviewing potential relationships with entities in Russia, Belarus and Ukraine. As a result of the dispute, Security Matters PTY put on hold its research and development in Ukraine while continuing its research and development activity in Israel and with European entities and undertook no business relationships with parties in those regions. It is yet unknown what other effects such dispute may have on other jurisdictions, mainly in Europe, and any such effect might affect our business and growth. We cannot predict the other future potential impacts of the dispute on our business or operations, especially if such dispute becomes more than a regional event. These events could impact our cash flows, business, results of operations and financial condition and heighten many of the other risks described in this prospectus.

 

22
 

 

Moreover, events may occur within or outside the jurisdictions in which we operate that could impact those economies, our operations and the price of the Ordinary Shares. These events include but are not limited to acts of terrorism, an outbreak of international hostilities, fires, floods, earthquakes, labor strikes, civil wars, natural disasters, outbreaks of disease or other natural or manmade events or occurrences that can have an adverse effect on the demand for our products and our ability to conduct business. While we seek to maintain insurance in accordance with industry practice to insure against the risks we consider appropriate after consideration of our needs and circumstances, no assurance can be given as to our ability to obtain such insurance coverage in the future at reasonable rates or that any coverage arranged will be adequate and available to cover any and all potential claims. The occurrence of an event that is not covered or fully covered by insurance could have a material adverse effect on our business, financial condition and results of operations.

 

If we are unable to successfully identify and integrate acquisitions, our results of operations could be adversely affected.

 

Acquisitions may be a significant component of our growth strategy and from time to time we may seek to identify and complete acquisitions. Our future acquisitions may not be successful or may not generate the financial benefits that we expected we would achieve at the time of acquisition. In addition, there can be no assurance that we will be able to locate suitable acquisition candidates in the future or acquire them on acceptable terms or, because of competition in the marketplace. Acquisitions involve special risks, including, without limitation, the potential assumption of unanticipated liabilities and contingencies, difficulty in assimilating the operations and personnel of the acquired businesses, disruption of our existing business, dissipation of our limited management resources and impairment of relationships with employees and customers of the acquired business as a result of changes in ownership. While we believe that strategic acquisitions can improve our competitiveness and profitability, these activities could have a material adverse effect on our business, financial condition and operating results.

 

We may incur significant costs such as transaction fees, professional service fees and other costs related to future acquisitions. We may also incur integration costs following the completion of any such acquisitions as we integrate the acquired business with the rest of our Company. Although we expect that the realization of efficiencies related to the integration of any acquired businesses will offset the incremental transaction and acquisition-related costs over time, this net financial benefit may not be achieved in the near term, or at all.

 

The industry in which we operate is competitive, and if we fail to compete effectively, we could experience price reductions, reduced margins or loss of revenues.

 

Generally, the track and trace and anti-counterfeit industry in which we operate is subject to global and domestic competition. We are unable to influence or control the conduct of our competitors and such conduct may detrimentally affect our financial and operating performance There are several competitors that operate in the anti-counterfeit and track-and-trace industries and if new competitors enter the market, or established companies develop new products and technologies that are superior to our current technology, our ability to exploit any technological advantage successfully may be affected. We may be unable to develop further products or keep pace with developments and may lose clients to competitors. If our competitors develop a more efficient business model or undertake a more aggressive marketing campaign, this is likely to affect our marketing strategies and results of operations adversely.

 

There is no guarantee that customers will adopt our products and we may be unable to compete successfully with more established track and trace and anti-counterfeit companies on price or quality or may be unsuited to the established preferences of potential customers.

 

23
 

 

Our continued growth, including our ability to manage our operations and meet our strategic objectives, depends on retaining our current employees upon whom we are dependent and attracting and retaining qualified personnel, and we may not be able to do so at a rate that will enable us to stand up to our expected growth or cope with specific demands that may arise.

 

Our success depends to a large extent upon the skills and experience of our executive officers, management and sales, marketing, operations and scientific staff. We may not be able to attract or retain qualified employees due to the intense competition for qualified personnel in the technology industry, as well as to geographic considerations, our ability to offer competitive compensation and benefits, and other reasons.

 

If we are not able to attract and retain the necessary qualified personnel to manage our operations and accomplish our business objectives, we may experience constraints that will adversely affect our ability to manufacture, sell and market our products or to support research and development programs effectively.

 

SMX Israel has entered into employment contracts with several of its executives including Haggai Alon, its founder and Chief Executive Officer, and Limor Moshe Lotker, its Chief Financial Officer. Due to the specific knowledge and experience of these executives regarding the industry, technology and market generally and to our company specifically, the loss of the services of any one of these executives could have a material adverse effect on us. We have not obtained a key person insurance policy on any officer.

 

Although our employment agreements contain non-compete clauses, Israeli law does not fully enforce employees’ non-compete obligations and may limit their application, including with regard to duration and scope.

 

Under Israeli case law an Israeli Court will usually only enforce non-compete provisions if the employee received specific consideration for it. While all of our employment agreements include specific provisions stipulating that special consideration was paid for the non-compete provision, a risk always exists that a Court will not enforce such.

 

We may not be able to anticipate or adapt to consumer preferences which may have an adverse effect on our business, cash flows, financial condition and results of operations.

 

Our success upon completion of the business combination will depend on our ability to develop and commercialize our technology. A failure to successfully develop and commercialize our technology could lead to a loss of opportunities and adversely impact on our business, cash flows, financial condition and results of operations.

 

The global market for our technology is ever changing due to new technologies, new products, changes in regulations and other factors influencing market acceptance or market rejection of our technologies. This market volatility and risks exists despite our best efforts in relation to market research, promotion and sales efforts.

 

Our business is dependent on consumer awareness and market acceptance of our products. We may not be able to anticipate and react to trends within the industries we target in a timely manner or accurately assess the impact that such trends may have on consumer preferences. Failure to respond to changes in consumer preferences or anticipate market trends may adversely affect our future revenues and performance. Although we have striven to establish market recognition for our products in the relevant industry, it is too early in the life cycle of our brand to determine whether markers, readers, blockchain technology and any further technology developed by us will achieve and maintain satisfactory levels of acceptance and sustained adoption by manufacturers and consumers. Our technology may not be accepted by the market or used in our proposed markets and industries. We may not be able to commercialize our products, which could adversely impact on business, cash flows, financial condition and results of operations.

 

We may not be able to adapt our markers to the needs of any customer or field which may have an adverse effect on our business, cash flows, financial condition and results of operations.

 

Research and development tailoring costs are required to adapt marker and scanning technology to different materials and industrial/commercial environments, potentially increasing the cost and time to market as we scale across customers and verticals. If we are unable to adapt our markers to the needs of any customer or field due to the costs of doing so, our business, cash flows, financial condition and results of operations could be adversely affected.

 

24
 

 

We will need in the future to raise additional funds, inter alia, by equity, debt, or convertible debt financings, to support our growth, and those funds may be unavailable on acceptable terms, or at all. As a result, we may be unable to meet our future capital needs, which may limit our ability to grow and jeopardize our ability to continue our business.

 

We plan to continue to make investments to support our growth and will require additional funds to respond to business challenges that may arise, including the need to develop new products and services, enhance our technology, scale and improve our operating infrastructure, or acquire complementary businesses and technologies. Accordingly, we will need to engage in equity, debt or convertible debt financings to secure additional funds. In raising additional funds by the issuance of equity securities or securities convertible into equity securities, our shareholders may experience dilution. Debt financing, such as credit facilities or corporate bonds, may involve covenants restricting our operations or our ability to incur additional debt. Debt financing may also require security arrangements including cash collateral agreements that restrict the availability of cash held as collateral which is the case for amounts we may borrow in the future. In addition, future equity financing or replacement or refinancing of any debt financings may not be available on terms favorable to us, or at all, and the fact that debt holders are repaid first may reduce our ability to raise a later equity financing and may limit the ability to distribute dividends.

 

If we are unable to obtain adequate financing or financing at terms satisfactory to us when we require it, we may be unable to pursue certain business opportunities, supply proper service to our customers, and our ability to continue to support our business growth and the then current business and to respond to business challenges may be impaired and our business may be harmed.

 

Legal proceedings, investigations or claims against us may be costly and time-consuming to defend and may harm our reputation and damage our business regardless of the outcome. In addition, our business and operations could be negatively affected if they become subject to any securities litigation or shareholder activism, which could cause us to incur significant expense, hinder execution of business and growth strategy and impact our share price.

 

We are currently not aware of any risk of litigation against us, but we may be involved in litigation disputes with third parties including suppliers, customers, employees, former employees and government bodies in the ordinary course of business. The occurrence of a litigation dispute may be costly and impact on our reputation which may have a material adverse effect on our business, cash flows, financial condition and results of operations. Insurance might not cover such claims, might not provide sufficient payments to cover all the costs to resolve one or more such claims and might not continue to be available at terms acceptable to us. A claim brought against us for which we are uninsured or underinsured could result in unanticipated costs, potentially harming our business, cash flows, financial position and results of operations.

 

Although not a director of that entity, Mr. Alon previously worked as the deputy general manager for business development of an Israeli public company, Plat Technologies International Ltd (“Plat”) which entered insolvency. In early 2017, an ILS 35.9 million shareholders claim was filed by the appointed Court officers at the end of the seven year statute of limitation period against 18 defendants, including Mr. Alon, regarding the collapse of Plat (“Claim”). The insurance policy covering directors and officers responded and are now handling the claim. Mr. Alon denies any wrongdoing and does not consider that he will be required to commit any significant time to the conduct of the Claim and therefore will not constrain his ability to perform his duties and obligations to Security Matters PTY. The parties agreed to try and amicably resolve the dispute in mediation under which the insurance company agreed to consider taking upon itself any compensation as to the liability of Mr. Alon, if any, in such mediation proceedings. Security Matters PTY is not a party to the Claim and the Claim does not relate to the business or the affairs of Security Matters PTY.

 

Our markers may contaminate or spoil the raw material into which our marker is inserted, which could damage our reputation, subject us to product liability claims and result in a loss of revenue.

 

While we follow production protocols and conduct quality assurance tests, our markers may contaminate the raw material or certain raw material ingredients may be spoiled, contaminated by chemicals, microorganisms or toxins, or include foreign materials or substances. The risk of contamination may lead to product recalls or other interventions, which may cause serious damage to our reputation as a marking solution which does not affect the characteristics of the materials or products, or result in product liability claims and loss of revenue.

 

25
 

 

Our markers may include hazardous materials which may put customers, employees and other parties in our supply chain at risk. If any person is harmed by hazardous materials in our markers, our reputation could be damaged and we could be subject to litigation which may adversely affect our business, cash flows, financial position and results of operations.

 

The markers used by us are produced from materials chosen specifically for a specific application. Markers may, in some cases, include low concentrations of materials that may be deemed hazardous materials and the production of the markers by our employees can include dealing with hazardous materials. While manufacturing is conducted according to the material’s Material Safety Data Sheets (MSDS) and other relevant safety guidelines, a risk of health, even if minimal, may arise. While the hazardous materials are sent to the customers at a low concentration (of the marker), the risk of misuse or error in production may cause damage to our employees or customers, which may affect our expenses and production abilities. While we take safety provisions with respect to the hazardous materials used in our markers, these safety precautions may not be sufficient to prevent harm to our employees or customers from the production of or use of, respectively, our markers. While we are in compliance with the requirements of ISO 9001:2015 standard for quality management and quality assurance as well as safety measures instructed by an external safety engineer, such safety provisions may not be sufficient to prevent human error or other causes of damage.

 

Our readers use x-rays and may be of danger if tampered with or otherwise not used in accordance with the user manual and safety rules.

 

Although we supply customers with strict instructions for the use of our readers, and although we take measures to avoid misuse of the readers and minimize the risk of damage from misuse of the readers, users and others may suffer damage from not following such user instructions and may seek legal actions against us, even if such users or others are at fault.

 

We may not be able to procure adequate insurance and any insurance we have or may have may not be of sufficient coverage

 

We and our subsidiaries seek to maintain appropriate policies of insurance consistent with those customarily carried by organizations in our industry sector, including product insurance, as well as cyber-risk and privacy-risk insurance. Any increase in the cost of insurance policies or the industry in which they operate could adversely affect our business, cash flows, financial condition and results of operations. Our insurance coverage may also be inadequate to cover losses we may sustain and the insurance company may refuse to provide coverage or demand excessive payment for such coverage. In particular, our insurance does not extend to any potential liability or claims made against us under our agreement with Isorad. Uninsured loss or a loss in excess of our insured limits could adversely affect our business, cash flows, financial condition and results of operations.

 

Our risk management policies and procedures, and those of our third-party vendors upon which we rely, may not be fully effective in identifying or mitigating risk exposure. If our policies and procedures do not adequately protect us from exposure to these risks, we may incur losses that would adversely affect our financial condition, reputation and market share.

 

We have developed risk management policies and procedures and we continue to refine such as we conduct our business. Our policies and procedures are meant to identify, monitor and manage risks may not be fully effective in mitigating our risk exposure. Further, as we are an R&D company and expand into new fields of business, our risk management policies and procedures may not be able to keep up with our current rapid rate of expansion adequately, and may not be adequate or sufficient to mitigate risks. Moreover, we are subject to the risks of errors and misconduct, including by our officers, employees and independent contractors, including fraud and non-compliance with policies. These risks are difficult to detect in advance and prevent or avoid, and could harm our business, results of operations or financial condition. Although we seek to maintain insurance and use other traditional risk-shifting tools when possible, such as third-party indemnification, where possible, to manage certain exposures, they are subject to terms such as deductibles, coinsurance, limits and policy exclusions, as well as risk of counterparty denial of coverage, default or insolvency. If our policies and procedures do not adequately protect us from exposure, and our exposure is not adequately covered by insurance or other risk-shifting tools, we may incur losses that would adversely affect our business, cash flows, financial condition and results of operations.

 

26
 

 

Risks Related to Technology, Intellectual Property and Data

 

We may be unable to, and it may be difficult and costly to, obtain, maintain, protect, or enforce our intellectual property and other proprietary rights sufficiently.

 

Our ability to operate our businesses depends, in part, upon our proprietary technology. We may be unable to protect our proprietary technology effectively, which would allow competitors to duplicate our technology and adversely affect our ability to compete with them.

 

We have applied for over a hundred patents. While we are not aware of any such patent applications or the technology infringing any third party’s patents, we have not undertaken an exhaustive assessment of existing patents to determine any overlapping technology or potential infringement, and we do not conduct a freedom to operate search or any other exhaustive search of patents that may limit our ability to supply solutions to specific customers or fields, as the costs of such would be prohibitive. Accordingly, there is a risk that a third party may claim that any patent application infringes that third party’s patent. Any event that would jeopardize our proprietary rights or any claims of infringement by third parties could have an adverse effect on our ability to market or exploit our technology.

 

There is no guarantee that our proposed patents that are the subject of the patent applications filed by us will provide adequate protection for our intellectual property, or that third parties will not infringe or misappropriate the patents or similar proprietary rights. In addition, there can be no assurance that we will not have to pursue litigation against other parties to assert our rights. There is no guarantee that any of the patents that have been applied for will be granted. If some or all of the patent applications are not granted, our ability to exploit our technology may be materially adversely affected.

 

If third parties claim that we infringe upon or otherwise violate their intellectual property rights, our business could be adversely affected.

 

Although we are not aware of any infringement on the rights of third parties, we may in the future be subject to claims that we have infringed or otherwise violated third parties’ intellectual property rights. There is patent, copyright, and other intellectual property development and enforcement activity in our industry and relating to the advanced technology we use in our business. Our future success depends in part on not infringing upon or otherwise violating the intellectual property rights of others. From time to time, our competitors or other third parties (including non-practicing entities and patent holding companies) may contend that we are infringing upon or otherwise violating their intellectual property rights, or attack our pending or approved patents, and we may be found to be infringing upon or otherwise violating such rights or otherwise in legal claims regarding patents or other intellectual property rights. We may be unaware of the intellectual property rights of others that may cover some or all of our current or future technology or conflict with our rights, and the patent and other intellectual property rights of others may limit our ability to improve our technology and compete effectively. Any claims of intellectual property infringement or other intellectual property violations, even those without merit, could cause the incurrence of costs and other direct, or indirect, damage to us, including:

 

be expensive and time consuming to defend;

 

27
 

 

cause us to cease making, licensing, or using any of our products that incorporate the challenged intellectual property;
   
require us to modify, redesign, reengineer or rebrand our products, if feasible;
   
damage our reputation;
   
hinder our ability to market or sell our products and services;
   
affect negotiations or executed agreements;
   
cause increase to our insurance policies premium or refusal of insurance companies to insure us;
   
divert management’s attention and resources; or
   
require us to enter into royalty or licensing agreements to obtain the right to use a third-party’s intellectual property.

 

Any royalty or licensing agreements, if required, may not be available to us on acceptable terms or at all. A successful claim of infringement against us could result in our being required to pay significant damages, enter into costly settlement agreements, or prevent us from offering our solutions, any of which could have a negative impact on our operating profits and harm our future prospects. We may also be obligated to indemnify our customers or business partners in connection with any such litigation and to obtain licenses, modify our solutions, or refund fees, which could further exhaust our resources. Such disputes could also disrupt our solutions, adversely affecting our customer satisfaction and ability to attract customers.

 

Under applicable employment laws, we may not be able to enforce covenants not to compete.

 

As part of our employment agreements with our employees we have confidentiality obligations. These agreements generally prohibit our employees, if they cease working for us, from competing directly with us or working for our competitors for a limited period. We may be unable to enforce these agreements under the laws of the jurisdictions in which our employees work and it may be difficult for us to restrict our competitors from benefitting from the expertise our former employees or consultants developed while working for us. For example, Israeli labor Courts have required employers seeking to enforce non-compete undertakings of a former employee to demonstrate that the competitive activities of the former employee will harm one of a limited number of material interests of the employer which have been recognized by the courts, such as the protection of a company’s trade secrets or other proprietary knowhow.

 

Risks Related to Our Legal and Regulatory Environment

 

Litigation, regulatory actions, consumer complaints and compliance issues could subject us to significant fines, penalties, judgments, remediation costs and/or requirements resulting in increased expenses.

 

In the ordinary course of business, we may be named as a defendant in various legal actions, including litigation or regulatory enforcement actions. All such legal actions are inherently unpredictable and, regardless of the merits of the claims, are often expensive, time-consuming, disruptive to our operations and resources, and distracting to management.

 

Changes in laws, regulations and standards and failure to comply with laws, regulations and standards may adversely affect our financial and operating performance and profitability.

 

Any changes to the existing regulatory framework or the imposition of new legislation or regulations applicable to any of the industries in which Security Matters PTY operates may adversely affect the financial and operating performance of Security Matters PTY. This risk factor applies to government policy and legislative changes in the United States, Australia, Israel, as well as the other jurisdictions in which we currently operate, or will operate in the future, or jurisdictions in which our current or future customers may operate.

 

28
 

 

Additionally, while we currently do not anticipate this, as the markers used in materials or products are of minuscule quantities, the markers may in the future be required to comply with health and safety laws in certain jurisdictions, and failure to comply with such laws may lead to penalties and other liabilities being imposed on us. In such circumstances, we may be required to suspend production or cease operations, which may lead to a materially adverse effect on our financial performance and profitability.

 

While we are not aware of any regulation or similar restriction that currently materially limits our ability to use our markers, such regulation or similar restriction may in the future limit our ability to sell our products and may require us either to avoid marking certain material or require us to disclose data to certain entities for certification process that may be required in order for us to use our markers.

 

The readers use X-range ray technology, which may thus require in certain jurisdictions specific authorization in order to import, manufacture or use such readers. Such authorization process in each such jurisdiction may be time and resources consuming, but may also limit the ability of users to use the readers without proper qualifications, as well as may require, in certain jurisdictions the supervision of such use.

 

Obligations and changes in laws or regulations relating to privacy, cybersecurity, and data protection, or any actual or deemed failure by us to comply with such laws and regulations that could adversely affect our business

 

We receive, collect, use, disclose, transmit, and store information, including certain sensitive data, relating to our customers and employees. Our collection and processing of such data in our business may subject us to certain state, federal, and international laws and regulations relating to privacy, cybersecurity, and data protection. These laws, rules, and regulations evolve frequently and their scope may continually change through new legislation, amendments to existing legislation, and changes in interpretation or enforcement, and may be inconsistent from one jurisdiction to another.

 

Changes in laws or regulations relating to privacy, cybersecurity, and data protection, particularly any new or modified laws or regulations that require enhanced protection of certain types of data or new obligations with regard to data retention, transfer, or disclosure, could greatly increase the cost of our operations or prevent us from providing certain services. Complying with these requirements through changing our policies and practices may be onerous and costly. These changes may in turn impair our ability to offer our existing or planned products and services or increase our cost of doing business. Further, we may become subject to privacy and data security laws from jurisdictions outside of our standard business operations in. Despite our efforts to comply with any applicable laws, regulations, and other obligations relating to privacy, cybersecurity, and data protection, it is possible that our interpretations of the law, practices, or our network could be inconsistent with, or fail or be alleged to fail to meet all requirements of, such laws, regulations, or obligations. Our failure, or the failure by our business partners or customers using our services to comply with applicable laws or regulations or any other obligations relating to privacy, cybersecurity, and data protection or any compromise of security that results in unauthorized access to, or use or release of personal information or other data relating to consumers or other individuals, or the perception that any of the foregoing types of failure or compromise has occurred, could damage our reputation, discourage new and existing business partners and customers from working with us, or result in fines, investigations, or proceedings by governmental agencies and private claims and litigation, any of which could adversely affect our business, cash flows, financial condition, and results of operations. Even if not subject to legal challenge, the perception of privacy concerns, whether or not valid, may harm our reputation and brand and adversely affect our business, cash flows, financial condition, and results of operations.

 

We invest significant resources in information technology protection and security measures. If these measures are targeted or breached, we may incur significant legal and financial exposure as a result of ransomware, loss of information, and related litigation. Moreover, we hold data of our employees and customers and we invest significant resources in information technology protection and security measures to ensure that such data is safe. If these measures are targeted or breached, we may incur significant reputational damage and related legal and financial exposure.

 

29
 

 

Risks Related to Our Operations in Israel

 

Conditions in Israel and relations between Israel and other countries could adversely affect our business.

 

Certain of our offices and R&D facilities are located in Israel. Accordingly, political, economic and military conditions in Israel and the surrounding region directly affect our business and operations and could materially and adversely affect our ability to continue to operate from Israel. Recently, for example, the current political situation in Israel where the ruling parties are attempting to implement laws that essentially allow the parliament to enact laws that are preemptively immune to judicial review could adversely affect our business and results of operations. In addition, since the State of Israel was established in 1948, a number of armed conflicts have occurred between Israel and its Arab neighbors. In the event that our facilities are damaged as a result of hostile action or hostilities otherwise disrupt the ongoing operation of our facilities, our ability to continue our operations could be materially adversely affected.

 

In recent years, and most recently restarting in October 2023 Israel has been engaged in sporadic armed conflicts with terrorist groups, including those that control the Gaza Strip and other regions close to Israel. In addition, Iran has threatened to attack Israel and may be developing nuclear weapons. Some of these hostilities were accompanied by missiles being fired from the Gaza Strip, Lebanon and Syria against civilian targets in various parts of Israel, including areas in which our employees and independent contractors are located, which negatively affected business conditions in Israel. Any hostilities involving Israel, regional political instability or the interruption or curtailment of trade between Israel and its trading partners could materially and adversely affect our operations and results of operations.

 

Our commercial insurance does not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli government currently covers the reinstatement value of property damage and certain direct and indirect damages that are caused by terrorist attacks or acts of war, such coverage would likely be limited, may not be applicable to our business (either due to the geographic location of our offices or the type of business that we operate) and may not reinstate our loss of revenue or economic losses more generally. Furthermore, we cannot assure that this government coverage will be maintained or that it will sufficiently cover our potential damages, or whether such coverage would be timely provided. Any losses or damages incurred by us could have a material adverse effect on our business, cash flows, financial condition and results of operations.

 

Further, in the past, the State of Israel and Israeli companies have been subjected to economic boycotts and Israeli legal reforms initiatives may cause countries to limit activities with Israel or otherwise apply certain restrictions, or may otherwise adversely affect our activities. Several countries still restrict doing business with Israel and Israeli companies, and additional countries may impose restrictions on doing business with Israel and Israeli companies if hostilities in Israel or political instability in the region continues or increases. These restrictive laws and policies, or significant downturn in the economic or financial condition of Israel, could materially and adversely affect our operations and product development, and could cause our sales to decrease.

 

A large concentration of our staff resides in Israel and many of our employees and independent contractors in Israel are required to perform military reserve duty, which may disrupt their work for us.

 

Many of our employees and independent contractors, including certain of our founders and certain members of our management team, operate from our headquarters that are located in central Israel. In addition, a number of our officers and directors are residents of Israel. Accordingly, political, economic and military conditions in Israel and the surrounding region may directly affect our business and operations.

 

In addition, many Israeli citizens are obligated to perform several days, and in some cases more, of annual military reserve duty each year until they reach the age of 40 (or older, for reservists who are military officers or who have certain occupations) and, in the event of a military conflict, may be called to active duty. In response to increases in terrorist activity, there have been periods of significant call-ups of military reservists, including since October 7, 2023. It is possible that there will be additional and continued military reserve duty call-ups in the future. Our operations could be disrupted by such call-ups, particularly if such call-ups include the call-up of members of our management, and given the current shortage of talent in Israel due to the recent acceleration of activity in startups, especially in the technology space. Such disruption could materially and adversely affect our business, financial condition and results of operations.

 

30
 

 

Risks related to Tax

 

The enactment of legislation implementing changes in taxation of international business activities, the adoption of other corporate tax reform policies, or changes in tax legislation or policies could impact the Company’s future financial position and results of operations.

 

Corporate tax reform, base-erosion efforts and tax transparency continue to be high priorities in many tax jurisdictions where we have business operations. As a result, policies regarding corporate income and other taxes in numerous jurisdictions are under heightened scrutiny and tax reform legislation is being proposed or enacted in a number of jurisdictions.

 

In 2015, the Organization for Economic Co-operation and Development (the “OECD”) published final recommendations on base erosion and profit shifting (“BEPS”). These recommendations proposed the development of rules directed at counteracting the effects of tax havens and preferential tax regimes in countries around the world. Several of the areas of tax law on which the BEPS project focused have led or will lead to changes in the domestic law of individual OECD jurisdictions. These changes include (amongst others) restrictions on interest and other deductions for tax purposes, the introduction of broad anti-hybrid regimes and reform of controlled foreign corporation rules. Changes are also expected to arise in the application of certain double tax treaties, which may restrict the ability of certain members of the Company to rely on the terms of relevant double tax treaties in certain circumstances.

 

On December 20, 2021, the OECD published the draft Global Anti-Base Erosion Model Rules which are aimed at ensuring that Multinational Enterprises (“MNEs”) will be subject to a global minimum 15% tax rate from 2023 (“GloBE Rules”). The GloBE Rules are part of the OECD/G20 Inclusive Framework on BEPS which currently has 141 participant countries. The EU Council adopted Council Directive 2022/25234 (the “GloBE Directive”) on 22 December 2022 to implement the GloBE Rules in the EU. The GloBE Directive provides for the introduction of rules designed to achieve a minimum effective taxation for MNEs and large-scale domestic groups with revenues of at least €750,000,000, operating in the EU’s internal market and beyond. It provides a common framework for implementing the GloBE Rules into EU Member States’ national laws by 31 December 2023. If the Company is regarded as part of an “MNE Group” (or large-scale domestic group) which has consolidated revenues of more than EUR 750,000,000 in at least two out of the previous four years, it may be within the scope of the GloBE Rules which may result in an increase in the Company’s tax costs and operational expenses.

 

Changes of law in individual jurisdictions which may arise as a result of the BEPS project or other tax measures may ultimately increase the tax base of individual members of the Company in certain jurisdictions or the worldwide tax exposure of the Company. Changes of law may also include revisions to the definition of a “permanent establishment” and the rules for attributing profit to a permanent establishment. Other changes may focus on the goal of ensuring that transfer pricing outcomes are in line with value creation.

 

Such changes to tax laws could increase their complexity and the burden and costs of compliance. Additionally, such changes could also result in significant modifications to existing transfer pricing rules and could potentially have an adverse impact on the Company’s taxable profits in various jurisdictions.

 

31
 

 

U.S. holders that directly or indirectly own 10% or more of our equity interests may be subject to adverse U.S. federal income tax consequences under rules applicable to U.S. shareholders of “controlled foreign corporations.”

 

A non-U.S. corporation generally will be classified as a controlled foreign corporation for U.S. federal income tax purposes (a “CFC”), if “10% U.S. equityholders” (as defined below) own, directly, indirectly or constructively, more than 50% of either (i) the total combined voting power of all classes of stock of such corporation entitled to vote or (ii) the total value of the stock of such corporation. We do not believe that the Company would be classified as a CFC at the time of Closing, although CFC status is determined after taking into account complex constructive ownership rules and, accordingly, there can be no assurance in this regard. However, certain of the Company’s non-U.S. subsidiaries may be classified as CFCs (as a result of the application of certain constructive ownership rules which treat the Company’s U.S. subsidiaries as owning the equity of those non-U.S. subsidiaries), and it is possible that we may be classified as a CFC in the future. The U.S. federal income tax consequences for U.S. holders who at all times are not 10% U.S. equityholders would not be affected by the CFC rules. However, a U.S. holder that owns (or is treated as owning, directly, indirectly or constructively, including by applying certain attribution rules) 10% or more of the combined voting power of all classes of our stock entitled to vote or the total value of our equity interests (including equity interests attributable to a deemed exercise of options and convertible debt instruments), or a “10% U.S. equityholder,” if we were classified as a CFC, would generally be subject to current U.S. federal income taxation on a portion of our applicable subsidiaries’ earnings and profits (as determined for U.S. federal income tax purposes) and our earnings and profits, regardless of whether such 10% U.S. equityholder receives any actual distributions (with certain exceptions in the case of CFCs attributed through downward attribution). In addition, if we were classified as a CFC, a portion of any gains realized on the sale of our common shares by a 10% U.S. equityholder may be treated as ordinary income. A 10% U.S. equityholder will also be subject to additional U.S. federal income tax information reporting requirements with respect to our subsidiaries that are classified as CFCs and with respect to us (if we or any of our subsidiaries were classified as a CFC) and substantial penalties may be imposed for noncompliance. We cannot provide any assurances that the Company will assist U.S. holders in determining whether the Company or any of its subsidiaries are treated as a CFC for U.S. federal income tax purposes or whether any U.S. holder is treated as a 10% U.S. equityholder with respect to any of such CFC or furnish to any holder information that may be necessary to comply with reporting and tax paying obligations if the Company, or any of its subsidiaries, is treated as a CFC for U.S. federal income tax purposes. Each U.S. holder should consult its own tax advisor regarding the CFC rules and whether such U.S. holder may be a 10% U.S. equityholder for purposes of these rules.

 

There is a risk that we will be a passive foreign investment company for any taxable year, which could result in adverse U.S. federal income tax consequences to U.S. investors in our shares.

 

In general, a non-U.S. corporation is a passive foreign investment company, or PFIC, for any taxable year in which (i) 75% or more of its gross income consists of passive income or (ii) 50% or more of the average quarterly value of its assets consists of assets that produce, or are held for the production of, passive income. For purposes of the above calculations, a non-U.S. corporation that owns at least 25% by value of the shares of another corporation is treated as if it held its proportionate share of the assets of the other corporation and received directly its proportionate share of the income of the other corporation. Passive income generally includes dividends, interest, rents, royalties and certain gains. Cash is a passive asset for these purposes.

 

Based on the expected composition of our income and assets and the value of our assets, including goodwill, we do not expect to be a PFIC for our current taxable year. However, the proper application of the PFIC rules to a company with a business such as ours is not entirely clear. Because the proper characterization of certain components of our income and assets is not entirely clear, because we will hold a substantial amount of cash following this offering, and because our PFIC status for any taxable year will depend on the composition of our income and assets and the value of our assets from time to time (which may be determined, in part, by reference to the market price of our shares, which could be volatile), there can be no assurance that we will not be a PFIC for our current taxable year or any future taxable year.

 

If we were a PFIC for any taxable year during which a U.S. investor holds shares, certain adverse U.S. federal income tax consequences could apply to such U.S. investor. See “Material Income Tax Considerations-U.S. Federal Income Taxation Considerations-Passive Foreign Investment Company Consequences” for additional information.

 

The Internal Revenue Service may not agree that the Company should be treated as a non-U.S. corporation for U.S. federal income tax purposes.

 

Although the Company is incorporated in Ireland, the Internal Revenue Service (“IRS”) may assert that it should be treated as a U.S. corporation (and therefore a U.S. tax resident) for U.S. federal income tax purposes pursuant to Section 7874 of the Internal Revenue Code of 1986, as amended (the “Code”). For U.S. federal income tax purposes, a corporation is generally considered a U.S. “domestic” corporation (or U.S. tax resident) if it is organized in the United States, and a corporation is generally considered a “foreign” corporation (or non-U.S. tax resident) if it is not a U.S. corporation. Because the Company is an entity incorporated in Ireland, it would generally be classified as a foreign corporation (or non-U.S. tax resident) under these rules. Section 7874 of the Code provides an exception under which a foreign incorporated and foreign tax resident entity may, in certain circumstances, be treated as a U.S. corporation for U.S. federal income tax purposes.

 

32
 

 

As more fully described in the section titled “Certain Material U.S. Federal Income Tax Considerations-Material U.S. Federal Tax Considerations-U.S. Federal Income Tax Treatment of the Company,” based on the terms of the Business Combination and certain factual assumptions, the Company is not currently expected to be treated as a U.S. corporation for U.S. federal income tax purposes under Section 7874 of the Code after the Business Combination. However, the application of Section 7874 of the Code is complex and is subject to detailed regulations (the application of which is uncertain in various respects and would be impacted by changes in such U.S. Treasury Regulations with possible retroactive effect) and is subject to certain factual uncertainties. Accordingly, there can be no assurance that the IRS will not challenge the status of the Company as a foreign corporation under Section 7874 of the Code or that such challenge would not be sustained by a court.

 

If the IRS were to successfully challenge under Section 7874 of the Code the Company’s status as a foreign corporation for U.S. federal income tax purposes, the Company and certain the Company shareholders would be subject to significant adverse tax consequences, including a higher effective corporate income tax rate on the Company and future withholding taxes on certain the Company shareholders, depending on the application of any income tax treaty that might apply to reduce such withholding taxes.

 

See “Certain Material U.S. Federal Income Tax Considerations-Material U.S. Federal Tax Considerations -U.S. Federal Income Tax Treatment of the Company” for a more detailed discussion of the application of Section 7874 of the Code to the Business Combination. Investors in the Company should consult their own tax advisors regarding the application of Section 7874 of the Code to the Business Combination.

 

Unanticipated changes in effective tax rates or adverse outcomes resulting from examination of our income or other tax returns could adversely affect our financial condition and results of operations.

 

We are subject to federal and state income taxes in the United States and potentially in other jurisdictions. Our future effective tax rates could be subject to volatility or adversely affected by a number of factors, including:

 

changes in the valuation of our deferred tax assets and liabilities;
   
expected timing and amount of the release of any tax valuation allowances;
   
tax effects of stock-based compensation;
   
changes in tax laws, regulations or interpretations thereof; or
   
lower than anticipated future earnings in jurisdictions where we have lower statutory tax rates and higher than anticipated future earnings in jurisdictions where we have higher statutory tax rates.

 

In addition, we may be subject to audits of our income, sales and other transaction taxes by taxing authorities. Outcomes from these audits could have an adverse effect on our financial condition and results of operations.

 

Future changes in U.S. and foreign tax laws could adversely affect the Company.

 

The U.S. Congress and the Organisation for Economic Co-operation and Development have focused on issues related to the taxation of multinational corporations. In particular, specific attention has been paid to “base erosion and profit shifting”, where payments are made between affiliates from a jurisdiction with high tax rates to a jurisdiction with lower tax rates. As a result, the tax laws in Ireland could change on a prospective or retroactive basis, and any such change could adversely affect the Company.

 

Risks related to Irish Law

 

The Company does not intend to pay dividends for the foreseeable future.

 

The Company has never declared or paid any cash dividends on its capital stock and does not intend to pay any cash dividends in the foreseeable future. The Company expects to retain future earnings, if any, to fund the development and growth of its business. Any future determination to pay dividends on the Company’s capital stock will be at the discretion of the Board of Directors of the Company (the “Board”).

 

33
 

 

Irish taxes may apply to any dividends paid or transfers of the Company’s securities.

 

If the Company pays dividends, such dividends may be subject to Irish dividend withholding tax or Irish income tax. Certain transfers of Ordinary Shares, Public Warrant and other securities issued by the Company may be subject to Irish capital acquisitions tax or stamp duty. In particular, Irish stamp duty will apply to any future transfer of Company securities which are not listed or held through DTC and generally the purchaser / transferee will be liable for the payment of the stamp duty arising.

 

Provisions in the Amended and Restated Memorandum and Articles of Association and under Irish law could make an acquisition of Lionheart more difficult, may limit attempts by the Company shareholders to replace or remove the Company’s management, may limit shareholders’ ability to obtain a favorable judicial forum for disputes with the Company or the Company’s directors, officers or employees, and may limit the market price of the Ordinary Shares, the Public Warrants and/or other securities issued by the Company.

 

Provisions in the Amended and Restated Memorandum and Articles of Association may have the effect of delaying or preventing a change of control or changes in the Company’s management. The Amended and Restated Memorandum and Articles of Association includes provisions that:

 

require that the Company’s Board be classified into three classes of directors with staggered three-year terms;
   
permit the Company’s Board to establish the number of directors and fill any vacancies and newly created directorships; and
   
prohibit shareholder action by written consent without unanimous approval of all holders of the Ordinary Shares.

 

Risks Related to this Offering

 

It is not possible to predict the actual number of shares we will sell under the SEPA to Yorkville or the actual gross proceeds resulting from those sales. Further, we may not have access to the full amount available under the SEPA with Yorkville.

 

Effective as of March 7, 2023, we entered into the SEPA with Yorkville, pursuant to which Yorkville has committed to purchase up to $25,000,000 of our Ordinary Shares, subject to certain limitations and conditions set forth in the SEPA. The Ordinary Shares that may be issued under the SEPA may be sold by us to Yorkville at our discretion from time to time.

 

We generally have the right to control the timing and amount of any sales of our Ordinary Shares to Yorkville under the SEPA. Sales of our Ordinary Shares, if any, to Yorkville under the SEPA will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to Yorkville all, some or none of the Ordinary Shares that may be available for us to sell to Yorkville pursuant to the SEPA.

 

Because the purchase price per share to be paid by Yorkville for the Ordinary Shares that we may elect to sell to Yorkville under the SEPA, if any, will fluctuate based on the market prices of our Ordinary Shares prior to each Advance made pursuant to the SEPA, if any, it is not possible for us to predict, as of the date of this prospectus and prior to any such sales, the number of Ordinary Shares that we will sell to Yorkville under the SEPA, the purchase price per share that Yorkville will pay for shares purchased from us under the SEPA, or the aggregate gross proceeds that we will receive from those purchases by Yorkville under the SEPA, if any. However, the SEPA has been negotiated so that Yorkville would always purchase our Ordinary Shares pursuant to its terms at a discount to market and, accordingly, our public stockholders may not experience a similar rate of return on any Ordinary Shares purchased by them on the open market, which would not have the benefit of any such discounts. Any such at-the-market purchases may make it harder for our shareholders to profit from their investments in our Company, when compared to Yorkville or otherwise.

 

34
 

 

Moreover, although the SEPA provides that we may sell up to an aggregate of $25,000,000 of our Ordinary Shares to Yorkville, 4,000,000 Ordinary Shares are being registered for resale under the registration statement that includes this prospectus. If we elect to sell to Yorkville all of the 4,000,000 Ordinary Shares being registered for resale under this prospectus, depending on the market price of our Ordinary Shares prior to each advance made pursuant to SEPA, the actual gross proceeds from the sale of all such shares may be substantially less than the $25,000,000 available to us under the SEPA, which could materially adversely affect our liquidity.

 

If it becomes necessary for us to issue and sell to Yorkville under the SEPA more than the 4,000,000 shares being registered for resale under this prospectus in order to receive aggregate gross proceeds equal to $25,000,000 under the SEPA, we must file with the SEC one or more additional registration statements to register under the Securities Act the resale by Yorkville of any such additional Ordinary Shares we wish to sell from time to time under the SEPA, which the SEC must declare effective. Any issuance and sale by us under the SEPA of Ordinary Shares in addition to the 4,000,000 Ordinary Shares being registered for resale by Yorkville under the registration statement that includes this prospectus could cause additional dilution to our shareholders.

 

We are not required or permitted to issue any Ordinary Shares under the SEPA if such issuance would breach our obligations under the rules or regulations of Nasdaq. In addition, Yorkville will not be required to purchase any Ordinary Shares if such sale would result in Yorkville’s beneficial ownership exceeding 4.99% of the then issued and outstanding Ordinary Shares. Our inability to access a part or all of the amount available under the SEPA, in the absence of any other financing sources, could have a material adverse effect on our business.

 

The sale and issuance of our Ordinary Shares to Yorkville will cause dilution to our existing shareholders, and the sale of the Ordinary Shares acquired by Yorkville, or the perception that such sales may occur, could cause the price of our Ordinary Shares to fall.

 

The purchase price for the shares that we may sell to Yorkville under the SEPA will fluctuate based on the price of our Ordinary Shares. Depending on a number of factors, including market liquidity, sales of such shares may cause the trading price of our Ordinary Shares to fall. If and when we do sell shares to Yorkville, Yorkville may resell all, some, or none of those shares at its discretion, subject to the terms of the SEPA. Therefore, sales to Yorkville by us could result in substantial dilution to the interests of other holders of our Ordinary Shares. Additionally, the sale of a substantial number of Ordinary Shares to Yorkville, or the anticipation of such sales, could make it more difficult for us to sell equity or equity-related securities in the future at a desirable time and price. The resale of shares Ordinary Shares by Yorkville in the public market or otherwise, including sales pursuant to this prospectus, or the perception that such sales could occur, could also harm the prevailing market price of our Ordinary Shares.

 

Following these issuances described above and following the expiration of lock-ups of certain other restricted shareholders and as restrictions on resale end and registration statements are available for use, the market price of our Ordinary Shares could decline if the holders of restricted or locked up shares sell them or are perceived by the market as intending to sell them. As such, sales of a substantial number of Ordinary Shares in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of Ordinary Shares.

 

Investors who buy Ordinary Shares at different times will likely pay different prices

 

Pursuant to the SEPA, we control the timing and amount of any sales of Ordinary Shares to Yorkville. If and when we elect to sell Ordinary Shares to Yorkville pursuant to the SEPA, Yorkville may resell all, some or none of such shares at its discretion and at different prices, subject to the terms of the SEPA. As a result, investors who purchase shares from Yorkville in this offering at different times will likely pay different prices for those shares, and so may experience different levels of dilution and in some cases substantial dilution and different outcomes in their investment results. Investors may experience a decline in the value of the shares they purchase from Yorkville in this offering as a result of future sales made by us to Yorkville at prices lower than the prices such investors paid for their shares in this offering. In addition, if we sell a substantial number of shares to Yorkville under the SEPA, or if investors expect that we will do so, the actual sales of shares or the mere existence of our arrangement with Yorkville may make it more difficult for us to sell equity or equity-related securities in the future at a desirable time and price.

 

35
 

 

Our management team will have broad discretion over the use of the net proceeds from our sale of Ordinary Shares to Yorkville, if any, and you may not agree with how we use the proceeds and the proceeds may not be invested successfully.

 

Our management team will have broad discretion as to the use of the net proceeds from our sale of Ordinary Shares to Yorkville, if any, and we could use such proceeds for purposes other than those contemplated at the time of commencement of this offering.

 

Accordingly, you will be relying on the judgment of our management team with regard to the use of those net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately. It is possible that, pending their use, we may invest those net proceeds in a way that does not yield a favorable, or any, return for us. The failure of our management team to use such funds effectively could have a material adverse effect on our business, financial condition, operating results and cash flows.

 

General Risk Factors

 

We do not expect to declare or pay dividends in the foreseeable future.

 

We do not expect to declare or pay dividends in the foreseeable future, as we anticipate that we will invest future earnings in the development and growth of our business. Therefore, holders of our securities will not receive any return on their investment unless they sell their securities, and holders may be unable to sell their securities on favorable terms or at all.

 

The Company will incur significant costs and devote substantial management time as a result of being subject to reporting requirements in the United States, which may adversely affect the operating results of the Company in the future.

 

As a company subject to reporting requirements in the United States, the Company incurs significant legal, accounting and other expenses that the Company would not have incurred as a private limited company in Ireland. For example, the Company is subject to the reporting requirements of the Exchange Act and is required to comply with the applicable requirements of the Sarbanes-Oxley Act and the Dodd-Frank Wall Street Reform and Consumer Protection Act, as well as rules and regulations subsequently implemented by the SEC, including the establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices. Compliance with these requirements increase the Company’s legal and financial compliance costs and make some activities more time consuming and costly, while also diverting management attention. In particular, the Company expects to incur significant expenses and devote substantial management effort toward ensuring compliance with the requirements of Section 404 of the Sarbanes-Oxley Act, which will increase when it is no longer an emerging growth company as defined by the JOBS Act.

 

36
 

 

The Company’s management has limited experience in operating a public company in the United States.

 

While the Company’s executive officers have experience in the management of a public company in Australia, the Company’s executive officers have limited experience in the management of a public company in the United States. The Company’s management team may not successfully or effectively manage its transition to a U.S. public company that will be subject to significant regulatory oversight and reporting obligations under federal securities laws. Their limited experience in dealing with the increasingly complex laws pertaining to U.S. public companies could be a significant disadvantage in that it is likely that an increasing amount of their time may be devoted to these activities which will result in less time being devoted to the management and growth of the Company. The Company may not have adequate personnel with the appropriate level of knowledge, experience, and training in the accounting policies, practices or internal controls over financial reporting required of public companies in the United States. The development and implementation of the standards and controls necessary for the Company to achieve the level of accounting standards required of a public company in the United States may require costs greater than expected. It is possible that the Company will be required to expand its employee base and hire additional employees to support its operations as a public company, which will increase its operating costs in future periods.

 

The stock price of the Ordinary Shares may be volatile.

 

The market price of the Ordinary Shares may be volatile. In addition to factors discussed elsewhere in this Risk Factors section, the market price of the Ordinary Shares may fluctuate significantly in response to numerous factors, many of which are beyond the Company’s control, including:

 

overall performance of the equity markets;
   
actual or anticipated fluctuations in the Company’s revenue and other operating results;
   
changes in the financial projections the Company may provide to the public or the failure to meet these projections;
   
failure of securities analysts to initiate or maintain coverage of the Company, changes in financial estimates by any securities analysts who follow the Company or the Company’s failure to meet these estimates of the expectations of investors;
   
the issuance of reports from short sellers that may negatively impact the trading price of the Ordinary Shares;
   
the Company’s stock being targeted by “naked” short sellers or other manipulative acts;
   
recruitment or departure of key personnel;
   
the economy as a whole and market conditions in the Company’s industry;
   
new laws, regulations, subsidies, or credits or new interpretations of them applicable to the Company’s business;
   
negative publicity related to real or perceived quality of the Company’s products;
   
rumors and market speculation involving the Company or other companies in the Company’s industry;
   
announcements by the Company or its competitors of significant technical innovations, acquisitions, strategic partnerships, or capital commitments;
   
lawsuits threatened or filed against the Company;

 

37
 

 

other events or factors including those resulting from war, incidents of terrorism or responses to these events or events related to changes, attempted changes, or anticipated changes in the Israeli or other legal or governmental system in jurisdictions in which the Company is active;
   
the expiration of contractual lock-up or market standoff agreements; and
   
sales or anticipated sales of shares of the Ordinary Shares by the Company or the Company’s shareholders.

 

In addition, the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. Stock prices of many companies have fluctuated in a manner unrelated or disproportionate to the operating performance of those companies. In the past, stockholders have instituted securities class action litigation following periods of market volatility.

 

The Company may issue additional Ordinary Shares or other equity securities without seeking approval of the Company’s shareholders, which would dilute your ownership interests and may depress the market price of the Ordinary Shares.

 

The Company has warrants and other convertible securities outstanding to purchase approximately 14 million Ordinary Shares (including over $8 million outstanding pre-funded warrants), compared to 18,186,028 Ordinary Shares issued and outstanding, as of February 26, 2024. Further, the Company may choose to seek third party or other financing to provide additional working capital, in which event the Company may issue additional equity securities. The Company may also issue additional Ordinary Shares or other equity securities of equal or senior rank in the future for any reason or in connection with, among other things, future acquisitions, the redemption of outstanding warrants, or repayment of outstanding indebtedness, without shareholder approval, in a number of circumstances.

 

The Company’s issuance of additional Ordinary Shares or other equity securities of equal or senior rank would have the following effects:

 

The Company’s existing shareholders’ proportionate ownership interest in the Company will decrease;
   
the amount of cash available per share, including for payment of dividends in the future, may decrease;
   
the relative voting strength of each previously outstanding Ordinary Share may be diminished; and
   
the market price of the Ordinary Shares may decline.

 

The Company is an “emerging growth company” and it cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make the Ordinary Shares less attractive to investors.

 

The Company is an “emerging growth company” as defined in the JOBS Act. As an emerging growth company, the Company is only required to provide two years of audited financial statements and only two years of related selected financial data and management discussion and analysis of financial condition and results of operations disclosure. In addition, the Company is not required to obtain auditor attestation of its reporting on internal control over financial reporting, has reduced disclosure obligations regarding executive compensation and is not required to hold non-binding advisory votes on executive compensation. In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of these accounting standards until they would otherwise apply to private companies. The Company has elected to take advantage of such extended transition period. The Company cannot predict whether investors will find the Ordinary Shares to be less attractive as a result of its reliance on these exemptions. If some investors find the Ordinary Shares to be less attractive as a result, there may be a less active trading market for the Ordinary Shares and the price of the Ordinary Shares may be more volatile.

 

The Company will remain an emerging growth company until the earliest of: (i) the end of the fiscal year in which the Company has total annual gross revenue of $1.07 billion; (ii) the last day of the Company’s fiscal year following the fifth anniversary of the date on which Lionheart consummated its initial public offering; (iii) the date on which the Company issues more than $1.0 billion in non-convertible debt during the preceding three-year period; or (iv) the end of the fiscal year in which the market value of the Ordinary Shares held by non- affiliates exceeds $700 million as of the last business day of its most recently completed second fiscal quarter.

 

38
 

 

Further, there is no guarantee that the exemptions available to the Company under the JOBS Act will result in significant savings. To the extent that the Company chooses not to use exemptions from various reporting requirements under the JOBS Act, it will incur additional compliance costs, which may impact the Company’s financial condition.

 

The Company will need additional capital in the future to meet its financial obligations and to pursue its business objectives. Additional capital may not be available on favorable terms, or at all, which could compromise the Company’s ability to meet its financial obligations and grow its business.

 

The Company will need to raise additional capital to fund operations in the future, pay substantial existing liabilities and obligations, and possibly finance future growth of acquisitions.

 

If the Company seeks to raise additional capital in order to meet various objectives, including developing existing or future technologies and solutions, refinancing or repaying indebtedness or other liabilities or obligations, increasing working capital, acquiring new clients, expanding geographically and responding to competitive pressures, capital may not be available on favorable terms or may not be available at all, which could have a material adverse effect on the continued development or growth of the Company. Lack of sufficient capital resources could significantly limit the Company’s ability to take advantage of business and strategic opportunities. Any additional capital raised through the sale of equity or debt securities with an equity component would dilute stock ownership. If adequate additional funds are not available, the Company may be required to delay, reduce the scope of, or eliminate material part of its business strategy, including acquiring potential new clients or the continued development of new or existing technologies or solutions and geographic expansion.

 

There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq. If we are not able to comply with the applicable continued listing requirements or standards of the Nasdaq Capital Markets, Nasdaq could delist our Ordinary Shares and Public Warrants.

 

The Company’s Ordinary Shares and Public Warrants are currently listed on the Nasdaq Capital Market, after failing to meet all of the listing standards of the Nasdaq Global Market. In order to maintain that listing, we must satisfy minimum financial and other continued listing requirements and standards, including those regarding minimum stockholders’ equity, minimum market value, minimum share price, and certain corporate governance requirements.

 

On January 26, 2024, the Company received a deficiency letter from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market, LLC (“Nasdaq”), notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) for continued listing on the Nasdaq Capital Market, as the bid price of the Company’s ordinary shares on the Nasdaq Capital Market was below $1.00 for 30 consecutive business days, from December 11, 2023 to January 25, 2024.

 

In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”), the Company has a period of 180 calendar days, or until July 24, 2024 (the “Compliance Date”), to regain compliance with the Minimum Bid Price Requirement. If, at any time before the Compliance Date, the closing bid price of the Company’s ordinary shares is at least $1.00 for a minimum of ten consecutive business days, the Staff will provide a written confirmation to the Company that it has regained compliance with the Minimum Bid Price Requirement.

 

If the Company does not regain compliance with the Minimum Bid Price Requirement by the Compliance Date, the Company may be eligible for additional time. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Minimum Bid Price Requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, by effecting a reverse stock split, if necessary. If the Company meets these requirements, Nasdaq will inform the Company that it has been granted an additional 180 calendar days. However, if it appears to Nasdaq that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that its securities will be subject to delisting. At that time, the Company may appeal the Staff’s delisting determination to a Nasdaq Listing Qualifications Panel (the “Panel”) pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. However, there can be no assurance that, if the Company receives a delisting notice and appeals the delisting determination by the Staff to the Panel, such appeal would be successful.

 

39
 

 

Additionally, there can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price Requirement, or will otherwise be compliant with other Nasdaq Listing Rules.

 

If Nasdaq delists the Ordinary Shares and/or the Public Warrants from trading on its exchange for failure to meet the listing standards, we and our stockholders could face significant material adverse consequences including:

 

a limited availability of market quotations for our securities;
   
reduced liquidity for our securities;
   
a determination that the Ordinary Shares is a “penny stock” which will require brokers trading in the Ordinary Shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities;
   
a limited amount of news and analyst coverage; and
   
a decreased ability to issue additional securities or obtain additional financing in the future.

 

The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” To the extent the Ordinary Shares and Public Warrants are listed on Nasdaq, they are covered securities. Although the states are preempted from regulating the sale of our securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. Further, if we were no longer listed on Nasdaq, our securities would not be covered securities and we would be subject to regulation in each state in which we offer our securities.

 

Future issuances of debt securities and equity securities may adversely affect us, including the market price of our Ordinary Shares and may be dilutive to existing shareholders.

 

We expect that significant additional capital will be needed in the future to continue our planned research, development and business operations. In the future, we may incur debt or issue equity ranking senior to our Ordinary Shares. Those securities will generally have priority upon liquidation. Such securities also may be governed by an indenture or other instrument containing covenants restricting our operating flexibility. Additionally, any convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than those of Ordinary Shares. Because our decision to issue debt or equity in the future will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing, nature or success of our future capital raising efforts. As a result, recent and future capital raising efforts may reduce the market price of Ordinary Shares and be dilutive to existing shareholders. In addition, our ability to raise additional capital through the sale of equity or convertible debt securities could be significantly impacted by the resale of Ordinary Shares by selling shareholders pursuant to one or more prospectuses, which could result in a significant decline in the trading price of Ordinary Shares and potentially hinder our ability to raise capital at terms that are acceptable to us or at all.

 

The JOBS Act permits “emerging growth companies” like the Company to take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies, which may make our Ordinary Shares less attractive to investors.

 

The Company currently qualifies as an “emerging growth company” as defined in Section 2(a)(19) of the Securities Act, as modified by the Jumpstart Its Business Startups Act of 2012, which is referred to as the “JOBS Act.” As such, the Company takes advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies for as long as it continues to be an emerging growth company, including the exemption from the auditor attestation requirements with respect to internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act. As a result, Company shareholders may not have access to certain information they deem important.

 

40
 

 

The Company cannot predict if investors will find Ordinary Shares less attractive because it relies on these exemptions. If some investors find Ordinary Shares less attractive as a result, there may be a less active trading market and share price for Ordinary Shares may be more volatile. The Company may incur increased legal, accounting and compliance costs associated with Section 404 of the Sarbanes-Oxley Act.

 

There is expected to be less publicly available information concerning the Company than there is for issuers that are not foreign private issuers because the Company will be considered a foreign private issuer and will be exempt from a number of rules under the Exchange Act, and will be permitted to file less information with the SEC than issuers that are not foreign private issuers.

 

The Company is considered a “foreign private issuer” under the Exchange Act. A foreign private issuer under the Exchange Act is exempt from certain rules under the Exchange Act, and is not required to file periodic reports and financial statements with the SEC as frequently or as promptly as companies whose securities are registered under the Exchange Act but are not foreign private issuers, or to comply with Regulation FD, which restricts the selective disclosure of material non-public information. The Company is exempt from certain disclosure and procedural requirements applicable to proxy solicitations under Section 14 of the Exchange Act. SMX currently prepares its financial statements in accordance with IFRS. The Company will not be required to file financial statements prepared in accordance with or reconciled to U.S. GAAP so long as its financial statements are prepared in accordance with IFRS as issued by the International Accounting Standards Board. The Company is not required to comply with Regulation FD, which imposes restrictions on the selective disclosure of material information to shareholders. The members of the Company’s board of directors, officers and principal shareholders are exempt from the reporting and “short-swing” profit recovery provisions of Section 16 of the Exchange Act with respect to their purchases and sales of Company securities. Accordingly, there will likely be less publicly available information concerning the Company than there is for companies whose securities are registered under the Exchange Act but are not foreign private issuers, and such information may not be provided as promptly as it is provided by such companies.

 

In addition, certain information may be provided by the Company in accordance with Irish law, which may differ in substance or timing from such disclosure requirements under the Exchange Act. As a foreign private issuer, under Nasdaq rules the Company is subject to less stringent corporate governance requirements. Subject to certain exceptions, the rules of Nasdaq permit a foreign private issuer to follow its home country practice in lieu of the listing requirements of Nasdaq, including, for example, certain internal controls as well as board, committee and director independence requirements. The Company intends from time to time to follow Irish corporate governance practices in lieu of Nasdaq corporate governance rules and most recently (a) followed Irish practices to amend its 2022 Incentive Equity Plan to increase the number of authorized shares under such plan without shareholder approval and (b) followed home country practice in lieu of the requirements under Nasdaq Rule 5635(d) to seek shareholder approval in connection with certain transactions involving the sale, issuance and potential issuance of its Ordinary Shares (or securities convertible into or exercisable for its Ordinary Shares) at a price less than certain referenced prices, if such shares equal 20% or more of the Company’s Ordinary Shares or voting power outstanding before the issuance, each as permitted under Irish law, and we cannot assure you that we will not avail ourselves of other such exceptions in the future. If the Company determines to follow Irish corporate governance practices in lieu of Nasdaq corporate governance standards, the Company will disclose each Nasdaq rule that it does not intend to follow and describe the Irish practice that the Company will follow in lieu thereof.

 

The Company may lose its foreign private issuer status in the future, which could result in significant additional costs and expenses. This would subject the Company to GAAP reporting requirements which may be difficult for it to comply with.

 

As a “foreign private issuer,” the Company would not be required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act and related rules and regulations. Under those rules, the determination of foreign private issuer status is made annually on the last business day of an issuer’s most recently completed second fiscal quarter.

 

In the future, the Company could lose its foreign private issuer status if a majority of its Ordinary Shares are held by residents in the United States and it fails to meet any one of the additional “business contacts” requirements. Although the Company intends to follow certain practices that are consistent with U.S. regulatory provisions applicable to U.S. companies, the Company’s loss of foreign private issuer status would make such provisions mandatory. The regulatory and compliance costs to the Company under U.S. securities laws if it is deemed a U.S. domestic issuer may be significantly higher. If the Company is not a foreign private issuer, the Company will be required to file periodic reports and prospectuses on U.S. domestic issuer forms with the SEC, which are more detailed and extensive than the forms available to a foreign private issuer. For example, the Company would become subject to the Regulation FD, aimed at preventing issuers from making selective disclosures of material information. The Company also may be required to modify certain of its policies to comply with good governance practices associated with U.S. domestic issuers. Such conversion and modifications will involve additional costs. In addition, the Company may lose its ability to rely upon exemptions from certain corporate governance requirements of Nasdaq that are available to foreign private issuers. For example, Nasdaq’s corporate governance rules require listed companies to have, among other things, a majority of independent board members and independent director oversight of executive compensation, nomination of directors, and corporate governance matters. As a foreign private issuer, the Company would be permitted to follow home country practice in lieu of the above requirements. As long as the Company relies on the foreign private issuer exemption to certain of Nasdaq’s corporate governance standards, a majority of the directors on its board of directors are not required to be independent directors, its compensation committee is not required to be comprised entirely of independent directors, and it will not be required to have a nominating committee. Also, the Company would be required to change its basis of accounting from IFRS as issued by the IASB to GAAP, which may be difficult and costly for it to comply with. If the Company loses its foreign private issuer status and fails to comply with U.S. securities laws applicable to U.S. domestic issuers, the Company may have to de-list from Nasdaq and could be subject to investigation by the SEC, Nasdaq and other regulators, among other materially adverse consequences.

 

41
 

 

COMMITTED EQUITY FINANCING

 

On February 23, 2023, we entered into the SEPA effective March 7, 2023 with Yorkville pursuant to which we have the right to sell to Yorkville up to $25,000,000 of our Ordinary Shares, subject to certain limitations and conditions set forth in the SEPA, from time to time during the term of the SEPA. All references to sales of our Ordinary Shares by us to Yorkville in this section relate to Yorkville subscribing, on the terms described in this section, for newly issued Ordinary Shares in the Company and all references to ‘sales’ or ‘sell’ shall be construed accordingly. Sales of Ordinary Shares to Yorkville under the SEPA, and the timing of any such sales, are at our option, and we are under no obligation to sell any securities to Yorkville under the SEPA. In accordance with our obligations under the SEPA, we have filed:

 

A Registration Statement on Form F-1 (Registration No. 333-272503), as supplemented, which registered under the Securities Act the resale by Yorkville of up to 4,516,464 Ordinary Shares that were issued and sold to Yorkville, under the SEPA (the “Initial Yorkville Registration Statement”);
A Registration Statement on Form F-1 (Registration No. 333-274378), as supplemented, which registered under the Securities Act the resale by Yorkville of up to 1,406,853 Ordinary Shares that were issued and sold to Yorkville, under the SEPA (the “Second Yorkville Registration Statement”);
A Registration Statement on Form F-1 (Registration No. 333-276258), as supplemented, which registered under the Securities Act the resale by Yorkville of up to 1,400,000 Ordinary Shares that were issued and sold to Yorkville, under the SEPA (the “Third Yorkville Registration Statement”); and
The registration statement that includes this prospectus with the SEC to register under the Securities Act the resale by Yorkville of up to an additional 4,000,000 Ordinary Shares that we may elect, in our sole discretion, to issue and sell to Yorkville, under the SEPA.

 

Upon the satisfaction of the conditions to Yorkville’s purchase obligation set forth in the SEPA, including that the registration statement of which this prospectus forms a part be declared effective by the SEC and the final form of this prospectus is filed with the SEC, we will have the right, but not the obligation, from time to time at our discretion until the first day of the month following the 36-month period after the date of the SEPA, to direct Yorkville to purchase a specified amount of Ordinary Shares (each such sale, an “Advance”) by delivering written notice to Yorkville (each, an “Advance Notice”). While there is no mandatory minimum amount for any Advance, it may not exceed the lesser of (i) an amount equal to one hundred percent (100%) of the average of the Daily Traded Amount during the five consecutive Trading Day immediately preceding an Advance Notice, or (ii) 1 million Common Shares.

 

The Ordinary Shares purchased pursuant to an Advance will be purchased at a price equal to (i) 96% of the VWAP of the Ordinary Shares during the period commencing upon receipt by the Company of written confirmation of acceptance of such Advance Notice by Yorkville, and which confirmation shall specify such commencement time, and ending on 4:00 p.m. New York City time on the applicable Advance Notice Date, subject to a 30% volume threshold as described below and in the SEPA or (ii) 97% of the lowest daily VWAP of the Ordinary Shares during the three consecutive trading days commencing on the Advance Notice Date; provided, however, that with respect to any clause (ii) Advance the Company may establish a minimum acceptable price in each Advance Notice below which the Company will not be obligated to make any sales to Yorkville. Other than such minimum acceptable price in a clause (ii) Advance, there is no pricing floor with respect to the Advances. “VWAP” means, for any trading day, the daily volume weighted average price of the Ordinary Shares for such trading day on the Nasdaq Stock Market during regular trading hours as reported by Bloomberg L.P.

 

Accordingly, as may otherwise be limited by Yorkville’s 4.99% beneficial ownership limitation and by the 30% volume threshold described below and in the SEPA, assuming we elect option (i) above (i.e., 96% of VWAP) for all Advances and there are no fluctuations in our Ordinary Shares’ trading price, assuming a stock price of $0.2659 (the closing price on February 26, 2024), we would receive gross proceeds per share of approximately $0.2553 per share, or approximately $1,021,200 if all of the Ordinary Shares registered pursuant to the Registration Statement on Form F-1 of which this prospectus forms a part, are sold. In such event, Yorkville would receive a profit of approximately $0.0106 per share, or approximately $42,400, if it sold all of such shares at the closing price of $0.2659 per share.

 

Similarly, as may otherwise be limited by Yorkville’s 4.99% beneficial ownership limitation and by the “minimum acceptable price” we may indicate with respect to each Advance, assuming we elect option (ii) above (i.e., 97% of average VWAP) for all Advances and there are no fluctuations in our Ordinary Shares’ trading price, assuming a stock price of $0.2659 (the closing price on February 26, 2024), we would receive gross proceeds per share of approximately $0.2579 per share, or approximately $1,031,600 if all of the Ordinary Shares registered pursuant to the Registration Statement on Form F-1 of which this prospectus forms a part, are sold. In such event, Yorkville would receive a profit of approximately $0.008 per share, or approximately $32,000, if it sold all of such shares at the closing price of $0.2659 per share.

 

42
 

 

Based on the 18,186,028 Ordinary Shares issued and outstanding as of the date of this prospectus, and assuming no sale of any Ordinary Shares purchased by Yorkville pursuant to one or more Advances, Yorkville would be able to purchase an aggregate of approximately 907,482 Ordinary Shares before it is limited by the 4.99% beneficial ownership limitation set forth in the SEPA. Any subsequent sales of our Ordinary Shares by Yorkville would reduce the number of Ordinary Shares owned by it and permit it to purchase more Ordinary Shares pursuant to Advances without hitting any of the ownership limitations to the extent of such reductions. Additionally, any decrease in our stock price would result in more of our Ordinary Shares being sold to Yorkville for the same amount of proceeds, and any of the ownership or registration limitations described in this section could then prevent us from raising a portion of the capital available under the SEPA.

 

In connection with an Advance Notice by the Company selecting an Option 1 Pricing Period, if the total number of Ordinary Shares traded on the Principal Market during the applicable Pricing Period is less than the Volume Threshold, then the number of Advance shares issued and sold pursuant to such Advance Notice shall be reduced to the greater of (a) 30% of the trading volume of the Company’s Ordinary Shares on the Principal Market during the Pricing Period as reported by Bloomberg L.P., or (b) the number of Ordinary Shares sold by the Investor during such Pricing Period, but not to exceed the amount requested in the Advance Notice. “Volume Threshold” shall mean a number of Ordinary Shares equal to the quotient of (a) the number of Advance shares requested by the Company in an Advance Notice divided by (b) 0.30.

 

We will control the timing and amount of any sales of Ordinary Shares to Yorkville, except with respect to conversions of the Pre-Paid Advances. Actual sales of our Ordinary Shares to Yorkville as an Advance under the SEPA will depend on a variety of factors to be determined by us from time to time, which may include, among other things, market conditions, the trading price of our Ordinary Shares and determinations by us as to the appropriate sources of funding for our business and operations.

 

In addition, at any time during the term of the SEPA, provided that there is a balance remaining outstanding under a promissory note evidencing a Pre-Paid Advance (as described above, and further below under “-Advances of Ordinary Shares Under the SEPA-Pre-Paid Advance”), Yorkville may cause an Advance Notice to be deemed delivered to the Company and the issuance and sale of the Company’s ordinary shares to Yorkville pursuant to an Advance, in accordance with the terms and subject to the limitations set forth in the SEPA.

 

The net proceeds under the SEPA to us will depend on the frequency and prices at which we sell Ordinary Shares to Yorkville. We expect that any proceeds received by us from such sales to Yorkville will be used for working capital and general corporate purposes. While Yorkville may experience a positive rate of return based on the current trading price of our Ordinary Shares, our public securityholders may not experience a similar rate of return on the ordinary shares they purchased due to differences in the purchase prices and the then current trading price at the time of any sale.

 

Yorkville has agreed that it and its affiliates will not engage in any short sales of the Ordinary Shares nor enter into any transaction that establishes a net short position in the Ordinary Shares during the term of the SEPA.

 

The SEPA will automatically terminate on the earliest to occur of (i) the first day of the month next following the 36-month anniversary of the date of the SEPA or (ii) the date on which Yorkville shall have made payment of Advances pursuant to the SEPA for Ordinary Shares equal to $25,000,000. We have the right to terminate the SEPA at no cost or penalty upon five (5) trading days’ prior written notice to Yorkville, provided that there are no outstanding Advance Notices for which Ordinary Shares need to be issued and the Company has paid all amounts owed to Yorkville pursuant to the SEPA. We and Yorkville may also agree to terminate the SEPA by mutual written consent. Neither we nor Yorkville may assign or transfer our respective rights and obligations under the SEPA, and no provision of the SEPA may be modified or waived by us or Yorkville other than by an instrument in writing signed by both parties.

 

43
 

 

As consideration for Yorkville’s commitment to purchase Ordinary Shares at our direction upon the terms and subject to the conditions set forth in the SEPA, we paid Yorkville, (i) a due diligence fee in the amount of $15,000 and (ii) a commitment fee in an amount equal to 1.5% of the Commitment Amount by the issuance of such number of Ordinary Shares that is equal to the Commitment Fee divided by the average daily VWAPs of our Ordinary Shares during the 3 Trading Days immediately following the closing of the Business Combination or 92,315 Ordinary Shares.

 

The SEPA contains customary representations, warranties, conditions and indemnification obligations of the parties. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.

 

We do not know what the purchase price for our Ordinary Shares will be and therefore cannot be certain as to the number of shares we might issue to Yorkville under the SEPA. As of February 26, 2024, there were 18,186,028 Ordinary Shares outstanding. Although the SEPA provides that we may sell up to $25,000,000 of our Ordinary Shares to Yorkville, 4,516,464 Ordinary Shares were registered for resale under the Initial Yorkville Registration Statement (all of which have been sold thereunder by Yorkville as of the date of this prospectus), 1,406,853 Ordinary Shares were registered for resale under the Second Yorkville Registration Statement (all of which have been sold thereunder by Yorkville as of the date of this prospectus), 1,400,000 Ordinary Shares were registered for resale under the Third Yorkville Registration Statement (of which 1,125,604 have been sold thereunder by Yorkville as of the date of this prospectus), and 4,000,000 Ordinary Shares are being registered for resale under the registration statement that includes this prospectus.

 

If and when we elect to issue and sell shares to Yorkville, we may need to register for resale under the Securities Act additional Ordinary Shares in order to receive aggregate gross proceeds equal to the $25,000,000 available to us under the SEPA, depending on market prices for our Ordinary Shares. If all of the 4,000,000 shares offered by Yorkville for resale under the registration statement that includes this prospectus were issued and outstanding as of the date hereof, such shares would represent approximately 18.03% of the total number of Ordinary Shares outstanding as of February 26, 2024. If we elect to issue and sell more than the 4,516,464 Ordinary Shares registered for resale under the Initial Yorkville Registration Statement, the 1,406,853 Ordinary Shares offered under the Second Yorkville Registration Statement, the 1,400,000 Ordinary Shares offered under the Third Yorkville Registration Statement and the 4,000,000 Ordinary Shares offered under this prospectus to Yorkville, we must first register for resale under the Securities Act any such additional shares, which could cause additional dilution to our shareholders. The number of shares ultimately offered for resale by Yorkville is dependent upon the number of Ordinary Shares we may elect to sell to Yorkville under the SEPA.

 

There are substantial risks to our shareholders as a result of the sale and issuance of Ordinary Shares to Yorkville under the SEPA. These risks include the potential for substantial dilution and significant declines in our share price. See the section entitled “Risk Factors.” Issuances of our Ordinary Shares in this offering will not affect the rights or privileges of our existing shareholders, except that the economic and voting interests of each of our existing shareholders will be diluted as a result of any such issuance. Although the number of Ordinary Shares that our existing shareholders own will not decrease as a result of sales, if any, under the SEPA, the shares owned by our existing shareholders will represent a smaller percentage of our total outstanding shares after any such issuance to Yorkville.

 

The below summary is qualified in its entirety by reference to the SEPA, a copy of which is filed as Exhibit 10.23 to the Registration Statement on Form F-1 of which this prospectus forms a part.

 

 44 

 

 

Advances of Ordinary Shares Under the SEPA

 

Pre-Paid Advance

 

In connection with the SEPA, and subject to the condition set forth therein, Yorkville advanced to the Company in the form of convertible promissory notes in an aggregate principal amount of $3.5 million (the “Pre-Paid Advance”). The Pre-Paid Advance was disbursed in two separate installments, the first for $1.5 million at the closing of the Business Combination, which was funded on March 9, 2023 and the second for $2 million upon the effectiveness of the Initial Yorkville Registration Statement. The purchase price for the Pre-Paid Advance is 92.0% of the Pre-Paid Advance. Such Pre-Paid Advances will be offset upon the issuance of Ordinary Shares to Yorkville at a price per share equal to the lower of (a) 100% of the daily VWAP of the Ordinary Shares on The Nasdaq Stock Market as of the trading day immediately prior to the date of the disbursement of the Pre-Paid Advance (the “Fixed Price”) (in the case of the first Pre-Paid Advance, $3.65), or (b) 93.0% of the lowest daily VWAP of the Ordinary Shares on Nasdaq during the seven trading days immediately prior to each purchase (the “Variable Price” and the lower of the Fixed Price and the Variable Price shall be referred to as the “Purchase Price”); however, in no event shall the Purchase Price be less $1.10 (the “Floor Price”). On July 27, 2023, we amended the promissory note evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (adjusted pursuant to the Reverse Stock Split), after we were required to repay in cash $500,000 of principal as a result of our stock price being below the original Floor Price as discussed further below. For example, with a Floor Price of $1.10 per share, the remaining outstanding Pre-Paid Advance of $470,334 are converted in full at such price may be converted into a maximum of over 427,576 shares, although that amount will be limited by the limitations set forth in the SEPA, such as the 4.99% beneficial ownership limitation and, accordingly, it is unlikely that the Company will be required to issue all such shares, even assuming all of such shares are registered by the Company for resale. Interest shall accrue on the outstanding balance of any Pre-Paid Advance at an annual rate equal to 0%, subject to an increase to 15% upon an event of default as described in the applicable promissory note. The maturity date will be 12-months after the initial closing of the Pre-Paid Advance. In July 2023, we repaid in full the first Pre-Paid Advance in the amount of $1.5 million, through a combination of cash and issuance of our Ordinary Shares upon conversion of the convertible note evidencing such first Pre-Paid Advance in accordance with its terms. Accordingly, as of the date of this prospectus, we have outstanding Pre-Paid Advances of $470,334 which are subject to conversion or repayment.

 

If, any time after a Pre-Paid Advance is issued, the daily VWAP is less than the Floor Price for five Trading Days during a period of 7 consecutive Trading Days (a “Floor Price Trigger”), or (ii) the Company has issued in excess of 95% of the Ordinary Shares available under the Exchange Cap (an “Exchange Cap Trigger”) (the last such day of each such occurrence, a “Trigger Date”) (a “Trigger Event”), the Company shall make monthly payments beginning on the 10th trading day after the Trigger Date and continuing on the same day of each successive calendar month, unless waived by Yorkville in its sole discretion. Each monthly payment shall be in an amount equal to the sum of (i) $500,000 of Principal in the aggregate among all promissory notes issued to the Investor (or the outstanding principal if less than such amount) (the “Triggered Principal Amount”), plus (ii) a payment premium of 7% in respect of such Triggered Principal Amount, and (iii) accrued and unpaid interest hereunder as of each payment date. The obligation of the Company to make monthly prepayments shall cease (with respect to any payment that has not yet come due) if any time after the Trigger Date (A) the daily VWAP is greater than the 110% of the Floor Price a period of five consecutive Trading Days in the event of a Floor Price Trigger, or (B) the date the Company has obtained stockholder approval to increase the number of Common Stock under the Exchange Cap and/or the Exchange Cap no longer applies, in the event of an Exchange Cap Trigger, unless a subsequent Trigger Event occurs. As stated above, in July 2023, the Floor Price Trigger was tripped and we paid one month of the Triggered Principal Amount plus the 7% payment premium. We amended the Floor Price to decrease it from $0.20506 to $0.05 ($1.10 as adjusted pursuant to the Reverse Stock Split) to conserve our cash resources and cease such Floor Price Trigger.

 

In addition, in the event there is a balance under any of the promissory notes evidencing a Pre-Paid Advance, Yorkville may cause an Advance Notice to be deemed delivered to the Company and the issuance and sale of Ordinary Shares to Yorkville pursuant to the Advance, all in accordance with the provisions described in the SEPA.

 

On February 2, 2024, the Company entered into a Letter Agreement with Yorkville dated February 1, 2024 (the “Letter Agreement”), which amends and supplements the SEPA.

 

Pursuant to the Letter Agreement, the Company agreed to make payments to Yorkville, which may include proceeds of Advances under the SEPA, to repay the amounts outstanding under the May Pre-Paid Advance plus Payment Premium (as defined in the SEPA), until all such amounts are fully repaid, and shall use commercially reasonable best efforts to do so by April 1, 2024. The Letter Agreement further provided that any proceeds from any capital raise after April 1, 2024, other than Advances under the SEPA, will be utilized to pay down outstanding principal, outstanding default interest and Payment Premium under the May Pre-Paid Advance. As a result, subsequent to the effective date of the Letter Agreement, the Company issued an aggregate of 1,000,000 Ordinary Shares as advances, the proceeds of which were applied to pay the first $100,000 fee described below and the remainder to repay a portion of the principal and interest outstanding under the convertible promissory note evidencing the remaining Pre-paid Advance.

 

 45 

 

 

The Company agreed to pay a fee to Yorkville equal to $200,000, of which $100,000 shall be payable from the next Advance after the date of the Letter Agreement and $100,000 shall be payable by April 1, 2024 (the “Second Tranche Fee”); provided, that the Second Tranche Fee will not be due if the total amount due and outstanding under the May Pre-Paid Advance is paid in full by April 1, 2024.

 

The Company further agreed to issue to Yorkville a 5-year warrant to purchase 250,000 ordinary shares of the Company at an exercise price of $0.0022 per share.

 

The issuance of the Ordinary Shares under the SEPA will be subject to certain limitations, including that (i) Yorkville may not purchase any Ordinary Shares that would result in it owning more than 4.99% of the Company’s Ordinary Shares or (ii) the aggregate number of Ordinary Shares issued pursuant to Pre-Paid Advances (including the aggregation with the issuance of Ordinary Shares under other Advances cannot exceed 19.9% of the Company’s Ordinary Shares as of as of the date of the SEPA (referred to as the “Exchange Cap”). The Exchange Cap shall not be applicable if: (i) the Company’s stockholders have approved the issuance of Common Shares in excess of the Exchange Cap in accordance with the applicable rules of the Principal Market or (ii) to the extent that (and only for so long as) the Average Price for the issuance of Ordinary Shares equals or exceed the lower of (i) the Nasdaq Official Closing Price (as reflected on Nasdaq.com) immediately preceding the 6th Trading Day following the date of closing of the Business Combination (the “Effective Date”); or (ii) the average Nasdaq Official Closing Price for the five Trading Days immediately preceding the Effective Date.

 

Termination of the SEPA

 

Unless earlier terminated as provided in the SEPA, the SEPA will terminate automatically on the earliest to occur of:

 

the first day of the month next following the 36-month anniversary of the date of the SEPA; and
   
the date on which Yorkville shall have purchased Ordinary Shares under the SEPA for an aggregate gross purchase price equal to $25,000,000;

 

We also have the right to terminate the SEPA at any time, at no cost or penalty, upon five (5) trading days’ prior written notice to Yorkville, provided that there are no outstanding Advance Notices under which we are yet to issue Ordinary Shares.

 

No Short-Selling by Yorkville

 

Yorkville has agreed that it and its affiliates will not engage in any short sales during the term of the SEPA and will not enter into any transaction that establishes a net short position with respect to the Ordinary Shares. The SEPA stipulates that Yorkville may sell our Ordinary Shares to be issued pursuant to an Advance Notice, following receipt of the Advance Notice, but prior to receiving such shares and may sell other Ordinary Shares acquired pursuant to the SEPA that Yorkville has continuously held from a prior date of acquisition.

 

Effect of Sales of our Ordinary Shares under the SEPA on our Shareholders

 

All Ordinary Shares that may be issued or sold by us to Yorkville under the SEPA that are being registered under the Securities Act for resale by Yorkville in this offering are expected to be freely tradable. The Ordinary Shares being registered for resale in this offering may be issued and sold by us to Yorkville from time to time at our discretion over the term of the SEPA. The resale by Yorkville of a significant amount of shares registered for resale in this offering at any given time, or the perception that these sales may occur, could cause the market price of our Ordinary Shares to decline and to be highly volatile. Sales of our Ordinary Shares, if any, to Yorkville under the SEPA will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to Yorkville all, some or none of the Ordinary Shares that may be available for us to sell to Yorkville pursuant to the SEPA.

 

 46 

 

 

If and when we do elect to sell Ordinary Shares to Yorkville pursuant to the SEPA, Yorkville may resell all, some or none of such shares in its discretion and at different prices subject to the terms of the SEPA. As a result, investors who purchase shares from Yorkville in this offering at different times will likely pay different prices for those shares, and so may experience different levels of dilution and in some cases substantial dilution and different outcomes in their investment results. Investors may experience a decline in the value of the shares they purchase from Yorkville in this offering as a result of future sales made by us to Yorkville at prices lower than the prices such investors paid for their shares in this offering. In addition, if we sell a substantial number of shares to Yorkville under the SEPA, or if investors expect that we will do so, the actual sales of shares or the mere existence of our arrangement with Yorkville may make it more difficult for us to sell equity or equity-related securities in the future at a desirable time and price.

 

Because the purchase price per share to be paid by Yorkville for the Ordinary Shares that we may elect to sell to Yorkville under the SEPA, if any, will fluctuate based on the market prices of our Ordinary Shares during the applicable Pricing Period (as defined in the SEPA), as of the date of this prospectus we cannot reliably predict the number of Ordinary Shares that we will sell to Yorkville under the SEPA, the actual purchase price per share to be paid by Yorkville for those shares, or the actual gross proceeds to be raised by us from those sales, if any. As of February 26, 2024, there were 18,186,028 Ordinary Shares outstanding. If all of the 4,000,000 Ordinary Shares offered for resale by Yorkville under the registration statement that includes this prospectus were issued and outstanding as of the date hereof, such shares would represent approximately 18.03% of the total number of Ordinary Shares outstanding.

 

Although the SEPA provides that we may, in our discretion, from time to time after the date of this prospectus and during the term of the SEPA, direct Yorkville to purchase Ordinary Shares from us in one or more Advances under the SEPA, for a maximum aggregate purchase price of up to $25,000,000, only 4,000,000 Ordinary Shares are being registered for resale under the registration statement that includes this prospectus. Assuming all of such 4,000,000 shares were sold to Yorkville at the 96% discount to the per share price of $0.2659 (which represents the closing price of the Ordinary Shares on Nasdaq on February 26, 2024), such number of shares would be insufficient to enable us to receive aggregate gross proceeds from the sale of such shares to Yorkville equal to Yorkville’s $25,000,000 total aggregate purchase commitment under the SEPA. While the market price of our Ordinary Shares may fluctuate from time to time after the date of this prospectus and, as a result, the actual purchase price to be paid by Yorkville under the SEPA for Ordinary Shares, if any, may also fluctuate, in order for us to receive the full amount of Yorkville’s commitment under the SEPA, it is possible that we may need to issue and sell more than the number of shares being registered for resale under the registration statement that includes this prospectus.

 

The issuance, if any, of our Ordinary Shares to Yorkville pursuant to the SEPA will not affect the rights or privileges of our existing shareholders, except that the economic and voting interests of each of our existing shareholders would be diluted. Although the number of Ordinary Shares that our existing shareholders own would not decrease as a result of sales, if any, under the SEPA, the Ordinary Shares owned by our existing shareholders would represent a smaller percentage of our total outstanding Ordinary Shares after any such issuance.

 

USE OF PROCEEDS

 

All of the Ordinary Shares offered by Yorkville pursuant to this prospectus will be sold by Yorkville for its own account. We will not receive any of the direct proceeds from these sales. However, we may receive up to $25,000,000 aggregate gross proceeds from any sales we make to Yorkville pursuant to the SEPA. The net proceeds from sales, if any, under the SEPA, will depend on the frequency and prices at which we sell Ordinary Shares to Yorkville after the date of this prospectus. See the section titled “Plan of Distribution” elsewhere in this prospectus for more information.

 

We expect to use any proceeds that we receive under the SEPA for working capital and general corporate purposes. As of the date of this prospectus, we cannot specify with certainty all of the particular uses, and the respective amounts we may allocate to those uses, for any net proceeds we receive. Accordingly, we will retain broad discretion over the use of these proceeds. Pending our use of the net proceeds as described above, we intend to invest the net proceeds pursuant to the SEPA in interest-bearing, investment-grade instruments.

 

DIVIDEND POLICY

 

The holders of Ordinary Shares are entitled to such dividends as may be declared by the Company’s board of directors. Dividends may be declared and paid out of the funds legally available therefor, or any other fund or account which can be authorized for this purpose in accordance with the ICA.

 

 47 

 

 

BUSINESS

 

Vision

 

The Company envisions itself as the next generation solution provider of brand protection, authentication and track and trace technology for the anti-counterfeit market. Its vision is to build confidence in the era of the digital economy, enabling parties to maintain trust in physical assets and processes. Its transformative solution aims at building on the principles of The United Nations’ Sustainability Development Goals, particularly Goal 12: “Ensure sustainable consumption and production patterns” that can create value for participants in the circular economy. As an increasing number of industries and sectors are committing to using recycled material and realizing the broader strategic vision of net zero carbon emissions, we believe our solution is the next generation for sustainability and the circular economy.

 

History

 

SMX Israel was incorporated in 2014 to provide brand protection and supply chain integrity solutions to businesses. It provides these solutions through the commercialization of the initial technology of tracking and tracing materials by observing and identifying markers (the “Source IP”). SMX Israel’s Source IP was initiated from the Soreq Nuclear Research Center, an Israeli government research and development institute for nuclear and photonic technologies under the Israeli Atomic Energy Commission (“Soreq”). In January 2015, SMX Israel entered into the Isorad License Agreement with Isorad Ltd. (an IP holding company of Soreq) to license the Source IP and develop and commercialize the technology (the “Isorad License Agreement”). Under the Isorad License Agreement, as amended, the Source IP can be utilized in almost any industry and with any product.

 

In 2018, SMX Israel merged into Security Matters PTY, an Australian company, to effect a listing on the Australian Securities Exchange under the symbol “ASX: SMX.” Security Matters PTY was incorporated in May 2018 under Australian law. SMX’s registered address is Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6. Security Matters PTY has two wholly-owned subsidiaries: Security Matters Ltd. (Israel), and SMX Beverages Pty Ltd. (Australia). It is also the record holder of 50% of Yahaloma Technologies Inc., a Canadian company and 51.9% of trueGold Consortium Pty Ltd., an Australian company.

 

SMX (Security Matters) Public Limited Company (f/k/a Empatan Public Limited Company) was formed on July 1, 2022 as a public limited company under the name Empatan Public Limited Company, incorporated in Ireland. The Company’s principal executive office is located at Mespil Business Centre, Mespil House, Sussex Road, Dublin 4, Ireland, D04 T4A6. The Company’s telephone number is +353 1 920 1000.

 

The Company was newly incorporated for the purposes of becoming a holding company following the Business Combination. Through the consummation of the Business Combination, the Company did not conduct any material activities other than those incident to its formation and the Business Combination and only had nominal assets consisting of cash and its interest in Merger Sub.

 

On March 7, 2023 (the “Closing Date”), the Company consummated its previously announced business combination pursuant to the BCA and its previously announced SID. Beginning on the day immediately prior to the Closing Date and finishing on the day immediately after the Closing Date, the following transactions occurred pursuant to the terms of the BCA:

 

Under the SID, Security Matters PTY proposed a scheme of arrangement under Part 5.1 of the Corporations Act (“Scheme”) and Capital Reduction which resulted in all shares in Security Matters PTY being cancelled in return for the issuance of Ordinary Shares, with the Company being issued one share in Security Matters PTY (“Security Matters Shares”) (this resulted in Security Matters PTY becoming a wholly owned subsidiary of the Company);

 

 48 

 

 

 

Under the SID, Security Matters PTY proposed an option scheme of arrangement under Part 5.1 of the Corporations Act (“Option Scheme”), which resulted in the Security Matters PTY options held by participants in the Option Scheme being subject to a cashless exercise based on a Black-Scholes valuation, in exchange for Security Matters Shares. Under the Scheme those shares were cancelled and the participants received Ordinary Shares on the basis of the Scheme consideration;
   
Security Matters PTY shareholders received consideration under the Scheme of 1 Ordinary Share per 10.3624 Security Matters Shares having an implied value of $10.00 per Ordinary Share and the Company became the holder of all of the issued shares in Security Matters PTY and Lionheart, with Security Matters PTY being delisted from the Australian Stock Exchange;
   
Merger Sub merged with and into Lionheart, with Lionheart surviving the merger as a wholly owned subsidiary of the Company; and
   
Existing Lionheart stockholders received Ordinary Shares in exchange for their existing Lionheart shares and existing Lionheart warrant holders had their warrants automatically adjusted to become exercisable in respect of Ordinary Shares instead of Lionheart shares.

 

The Company is subject to certain of the informational filing requirements of the Exchange Act. Since the Company is a “foreign private issuer,” it is exempt from the rules and regulations under the Exchange Act prescribing the furnishing and content of proxy statements, and the officers, directors and principal shareholders of the Company are exempt from the reporting and “short-swing” profit recovery provisions contained in Section 16 of the Exchange Act with respect to their purchase and sale of Parent Shares. In addition, the Company is not required to file reports and financial statements with the SEC as frequently or as promptly as U.S. public companies whose securities are registered under the Exchange Act. However, the Company is required to file with the SEC an Annual Report on Form 20-F containing financial statements audited by an independent accounting firm. The SEC maintains a website at http://www.sec.gov that contains reports and other information that the Company files with or furnishes electronically to the SEC.

 

Overview

 

The Company provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

 

Its proprietary marker system embeds a permanent or removable (depending on the needs of the customer) mark on solid, liquid or gaseous objects or materials. Each marker is comprised of a combination of marker codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with an innovative patented reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers or on a blockchain ledger, to protect data integrity and custody.

 

Business Model

 

The Company’s business model targets leading brands and manufacturers (as opposed to directly targeting consumers) in order to create a new market standard for circular economy solutions, brand authentication and supply chain integrity. The Company offers both business-to-business sales and “white label” solutions, depending on the needs of customers and the ultimate end use based on either a fixed fee or volume-based revenue model (or both).

 

The Company may work directly with the manufacturer of the products or through the manufacturer’s raw material supplier so that the manufacturer is not required to change (or is required to make no more than minimal changes to) its manufacturing process in order to implement Security Matters PTY technology in the production process. Gaining the trust of raw material producers is the first stage, which in turn allows for credibility and trust when supplying solutions to brand owners, manufacturers and suppliers, which is a key step for its success.

 

 49 

 

 

Product and Applications

 

Product

 

The Company provides a solution comprised of three components: (1) a physical or chemical marker system coupled with (2) a reader and connected to (3) a blockchain digital platform.

 

Markers

 

Markers are embedded sub-molecular particles applied to a solid, liquid or gas. The Company uses various building blocks, comprised of a variety of molecules, to serve as markers for materials and products. For each project, its team selects a combination of molecules based on the specification of the customer and marked material (for example, the marked medium, the production process, the end use of the product and regulatory requirements, among others). The Company’s innovative reader can identify the marker and identify a response at a sub molecular building block level, designed to make the marker identification more accurate.

 

The ability to more accurately identify the concentration level of a marker allows Security Matters PTY to use numerous markings from a variety of different molecules. This enables it to not only identify the marker, but also identify the concentration within a product within a pre-defined range and “read” whether the marked material was diluted (authenticating not only the marked goods but also identifying the quantity).

 

Based on the specifications of the marked product, Security Matters PTY can mark materials based on several techniques, allowing its solution to be implemented across materials and processes. Markers can carry information denoting each origins of manufacture, product provenance, date of production and many other types of data, depending on customer needs.

 

The Company can produce either permanent or removable markers that can be applied either topically or internally to material in any state of matter (solid, liquid or gas) to form an “Intelligence on Things,” or “IOT2” marking system. The IOT2 concept involves marking products during or after the manufacturing process by inserting or applying materials to the products and encoding information through this process, namely by the treatment of materials or affixing and embedding product authentication security devices. The IOT2 concept allows for materials in a wide variety of products to be protected against counterfeiting, tampering, and diversion, and to help ensure the integrity of genuine products and manage the supply chain and logistics processes.

 

The marker supports invisible, indelible, and non-damaging tracking of distinctive molecules designed to ensure uniqueness and prevent duplication or counterfeiting. The marker is designed to not in any way affect the properties of the material it is applied to-it simply becomes a part of that material. The molecules are designed to be inert, inactive, and invisible to the human eye.

 

Readers

 

Markers are embedded in the material and can only be read by designated readers. A reader scans for the existence of markers. If the reading satisfies a pre-determined condition set by Security Matters PTY (which can be programmed), than the reader can identify the marked product and convey information about such product to the customer.

 

The Company currently utilizes an x-ray wave reader that is modified according to its specifications to allow it to scan its proprietary markers. The reader and Security Matters PTY’s algorithm are designed to make its detection method unique and prevent duplication or interference with its markers. The reader is available as hand-held device or industrial apparatus for large-scale applications, with the ability to read the embedded material data from a physical or chemical marker without requiring lengthy and expensive laboratory testing for confirmation.

 

 50 

 

 

Platform

 

Blockchain technology is a ledger of records, which are linked and designed to be secured using cryptography from third party infrastructure and Security Matters PTY’s architecture. The Company can record a marker manifestation on the blockchain and store this information in cloud computing data storage. It has developed an algorithm designed to securely connect its reader to an existing platform (licensed from a SaaS provider) and record changing ownership and other information to the blockchain. Once Security Matters PTY’s blockchain solution is implemented, a marked good or material is scanned in order to identify the marker, the results can be verified on the blockchain in order to confirm the data embedded in it, such as the identity of the producer, date of production, supplier and past owners. During the same scan, the reader can record to the blockchain a change of location or ownership of the marked product or material.

 

The IOT2 concept mentioned above also refers to the retrieving, analyzing and processing of encoded information embedded on products and product components and uploading such information to a cloud computing system or to a distributed blockchain system, creating a digital twin to a physical product for the purpose of product authentication, brand protection, tracking and tracing products and product components, supply chain management, and logistical processes.

 

Applications

 

The Company’s solution offers the following applications across industries:

 

Process Tracing

 

Process tracing involves the upstream marking of raw material and blockchain-backed scanning throughout processing stages to allow for full traceability of raw material across its life cycle. Manufacturers are under increasing consumer and regulatory pressure to prove material provenance in order to be able to certify compliance with environmental, social and governance, or ESG, sourcing practices and carbon content of finished goods. Through upstream marking of raw material and blockchain-backed scanning throughout the processing stages, Security Matters PTY’s technology enables real tracking and tracing of materials, including the source of those materials. Additionally, Security Matters PTY’s technology enables manufacturers to know whether any used items are theirs and enables them to pay third parties to collect their used products, creating a market for collecting used products and selling them to other manufacturers.

 

Authentication

 

Growing concerns about component tampering along high security or critical infrastructure product supply chains and increasing counterfeit issues for high value density products are also issues that Security Matters PTY’s marking and authenticating process is designed to address. Manufacturers can validate product authenticity to their customers by marking final products or prime components and scanning the marker at a retail location or as part of the process of recycling their products.

 

Sustainability and Circular Economics

 

The end-to-end technology solution covers three product lifecycles to enhance the circular economy from raw material to manufacturing/production, packaging, and end-of-life, enabling it to re-enter the economy for recycling or reuse. By marking upstream raw material and later scanning recycled content at waste collection points, an advanced sorting of materials is enabled which can increase the value of recycled content and in turn help to increase global recycling rates and recycled content certification.

 

Key Strengths

 

Innovative Technology

 

The Company’s technology can serve various manufacturers’ needs such as brand protection, authentication, track and trace for supply chain integrity and quality assurance. This technology has the potential to disrupt several industries and enable manufacturers and brand owners to be better able to protect their products.

 

 51 

 

 

Growing Addressable Market

 

The circular economy represents a potential opportunity for global economic growth as society moves towards a more sustainable future and as manufacturers and other entities come under increasing consumer and regulatory pressure to comply with ESG sourcing practices.

 

Experienced Development Technology Team

 

The Company’s technology team is an experienced team of professionals, with a track record in the industrial sector and governmental agencies.

 

Cross Segment Activity and Collaborative Relationships

 

The Company’s technology is applicable for multiple industries. The growth potential of the Company is derived from its ability to provide an adaptive solution for multiple market segments, based on a unified technology solution. The Company also has collaborative relationships with leading companies which can provide it with access to various entities to which to sell its technology. This is part of the Company’s strategy to create strategic partnerships with market leaders across its main segments of activity.

 

Sustainability

 

The Company believes regulatory and consumer pressure to increase recycling rates of high-pollution materials, such as plastics and rubber as well as growing sustainability concerns and requirements to preserve resources and minimize pollution are important drivers for our growth. Thus, any such sustainability regulations and consumer pressure promoting solutions that enable the circular economy, including the solutions that Security Matters PTY offers, can help to drive our growth.

 

Business Strategy

 

The Company’s roadmap for entry into markets it identifies is as follows:

 

Market Leader Adoption. Adoption of the solution by a market leader that provides a “seal of approval” that the technology is valid for the industry and generates added value.
   
Becoming an Industry Standard. Leverage the market leader’s position in the market to increase adoption by other companies along the value chain.
   
Regulator Adoption. In the future, Security Matters PTY aims to become the preferred solution by regulators and professional associations in each industry.

 

Research and Development

 

Given the varied needs of different industries, the Company’s research and development processes are divided according to industry.

 

Plastics, Rubber and Other Materials

 

In 2022, Security Matters PTY completed a successful trial of marking recycled plastics by studying the impact of gravimetric and volumetric feeding methods on final Post Consumer Recyclate, or PCR, readings. The compounding master batch and extrusion processes of these trials were performed on a pilot scale in a fully commercial and industrial facility. The Company’s team demonstrated its ability to manage the process remotely, indicating the viability of industrial scale adoption.

 

 52 

 

 

The successful trial provides plastic manufacturer and importing companies with a proof of concept, enabling them to more accurately identify and audit, via an automated transparent reporting system, the polymer type, number of loops and the amount of recycled content despite the size and color of the plastic. As a result, the Company is positioning itself to be able to offer plastic manufacturing and importing companies the ability to promote their operations as being sustainable and environmentally friendly. Combined with its ability to digitally certify the materials, the Company is also positioning itself to offer these companies the ability to avoid human/manual-paper auditing and use technology/automated auditing, which helps to reduce the potential for human errors and can provide for cost savings.

 

In March 2023, the Company announced that it succeeded for the first time in verifying a marker substance for natural rubber in a tire and so throughout the entire production process. The dedicated marker technology, which the Company and Continental optimized for use in natural rubber, is designed to create greater transparency along the entire value chain of tires and technical rubber products from Continental. Provided with special security features, the use of the marker substances enables the invisible marking of natural rubber with information on its geographical origin. This means, for example, that responsibly sourced natural rubber and its origin can be verified at every stage of the supply chain all the way through to the customer.

 

In the field test, the marker substance was added to responsibly grown latex during harvesting and withstood not only the intensive preparations involved in the production of natural rubber but also the tire manufacturing process itself. In the manufactured tire, the data was retrieved using special, purpose-built software and a reader and correctly interpreted. The appearance and performance of a bicycle tire containing the invisible marker remained unchanged.

 

The Company expects that Continental will use the new marker technology on a larger scale in the future during the process of sourcing its rubber and also to integrate it in other rubber products. As part of the industrialization of this technology, it is conceivable to link the markers with blockchain technology. This could provide additional support for tamper-free monitoring of compliance with quality standards and quality criteria along the complex supply chain of natural rubber.

 

Plastic Cycle Token

 

On November 28, 2023, the Company announced the planned launch of a plastic cycle token, scheduled for release in Q2 2024. The initiative is being designed to present a reliable, ethical digital credit platform, aiming to capitalize on billions of dollars in recyclable plastics credits in a newly created market.

 

The tradeable plastic cycle token is being designed to enable companies to transition towards sustainable practices, encouraging entities within and outside the plastic ecosystem, including oil producers and waste management firms, to increase recycled content utilization.

 

This initiative is also expected to position the SMX Plastic Cycle Token as a next-generation alternative to carbon credits, creating a new paradigm in the Impact ESG investment landscape. Each token is being designed to represent a quantifiable amount of recycled plastic using SMX’s technology to physically mark the plastics, potentially offering a tangible impact on environmental circularity.

 

Gold and Other Metals

 

Gold

 

Security Matters PTY formed a joint initiative with Perth Mint to develop a mine-to-marketplace ethical gold supply chain technology solution. Since the incorporation of trueGold Consortium Pty Ltd (“trueGold”) in June 2020, this research and development project aims to promote a ‘mine to product’ transparency solution dedicated to responsible mining of materials. Security Matters PTY’s track & trace technology provides information on the origin of the materials and how they move across production and distribution chains towards recycling and back to refining.

 

On July 29, 2020, Security Matters PTY signed a shareholders’ agreement with W.A. Mint Pty Ltd. (“Perth Mint”) and trueGold. The shareholders’ agreement and the ancillary agreements discuss the establishment of a new entity-trueGold-by Security Matters PTY and Perth Mint. Security Matters PTY granted to trueGold, subject to the terms of the license agreement, an exclusive, worldwide, perpetual license to use Security Matters PTY’s technology for the purpose of commercializing it within the industry comprising gold as a precious metal (as elaborated below). Security Matters PTY owns any development of its intellectual property and, while trueGold owns all generated data it creates, trueGold granted to Security Matters PTY a free non-exclusive, irrevocable, perpetual, royalty free license to use the generated data, subject to regulatory requirements and to the extent that it relates to the Isorad License Agreement technology or Security Matters PTY’s technology. The parties agreed that neither of Perth Mint or Security Matters PTY are required to provide any funding to trueGold and that any investment by any of them in trueGold from time to time will be by way of in-kind contributions. Third party equity investors will contribute the working capital will fund R&D, development capital and other expenses in accordance with the business plan.

 

 53 

 

 

Other than with the consent of the other shareholders or between affiliates (defined, inter alia, as a related body corporate of a shareholder; a company in which the shareholder beneficially owns 50% or more of the issued shares) a transfer of shares will be done subject to a right of first refusal of the other shareholders, whom will also have tag-along rights and a drag-along (as elaborated below). Under the constitution (as amended in July, 2022, to add the specific right of Security Matters PTY to purchase shares before any other shareholders) any shareholder wishing to transfer shares must notify the board of directors and, before the board of directors authorize the transfer of any share or shares, the share or shares must first have been offered to Security Matters PTY (for its own benefit and unless Security Matters PTY is 50% owned by one entity), and if SMX does not notify within 30 days that it wishes to purchase, then to all other shareholders (including Security Matters PTY) at a price to be agreed on by the transferor and the directors of trueGold. If the transferor and the directors of trueGold are unable to agree on a price, the price of the relevant shares will be a price which: represents a fair market price; and is determined by expert determination administered by the Australian Disputes Centre (ADC) in accordance with the ADC Rules for Expert Determination which are operating at the time the matter is referred to ADC, which Rules are incorporated into the constitution of trueGold. The determination of such person in relation to the price of the relevant shares will be final and binding on all shareholders.

 

Subject to certain terms and conditions, a drag-along right is established under which where shareholders wish to dispose of all of their share to a third party that wishes to acquire 100% of trueGold and 75% or more of the aggregate number of shares on issue at that time agreed, the remaining shareholders may be forced to transfer to the third party all of the shares held by each of the remaining shareholders. In case of a deadlock (defined as a case where the board of directors disagrees on a material matter regarding the fundamental operation of trueGold or the business and cannot resolve the disagreement within 10 business days of the disagreement first arising), if the shareholders are unable to reach agreement on any matter, a dispute resolution mechanism was created.

 

The board of directors of trueGold was agreed to consist of not less than three and not more than seven. The board is comprised as follows: Security Matters PTY may appoint (remove or replace) up to two directors; Zeren Browne; Perth Mint may appoint (remove or replace) up to two directors; and Hugh Morgan, who is a non-executive, independent chair. A list of resolutions was set, which require a board majority including at least one Security Matters PTY appointed director and one Perth Mint appointed director. Another list of resolutions was set, which require a resolution carried by a majority of the shareholders including Security Matters PTY and Perth Mint. trueGold and Yahaloma (defined below) agreed to bear the payments to Soreq related thereto of 4.2% of its revenues. SMX’s CEO, Mr. Haggai Alon, provides CEO services to trueGold and reports to the board of directors of trueGold, and Zeren Browne provides General Manager services to trueGold.

 

On October 3, 2023, Security Matters PTY entered into the Investment Agreement with trueGold. Pursuant to the Investment Agreement, the AUD475,000 of indebtedness as of June 30, 2023 trueGold owes to Security Matters PTY was waived by Security Matters PTY in exchange for the issuance of additional shares of True Gold (the “True Gold Shares”) such that Security Matters PTY’s holdings in trueGold shall be increased to 51.9% of the total issued and outstanding shares of trueGold, making Security Matters PTY the majority owner of trueGold. Additionally, the existing license agreement as between Security Matters PTY and trueGold was amended to include additional intellectual property of Security Matters PTY to be licensed to trueGold thereunder. Security Matters PTY shall further supply to trueGold a credit line for research and development work by its employees of up to AUD1,000,000, free of interest and collateral.

 

trueSilver

 

On June 7, 2023, we announced that we are in the process of creating a new subsidiary, trueSilver, and that we have entered into a 120 day exclusive agreement with Sunshine Minting Inc. (“Sunshine”), to create a path to full transparency and traceability for silver products from mine site to final products and recycling and the creation of an industry standard. During the 120-day exclusivity period, Sunshine shall evaluate our technology for its use, with possible further collaborations thereafter.

 

 54 

 

 

In July 2023, we transferred the ownership of our wholly owned granddaughter company “Security Matters Canada Ltd.” from ownership by our subsidiary Security Matters PTY to direct ownership by the Company and renamed it “TrueSilver SMX Platform Ltd.”

 

Non-Ferrous Metals

 

On November 29, 2022, Security Matters PTY signed a products distribution and SAAS reseller agreement with Sumitomo Corporation, a Japanese corporation. Under such agreement, Security Matters PTY appointed Sumitomo to act as Security Matters PTY’s exclusive, worldwide distributor to market and sell markers, readers and Security Matters PTY services to customers for application in the Non-Ferrous Metals Market (as defined below) only, subject to the customer entering into with Security Matters PTY its standard product license agreement. The “Non-Ferrous Metals Market” is defined as all supply chain market segments of the industry for aluminum, copper, lead, nickel, zinc, molybdenum, cobalt, lithium and tin.

 

The price at which Security Matters PTY shall sell products to Sumitomo and the license fee at which Security Matters PTY shall license Security Matters PTY products and Security Matters PTY service to Sumitomo shall be a discount of the invoices issued to the customers.

 

Generally, the agreement shall remain in effect for an initial term of five years from the effective date of first commercial sale by Security Matters PTY to Sumitomo of any products. The companies have agreed that over the coming years there is a target to reach US$35 million in sales.

 

Alcoholic Beverages

 

In December 2021, Security Matters PTY acquired all the holdings SMX Beverages Pty Ltd, a joint venture incorporated in February 2020 for the promotion of solutions in the alcoholic beverage industries including in relation to the prevention of counterfeit alcoholic beverages, circular economy concepts and packaging and supply chain within those industries.

 

Diamonds and Precious Stones

 

On April 30, 2019, Security Matters PTY signed an agreement with Trifecta Industries Inc. (“Trifecta”) for the commercialization of Security Matters PTY’s trace technology in the diamonds and precious stone industry. Under the terms of the agreement, Security Matters PTY and Trifecta established a new entity-Yahaloma Technologies Inc. (“Yahaloma”), which is equally held by Security Matters PTY and Trifecta.

 

Both parties covenanted not to pursue the use of Security Matters PTY’s technology for diamonds and precious stones, or any other venture related to the testing of the origin of diamonds or precious stone, other than through the Yahaloma. Additionally, in agreement with Isorad, all rights in and to any intellectual property related to the diamonds and precious stones industry that is developed by or for Yahaloma is jointly owned in equal parts by the Security Matters PTY, Yahaloma and Soreq.

 

Security Matters PTY continues to develop the technology and will supply Yahaloma technical services. Security Matters PTY bears the cost of such R&D services but the agreed hourly costs of Security Matters PTY’s staff is recorded as a shareholders loan of Security Matters PTY to Yahaloma, once the first USD 250,000 to be paid by Trifecta are exhausted (which is yet to happen). Trifecta supplies Yahaloma diamonds and other raw materials, which remain in the ownership of Trifecta. If Security Matters PTY causes damage to such diamonds during the R&D process, this will be reported the Trifecta and the damage recorded as a shareholders loan of Trifecta to Yahaloma. Trifecta will supply Yahaloma services of business development. Trifecta bears the cost of such services but the agreed hourly costs of Trifecta’s staff is recorded as a shareholders loan of Trifecta to Yahaloma. Management of Yahaloma is agreed to be jointly, with certain special resolutions requiring agreement of both parties. Actual day-to-day management is in Canada.

 

 55 

 

 

In addition to the shareholders loan extended by man-hours as stipulated above, the parties covenanted to extend up to USD 1 million to Yahaloma (USD 350,000 by Security Matters PTY and USD 650,000 by Trifecta, with USD 250,000 extended by Trifecta registered as capital and all other funds as shareholders loans). Funds were agreed to be injected upon reaching certain milestones. The Security Matters PTY loan of USD 350,000 are to be injected only upon reaching future milestones and only if such funds will be required, which stage has not yet arrived. Such Security Matters PTY loan will bear an interest rate of 5% per annum. Upon Yahaloma being able to repay the shareholders loans, first a sum of USD 250,000 will be repaid to Trifecta and then all other shareholders loans will be repaid pro-rata. Only after repayment of all shareholders loans will Yahaloma distribute profits.

 

A party may not transfer its shares to others without the prior approval of the other party other than a transfer to an affiliate (defined as an entity directly or indirectly controlled by a party or directly or indirectly controls such party or is directly or indirectly controlled by a person which also, directly or indirectly, controls such person) done after 30 days’ notice to the other party, and after the affiliate agrees to adopt the agreement.

 

Yahaloma agreed to bear the payments to Soreq related thereto (as described in “Gold and Other Metals” above).

 

Electronics

 

Security Matters PTY has joined an alliance formed by six founding partners, among them the World Business Council for Sustainable Development, to set a shared vision for a circular economy for electronics, called the Circular Electronics Partnership. This group of global companies has been brought together to reduce e-waste and to commit to a roadmap for a circular economy for electronics by 2030.

 

Fashion

 

In December 2020, Security Matters PTY announced that it had launched a Fashion Sustainability Competence Centre to enable fashion brands globally, to transition successfully to a sustainable circular economy by being able to identify the origination of their raw materials and hence, recycle their own unsold and/or end-of-life merchandise (garments, footwear and accessories including sunglasses) back into new high-quality materials and new fashion merchandise Security Matters PTY’s technology is applicable across a range of materials including leather, silk, cotton, wool, coated canvas, vegan leather, polyesters, cashmere, metals (e.g., gold & metallic parts) and plastics; and its applications encompass finished leather goods, shoes, garments, and accessories. Security Matters PTY is also collaborating with several luxury fashion conglomerates on R&D projects to trace the origin of raw materials used in their supply chain and is in commercial negotiations regarding the implementation of its solution with partners in the industry.

 

In July 2023, we changed the name of the wholly owned subsidiary from “SMX France” to “SMX Fashion and Luxury” in anticipation for such company to be used for the fields of fashion and luxury.

 

Intellectual Property

 

The ability of Security Matters PTY to develop and maintain proprietary IT is crucial to our success. Since 2015, Security Matters PTY technology has been protected by more than 20 patent families and more than 100 patents filed around the world in various stages with respect to our marking and reading technologies. The table below lists the 20 patent families. Under each patent family, we note the countries under which such patents have been filed.

 

 56 

 

 

The following table provides a list of Security Matters PTY’s patents that have passed the international phase (PCT) and may be publicly disclosed:

 

Patent

Family

  Countries   Type  

Title and

Type of

Patent

Protection

  US Status   US App#’s  

US Filing

Date

  US Patent #  

US

Publication

 

US

Expiration

Date

1  

US

Taiwan

Japan

China

Europe

Israel

Republic of

Korea

  PCT   System and method for reading x-ray-fluorescence marking   Registered  

15/563,756

 

16/709,804

 

Mar 2016

 

Mar 2016

 

US10539521B2

 

US10969351B2

 

Jan.2020

 

Apr 2021

 

Jul 2036

 

Mar 2036

                                     
2  

US

Australia

China

Europe

Israel

Japan

Korea

  PCT   Authentication of metallic objects   Registered   16/074,226   Feb 2017   US11446951B2   Sep 2022   Jan 2040
                                     
3  

US

Australia

Europe

Israel

Korea

  PCT   Access control system and method thereof  

Published/

 

Pending

  16/083,966   Mar 2017   US20200242865A1   Jul 2020    
                                     
4  

US

Australia

China

Europe

Israel

Japan

Korea

  PCT   A method and a system for XRF marking and reading XRF marks of electronic systems  

Registered

 

Registered

 

16/091,222

 

16/834,732

  Apr 2017   US10607049B2   Mar 2020   Apr 2037
                                     
5  

US

Australia

China

Europe

Austria

Germany

Estonia

Spain

Finland

France

Great Britain

Latvia

Sweden

Israel

Japan

Korea

  PCT   An XRF analyzer for identifying a plurality of solid objects, a sorting system and a sorting method thereof   Registered   US16/311,290   Jun 2021   US10967404B2   Apr 2021   Dec 2037
                                     
6  

US

Australia

Canada

Europe

Israel

South Africa

  PCT   Method for marking and authenticating precious stones  

Registered

 

Pending

 

16/328,526

 

17/666,866

  Aug 2017   US11320384B   May 2022   Oct 2038

 

 57 

 

 

Patent

Family

  Countries   Type  

Title and

Type of

Patent

Protection

  US Status   US App#’s  

US Filing

Date

  US Patent #  

US

Publication

 

US

Expiration

Date

7  

US

Australia

China

Europe

Israel

Korea

Taiwan

Japan

Ukraine

  PCT   X- ray fluorescence system and method for identifying samples   Registered   16/334,431   Sep 2017   US11112372B2   Sep 2021   Jun 2038
                                     
8  

US

Australia

China

Europe

Israel

Japan

Korea

  PCT   Method for Detecting Mishandling and Misuse of Food Products   Pending   16/336,712   Sep 2017   US20210321649A1   Oct 2021    
                                     
9  

US

Australia

China

Europe

Israel

Japan

Korea

  PCT   XRF-Identifiable Transparent Polymers   Registered   16/340,913   Oct 2017   US11193007B2   Dec2021   Apr 2038
                                     
10  

US

Australia

China

Europe

Israel

Japan

Korea

  PCT   A System for Virtual Currency based on Blockchain Architecture and Physical Marking   Pending   16/609,686   May 2018   US20200184465A1   Jun 2020    
                                     
11  

US

Australia

Europe

Israel

Korea -

Application

discontinuation

  PCT   An Object Marking System for Authentication and Verification   Registered   16/609,700   May 2018   US11221305B2   Jan 2022   Oct 2038
                                     
12  

US

Australia

Canada

China

Europe

Israel

Japan

Korea

  PCT   Management of Recyclable Goods and Their Source Materials  

Application

 

Filed

  17/766,874   Oct 2020   WO2021070182A1   Apr 2021    
                                     
13  

US

Australia

China

Europe

Hong-Kong

Israel

Japan

Korea

  PCT  

Systems and Methods for Supply Chain Management and Integrity

 

Verification Via Blockchain

 

Application

 

filed

  16/980,693   Mar 2019   WO2019175878A1   Sep 2019    

 

 58 

 

 

Patent

Family

  Countries   Type  

Title and

Type of

Patent

Protection

  US Status   US App#’s  

US Filing

Date

  US Patent #  

US

Publication

 

US

Expiration

Date

14  

US

Australia

Azerbaijan

Brazil

Canada

China

Europe

Hong-Kong

Indonesia

Israel

Japan

Korea

Malaysia

Singapore

Uzbekistan

  PCT   System and Method for Detection and Identification of Foreign Elements in a Substance  

Application

 

filed

  17/285,167   Oct 2019   US20210325323A1   Oct 2021    
                                     
15  

US

Australia

Canada

Europe

Israel

Japan

Korea

  PCT   Method and System for Classification of Samples  

Application

 

filed

  17/594,406   Apr 2020   WO2020212969A1   Oct 2022    
                                     
16  

US

Australia

Canada

Europe

Israel

Japan

Korea

  PCT   Traceable Composite Polymers and Preparation Methods Thereof Traceable Composite Polymers and Preparation Methods Thereof for Providing Transparency in Production Value Chains  

Pending

 

Pending

 

17/626,916

 

17/626,923

 

Jul 2020

 

Jul 2020

 

US20220251252A1

 

US20220259356A1

 

Aug 2022

 

Aug 2022

 

Pending

 

Pending

                                     
17  

US

Australia

Canada

Europe

Israel

Japan

Korea

  PCT   Traceable Composite Polymers and Preparation Methods Thereof Traceable Composite Polymers and Preparation Methods Thereof for Providing Transparency in Production Value Chains  

Pending

 

Pending

 

17/626,916

 

17/626,923

 

Jul 2020

 

Jul 2020

 

US20220251252A1

 

US20220259356A1

 

Aug 2022

 

Aug 2022

   
                                     
18  

US

Australia

Canada

Europe

Israel

Japan

Korea

  PCT   Traceable Composite for Marking Seeds and Plants  

Application

 

Filed

  17/639,397   Sep 2020   20220312711 A1   Oct 2022    
                                     
19  

US

Australia

Canada

China

Europe

Israel

Japan

Korea

  PCT   Management of Recyclable Goods and Their Source Materials  

Application

 

Filed

  17/769,175   Oct 2020   WO2021074919A1   Apr 2022    
                                     
20  

PCT/

IL2021/050325

  PCT   Device and Method for Detection of Viruses By XRF  

Application

 

filed

      Mar 2021   WO2021191899A1   Sep 2021    

 

 59 

 

 

Abstracts

 

Patent Family 1:

 

System and method for reading x-ray-fluorescence marking (US10,539,521, granted, expires 13/07/2036; US10969351B2, granted, expires 31/03/2036). Abstract: Method and systems are presented for authentication of precious stones, according to their natural ID and/or predetermined markings created in the stones, based on unique characteristic radiation response of the stone to predetermined primary radiation.

 

Patent Family 2:

 

Authentication of metallic objects (US16/074,226, granted, expires 25/01/2040). Abstract: The present invention provides an anti-counterfeit marking technique for verifying authenticity of objects using x-ray fluorescence (XRF) analysis.

 

Patent Family 3:

 

Access control system and method thereof (US16/083,966, Pending, filed 21/03/2017). Abstract: The present invention relates to an access control system, an access object and a method for access control. The access control system comprises an access request receiving device being configured and operable for receiving an access object; the access request receiving device comprising an emitter configured and operable for irradiating the access object with a radiation having a wavelength in the range of about 10”12 and 10”9 m and a detector configured and operable for detecting a response signal from the irradiated access object; a control circuit being configured and operable to receive the response signal from the access request receiving device and process the response signal to identify spectral features indicative of an XRF signature of the access object; wherein the control circuit is adapted to generate an unlocking signal for switching a module device between a locked state and an unlocked state upon identification of the XRF signature.

 

Patent Family 4:

 

A method and a system for XRF marking and reading XRF marks of electronic systems (US10,607,049, granted, expires 04/042037, US16/834,732, granted, expires 04/12/2037). Abstract: Methods and systems for verifying compatibility of components (e.g. parts or devices) of an electronic system are disclosed. In certain embodiments the method includes: irradiating a first and second components presumably associated with the electronic system, with XRF exciting radiation, and detecting one or more XRF response signals indicative of a first and a second XRF signatures, emitted from the first and second components in response to the irradiation. Then the first and second XRF signatures are processed to determine whether they are associated with respectively a first and second XRF marking compositions on the first and second components, and the compatibility of the first and second components to the electronic system is determined/verified based on the correspondence between the first and a second XRF signatures/marking. Certain embodiments also disclose electronic systems including at least a first and a second electronic components/devices respectively having the first and second XRF marking compositions that enable verification of compatibility of the components. Certain embodiments disclose techniques for pairing the first and second components (e.g. devices) based a correspondence between the first and second XRF signatures/markings thereof. Certain embodiments disclose various calibration techniques for calibrating the XRF measurements of XRF markings applied to different substrate materials of the electronic components.

 

Patent Family 5:

 

An XRF analyzer for identifying a plurality of solid objects, a sorting system and a sorting method thereof (US10,967,404, granted, expires 04/12/2037). Abstract: The present invention discloses a novel XRF analyzer capable of simultaneously identifying the presence of a marking composition in a plurality of objects by modulating/varying the intensity of the excitation beam on the different objects and measuring the secondary radiation thereof. The XRF analyzer comprises a radiation emitter assembly adapted for emitting at least one X-Ray or Gamma-Ray excitation radiation beam having a spatial intensity distribution for simultaneously irradiating the plurality of objects; a radiation detector for detecting secondary radiation X-Ray signals arriving from a plurality of objects in response to irradiation of the objects by X-Ray or Gamma-Ray radiation, and providing data indicative of spatial intensity distribution of the detected data X-Ray signals on the plurality of objects; and a signal reading processor in communication with the detector, the processor being adapted for receiving and processing the detected response X-Ray signals to verify presence of the marking composition included at least one surface of each object of the plurality objects.

 

Patent Family 6:

 

Method for marking and authenticating precious stones (US16/091,222, granted, expires 20/10/2038, US Divisional 17/666,866, pending, filed 08/02/2022). Abstract: Method and systems are presented for authentication of precious stones, according to their natural ID and/or predetermined markings created in the stones, based on unique characteristic radiation response of the stone to predetermined primary radiation.

 

 60 

 

 

Patent Family 7:

 

X-ray fluorescence system and method for identifying samples (US11,112,372, granted, expires 03/06/2038). Abstract: A control system and method are presented for controlling operation of an X-ray Fluorescent (XRF) system for detecting at least one material carried by a sample, for example at least one marker carried by the sample. The control system comprises: data input utility for receiving input data comprising material/marker related data about said at least one material/marker; and data processor and analyzer utility. The data processor and analyzer utility is configured and operable for analyzing the input data and determining optimal geometrical characteristics of the XRF system for optimizing operational conditions of said XRF system to maximize amount of primary X-ray radiation that reaches a predetermined region of the sample and is absorbed by a volume of said region and to maximize a portion of secondary radiation emitted from said region that reaches a detector of the XRF system; and for generating operational data to the XRF system enabling adjustment of the geometrical characteristics of the XRF system.

 

Patent Family 8:

 

Method for Detecting Mishandling and Misuse of Food Products (US16/366,712, Pending, filed 25/09/2017). Abstract: The present invention provides a method of labeling a product for human or animal use with an XRF identifiable label, the method comprising forming a pattern of at least one FDA-grade material identifiable by XRF on at least an area of the product. Wherein the pattern is optionally at least partially invisible to the naked eye and has predefined identifiable properties, wherein the product is selected from foods, therapeutics and cosmetics.

 

Patent Family 9:

 

XRF-Identifiable Transparent Polymers (US11,193,007, granted, expires 02/03/2038). Abstract: The invention provides formulations and masterbatches of a polymeric material and XRF-identifiable markers, for producing transparent elements including a polymer and at least one XRF-identifiable marker for a variety of industrial uses.

 

Patent Family 10:

 

A System for Virtual Currency based on Blockchain Architecture and Physical Marking (US16/609,686, Pending, filed 08/05/2018). Abstract: Methods and system for management of transactions of marked objects are disclosed. In an embodiment, a method for recording a marked object includes: determining specific and unique marking of the object by a reader unit; and communicating encrypted data indicative of the marking and data indicative of the marked object to at least one server system, for generating at least one record of the object and its marking thereat. The at least one server system may be a distributed blockchain system including: at least one blockchain service module adapted for recording transactions of objects in a blockchain; and at least one management service module adapted for authorization of each transaction of an object based on authentication of the transaction by: providing a reader unit with a certain reading scheme/parameters that authorize/enable the reader unit to correctly read the specific marking on the object; and obtaining from the reader unit in response, a reading data indicative of the marking being read using the reading scheme, and authenticating the object based on a match between the reading data and stored data of the object’s marking which is stored by the at least one server. In turn, before carrying out a request for recordation of a transaction for the object in the blockchain, the blockchain service module is adapted to await authorization of the transaction from the management service.

 

Patent Family 11:

 

An Object Marking System for Authentication and Verification (US11,221,305, granted, expires 23/10/2038). Abstract: Systems and methods for marking of objects, such as keys/key-blanks, in a production line are disclosed. The objects are marked by applying a marking composition(s) to pre-selected areas on the surface thereof. The system includes a marking unit for dispensing a volume of marking composition in one or more localized pre-selected areas on the surface of an object to be marked; a holder/gripper for positioning the object to be marked in one or more positions relative to the marking unit so as to allow the marking unit to dispense the marking composition on the one or more pre-selected localized areas; a reading/verification unit for detecting the marking composition applied to the object thereby verifying that the objects are properly marked; an orientation sensing unit for identifying the orientation of the object to be marked relatively to the holder. The system also includes a controller configured for controlling the operation of the holder, orientation sensing unit, and the marking unit. The reading/verification unit is adapted to identify the marking composition in the one or more pre-selected areas on surface of the object by detecting an electromagnetic signal (such as XRF signal) emitted from the marking composition (e.g. in response to its illumination by X-ray or gamma-ray).

 

Patent Family 12:

 

Management of Recyclable Goods and Their Source Materials (US17/766,874, Pending, filed 07/10/2020). Abstract: Techniques for monitoring production and reuse of a recyclable material, and/or determining a currency or quality measure thereof, are disclosed. In the disclosed embodiments one or more markers are introduced into ingredient material components of the recyclable material, where the one or more markers being indicative of one or more properties of at least one of the ingredient material components. Information indicative of at least the one or more properties is recorded in a database comprising a plurality of records, each associated with at least one of the one or more markers. A signal obtained from a product comprising the recyclable material is processed for determining presence of at least one of the one or more markers, and based thereon the information recorded in at least one of the database records associated therewith, and a quality or currency measure of at least one of the ingredient material components of the recyclable material comprised in the product is determined based on the one or more properties indicative by the information.

 

 61 

 

 

Patent Family 13:

 

Systems and Methods for Supply Chain Management and Integrity Verification Via Blockchain (US16/980,693, Pending, filed 14/03/2019). Abstract: Systems and methods for managing transactions of physical objects are disclosed. The system is connectable to a first distributed ledger adapted to record object transactions associated with transactions of one or more physical objects between parties. The system includes a second distributed ledger adapted to record data indicative of object handling operations carried out with respect to the one or more physical objects; and an object handling management module adapted to authenticate handling operations carried out with respect to the one or more physical objects. The object handling management module is configured and operable for obtaining parameters of execution of the handling operations, authenticating the parameters of execution of the handling operations, and recording the authenticated handling operations in the second distributed ledger. The system thereby enables recordation of the object transactions associated with the one or more physical objects upon authenticating that the parameters of execution of the handling operations that are carried out with respect to the one or more physical objects satisfy one or more respective predetermined conditions.

 

Patent Family 14:

 

System and Method for Detection and Identification of Foreign Elements In A Substance (US17/285,167, Pending, filed 18/10/2019). Abstract: In one embodiment, a system and method for inspecting a substance to detect and identify predetermined foreign element(s) in the substance. The foreign element may carry X-ray responding material compositions, emitting X-ray signals in response to primary exciting X-ray or Gamma-ray radiation. The inspection is performed during a relative displacement between the substance and an inspection zone, defined by an overlap region between a solid angle of emission of an X-ray/Gamma-ray source and a solid angle of detection of X-ray radiation, along a predetermined movement path, as the substance moves along said path, the detected X-ray radiation includes X-ray response signals from successive portions of the substance propagating towards, through, and out of said overlap region. Measured data indicative of X-ray response signals is analyzed to identify a signal variation pattern over time indicative of a location of at least one foreign element carrying an X-ray responsive marker.

 

Patent Family 15:

 

Method and System for Classification of Samples (US17/594,406, Pending. filed 05/04/2020). Abstract: A method and system are provided for model-based analysis of samples of interest and management of sample classification. Predetermined modeled data is provided comprising data indicative of K models for respective K measurement schemes based on a predetermined function having a spectral line shape, data indicative of M characteristic vectors of M predetermined group to which different samples relate, and data indicative of a common vector of weights for the M groups. A data processor utilizes said data and operates to apply model-based processing to measured spectral data of a sample of interest using said predetermined modeled data, and generate classification data indicative of relation of said specific sample of interest to one of said M predetermined groups.

 

Patent Family 16:

 

Traceable Composite Polymers and Preparation Methods Thereof Traceable Composite Polymers and Preparation Methods Thereof for Providing Transparency In Production Value Chains (US17/626,916, Pending, filed 15/07/2020). Abstract: The present invention is in the field of polymers comprising XRF identifiable tracers allowing information to be encoded by the polymers, and in particular polymers for conservation, restoration and retouching in artworks, electronics, coatings, plastics etc.

 

Patent Family 17:

 

Traceable Composite Polymers and Preparation Methods Thereof Traceable Composite Polymers and Preparation Methods Thereof for Providing Transparency In Production Value Chains (US17/626,923, Pending, filed 15/07/2020). Abstract: The present invention is in the field of polymers comprising identifiable tracers by spectroscopic methods such as XRF, IR, NIR and XRD allowing information to be encoded by the polymers, and in particular polymers for conservation, restoration and retouching in artworks, electronics, coatings, plastics, packaging, 3D printing, rubber, and the like.

 

Patent Family 18:

 

Traceable Composite for Marking Seeds and Plants (US17/639,397, application filed, filed 02/09/2020). Abstract: The invention concerns compositions and methods for authenticating an agricultural product.

 

 62 

 

 

Patent Family 19:

 

Management of Recyclable Goods and Their Source Materials (US17/769,175, application filed, filed 15/10/2020). Abstract: Techniques for managing production and reuse of a recyclable material are disclosed. Combination of markers introduced into one or more ingredient material components of recyclable materials are used to indicate one or more properties of at least one of the ingredient material components e.g., a type of material used, percentage of the material type in the recyclable material, and suchlike. A signal obtained from a product comprising the recyclable material can be processed to detect presence or absence of the combination of markers therein. Based on the detection of the combination of markers, information indicative of the one or more properties of the at least one ingredient material component is determined, and based on the information it is decided either about a suitable recycling process for reusing the at least one ingredient material component, or a suitable disposal process for disposing the product.

 

Patent Family 20:

 

Device and Method for Detection of Viruses by XRF (PCT/IL2021/050325, National Phase due by September 26, 2022). Abstract: The invention provides methods and tools for the directed and indirect detection of infection with micro-organisms pathogens in biological and non- biological samples, and specifically applications of XRF (X-ray fluorescence) methodology for the detection of infections with viral and bacterial pathogens responsible for the widespread epidemics in mammals and humans, including the current pandemic of COVID-19.

 

Marketing and Sales

 

The Company intends to concentrate its market penetration efforts into the U.S. market, including recruitment of sales and marketing personnel, either located in the U.S. or with U.S. orientation, participation in various professional expos, conventions and exhibitions and entering into agreements or arrangements with distributors in the U.S. markets and commencing collaborative relationships with commercial entities for the development of new customized products. Moreover, the Company intends to continue to invest significant resources in research and development in order to improve and build on its array of existing solutions and strive to develop new innovative products in sync with new market technological developments. The Company plans to further advance its innovative technology and commercialization efforts by:

 

engaging with additional suppliers and service providers in order to improve and streamline its product development process and supply chain;
   
increasing marketing and sales activities, concentrating on specific target markets;
   
increasing participation in professional expos, conventions and exhibitions; and
   
establishing partnerships and collaborations with strategic customers and entities in the segments relevant to its technology.

 

The Company’s pricing is based on the perceived value proposition of its solution for its customers. The pricing model is expected to be comprised of three components:

 

set-up fee (for initial consultations);
   
marker implementation fee (typically on a per item or per kg basis) and sale or lease of readers; and
   
service fee (for reading, blockchain services and other support services).

 

Pricing may also include an annual license fee, payment of royalties, pay-per-read, or other models.

 

 63 

 

 

Target Industries

 

Fashion

 

For the fashion industry, the Company’s technology enables authentication from raw materials to retail stores and beyond:

 

 

Its technology targets the luxury fashion industry by enabling high-end brands to:

 

verify the origin of raw materials to prevent fraud;
   
control material usage during the manufacturing process;
   
track a product’s journey from the first point of manufacturing to delivery to customers.
   
share information on product traceability with customers to prevent fraud in returned products;
   
generate secondary and reseller demand by demonstrating product authenticity; and
   
improve upcycling and recycling processes through material recognition, grading, and recycled content certification.

 

Electronics

 

For the electronics industry, the Company’s technology enables end-to-end traceability and authentication from raw material to point of use.

 

 

 64 

 

 

Its technology targets semiconductor manufacturers enabling a manufacturer to:

 

verify the origin of raw material;
   
control material usage;
   
demonstrate product authenticity along its supply chain;
   
detect tampering during use (e.g., when giving products off-premises for maintenance or other reasons); and
   
implement upcycling and/or recycling programs through material recognition, grading, and recycled content certification.

 

Gold and Other Metals

 

The Company’s technology allows for the tracing of gold or other metals from mine to consumer.

 

 

Its technology enables gold and other metal refineries, mining companies, and bullion banks to:

 

prove the origin and mine location of the gold or other metal;
   
facilitate the sale or trading of gold or other metal from ESG-compliant mines; and
   
demonstrate that their products are ESG-compliant to customers and end-users.

 

 65 

 

 

Plastics, Rubber and Other Materials

 

Given the challenges around mechanical recycling, chemical recycling is emerging as a promising solution to help tackle the global challenge associated with single use plastic waste. An embedded chemical marker allows for better tracking, monitoring and sorting of post-consumer plastic with the Circular Value Chain Approach. The Company’s technology is applicable throughout the life cycle of the material or product, from raw material to production to recycling. Its technology enables plastic footprint transparency and traceability along the supply chain.

 

 

Its digital twin technology can address a key challenge of the first step to identify, track and trace commodities produced in emerging countries for use in the developed countries, such as rubber or food commodities (e.g., cocoa, soy, and palm oil). The creation of a digital twin for each physical good enables participants in the value chain to come together and form the global ledger for the goods. As a number of industries and sectors are increasing their commitments to recycling, many companies are realizing the need for sustainability and circular economies.

 

Competition

 

Armed with its various products and designs, the Company believes it possesses a unique combination of knowledge and features. It has established an innovative, cross- segment technology, developed over several years by an experienced and dedicated team of scientists, which it believes create a barrier to entry to its competitors.

 

The Company’s product is currently undergoing pilot projects with customers with strong international presence. The customizable nature of its technology allows Security Matters PTY to embed the technology in multiple products, from silk to rubber to diamonds to gold to plastics, across multiple segments.

 

The Company is constantly striving to improve its competitive status in the market by:

 

entering into agreements or arrangements with large and high-profile customers in the industry, which it believes enhances its status and reputation in multiple markets and provides opportunities to enter into new agreements or arrangements with new customers;
   
entering into agreements or arrangements with strategic partners in order to strengthen its position to become the new industry standard; and
   
Providing high level development and support services to customers, to promote customer retention, and encourage its customers to rely on Security Matters PTY to use its technologies for future projects.

 

Facilities

 

The Company’s main business activities are conducted at SMX Israel’s headquarters in central Israel. It leases 363 square meters of office space at this location under a lease until May 31, 2027, with an option to extend the lease with an additional rental fee of 10% for an additional five years. The Company also leases an additional adjacent building of 146 square meters where it conducts research and development activities. The lessor (who represented that he is not aware of any such impending circumstances) has the right to shorten the lease with 90 days-notice if it is demanded by a government entity to evacuate the premises, to change the agreement or to pay fines due to the agreement. The Company believes that its current facilities are suitable and sufficient to meet its anticipated needs for the foreseeable future.

 

 66 

 

 

Government Royalty Obligations and Regulations

 

Israeli R&D Law

 

The Government of Israel encourages research and development projects oriented towards products for export or projects which will otherwise benefit the Israeli economy. This is conducted by the Israel Innovation Authority (IIA), which replaced the former Office of the Chief Scientist (OCS).

 

Under Israeli laws with respect to research and development, which is referred to as R&D Law, a royalty of between 3% to 5% applies to the net sales of products developed from a project funded by the IIA, beginning with the commencement of sales of products developed with grant funds and ending when a dollar-linked amount equal to 100% of the grant plus interest at LIBOR has been repaid. The terms of the R&D Law also place restrictions on the location of the manufacturing of products developed with government grants, which, in general, must be performed in Israel, and on the transfer to third parties of technologies developed through projects in which the government participates. Security Matters PTY’s research and development team will remain in Israel and all funds previously received by way of a grant from IIA have been invested in Israel.

 

The IIA has published a directive incorporating most of the former provisions, including those with respect to transfer of manufacturing rights, transfer of know-how and others. These provisions include limitations and requirements for payment with respect to outsourcing or transferring development or manufacturing activities with respect to any product or technology outside of Israel, and change in control in companies which received government funding from the OCS or IIA, which may impair ability to sell technology assets outside of Israel or to outsource, transfer develop or manufacture with respect to any product or technology that received government funding under the R&D Law outside of Israel, or consummate a change in control in the Company, all without prior approval of the IIA.

 

In May 2017, the IIA published the Rules for Granting Authorization for Use of Know-How Outside of Israel, or the Licensing Rules. The Licensing Rules enable the approval of licensing arrangements and other arrangements for granting of an authorization to an entity outside of Israel to use know-how developed under research and development programs funded by the IIA. Subject to payment of a “License Fee” to the IIA, at a rate that will be determined by the IIA in accordance with the Licensing Rules, the IIA may now approve arrangements for the license of know-how outside of Israel. This allows companies that have received IIA support to commercialize know-how in a manner which was not previously available. In addition, the IIA has recently published a directive incorporating most of the former provisions, including those with respect to transfer of manufacturing rights, transfer of know-how and others.

 

Security Matters PTY had one approved project with the IIA (project number 55715, approved on November 23, 2015) of a 40% grant out of a project of up to approximately $400 thousand under which it received $196 thousand in prior years. Security Matters PTY passed a final review by the IIA and no additional funding is expected to be received under the project.

 

Security Matters PTY is obligated to pay 3% of our relevant revenues for the first three years, and 4% of the relevant revenues for further years, until repayment of the entire grant, being $196 thousand. To date we paid about $1 thousand out of such amount.

 

Approved Enterprise

 

The Israeli Encouragement of Capital Investments Law, 1959, is intended to encourage investment in industry in Israel in national priority areas, to promote economic initiatives while giving preference to advanced and innovative industries, and to strengthen development areas. Based on the Investment Law, the Investment Center may, on application, grant the status of “Approved Enterprise” for Capital Investments in industry and tourism. Certificates of approval are issued and such approval entitles the project to receive substantial support from the State. The support may be in the form of reduced taxation, investment grants or other benefits specifically designed to encourage capital investment in Israel. Such State support is conditional on certain restrictions on the activities of a supported company, which restrictions may not easily be alleviated.

 

In December 2016, Security Matters PTY received approval as an Approved Enterprise (File 24638, Plan 429, Motion 120941) for the building of a factory for the marking of materials with an investment of ILS 3,700,000, provided that at least 24% of the investment will be financed by the issuance of new shares. Due to changes in our activity plans, we did not pursue such project and did not take any funds under such Approved Enterprise.

 

 67 

 

 

Isorad License Agreement

 

Under the Isorad License Agreement (as amended), Security Matters PTY received from Isorad an exclusive, worldwide, royalty-bearing license, to make use of (including, without limitation, to develop, manufacture, use, market, offer for sale, sell, export and import in the field of marking methods) US patent number 8158432 B2 and the technology derived from it can be utilized in almost any industry and with any product. Additionally, any uses for the Israeli Security Forces and/or its purposes will be conducted via us at a “cost plus” price to be agreed. While Isorad and Soreq reserve the right to freely continue to research and develop the technology, Security Matters PTY has a right of first offer to any newly developed technology. If the Source IP is developed further by Soreq and Soreq wishes to commercialize the new technology, then Soreq must offer the right to commercialize the new technology to Security Matters PTY in the first instance.

 

Security Matters PTY and its affiliate are to pay Isorad royalties for 25 years as of January 1, 2020 in the amount of 2.2% of all gross sales by the Company, our affiliates or sublicensees and after 25 years the license becomes royalty-free. Gross sales are defined under the Isorad License Agreement to include the total amount invoiced or received by Security Matters PTY and/or its affiliates, including, without limitation, for sale of products and provision of services. If Security Matters PTY charges a fee for sublicensing or an option for a sublicense, for which it does not pay the 2.2% royalty described above, such income will be subject to royalty payment of 15% of the amounts received. The royalties for revenues from sub-licensing the technology are payable as of January 1, 2020.

 

Upon the occurrence of the next M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of ours and similar event) Security Matters PTY is to pay a cash amount equal to 1.5% of the Exit Consideration (as such term is defined in such agreement). Additionally, Isorad was issued 864,000 options to purchase shares of Security Matters PTY and is entitled to receive 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and any amount actually received against equity or other funding during a period of 13 months thereafter (to be paid after reaching an aggregated received amount of US$27 million, or at the end of such 13 months, the earlier thereof). This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

Under the Isorad Agreement, Isorad can only refuse to approve a sublicense based on governmental defense, security, governmental policy, political and other official State of Israel policy considerations. A sublicensee cannot further grant, directly or indirectly, to any third party any sublicense or rights to the technology and cannot further assign the sublicense agreement.

 

Specifically as to Yahaloma, the royalty rate on gross sales of Yahaloma, to be paid by Yahaloma, are 4.2% (and not 2.2% that applies solely to Security Matters PTY, its other affiliates and to other sublicensees). Upon the occurrence of an M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of Yahaloma and similar event), Isorad is entitled to a fee equal to 1% of the total consideration paid to, received by, or distributed to, Yahaloma and/or its shareholders and/or its affiliates in connection with the event, including, without limitation, all cash, securities or other property which is received by Yahaloma and/or its shareholders in connection with such event of two such events (i.e. twice) at its choice.

 

The Isorad License Agreement will continue in full force and effect until terminated pursuant to its terms. If either party does not remedy a material breach of its obligations within 180 days of notice of the material breach, the non-defaulting party may terminate the Isorad License Agreement immediately. Isorad may terminate the agreement by providing 30 days prior written notice if the royalties payable to Isorad are $nil in any semi-annual report and we have breached other certain obligations (such as a failure to maintain a patent or patent application in the previous semi-annual review period).

 

Security Matters PTY has provided broad indemnities to Isorad and Soreq and their related parties under the terms of the Isorad License Agreement. The Isorad License Agreement is governed by the laws of Israel.

 

Safety Certifications and Permits

 

Security Matters PTY is in compliance with the requirements of the ISO 9001:2015 standard for quality management and quality assurance. The ISO organization promotes worldwide proprietary, industrial and commercial standards. Security Matters PTY is examined annually to verify that we comply with the ISO standards of excellence, safety, quality, process management and risks management, and currently holds an ISO certificate valid through April 26, 2024.

 

Under the provisions of the Israeli Non Ionizing Radiation Law, and the Work Safety regulations (regarding employment safety and health of those working with non-ionizing radiation), the Company is required to hold a valid license for operations involving non ionizing radiation as well as employ a safety expert with qualifications as defined by the law. As of May 8, 2022, Security Matters PTY has a valid license for operations involving non ionizing radiation and employs a safety expert as required by law. Additionally, the import and use of its readers may be subject to a license requirement in certain jurisdictions, which requirement may change from one jurisdiction to another.

 

Employees

 

As of February 26, 2024, the Company had 32 employees, 24 full time employees and 4 part time employees located in Israel. The Company also has two employees in Singapore, one in Australia and one in the United Kingdom.

 

None of the Company’s employees are members of a union or subject to the terms of a collective bargaining agreement. In Israel, the Company is subject to certain Israeli labor laws, regulations and Labor Court precedent rulings, as well as certain provisions of collective bargaining agreements applicable to the Company by virtue of extension orders issued in accordance with relevant labor laws by the Israeli Ministry of Economy and Industry, and which apply such agreement provisions to the Company’s employees even though they are not part of a union that has signed a collective bargaining agreement.

 

All of the Company’s employment and consulting agreements include standard non-compete and intellectual property assignment provisions, as well as strict confidentiality obligations. The enforceability of non-compete provisions may be limited by Israeli law.

 

The Company has a diversity policy in effect, last updated and approved by the board on February 7, 2021, according to which we are committed to gender diversity across its Board of Directors, senior management team and across its entire workforce, with a particular goal of increasing the representation of women in all areas.

 

Legal Proceedings

 

From time to time, the Company may become involved in legal proceedings or may be subject to claims arising in the ordinary course of our business. Although the results of these proceedings and claims cannot be predicted with certainty, the Company currently believes that the final outcome of these ordinary course matters will not have a material adverse effect on our business, operating results, financial condition or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

 

 68 

 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis provide information which our management believes is relevant to an assessment and understanding of the Company’s consolidated results of operations and financial condition. This discussion and analysis should be read together with our unaudited interim condensed consolidated financial statements and related notes as of June 30, 2023, and the audited consolidated financial statements and related notes as of December 31, 2022 of our Company and our predecessor companies included elsewhere in this prospectus. This discussion and analysis should also be read together with the section of this prospectus entitled “Business”. In addition to historical financial information, this discussion and analysis contains forward-looking statements based upon current expectations that involve risks, uncertainties and assumptions. See the section entitled “Cautionary Statement Regarding Forward-Looking Statements” elsewhere in this prospectus. Actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under “Risk Factors” or elsewhere in this prospectus.

 

Business

 

SMX integrates chemistry, physics, and computer science to give materials memory and create a culture of transparency and trust across multiple industries. The Company’s nearly 100 patents support unique marking, measuring, and tracking technologies allowing clients to seamlessly deploy transparency at all levels of development and provide stakeholders with a complete provenance of material composition and history, from virgin material to recycled, to address manufacturing challenges and ESG goals while maintaining sustainable growth. As a result, SMX’s technologies are designed and developed to help companies address ESG commitments and transition more successfully to a low-carbon economy.

 

The Company’s technology seeks to enable global companies across various industries to transition more successfully to a sustainable circular economy. By adopting our technology, they would be able to tangibly measure and track the raw material from origination, through the supply chain and at the end of life-where the amount of material recycled/reused from that product item can be measured and as well as the number of times that specific material/item has been recycled/reused.

 

The Company provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

 

Its proprietary marker system embeds a permanent or removable (depending on the needs of the customer) mark on solid, liquid or gaseous objects or materials. Each marker is comprised of a combination of marker codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with an innovative patented reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers or on a blockchain ledger, to protect data integrity and custody.

 

History

 

SMX Israel was incorporated in 2014 to provide brand protection and supply chain integrity solutions to businesses. It provides these solutions through the commercialization of the initial technology of tracking and tracing materials by observing and identifying markers (the “Source IP”). SMX Israel’s Source IP was initiated from the Soreq Nuclear Research Center, an Israeli government research and development institute for nuclear and photonic technologies under the Israeli Atomic Energy Commission (“Soreq”). In January 2015, SMX Israel entered into the Isorad License Agreement with Isorad Ltd. (an IP holding company of Soreq) to license the Source IP and develop and commercialize the technology (the “Isorad License Agreement”). Under the Isorad License Agreement, as amended, the Source IP can be utilized in almost any industry and with any product.

 

SMX Israel merged into Security Matters PTY, an Australian company, to effect a listing on the Australian Securities Exchange under the symbol “ASX: SMX.” At that time, Security Matters PTY had three wholly-owned subsidiaries: Security Matters Ltd. (Israel), SMX Fashion and Luxury (France), and SMX Beverages Pty Ltd. (Australia). It was also the record holder of 50% of Yahaloma Technologies Inc., a Canadian company and, as of October 3, 2023, 51.9% of trueGold Consortium Pty Ltd., an Australian company.

 

 69 

 

 

On March 7, 2023 (the “Closing Date”), the Company consummated its previously announced business combination pursuant to the BCA and its previously announced SID. Beginning on the day immediately prior to the Closing Date and finishing on the day immediately after the Closing Date, the following transactions occurred pursuant to the terms of the BCA:

 

Security Matters PTY proposed a scheme of arrangement under Part 5.1 of the Corporations Act (“Scheme”) and Capital Reduction which resulted in all shares in Security Matters Limited being cancelled in return for the issuance of the Company’s Ordinary Shares, with the Company being issued one share in Security Matters PTY (“Security Matters Shares”) (this resulted in Security Matters PTY becoming a wholly owned subsidiary of the Company);
   
Security Matters PTY proposed an option scheme of arrangement under Part 5.1 of the Corporations Act (“Option Scheme”), which resulted in the Security Matters PTY options held by participants in the Option Scheme being subject to a cashless exercise based on a Black-Scholes valuation, in exchange for Security Matters Shares. Under the Scheme those shares were cancelled and the participants received Ordinary Shares on the basis of the Scheme consideration;
   
Security Matters PTY shareholders received consideration under the Scheme of 1 Ordinary Share per 10.3624 Security Matters Shares having an implied value of $10.00 per Ordinary Share and the Company became the holder of all of the issued shares in Security Matters PTY and Lionheart, with Security Matters PTY being delisted from the Australian Stock Exchange;
   
Merger Sub merged with and into Lionheart, with Lionheart surviving the merger as a wholly owned subsidiary of the Company;
   
Existing Lionheart stockholders received Ordinary Shares in exchange for their existing Lionheart shares and existing Lionheart warrant holders had their warrants automatically adjusted to become exercisable in respect of Ordinary Shares instead of Lionheart shares; and
   
The Company’s Ordinary Shares were listed on NASDAQ under the ticker SMX and the Public Warrants were listed under the ticker SMXWW.

 

As a result of the Business Combination, the Company owns the entire share capital of Security Matters PTY. Accordingly, for financial reporting purposes, Security Matters PTY (the legal subsidiary) is the accounting acquirer and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the Business Combination, and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference between the fair value of the shares deemed to have been issued by Security Matters PTY and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.

 

Key Factors Affecting Operating Results

 

The Company believes that its performance and future success depend on several factors that present significant opportunities for us but also pose risks and challenges, including those discussed below and in the section of this prospectus titled “Risk Factors.

 

Commercial Agreements

 

The Company’s technology seeks to enable global companies across various industries to transition more successfully to a sustainable circular economy. By adopting our technology, they can be able to tangibly measure and track the raw material from origination, through the supply chain and at the end of life-where the amount of material recycled/reused from that product item can be measured and as well as the number of times that specific material/item has been recycled/reused.

 

 70 

 

 

Due to the fact that we aim our sales efforts at large international market-makers conglomerates, our sale cycle is relatively slow and there is a larger risk that at any time, due to many reasons that are beyond our control, the sale cycle will be broken and all efforts will be lost.

 

The Company has received interest in its technology from several international market-makers conglomerates as well as parties interested in making such technology a market standard, which will greatly assist the creation of future income. Any delays in the successful completion of projects or the creation of a market standard, as well as the materialization of any of the risks described in the section entitled “Risk Factors” above may impact the ability to generate revenue.

 

Components of Operating Results

 

The results of operations presented below should be reviewed in conjunction with the consolidated financial statements and notes included elsewhere in this prospectus.

 

Revenue

 

To date, we have not yet generated significant revenue from the sale of our technology, partly as a result of focusing on onboarding a client portfolio, building the foundation to be an industry standard and best practice and to be ready for full and fast deployment to commercial global service.

 

Operating Expenses

 

The Company’s current operating expenses consist of the following components: research and development expenses, general and administrative expenses and selling and marketing expenses. The Company is working to maintain discipline on expenses over time.

 

Research and Development Expenses, net

 

The Company’s research and development expenses consist primarily of wage and salary related expenses, subcontractors and consultants, depreciation and amortization of equipment, research expenses and share-based compensation expenses. The Company expects that its research and development expenses will increase as the Company continues to develop its products and recruit additional research and development employees.

 

The Company is engaged in Proof of Concept (POC) agreements according to which it receives funds for financing research and development expenses from prospective customers. Those funds are reimbursements for expenses and therefore are offset against the related R&D expenses in profit or loss.

 

General and Administrative Expenses

 

General and administrative expenses consist primarily of professional services fees, wages and salary related expenses, share-based compensation, facility-related costs, insurance and other general and administrative expenses. In the six months ended June 30, 2023, general and administrative expenses also include the costs that are related to the Business Combination.

 

Selling and Marketing Expenses

 

Selling and marketing expenses consist primarily of digital advertising and business development consultants.

 

Finance Income and Expenses

 

Finance expenses, net consists primarily of revaluation of financial liabilities at fair value, interest on borrowings, exchange rate difference, fees and commissions to banks and income on short-term deposits.

 

 71 

 

 

Foreign currency

 

The consolidated financial statements are prepared in US Dollars, which is the presentation currency of the Company. Security Matters PTY’s functional currency is Australian Dollars. The functional currency of SMX Israel is New Israeli Shekels.

 

Transactions and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting Standard (IAS) 21 (“The Effects of Changes in Foreign Exchange Rates”). Accordingly, transactions and balances have been converted as follows:

 

Assets and liabilities - at the rate of exchange applicable at the reporting date;
Expense items - at annual average rate at the statements of financial position date.
Share capital, capital reserve and other capital movement items were at rate of exchange as of the date of recognition of those items.
Accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned above.
Exchange gains and losses from the aforementioned conversion are recognized in the statement of other comprehensive lose in Foreign.

 

Comparison of the Six Months Ended June 30, 2023, and 2022

 

The following table summarizes our historical results of operations for the periods indicated:

 

   Six Months Ended June 30 
U.S. dollars in thousands (except of per share data)  2023   2022 
Research and development expenses   (1,172)   (933)
Selling and marketing expenses   (228)   (378)
General and administrative expenses   (13,350)   (1,200)
Listing expenses   (16,802)   (- ) 
Operating Loss   (31,552)   (2,511)
Finance expenses   (2,496)   (36)
Finance income   1,143    105 
Share of net loss of associated companies   (104)   - 
Loss before income tax   (33,009)   (2,442)
Income tax   -    - 
Loss for the period   (33,009)   (2,442)
Basic and diluted loss per share attributable to shareholders   *(39.46)   **(3.36)

 

* After giving effect to the reverse stock split

** Restated as a result of the Business Combination and after giving effect to the reverse stock split

 

Operating loss for the six months ended June 30, 2023 was $31,552 thousand compared to $2,511 thousand for the six months ended June 30, 2022, an increase of $29,041 thousand, or 1,156%. The major increase is due to the costs that are related to the Business Combination, with listing expenses which amounted to $16,802 thousand and transaction cost which amounted to $7,792 thousand.

 

Research and Development Expenses, net

 

The Company’s research and development expenses for the six months ended June 30, 2023, amounted to $1,172 thousand representing an increase of $239 thousand, or 26%, compared to $933 thousand for the six months ended June 30, 2022. The major changes in research and development expenses were an increase of $169 thousand in Share based compensation, a decrease of 327 thousand in salaries and related expenses and a decrease of $265 thousand in Subcontractors and research expenses that were offset against the reimbursement from paid pilots and proof of concept projects that decreased in $671 thousand.

 

 72 

 

 

General and Administrative Expenses

 

The Company’s general and administrative expenses amounted to $13,350 thousand for the six months ended June 30, 2023, an increase of $12,150 thousand, or 1,013%, compared to $1,200 for the six months ended June 30, 2022. The increase was primarily attributable to $7,792 thousand in transaction cost, an increase of $1,526 thousand in Advertising, Public and Investors Relations, an increase of $1,723 thousand in share-based compensation, an increase of $375 thousand in travel expenses, an increase of $310 thousand in insurance costs and an increase of $235 thousand in wages and salaries related expenses reflecting an increase in the number of employees and in related salary expenses.

 

Selling and Marketing Expenses

 

The Company’s selling and marketing expenses totaled $228 thousand for six months ended June 30, 2023, a decrease of $150 thousand, or 40%, compared to $378 thousand for the six months ended June 30, 2022, and was primarily due to a decrease in digital advertising cost.

 

Finance Income and Expenses

 

The Company’s finance income for the six months ended June 30, 2023, totaled $1,143 thousand, an increase of $1,038 thousand, or 989%, compared to $105 thousand for the six months ended June 30, 2022. The increase is primarily due to revaluation of financial liabilities, which consist of warrants and a Convertible note, at fair value.

 

The finance expense for the six months ended June 30, 2023, totaled $2,496 thousand, an increase of $2,460 thousand, or 6,833%, compared to $36 thousand for the six months ended June 30, 2022. The increase is related to a revaluation of financial liabilities, which consist of bridge loans, at fair value.

 

Share of Net Profit/Loss of Associated Companies

 

As of June 30, 2023, and December 31, 2022, the carrying amount of the investment in associated companies is $112 thousand and $221 thousand, respectively.

 

Share of net loss of associated companies consists of equity loss from associated joint venture activity for the six months ended June 30, 2023, totaled $104 thousand.

 

Income Tax

 

As of June 30, 2023, the Company estimated carry forward tax losses was $56,106 thousand (June 30, 2022: $19,927 thousand) which may be carried forward and offset against taxable income for an indefinite period in the future. The Company did not recognize deferred tax assets relating to carry forward losses in the financial statements because their utilization in the foreseeable future is not probable.

 

Net Loss attributable to shareholders

 

As a result of the forgoing, our net loss for the six months ended June 30, 2023, was $33,009 thousand, compared to $2,442 thousand for the six months ended June 30, 2022, an increase of $30,567 thousand, or 1,252%.

 

 73 

 

 

Comparison of the Years Ended December 31, 2022 and December 31, 2021

 

The following table summarizes our historical results of operations for the periods indicated:

 

   Year Ended
December 31,
 
U.S. dollars in thousands (except of per share data)  2022   2021 
         
Research and development expenses   1,898    2,039 
Selling and marketing expenses   569    453 
General and administrative expenses   2,723    2,482 
           
Operating Loss   (5,190)   (4,974)
Finance expenses   (1,128)   (101)
Finance income   28    237 
Share of net profit (loss) of associate companies   106    (101)
           
Loss before income tax   (6,184)   (4,939)
           
Income tax   -    - 
           
Loss for the year   (6,184)   (4,939)
           
Basic and diluted loss per share attributable to shareholders**   (8.47)   (7.41)

 

** Restated as a result of the Business Combination and after giving effect to the reverse stock split

 

As a result of the foregoing, our operating loss for year ended December 31, 2022 was $5,190 thousand compared to an operating loss of $4,974 thousand for year ended December 31, 2021, an increase of $216 thousand, or 4.3%.

 

Research and Development Expenses, net

 

The Company’s research and development expenses for the year ended December 31, 2022, amounted to $1,898 thousand, representing a decrease of $141 thousand, or 7%, compared to $2,039 thousand for the year ended December 31, 2021. The major changes in research and development expenses were an increase of $371 thousand in salaries and related expenses that were offset against the reimbursement from paid pilots and proof of concept projects that increased in $335 thousand and Subcontractors and consultants’ expenses that decreased in $257 thousand.

 

General and Administrative Expenses

 

The Company’s general and administrative expenses totaled $2,723 thousand for the year ended December 31, 2022, a net increase of $241 thousand, or 10%, compared to $2,482 for the year ended December 31, 2021. The net increase was primarily attributable to an increase of $183 thousand in wages and salaries related expenses reflecting an increase in the number of employees and an increase of $223 thousand in travel expenses offset by decrease of $194 thousand in share-based compensation expenses.

 

Selling and Marketing Expenses

 

The Company’s selling and marketing expenses totaled $569 thousand for the year ended December 31, 2022, an increase of $116 thousand, or 26%, compared to $453 thousand for the year ended December 31, 2021, and was primarily due to an increase in digital advertising cost associated with our marketing efforts.

 

Finance Income and Expenses

 

The Company’s finance income for the year ended December 31, 2022, totaled $28 thousand, a decrease of $209 thousand, or 88%, compared to $237 thousand for the year ended December 31, 2021. The Company’s finance expenses totaled $1,128 thousand for the year ended December 31, 2022, an increase of $1,027 thousand or 1,017%, compared to $101 thousand for the year ended December 31, 2021.

 

 74 

 

 

Share of Net Profit/Loss of Associated Companies

 

Shares of net profit of associated companies consists of equity profit from associated joint venture activity for the year ended on December 31, 2022 at the amount of $106 thousand and share of net loss of associated companies consists of equity loss from associated joint venture activity for the year ended on December 31, 2021 at the amount of $101 thousand. As of December 31, 2022 and December 31, 2021, the carrying amount of the investment in associated companies is $221 thousand and $147 thousand, respectively.

 

Income Tax

 

As of December 31, 2022, the Company estimated carry forward tax losses of approximately $24,106 thousand (December 31, 2021: $17,659 thousand) which may be carried forward and offset against taxable income for an indefinite period in the future. The Company and its subsidiaries did not recognize deferred tax assets relating to carry forward losses in the financial statements because their utilization in the foreseeable future is not probable.

 

Net Loss attributable to shareholders

 

As a result of the forgoing, our net loss for the year ended December 31, 2022 was $6,184 thousand, compared to $4,939 thousand for the year ended December 31, 2021, an increase of $1,245 thousand, or 25%.

 

Liquidity and Capital Resources

 

Overview

 

Since our inception through June 30, 2023 and thereafter, the Company has funded its operations principally through the issuance of Ordinary Shares, warrants, convertible notes, loans from investors and related parties and reimbursement from prospected customers for paid pilots and proof-of-concept projects. As of June 30, 2023, the Company had $3,020 thousand in cash and cash equivalents. In addition, in September 2023, the Company raised gross proceeds of approximately $2,500 thousand, before deducting fees and other offering expenses payable by the Company, from the sale of a convertible promissory note and warrants to an institutional investor, and in December 2023, the Company induced certain holders of its outstanding Warrants Bs to exercise an aggregate of 606,060 of such warrants at a reduced exercise price of $1.15 per share, for aggregate gross proceeds, to the Company of approximately $697,000 before deducting fess and other offering expenses payable by the Company.

 

The table below presents our cash flows for the periods indicated:

 

   For the Six Months Ended
June 30,
   For the Year Ended
December 31,
 
U.S. dollars in thousands  2023   2022   2022   2021 
Net cash used in operating activities   7,675    2,862    5,223    3,908 
Net cash used in investing activities   393    966    1,127    1,765 
Net cash provided by financing activities   9,703    542    3,846    6,118 
                     
Net increase (decrease) in cash and cash equivalents   1,635    (3,286)   (2,504)   445 

 

Operating Activities

 

Net cash used in operating activities was $7,675 thousand during the six months ended June 30, 2023, compared to net cash used in operating activities of $2,862 thousand during the six months ended June 30, 2022. The increase was primarily used for transaction costs and payments that are related to the Business Combination.

 

Net cash used in operating activities was $5,223 thousand during the year ended December 31, 2022, compared to net cash used in operating activities of $3,908 thousand during the year ended December 31, 2021. The increase was primarily used for payment of salaries and related expenses, travel expenses, research and development, subcontractors, consultants and materials. In addition, the increase in cash used in operating activities derived from a material increase in prepaid expenses related to the BCA.

 

 75 

 

 

Investing Activities

 

Net cash used in investing activities was $393 thousand during the six months ended June 30, 2023 and consisted of cost of capitalized development expenses in the amount of $383 thousand and $10 thousand used for purchasing property, plant and equipment. Net cash used in investing activities was $966 thousand during the six months ended June 30, 2022, consisted of cost of capitalized development expenses in the amounts of $783 thousand and $183 thousand, which were used for purchasing property and equipment.

 

Net cash used in investing activities was $1,127 thousand during the year ended December 31, 2022 and consisted of cost of capitalized development expenses in the amount of $975 thousand and $152 thousand used for purchasing property, plant and equipment. Net cash used in investing activities was $1,765 thousand during the year ended December 31, 2021, and consisted of cost of capitalized development expenses in the amounts of $1,468 thousand and $297 thousand, which were used for purchasing property and equipment.

 

Financing Activities

 

Net cash provided by financing activities was $9,703 thousand during the six months ended June 30, 2023, consisted mainly of $3,220 thousand in advance payment for equity, $2,923 thousand for net proceeds from issuance of shares in the Business Combination, an aggregate of $2,811 thousand net proceeds from the issuance of bundled securities, $550 thousand in proceeds from bridge loans and $250 thousand in proceeds from the issuance of a convertible note.

 

Net cash provided by financing activities was $542 thousand during the six months ended June 30, 2022, consisted mainly of $581 thousand in proceeds from the issuance of convertible notes, which was partially offset by payment of $39 thousand for lease liabilities.

 

Net cash provided by financing activities was $3,846 thousand during the year ended December 31, 2022, consisted mainly of $3,310 thousand in proceeds from bridge loans and warrants and $581 thousand of net proceeds from issuance of convertible notes and $182 thousand net issuance of shares, which was partially offset by payment of $172 thousand for loan repayment to related parties. Net cash provided by financing activities was $6,118 thousand during the year ended December 31, 2021, consisted mainly of $5,892 thousand in proceeds from net issuance of shares and warrants and $395 thousand of net proceeds from the exercise of warrants, which was partially offset by payment of $98 thousand for lease liabilities and loan repayment to related parties of $103 thousand.

 

Current Outlook

 

The Company has incurred and continues to incur losses, and continues to generate negative cash flows from operations since inception in 2015. Since the Company’s inception, it has not generated significant revenue from the sale of products.

 

As of June 30, 2023 and December 31, 2022, the Company had $3,020 thousand and $1,398 thousand, respectively, in cash and cash equivalents, which the Company has been using and continues to use for working capital and general corporate purposes since those dates. Since June 30, 2023, the Company has raised an additional approximately $6.0 million in funding from various investors. The Company expects that its existing cash and cash equivalents, along with amounts it may draw down under the SEPA, and receivables from clients once paid, will be sufficient to fund its operations for the foreseeable future but perhaps at a delayed or reduced scope. In addition, the Company has outstanding approximately $12 million in existing payables and other liabilities related to expenses of the Business Combination, of which approximately $8.5 million is deferred through the second quarter of 2024 when such amounts are expected to be paid. The Company expects to fund the payment of such amounts out of available cash, the Yorkville SEPA, referred to below, ongoing activities of the Company and possibly other capital raisings in 2024. Further, the Company’s operating plans may change as a result of many factors that may currently be unknown to it, and it may need to seek additional funds sooner than planned. The Company’s future capital requirements will depend on many factors, including:

 

the progress and costs of our research and development activities;
   
the costs of filing, prosecuting, enforcing and defending patent claims and other intellectual property rights;
   
the potential costs of contracting with third parties to provide marketing and distribution services for us or for building such capacities internally; and
   
the magnitude of our general and administrative expenses.

 

 76 

 

 

Until the Company can generate significant recurring revenues and profit, the Company expects to satisfy its future cash needs through capital raising and shareholders’ financial support. The Company cannot be certain that additional funding will be available when needed, on acceptable terms, if at all. The Company’s outstanding warrants are either out of the money or have nominal exercise prices; accordingly, the Company does not expect to raise any material additional funds from the exercise of outstanding warrants in at least the short-term. If funds are not available, the Company may be required to delay or reduce the scope of research or development plans.

 

We can give no assurances that we will be able to secure additional sources of funds to support our operations on acceptable terms, or at all, or, if such funds are available to us, that such additional financing will be sufficient to meet our needs. If we raise additional funds by issuing equity or convertible debt securities, including pursuant to the SEPA, it could result in dilution to our existing stockholders or increased fixed payment obligations. In addition, as a condition to providing additional funds to us, future investors may demand, and may be granted, rights superior to those of existing stockholders. If we incur additional indebtedness, we could become subject to covenants that would restrict our operations and potentially impair our competitiveness, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. Additionally, any future collaborations we enter into with third parties may provide capital in the near term but may not be on terms that are favorable to us. Any of the foregoing could significantly harm our business, financial condition and results of operations. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may be required to reduce the scope of the commercialization of our planned products or delay, scale back or discontinue the development of one or more of our product candidates.

 

We may also need to take certain other actions to allow us to maintain our projected cash and projected financial position, including but not limited to additional reductions in general and administrative costs, sales and marketing costs, and other discretionary costs. Although we believe such plans, if executed and coupled with the above described sources of liquidity, should provide us with financing to meet our needs, successful completion of such plans is dependent on factors outside of our control.

 

We anticipate that we will continue to incur net losses into the foreseeable future as we continue our development of our product candidates, and expand our corporate infrastructure.

 

Contractual Obligations

 

Reciprocal Standby Equity Purchase Agreement

 

Effective March 7, 2023, we entered into the SEPA with Yorkville, whereby we have the right, but not the obligation, to sell to Yorkville up to $25.0 million of our Ordinary Shares at our request, subject to the terms therein. We have received as loans Pre-Advances of $3.5 million, of which as of the date of this prospectus, an aggregate of approximately $3.0 million in principal have been converted into our Ordinary Shares or repaid in cash. We may from time to time offer and sell our Ordinary Shares under the SEPA, which is expected to provide us with an additional source of liquidity.

 

Our decision to make any Advance under the SEPA will depend on a variety of factors to be determined by us from time to time, including, among other things, the trading price of our Ordinary Shares and determination by us that other sources of capital may be more beneficial, and determinations by us as to the appropriate sources of funding for our business and operations.

 

 77 

 

 

We do not believe that the existence of the SEPA will have any adverse effect on our ability to raise any capital from other sources except that pursuant to the SEPA, we are not permitted to enter into any variable rate transactions during the term of the SEPA, which could result in potential investors declining to consider investing in our Company on terms agreeable to us or at all.

 

Leases

 

SMX Israel is a party to a lease agreement dated January 14, 2020, and amended as of December 24, 2020 (the “Lease”). Under the Lease, it is obligated to pay ILS 253 thousand plus VAT per year. The Lease will expire on May 31, 2027, with an additional option of 5 years, unless terminated by the landlord due to a requirement of a governmental authority to modify or terminate the Lease, pursuant to the terms of the lease.

 

Borrowings

 

On September 19, 2023, the Company amended the loan agreements dated September 7, 2015, by and between SMX Israel, the Company’s shareholders and Kamea Fund. Pursuant to the amendment to the loan agreements, Kamea agreed to convert US$657 thousand of indebtedness under the loan agreements into 487,281 ordinary shares (post share reverse split) of the Company, as payment in full for such indebtedness; provided however, that in the event the proceeds received from Kamea with respect to any sales of the shares are not at least equal to the indebtedness amount, the Company will remain liable to Kamea for the balance of the indebtedness amount

 

Additionally, Kibbutz Ketura provides administrative services for SMX Israel for which it was debited $19 thousand and $25 thousand for the six month ended June 30, 2023 and June 30, 2022, respectively.

 

Security Matters PTY and the Company borrowed an aggregate of $3,860 thousand from private investors between September 2022 and February 2023, which loans are due no earlier than May 31, 2024. All of such loans have an interest rate of 10% per annum. Each such lender (except for one lender which lent an amount of $1,000 thousand which is not entitled to the redeemable warrants), further received 20% redeemable 5-year warrant coverage to subscribe for Ordinary Shares at $11.50 per share, plus 5% 5-year bonus warrant coverage to subscribe for Ordinary Shares at $11.50 per share and a first priority security interest in the shares of Security Matters PTY’s interest in trueGold Consortium Pty Ltd. In March 2023, the Company signed an addendum to the Bridge Loans agreements which converted $1,350 thousand into common shares and deferred the remaining cash payments to March 31, 2024.

 

On or about January 12, 2024, the Company issued an aggregate of 4,032,256 Ordinary Shares and warrants to purchase an aggregate of 4,032,256 ordinary shares, to the lenders, in exchange for the cancellation of an aggregate of (a) approximately $750 thousand in principal owed to the lenders and (b) $1,450 thousand cash value of Redeemable Warrants. The Company also issued 457,682 Ordinary Shares to a service provider (the “Service Provider”) as payment in full for $260,000 worth of services previously provided to the Company by the Service Provider. Such transactions were evidenced by a series of substantially similar Conversion and Exchange Rights Agreements executed as of December 31, 2023.

 

In January 2023, the Company borrowed $250 thousand from a private investor, which loan is due December 31, 2024. Such loan has an interest rate of 15% per annum, and is convertible at a conversion price of $10.00 per share, and the holder further received 5% redeemable 5-year warrant coverage to subscribe for Ordinary Shares at $11.50 per share, plus 5% 5-year bonus warrant coverage to subscribe for Ordinary Shares at $11.50 per share.

 

 78 

 

 

On September 6, 2023, the Company consummated the transactions pursuant to a Securities Purchase Agreement dated as of September 5, 2023 and issued and sold to an institutional investor a promissory note with a fixed conversion price of $1.6378 and warrants, for gross proceeds to SMX of approximately $2,500 thousand, before deducting fees and other offering expenses payable by the Company. The note was issued in the principal amount of $4,290 thousand, all of which have been converted as of the date of this prospectus into an aggregate of 2,619,377 Ordinary Shares. The actual amount loaned by the investor pursuant to the Note was $2,574 thousand after a 40% original issue discount. The maturity date of the note is the 12-month anniversary of the effective date, and is the date upon which any remaining accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of 12% per year and shall be payable on the maturity date or upon acceleration or by prepayment or otherwise. The investor has the right, at any time, to convert all or any portion of the then outstanding and unpaid principal amount and interest (including any costs, fees and charges) into Ordinary Shares at a fixed conversion price of $1.6378 per share. Any such conversion is subject to customary adjustments and limitations set forth in the note, including for fundamental transactions. Additionally, as part of the transaction, we issued two warrants to the Investor, an “A” Warrant and a “B” Warrant. The A Warrant for 3,929,051 Ordinary Shares has an exercise price of $0.0022 per share, subject to customary adjustments, and may be exercised at any time until the five year anniversary of the A Warrant. As of February 26, 2024, the investor exercised the Warrant A for 653,595 Ordinary Shares. Subsequent to February 26, 2024, the investor exercised the Warrant A for 736,274 Ordinary Shares. The B Warrant for 2,619,367 Ordinary Shares has an exercise price of $1.6378 per share, subject to customary adjustments, and may be exercised at any time until the five year anniversary of the B Warrant. In no case shall the Company convert the note or exercise the A Warrants or the B Warrants if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of 4.99% of the Company’s issued and outstanding Ordinary Shares.

 

Government Grants

 

As of June 30, 2023 and December 31, 2022, the Company has a contingent liability of $141 thousand and $135 thousand respectively, for government grant it received for the use of research and development activities from Israel Innovation Authority (IIA). The Company is subject to paying 3% of its relevant revenues for the first three years, and 4% of the relevant revenues for further years, until repayment of the entire grant.

 

Isorad License Agreement

 

In January 2015, the Company entered into the Isorad License Agreement with Isorad Ltd. (a company wholly owned by the State of Israel with rights to exclusively commercialize the Soreq Research Center technology for civilian uses), according to which the Company was granted technological license in return for future royalties based on 2.2% of gross sales by the Company and its affiliates and after 25 years the license becomes royalty-free. Upon the occurrence of an M&A event (as such event is defined in the agreement to include mergers, sale of all or substantially all the assets of ours and similar event), in the first M&A event, the Company is to pay a consideration equal to 1% of the amount received or transferred and in the second M&A event, a consideration equal to 2% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

In January 2023, the Company signed an amendment to the Isorad License Agreement that provided for the following: (1) for the BCA with Lionheart, (a) Isorad was issued 864,000 options to purchase shares of the Company, which options were issued in January 2023 and valued using the Black-Scholes pricing model, with the main parameters used being: (1) risk-free rate: 3.42%; (2) expected volatility: 81.92%: (3) expected term: up to 3 years; and (4) expected dividend yield: 0%; and (b) Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of $27 million, or at the end of such 13 months, the earlier thereof); and (2) Exit fee - in the occurrence of the first M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA, the Company is to pay a cash amount equal to 1.5% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter. In the six months ended June 30, 2023, based on the funds the Company actually received, the Company recognized a technology license intellectual property at the amount of $101 thousand against a liability that reflects the due amount.

 

Quantitative and Qualitative Disclosures about Market Risk

 

The Company is exposed to market risks in the ordinary course of business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of U.S. dollar/ILS Israeli Shekels exchange rates, which is discussed in detail in the following paragraph.

 

 79 

 

 

Foreign Currency Exchange Risk

 

Currency Fluctuations

 

The Company’s operating expenses are denominated in USD and ILS, and therefore are currently subject to foreign currency risk. We have been affected by changes in the rate of ILS currency compared to the U.S. dollar, as the ILS decreased against the U.S. dollar by approximately 6% and 13% in the six months ended June 30, 2023 and June 30 2022, respectively.

 

The Company’s policy is not to enter into any currency hedging transactions, and we cannot assure you that we will not be adversely affected by currency fluctuations in the future.

 

Credit Risk

 

Credit risk is a risk of financial loss if a counterparty or customer fails to meet its contractual obligations. We closely monitor the activities of our counterparties and control the access to its intellectual property which enables it to ensure a prompt collection. Our main financial assets are cash and cash equivalents as well as other receivables and represent the Company’s maximum exposure to credit risk in connection with its financial assets. Wherever possible and commercially practical, the Company holds cash with major and sound financial institutions in Israel and Australia.

 

Liquidity Risk

 

Liquidity risk is the risk that we will encounter in meeting our obligations associated with our financial liabilities that are settled by delivering cash or another financial asset. The Company seeks to minimize that risk by maintaining sufficient cash and other highly liquid current assets and by having available an adequate amount of committed credit facilities. For more details, please refer to the section titled, “Liquidity and Capital Resources”.

 

Critical Accounting Policies and Estimates

 

Reverse Acquisition Transaction

 

As a result of the Business Combination, the Company owns the entire share capital of Security Matters PTY Ltd. Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the transaction ($11,599 thousand), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $16,802 thousand, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at closing date.

 

The Company is initially consolidated in the financial statements from the Closing Date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($4,921 thousand) and trade and other payables and warrants ($10,127 thousand) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:

 

1. The assets and liabilities of Security Matters PTY have been recognized and measured in the consolidated financial statements of the Company for the six month period ended June 30, 2023, at their pre-combination carrying amounts.
   
2. The retained earnings and other equity balances recognized in the consolidated financial statements of the Company for the six month period ended June 30, 2023, are the retained earnings and other equity balances of Security Matters PTY immediately before the Business Combination.

 

 80 

 

 

3. The amount recognized as issued equity instruments in the consolidated financial statements of the Company for the six month period ended June 30, 2023, has been determined by adding to the issued equity of Security Matters PTY immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.
   
4. The statement of comprehensive loss in the consolidated financial statements of the Company for the six month period ended June 30, 2023, reflects that of Security Matters PTY for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.

 

BOARD OF DIRECTORS AND EXECUTIVE MANAGEMENT

 

Management and Board of Directors

 

The following sets forth certain information, as of February 26, 2024, concerning our executive officers and members of the Board.

 

Name   Age   Position
Director        
Ophir Sternberg   53   Chairman of the Board
Haggai Alon   49   Director
Amir Bader   60   Director
Pauline Khoo   63   Director
Roger Meltzer   72   Director
Thomas Hawkins   62   Director
Zeren Browne   44   Director
Executive Officers        
Haggai Alon   49   Chief Executive Officer
Limor Moshe Lotker   53   Chief Financial Officer
Zeren Browne   44   Executive Vice President, Chief Strategy Officer, Managing Director of trueGold

 

Information about Directors

 

Ophir Sternberg. Mr. Sternberg, our Chairman, was the Chairman, President and Chief Executive Officer of Lionheart since its inception through the Business Combination. He has been our Chairman since the Business Combination, and has over 28 years of experience acquiring, developing, repositioning and investing in all segments of the real estate industry, including office, industrial, retail, hospitality, ultra-luxury residential condominiums and land acquisitions. Mr. Sternberg is the Founder and Chief Executive Officer of Miami-based Lionheart Capital, founded in 2010. Lionheart Capital is a Miami-based diversified investment firm focused on building shareholder value in high-growth companies.

 

Mr. Sternberg began his career assembling, acquiring and developing properties in emerging neighborhoods in New York City, which established his reputation for identifying assets with unrealized potential and combining innovative partnerships with efficient financing structures to realize above average returns. Mr. Sternberg came to the United States in 1993 after completing three years of military service within an elite combat unit for the Israeli Defense Forces.

 

 81 

 

 

Under Mr. Sternberg’s leadership, Lionheart Capital executed numerous prominent real estate transactions and repositions, including The Ritz-Carlton Residences in Miami Beach, which resulted in a total sell-out value in excess of $550 million, as well as purchase of the development’s site, the former Miami Heart Institute. Additionally, Mr. Sternberg led the $120 million sale of The Seagull Hotel, making it the highest grossing hotel sale of 2020 in Miami Beach. Mr. Sternberg and Lionheart Capital are currently in development on a number of other projects, including retail properties in Miami’s fashion and culture epicenter, The Design District. In addition to The Ritz-Carlton Residences, Miami Beach, Lionheart Capital also developed The Ritz-Carlton Residences Singer Island, Palm Beach, cementing a reputation for developing high-end luxury branded properties.

 

In 2017, Mr. Sternberg founded Out of the Box Ventures, LLC, a Lionheart Capital subsidiary, to acquire and reposition distressed retail properties throughout the United States. With 19 properties in 14 states, Out of the Box Ventures currently controls over 5 million square feet of big box stores, shopping centers and enclosed regional mall properties with plans to improve and expand upon these acquisitions.

 

Mr. Sternberg and Lionheart Capital are dedicated to working with best-in-class operators and partners such as Marriot International. Lionheart Capital has been able to execute numerous, marquee transactions due largely in part to Mr. Sternberg’s extensive industry relationships particularly with key institutional investors.

 

In March 2020, Mr. Sternberg became Chairman of Nasdaq-listed OPES which on June 30, 2020, announced a definitive agreement to merge with BurgerFi International LLC. The OPES-BurgerFi merger closed on December 16, 2020 to form BurgerFi International Inc., or BurgerFi, a fast-causal “better burger” concept that consists of approximately 120 restaurants nationally and internationally. Mr. Sternberg is the Chairman of the Nasdaq-listed company, BurgerFi (NASDAQ: BFI). The OPES team, led by Mr. Sternberg, evaluated over 50 potential targets and negotiated business combination terms with multiple candidates in a span of a few months and acquired BurgerFi at what it believed was an attractive multiple relative to its peers.

 

In addition, in May 2021, Lionheart Capital led a partnership group to purchase the iconic American powerboat business, Cigarette Racing Team, from its longtime owner.

 

In addition, since its inception in December 2019, Mr. Sternberg has been the Chairman, President and Chief Executive Officer of Nasdaq-listed Lionheart Acquisition Corporation II (“Lionheart II”), a SPAC. Lionheart II completed its initial public offering in August 2020, in which it sold an aggregate of 23,000,000 units (including the exercise of the underwriters’ over-allotment option), each unit consisting of one share of Lionheart II Class A common stock and one-half of one redeemable warrant for one share of Lionheart II Class A common stock, for an offering price of $10.00 per unit, generating aggregate proceeds of $230,000,000. Lionheart II’s units, shares of Class A common stock and warrants currently trade on Nasdaq under the symbols “LIONU,” “LION” and “LIONW,” respectively. On July 12, 2021, Lionheart II announced a $32.6 billion business combination with MSP Recovery, Inc. (d/b/a LifeWallet) (NASDAQ: LIFW), a leader in data-driven solutions that recovers improperly paid benefits on behalf of Medicare, Medicaid and other commercial payers. The Lionheart II-MSP merger closed on May 23, 2022. Mr. Sternberg serves on the Board of Directors of MSP Recovery, Inc. Mr. Sternberg is qualified to serve as a director due to his extensive experience in acquiring, developing, repositioning and investing in all segments of the real estate industry.

 

Haggai Alon. Haggai Alon is the founder of Security Matters (SMX) and has served as the CEO of SMX Israel since 2015 and a director and CEO of SMX since July 2018. Mr. Alon is also the CEO and a board member of trueGold Consortium Pty Ltd since June 2020. Mr. Alon has over 25 years of experience in commercializing technology. Haggai Alon held several roles during his time at the Ministry of Defense and was the CEO of an economic consulting firm focusing on M&A. He has a master’s degree from the Tel Aviv and Haifa Universities in international relations and political science and. Out of a total of 27 patent families filed in the name of SMX, Haggai Alon is a named inventor on 26 of them. Most of the applications that are part of these patent families are under examination, many are still unpublished. In 7 of the 26 patent families Haggai Alon is a named inventor, the patents have been issued in a variety of jurisdictions. Presently, Haggai Alon is a named inventor on 19 patents, all of which are in the public domain. He has also published a White Paper-New Plastic Economic Order: To regulate the entire value chain, not just the product, which calls for a transition to a new regulatory approach by the EU over plastics. Mr. Alon’s founding of Security Matters and his experience as CEO of Security Matters since 2015 makes him a valuable asset to our board.

 

 82 

 

 

Amir Bader. Amir Bader is has served as the CEO of the Dairy Farm at the Golan Heights, currently the manager of one of Israel’s largest dairy farms, since April 2017. Previously, Mr. Bader served as the CEO of Degenya Cooperative Agricultural Association from 2012 through 2016. Mr. Bader has been a director of SMX since July 2018. Mr. Bader and has more than 38 years of experience at managerial positions in dairy farms and other agricultural projects in Israel and Europe. Amir Bader also served as Kibbutz Degania A’s business manager for five years, during that period he served as the board member of several subsidiaries and companies related to the Kibbutz. Amir Bader brings to the Company board extensive experience in the management of agricultural businesses.

 

Pauline Khoo. Ms. Khoo currently serves as the Wealth Planning Manager at Mishcon de Reya since January 2022 and was previously the Managing Director of Credit Suisse Trust Limited from August 2009 to December 2021. Ms. Khoo has more than forty years of financial and managerial experience in financial institutions, law firms and various companies. Ms. Khoo is a member of the Institute of Chartered Secretaries (by completing exams), the Society of Trust and Estate Practitioners, the Institute of Chartered Secretaries and Administrators Chartered Trustee of Singapore Trustees Association, Family Firm Institute-Business Advisory and Family Advisory and a senior member of the Global-Asia Family Office Circle. We believe Ms. Khoo is well qualified to serve on our board due to her more than forty years of experience in financial and managerial positions.

 

Thomas Hawkins. Thomas Hawkins, a director of Lionheart until the Business Combination, previously served as a Management Consultant for MEDNAX, Inc. from February 2014 to December 2017, after serving as General Counsel and Board Secretary from April 2003 to August 2012. Prior to that, Mr. Hawkins worked for New River Capital Partners as a Partner from January 2000 to March 2003; AutoNation, Inc. as Senior Vice President of Corporate Development from May 1996 to December 1999; Viacom, Inc. as Executive Vice President from September 1994 to May 1996; and Blockbuster Entertainment Corporation as Senior Vice President, General Counsel, and Secretary from October 1989 to September 1994. Mr. Hawkins currently serves on the board of directors of the Alumni Association of the University of Michigan and Jumptuit Inc., a data analytics technology company. Mr. Hawkins also serves on the board of directors of MSP Recovery. Mr. Hawkins received his Juris Doctor from Northwestern University in 1986 and his A.B. in Political Science from the University of Michigan in 1983. Mr. Hawkins is qualified to serve as a director due to his experience as a senior executive and chief legal officer at several public companies (including his experience acquiring companies) and with counseling and serving on boards of directors.

 

Roger Meltzer, Esq. Mr. Meltzer practiced law at DLA Piper LLP from 2007 and held various roles: Global Co-Chairman (2015 through 2020), and currently as Chairman Emeritus; Americas Co-Chairman (2013 through 2020); Member, Office of the Chair (2011 through 2020); Member, Global Board (2008 through 2020); Co-Chairman, U.S. Executive Committee (2013 through 2020); Member, U.S. Executive Committee (2007 through 2020); and Global Co-Chairman, Corporate Finance Practice (2007 through 2015). Prior to joining DLA Piper LLP, Mr. Meltzer practiced law at Cahill Gordon & Reindel LLP from 1977 to 2007 where he was a member of the Executive Committee from 1987 through 2007, Co-Administrative Partner and Hiring Partner from 1987 through 1999, and Partner from 1984 through 2007. Mr. Meltzer currently serves on the Advisory Board of Harvard Law School Center on the Legal Profession (May 2015-Present); and the Board of Trustees, New York University Law School (September 2011-Present); and previously served on the Corporate Advisory Board, John Hopkins, Carey Business School (January 2009-December 2012). He has previously served on the board of directors of: Lionheart II Corp (March 2021 to May 2022), Lionheart III Corp (March 2021 to August 2022), Haymaker Acquisition Corp. III (February 2021 to July 2022), certain subsidiaries of Nordic Aviation Capital (December 2021 to April 2022), The Legal Aid Society (November 2013 to January 2020), Hain Celestial Group, Inc. (December 2000 to February 2020), American Lawyer Media (January 2010 to July 2014) and The Coinmach Service Corporation (December 2009 to June 2013). Mr. Meltzer has also received several awards and honors and has been actively involved in philanthropic activity throughout his career. Mr. Meltzer received Juris Doctor degree in law from New York University School of Law and an A.B. from Harvard College. In February 2021, Mr. Meltzer joined the board of directors of Haymaker Acquisition Corp. 4, a special purpose acquisition company focused on identifying and implementing value creation initiatives within the consumer and consumer-related products and services industries. In May 2022, Mr. Meltzer joined the board of directors of MSP Recovery, Inc. following its business combination with Lionheart Acquisition Corp. II. In August 2022, Mr. Meltzer joined the board of directors of the Company following the Business Combination. In April 2023, Mr. Meltzer joined the board of directors of Cyxtera Technologies, Inc., a company specializing in colocation and interconnection services, with a footprint of more than 60 data centers in over 30 markets. In November 2023, Mr. Meltzer joined the board of directors of Audacy Inc., a leading multi-platform audit content and entertainment company. Mr. Meltzer also serves on the board of directors of various private companies as well.

 

 83 

 

 

Zeren Browne. Ms. Browne has previously held senior management roles and led the marketing and commercial business activities for brands under luxury & lifestyle conglomerates LVMH and Estee Lauder Companies. Ms. Browne has been the Executive Vice President and Chief Strategy Officer, of the Company and its predecessors since July 2018. She was formerly the Managing Director at Mulloway Pty Limited from October 2016 to July 2020 and is currently the Managing Director of trueGold Consortium Pty Limited since June 2020. Ms. Browne holds a Bachelor of Commerce Degree and an advanced MBA Degree from The University of Western Australia, where she was awarded the Dux and The Women in Management Scholarship. Ms. Browne brings more than 20 years’ experience in global marketing and strategic brand management to our board.

 

Information about Executive Officers

 

Haggai Alon. See “Information about Directors” above.

 

Limor Moshe Lotker. Ms. Limor Lotker, CPA was appointed as Chief Financial Officer of SMX since May 2021. Ms. Lotker is a qualified Israel chartered accountant with over 20 years’ experience. Ms. Lotker previously worked in various roles at Baya Technologies Ltd., including Deputy CEO and CFO, from June 2009 to May 2021. Ms. Lotker is highly experienced in financial and operational aspects of the business controllership and leading finance and investing processes. She has vast experience with publicly traded companies.

 

Mr. Alon and Ms. Lotker have employment agreements with Security Matters Ltd., an Israeli company and subsidiary of SMX, and as provided in their employment agreement will provide services to Security Matters Ltd., and its parent and any wholly owned subsidiary thereof. Pursuant to their employment agreements, Mr. Alon and Ms. Lotker will receive a salary of approximately US$295,000 and US$203,000, respectively, and be entitled to other benefits such as receipt of options and bonus payments.

 

Zeren Browne. See “Information about Directors” above.

 

Family Relationships

 

There are no family relationships among any of our executive officers or directors.

 

Foreign Private Issuer Exemption

 

We are a “foreign private issuer,” as defined by the SEC. As a result, in accordance with Nasdaq rules, we may comply with home country governance requirements and certain exemptions thereunder rather than complying with Nasdaq corporate governance standards. While we expect to voluntarily follow most Nasdaq corporate governance rules, we may choose to take advantage of the following limited exemptions:

 

Exemption from filing quarterly reports on Form 10-Q containing unaudited financial and other specified information or current reports on Form 8-K upon the occurrence of specified significant events;

 

 84 

 

 

Exemption from Section 16 rules requiring insiders to file public reports of their securities ownership and trading activities and providing for liability for insiders who profit from trades in a short period of time;
   
Exemption from quorum requirements for shareholder meetings;
   
Exemption from the Nasdaq rules applicable to domestic issuers requiring disclosure within four business days of any determination to grant a waiver of the code of business conduct and ethics to directors and officers;
   
Exemption from the requirement to obtain shareholder approval for certain issuances of securities, including shareholder approval of share option plans;
   
Exemption from the requirement that our audit committee have review and oversight responsibilities over all “related party transactions,” as defined in Item 7.B of Form 20-F;
   
Exemption from the requirement that our board have a compensation committee that is composed entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities. We currently have only director who serves on the compensation committee who meets the heightened independence standards for members of a compensation committee; and
   
Exemption from the requirements that director nominees are selected, or recommended for selection by our board, either by (1) independent directors constituting a majority of our board’s independent directors in a vote in which only independent directors participate, or (2) a committee comprised solely of independent directors, and that a formal written charter or board resolution, as applicable, addressing the nominations process is adopted.

 

Furthermore, Nasdaq Rule 5615(a)(3) provides that a foreign private issuer, such as we, may rely on home country corporate governance practices in lieu of certain of the rules in the Nasdaq Rule 5600 Series and Rule 5250(d), provided that we nevertheless comply with Nasdaq’s Notification of Noncompliance requirement (Rule 5625), the Voting Rights requirement (Rule 5640) and that we have an audit committee that satisfies Rule 5605(c)(3), consisting of committee members that meet the independence requirements of Rule 5605(c)(2)(A)(ii). Most recently, we have elected to (a) amend our 2022 Equity Incentive Plan to increase the number of shares authorized under the plan without stockholder approval, and (b) follow home country practice in lieu of the requirements under Nasdaq Rule 5635(d) to seek shareholder approval in connection with certain transactions involving the sale, issuance and potential issuance of our Ordinary Shares (or securities convertible into or exercisable for our Ordinary Shares) at a price less than certain referenced prices, if such shares equal 20% or more of the Company’s Ordinary Shares or voting power outstanding before the issuance, each as permitted under Irish law.

 

Accordingly, our shareholders will not have the same protections afforded to shareholders of companies that are subject to all of the corporate governance requirements of Nasdaq. We may utilize these exemptions for as long as we continue to qualify as a foreign private issuer.

 

Corporate Governance

 

The Company structured its corporate governance in a manner it believes closely aligns its interests with those of its shareholders. Notable features of this corporate governance include:

 

The Company has four independent directors and independent director representation on our audit and compensation committees immediately. Furthermore, until members of a nominating committee have been appointed, director nominees will be selected, or recommended for the Board’s selection, by independent directors constituting a majority of the Board’s independent directors in a vote in which only independent directors participate.
   
The independent directors will meet regularly in executive sessions without the presence of our corporate officers or non-independent directors;
   
The Company implemented a range of other corporate governance practices, including a robust director education program.

 

85
 

 

At this time, the Company does not have on its Audit Committee at least one member who qualifies as an “audit committee financial expert” as defined by the SEC; however, the Company believes that all of the audit committee members are able to read and understand fundamental financial statements, including the Company’s balance sheet, income statement, and cash flow statement. Additionally, at least one member of the audit committee has past employment experience in finance or accounting, requisite professional certification in accounting, or any other comparable experience or background which results in the individual’s financial sophistication, and accordingly believes that the audit committee can properly fulfill its functions and role as if at least one member was an “audit committee financial expert” as defined by the SEC.

 

Classified Board of Directors

 

In accordance with the Company’s Amended and Restated Memorandum and Articles of Association, its board of directors shall be divided into three classes of directors with staggered terms depending on the class. The Board has designated Amir Bader and Thomas Hawkins as Class I Directors with terms ending in 2026, Pauline Khoo, Roger Meltzer and Zeren Browne as Class II Directors with terms ending in 2024, and Haggai Alon and Ophir Sternberg as Class III Directors with terms ending in 2025.

 

Independence of our Board of Directors

 

Four of the Company’s seven directors are independent as defined in Nasdaq listing standards and applicable SEC rules and the Company’s board of directors has an independent audit committee and a compensation committee. Furthermore, until members of a nominating committee have been appointed, director nominees will be selected, or recommended for the Board’s selection, by independent directors constituting a majority of the Board’s independent directors in a vote in which only independent directors participate.

 

Board Committees

 

Audit Committee

 

The audit committee is responsible for, among other things:

 

appointing, compensating, retaining, evaluating, terminating and overseeing our independent registered public accounting firm;
discussing with our independent registered public accounting firm their independence from management;
reviewing, with our independent registered public accounting firm, the scope and results of their audit;
approving all audit and permissible non-audit services to be performed by our independent registered public accounting firm;
overseeing the financial reporting process and discussing with management and our independent registered public accounting firm the annual financial statements that we file with the SEC;
overseeing our financial and accounting controls and compliance with legal and regulatory requirements;
reviewing our policies on risk assessment and risk management;
reviewing related person transactions; and
establishing procedures for the confidential anonymous submission of concerns regarding questionable accounting, internal controls or auditing matters.

 

The members of the Company’s audit committee are Pauline Khoo, Chairperson, Amir Bader and Thomas Hawkins.

 

Each member of the Company’s audit committee qualifies as independent directors according to the rules and regulations of the SEC and Nasdaq with respect to audit committee membership. In addition, all audit committee members meet the requirements for financial literacy under applicable SEC and Nasdaq rules The audit committee’s charter is available on the Company’s website. The reference to the Company’s website address in this prospectus does not include or incorporate by reference the information on the Company’s website into this prospectus.

 

86
 

 

Compensation Committee

 

The compensation committee is responsible for, among other things:

 

reviewing and approving the corporate goals and objectives, evaluating the performance of and reviewing and approving, (either alone or, if directed by the board of directors, in conjunction with a majority of the independent members of the board of directors) the compensation of our Chief Executive Officer;
overseeing an evaluation of the performance of and reviewing and setting or making recommendations to our board of directors regarding the compensation of our other executive officers;
reviewing and approving or making recommendations to our board of directors regarding our incentive compensation and equity-based plans, policies and programs;
reviewing and approving all employment agreement and severance arrangements for our executive officers;
making recommendations to our shareholders regarding the compensation of our directors; and
retaining and overseeing any compensation consultants.

 

The members of the Company’s compensation committee are Roger Meltzer, Chairperson, Pauline Khoo and Amir Bader, all of whom qualify as independent directors according to the rules and regulations of the SEC and Nasdaq with respect to compensation committee membership, including the heightened independence standards for members of a compensation committee. The compensation committee’s charter is available on the Company’s website. The reference to the Company’s website address in this prospectus does not include or incorporate by reference the information on the Company’s website into this prospectus.

 

Nominating and Corporate Governance Committee

 

The Company has not yet appointed members of the Board of Directors to a nominating committee. Any nominating committee would be responsible for, among other things:

 

identifying individuals qualified to become members of our board of directors, consistent with criteria approved by our board of directors;
overseeing succession planning for our Chief Executive Officer and other executive officers;
periodically reviewing our board of directors’ leadership structure and recommending any proposed changes to our board of directors;
overseeing an annual evaluation of the effectiveness of our board of directors and its committees; and
developing and recommending to our board of directors a set of corporate governance guidelines.

 

Until members of a nominating committee have been appointed, director nominees will be selected, or recommended for the Board’s selection, by independent directors constituting a majority of the Board’s independent directors in a vote in which only independent directors participate.

 

Any nominating and corporate governance committee charter would be available on the Company’s website. The reference to the Company’s website address in this prospectus does not include or incorporate by reference the information on the Company website into this prospectus.

 

Limitation on Liability and Indemnification of Directors and Officers

 

The Company is subject to the ICA. Subject to exceptions, the ICA does not permit a company to exempt a director or certain officers from, or indemnify a director against, liability in connection with any negligence, default, breach of duty or breach of trust by a director in relation to the company. The exceptions allow a company to (i) purchase and maintain director and officer insurance against any liability attaching in connection with any negligence, default, breach of duty or breach of trust owed to the company; and (ii) indemnify a director or other officer against any liability incurred in defending proceedings, whether civil or criminal (a) in which judgement is given in his or her favor or in which he or she is acquitted or (b) in respect of which an Irish court grants him or her relief from any such liability on the grounds that he or she acted honestly and reasonably and that, having regard to all the circumstances of the case, he or she ought fairly to be excused for the wrong concerned.

 

87
 

 

Under the Company’s Amended and Restated Memorandum and Articles of Association, subject to certain limitations and so far as may be permitted by the ICA, each director, officer or employee of the Company, and each person who is or was serving at the request of the Company as a director, officer or employee of another company, or of a partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans maintained or sponsored by the Company, shall be entitled to be indemnified by the Company against all costs, charges, losses, expenses and liabilities incurred by him or her in the execution and discharge of his or her duties or in relation thereto, including any liability incurred by him or her in defending any proceedings, civil or criminal, which relate to anything done or omitted or alleged to have been done or omitted by him or her as a director, officer or employee of the Company or such other company, partnership, joint venture, trust or other enterprise, and in which judgment is given in his or her favor (or the proceedings are otherwise disposed of without any finding or admission of any material breach of duty on his or her part) or in which he or she is acquitted or in connection with any application under any statute for relief from liability in respect of any such act or omission in which relief is granted to him or her by the court. However, any such indemnity shall not be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable for fraud or dishonesty in the performance of his or her duty to the Company unless and only to the extent that the courts of Ireland or the court in which such action or suit was brought shall determine upon application that despite the adjudication of liability, but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses as the court shall deem proper.

 

The Company on closing entered into indemnification agreements with each of its directors to provide contractual indemnification providing for indemnification and advancements by the Company of certain expenses and costs relating to claims, suits or proceedings arising from his or her service to the Company, and to Lionheart if applicable or, at Lionheart’s request, service to other entities, as officers or directors occurring at or prior to the Business Combination, to the maximum extent permitted by applicable law.

 

The Company maintains standard policies of insurance under which coverage is provided (1) to its directors and officers against loss arising from claims made by reason of breach of duty or other wrongful act, while acting in their capacity as directors and officers of the Company, and (2) to the Company with respect to payments which may be made by the Company to such officers and directors pursuant to any indemnification provision contained in the Company’s Amended and Restated Memorandum and Articles of Association or otherwise as a matter of law.

 

Board Leadership Structure

 

It is not anticipated that a policy requiring the positions of the Chairperson of the Board and Chief Executive Officer to be separate or held by the same individual will be implemented by the Board, as the Board’s determination is expected to be based on circumstances existing from time to time, based on criteria that are in the Company’s best interests and the best interests of its stockholders, including the composition, skills and experience of the Board and its members, specific challenges faced by the Company or the industry in which it operates and governance efficiency. If the Board convenes for a meeting, it is expected that the non-management directors will meet in one or more executive sessions, if the circumstances warrant. The Board may consider appointing a lead independent director, if the circumstances warrant.

 

Risk Oversight

 

Upon the consummation of the Business Combination, the Board administered the risk oversight function directly through the Board as a whole, as well as through its committees, where applicable, monitoring and assessing strategic risk exposure, enterprise risk, and governance risks. The audit committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures. The allocation of risk oversight responsibility may change, from time to time, based on the evolving needs of the Company.

 

Code of Business Conduct and Ethics

 

The Board adopted a Code of Ethics applicable to our directors, executive officers and team members that complies with the rules and regulations of Nasdaq and the SEC. The Code of Ethics is available on the Company’s website. In addition, the Company intends to post on the Corporate Governance section of its website all disclosures that are required by law or Nasdaq listing standards concerning any amendments to, or waivers from, any provision of the Code of Ethics. The reference to the Company’s website address in this prospectus does not include or incorporate by reference the information on the Company’s website into this prospectus.

 

88
 

 

Executive Officer and Director Compensation

 

The aggregate compensation paid by Security Matters PTY to Security Matters PTY’s directors for the fiscal years ended December 31, 2023 and December 31, 2022 was approximately US$23 thousand and US$136 thousand. The compensation amount included 322,317 shares that were granted to its directors as a group.

 

The aggregate compensation paid by to our senior executive officers for the fiscal years ended December 31, 2023 and December 31, 2022 was approximately US$913 thousand and US$541 thousand. In fiscal years 2023 and 2022, our predecessor granted stock option awards to its executive officers to acquire an aggregate of 200,000 of Security Matters PTY’s ordinary shares, all of the options are subject to performance condition. In fiscal year 2023, we granted an aggregate of 81,551 restricted stock units to our executive officers.

 

The Company’s CEO, CFO and Executive Vice President are subject to the terms of their employment agreements with SMX Israel. It is expected that any executive compensation program beyond existing arrangements will include:

 

annual base salaries;
   
performance bonus opportunities, potentially in cash and/or equity awards;
   
long term incentive compensation in the form of stock options, restricted stock and stock appreciation awards, among others, and
   
with regard to key executive officers, formal employment arrangements to include change of control provisions.

 

Director Compensation

 

For the fiscal year ended December 31, 2023, each independent director was granted restricted stock units in an amount equal to $150,000 divided by the closing price on the last trading day of the fiscal year, generally to vest on the one-year anniversary of the date of grant and be settled in Ordinary Shares, subject to such director’s continuous services as a director until such time and earlier vesting due to a change of control. In addition, each committee chair is entitled to receive an additional grant annually of restricted stock units in an amount equal to $15,000 divided by the closing price on the last trading day of the fiscal year, subject to the same terms listed in the prior sentence. Mr. Alon and Ms. Browne will not receive any director compensation as their compensation is governed by their individual employment agreements. The Company’s directors, other than Mr. Alon and Ms. Browne, were granted an aggregate of 8,018 restricted stock units.

 

2022 Incentive Equity Plan and Other Plan Options

 

Our board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan (“2022 Incentive Equity Plan”), which was subsequently amended by our board of directors, which reserved for grant and authorized 231,019 Ordinary Shares. Additionally, pursuant to the 2022 Incentive Equity Plan, the Ordinary Shares reserved for issuance thereunder will automatically increase annually by 5% on the first day of each fiscal year beginning with the 2023 fiscal year, by an amount equal to 5% of the number of outstanding shares of the Company as of the last day of the prior fiscal year. As of the date of this prospectus, an aggregate of 225,407 restricted stock units or stock options have been granted under the 2022 Incentive Equity Plan. The Company received stockholder approval at its 2023 annual general meeting of shareholders held on December 21, 2023, which increased the number of ordinary shares by 1,500,000 to a total of 1,731,019 ordinary shares.

 

The 2022 Incentive Equity Plan provides for the grant of options, restricted shares units, phantom shares or substitute awards or any combination of the foregoing including such other awards that may be denominated or payable in, value in whole or in part, by reference to or otherwise based upon, or related to, shares to our employees, directors, and consultants and any of our affiliates’ employees and consultants.

 

Our board of directors, or any person or persons or committee to whom decision-making authority with respect to the 2022 Incentive Equity Plan is delegated by our board of directors (the “Administrator”) will administer the 2022 Incentive Equity Plan.

 

89
 

 

Our board of directors and the Administrator have the authority to amend or suspend the 2022 Incentive Equity Plan at any time and from time to time, and our Board has the authority to terminate the 2022 Incentive Equity Plan provided that such action does not materially impair the existing rights of any participant without such participant’s written consent. Certain material amendments also require the approval of our shareholders.

 

In addition, as part of the Business Combination, we assumed an aggregate of 1,326,747 options originally granted under Security Matters PTY’s 2018 Share Option Plan.

 

DESCRIPTION OF SECURITIES

 

General

 

The Company is a public limited company organized and existing under the laws of Ireland. The Company was formed on July 1, 2022 as a public limited company incorporated in Ireland under the name “Empatan Public Limited Company” and underwent a change of name to SMX (Security Matters) Public Limited Company on February 17, 2023. The Company’s affairs are governed by the Company’s Amended and Restated Memorandum and Articles of Association, the ICA, and the laws of Ireland.

 

The following are summaries of material provisions of the Company’s Amended and Restated Memorandum and Articles of Association and the ICA, insofar as they relate to the material terms of the Ordinary Shares.

 

Ordinary Shares

 

The following are summaries of material provisions of the Company’s Amended and Restated Memorandum and Articles of Association, and the ICA, insofar as they relate to the material terms of the Ordinary Shares.

 

General. The authorized share capital of the Company is US$100,000,000 divided into 36,363,636,364 Ordinary Shares with a nominal value of US$0.0022 each, 200,000,000,000 preferred shares with a nominal value of US$0.0001 each and €25,000 divided into 25,000 deferred Ordinary Shares with a nominal value each of €1.00 each.

 

Immediately prior to consummation of the Business Combination, the Company had issued and paid-up share capital of (i) €25,000 representing 25,000 deferred shares of €1.00 each and (ii) US$0.0001 representing one Ordinary Share of US$0.0001 each in the capital of the Company, in order to satisfy statutory capitalization requirements for all Irish public limited companies.

 

Dividends. The holders of Ordinary Shares are entitled to such dividends as may be declared by the Company’s board of directors. Dividends may be declared and paid out of the funds legally available therefor, or any other fund or account which can be authorized for this purpose in accordance with the ICA.

 

Voting Rights. Each Ordinary Share shall be entitled to one vote on all matters subject to the vote at general meetings of the Company. Voting at any meeting of shareholders is by way of a poll, which shall be taken in such manner as the chairperson of the meeting directs.

 

An ordinary resolution to be passed at a meeting by the shareholders requires the affirmative vote of a simple majority of the votes attaching to the Ordinary Shares cast at a meeting, while a special resolution requires the affirmative vote of no less than 75% of the votes cast attaching to the outstanding Ordinary Shares at a meeting. Where the shareholders wish to act by way of written resolution in lieu of holding a meeting, unanimous consent of the holders of the Ordinary Shares shall be required. A special resolution will be required for important matters such as a change of name, reducing the share capital or making changes to the Company’s Amended and Restated Memorandum and Articles of Association.

 

Transfer of Ordinary Shares. Subject to the restrictions contained in the BCA with respect to the Ordinary Shares, and subject to any further restrictions contained in the Amended and Restated Memorandum and Articles of Association, any shareholder may transfer all or any of his or her Ordinary Shares by an instrument of transfer in the usual or common form or any other form approved by the Company’s Board.

 

90
 

 

Liquidation. On a return of capital on winding-up or otherwise (other than on conversion, redemption or purchase of Ordinary Shares), assets available for distribution among the holders of Ordinary Shares shall be distributed among the holders thereof on a pro rata basis. If the Company’s assets available for distribution are insufficient to repay all of the paid-up capital, the assets will be distributed so that the losses are borne by the Company’s shareholders proportionately.

 

General Meetings of Shareholders. Shareholders’ meetings may be convened by the board of directors on the requisition of the shareholders or, if the Board fails to so convene a meeting, such extraordinary general meeting may be convened by the requisitioning shareholders where the requisitioning shareholders hold not less than 10% of the paid up share capital of the Company. Any action required or permitted to be taken at any annual or extraordinary general meetings may be taken only upon the vote of the shareholders at an annual or extraordinary general meeting duly noticed and convened in accordance with the Company’s Amended and Restated Memorandum and Articles of Association and the ICA. Unanimous consent of the holders of the Ordinary Shares shall be required before the shareholders may act by way of written resolution without a meeting.

 

Public Warrants

 

Each whole Public Warrant shall entitle the holder thereof to purchase one Ordinary Share at an exercise price of US$253.00 per share.

 

Subject to the terms of the BCA, on the consummation of the Business Combination, each Lionheart Public Warrant remained outstanding but was automatically adjusted to become one Public Warrant. Each such Public Warrant continues to have, and be subject to, the same terms and conditions set forth in the warrant agreement pursuant to which such Lionheart Public Warrant was issued immediately prior to the consummation of the Business Combination, except that each Public Warrant is exercisable (or will become exercisable in accordance with its terms) for that number of whole Ordinary Shares equal to the number of Lionheart Private Shares that were issuable upon exercise of such Lionheart Public Warrant that was outstanding immediately prior to the consummation of the Business Combination, and subject to adjustment pursuant to the subsequent reverse stock split. In addition, each Lionheart Private Warrant remains outstanding but is automatically adjusted to become one Public Warrant, subject to adjustment pursuant to the subsequent reverse stock split (each a “Parent Founder Warrant”). Each such Parent Founder Warrant continues to have, and be subject to the same terms and conditions set forth in the warrant agreement pursuant to which such Lionheart Private Warrant was issued immediately prior to the consummation of the Business Combination, except that each Parent Founder Warrant is exercisable (or will become exercisable in accordance with its terms) for that number of whole Ordinary Shares equal to the number of Lionheart Private Shares that were issuable upon exercise of such Lionheart Private Warrant that was outstanding immediately prior to the consummation of the Business Combination, subject to adjustment pursuant to the subsequent reverse stock split. As used herein: (1) “Lionheart Private Shares” shall mean the 400,000 shares of Lionheart Class A Common Stock, included in the units (“Lionheart Private Units”) issued in private placements at the time of the consummation of the initial public offering by Lionheart, which closed on November 8, 2021 (“IPO”), including (a) one Lionheart Class A Common Stock and (b) one-half of a warrant, with whole warrants entitling the holder thereof to purchase one Lionheart Class A Common Stock at an exercise price of $11.50 per share; (2) “Lionheart Private Warrants” shall mean (a) each warrant issued in private placements at the time of the consummation of the IPO, entitling the holder thereof to purchase one Lionheart Class A Common Stock at an exercise price of $11.50 per share and (b) each warrant issued as a component of Lionheart Private Units; and (3) “Lionheart Public Warrants” shall mean each warrant issued as a component of the Lionheart Public Units.

 

The Company is not obligated to deliver any Ordinary Shares pursuant to the exercise of a Public Warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Ordinary Shares underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations described below with respect to registration. No Public Warrant will be exercisable, and the Company will not be obligated to issue Ordinary Shares upon exercise of a Public Warrant unless the Ordinary Shares issuable upon such Public Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Public Warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Public Warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any Public Warrant.

 

91
 

 

The Company has agreed that as soon as practicable, but in no event later than 30 days after the closing of the Business Combination, the Company would use its best efforts to file with the SEC a registration statement for the registration under the Securities Act of the Ordinary Shares issuable upon exercise of the Public Warrants and thereafter will use its best efforts to cause the same to become effective within 60 business days following the closing of the Transactions and to maintain a current prospectus relating to the Ordinary Shares issuable upon exercise of the Public Warrants, until the expiration of the Public Warrants in accordance with the provisions of that certain warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and Lionheart (the “Warrant Agreement”). If a registration statement covering the Ordinary Shares issuable upon exercise of the Public Warrants is not effective by the 60th business day after the closing of the Transactions, holders of the Public Warrants may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise Public Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. If that exemption, or another exemption, is not available, holders of the Public Warrants will not be able to exercise their Public Warrants on a cashless basis. Once the Public Warrants become exercisable, the Company may call the Public Warrants for redemption:

 

in whole and not in part;
   
at a price of $0.22 per warrant;
   
upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and
   
if, and only if, the reported last reported sale price of the Ordinary Shares equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders.

 

If and when the Public Warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of Ordinary Shares upon exercise of the Public Warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. The Company will use its best efforts to register or qualify such shares under the blue sky laws of the state of residence in those states in which the Public Warrants were offered.

 

The Company has established the last of the redemption criteria discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the Public Warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the Public Warrants, each holder of the Public Warrants will be entitled to exercise its Public Warrant prior to the scheduled redemption date. However, the price of the Ordinary Shares may fall below the $396 redemption trigger price (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) as well as the $253 warrant exercise price after the redemption notice is issued.

 

If the Company calls the Public Warrants for redemption as described above, the Company’s management will have the option to require any holder that wishes to exercise its Public Warrant to do so on a “cashless basis.” In determining whether to require all holders to exercise their Public Warrants on a “cashless basis,” the Company’s management will consider, among other factors, the Company’s cash position, the number of Public Warrants that are outstanding and the dilutive effect on the Company’s shareholders of issuing the maximum number of Ordinary Shares issuable upon the exercise of Public Warrants. If the Company’s management takes advantage of this option, all holders of Public Warrants would pay the exercise price by surrendering their Public Warrants for that number of Ordinary Shares equal to the quotient obtained by dividing (x) the product of the number of Ordinary Shares underlying the Public Warrants, multiplied by the difference between the exercise price of the Public Warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” means the average last reported sale price of the Ordinary Shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of Public Warrants.

 

92
 

 

If the Company’s management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of Ordinary Shares to be received upon exercise of the Public Warrants, including the “fair market value” in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. The Company believes this feature is an attractive option to the Company if they do not need the cash from the exercise of the Public Warrants after the closing of the transactions contemplated by the BCA, the SID and the Ancillary Agreements.

 

A holder of a Public Warrant may notify the Company in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (or such other amount as a holder may specify) of the Ordinary Shares outstanding immediately after giving effect to such exercise.

 

If the number of outstanding Ordinary Shares is increased by a stock dividend payable in Ordinary Shares, or by a split-up of Ordinary Shares or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the number of Ordinary Shares issuable on exercise of each Public Warrant will be increased in proportion to such increase in the outstanding Ordinary Shares. A rights offering to holders of Ordinary Shares entitling holders to purchase Ordinary Shares at a price less than the fair market value will be deemed a stock dividend of a number of Ordinary Shares equal to the product of (i) the number of Ordinary Shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Ordinary Shares) and (ii) one (1) minus the quotient of (x) the price per share of Ordinary Shares paid in such rights offering divided by (y) the fair market value. For these purposes (i) if the rights offering is for securities convertible into or exercisable for Ordinary Shares, in determining the price payable for the Ordinary Shares, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average price of the Ordinary Shares as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the Ordinary Shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

 

In addition, if the Company, at any time while the Public Warrants are outstanding and unexpired, pays a dividend or makes a distribution in cash, securities or other assets to the holders of the Ordinary Shares on account of such Ordinary Shares (or other shares of the Company’s capital stock into which the Public Warrants are convertible), other than (a) as described above or (b) certain ordinary cash dividends, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each Ordinary Share in respect of such event.

 

If the number of outstanding Ordinary Shares is decreased by a consolidation, combination, reverse stock split or reclassification of Ordinary Shares or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of Ordinary Shares issuable on exercise of each Public Warrant will be decreased in proportion to such decrease in outstanding Ordinary Shares.

 

Whenever the number of Ordinary Shares purchasable upon the exercise of the Public Warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of Ordinary Shares purchasable upon the exercise of the Public Warrants immediately prior to such adjustment, and (y) the denominator of which will be the number of Ordinary Shares so purchasable immediately thereafter.

 

93
 

 

In case of any reclassification or reorganization of the outstanding Ordinary Shares (other than those described above or that solely affects the par value of such Ordinary Shares), or in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding Ordinary Shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the holders of the Public Warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Public Warrants and in lieu of the Ordinary Shares immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Public Warrants would have received if such holder had exercised their Public Warrants immediately prior to such event. If less than 70% of the consideration receivable by the holders of Ordinary Shares in such a transaction is payable in the form of Ordinary Shares in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the Public Warrant properly exercises the Public Warrant within thirty days following public disclosure of such transaction, the Public Warrant exercise price will be reduced as specified in the Warrant Agreement based on the Black-Scholes value (as defined in the Warrant Agreement) of the Public Warrant. The purpose of such exercise price reduction is to provide additional value to holders of the Public Warrants when an extraordinary transaction occurs during the exercise period of the Public Warrants pursuant to which the holders of the Public Warrants otherwise do not receive the full potential value of the Public Warrants in order to determine and realize the option value component of the Public Warrant. This formula is to compensate the warrant holder for the loss of the option value portion of the Public Warrant due to the requirement that the warrant holder exercise the warrant within 30 days of the event. The Black-Scholes model is an accepted pricing model for estimating fair market value where no quoted market price for an instrument is available.

 

The Warrant Agreement provides that the terms of the Public Warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 65% of the then outstanding Public Warrants to make any change that adversely affects the interests of the registered holders of the Public Warrants.

 

The Public Warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless basis, if applicable), by certified or official bank check payable to the Company, for the number of Public Warrants being exercised. The warrant holders do not have the rights or privileges of holders of Ordinary Share and any voting rights until they exercise their Public Warrants and receive Ordinary Shares. After the issuance of Ordinary Shares upon exercise of the Public Warrants, each holder will be entitled to one (1) vote for each share held of record on all matters to be voted on by Company shareholders.

 

No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down to the nearest whole number the number of Ordinary Shares to be issued to the warrant holder.

 

The Company has agreed that, subject to applicable law, any action, proceeding or claim against the Company arising out of or relating in any way to the Warrant Agreement will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and the Company irrevocably submits to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. This provision applies to claims under the Securities Act but does not apply to claims under the Exchange Act or any claim for which the federal district courts of the United States of America are the sole and exclusive forum.

 

History of Security Issuances

 

Upon its formation, the Company issued one ordinary share at a price of US$0.0001 each to Doron Afik, and subsequently issued 25,000 deferred ordinary shares at a price of €1.00 per share, to Doron Afik. Immediately prior to consummation of the Business Combination, the Company had paid up capital of €25,000 and US$0.0001.

 

Transfer Agent

 

The transfer agent for the Ordinary Shares is Continental Stock Transfer & Trust Company.

 

Comparison of Irish and Delaware Corporate Governance And Shareholder Rights

 

As holders of Ordinary Shares may be unfamiliar with corporate governance and shareholder rights of Irish public limited company when compared to a Delaware corporation, the below summarizes and compares certain corporate governance and shareholder rights of the Company, an Irish Public Limited Company, and Lionheart, a Delaware corporation, from immediately prior to the Business Combination.

 

94
 

 

    Ireland   Delaware
PRINCIPAL APPLICABLE LEGISLATION   The ICA   Delaware General Corporation Law
     
CORPORATE PURPOSE   The objects for which the Company was established are very broad and allow the Company to engage in a wide range of activities for which a company may be incorporated under the ICA.   The purpose of Lionheart is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of Delaware
     
SHAREHOLDER VOTING  

Except where a greater majority is required by the Irish Companies Act or otherwise prescribed by the Company’s Amended Memorandum and Articles of Association, any question, business or resolution proposed at any general meeting shall be decided by a resolution approved by a simple majority of votes cast, in person or by proxy, at a general meeting of the Company shareholders at which a quorum is present (referred to under Irish law as an “ordinary resolution”).

 

An ordinary resolution is needed, among other matters, to appoint a Company director (where the appointment is by shareholders), to remove a Company director and to provide, vary or renew the Company’s directors’ authority to allot relevant securities.

 

Irish law requires approval of certain matters by a resolution approved by not less than 75% of the votes cast, in person or by proxy, at a general meeting of shareholders at which a quorum is present (referred to under Irish law as a “special resolution”).

  Generally, approval of routine corporate matters that are put to a stockholder vote require the affirmative vote of the majority of shares present in person or represented by proxy at the meeting and entitled to vote on the subject matter.

 

95
 

 

    Ireland   Delaware
PRINCIPAL APPLICABLE LEGISLATION   The ICA   Delaware General Corporation Law
     
CORPORATE PURPOSE   The objects for which the Company was established are very broad and allow the Company to engage in a wide range of activities for which a company may be incorporated under the ICA.   The purpose of Lionheart is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law of Delaware
     
SHAREHOLDER VOTING  

Except where a greater majority is required by the Irish Companies Act or otherwise prescribed by the Company’s Amended Memorandum and Articles of Association, any question, business or resolution proposed at any general meeting shall be decided by a resolution approved by a simple majority of votes cast, in person or by proxy, at a general meeting of the Company shareholders at which a quorum is present (referred to under Irish law as an “ordinary resolution”).

 

An ordinary resolution is needed, among other matters, to appoint a Company director (where the appointment is by shareholders), to remove a Company director and to provide, vary or renew the Company’s directors’ authority to allot relevant securities.

 

Irish law requires approval of certain matters by a resolution approved by not less than 75% of the votes cast, in person or by proxy, at a general meeting of shareholders at which a quorum is present (referred to under Irish law as a “special resolution”).

  Generally, approval of routine corporate matters that are put to a stockholder vote require the affirmative vote of the majority of shares present in person or represented by proxy at the meeting and entitled to vote on the subject matter.

 

96
 

 

    Ireland   Delaware
   

A special resolution is needed, among other matters, to amend the Company’s Amended Memorandum and Articles of Association, to disapply statutory pre-emption rights on the issuance of equity securities of the Company and to reduce the Company’s company capital.

 

Additionally, the rights attaching to a particular class of shares may only be varied if (a) the holders of seventy five percent (75%) of the nominal value of the issued shares of that class consent in writing to the variation, or (b) a special resolution, passed at a separate general meeting of the holders of that class, sanctions the variation.

   
     
SHAREHOLDER APPROVAL OF BUSINESS COMBINATION      

Mergers generally require approval of a majority of all outstanding shares.

 

Mergers in which less than 20% of the acquirer’s stock is issued generally do not require acquirer stockholder approval.

 

Mergers in which one corporation owns 90% or more of a second corporation may be completed without the vote of the second corporation’s board of directors or stockholders.

     
SPECIAL VOTE REQUIRED FOR COMBINATIONS WITH INTERESTED SHAREHOLDERS       A corporation may not engage in a business combination with an interested stockholder for a period of three years after the time of the transaction in which the person became an interested stockholder.
     

 

SHAREHOLDER RIGHTS PLAN   Subject to applicable law, the Company’s Amended Memorandum and Articles of Association provides the Board with the power to adopt a shareholder rights’ plan upon such terms as the Board deems expedient in the best interests of the Company, and to exercise any power of the Company to grant rights (including approving the execution of any documents relating to the grant of such rights) to subscribe for ordinary Shares or preference shares in the capital of the Company in accordance with the terms of such rights’ plan. The Company’s ability to adopt a rights’ plan or to take other anti-takeover measures after the Board has received an approach which may lead to an offer or has reason to believe an offer is, or may be, imminent would be restricted by the frustrating actions’ prohibition of the Irish Takeover Rules. A number of Irish companies have pre-existing rights’ plans, which automatically trigger in specified circumstances without the need for a target board decision (other than a decision to disarm), although the validity of these plans has not been tested with the Irish Takeover Panel or in the Irish courts.    

 

97
 

 

    Ireland   Delaware
APPRAISAL RIGHTS       Stockholders have appraisal rights in certain circumstances as provided for under the DGCL.
     
SHAREHOLDER CONSENT TO ACTION WITHOUT MEETING   As set out in the Company’s Amended Memorandum and Articles of Association, for so long as the Company has more than one shareholder, any action required or permitted to be taken by the holders of shares of the Company requires the unanimous consent of the holders of the Ordinary Shares before the shareholders may act by way of written resolution in lieu of holding a duly called annual or extraordinary general meeting of such shareholders.   As set out in the charter, except as may be otherwise provided for any action required or permitted to be taken by the stockholders of Lionheart must be effected by a duly called annual or special meeting of such stockholders and may not be effected by written consent of the stockholders other than with respect to Lionheart’s Class B Common Stock with respect to which action may be taken by written consent.
     
MEETINGS OF SHAREHOLDERS   The quorum is set in the Company’s Amended Memorandum and Articles of Association. Two members present in person or by proxy and having the right to attend and vote at the meeting and together holding shares representing more than 50% of the votes that may be cast by all members at the relevant time shall be a quorum at a general meeting; provided, however, that at any time when the Company is a single-member company, one member of the Company present in person or by proxy, at a general meeting of it shall be a quorum.   The quorum is set in Lionheart’s Bylaws. The holders of a majority of the shares of capital stock issued and outstanding and entitled to vote, represented in person or by proxy, shall constitute a quorum at all meetings of the stockholders for the transaction of business, except as otherwise provided by statute or by the charter. If, however, such quorum shall not be present or represented at any meeting of the stockholders, the stockholders present in person or represented by proxy shall have power to adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall be present or represented. At such adjourned meeting at which a quorum shall be present or represented any business may be transacted which might have been transacted at the meeting as originally notified.

 

98
 

 

    Ireland   Delaware
DISTRIBUTIONS AND DIVIDENDS; REPURCHASES AND REDEMPTIONS  

Under Irish law, the Company may only pay dividends and make other distributions (and, generally, make share repurchases and redemptions) out of distributable profits. In addition, no dividend may be paid or other distribution, share repurchase or redemption made by the Company unless the net assets of the Company are equal to, or exceed, the aggregate of the Company’s called-up share capital plus its un-distributable reserves and the dividend or other distribution, share repurchase or redemption does not reduce the Company’s net assets below such aggregate

 

The Company’s Amended Memorandum and Articles of Association authorizes the Board to pay such dividends as appears to the Board to be justified by the profits of the Company.

 

The Board may also recommend a dividend to be approved and declared by the Company’s shareholders at a general meeting, provided that no such dividend may exceed the amount recommended by the Board.

  Stockholders have the right to receive dividends to the extent declared by the board of directors.
     
NUMBER OF DIRECTORS  

Under the Company’s Amended and Restated Memorandum and Articles of Association, the number of directors shall from time to time be not less than two nor more than seven.

 

Under the Company’s Amended and Restated Memorandum and Articles of Association, the Board will be divided into three classes designated as Class I, Class II and Class III. The term of the initial Class I directors shall terminate at the conclusion of the Company’s 2026 annual general meeting; the term of the initial Class II directors shall terminate on the conclusion of the Company’s 2024 annual general meeting; and the term of the initial Class III directors shall terminate on the conclusion of the Company’s 2025 annual general meeting. Directors are eligible to stand for re-election at the relevant annual general meeting. Directors shall be re-elected for a three-year term.

 

Size of Board: Under Lionheart’s charter, the number of directors, other than those who may be elected by the holders of one or more series of the Preferred Stock voting separately by class or series, shall be fixed from time to time exclusively by Lionheart’s board of directors pursuant to a resolution adopted by a majority of Lionheart’s board of directors.

 

Election of Directors: Under Lionneart’s charter, the board of directors is divided into three classes, as nearly equal in number as possible and designated Class I, Class II and Class III. Lionheart’s board of directors is authorized to assign members of the board already in office to Class I, Class II or Class III. Each of the successors elected to replace the class of directors whose term expires at that annual meeting shall be elected for a three-year term or until the election and qualification of their respective successors in office, subject to their earlier death, resignation or removal.

 

99
 

 

    Ireland   Delaware
VACANCIES ON BOARD OF DIRECTORS  

Any vacancy on the Board, including a vacancy that results from an increase in the number of directors or a vacancy that results from the removal of a director in accordance with the Company’s Amended and Restated Memorandum and Articles of Association, may be filled by a majority of the directors then in office or by ordinary resolution of the shareholders (i.e., a simple majority of the members attending and voting). The replacement director will hold office until the next annual general meeting at which the director he replaces would have been subject to retirement by rotation.

 

In the event of a contested election (i.e., where the number of the Company director nominees exceeds the number of the Company directors to be elected), each of those nominees shall be voted upon as a separate resolution and the directors of the Company shall be elected by a plurality of the votes cast in person or by proxy at any such meeting. “Elected by a plurality” means the election of those of the Company director nominees equaling in number the number of positions to be filled at the relevant general meeting that receive the highest number of votes.

  Under Lionheart’s charter, newly created directorships resulting from an increase in the number of directors and any vacancies on the board of directors resulting from death, resignation, retirement, disqualification, removal or other cause may be filled solely and exclusively by a majority vote of the remaining directors then in office, even if less than a quorum, or by a sole remaining director (and not by the stockholders), and any director so chosen will hold office for the remainder of the full term of the class of directors to which the new directorship was added or in which the vacancy occurred and until his or her successor has been elected and qualified, subject, however, to such director’s earlier death, resignation, retirement, disqualification or removal.
     
REMOVAL OF DIRECTORS; STAGGERED TERM OF DIRECTORS   Under Irish law, the Company shareholders may remove a director without cause by ordinary resolution, before the expiration of his or her period of office by way of ordinary resolution, provided that at least 28 clear days’ notice of the resolution is given to the Company, and the shareholders comply with the relevant procedural requirements of the ICA. Under Irish law, one or more Company shareholders representing not less than 10% of the paid-up share capital of the Company carrying voting rights may requisition the holding of an extraordinary general meeting at which a resolution to remove a director and appoint another person in his or her place may be proposed.   Lionheart’s charter, whenever the holders of one or more series of the preferred stock shall have the right, voting separately by class or series, to elect one or more directors, the term of office, the filling of vacancies, the removal from office and other features of such directorships shall be governed by the terms of such series of the preferred stock as set forth in Lionheart’s charter and such directors shall not be included in any of the classes created pursuant to Lionheart’s charter unless expressly provided by such terms.

 

    Ireland   Delaware
        Any or all of the other directors may be removed from office at any time, but only for cause and only by the affirmative vote of the holders of a majority of the voting power of all then outstanding shares of the capital stock entitled to vote generally in the election of directors, voting together as a single class.
     
COMMITTEES   Under the Amended and Restated Memorandum and Articles of Association, the directors of the Company may establish one or more committees consisting in whole or in part of members of the Board. The composition, function, power and obligations of any such committee will be determined by the Board from time to time.    
     
CUMULATIVE VOTING       Under the charter the holders of shares of Ordinary Shares shall not have cumulative voting rights with regard to election of directors.
     
AMENDMENT OF GOVERNING DOCUMENTS   The Amended and Restated Memorandum and Articles of Association may only be amended by a special resolution of the shareholders.   Pursuant to the DGCL, the affirmative vote of the holders of a majority of the voting power of the Ordinary Shares entitled to vote thereon is required to amend, alter, or repeal provisions of the charter, subject to any additional vote required therein. In addition, for so long as any shares of Class B Stock shall remain outstanding, the, affirmative vote of the holders of a majority of the shares of Class B Stock outstanding, voting separately as a single class, shall be required to amend, alter or repeal any provision of the charter, in a manner that would alter or change the powers, preferences or relative, participating, optional or other or special rights of the Class B Stock; and the affirmative vote of the holders of at least 65% of all outstanding shares of the Ordinary Shares, shall be required to amend Article IX regarding business combinations and redemption rights.

 

100
 

 

    Ireland   Delaware
INDEMNIFICATION OF DIRECTORS AND OFFICERS  

Subject to exceptions, the ICA does not permit a company to exempt a director or certain officers from, or indemnify a director against, liability in connection with any negligence, default, breach of duty or breach of trust by a director in relation to the company.

 

The exceptions allow a company to (i) purchase and maintain director and officer insurance against any liability attaching in connection with any negligence, default, breach of duty or breach of trust owed to the company and (ii) indemnify a director or other officer against any liability incurred in defending proceedings, whether civil or criminal (a) in which judgement is given in his or her favor or in which he or she is acquitted or (b) in respect of which an Irish court grants him or her relief from any such liability on the grounds that he or she acted honestly and reasonably and that, having regard to all the circumstances of the case, he or she ought fairly to be excused for the wrong concerned.

 

Under the Amended and Restated Memorandum and Articles of Association, subject to certain limitations and so far as may be permitted by the ICA, each director, officer or employee of the Company, and each person who is or was serving at the request of the Company as a director, officer or employee of another company, or of a partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans maintained or sponsored by the Company shall be entitled to be indemnified by the Company against all costs, charges, losses, expenses and liabilities incurred by him or her in the execution and discharge of his or her duties or in relation thereto, as more particularly described in the section titled “Indemnification of Directors and Officers.”

 

Under the charter, the Lionheart, to the fullest extent permitted by Section 145 of DGCL, shall indemnify and hold harmless each person who is or was made a party or is threatened to be made a party to or is otherwise involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative by reason of the fact that he or she is or was a director or officer of Lionheart or, while a director or officer of Lionheart, is or was serving at the request of Lionheart as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, other enterprise or nonprofit entity, including service with respect to an employee benefit plan, each of whom is an “indemnitee,” whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent, or in any other capacity while serving as a director, officer, employee or agent, against all liability and loss suffered and expenses (including, without limitation, attorneys’ fees, judgments, fines, ERISA excise taxes and penalties and amounts paid in settlement) reasonably incurred by such indemnitee in connection with such proceeding.

 

Expenses (including attorneys’ fees) incurred by an indemnitee in defending any civil, criminal, administrative, or investigative action, suit or proceeding for which such officer or director may be entitled to indemnification under the charter shall be paid by Lionheart in advance of the final disposition of such action, suit or proceeding upon receipt of an undertaking by or on behalf of such director or officer to repay such amount if it shall finally be determined that he is not entitled to be indemnified by Lionheart.

 

101
 

 

    Ireland   Delaware
    It is expected that the Company will purchase and maintain directors and officers insurance on behalf of its directors, secretary, and employees.    
     
LIMITED LIABILITY OF DIRECTORS   Under the ICA, a director of the Company may be liable to the Company where such director acts in breach of certain of his or her fiduciary duties.   Under the charter, a director shall not be personally liable to Lionheart or its stockholders for monetary damages for breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under DGCL unless a director violated his or her duty of loyalty to Lionheart or its stockholders, acted in bad faith, knowingly or intentionally violated the law, authorized unlawful payments of dividends, unlawful stock purchases or unlawful redemptions, or derived improper personal benefit from his or her actions as a director.
     
ADVANCE NOTIFICATION REQUIREMENTS FOR PROPOSALS OF SHAREHOLDERS  

The Company’s Amended and Restated Memorandum and Articles of Association requires that an annual general meeting shall be convened by not less than twenty-one clear days’.

 

The Company’s Amended and Restated Memorandum and Articles of Association requires that, subject to the ICA, all extraordinary general meetings shall be convened by not less than 21 clear days’ notice except that they may be called by not less than 14 clear days’ notice where (i) all members, who hold shares that carry rights to vote at the meeting, are permitted to vote by electronic means at the meeting; and (ii) a special resolution reducing the period of notice to 14 days has been passed at the immediately preceding annual general meeting, or at a general meeting held since that meeting.

  A Lionheart stockholder must (i) give timely notice thereof in proper written form to the Secretary, and (ii) the business must be a proper matter for stockholder action. To be timely, a stockholder’s notice must be received by the Secretary at the principal executive offices of Lionheart not less than 90 or more than 120 days before the anniversary date of the immediately preceding meeting. The public announcement of an adjournment or postponement of an annual meeting shall not commence a new time period (or extend any time period) for the giving of a stockholder’s notice. Additionally, the stockholder must provide information pursuant to the advance notice provisions in Lionheart’s bylaws.

 

102
 

 

    Ireland   Delaware
    “clear days” means calendar days and excludes: the day when the notice is given or deemed to be given and the day for which it is given or on which it is to take effect    
         
SHAREHOLDERS’ SUITS  

The Company’s Amended and Restated Memorandum and Articles of Association provides that any dispute or claim arising out of or in connection with the Company’sAmended and Restated Memorandum and Articles of Association will be governed by, and construed in accordance with, the laws of Ireland and that the courts of Ireland will have exclusive jurisdiction to settle any dispute arising out of or in connection with the Company’s Amended and Restated Memorandum and Articles of Association.

 

The Company’s Amended and Restated Memorandum and Articles of Association separately provides that unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Exchange Act or the Securities Act.

  The charter provides that unless Lionheart consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall, to the fullest extent permitted by law, be the sole and exclusive forum for any stockholder (including a beneficial owner) to bring (i) any derivative action or proceeding brought on behalf of Lionheart, (ii) any action asserting a claim of breach of a fiduciary duty owed by any director, officer, employee or agent of Lionheart to Lionheart or Lionheart’s stockholders, or any claim for aiding and abetting such alleged breach, (iii) any action asserting a claim against the Lionheart, its directors, officers or employees arising pursuant to any provision of the DGCL or the Bylaws, or (iv) any action asserting a claim against Lionheart, its directors, officers or employees governed by the internal affairs doctrine, except for, as to each of (i) through (iv) above, any claim as to which the Court of Chancery determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery, or arising under the federal securities laws, including the Securities Act of 1933, as amended, and the rules and regulations thereunder as to which the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the sole and exclusive forum, unless Lionheart consents in writing to the selection of an alternative forum.

 

103
 

 

    Ireland   Delaware
RIGHT TO INSPECT CORPORATE BOOKS AND RECORDS       Any stockholder may inspect the corporation’s books and records for a proper purpose during the usual hours for business.
     
RIGHTS TO INSPECT SHAREHOLDER LIST       Under Section 220 of the DGCL, a stockholder or its agent has a right to inspect Lionheart’s stock ledger, a list of all of its stockholders and its other books and records during the usual hours of business upon written demand stating his purpose (which must be reasonably related to such person’s interest as a stockholder). If Lionheart refuses to permit such inspection or refuses to reply to the request within five business days of the demand, the stockholder may apply to the Delaware Court of Chancery for an order to compel such inspection.
     
CLASS ACTION SUITS       Generally, Lionheart is subject to potential liability under the federal securities laws and under Delaware law. Under the DGCL, a stockholder may bring a derivative action on behalf of the corporation to enforce the rights of the corporation. Generally, a person may institute and maintain such a suit only if such person was a stockholder at the time of the transaction that is the subject of the suit or his or her shares thereafter devolved upon him or her by operation of law. The DGCL also requires that the derivative plaintiff make a demand on the directors of the corporation to assert the corporate claim before the suit may be prosecuted by the derivative plaintiff, unless such demand would be futile. In certain circumstances, class action lawsuits are available to stockholders.

 

104
 

 

CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS

 

Business Combination

 

On March 7, 2023, we consummated the Business Combination. See “Explanatory Note” and “Item 4.A History and Development of the Company” in our Annual Report on Form 20-F filed by us with the SEC on March 13, 2023, as well as “Prospectus Summary-Recent Developments-Business Combination,” and “Description of Securities-Public Warrants” included elsewhere in this prospectus, for a discussion of the Business Combination and the related party transactions with respect to the Business Combination.

 

General Legal Counsel

 

On January 10, 2017, an affiliate of Lionheart’s Sponsor, Lionheart Equities, LLC (“Lionheart Equities”), engaged Jessica L. Wasserstrom, LLC (“Wasserstrom”), to represent Lionheart Capital and its affiliated companies, as corporate general counsel and otherwise in connection with any corporate and/or transactional matters as requested by Lionheart Equities. The engagement letter between Lionheart Equities and Wasserstrom is for an indefinite period only subject to termination rights of either party, of which no termination has occurred since the agreement was executed. Jessica Wasserstrom, the principal of Wasserstrom, currently holds the title of Chief Legal Officer of Lionheart Equities and its affiliated companies.

 

In connection therewith, Wasserstrom was specifically engaged by Lionheart to provide counsel for general corporate legal matters, including related to mergers and acquisitions activity and, as such, may be deemed to be a related party of Lionheart. For the years ended December 31, 2022 and 2021, Lionheart incurred an aggregate of $402,199 and $150,000, respectively, of legal fees from Wasserstrom, an aggregate of $552,199 are recorded within accrued expenses and remain unpaid and outstanding as of December 31, 2022.

 

Chairman Agreement

 

Mr. Ophir Sternberg and the Company entered into a Chairman Agreement (the “Chairman Agreement”). Pursuant to the Chairman Agreement, beginning at the closing of the Business Combination, Mr. Sternberg will serve as the Chairman of the Board for so long as he serves as a member of the Board, unless he is earlier terminated. Mr. Sternberg will not receive any cash compensation for his service on the Board nor will he be entitled to participate in any employee benefit plans of the Company.

 

The Chairman Agreement provides that Mr. Sternberg will be granted restricted stock units of the Company representing 3% of the issued and outstanding Ordinary Shares as of the grant date in accordance with and subject to the terms and conditions of the Company’s 2022 Incentive Equity Plan. Mr. Sternberg’s restricted stock units are subject to time-based vesting, as follows: 20% vest on the grant date, and the remaining restricted stock units will vest in quarterly installments thereafter over a period of three years subject to his continued service on the Board as of each vesting date subject to earlier vesting as forth below.

 

In the event of the expiration or termination of the Chairman Agreement for any reason other than termination for Cause (as defined in the Chairman Agreement), any unvested outstanding equity awards held by Mr. Sternberg will immediately vest and become nonforfeitable. In the event of the termination of the Chairman Agreement by the Company for Cause, all unvested outstanding equity awards will be cancelled and forfeited, and Mr. Sternberg will not be entitled to any payment in connection therewith.

 

The Chairman Agreement states that Mr. Sternberg will honor his confidentiality obligations after the termination of his services.

 

Independent Contractor Agreement

 

Mr. Faquiry Diaz and the Company entered into an independent contractor agreement (the “Independent Contractor Agreement”). The Independent Contractor Agreement provides for an initial term of three years that automatically renews for one-year terms thereafter, so long as Ophir Sternberg is the Chairman of the Board. Notwithstanding the foregoing, the Independent Contractor Agreement is terminable by either party at any time, with or without Cause (as defined in the Independent Contractor Agreement), effective upon notice to the other party.

 

105
 

 

In exchange for his services, Mr. Diaz Cala will be compensated and reimbursed in the total amount of $84,000, annually, payable in twelve equal monthly payments. In addition, the Independent Contractor Agreement provides that Mr. Diaz Cala will be granted restricted stock units of the Company representing 1% of the issued and outstanding Ordinary Shares as of the grant date in accordance with and subject to the terms and conditions of the Company’s 2022 Incentive Equity Plan. Mr. Diaz Cala’s restricted stock units are subject to time-based vesting, as follows: 20% vest on the grant date, and the remaining restricted stock units will vest in quarterly installments thereafter over a period of three years subject to his continued service on the Board as of each vesting date subject to earlier vesting as set forth below.

 

In the event of the termination of the Independent Contractor Agreement by the Company without Cause or upon a Change in Control (each such term as defined in the Independent Contractor Agreement), any unvested outstanding equity awards held by Mr. Diaz Cala will immediately vest and become nonforfeitable. In the event of the termination of the Independent Contractor Agreement for Cause by the Company or for any reason by Mr. Diaz Cala, all unvested outstanding equity awards will be cancelled and forfeited without consideration.

 

The Independent Contractor Agreement also contains non-solicitation and non-competition covenants, generally prohibiting Mr. Diaz Cala from (i) soliciting or hiring employees or business contacts during the one-year period that follows the termination of the Independent Contractor Agreement and (ii) directly or indirectly competing with the Company during the term of the Independent Contractor Agreement. In addition, the Independent Contractor Agreement states that Mr. Diaz Cala will honor his confidentiality obligations after the termination of his services.

 

The only discussions involving continuing employment or involvement for any persons affiliated with Lionheart before the Business Combination were with Ophir Sternberg relating to the Chairman Agreement with The company and with Faquiry Diaz relating to an independent contractor agreement, with the Company, which provides for certain services to the Company. There has not been any formal or informal commitment to retain any financial advisors after the Business Combination, and there are no pre-existing relationships between Lionheart (or individuals affiliated with Lionheart) and additional investors.

 

Borrowings From Related Parties

 

In 2015, SMX Israel signed an agreement to receive a loan of ILS 2 Million (US$512,558 at 2015) from Kibbutz Ketura, and Kibbutz Degania A, an entity associated with Mr. Bader on back-to-back terms from a third party (the Kamea Fund). The loan bears an interest at an annual rate of 4%. The loan was fully repaid in August 2022. The balance as of December 31, 2021 was US$269,311 (including provision for bonus at the amount US$87,311), and as of December 31, 2020 was US$279,939. The balance includes interest and there was no change in the interest rate.

 

In consideration with providing the funding, SMX Israel agreed to provide, as additional consideration, a bonus payment on the occurrence of an exit or major liquidity event. The bonus payment is capped at ILS 3 Million (approximately US$965,000) per each of Kibbutz Ketura and Kibbutz Degania A (together, the “Bonus Payments”). The Bonus Payments are intended to operate in one of the two trigger events: (i) dividend distributions by Security Matters Ltd.; or (ii) the sale of shares by either Kibbutz Ketura and Kibbutz Degania A in SMX Israel (either in the event of a takeover or otherwise). Only if the aggregate amounts of one of the two trigger events exceeds the investment of Kibbutz Ketura and Kibbutz Degania A in SMX Israel (by loan or shares), the either party would be entitled to the Bonus Payment.

 

We entered into an Amended and Restated Promissory Note dated as of March 7, 2023 in the principal amount of $549,000, in favor of Lionheart Management, LLC and Lionheart Equities, LLC, which are affiliates of Ophir Sternberg, our Chairman of the Board, Such note was amended in April 2023 to extend the maturity date thereunder to June 10, 2024; however, we prepaid the note in full in May 2023. Such note amended and restated a Promissory Note, executed by Lionheart in favor of the holders, in the original aggregate principal amount of $549,000, to reflect the assumption of all rights and responsibilities of Lionheart by the Company.

 

106
 

 

In August 2022, the Company signed an addendum to the Loan agreement that reduces the amount of the Bonus payment for both lenders to a total fixed amount of ILS 2.5 million ($710 thousand) that was to be paid upon the completion of the Business Combination. On March 2, 2023, the Bonus payment date was postponed to March 31, 2024 and on April 28, 2023, it was further postponed to June 1, 2024.

 

On September 19, 2023, the Company amended the loan agreements dated September 7, 2015, by and between SMX Israel, the Company’s shareholders and Kamea Fund. Pursuant to the amendment to the loan agreements, Kamea agreed to convert $657 thousand of indebtedness under the loan agreements into 487,281 ordinary shares (post share reverse split) of the Company, as payment in full for such indebtedness; provided however, that in the event the proceeds received from Kamea with respect to any sales of the shares are not at least equal to the indebtedness amount, the Company will remain liable to Kamea for the balance of the indebtedness amount

 

Additionally, Kibbutz Ketura provides administrative services for SMX Israel for which it was paid US$36 thousand in 2022 and US$39 thousand in 2021. Until 2020, SMX Israel’s lab was located in Kibbutz Ketura.

 

Proof Of Concept Projects Paid By Affiliated Companies

 

The Company is engaged in Proof of Concept (POC) agreements according to which it receives funds for financing research and development expenses from prospective customers and affiliated companies. Affiliated companies paid for reimbursement of POC projects the amount of US$1,091 thousand in 2021 and US$1,426 thousand in 2022.

 

Lock-Up Agreements

 

At the closing of the Business Combination, certain of our shareholders, executive officers and directors entered into lock-up agreements, as filed hereto as Exhibit 4.34 through 4.43, pursuant to which, among other things, they agreed not to offer, sell, contract to sell or otherwise transfer or dispose of any of their Ordinary Shares for six months after the Closing Date, subject to the exceptions described in the agreements.

 

Review, Approval or Ratification of Transactions with Related Persons

 

We have a related party transaction policy that requires the review and, if applicable, approval or ratification of any related party transaction by the Audit Committee.

 

SECURITIES ACT RESTRICTIONS ON RESALE OF SECURITIES

 

Rule 144

 

Pursuant to Rule 144 under the Securities Act (“Rule 144”), a person who has beneficially owned restricted shares of our Ordinary Shares or our warrants for at least six months would be entitled to sell their securities provided that (1) that person is not deemed to have been an affiliate of us at the time of, or at any time during the three months preceding, a sale and (2) we are subject to the Exchange Act periodic reporting requirements for at least three months before the sale and have filed all required reports under Section 13 or 15(d) of the Exchange Act during the 12 months (or such shorter period as we were required to file reports) preceding the sale.

 

Persons who have beneficially owned restricted shares of our Ordinary Shares or our warrants for at least six months but who are affiliates of us at the time of, or at any time during the three months preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of:

 

1% of the total number of shares of our Ordinary Shares then outstanding; or
   
the average weekly reported trading volume of our Ordinary Shares during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale.

 

107
 

 

Sales by our affiliates under Rule 144 are also limited by manner of sale provisions and notice requirements and to the availability of current public information about us.

 

Restrictions on the Use of Rule 144 by Shell Companies or Former Shell Companies

 

Rule 144 is generally not available for the resale of securities initially issued by shell companies or issuers that have been at any time previously a shell company. However, Rule 144 also includes an important exception to this prohibition if the following conditions are met:

 

the issuer of the securities that was formerly a shell company has ceased to be a shell company;
   
the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;
   
the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and
   
at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company.

 

While we were formed as a shell company, since the completion of the Business Combination we are no longer a shell company, and so, once the conditions set forth in the exceptions listed above are satisfied, Rule 144 will become available for the resale of the above noted restricted securities.

 

BENEFICIAL OWNERSHIP OF SECURITIES

 

Security Ownership of Certain Beneficial Owners and Management of the Company

 

The following table sets forth the information regarding the beneficial ownership of the Ordinary Shares as of February 26, 2024:

 

each person known by the Company to be the beneficial owner of more than 5% of the Company’s Ordinary Shares; and
   
each of the Company’s current executive officers and directors and all of the Company’s executive officers and directors as a group.

 

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security, and includes shares underlying warrants and options, as applicable, that are currently exercisable or convertible or exercisable or convertible within 60 days. Ordinary Shares that may be acquired within 60 days of February 26, 2024 pursuant to the exercise of warrants or options are deemed to be outstanding for the purpose of computing the percentage ownership of such holder but are not deemed to be outstanding for computing the percentage ownership of any other person or entity shown in the table.

 

Unless otherwise indicated, we believe that all persons named in the table below have sole voting and investment power with respect to the Ordinary Shares beneficially owned by them.

 

The percentage of Ordinary Shares beneficially owned is computed on the basis of 18,186,028 Ordinary Shares outstanding on February 26, 2024.

 

108
 

 

Name and Address of Beneficial Owners  Number of Ordinary Shares   Percentage of Total Voting Power 
Haggai Alon(1)   105,524    * 
Ophir Sternberg(2)(3)   189,929    1.04%
Amir Bader(4)   12,533    * 
Zeren Browne(5)   11,988    * 
Pauline Khoo(6)   12,674    * 
Limor Moshe Lotker(7)   1,755    * 
Thomas Hawkins(8)   13,952    * 
Roger Meltzer(8)   13,952    * 
All executive officers and directors as a group (8 persons)   362,307    1.96%
Greater than 5% Holders          
Lionheart Equities, LLC(2)   138,367    0.76%
Doron Afik(9)   1,879,930    10.33%
Khoo Boon Hui(10)   883,491    4.86%

 

* Less than 1%
   
(1) Represents shares held by Benguy Escrow Company Ltd., a testamentary trust of which Mr. Alon is the beneficiary. Doron Afik is the trustee of Benguy Escrow Company Ltd. The amount of beneficial ownership includes 2,193 (adjusted pursuant to the Reverse Stock Split) Ordinary Shares issuable as a result of Security Matters PTY options held, that are currently exercisable or exercisable within 60 days. Also includes 23,102 (adjusted pursuant to the Reverse Stock Split) vested restricted stock units that settle into Ordinary Shares granted to Mr. Alon, and an additional 3,850 (adjusted pursuant to the Reverse Stock Split) restricted stock units that settle into Ordinary Shares that vest within 60 days from February 26, 2024. Also includes 50,000 restricted stock units that settle into Ordinary Shares that vest within 60 days from February 26, 2024. Does not include an additional 57,755 (adjusted pursuant to the Reverse Stock Split) restricted stock units that do not vest within 60 days of February 26, 2024.
(2) Includes warrants to purchase 85,568 (adjusted pursuant to the Reverse Stock Split) Ordinary Shares held in the name of Lionheart Equities, LLC. Ophir Sternberg, Lionheart’s Chairman, President and Chief Executive Officer, is the member of the Sponsor. Mr. Sternberg disclaims beneficial ownership over any securities owned by the Sponsor in which he does not have any pecuniary interest.
(3) Includes 18,482 (adjusted pursuant to the Reverse Stock Split) restricted stock units that settle into Ordinary Shares granted to Mr. Sternberg. Also includes 30,000 restricted stock units that settle into Ordinary Shares that vest within 60 days from February 26, 2024. Does not include an additional 33,883 (adjusted pursuant to the Reverse Stock Split) restricted stock units that do not vest within 60 days of February 26, 2024.
(4) Includes 11,111 restricted stock units that settle into Ordinary Shares that vest within 60 days from February 26, 2024.
(5) Represents shares held by Sooperduper Pty Ltd., which is owned by Ms. Browne and Simon Browne. Ms. Browne is the control person of Sooperduper Pty Ltd. Also includes 11,111 restricted stock units that settle into Ordinary Shares that vest within 60 days from February 26, 2024
(6) Represents shares held by in nominee by HSBC Bank Australia Limited. Also includes 11,111 restricted stock units that settle into Ordinary Shares that vest within 60 days from February 26, 2024.
(7) Reflects 1,755 (adjusted pursuant to the Reverse Stock Split) Ordinary Shares issuable as a result of Security Matters PTY options that are currently exercisable or exercisable within 60 days from February 26, 2024.
(8) Includes warrants to purchase 341 (adjusted pursuant to the Reverse Stock Split) Ordinary Shares. Also includes 11,111 restricted stock units that settle into Ordinary Shares that vest within 60 days from February 26, 2024.
(9) Includes 5,556 restricted stock units that settle into Ordinary Shares that vest within 60 days from February 26, 2024.
(10) Includes 3,333 restricted stock units that settle into Ordinary Shares that vest within 60 days from February 26, 2024.

 

109
 

 

SELLING STOCKHOLDERS

 

This prospectus relates to the offer and sale by Yorkville of up to 4,000,000 Ordinary Shares that may be issued by us to Yorkville under the SEPA. For additional information regarding the Ordinary Shares included in this prospectus, see the section entitled “Committed Equity Financing” above. We are registering the Ordinary Shares included in this prospectus pursuant to the provisions of the SEPA we entered into with Yorkville on February 23, 2023, as amended, in order to permit Yorkville to offer the shares included in this prospectus for resale from time to time. Except for the transactions contemplated by the SEPA, and as set forth in the section entitled “Plan of Distribution” in this prospectus, Yorkville has not had any material relationships with us within the past three years. As used in this prospectus, the term “Yorkville” mean YA II PN, LTD., a Cayman Islands exempt limited partnership.

 

The table below presents information regarding Yorkville and the Ordinary Shares that may be resold by Yorkville from time to time under this prospectus. This table is prepared based on information supplied to us by Yorkville and reflects holdings as of February 26, 2024. The number of shares in the column “Maximum Number of Ordinary Shares to be Offered Pursuant to this Prospectus” represents all of the Ordinary Shares being offered for resale by Yorkville under this prospectus. Yorkville may sell some, all or none of the shares being offered for resale in this offering. We do not know how long Yorkville will hold the shares before selling them, and we are not aware of any existing arrangements between Yorkville and any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of our Ordinary Shares being offered for resale by this prospectus.

 

Beneficial ownership is determined in accordance with Rule 13d-3(d) promulgated by the SEC under the Exchange Act, and includes Ordinary Shares with respect to which Yorkville has sole or shared voting and investment power. The percentage of Ordinary Shares beneficially owned by Yorkville prior to the offering shown in the table below is based on an aggregate of 18,186,028 Ordinary Shares outstanding on February 26, 2024. Because the purchase price to be paid by Yorkville for Ordinary Shares, if any, that we may elect to sell to Yorkville in one or more Advances from time to time under the SEPA will be determined on the applicable Advance Dates for such Advances, the actual number of Ordinary Shares that we may sell to Yorkville under the SEPA may be fewer than the number of shares being offered for resale under this prospectus. The fourth column assumes the resale by Yorkville of all of Ordinary Shares being offered for resale pursuant to this prospectus.

 

We have determined beneficial ownership in accordance with the rules of the SEC. Except as indicated by the footnotes below, we believe, based on the information furnished to us, that Yorkville has sole voting and investment power with respect to all Ordinary Shares that they beneficially own, subject to applicable community property laws. Except as otherwise described below, based on the information provided to us by Yorkville, Yorkville is not a broker-dealer or an affiliate of a broker-dealer.

 

We may amend or supplement this prospectus from time to time in the future to update or change this Selling Stockholder list and the securities that may be resold.

 

  

Number of Ordinary Shares

Beneficially Owned

  

Maximum

Number of

Ordinary

Shares Being

  

Ordinary Shares Beneficially

Owned After the Offered

Ordinary Shares are Sold

 
Name of Selling Stockholder  Number   Percent   Offered   Number(1)   Percent 
YA II PN, LTD (2)   (3)   (3)   -    -    - 

 

* Less than 1%

(1) Assumes the sale of all shares being offered pursuant to this prospectus.
(2) Yorkville is a fund managed by Yorkville Advisors Global, LP (“Yorkville LP”). Yorkville Advisors Global II, LLC (“Yorkville LLC”) is the General Partner of Yorkville LP. All investment decisions for Yorkville are made by Yorkville LLC’s President and Managing Member, Mr. Mark Angelo. The business address of Yorkville is 1012 Springfield Avenue, Mountainside, NJ 07092.
(3) Excludes an indeterminable number of Ordinary Shares that may be issued pursuant to the SEPA, which is computed based on the Company’s stock price from time to time. See “Committed Equity Financing” above

 

110
 

 

CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS

 

The following is a discussion of certain material U.S. federal income tax considerations generally applicable to the acquisition, ownership, and disposition of the Ordinary Shares by a “U.S. Holder.” This discussion applies only to the Ordinary Shares that are held by a U.S. Holder as “capital assets” within the meaning of Section 1221 of the Internal Revenue Code of 1986, as amended (the “Code”) (generally, property held for investment). This discussion does not describe all U.S. federal income tax considerations that may be relevant to a U.S. Holder in light of such U.S. Holder’s particular circumstances, nor does it address any state, local, or non-U.S. tax considerations, any non-income tax (such as gift or estate tax) considerations, the alternative minimum tax, the special tax accounting rules under Section 451(b) of the Code, the Medicare contribution tax on net investment income, or any tax consequences that may be relevant to U.S. holders that are subject to special tax rules, including, without limitation:

 

banks or other financial institutions;
insurance companies;
mutual funds;
pension or retirement plans;
S corporations;
broker or dealers in securities or currencies;
traders in securities that elect mark-to-market treatment;
regulated investment companies;
real estate investment trusts;
trusts or estates;
tax-exempt organizations (including private foundations);
persons that hold the Ordinary Shares as part of a “straddle,” “hedge,” “conversion,” “synthetic security,” “constructive ownership transaction,” “constructive sale,” or other integrated transaction for U.S. federal income tax purposes;
persons that have a functional currency other than the U.S. dollar;
certain U.S. expatriates or former long-term residents of the United States;
persons owning (directly, indirectly, or constructively) 5% (by vote or value) or more of our stock;
persons that acquired the Ordinary Shares pursuant to an exercise of employee stock options or otherwise as compensation;
partnerships or other entities or arrangements treated as pass-through entities for U.S. federal income tax purposes and investors in such entities;
“controlled foreign corporations” within the meaning of Section 957(a) of the Code;
“passive foreign investment companies” within the meaning of Section 1297(a) of the Code; and
corporations that accumulate earnings to avoid U.S. federal income tax.

 

If a partnership (including an entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds the Ordinary Shares, the tax treatment of a partner in such partnership generally will depend on the status of the partner and the activities of the partnership and the partner. Partnerships holding the Ordinary Shares should consult their tax advisors regarding the tax consequences in their particular circumstances.

 

This discussion is based on the Code, the U.S. Treasury regulations promulgated thereunder, administrative rulings, and judicial decisions, all as currently in effect and all of which are subject to change or differing interpretation, possibly with retroactive effect. Any such change or differing interpretation could alter the tax consequences described herein. Furthermore, there can be no assurance that the Internal Revenue Service (the “IRS”) will not challenge the tax considerations described herein and that a court will not sustain such challenge.

 

111
 

 

For purposes of this discussion, a “U.S. Holder” is a beneficial owner of the Ordinary Shares, that is, for U.S. federal income tax purposes:

 

an individual who is a U.S. citizen or resident of the United States;
a corporation (including an entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof, or the District of Columbia;
an estate the income of which is subject to U.S. federal income taxation regardless of its source; or
a trust (i) if a court within the United States is able to exercise primary supervision over the administration of the trust and one or more “United States persons” within the meaning of Section 7701(a)(30) of the Code have the authority to control all substantial decisions of the trust or (B) that has in effect a valid election under applicable U.S. Treasury regulations to be treated as a United States person.

 

THIS DISCUSSION IS FOR GENERAL INFORMATIONAL PURPOSES ONLY AND IS NOT TAX ADVICE. THIS SUMMARY IS NOT INTENDED TO CONSTITUTE A COMPLETE ANALYSIS OF ALL TAX CONSIDERATIONS APPLICABLE TO U.S. HOLDERS WITH RESPECT TO THE ACQUISITION, OWNERSHIP, AND DISPOSITION OF ORDINARY SHARES, PRE-FUNDED WARRANTS, WARRANTS, AND WARRANT SHARES. U.S. HOLDERS SHOULD CONSULT THEIR OWN TAX ADVISORS AS TO THE TAX CONSIDERATIONS APPLICABLE TO THEM IN LIGHT OF THEIR OWN PARTICULAR CIRCUMSTANCES.

 

Distributions on the Ordinary Shares

 

Subject to the PFIC rules discussed below under “-Passive Foreign Investment Company Rules,” distributions on the Ordinary Shares generally will be taxable as a dividend for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Such distributions in excess of our current and accumulated earnings and profits will constitute a return of capital that will be applied against and reduce (but not below zero) the applicable U.S. Holder’s adjusted tax basis in its Ordinary Shares. Any remaining excess will be treated as gain realized on the sale or other taxable disposition of the Ordinary Shares and will be treated as described below under “-Sale or Other Taxable Disposition of the Ordinary Shares.” The amount of any such distributions will include any amounts required to be withheld by us (or another applicable withholding agent) in respect of any non-U.S. taxes. Any such amount treated as a dividend will be treated as foreign-source dividend income. Any such dividends received by a corporate U.S. Holder generally will not qualify for the dividends-received deduction generally allowed to U.S. corporations in respect of dividends received from other U.S. corporations. With respect to non-corporate U.S. Holders, any such dividends generally will be taxed at currently preferential long-term capital gains rates only if (i) the Ordinary Shares are readily tradable on an established securities market in the United States or we are eligible for benefits under an applicable tax treaty with the United States, (ii) we are not treated as a PFIC with respect to the applicable U.S. Holder at the time the dividend was paid or in the preceding year, and (iii) certain holding period and other requirements are met. Any such dividends paid in a currency other than the U.S. dollar generally will be the U.S. dollar amount calculated by reference to the exchange rate in effect on the date of actual or constructive receipt, regardless of whether the payment is in fact converted into U.S. dollars at that time. A U.S. Holder may have foreign currency gain or loss if the dividend is converted into U.S. dollars after the date of receipt.

 

As noted above and subject to applicable limitations, taxing jurisdictions other than the United States may withhold taxes from distributions on the Ordinary Shares, and a U.S. Holder may be eligible for a reduced rate of withholding to the extent there is an applicable tax treaty between the applicable taxing jurisdiction and the United States and/or may be eligible for a foreign tax credit against the U.S. Holder’s U.S. federal income tax liability. The foreign tax credit rules are complex and U.S. Holders should consult their tax advisers regarding the application of such rules, including the creditability of foreign taxes, in their particular circumstances.

 

Sale or Other Taxable Disposition of the Ordinary Shares

 

Subject to the PFIC rules discussed below under “-Passive Foreign Investment Company Rules,” upon any sale or other taxable disposition of the Ordinary Shares, a U.S. Holder generally will recognize gain or loss in an amount equal to the difference, if any, between (i) the sum of (A) the amount of cash and (B) the fair market value of any other property received in such sale or disposition and (ii) the U.S. Holder’s adjusted tax basis in the Ordinary Shares. Any such gain or loss generally will be capital gain or loss and will be long-term capital gain or loss if the U.S. Holder’s holding period for such Ordinary Shares exceeds one year. Long-term capital gain recognized by non-corporate U.S. Holders generally will be taxed at currently preferential long-term capital gains rates. The deductibility of capital losses is subject to limitations. For foreign tax credit purposes, any such gain or loss generally will be treated as U.S. source gain or loss.

 

112
 

 

If the consideration received by a U.S. Holder upon a sale or other taxable disposition of the Ordinary Shares is not paid in U.S. dollars, the amount realized will be the U.S. dollar value of such payment calculated by reference to the exchange rate in effect on the date of such sale or disposition. A U.S. Holder may have foreign currency gain or loss to the extent of the difference, if any, between (i) the U.S. dollar value of such payment on the date of such sale or disposition and (ii) the U.S. dollar value of such payment calculated by reference to the exchange rate in effect on the date of settlement.

 

U.S. Holders should consult their tax advisors regarding the tax consequences of a sale or other taxable disposition of the Ordinary Shares, including the creditability of foreign taxes imposed on such sale or disposition by a taxing jurisdiction other than the United States, in their particular circumstances.

 

U.S. Federal Income Tax Treatment of the Company

 

A corporation is generally considered for U.S. federal income tax purposes to be a tax resident in the jurisdiction of its organization or incorporation. Accordingly, under the generally applicable U.S. federal income tax rules, the Company, which is organized under the laws of Ireland, would be classified as a non-U.S. corporation (and, therefore, not a U.S. tax resident) for U.S. federal income tax purposes. Section 7874 of the Code provides an exception to this general rule (more fully discussed below), under which a non-U.S. incorporated entity may, in certain circumstances, be treated as a U.S. corporation for U.S. federal income tax purposes. These rules are complex and there is limited guidance regarding their application.

 

Under Section 7874, a corporation created or organized outside the United States (i.e., a non-U.S. corporation) will nevertheless be treated as a U.S. corporation for U.S. federal income tax purposes (and, therefore, as a U.S. tax resident subject to U.S. federal income tax on its worldwide income) if each of the following three conditions are met: (i) the non-U.S. corporation, directly or indirectly, acquires substantially all of the properties held directly or indirectly by a U.S. corporation (including through the acquisition of all of the outstanding shares of the U.S. corporation); (ii) the non-U.S. corporation’s “expanded affiliated group” does not have “substantial business activities” in the non-U.S. corporation’s country of organization or incorporation and tax residence relative to the expanded affiliated group’s worldwide activities (this test is referred to as the “substantial business activities test”); and (iii) subject to the Third Country Rule discussed below, after the acquisition, the former stockholders of the acquired U.S. corporation hold at least 80% (by either vote or value) of the shares of the non-U.S. acquiring corporation by reason of holding shares in the U.S. acquired corporation (taking into account the receipt of the non-U.S. corporation’s shares in exchange for the U.S. corporation’s shares) as determined for purposes of Section 7874 (this test is referred to as the “Ownership Test”).

 

For purposes of Section 7874, the first condition described above will be met with respect to the Business Combination because the Company will acquire indirectly all of the assets of Lionheart through the Business Combination, and the Company, including its “expanded affiliated group,” is not expected to satisfy the substantial business activities test upon consummation of the Business Combination. As a result, whether Section 7874 will apply to cause the Company to be treated as a U.S. corporation for U.S. federal income tax purposes following the Business Combination should depend on the satisfaction of the Ownership Test.

 

Based upon the terms of the Business Combination, the rules for determining share ownership under Section 7874 and the Treasury Regulations promulgated thereunder, and certain factual assumptions, Lionheart and the Company currently expect that the Section 7874 ownership percentage of the Lionheart stockholders in the Company should be less than 80%.

 

Even so, Treasury Regulations promulgated under Section 7874 include a rule that generally provides that, if (i) there is an acquisition of a U.S. corporation by a non-U.S. corporation in which the Section 7874 ownership percentage is at least 60% (without the application of the Third Party Rule, as defined below), and (ii) in a related acquisition, the non-U.S. corporation acquires another non-U.S. corporation and the acquiring non-U.S. corporation is not subject to tax as a resident in the foreign country in which the acquired non-U.S. corporation was subject to tax as a resident prior to the acquisition, then stock of the acquiring non-U.S. corporation held by former stockholders of the acquired non-U.S. corporation by reason of having held stock in the acquired non-U.S. corporation is excluded in applying the Ownership Test. This rule is referred to herein as the “Third Country Rule.” If applicable, the Third Country Rule increases the Section 7874 ownership percentage and generally results in the acquiring non-U.S. corporation meeting the Ownership Test.

 

113
 

 

Because the Company acquired Security Matters PTY as part of the Business Combination, and Security Matters PTY is not subject to tax as a resident of Ireland (the country in which the Company is subject to tax as a resident), the stock of the Company held by former Security Matters PTY shareholders by reason of having held stock in Security Matters PTY is excluded from applying the Ownership Test, the Third Country Rule could apply to the Business Combination if the Section 7874 ownership percentage of Lionheart stockholders in the Company were at least 60%. Based upon the terms of the Business Combination, the rules for determining share ownership under Section 7874 and the Treasury Regulations promulgated thereunder, and certain factual assumptions, Lionheart and the Company currently expect that the Section 7874 ownership percentage of the Lionheart stockholders in the Company should be less than 60%.

 

Accordingly, the Company is not expected to be treated as a U.S. corporation for U.S. federal income tax purposes under Section 7874. However, whether the Ownership Test has been satisfied must be finally determined after completion of the Business Combination, by which time there could be adverse changes to the relevant facts and circumstances. Further, for purposes of determining the ownership percentage of former Lionheart stockholders for purposes of Section 7874, former Lionheart stockholders will be deemed to own an amount of Ordinary Shares in respect to certain redemptions by Lionheart prior to the Business Combination. In addition, as discussed above, the rules for determining ownership under Section 7874 are complex, unclear and the subject of ongoing regulatory change. Accordingly, there can be no assurance that the IRS would not assert a contrary position to those described above or that such an assertion would not be sustained by a court.

 

If the Company were to be treated as a U.S. corporation for U.S. federal income tax purposes, it could be subject to substantial liability for additional U.S. income taxes, and the gross amount of any dividend payments to its non-U.S. holders could be subject to 30% U.S. withholding tax, depending on the application of any income tax treaty that might apply to reduce the withholding tax.

 

The remainder of this discussion assumes that the Company will not be treated as a U.S. corporation for U.S. federal income tax purposes under Section 7874.

 

Possible Constructive Distributions

 

The terms of each Public Warrant provide for an adjustment to the number of Ordinary Shares for which the Public Warrant may be exercised or to the exercise price of the Public Warrant in certain events, as discussed in the section entitled “Description of Securities.” An adjustment which has the effect of preventing dilution generally is not taxable. A U.S. holder of a Public Warrant would, however, be treated as receiving a constructive distribution from the Company if, for example, the adjustment increases the holder’s proportionate interest in the Company’s assets or earnings and profits (e.g., through an increase in the number of Ordinary Shares that would be obtained upon exercise of such warrant) as a result of a distribution of cash to the holders of the Ordinary Shares which is taxable to the U.S. holders of such shares as described under the section entitled “-Distributions on Ordinary Shares” above. Such constructive distribution would be subject to tax as described under that section in the same manner as if the U.S. holder of such warrant received a cash distribution from the Company equal to the fair market value of such increased interest. The rules regarding constructive distributions are complex. U.S. holders should consult their own tax advisors regarding the application of the rules to them in light of their own circumstances.

 

Passive Foreign Investment Company Rules

 

Generally. The treatment of U.S. holders of the Ordinary Shares could be materially different from that described above if the Company is treated as a passive foreign investment company (a “PFIC”), for U.S. federal income tax purposes. A PFIC is any foreign corporation with respect to which either: (i) 75% or more of the gross income for a taxable year constitutes passive income for purposes of the PFIC rules, or (ii) 50% or more of such foreign corporation’s assets in any taxable year (generally based on the quarterly average of the value of its assets during such year) is attributable to assets, including cash, that produce passive income or are held for the production of passive income. Passive income generally includes dividends, interest, certain royalties and rents, annuities, net gains from the sale or exchange of property producing such income and net foreign currency gains. The determination of whether a foreign corporation is a PFIC is based upon the composition of such foreign corporation’s income and assets (including, among others, its proportionate share of the income and assets of any other corporation in which it owns, directly or indirectly, 25% (by value) of the stock), and the nature of such foreign corporation’s activities. A separate determination must be made after the close of each taxable year as to whether a foreign corporation was a PFIC for that year. Once a foreign corporation qualifies as a PFIC it is, with respect to a shareholder during the time it qualifies as a PFIC, and subject to certain exceptions, always treated as a PFIC with respect to such shareholder, regardless of whether it satisfied either of the qualification tests in subsequent years.

 

114
 

 

Based on the projected composition of the Company’s income and assets, including goodwill, the Company does not expect to be classified as a PFIC for its taxable year that includes the date of the Business Combination. The tests for determining PFIC status are applied annually after the close of the taxable year, and it is difficult to predict accurately future income and assets relevant to this determination. The fair market value of the assets of the Company is expected to depend, in part, upon (a) the market value of the Ordinary Shares, and (b) the composition of the assets and income of the Company. Further, because the Company may value its goodwill based on the market value of the Ordinary Shares, a decrease in the market value of the Ordinary Shares and/or an increase in cash or other passive assets (including as a result of the Business Combination) would increase the relative percentage of its passive assets. Moreover, any interest income that the Company earns on its cash deposits would generally be treated as passive income and increase the risk that the Company would be treated as a PFIC. The application of the PFIC rules is subject to uncertainty in several respects and, therefore, no assurances can be provided that the IRS will not assert that the Company is a PFIC for the taxable year that includes the date of the Business Combination or in a future year.

 

If the Company is or becomes a PFIC during any year in which a U.S. holder holds Ordinary Shares, there are three separate taxation regimes that could apply to such U.S. holder under the PFIC rules, which are the (i) excess distribution regime (which is the default regime), (ii) mark-to-market regime and (iii) QEF regime (as defined below). A U.S. holder who holds (actually or constructively) stock in a foreign corporation during any year in which such corporation qualifies as a PFIC is subject to U.S. federal income taxation under one of these three regimes. The effect of the PFIC rules on a U.S. holder will depend upon which of these regimes applies to such U.S. holder. However, dividends paid by a PFIC are generally not eligible for the lower rates of taxation applicable to qualified dividend income (“QDI”) under any of the foregoing regimes.

 

Excess Distribution Regime. If a U.S. holder does not make a mark-to-market election, as described below, the U.S. holder will be subject to the default “excess distribution regime” under the PFIC rules with respect to (i) any gain realized on a sale or other disposition (including a pledge) of Ordinary Shares, and (ii) any “excess distribution” received on Ordinary Shares (generally, any distributions in excess of 125% of the average of the annual distributions on Ordinary Shares during the preceding three years or the U.S. holder’s holding period, whichever is shorter). Generally, under this excess distribution regime:

 

the gain or excess distribution will be allocated ratably over the period during which the U.S. holder held Ordinary Shares;
   
the amount allocated to the current taxable year, will be treated as ordinary income; and
   
the amount allocated to prior taxable years will be subject to the highest tax rate in effect for that taxable year, and the interest charge generally applicable to underpayments of tax will be imposed on the resulting tax attributable to each such year.

 

The tax liability for amounts allocated to years prior to the year of disposition or excess distribution will be payable generally without regard to offsets from deductions, losses and expenses. In addition, gains (but not losses) realized on the sale of Ordinary Shares cannot be treated as capital gains, even if you hold the shares as capital assets. Further, no portion of any distribution will be treated as QDI.

 

115
 

 

Mark-to-Market Regime. Alternatively, a U.S. holder may make an election to mark marketable shares in a PFIC to market on an annual basis. PFIC shares generally are marketable if: (i) they are “regularly traded” on a national securities exchange that is registered with the Securities and Exchange Commission or on the national market system established under Section 11A of the Securities Exchange Act of 1934; or (ii) they are “regularly traded” on any exchange or market that the Treasury Department determines to have rules sufficient to ensure that the market price accurately represents the fair market value of the stock. It is expected that Ordinary Shares, which are expected to be listed on Nasdaq, will qualify as marketable shares for the PFIC rules purposes, but there can be no assurance that Ordinary Shares will be “regularly traded” for purposes of these rules. Pursuant to such an election, a U.S. holder would include in each year as ordinary income the excess, if any, of the fair market value of such stock over its adjusted basis at the end of the taxable year. A U.S. holder may treat as ordinary loss any excess of the adjusted basis of the stock over its fair market value at the end of the year, but only to the extent of the net amount previously included in income as a result of the election in prior years. A U.S. holder’s adjusted tax basis in the PFIC shares will be increased to reflect any amounts included in income, and decreased to reflect any amounts deducted, as a result of a mark-to-market election. Any gain recognized on a disposition of Ordinary Shares will be treated as ordinary income and any loss will be treated as ordinary loss (but only to the extent of the net amount of income previously included as a result of a mark-to-market election). A mark-to-market election only applies for the taxable year in which the election was made, and for each subsequent taxable year, unless the PFIC shares ceased to be marketable or the IRS consents to the revocation of the election. U.S. holders should also be aware that the Code and the Treasury Regulations do not allow a mark-to-market election with respect to stock of lower-tier PFICs that is non-marketable. There is also no provision in the Code, Treasury Regulations or other published authority that specifically provides that a mark-to-market election with respect to the stock of a publicly traded holding company (such as the company) effectively exempts stock of any lower-tier PFICs from the negative tax consequences arising from the general PFIC rules. U.S. holders should consult their own tax advisors to determine whether the mark-to-market tax election is available to them and the consequences resulting from such election. In addition, U.S. holders of Public Warrants will not be able to make a mark-to-market election with respect to their Public Warrants.

 

QEF Regime. Alternatively, a U.S. holder of a PFIC may avoid the adverse PFIC tax consequences described above in respect of stock of the PFIC (but not warrants) by making and maintaining a timely and valid qualified electing fund (“QEF”) election (if eligible to do so) to include in income its pro rata share of the PFIC’s net capital gains (as long-term capital gain) and other earnings and profits (as ordinary income), on a current basis, in each case whether or not distributed, in the first taxable year of the U.S. Holder in which or with which the PFIC’s taxable year ends and each subsequent taxable year. In order to comply with the requirements of a QEF election, a U.S. Holder must receive a PFIC Annual Information Statement from the PFIC. The company does not presently intend to provide a PFIC Annual Information Statement in order for U.S. Holders to make or maintain a QEF election. However, as described above, the company does not expect to be classified as a PFIC for the taxable year that includes the Business Combination.

 

PFIC Reporting Requirements. A U.S. holder of Ordinary Shares will be required to file an annual report on IRS Form 8621 containing such information with respect to its interest in a PFIC as the IRS may require. Failure to file IRS Form 8621 for each applicable taxable year may result in substantial penalties and result in the U.S. holder’s taxable years being open to audit by the IRS until such Forms are properly filed.

 

Additional Reporting Requirements

 

Certain U.S. holders holding specified foreign financial assets with an aggregate value in excess of the applicable dollar thresholds are required to report information to the IRS relating to Ordinary Shares, subject to certain exceptions (including an exception for Ordinary Shares held in accounts maintained by U.S. financial institutions), by attaching a complete IRS Form 8938 to their tax return, for each year in which they hold Ordinary Shares. Substantial penalties apply to any failure to file IRS Form 8938, unless the failure is shown to be due to reasonable cause and not willful neglect. Also, in the event a U.S. holder does not file IRS Form 8938 or fails to report a specified foreign financial asset that is required to be reported, the statute of limitations on the assessment and collection of U.S. federal income taxes of such U.S. holder for the related taxable year may not close before the date which is three years after the date on which the required information is filed. U.S. holders should consult their tax advisors regarding the effect, if any, of these rules on the ownership and disposition of Ordinary Shares.

 

Certain U.S. holders may be required to file an IRS Form 926 (Return by a U.S. Transferor of Property to a Foreign Corporation) to report a transfer of property to the company. Substantial penalties may be imposed on a U.S. holder that fails to comply with this reporting requirement and the statute of limitations on the assessment and collection of U.S. federal income taxes will be extended in the event of any such failure to comply.

 

116
 

 

Non-U.S. Holders

 

This section applies to non-U.S. holders. For purposes of this discussion, a “non-U.S. holder” means a beneficial owner (other than a partnership or an entity or arrangement so characterized for U.S. federal income tax purposes) of Ordinary Shares or Public Warrants that is not a U.S. holder, including:

 

a nonresident alien individual, other than certain former citizens and residents of the United States;
   
a foreign corporation; or
   
a foreign estate or trust;

 

but, generally, does not include an individual who is present in the United States for 183 days or more in the taxable year of disposition.

 

Ownership and Disposition of Ordinary Shares and Public Warrants by Non-U.S. Holders. A non-U.S. holder of Ordinary Shares will generally not be subject to U.S. federal income tax or, subject to the discussion below under “-Information Reporting and Backup Withholding,” U.S. federal withholding tax on any dividends received on Ordinary Shares or any gain recognized on a sale or other disposition of Ordinary Shares (including, any distribution to the extent it exceeds the adjusted basis in the non-U.S. holder’s Ordinary Shares) unless the dividend or gain is effectively connected with the non-U.S. holder’s conduct of a trade or business in the United States and, if required by an applicable tax treaty, is attributable to a permanent establishment maintained by the non-U.S. holder in the United States. In addition, special rules may apply to a non-U.S. holder that is an individual present in the United States for 183 days or more during the taxable year of the sale or disposition, and certain other requirements are met. Such holders should consult their own tax advisors regarding the U.S. federal income tax consequences of the sale or disposition of Ordinary Shares.

 

Dividends and gains that are effectively connected with a non-U.S. holder’s conduct of a trade or business in the United States (and, if required by an applicable income tax treaty, are attributable to a permanent establishment or fixed base in the United States) generally will be subject to U.S. federal income tax at the same regular U.S. federal income tax rates applicable to a comparable U.S. holder and, in the case of a non-U.S. holder that is a corporation for U.S. federal income tax purposes, also may be subject to an additional branch profits tax at a 30% rate or a lower applicable tax treaty rate.

 

The U.S. federal income tax treatment of a non-U.S. holder’s exercise of a Public Warrant, or the lapse of a Public Warrant held by a non-U.S. holder generally will correspond to the U.S. federal income tax treatment of the exercise or lapse of a warrant by a U.S. holder, as described under “-Exercise or Lapse of a Public Warrant,” above, although to the extent a cashless exercise results in a taxable exchange, the consequences would be similar to those described in the preceding paragraphs above for a non-U.S. holder’s gain on the sale or other disposition of the Ordinary Shares and Public Warrants.

 

Information Reporting and Backup Withholding

 

Payments of dividends and sales proceeds that are made within the United States or through certain U.S.-related financial intermediaries are subject to information reporting, and may be subject to backup withholding, unless (i) the U.S. Holder is a corporation or other exempt recipient or (ii) in the case of backup withholding, the U.S. Holder provides a correct taxpayer identification number and certifies that it is not subject to backup withholding. Backup withholding (currently at a rate of 24%) may apply to such amounts if the U.S. holder fails to provide an accurate taxpayer identification number (generally on an IRS Form W-9 provided to the paying agent of the U.S. holder’s broker) or is otherwise subject to backup withholding. U.S. Holders may be subject to information reporting to the IRS and possible U.S. backup withholding with respect to their Ordinary Shares, Pre-Funded Warrants, Warrants and Warrant Shares. U.S. holders should consult their own tax advisors regarding the application of the U.S. information reporting and backup withholding rules.

 

117
 

 

Information returns may be filed with the IRS in connection with, and non-U.S. holders may be subject to backup withholding on amounts received in respect of their Company Public Shares, Company Public Warrants or their Ordinary Shares, unless the non-U.S. holder furnishes to the applicable withholding agent the required certification as to its non-U.S. status, such as by providing a valid IRS Form W-8BEN, IRS Form W-8BEN-E or IRS Form W-8ECI, as applicable, or the non-U.S. holder otherwise establishes an exemption. Dividends paid with respect to Ordinary Shares and proceeds from the sale of other disposition of Ordinary Shares and other securities received in the United States by a non-U.S. holder through certain U.S.-related financial intermediaries may be subject to information reporting and backup withholding unless such non-U.S. holder provides proof of an applicable exemption or complies with certain certification procedures described above, and otherwise complies with the applicable requirements of the backup withholding rules.

 

Backup withholding is not an additional tax. Amounts withheld as backup withholding may be credited against the holder’s U.S. federal income tax liability, and a holder may obtain a refund of any excess amounts withheld under the backup withholding rules by timely filing the appropriate claim for a refund with the IRS and furnishing any required information.

 

FATCA

 

Sections 1471 through 1474 of the Code and the Treasury regulations and administrative guidance promulgated thereunder (commonly referred to as the “Foreign Account Tax Compliance Act” or “FATCA”) generally impose U.S. federal withholding tax of 30% on certain withholdable payments to a “foreign financial institution” (as defined in the Code) (an “FFI”) unless the FFI (1) enters into an agreement with the IRS (or is subject to an applicable intergovernmental agreement) to withhold on certain payments and to collect and provide to the IRS (or local revenue authorities, as required under an applicable intergovernmental agreement) information regarding United States persons who hold accounts with the FFI and its affiliates (including certain foreign entities owned by United States persons), and (2) provides the payor with a properly completed IRS Form W-8BEN-E to document its status or the FFI otherwise qualifies for an exemption. This IRS Form W-8BEN-E must include the FFI’s Global Intermediary Identification Number, which is obtained by registering with the IRS.

 

FATCA may also impose a 30% withholding tax on withholdable payments to a “non-financial foreign entity” (as defined in the Code) unless the entity provides the withholding agent with a properly completed IRS Form W-8BEN-E certifying that it does not have any “substantial United States owners” (as defined in the Code) or identifying its direct and indirect substantial United States owners or the entity otherwise qualifies for an exemption.

 

For purposes of FATCA, “withholdable payments” generally include U.S.-source payments otherwise subject to non-resident withholding tax (e.g., U.S. source interest or dividends), and, subject to the proposed Treasury regulations discussed below, payments of gross proceeds from the sale or other disposition of any property of a type that can produce U.S. source interest or dividends (e.g., retirements and redemptions of indebtedness, sales of securities, or redemptions of stock in a U.S. corporation), even if the payment would otherwise not be subject to U.S. non-resident withholding tax (e.g., because it is capital gain).

 

While withholding under FATCA would have applied also to payments of gross proceeds from the sale or other disposition of property, proposed Treasury regulations eliminate FATCA withholding on payments of gross proceeds entirely. Taxpayers generally may (but are not required to) rely on these proposed Treasury regulations until final Treasury regulations are issued. Redeeming non-U.S. holders are encouraged to consult with their own tax advisors regarding the possible application of FATCA to redemptions of Company Public Shares.

 

CERTAIN MATERIAL IRISH TAX CONSIDERATIONS TO NON-IRISH HOLDERS

 

Scope

 

The following is a summary of the anticipated material Irish tax consequences of the acquisition, ownership and disposal of Ordinary Shares covered by this offering. The summary is based upon Irish tax laws and the practice of the Irish Revenue Commissioners in effect on the date of this prospectus and confirmations which have been received from the Irish Revenue Commissioners. Changes in law and/or administrative practice may result in a change in the tax consequences described below, possibly with retrospective effect.

 

118
 

 

A “Non-Irish Holder” is an individual who beneficially owns, that is neither a resident nor ordinarily resident in Ireland for Irish tax purposes and does not hold their Ordinary Shares, in connection with a trade carried on by such person through an Irish branch or agency.

 

This summary does not constitute tax advice and is intended only as a general guide. The summary is not exhaustive and securityholders should consult their tax advisors about the Irish tax consequences (and tax consequences under the laws of other relevant jurisdictions) of the acquisition, ownership and disposal of Ordinary Shares. The summary applies only to Non-Irish Holders who own their Ordinary Shares, as capital assets and does not apply to other categories of Non-Irish Holders, such as dealers in securities, trustees, insurance companies, collective investment schemes and Non-Irish Holders who acquired, or are deemed to have acquired, their Ordinary Shares by virtue of an Irish office or employment (performed or carried on to any extent in Ireland).

 

Irish Tax on Chargeable Gains (Irish CGT)

 

The current rate of tax on chargeable gains (where applicable) in Ireland is 33%.

 

Non-Irish Holders will not be within the territorial scope of a charge to Irish CGT on a disposal of Ordinary Shares, provided that such Ordinary Shares neither (a) were used in or for the purposes of a trade carried on by such Non-Irish Holder through an Irish branch or agency, nor (b) were used, held or acquired for use by or for the purposes of an Irish branch or agency.

 

Stamp Duty

 

The rate of stamp duty (where applicable) on transfers of shares or warrants of Irish incorporated companies is 1% of the greater of the price paid or market value of the shares or warrants acquired. Where Irish stamp duty arises it is generally a liability of the transferee. However, in the case of a gift or transfer at less than fair market value, all parties to the transfer are jointly and severally liable.

 

Irish stamp duty may be payable in respect of transfers of the Ordinary Shares, depending on the manner in which the Ordinary Shares are held. The Company entered into arrangements with the Depository Trust Company (“DTC”) to allow the Ordinary Shares to be settled through the facilities of DTC.

 

Ordinary Shares Held Through DTC

 

The Irish Revenue Commissioners have confirmed to the Company that transfers of Ordinary Shares effected by means of the transfer of book entry interests in DTC will not be subject to Irish stamp duty.

 

Ordinary Shares Held Outside of DTC or Transferred Into or Out of DTC

 

A transfer of Ordinary Shares, where any party to the transfer holds such Ordinary Shares outside of DTC will be subject to Irish stamp duty at a rate of 1% of the higher of consideration paid or the market value of the Ordinary Shares transferred unless an exemption applies.

 

Holders of Ordinary Shares wishing to transfer their Ordinary Shares into (or out of) DTC may do so without giving rise to Irish stamp duty provided that:

 

there is no change in the beneficial ownership of such shares as a result of the transfer; and
   
the transfer into (or out of) DTC is not effected in contemplation of a sale of such shares or warrants by a beneficial owner to a third party.

 

Withholding Tax on Dividends (DWT)

 

Distributions made by the Company will, in the absence of one of many exemptions, be subject to DWT, currently at a rate of 25%.

 

119
 

 

For DWT and Irish income tax purposes, a distribution includes any distribution that may be made by the Company to holders of Ordinary Shares, including cash dividends, non-cash dividends and additional stock taken in lieu of a cash dividend. Where an exemption from DWT does not apply in respect of a distribution made to a holder of Ordinary Shares, the Company is responsible for withholding DWT prior to making such distribution.

 

General Exemptions

 

Irish domestic law provides that a non-Irish resident holder of Ordinary Shares is not subject to DWT on distributions received from the Company if such holder is beneficially entitled to the distribution and is either:

 

a person (not being a company) resident for tax purposes in a Relevant Territory (including the United States) and is neither resident nor ordinarily resident in Ireland (for a List of Relevant Territories for DWT purposes see Exhibit 99.1 to the Registration Statement on Form F-1 to which this prospectus forms a part);
   
a company resident for tax purposes in a Relevant Territory, provided such company is not under the control, whether directly or indirectly, of a person or persons who is or are resident in Ireland;
   
a company that is controlled, directly or indirectly, by persons resident in a Relevant Territory and who is or are (as the case may be) not controlled by, directly or indirectly, persons who are not resident in a Relevant Territory;
   
a company whose principal class of shares (or those of its 75% direct or indirect parent) is substantially and regularly traded on a stock exchange in Ireland, on a recognized stock exchange either in a Relevant Territory or on such other stock exchange approved by the Irish Minister for Finance; or
   
a company that is wholly owned, directly or indirectly, by two or more companies where the principal class of shares of each of such companies is substantially and regularly traded on a stock exchange in Ireland, a recognized stock exchange in a Relevant Territory or on such other stock exchange approved by the Irish Minister for Finance;

 

and provided, in all cases noted above (but subject to “-Shares Held by U.S. Resident Shareholders” below), the Company or, in respect of Ordinary Shares held through DTC, any qualifying intermediary appointed by the Company, has received from the holder of such Ordinary Shares, where required, the relevant DWT Forms prior to the payment of the distribution. In practice, in order to ensure sufficient time to process the receipt of relevant DWT Forms, the holders of Ordinary Shares, where required, should furnish the relevant DWT Form to:

 

its broker (and the relevant information is further transmitted to any qualifying intermediary appointed by the Company) before the record date for the distribution (or such later date before the distribution payment date as may be notified to the holder of Ordinary Shares by the broker) if its Ordinary Shares are held through DTC; or
   
the Company’s transfer agent before the record date for the distribution if its Ordinary Shares are held outside of DTC.

 

Links to the various DWT Forms are available at: http://www.revenue.ie/en/tax/dwt/forms/index.html. The information on such website does not constitute a part of, and is not incorporated by reference into, this prospectus.

 

For non-Irish resident holders of Ordinary Shares that cannot avail themselves of one of Ireland’s domestic law exemptions from DWT, it may be possible for such holder of Ordinary Shares to rely on the provisions of a double tax treaty to which Ireland is party to reduce the rate of DWT.

 

Ordinary Shares Held by U.S. Resident Shareholders

 

Distributions paid in respect of Ordinary Shares that are owned by a U.S. resident and held through DTC will not be subject to DWT provided the address of the beneficial owner of such Ordinary Shares in the records of the broker holding such Ordinary Shares is in the United States (and such broker has further transmitted the relevant information to a qualifying intermediary appointed by the Company). It is strongly recommended that such holders of Ordinary Shares ensure that their information is properly recorded by their brokers (so that such brokers can further transmit the relevant information to a qualifying intermediary appointed by the Company).

 

120
 

 

If any holder of Ordinary Shares that is resident in the United States receives a distribution from which DWT has been withheld, the holder of Ordinary Shares should generally be entitled to apply for a refund of such DWT from the Irish Revenue Commissioners, provided the holder of Ordinary Shares is beneficially entitled to the distribution.

 

Ordinary Shares Held by Residents of Relevant Territories Other Than the United States

 

Holders of Ordinary Shares who are residents of Relevant Territories, other than the United States, must satisfy the conditions of one of the exemptions referred to above under the heading “-General Exemptions”, including the requirement to furnish valid DWT Forms, in order to receive distributions without suffering DWT. If such holders of Ordinary Shares hold their Ordinary Shares through DTC, they must provide the appropriate DWT Forms to their brokers (so that such brokers can further transmit the relevant information to a qualifying intermediary appointed by the Company) before the record date for the distribution (or such later date before the distribution payment date as may be notified to holder of Ordinary Shares by the broker). If such holders of Ordinary Shares hold their Ordinary Shares outside of DTC, they must provide the appropriate DWT Forms to the Company’s transfer agent before the record date for the distribution.

 

Distributions paid in respect of Ordinary Shares that are held outside of DTC and are owned a U.S. resident will not be subject to DWT if such holder of Ordinary Shares provides a completed IRS Form 6166 or a valid DWT Form to the Company’s transfer agent to confirm its U.S. residence and claim an exemption. It is strongly recommended that such holders provide the appropriate completed IRS Form 6166 or DWT Form to the Company’s transfer agent as soon as possible after receiving their Ordinary Shares.

 

If any holder of Ordinary Shares who is resident in a Relevant Territory receives a distribution from which DWT has been withheld, the holder of Ordinary Shares may be entitled to a refund of DWT from the Irish Revenue Commissioners provided the holder of Ordinary Shares is beneficially entitled to the distribution.

 

Securities Held by Other Persons

 

Holders of Ordinary Shares that do not fall within any of the categories specifically referred to above may nonetheless fall within other exemptions from DWT and should provide the applicable DWT Form to confirm its entitlement to such an exemption in advance of payment of any distributions. If any holders of Ordinary Shares are exempt from DWT, but receive distributions subject to DWT, such holders of Ordinary Shares may apply for refunds of such DWT from the Irish Revenue Commissioners.

 

Distributions paid in respect of Ordinary Shares held through DTC that are owned by a partnership formed under the laws of a Relevant Territory and where all the underlying partners are resident in a Relevant Territory will be entitled to exemption from DWT if all of the partners complete the appropriate DWT Forms and provide them to their brokers (so that such brokers can further transmit the relevant information to a qualifying intermediary appointed by the Company) before the record date for the distribution (or such later date before the distribution payment date as may be notified to the holder of Ordinary Shares by the broker). If any partner is not a resident of a Relevant Territory, no part of the partnership’s position is entitled to exemption from DWT.

 

Qualifying Intermediary

 

Prior to paying any distribution on its Ordinary Shares, the Company will put in place an agreement with an entity that is recognized by the Irish Revenue Commissioners as a “qualifying intermediary,” which will provide for certain arrangements relating to distributions in respect of Ordinary Shares that are held through DTC, which are referred to as the “Deposited Securities.” The agreement will provide that the qualifying intermediary shall distribute or otherwise make available to Cede & Co., as nominee for DTC, any cash dividend or other cash distribution with respect to the Deposited Securities after the Company delivers or causes to be delivered to the qualifying intermediary the cash to be distributed.

 

The Company will rely on information received directly or indirectly from its qualifying intermediary, brokers and its transfer agent in determining where holders of Ordinary Shares reside, whether they have provided the required U.S. tax information and whether they have provided the required DWT Forms. Holders of Ordinary Shares that are required to file DWT Forms in order to receive distributions free of DWT should note that such forms are generally valid, subject to a change in circumstances, until December 31 of the fifth year after the year in which such forms were completed.

 

121
 

 

Additional anti-avoidance measures

 

Additional withholding measures will apply to payments of distributions on Ordinary Shares with effect from 1 April 2024. Notwithstanding the above stated exemptions, payments of distributions to associated entities in jurisdictions that are on the EU list of non-cooperative jurisdictions or zero-tax jurisdictions may be subject to DWT on payment following that date. Association for these purposes generally means a 50% ownership connection (assessed on the basis of share ownership, voting power or entitlement to profits on a distribution) or the ability to control the board of directors.

 

Income Tax on Dividends Paid

 

Irish income tax may arise for certain persons in respect of distributions received from Irish resident companies.

 

A Non-Irish Holder that is entitled to an exemption from DWT will generally have no Irish income tax or universal social charge liability on a distribution from the Company. A Non-Irish Holder that is not entitled to an exemption from DWT, and therefore is subject to DWT, generally will have no additional Irish income tax liability or liability to universal social charge. The DWT deducted by the Company discharges the Irish income tax liability and liability to universal social charge.

 

Capital Acquisitions Tax (CAT)

 

CAT comprises principally gift tax and inheritance tax on property situated in Ireland for CAT purposes or otherwise within the territorial scope of CAT. CAT could apply to a gift or inheritance of the Ordinary Shares because the Ordinary Shares should be regarded as property situated in Ireland for CAT purposes. The person who receives the gift or inheritance has primary liability for CAT.

 

CAT is currently levied at a rate of 33% on the value of any taxable gift or inheritance above certain tax-free thresholds. The appropriate tax-free threshold depends upon (1) the relationship between the donor and the donee and (2) the aggregation of the values of previous taxable gifts and inheritances received by the donee from persons within the same group threshold. Gifts and inheritances passing between spouses are exempt from CAT, as are gifts to certain charities. Children have a lifetime tax-free threshold of €335,000 in respect of taxable gifts or inheritances received from their parents. There is also a “small gift exemption” from CAT whereby the first €3,000 of the taxable value of all taxable gifts taken by a donee from any one donor, in each calendar year, is exempt from CAT and is also excluded from any future aggregation. This exemption does not apply to an inheritance.

 

THE IRISH TAX CONSIDERATIONS SUMMARIZED ABOVE ARE FOR GENERAL INFORMATION ONLY AND ARE NOT INTENDED TO PROVIDE ANY DEFINITIVE TAX REPRESENTATIONS TO HOLDERS. EACH SECURITYHOLDER SHOULD CONSULT HIS OR HER TAX ADVISOR AS TO THE PARTICULAR CONSEQUENCES THAT MAY APPLY TO SUCH SECURITYHOLDER.

 

122
 

 

PLAN OF DISTRIBUTION

 

The Ordinary Shares offered by this prospectus are being offered by Yorkville. The shares may be sold or distributed from time to time by Yorkville directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which may be changed. We will not receive any of the proceeds from the sale of the securities by Yorkville. We may receive up to $25,000,000 aggregate gross proceeds under the SEPA from any sales we make to Yorkville pursuant to the SEPA. The net proceeds from sales, if any, under the SEPA, will depend on the frequency and prices at which we sell Ordinary Shares to Yorkville after the date of this prospectus.

 

The sale of our Ordinary Shares offered by this prospectus could be effected in one or more of the following methods:

 

ordinary brokers’ transactions;
   
transactions involving cross or block trades;
   
through brokers, dealers, or underwriters who may act solely as agents;
   
“at the market” into an existing market for our Ordinary Shares;
   
in other ways not involving market makers or established business markets, including direct sales to purchasers or sales effected through agents;
   
in privately negotiated transactions; or
   
any combination of the foregoing.

 

In order to comply with the securities laws of certain states, if applicable, the shares may be sold only through registered or licensed brokers or dealers. In addition, in certain states, the shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from the state’s registration or qualification requirement is available and complied with.

 

Yorkville is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act.

 

Yorkville has informed us that it intends to use one or more registered broker-dealers to effectuate all sales, if any, of our Ordinary Shares that it may acquire from us pursuant to the SEPA. Such sales will be made at prices and at terms then prevailing or at prices related to the then current market price. Such registered broker-dealer may, in some circumstances (for instance if such registered broker-dealer’s involvement is not limited to receiving commission not in excess of the usual and customary distributor’s or seller’s commissions), be considered to be an underwriter within the meaning of Section 2(a)(11) of the Securities Act. Yorkville has informed us that each such broker-dealer may receive commissions from Yorkville for executing such sales for Yorkville and, if so, such commissions will not exceed customary brokerage commissions.

 

Brokers, dealers, underwriters or agents participating in the distribution of our Ordinary Shares offered by this prospectus may receive compensation in the form of commissions, discounts, or concessions from the purchasers, for whom the broker-dealers may act as agent, of the shares sold by Yorkville through this prospectus. The compensation paid to any such particular broker-dealer by any such purchasers of our Ordinary Shares sold by Yorkville may be less than or in excess of customary commissions. Neither we nor Yorkville can presently estimate the amount of compensation that any agent will receive from any purchasers of our Ordinary Shares sold by Yorkville.

 

We know of no existing arrangements between Yorkville or any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of the Ordinary Shares offered by this prospectus.

 

123
 

 

We may from time to time file with the SEC one or more supplements to this prospectus or amendments to the registration statement of which this prospectus forms a part to amend, supplement or update information contained in this prospectus, including, if and when required under the Securities Act, to disclose certain information relating to a particular sale of shares offered by this prospectus by Yorkville, including with respect to any compensation paid or payable by Yorkville to any brokers, dealers, underwriters or agents that participate in the distribution of such shares by Yorkville, and any other related information required to be disclosed under the Securities Act.

 

We will pay the expenses incident to the registration under the Securities Act of the offer and sale of our Ordinary Shares covered by this prospectus by Yorkville.

 

As consideration for Yorkville’s commitment to purchase Ordinary Shares at our direction upon the terms and subject to the conditions set forth in the SEPA, we paid Yorkville, (i) a due diligence fee in the amount of $15,000 and (ii) a commitment fee in an amount equal to 1.5% of the Commitment Amount by the issuance of such number of Common Share that is equal to the Commitment Fee divided by the average daily VWAPs of the Common Shares during the 3 Trading Days immediately following the closing of the Business Combination.

 

We also have agreed to indemnify Yorkville and certain other persons against certain liabilities in connection with the offering of our Ordinary Shares offered hereby, including liabilities arising under the Securities Act or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. Yorkville has agreed to indemnify us against liabilities under the Securities Act that may arise from certain written information furnished to us by Yorkville specifically for use in this prospectus or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons, we have been advised that in the opinion of the SEC this indemnification is against public policy as expressed in the Securities Act and is therefore, unenforceable.

 

We estimate that the total expenses for the offering will be approximately $40,000.00

 

Yorkville has represented to us that at no time prior to the date of the SEPA has Yorkville or any entity managed or controlled by Yorkville, engaged in or effected, in any manner whatsoever, directly or indirectly, for its own account or for the account of any of its affiliates, any short sale or any transaction, which establishes a net short position with respect to our Ordinary Shares. Yorkville has agreed that during the term of the SEPA, none of Yorkville, its officers, its sole member, or any entity managed or controlled by Yorkville, will enter into or effect, directly or indirectly, any of the foregoing transactions for its own account or for the account of any other such person or entity.

 

We have advised Yorkville that it is required to comply with Regulation M promulgated under the Exchange Act. With certain exceptions, Regulation M precludes Yorkville, any affiliated purchasers, and any broker-dealer or other person who participates in the distribution from bidding for or purchasing, or attempting to induce any person to bid for or purchase any security which is the subject of the distribution until the entire distribution is complete. Regulation M also prohibits any bids or purchases made in order to stabilize the price of a security in connection with the distribution of that security. All of the foregoing may affect the marketability of the securities offered by this prospectus.

 

This offering will terminate on the date that all of our Ordinary Shares offered by this prospectus have been sold by Yorkville.

 

Our Ordinary Shares and Public Warrants are listed on The Nasdaq Stock Market LLC under the symbols “SMX” and “SMXWW,” respectively.

 

124
 

 

EXPENSES RELATED TO THE OFFERING

 

   U.S. dollar 
SEC Registration Fee  $175.91 
Legal Fees and Expenses  $10,000.00 
Accounting Fees and Expenses  $5,000.00 
Printing Expenses  $5,000.00 
Miscellaneous Expenses  $4,824.09 
Total  $25,000.00 

 

SERVICE OF PROCESS AND ENFORCEMENT OF CIVIL LIABILITIES UNDER U.S. SECURITIES LAWS

 

The Company is incorporated in Ireland and conducts a majority of its operations through its subsidiary, Security Matters PTY, located outside the United States. The majority of the Company’s assets are located outside the United States. A majority of the Company’s officers reside outside the United States and a substantial portion of the assets of those persons are located outside of the United States. As a result, it could be difficult or impossible for you to bring an action against the Company or against these individuals outside of the United States in the event that you believe that your rights have been infringed under the applicable securities laws or otherwise. Even if you are successful in bringing an action of this kind, the laws outside of the United States could render you unable to enforce a judgment against the Company’s assets or the assets of the Company’s officers.

 

LEGAL MATTERS

 

The validity of our Ordinary Shares has been passed upon by Arthur Cox LLP, Irish counsel to the Company.

 

EXPERTS

 

The consolidated financial statements of Security Matters PTY (formerly Security Matters Limited) as of December 31, 2022 and 2021, and for each of the three years in the period ended December 31, 2022, included in this Registration Statement on Form F-1 have been so included in reliance on the report of BDO Ziv Haft, an independent registered public accounting firm, appearing elsewhere herein and in this registration statement, given on the authority of said firm as experts in auditing and accounting.

 

The financial statements of the Company as of December 31, 2022 and July 1, 2022 (inception), included in this Registration Statement on Form F-1 have been so included in reliance on the report of BDO Ziv Haft, an independent registered public accounting firm, appearing elsewhere herein and in this registration statement, given on the authority of said firm as experts in auditing and accounting.

 

WHERE YOU CAN FIND MORE INFORMATION

 

We have filed with the SEC a registration statement (including amendments and exhibits to the registration statement) on Form F-1 under the Securities Act with respect to the Ordinary Shares offered in this prospectus.

 

This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement or the exhibits and schedules filed therewith. For further information with respect to us and our securities offered hereby, reference is made to the registration statement and the exhibits and schedules filed therewith. Statements contained in this prospectus regarding the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and each such statement is qualified in all respects by reference to the full text of such contract or other document filed as an exhibit to the registration statement.

 

We are subject to the periodic reporting and other information requirements of the Exchange Act as applicable to a “foreign private issuer,” and we will file annual reports and other information from time to time with the SEC in accordance with such requirements. Our SEC filings will be available to the public on the internet at a website maintained by the SEC located at www.sec.gov.

 

We also maintain an Internet website at https://smx.tech. We will make available on our website, free of charge, the following documents as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC: our Annual Reports on Form 20-F; our reports on Form 6-K; amendments to these documents; and other information as may be required by the SEC. The information contained on, or that may be accessed through, our website is not part of, and is not incorporated into, this prospectus.

 

125
 

 

INDEX TO FINANCIAL STATEMENTS

 

SECURITY MATTERS LIMITED

 

 

Page

   
Report of independent registered public accounting firm PCAOB # 1185 F-3
Consolidated statements of financial position F-4
Consolidated statements of comprehensive loss F-5
Consolidated statements of changes in equity F-6 to F-8
Consolidated statements of cash flows F-9
Notes to the consolidated financial statements F-10 to F-36

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

 

  Page
   
Report of independent registered public accounting firm PCAOB # 1185 F-38
Statements of financial position F-39
Notes to the financial statements F-40 - F-42
Interim condensed consolidated statements of financial position as of June 30, 2023 F-44
Interim condensed consolidated statements of comprehensive loss as of June 30, 2023 F-45
Interim condensed consolidated statements of changed in shareholders’ equity (deficit) as of June 30, 2023 F-46
Notes to the unaudited interim condensed consolidated financial statements as of June 30, 2023 F-50 - F-60

 

F-1
 

 

SECURITY MATTERS LIMITED

 

CONSOLIDATED FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2022 AND 2021

 

The amounts are stated in thousands of U.S. Dollars

 

F-2
 

 

Report of Independent Registered Public Accounting Firm

to the Shareholders of

 

Security Matters Limited

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated statements of financial position of Security Matters Limited and subsidiaries (the “Company”) as of December 31, 2022, and 2021, the related consolidated statements of comprehensive loss, changes in equity, and cash flows for each of the three years in the period ended December 31, 2022, and the related notes (collectively, the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022, and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022, in conformity with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Tel-Aviv, Israel   /s/ Ziv Haft

April 25, 2023

We have served as the Company’s auditor since 2022

  Certified Public Accountants (Isr.)
    BDO Member Firm

 

F-3
 

 

 

SECURITY MATTERS LIMITED

 

CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

 

    

December 31,

2022

  

December 31,

2021

 
  Note  US$ in thousands, except per share data 
Current assets            
Cash and cash equivalents     1,398    4,171 
Other current assets 4   3,673    920 
Total current assets     5,071    5,091 
Non-current assets            
Property and equipment, net 5   969    1,192 
Intangible assets, net 8   5,027    3,908 
Investment in associated companies 7   221    147 
Total non-current assets     6,217    5,247 
             
Total assets     11,288    10,338 
             
Current liabilities            
Trade payables     2,972    916 
Lease liabilities 9   30    37 
Other payables 10   650    673 
Convertible note 6   563     
Borrowings from related parties 11   710    270 
Total current liabilities     4,925    1,896 
Non-current liabilities            
Lease liabilities 9   440    466 
Bridge loans and derivative financial liabilities 12   3,682     
Other liabilities 19   85    85 
Total non-current liabilities     4,207    551 
             
Total liabilities     9,132    2,447 
             
Equity            
Issued capital 13        
Additional paid-in capital 13   32,713    31,504 
Foreign currency translation     (537)   223 
Accumulated losses     (30,020)   (23,836)
Total equity     2,156    7,891 
Total liabilities and equity     11,288    10,338 

 

/s/ Limor Moshe Lotker   /s/ Haggai Alon   April 25, 2023

Limor Moshe Lotker

Chief Financial Officer

 

Haggai Alon

Chief Executive Officer

 

Date of approval of financial

statements

 

The accompanying notes are an integral part of the financial statements.

 

F-4
 

 

 

SECURITY MATTERS LIMITED

 

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

 

               
    

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
  Note  US$ in thousands 
Revenue             13 
Cost of sales             10 
Gross profit             3 
Research and development expenses, net 14   1,898    2,039    1,689 
Selling and marketing expenses     569    453    427 
General and administrative expenses 15   2,723    2,482    2,447 
Operating loss     (5,190)   (4,974)   (4,560)
Finance expenses     1,128    101    79 
Finance income     28    237    67 
Share of net profit (loss) of associated companies 7   106    (101)   (1)
Loss before income tax     (6,184)   (4,939)   (4,573)
Income tax 16            
Loss after income tax for the year attributable to shareholders     (6,184)   (4,939)   (4,573)
                  
Other comprehensive income (loss):                 
Items that will not be reclassified to profit or loss:                 
Foreign currency translation     (522)   (7)   388 
                  
Items that will or may be reclassified to profit or loss:                 
Exchange gains arising on translation of foreign operations     (238)   (375)    
Other comprehensive income (loss), net of tax     (760)   (382)   388 
                  
Total comprehensive loss     (6,944)   (5,321)   _(4,185)
Loss per share attributable to shareholders                 
                  
Basic and diluted loss per share attributable to shareholders 17   (0.04)   (0.03)   (0.04)

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-5
 

 

 

SECURITY MATTERS LIMITED

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

                          
  

Issued

capital

  

Additional

paid-in

capital

  

Foreign

currency

translation

  

Accumulated

loss

   Total equity 
   US$ in thousands 
Balance as of January 1, 2022       31,504    223    (23,836)   7,891 
Comprehensive loss                         
Loss after income tax for the year               (6,184)   (6,184)
Other comprehensive loss for the year           (760)       (760)
Total comprehensive loss for the year            (760)   (6,184)   (6,944)
                          
Issuance of shares, net       182            182 
Share-based compensation       306            306 
Issuance of options to acquire intangible asset       721            721 
                          
Balance as of December 31, 2022       32,713    (537)   (30,020)   2,156 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-6
 

 

 

SECURITY MATTERS LIMITED

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

  

Issued

capital

  

Additional

paid-in

capital

  

Foreign

currency

translation

  

Accumulated

loss

   Total equity 
   US$ in thousands 
Balance as of January 1, 2021       24,733    605    (18,897)   6,441 
Comprehensive loss                         
Loss after income tax for the year               (4,939)   (4,939)
Other comprehensive loss for the year           (382)       (382)
Total comprehensive loss for the year           (382)   (4,939)   (5,321)
                          
Issuance of shares, net       5,892            5,892 
Exercise of warrants       395            395 
Share-based compensation       484            484 
                          
Balance as of December 31, 2021       31,504    223    (23,836)   7,891 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-7
 

 

 

SECURITY MATTERS LIMITED

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

 

  

Issued

capital

  

Additional

paid-in

capital

  

Foreign

currency

translation

  

Accumulated

loss

   Total equity 
   US$ in thousands 
Balance as of January 1, 2020       17,357    217    (14,324)   3,250 
Comprehensive loss                         
Loss after income tax for the year               (4,573)   (4,573)
Other comprehensive income for the year           388        388 
Total comprehensive loss for the year           388    (4,573)   (4,185)
                          
Issuance of shares, net       6,857            6,857 
Exercise of warrants                    
Share-based compensation       519            519 
                          
Balance as of December 31, 2020       24,733    605    (18,897)   6,441 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-8
 

 

 

SECURITY MATTERS LIMITED

 

CONSOLIDATED STATEMENTS OF CASH FLOWS 

 

  

Year ended

December 31,

2022

  

Year ended

December 31,

2021

  

Year ended

December 31,

2020

 
   US$ in thousands     
Cash flows from operating activities:               
Loss before tax for the year   (6,184)   (4,939)   (4,573)
Share based compensation   252    431    483 
Increase in other current assets   (2,936)   (463)   (162)
Depreciation and amortization   290    315    219 
Increase in trade payables   2,217    401    323 
Increase in other payables   114    60    150 
Increase (decrease) in other liabilities   17    (3)   (15)
Change in fair value of financial liabilities   387    -    - 
Decrease in provision   -    -    (6)
Interest on leases   51    47    29 
Provision of borrowing to related parties   621    89    - 
Share in (earnings) losses of associated companies, net   (106)   101    1 
Issuance of shares for directors   54    53    36 
Net cash flow used in operating activities   (5,223)   (3,908)   (3,515)
                
Cash flows from investing activities:               
Purchase of property, plant and equipment   (152)   (297)   (235)
Capitalized development cost   (975)   (1,468)   (723)
Net cash flow used in investing activities   (1,127)   (1,765)   (958)
                
Cash flows from financing activities:               
Payments of borrowings to related parties   (172)   (103)   (144)
Payment of lease liabilities   (55)   (98)   (12)
Exercise of warrants   -    395    - 
Proceeds from issuance of convertible notes   581    -    - 
Proceeds from issuance of shares, net   182    5,892    6,857 
Proceeds from bridge loans and warrants   3,310    32    - 
Net cash flow from financing activities   3,846    6,118    6,701 
                
Increase (decrease) in cash and cash equivalents   (2,504)   445    2,228 
Cash and cash equivalents at beginning of year   4,171    4,341    1,708 
Exchange rate differences on cash and cash equivalent   (269)   (615)   405 
Cash and cash equivalents at end of year   1,398    4,171    4,341 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-9
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 1 – GENERAL:

 

A.Security Matters Limited (“Security Matters” or the “Company”, and together with its subsidiaries, the “Group”) was incorporated in May 2018 under Australian law. Security Matters’ registered address is Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6.

 

The Group engages in research and development to permanently and irrevocably “mark” any object either solid, liquid or gas, allowing identification, circularity, proof of authenticity, tracking supply chain movements and quality assurance for countless products in virtually every industry.

 

 

Security Matters’ technology comprises a chemical-based hidden “barcode” system, alongside a unique “reader” to identify these codes, and a blockchain record to store and protect ownership data. Security Matters offers a business-to-business (B2B), “white-label” solution that serves market leaders’ needs for authentication, supply chain integrity and quality assurance.

 

B.On March 7, 2023 the business combination (the “Business Combination”) with Lionheart III Corp (“Lionheart”) was completed, following that a newly-formed parent company – SMX (Security Matters) Public Limited Company (“SMX PLC”), (formerly called Empatan Public Limited Company) is listed in the NASDAQ stock exchange under the ticker SMX.

 

On July 26, 2022, the Company and Lionheart, a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (“BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders receiving SMX PLC Shares and warrants in exchange for their existing Lionheart shares and warrants and all shares in the Company being cancelled in return for SMX PLC shares and resulting in the Company becoming a wholly owned subsidiary of SMX PLC.

 

The Business Combination resulted in 97.58% redemption and with 3,061 remaining funds in the trust account. The transaction cost amounted to 17,300.

 

C.During the 12 months ended December 31, 2022, the Company incurred operating losses and negative cash flows from operating activities. The Company has not yet generated significant revenues. As discussed in Note 12, during the fourth quarter of 2022 the Company entered into binding loan agreements with existing shareholders. As discussed in Note 24 (4), the Company executed an equity line agreement. The Company has also the ability to decrease its expenses in order to meet its existing cash flow streams. Management believes that the proceeds from the recent funding agreements, combined with its cash on hand, equity line and the Company’s plans, are sufficient to meet the Company’s obligations as they come due in the foreseeable future. There are no assurances, however, that the Company will be able to obtain an adequate level of financial resources that are required for its long-term business plan.

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES:

 

The significant accounting policies followed in the preparation of the financial statements, on a consistent basis, are:

 

Basis of preparation

 

These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). The financial statements have been prepared under the historical cost convention except for certain financial liabilities which are measured at fair value until conversion. The Company has elected to present the statement of comprehensive income using the function of expense method.

 

Principles of consolidation

 

The consolidated financial statements incorporate the assets and liabilities of all subsidiaries of Security Matters Limited as of December 31, 2022 and 2021 and the results of all subsidiaries for the three years in the period then ended. Security Matters Limited and its subsidiaries together are referred to in these financial statements as the Group or the “consolidated entity”.

 

Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is obtained by the Company and until the date that control is lost.

 

Intercompany transactions between entities in the consolidated entity are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of the impairment of the asset transferred.

 

Accounting Estimates and Assumptions

 

The preparation of the consolidated financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities and expenses. These estimates and underlying assumptions are reviewed regularly. Changes in accounting estimates are reported in the period of the change in estimate. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements, are disclosed in note 3.

 

Cash and cash equivalents

 

Cash equivalents are considered by the Group to be highly liquid investments, including, inter alia, short-term deposits with banks and the maturity of which do not exceed three months at the time of deposit, and which are not restricted.

 

F-10
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Foreign currency

 

The consolidated financial statements are prepared in US Dollars which is the presentation currency of the Group. Security Matters Limited’s functional currency is Australian Dollars.

 

The functional currency of Security Matters Ltd. (Israel) is New Israeli Shekels. The functional currency of Security Matters Canada Ltd. Is Canadian Dollars. The functional currency of Security Matters France Ltd. Is Euro. The functional currency of SMX Beverages Pty Ltd. Is Australian Dollars.

 

Transactions and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting Standard (IAS) 21 (“The Effects of Changes in Foreign Exchange Rates”). Accordingly, transactions and balances have been converted as follows:

 

Assets and liabilities – at the rate of exchange applicable at the reporting date;
Expense items – at annual average rate at the statements of financial position date.
Share capital, capital reserve and other capital movement items were at rate of exchange as of the date of recognition of those items.
Accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned above.
Exchange gains and losses from the aforementioned conversion are recognized in the statement of other comprehensive lose in Foreign Currency Translation Reserve.

 

Investments in associated companies

 

Investments in associated companies are accounted under the equity method and are initially recognized at cost. The investment’s cost includes transaction costs. The consolidated financial statements include the Group’s share in net income or loss, in other comprehensive income or loss, and in the net assets of associated companies accounted by the equity method from the date when significant influence or joint control materialized, until the date on which the conditions for significant influence or joint control are no longer met.

 

Losses of an associate in amounts which exceed its equity are recognized by the Company to the extent of its investment in the associate plus any losses that the Company may incur as a result of a guarantee or other financial support provided in respect of the associate.

 

Loss per share

 

Basic loss per share

 

Basic loss per share is calculated by dividing the net loss attributable to the owners of Security Matters Limited, by the weighted average number of ordinary shares outstanding during the financial year, adjusted for bonus elements in ordinary shares issued during the financial year.

 

Diluted earnings per share

 

Potential ordinary shares are included in the computation of diluted earnings per share when their conversion decreases earnings per share. Potential Ordinary shares that are converted during the period are included in diluted earnings per share only until the conversion date and from that date in basic earnings per share.

 

Governmental grants

 

Government grants received for the use of research and development activities, for which the Group undertook to pay royalties to the state, contingent on future sales arising from this financing, were treated as forgivable loans. The grant was recognized as a liability in the financial statements, except when there is reasonable assurance that the Group will comply with the conditions for the forgiveness of the loan, then it would be recognized as a government grant. When the loan bears a below-market rate of interest, the liability is recognized at its fair value in accordance with the market interest rate prevailing at the time of receiving the grant. The difference between the consideration received and the liability recognized at inception was treated as a government grant and recognized as a reimbursement of research expenses. The repayment of the liability to the state is reviewed every reporting period, with changes in the liability resulting from a change in the expected royalties recognized in profit or loss.

 

F-11
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Fair value measurement

 

Fair value is the price that would be received when selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:

 

A.In the principal market for the asset or liability; or
B.In the absence of a principal market, in the most advantageous market for the asset or liability.

 

The principal or the most advantageous market must be accessible to the Group.

 

The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.

 

A fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.

 

The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.

 

Classification of financial instruments by fair value hierarchy

 

The financial instruments presented in the statements of financial position at fair value are grouped into classes with similar characteristics using the following fair value hierarchy which is determined based on the source of input used in measuring fair value:

 

  Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities.
  Level 2 - Inputs other than quoted prices included within Level 1 that are observable either directly or indirectly.
  Level 3 - Inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).

 

Financial assets

 

The Group classifies its financial assets into one of the following categories, depending on the purpose for which the asset was acquired. The Group’s accounting policy for each category is as follows:

 

Other receivables: These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They arise principally through the provision of goods and services, but also incorporate other types of contractual monetary asset. These assets are carried at amortized cost less any provision for impairment.

 

The Group has no financial assets classified at Fair value through profit or loss.

 

Financial liabilities

 

financial liabilities measured at amortized cost:

 

Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.

 

After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, which ensures that any interest expense over the period is at a constant interest rate on the balance of the liability carried in the statement of financial position, except for

 

measured at fair value through profit or loss:

 

These financial liabilities comprise of derivatives that are options which are to be settled in equity instruments but nevertheless do not meet the definitions of equity instrument. At initial recognition, the Group measures those financial liabilities at fair value. Transaction costs are recognized in profit or loss. After initial recognition, changes in fair value are recognized in profit or loss.

 

F-12
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Impairment of financial assets

 

The Group recognizes a loss allowance for expected credit losses on financial assets which are either measured at amortized cost or fair value through other comprehensive income. The measurement of the loss allowance depends upon the Group’s assessment at the end of each reporting period as to whether the financial instrument’s credit risk has increased significantly since initial recognition, based on reasonable and supportable information that is available, without undue cost or effort to obtain.

 

Where there has not been a significant increase in exposure to credit risk since initial recognition, a 12-month expected credit loss allowance is estimated. This represents a portion of the asset’s lifetime expected credit losses that is attributable to a default event that is possible within the next 12 months. Where a financial asset has become credit impaired or where it is determined that credit risk has increased significantly, the loss allowance is based on the asset’s lifetime expected credit losses. The amount of expected credit loss recognized is measured on the basis of the probability weighted present value of anticipated cash shortfalls over the life of the instrument discounted at the original effective interest rate. The loss allowance is recognized in profit or loss.

 

Impairment of non-financial assets

 

Intangible assets that have an indefinite useful life are not subject to amortization and are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired. Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount. Recoverable amount is the higher of an asset’s fair value less costs of disposal and value-in-use. The value-in-use is the present value of the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.

 

Property, plant and equipment

 

Items of property, plant and equipment are initially recognized at cost. Cost includes directly attributable costs and the estimated present value of any future costs of dismantling and removing items. Depreciation is computed by the straight-line method, based on the estimated useful lives of the assets, as follows:

 

   % 
Computers   33 
Machines and equipment   20 
Furniture and office equipment   10 
Leasehold improvements   5 

 

Leasehold improvements are depreciated over the term of the expected lease including optional extension, or the estimated useful lives of the improvements, whichever is shorter.

 

Reimbursement of research and development expenses

 

Reimbursements in proof of concept (POC) agreements of expenditures on research and development in order to achieve commercial agreement once this activity will be result successful, are offset in profit or loss against the related expenses (research and development expenses). Any IP generated from this activity remains at the ownership of the Group.

 

F-13
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Right-of-use assets

 

All leases are accounted for by recognizing a right-of-use asset and a lease liability, excluding leases where the lease term is 12 months or less, or where the underlying asset is of low-value. These leases expenditures are recognized on a straight-line basis over the lease term.

 

A right-of-use asset is recognized at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of any lease incentives received.

 

Right-of-use assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever is the shorter. Where the Group expects to obtain ownership of the leased asset at the end of the lease term, the depreciation is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.

 

Lease liabilities

 

All leases are accounted for by recognizing a right-of-use asset and a lease liability. Lease liabilities are measured at the present value of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the rate implicit in the lease unless (as is typically the case) this is not readily determinable, in which case the Group’s incremental borrowing rate on commencement of the lease is used. Variable lease payments are only included in the measurement of the lease liability if they depend on an index or rate. In such cases, the initial measurement of the lease liability assumes the variable element will remain unchanged throughout the lease term. Other variable lease payments are expensed in the period to which they relate.

 

On initial recognition, the carrying value of the lease liability also includes:

 

  amounts expected to be payable under any residual value guarantee.
  the exercise price of any purchase option granted in favor of the Group if it is reasonably certain to exercise that option.
  any penalties payable for terminating the lease, if the term of the lease has been estimated on the basis of termination option being exercised.

 

Subsequent to initial measurement lease liabilities increase as a result of interest charged at a constant rate on the balance outstanding and are reduced for lease payments made. Lease liabilities are remeasured when there is a change in future lease payments arising from a change in an index or rate or when there is a change in the assessment of the term of any lease the remeasurement being recognized in front of the right of use assets.

 

Employee benefits

 

The Group has several employee benefit plans as to Israeli employees:

 

1.Short-term employee benefits: Short-term employee benefits include salaries, paid annual leave, paid sick leave, recreation and social security contributions and are recognized as expenses as the services are rendered. A liability in respect of a cash bonus or a profit-sharing plan is recognized when the Group has a legal or constructive obligation to make such payment as a result of past service rendered by an employee and a reliable estimate of the amount can be made.
2.Post-employment benefits: The plans are normally financed by contributions to insurance companies and classified as defined contribution plans or as defined benefit plans. The Group has defined for most of its employees contribution plans pursuant to Section 14 to the Israel Severance Pay Law since 2004 under which the Group pays fixed contributions and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient amounts to pay all employee benefits relating to employee service in the current and prior periods.

 

Contributions to the defined contribution plan in respect of severance or retirement pay are recognized as an expense simultaneously with receiving the employee’s services and no additional provision is required in the financial statements except for the unpaid contribution.

 

F-14
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Intangible assets

 

Intangible assets include capitalized technology development costs. Expenditures on research activities are recognized in profit or loss as incurred. Expenditures on internally developed products are mainly employee salaries and legal fees for filing of patents and are capitalized when the Group demonstrates all the following criteria:

 

  a. The technical feasibility of completing the intangible asset so that it will be available for use or sale.
  b. The intention to complete the intangible asset and use or sell it.
  c. The ability to use or sell the intangible asset.
  d. The probability of the intangible asset to generate future economic benefits. Among other things, the Group considers the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset.
  e. The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.
  f. The ability to measure reliably the expenditures attributable to the intangible asset during its development.

 

The recognition criteria above are considered by the Group at each stage of development to determine when the criteria have been initially met in full.

 

The technical feasibility criteria is determined to be met when the milestone of initial marking and reading capabilities is satisfied. The milestone’s identification occurs only following a detailed broad mapping of the raw material characteristics and establishing the formula for the chemical marker architecture to be embedded into the raw material based on industry standards and regulations. The result is the initial evidence that the x-ray algorithm of the designated reader is in a stage that can identify the marker and convey information. At this stage, the Group believes that the technical feasibility of completing the development for use is probable.

 

The Group notes that technical feasibility has been established and the achieved technology is ready for the next stage which consists of performing a proof-of-concept pilot with an industry partner, in order to adapt the technology for the relevant industry and adjust the development to meet the industry’s needs.

 

Currently, the Group’s capitalized development activities focus on:

 

  1. Development of marker architecture to be embedded topically or in-situ (application) for each material/product within the optimal industrial manufacturing phase, based on industry standards and regulations.
  2. Semi Industrial scale – technology implementation in semi-industrial production.
  3. Development of a digital platform to support the end-to-end traceability from raw material to final product to recycling.

 

The Group’s management has the full intention to complete the development of the technology and ultimately to sell it. This intention is demonstrated by initiating partnerships with industry market leaders and continuing the development into the next phase. The Group’s intention is also reflected in the Group’s approved budget.

 

The Group’s management intends to concentrate its future sales and marketing efforts in the U.S. market, including recruitment of sales and marketing personnel. It plans to advance successful proof-of-concept pilots performed with industry leading partners, and further advance its innovative technology and commercialization efforts and collaborations in the segments relevant to its technology.

 

The Group’s business model targets leading brands and manufacturers in order to create a new market standard for circular economy solutions, brand authentication and supply chain integrity. The Group’s technology is applicable for multiple industries such as gold, fashion, electronics and circular economy – plastic and rubber. The Group is able to provide an adaptive solution for multiple market segments, based on a unified technology solution, through collaborative relationships with leading market companies which provide it with access to various potential entities to sell its solution. This is part of the Group’s strategy to create strategic partnerships with market leaders across its main segments of activity. The Group believes that this close collaboration with market leaders, and developing a product that meets their requests, suggest that there is a strong potential market for its development.

 

F-15
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Intangible assets (Cont.)

 

Adequate technical and financial resources are available to complete the development; the development will be completed by the Group’s technology team which consists of professional experienced scientists and engineers, with a track record in the industrial sector and with financial resources successfully raised through the issuance of ordinary shares and loans. The Group has already accomplished its core technology development and is currently focused on development of specific adjustments for different market segments. This stage is focused and short-termed, therefore, management believes that limited financial resources are required for completing the development and that there is high probability for commencing commercial agreements following the successful proof-of-concept pilots.

 

The Group has financial systems in place that allow it to maintain records in sufficient detail that enable it to measure reliably the expenditures attributable to the intangible asset during its development.

 

Development expenditures not satisfying all the above criteria are recognized in the consolidated statement of comprehensive income as incurred.

 

Subsequent measurement

 

In subsequent periods, capitalized development expenditures are measured at cost less accumulated amortization and accumulated impairment losses.

 

An asset is ready for its intended use, when the developed technology becomes operational and the Group completes an initial customization for a client’s specific needs, which means that the technology is fully implemented in the customer’s manufacturing processes and ready for its intended use. The management estimates that in approximately two years such customization will be completed, and amortization will commence.

 

Intangible assets with a finite useful life are amortized over their estimated useful lives and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for intangible assets are reviewed at least at each year end.

 

The carrying amount of these assets is reviewed whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. An expenditure incurred in development activities, including the Group’s software development is capitalized only where it clearly increases the economic benefits to be derived from the asset to which it relates, the expenditure will lead to new or substantially improved products, the products are technically and commercially feasible and the Group has sufficient resources to complete the development and reach the stage for which the product is ready for use.

 

All other expenditure, including those incurred in order to maintain an intangible assets current level of performance, is expensed as incurred.

 

Share-based compensation

 

The Group measures the share-based expense and the cost of equity-settled transactions with employees and service providers by reference to the fair value of the equity instruments at the date at which they are granted. The Group selected the Black-Scholes model as the Group’s option pricing model to estimate the fair value of the Group’s options awards. The model is based on share price, grant date and on assumptions regarding expected volatility, expected life of the options, expected dividend, and a no risk interest rate. As for granted options which are settled in equity instruments, the fair value of the options at the grant date is charged to the statement of comprehensive loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting period is based on the number of options that eventually vest.

 

New standards, interpretations and amendments not yet effective

 

The Group has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective. There are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future accounting periods that the Group has decided not to adopt early.

 

The following amendments are effective for the period beginning January 1, 2023:

 

Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2);
Definition of Accounting Estimates (Amendments to IAS 8); and
Deferred Tax Related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12).

 

The following amendments are effective for the period beginning January 1, 2024:

 

IFRS 16 Leases (Amendment – Liability in a Sale and Leaseback)
IAS 1 Presentation of Financial Statements (Amendment – Classification of Liabilities as Current or Non-current)
IAS 1 Presentation of Financial Statements (Amendment – Non-current Liabilities with Covenants)

 

The Group is currently assessing the impact of these new accounting standards and amendments.

 

The Group does not expect any other standards issued by the IASB, but not yet effective, to have a material impact on the Group.

 

F-16
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 3 – CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS:

 

In the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant effect on the amounts recognized in the financial statements.

 

The preparation of the financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities, revenues and expenses. Changes in accounting estimates are reported in the period of the change in estimate. The key assumptions made in the financial statements are discussed below.

 

Share based payments

 

The Group has a share-based remuneration scheme for employees. The fair value of share options is estimated by using the Black-Scholes model, which was derived to model the value of the firm’s equity over time. The simulation model was designed to take into account the unique terms and conditions of the performance shares and share options, as well as the capital structure of the firm and the volatility of its assets, on the date of grant based on certain assumptions. Those conditions are described in the share-based compensation note and include, among others, the dividend growth rate, expected share price volatility and expected life of the options. The fair value of the equity settled options granted is charged to statement of profit or loss over the vesting period of each tranche and the credit is taken to equity, based on the consolidated entity’s estimate of shares that will eventually vest.

 

Intangible assets

 

The Group capitalizes costs for its developed projects when specific criteria are met. Initial capitalization of costs is based on management’s judgement that technological and economic feasibility is achievable, usually when a product development project has reached a defined milestone according to an established project management model. The management makes assumptions regarding the expected future economic benefit to be derived from the intangible asset and therefore whether the capitalized costs are expected to be recovered.

 

This amount of capitalized costs includes significant investment in the development of marking and reading capabilities in the subject material. Prior to being marketed, the Group will obtain a proof-of-concept pilot with an industry leading partner. The innovative nature of the product gives rise to some judgement as to whether the proof-of-concept will be successful such that it will lead to obtaining commercial contracts with customers. See also Note 2 – Intangible Assets.

 

The Management bases its estimates on historical experience, assumptions, and information currently available and deemed to be reasonable at the time the financial statements are prepared. However, actual amounts may differ from the estimated amounts as more detailed information becomes available. Estimates and assumptions are reviewed on an ongoing basis and, if necessary, changes are recognized in the period in which the estimate is revised.

 

Financial liability at fair value

 

The fair value of financial liabilities at fair value was estimated by using a Black Scholes model and Monte-Carlo simulation approach, which was aimed to model the value of the Company’s assets over time. The simulation approach was designed to take into account the terms and conditions financial liability, which are described in Note 12 and Note 23, as well as the capital structure of the Company and the volatility of its assets. The valuation was performed based on management’s assumptions and projections.

 

NOTE 4 – OTHER CURRENT ASSETS:

 

  

December 31,

2022

  

December 31,

2021

 
Prepaid expenses (*)   3,157    454 
Tax authorities   358    280 
Proof of concept receivables   86    116 
Other   72    70 
Total   3,673    920 

 

*The prepaid expenses include 3,123 for December 31, 2022, which related to the anticipated SPAC transaction costs (refer to Note 1).

 

F-17
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 5 – PROPERTY AND EQUIPMENT, NET:

 

   Leasehold improvements   Machines and Equipment   Furniture and Office Equipment   Computers   Right of use assets   Total 
                         
Cost                              
At January 1, 2022   81    1,233    83    99    628    2,124 
Additions   -    135    -    17    49    201 
Deductions                       (21)   (21)
Depreciation   4    202    7    19    39    271 
Currency translation adjustments   (18)   (221)   (18)   (14)   (64)   (335)
At December 31, 2022   63    1,147    65    102    592    1,969 
Accumulated depreciation                              
At January 1, 2022   20    645    33    72    162    932 
Depreciation   4    202    7    19    39    271 
Currency translation adjustments   (6)   (148)   (9)   (17)   (23)   (203)
At December 31, 2022   18    699    31    74    178    1,000 
Net book value at December 31, 2022   45    448    34    28    414    969 

 

   Leasehold improvements   Machines and Equipment   Furniture and Office Equipment   Computers   Right of use assets   Total 
     
Cost                              
At January 1, 2021   69    847    73    72    606    1,667 
Additions   3    275    1    18    -    297 
Depreciation   5    187    7    16    72    287 
Currency translation adjustments   9    111    9    9    22    160 
At December 31, 2021   81    1,233    83    99    628    2,124 
Accumulated depreciation                              
At January 1, 2021   13    399    23    49    85    

569

 
Depreciation   5    187    7    16    72    287 
Currency translation adjustments   2    59    3    7    5    76 
At December 31, 2021   20    645    33    72    162    932 
Net book value at December 31, 2021   61    588    50    27    466    1,192 

 

F-18
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 6 – CONVERTIBLE NOTE:

CONVERTIBLE NOTES

 

In May 2022, the Company issued 828,240 convertible notes (the “Convertible Notes”), with a face value of AUD 1 (USD 0.7) per each Convertible Note, for an aggregate amount of AUD 828 thousand (569). The Convertible Notes have a maturity date of six months from issuance date. The conversion price is as follows: (i) if the Company executes a binding agreement for an M&A transaction or receives USD $20 million or more in return for the issuance of shares on or before December 31, 2022, the principal amount of each Convertible Note will automatically be converted into shares in the Company. The issuance price per share will be calculated at a 20% discount to the higher of the offer price or price paid by the investors participating in the qualified transaction, as such term is defined in the Convertible Notes agreement, subject to a floor cap of no lower than AUD 0.15 (USD 0.11) per share. In July 2022, the Company entered into a Business Combination Agreement that will be subject to de-listing of the Company’s ordinary share capital from the Australian Stock Exchange following receiving an Australian court approval of the future merger (ii) if the Company has not executed a binding agreement for a qualified transaction until December 31, 2022, the Convertible Notes balance will automatically convert into ordinary shares at that date. The issuance price per share will be calculated at a 20% discount to the 5-21 day volume weighted average price to December 31, 2022, as such term is defined in the Convertible Notes agreement, subject to a cap of no lower than AUD 0.15 (USD 0.11) per share, and on December 31, 2022 the investors will also be issued unlisted two year options on a 1:2 basis with an exercise price of AUD 0.45 (USD 0.32) per share. As of December 31, 2022, the Convertible Note amounted to 563.

 

In July 2022, an amendment to the Convertible Notes agreements was signed between the Company and the investors which prescribes a cancellation of the Convertible Notes and replacing them with the issuance of 1,000,000 ordinary shares of the Company (with the occurrence of the Business Combination).

 

On March 7, 2023, the Convertible Notes were converted to 1,000,000 ordinary shares of the Company.

 

NOTE 7 – INVESTMENTS IN ASSOCIATED COMPANIES:

 

 SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES

Entity  

Country of

Incorporation

 

Percentage Owned

December 31, 2022

 

Percentage Owned

December 31, 2021

Yahaloma Technologies Inc.   Canada   50%   50%
True Gold Consortium Pty Ltd   Australia   44.4%   45.5%
SMX Beverages Pty Ltd   Australia   100%   50%

 

The proportion of ownership interest is equal to the proportion of voting power held.

 

F-19
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 7 – INVESTMENTS IN ASSOCIATED COMPANIES (CONT.):

 

Yahaloma Technologies Inc.

 

On April 30, 2019, Security Matters Ltd. Signed an agreement with Trifecta Industries Inc. (“Trifecta”) for the commercialization of Security Matters Ltd.’s trace technology in the diamonds and precious stone industry.

 

Under the terms of the agreement, Security Matters Ltd. And Trifecta established a new entity – Yahaloma Technologies Inc. (“Yahaloma”), which is equally held by Security Matters Limited and Trifecta.

 

Yahaloma will have the exclusive rights and responsibility to commercialize the Group’s intellectual property in the area of diamonds or precious stone. Management has assessed the transaction and reached the conclusion that the new entity is jointly controlled by Security Matters Limited and Trifecta. Management has further determined that the contractual arrangement provides the parties to the joint arrangement with rights to the net assets of the arrangement. The contractual arrangement establishes each party’s share in the profit or loss relating to the activities of the arrangement. The arrangement is a joint venture and the Company’s interests in this joint venture is accounted for using the equity method of accounting.

 

SMX Beverages Pty Ltd

 

On February 10, 2020, the Company signed an agreement with Global BevCo Pty Ltd. (“Global BevCo”), an Australian company for the commercialization of Group’s trace technology in the alcoholic beverages industry. Under the terms of the agreement, the Company and Global BevCo established a new private entity, SMX Beverages Pty Ltd (“SMX-B”), which is equally held by the above two-mentioned entities. The Company has the exclusive rights and responsibility to commercialize the Group’s intellectual property in the area of alcoholic beverages.

 

The joint arrangement is a joint venture and the Company’s interests in its associate is accounted for using the equity method of accounting.

 

On December 24, 2021, the Company signed an agreement with Global BevCo to acquire the remaining 50% shares in SMX-B in exchange for 8,000,001 options of the Company at exercise price of AUD 0.4, with an expiration date of March 25, 2027. Total fair value is AUD 960,000 (USD 721,424), and the acquisition was settled on March 25, 2022. The Company assigned the consideration to technology license intellectual property. The total fair value of the options was determined according to Black & Scholes model, free rate interest of 2.5%, expected life 5 years. The acquisition agreement also provides a five-year consulting agreement to Global BevCo including AUD 13,500 per month and a 5% revenue share for referred clients.

 

True Gold Consortium Pty Ltd

 

On July 29, 2020, the Company signed a shareholders’ agreement with W.A. Mint Pty Ltd. And True Gold Consortium Pty Ltd. (“True Gold”). The purpose of the agreement is to set the framework for True Gold’s activity. True Gold’s goal is to establish an industry standard with the development of an innovative system that can mark (at a molecular level), track and trace gold bars and gold through every stage of the supply chain with blockchain technology. Under the terms of the agreement, True Gold will be equally held by the above two-mentioned entities, with the goal of adding other shareholders.

 

The Company’s management has assessed the transaction and reached the conclusion that the new entity is jointly controlled by Security Matters Limited, and W.A. Mint Pty Ltd. The Company’s management has further determined that the contractual arrangement provides the parties to the joint arrangement with rights to the net assets of the arrangement. The contractual arrangement establishes each party’s share in the profit or loss relating to the activities of the arrangement. The arrangement is a joint venture and the Company’s interests in this joint venture is accounted for using the equity method of accounting.

 

F-20
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 7 – INVESTMENTS IN ASSOCIATED COMPANIES (CONT.):

 

Reconciliation of the consolidated entity’s carrying amount

 

 SCHEDULE OF INFORMATION ABOUT CONSOLIDATED STRUCTURED ENTITIES

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
Security Matters Limited’s share of net assets   115    248    249 
Company’s share in net profits (losses) of associated companies   106    (101)   (1)
Closing carrying amount   221    147    248 

 

NOTE 8 – INTANGIBLE ASSETS, NET:

 

 SUMMARY OF INTANGIBLE ASSETS NET

                
  

Capitalization of

development cost

  

Purchased

license

   Total 
   US$ in thousands   US$ in thousands   US$ in thousands 
COST               
As of January 1, 2022   4,024    -    4,024 
Capitalized development cost   975    721    1,696 
Currency translation adjustments   (500)   (66)   (566)
As of December 31, 2022   4,499    655    5,154 
                
Accumulated amortization               
As of January 1, 2022   116    -    116 
Amortization   14    -    14 
Currency translation adjustments   (3)   -    (3)
As of December 31, 2022   127    -    127 
                
Net book value as of December 31, 2022   4,372    655    5,027 

 

F-21
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 8 – Intangible assets, NET (CONT.):

 

      
   Capitalization of development cost 
   US$ in thousands 
COST     
As of January 1, 2021   2,332 
Capitalized development cost   1,468 
Currency translation adjustments   224 
As of December 31, 2021   4,024 
      
Accumulated amortization     
As of January 1, 2021   88 
Amortization   28 
As of December 31, 2021   116 
      
Net book value as of December 31, 2021   3,908 

 

An intangible asset at the amount of 145 is being amortized, the amortization completed by December 31, 2022. The rest of the intangible asset balance has not yet been amortized.

 

Intangible assets as of December 31, 2022, consist of capitalized technology development costs of the Group’s core technology as well as the cost of the exclusive license intellectual property (721) which includes the addition amount as a result of the acquisition of additional 50% interest in SMX Beverages Pty Ltd (Note 7). The acquired rights have not yet commenced amortization as the license was not yet commenced usage.

 

NOTE 9 – LEASES:

 

The Group has lease contracts for office facilities (including a lab) and motor vehicles used in its operations. Leases of office and lab facilities generally have lease term of 12 years, motor vehicles generally have lease terms of 3 years.

 

Set out below are the carrying amounts of right-of-use assets recognized and the movements during the period:

 

 SCHEDULE OF RIGHT OF USE ASSETS

                
  

Office and lab

facilities

  

Motor

vehicles

  

Total

 
At January 1, 2022   446    20    466 
Additions   49        49 
Foreign currency translation   (35)   (6)   (41)
Deductions   (7)   (14)   (21)
Depreciation expense   (39)       (39)
As at December 31, 2022   414        414 

 

F-22
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 9 – LEASES (CONT.):

 

Set out below are the carrying amounts of lease liabilities and the movements during the period:

 

 SCHEDULE OF LEASE LIABILITY

           
  

December 31,

2022

  

December 31,

2021

 
At January 1,   503    589 
Additions   49     
Deductions   (21)    
Accretion of interest   51    47 
Foreign exchange differences   (57)   (35)
Lease Payments   (55)   (98)
As at December 31,   470    503 
           
Current   30    37 
Non-current   440    466 

 

The following are the amounts recognized in profit or loss:

 

 SCHEDULE OF CARRYING AMOUNTS OF LEASE LIABILITIES RECOGNIZED IN PROFIT OR LOSS

           
  

December 31,

2022

  

December 31,

2021

 
Depreciation expense of right-of-use assets   39    72 
Interest expense on lease liabilities   51    47 
Foreign Exchange different   16    (35)
Expense relating to short-term leases   -    - 
Total amount recognized in profit or loss   106    84 

 

NOTE 10 – OTHER PAYABLES:

 

 SCHEDULE OF OTHER PAYABLES

           
  

December 31,

2022

  

December 31,

2021

 
         
Employees, salaries and related liabilities   392    500 
Related party   56    24 
Liabilities for grants received (Note 19)   50    30 
Accrued expenses       49 
Derivative financial liability (Note 13)       32 
Other   152    38 
Total   650    673 

 

F-23
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 11 BORROWINGS FROM RELATED PARTIES:

 

In 2015, the Group signed an agreement to receive a loan of ILS 2 million (approximately 513) from its shareholders.

 

These loan bears interest at an annual rate of 4%.

 

  

December 31,

2022

  

December 31,

2021

 
Balance at January 1,   270    280 
Payment of borrowings   (172)   (103)
Provision for bonus (include interest)   621    89 
Exchange rate differences   (9)   4 
Balance at December 31,   710    270 

 

In consideration of providing funding as a seed capitalist, the Company agreed to provide, as additional consideration, a bonus payments (the “Bonus Payments”) on the occurrence of an exit or major liquidity event. In any way, the Bonus Payments are capped at ILS 3 million (approximately 965) per each of the two lenders.

 

The Bonus Payments are intended to operate in one of the two trigger events:

 

(i)dividend distributions paid by the Company; or

 

(ii)the sale of shares by a lender in Security Matters Ltd. (either in the event of a takeover or otherwise)

 

Only if the aggregate amounts of one of the two trigger events exceeds the investment of the lenders in the Company (in a way of loan or shares), then the lender would be entitled the Bonus Payments based on a formula set forth in the agreement.

 

The amount of the Bonus Payments is the amount that exceeds the aggregate sum invested in the Company (in a way of loan or shares) by the lender divided by several factors according to the formula as set forth in the agreement.

 

There is no time limit to pay the Bonus Payments. Once the Company has paid each Bonus Payment in its entirety (i.e., the cap of ILS 3 million has been paid to each Lender), then the Company has fulfilled its obligations. When the Bonus Payments are not expected to be made, the resulting cash flows will not affect profit and loss until the point in which the Company estimates that the liquidity events will take place. As of December 31, 2021, the Company estimated that is more likely than not that the shareholders will sell their shares in 2022 which will entitle them to the Bonus Payments. The amount of the Bonus Payment is subject to assumptions that were made with the assistance of external appraisal. As a result, the increase in the carrying amount of the liability was charged as expense of $87 to profit and loss in 2021. In August 2022 the loan from related party has been fully repaid. In August 2022, the Company signed an addendum to the loan agreement that reduces the total amount of the Bonus Payments to ILS 2.5 million (approximately $710), to be paid upon the completion of the business combination (refer also to Note 24 – Subsequent Events). As of December 31, 2022, the Company estimated that is more likely than not that the business combination will be completed in the foreseeable future, as a result, the Company updated the liability according to the addendum which described above, the carrying amount of the liability was increased to $710 and charged as expense of $621 to profit and loss in 2022.

 

NOTE 12 – BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY:

 

Between August to December 2022, the Company entered into bridge loan agreements (the “Bridge Loans”) with seven lenders, which lent the Company an aggregate amount of 3,310. The Bridge Loans have a maturity date of up to two years and bears interest rate of 10% per annum. The Bridge Loans were accounted for in accordance with amortized cost method.

 

F-24
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 12 – BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (CONT.):

 

As part of the Bridge Loans agreements, the lenders were granted with three types of warrants:

 

(i)Bonus Warrants – 215,500 warrants to purchase ordinary shares of SMX PLC (refer to Note 1) at an exercise price of USD 11.50 per share. The Bonus Warrants term is five years commencing upon the Business Combination (refer to Note 1).

 

Management utilized a third-party appraiser to assist them in valuing the Bonus Warrants. The fair value of the Bonus Warrants was calculated using the Black and Scholes model. As of December 31, 2022, the fair value of the Bonus Warrants was 24.

 

(ii)Redeemable Warrants Type 1 – 342,000 warrants to purchase ordinary shares of SMX PLC (refer to Note 1) at a purchase price of USD 11.50 per share. The Redeemable Warrants Type 1 term is five years commencing upon the Business Combination (refer to Note 1).

 

50.00% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the Business Combination for USD 5.00 per warrant.
25.00% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder for the 30 days following the third anniversary of the Business Combination for USD 5.00 per warrant.
25.00% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder for the 30 days following the fourth anniversary of the Business Combination for USD 5.00 per warrant.

 

Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of SMX PLC based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary.

 

Management utilized a third-party appraiser to assist them in valuing the Redeemable Warrants Type 1. The fair value of the Redeemable Warrants Type 1 was calculated using Monte-Carlo simulation model. As of December 31, 2022, the fair value of the Redeemable Warrants Type 1 was 1,973.

 

(iii)Redeemable Warrants Type 2 – 120,000 warrants to purchase ordinary shares of SMX PLC (refer to Note 1) at a purchase price of USD 11.50 per share. The Redeemable Warrants Type 2 term is five years commencing upon the Business Combination (refer to Note 1).

 

50.00% of the Redeemable Warrants Type 2 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the first anniversary of the Business Combination for USD 5.00 per warrant.
50.00% of the Redeemable Warrants Type 2 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the second anniversary of the Business Combination for USD 5.00 per warrant.

 

Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of SMX PLC based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary.

 

Management utilized a third-party appraiser to assist them in valuing the Redeemable Warrants Type 2. The fair value of the Redeemable Warrants Type 2 was calculated using Monte-Carlo simulation model. As of December 31, 2022, the fair value of the Redeemable Warrants Type 1 was 696.

 

The main assumptions used in the three valuation models described above were: (1) risk free rate 3.99%; (2) volatility of assets 81.03%; and (3) excepted terms of the warrants -5.18 years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.

 

In the event that the Business Combination shall not be consummated, the Bonus Warrants and the Redeemable Warrants type 1 and 2 shall be exchanged for such number of warrants for the Company’s ordinary shares.

 

F-25
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 13 – SHAREHOLDERS’ EQUITY

 

A.The ordinary shares in the Company confer upon their holders the right to receive notice to participate and vote in general meetings of the Company, and the right to receive dividends, if and when declared.

 SCHEDULE OF ORDINARY SHARES

    Number of shares 
    December 31, 2022   December 31, 2021 
    Authorized  

Issued and

outstanding

   Authorized  

Issued and

outstanding

 
Ordinary shares    167,854,581    167,854,581    165,532,264    165,532,264 

 

Ordinary shares

 

Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have no par value and the company does not have a limited amount of authorised capital.

 

B.Increase in issued share capital:

 

1)In August 2022, the Company raised capital, in consideration of an aggregate of 254 net proceeds. An amount of 22 capital raise fee was paid in cash to the financial advisor. The Company issued 2,000,000 shares.

 

2)In October 2021, the Company raised capital, in consideration of an aggregate of 1,890 net proceeds. An amount of 115 capital raise fee was paid in cash to the financial advisor. The Company issued 8,938,666 shares and 4,469,333 warrants. The terms of the warrants specify that each warrant has an exercise price of AUD 0.4 and expires in March 2022. Upon exercise the holder would receive one ordinary share and another unlisted warrant that bears an exercise price of AUD 0.7, converted to one ordinary share and expired on January 20, 2023. The warrants were considered to be a derivative financial liability and measured at fair value. The fair value of the warrant derivative is not material.

 

3)In May 2021, the Company issued 15,270,249 shares in consideration of an aggregate of 4,034 net proceeds.

 

4)During 2021, 1,774,744 warrants were exercised to 1,774,744 ordinary shares, for aggregate net proceeds of 395.

 

F-26
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 13 – SHAREHOLDERS’ EQUITY (CONT.):

 

C.Options granted to employees and service providers:

 

1)In June 2018, the Company has adopted a Share Option Plan (the “Plan”) to provide an incentive to retain, in the employment or service or directorship of the Company and provide the ability to attract new employees, directors or consultants whose services are considered valuable. The persons eligible to participate in the Share Option Plan include employees, directors and consultants of the Company or any subsidiary of the Company.

 

2)A summary of the status of the Company’s Share Option Plan granted to employees (including performance-based awards) and changes during the relevant period ended on that date is presented below:

 

 SCHEDULE OF SHARE OPTION GRANTED

  

Year ended

December 31, 2022

  

Year ended

December 31, 2021

 
  

Number

of options (in thousands)

  

Weighted average

Exercise price (AUD)

  

Number

of options

(in thousands)

  

Weighted average

Exercise price (AUD)

 
Outstanding at beginning of year   11,280    0.27    9,530    0.23 
Issue of options   1,000    0.27    1,850    0.45 
Expired   (7,600)   0.22    (100)   0.34 
                     
Outstanding at end of year   4,680    0.35    11,280    0.27 
Exercisable options   2,835    0.28    4,318    0.27 

 

The options to employees outstanding as of December 31, 2022, are comprised, as follows:

 

 SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING

Exercise price (AUD) 

Outstanding

as of

December 31, 2022

  

Weighted average remaining

contractual term

  

Exercisable

as of

December 31, 2022

  

Weighted average remaining

contractual term

 
       (years)       (years) 
0.12-0.2   800   4.59    400    4.64 
0.2   955   0.67    878    0.67 
0.31-0.357   2075   2.56    1432    2.15 
0.6   100   2.24    100    2.24 
0.7   750   3.97    25    3.74 
    4,680        2,835      

 

1.In 2022, the Company granted 600,000 options to employees and 1,600,000 options to consultants. These grants carry an exercise price of between AUD 0.03-0.14, vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years. The fair value at grant date is 154.

 

2.In 2021, the Company granted 250,000 options to employees and 5,400,000 options to consultants. These grants carry an exercise price of between AUD 0.35-0.70, vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years. The fair value at grant date is 622.

 

F-27
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 13 – SHAREHOLDERS’ EQUITY (CONT.):

 

D.Options granted to employees and service providers (cont.):

 

3.In 2020, the Company granted 1,055,000 options to employees, 750,000 options to consultants and 2,500,000 options to a board member. These grants carry an exercise price of between AUD 0.20-0.70, vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years. The fair value at grant date is 533.

 

4.The Company granted 322,317 shares in 2022 and 257,562 shares in 2021 to its Board members in lieu of cash remuneration. The fair value at grant date is 54 in 2022 and 53 in 2021.

 

5.The expenses for the options that were not recognized as of December 31, 2022, amount to 152.

 

6.The options issued in 2022 and 2021, were valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: 0.11-3.55%; (2) expected volatility: 64-118%: (3) expected term: up to 5 years; and (4) expected dividend yield: 0%.

 

E.Performance options:

 

1)In August 2018, two Executive Directors were granted 10,000,000 Performance Options with an exercise price of AUD 0.2, for which their remuneration will be dependent on the Company satisfying several commercial and technological milestones. These milestones are reviewed by the Board of Directors and need to be achieved in 4 years since the date it was granted. If the milestones are not reached in 4 years, the options will expire. As of December 31, 2022, the Company did not reach the milestones. The Performance Options were expired.

 

2)In August 2021, Executive Director was granted 167,000 options and a key management was granted 500,000 options based on a non-market condition for which if the Company raises an aggregated amount of at least 10 million in one raise (including by way of a merger with a company with such amount in its treasury) 80% of the options will become vested. If an amount of 20 million or more is raised in one raise all options will become vested. The exercise price is AUD 0.7 and the expiration date is December 6, 2026. The Company believes it is probable that the milestone will be reached. The fair value at grant date is 98.

 

3)In July 2021, several employees were granted 1,100,000 options based on a non-market condition for which the options shall vest upon meeting the following conditions: (1) Company raised an aggregated amount of at least 20 million (including by way of a merger with a company with such amount in its treasury) (2) 25% of the options shall vest after one year and thereafter 6.25% at the end of every three months (3) the employees must continue to provide services to Company. The exercise price is AUD 0.351 and the expiration date is by July – September 2026. The Company believes it is probable that the milestone will be reached. The fair value at grant date is 214.

 

4)In July 2022, several employees were granted 200,000 options based on a non-market condition for which the options shall vest upon meeting the following conditions: 25% on the first anniversary of the Vesting Commencement Date and additional 6.25% at the end of each three months of continuous services thereafter. However, if Company or a parent thereof commences trading on NASDAQ, all options shall become fully vested. The exercise price is AUD 0.7-0.8 and the expiration date is by July 2027. The options became fully vested on the consummation of the Business Combination in 2023. The fair value at grant date is 10.

 

F-28
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 13 – SHAREHOLDERS’ EQUITY (CONT.):

 

E. Performance options (cont.):

 

5)In June 2022, a key management was granted 200,000 options based on a non-market condition for which the options shall vest upon meeting the following conditions: The options will vest upon successful listing on NASDAQ/merger with SPAC. The exercise price is AUD 0.4 and the expiration date is by June 2027. The options became fully vested on the consummation of the Business Combination in 2023. The fair value at grant date is 5.

 

6)In May 2022, a consultant was granted 250,000 options based on a non-market condition for which if the options will vest upon successful IPO of the Company on NASDAQ. The exercise price is AUD 0.11 and the expiration date is May 26, 2027. The options became fully vested on the consummation of the Business Combination in 2023. The fair value at grant date is 19.

 

NOTE 14 – RESEARCH AND DEVELOPMENT EXPENSES, NET:

 

 SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
Salaries and related expenses   2,166    1,795    1,186 
Subcontractors and consultants   374    631    509 
Research expenses   316    252    155 
Depreciation and amortization   255    287    243 
Share based compensation   127    100    47 
Travel expenses   50    42    11 
Freight   30    23    33 
Other   6    -    53 
Reimbursement from paid pilots and proof of concept projects   (1,426)   (1,091)   (548)
Total   1,898    2,039    1,689 

 

NOTE 15 – GENERAL AND ADMINISTRATIVE EXPENSES:

 

 SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
Professional services   1,105    1,089    1,257 
Wages and salaries related   935    752    409 
Travel expenses   223    -    65 
Office and maintenance   145    116    120 
Share based compensation   137    331    436 
Insurance   60    102    101 
Depreciation and amortization   35    28    16 
Other   83    64    43 
Total   2,723    2,482    2,447 

 

F-29
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 16 – TAXES ON INCOME:

 

1.The Company is incorporated and domiciled in Australia where the applicable tax rate is 27.5%.
  
2.Theoretical tax:

 

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
Reconciliation of income tax at the statutory rate               
Loss before income tax   (6,184)   (4,939)   (4,573)
                
Theoretical tax rate of 27.5%   (1,701)   (1,358)   (1,257)
                
Tax effect amounts which are not deductible/(taxable) in calculating taxable income:               
Non-deductible expenditure and others   335    118    132 
Unrecognized temporary differences and tax losses for which deferred tax weren’t recognized   1,366    1,240    1,125 
Income tax / (benefit)            

 

3.As of December 31, 2022, the Group has estimated carry forward tax losses of approximately 24,106 (2021: 17,659 2020:13,151) which may be carried forward and offset against taxable income for an indefinite period in the future. The Group did not recognize deferred tax assets relating to carry forward losses in the financial statements because their utilization in the foreseeable future is not probable.

 

NOTE 17 – LOSS PER SHARE

 

 SCHEDULE OF LOSS PER SHARE

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
             
Net loss attributable to the owners of the company   (6,184)   (4,939)   (4,573)
                
Basic and diluted loss per share   (0.04)   (0.03)   (0.04)
Weighted average number of ordinary shares               
Weighted average number of ordinary shares used in calculating basic and diluted loss per share   167,855    151,850    125,960 

 

F-30
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 18 – RELATED PARTIES:

 

Key Management Personnel Compensation and other related party transactions and balances:

 

The key management personnel, among others includes board members, CEO and CFO.

 

The totals of remuneration paid to Key Management Personnel and related parties during the years are as follows:

 

 SCHEDULE OF KEY MANAGEMENT PERSONNEL

1. Transactions with related parties: 

December 31,

2022

  

December 31,

2021

 

Issuance of options to related party

 

721

   - 
Short-term salary and fees   508    475 
Loan repayment   172    103 
Share based payments   98    105 
Post-employment retirement benefits   94    92 
Payment for Administrative services   36    39 
Non-monetary benefits   29    11 
Proof of Concept projects paid by affiliated companies   (1,064)   (695)
   (594)   130 

 

2. Balance with related parties:    

December 31,

2022

  

December 31,

2021

 
Key management  Salary and related   (99)   (86)
Directors  Salary and related   (82)    (11)
Shareholders  Borrowings from related parties   (710)   (270)
Shareholders  Other accounts payable   (56)   (24)
Joint Ventures  Other receivables   59    74 
Joint Ventures  Investment in subsidiary   221    147 
       (667)   (170)

 

NOTE 19 – GOVERNMENT GRANTS

 

The Government of Israel encourages research and development projects oriented towards products for export or projects which will otherwise benefit the Israeli economy. This is conducted via the Israel Innovation Authority (IIA), which replaced the former Office of the Chief Scientist (OCS).

 

The Group has an approved project with the IIA under which it received a total of 162 in prior years.

 

The Group is subject to paying 3% of its relevant revenues until repayment of the entire grant. As of December 31, 2022, the Group paid an amount of 3.

 

The difference between the consideration received and the liability recognized at inception (present value) was treated as a government grant according to IAS 20 and recognized as a reimbursement of research expenses.

 

 SCHEDULE OF GOVERNMENT GRANTS

  

December 31,

2022

  

December 31,

2021

 
Short term liability at year end   50    30 
Long term liability at year end   85    85 
Total   135    115 

 

F-31
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 20 – CONTROLLED ENTITIES

 

The ultimate legal parent entity of the Group is Security Matters Limited, incorporated and domiciled in Australia. The consolidated financial statements incorporate the assets, liabilities and results of the following subsidiaries in accordance with the accounting policies described in Note 2.

 

Controlled entity 

Country of

Incorporation

  

Percentage Owned

December 31, 2022

  

Percentage Owned

December 31, 2021

 
Security Matters Ltd.   Israel    100%   100%
Security Matters Canada Ltd.   Canada    100%   100%
Security Matters France Ltd.   France    100%   100%
SMX Beverages Pty Ltd.   Australia    100%   50%

 

Security Matters Canada

 

Security Matters Canada was founded in March 2021 for commercializing the group’s activity in Canada. During the period Security Matters Canada has not yet started its operations.

 

Security Matters France

 

Security Matters France was founded in June 2021 for commercializing the group’s activity in EU. During the period Security Matters France has not yet started its operations.

 

SMX Beverages Pty Ltd

 

SMX Beverages Pty Ltd was founded in February 2020 as a joint venture for commercializing the group’s alcoholic beverages activity. Since March 2022, SMX Beverages Pty Ltd has been a wholly owned subsidiary (Note 7). During the period SMX Beverages Pty Ltd has not yet started its operations.

 

NOTE 21 – COMMITMENTS AND CONTINGENT LIABILITIES:

 

As part of the Board’s ongoing regulatory compliance process, the Board continues to monitor legal and regulatory developments and their potential impact on the Company. Management is not aware of any contingencies that may have a significant impact on the financial position of the Company.

 

1.In January 2015, the Company entered an agreement with Isorad Ltd. (a company wholly owned by the State of Israel with rights to exclusively commercialize the Soreq Research Center technology for civilian uses), according to which the Company was granted technological license in return for future royalties based on 2.2% of Gross sales by the Company and its affiliates and after 25 years the license becomes royalty-free. Upon the occurrence of an M&A event (as such event is defined in the agreement to include mergers, sale of all or substantially all the assets of ours and similar event), in the first M&A event, the Company is to pay a consideration equal to 1% of the amount received or transferred and in the second M&A event, a consideration equal to 2% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

On January 2023, the Company signed an amendment to the agreement that determine the following: (1) for the BCA with Lionheart, Isorad was issued (a) 864,000 options to purchase shares of the Company, the options were issued in January 2023 and valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: 3.42%; (2) expected volatility: 81.92%: (3) expected term: up to 3 years; and (4) expected dividend yield: 0%; (b) Additionally, Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of 27 million, or at the end of such 13 months, the earlier thereof). (2) Exit fee - in the occurrence of the first M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA with SPAC, the Company is to pay a cash amount equal to 1.5% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

F-32
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 21 – COMMITMENTS AND CONTINGENT LIABILITIES (CONT.):

 

2.The Group leases its offices and laboratory under an operating lease agreement, as well as two company cars which are all recognized within lease balances in the financial statements.

 

3.As Described in Note 11 borrowings from related parties, the Company is committed to pay a bonus payment upon achieving certain goals. The Bonus Payments were examined by an external valuator and based on management’s projections and insights it has estimated that the value of the Lender’s Bonus is estimated at the amount of 87 as of December 31, 2021. In August 2022, the Company signed an addendum to the loan agreement that reduces the maximum total amount of the Bonus Payments to ILS 2.5 million (approximately 710), to be paid upon the completion of the business combination. As of December 31, 2022, the bonus was recorded in the amount of 710.

 

4.As Described in Note 19 Government grants, the Company has a contingent liability of 166 (unpaid governance grant dependent on the Company’s future revenues) for the Israel Innovation Authority (IIA), which replaced the former Office of the Chief Scientist (OCS) for grants received to fund an approved research and development project.

 

NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT:

 

Financial risk management objectives

 

The Group’s activities expose it to a variety of financial risks: foreign currency risk, credit risk and liquidity risk. The Group’s overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the financial performance of the Group. The Group uses different methods to measure different types of risk to which it is exposed. These methods include sensitivity analysis in the case of interest rate, foreign exchange and other price risks, ageing analysis for credit risk and beta analysis in respect of investment portfolios to determine market risk.

 

Foreign currency risk

 

Currency risk is the risk that the value of financial instruments will fluctuate due to changes in foreign exchange rates. Currency risk arises when future commercial transactions and recognized assets and liabilities are denominated in a currency that is not the Group’s functional currency. The Group is exposed to foreign exchange risk arising from currency exposure primarily with respect to the USD and Euro. The Group’s policy is not to enter into any currency hedging transactions.

 

The carrying amounts of the Group foreign currency denominated monetary liability at the reporting date are as follows:

 

 SCHEDULE OF FOREIGN CURRENCY RISK

   Assets   Liabilities 
  

December 31,

2022

  

December 31,

2021

  

December 31,

2022

  

December 31,

2021

 
USD   1,214    481    (99)    
EUR   28    135    (73)    
    1,242    616    (172)    

 

F-33
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT.):

 

Sensitivity analysis

 

A 10% strengthening of the United States Dollar against the following currencies would have increased (decreased) equity and the income statement by the amounts shown below. This analysis assumes that all other variables, in particular interest rates, remain constant. For a 10% weakening of the United States Dollar against the relevant currency, there would be an equal and opposite impact on the profit and other equity.

 

  

December 31,

2022

  

December 31,

2021

 
Assets less liabilities   1,115    481 
    10%   10%
    112    48 

 

Price risk

 

The consolidated entity is not exposed to any significant price risk.

 

Interest rate risk

 

The consolidated entity is not exposed to any significant interest rate risk.

 

Credit risk

 

Credit risk arises when a failure by counterparties to discharge their obligations could reduce the amount of future cash inflows from financial assets on hand at the balance sheet date. The Group closely monitors the activities of its counterparties and controls the access to its intellectual property which enables it to ensure the prompt collection. The Group’s main financial assets are cash and cash equivalents as well as other receivables and represent the Group’s maximum exposure to credit risk in connection with its financial assets. Wherever possible and commercially practical, the Group holds cash with major financial institutions in Israel and Australia.

 

The carrying amount of financial assets represents the maximum credit exposure. The maximum exposure to credit risk at the reporting date was:

 

 SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE

  

December 31,

2022

  

December 31,

2021

 
Cash and cash equivalents   1,398    4,171 
Other receivables   158    920 
Total   1,556    5,091 

 

F-34
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT.):

 

Liquidity risk

 

Liquidity risk is the risk that arises when the maturity of assets and the maturity of liabilities do not match. An unmatched position potentially enhances profitability but can also increase the risk of loss. The Group has procedures to minimize such loss by maintaining sufficient cash and other highly liquid current assets and by having available an adequate amount of committed credit facilities. As of the balance sheet date, the Group has a positive working capital.

 

The following tables detail the Group’s remaining contractual maturity for its financial liabilities. The tables have been drawn up based on the undiscounted cash flows of financial liabilities based on the earliest date on which the Group can be required to pay.

 

 SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES

As of December 31, 2022 

Less than 1

year

   1-5 years   Over 5 years 
             
Financial liabilities at amortized cost               
Trade and other payables   3,622         
Bridge loans (Note 23)       989     
Government grants   75    84     
Lease liability   72    371    270 
Borrowings   710         
Total   4,479    1,444    270 

 

As of December 31, 2021 

Less than 1

year

   1-5 years   Over 5 years 
             
Financial liabilities at amortized cost               
Trade and other payables   1,589         
Lease liability   37    272    193 
Borrowings   270         
Total   1,896    272    193 


 

F-35
 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 23 – FAIR VALUE MEASUREMENT:

 

Fair value hierarchy

 

The following tables detail the consolidated entity’s assets and liabilities, measured or disclosed at fair value, using a three-level hierarchy, based on the lowest level of input that is significant to the entire fair value measurement, being:

 

Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date

 

Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly

 

Level 3: Unobservable inputs for the asset or liability

 

As of December 31, 2022  Level 1   Level 2   Level 3   Total 
   US$ in thousands 
Liabilities                    
Derivative financial liabilities (Note 22)           2,693    2,693 
Total           2,693    2,693 

 

As of December 31, 2021  Level 1   Level 2   Level 3   Total 
   US$ in thousands 
Liabilities                    
Derivative financial liability       32        32 
Total       32        32 

 

NOTE 24 – SUBSEQUENT EVENTS:

 

Since the reporting date the following significant events have occurred:

 

1.On January 25, 2023, the Company issued 250,000 in principal amount of convertible notes for an aggregate amount of 250. These convertible notes have a maturity date of the earlier between December 31, 2024 and the date of any change in control (excluding the Business Combination). The convertible notes has an interest rate of 15% per annum. The convertible notes shall be converted into common shares at a conversion price of USD 10.
2.In January 2023, the Company signed an amendment to the agreement with Isorad that determine the following: (1) for the BCA with Lionheart, Isorad was issued (a) 864,000 options to purchase shares of the Company, the options were issued in January 2023 and valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: 3.42%; (2) expected volatility: 81.92%: (3) expected term: up to 3 years; and (4) expected dividend yield: 0%; (b) Additionally, Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of 27 million, or at the end of such 13 months, the earlier thereof). (2) Exit fee - in the occurrence of the first M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA with SPAC, the Company is to pay a cash amount equal to 1.5% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.
3.On March 2, 2023, the Group signed an amendment that postponed the Bonus payment from borrowing from related party to March 31, 2024 (see Note 11).
4.In February 2023, SMX PLC entered a Standby Equity Facility to raise up to USD $25,000 of common stock over the course of 36 months. SMX PLC will issue to the investor the common stock at a purchase price as one of two options (i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period. SMX PLC issued in advance part of the common stocks for proceeds of $3,500 as follows (i) $1,500 at the initial closing (was received on March 2023) (ii) $2,000 upon effectiveness of a registration statement that was initially filed in March 2023.
5.During 2023, the Company entered into an additional bridge loan agreement (the “Additional Bridge Loans”), in which the Company raised an aggregate amount of $550. The Additional Bridge Loans have a maturity date of up to two years and bears interest rate of 10% per annum.
6.In March 2023, the Group signed an addendum to the Bridge Loans agreements (see also Note 12) which converted $1,350 into common shares and deferred the remaining cash payments to March 31, 2024.
7.On March 7, 2023, certain of the Company’s Convertible Notes (see also Note 6) were converted to 1,000,000 ordinary shares of the Company.
8.The financial statements were authorized for issuance on April 25, 2023.

 

F-36
 

 

SMX (SECURITY MATTERS)

PUBLIC LIMITED COMPANY

 

FINANCIAL STATEMENTS

AS OF DECEMBER 31, 2022 AND JULY 1, 2022

 

The amounts are stated in thousands of EURO

 

_______________________

________________

____________

 

F-37
 

 

Report of Independent Registered Public Accounting Firm

to the Shareholders of

SMX (Security Matters) Public Limited Company

 

Opinion on the Financial Statements

 

We have audited the accompanying statements of financial position of SMX (Security Matters) Public Limited Company (the “Company”) as of December 31, 2022, and July 1, 2022 (inception), and the related notes (collectively, the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022, and July 1, 2022 (inception) in conformity with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”).

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Tel-Aviv, Israel   /s/ Ziv Haft

April 25, 2023

We have served as the Company’s auditor since 2023

  Certified Public Accountants (Isr.)
    BDO Member Firm

 

F-38
 

 

       December 31, 2022   July 1, 2022 
   Note   EURO in thousands 
Current assets               
Cash and cash equivalents        25    *
Total assets        25    *
                
Equity               
Issued capital   3         
Additional paid-in capital   3    25    *
Total equity        25    *

 

(*)Less than 1 thousand.

 

/s/ Limor Moshe Lotker   /s/ Haggai Alon   April 25, 2023

Limor Moshe Lotker

Chief Financial Officer

 

Haggai Alon

Chief Executive Officer

  Date of approval of financial statements

 

The accompanying notes are an integral part of the financial statements.

 

F-39
 

 

NOTE 1 – GENERAL:

 

A. SMX (Security Matters) Public Limited Company (the “Company”) was incorporated in July 1, 2022 under the laws of Ireland with registered number 722009 and its registered office at Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6.
   
B. The Corporation has not engaged in any activities except in connection with its formation.
   
C.

On July 26, 2022, Security Matters Limited and Lionheart III Corp (“Lionheart”), a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (“BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders receiving Security Matters Limited shares and warrants in exchange for their existing Lionheart shares and warrants and all shares in Security Matters Limited being cancelled in return for the Company’s shares and resulting in that Security Matters Limited becoming a wholly owned subsidiary of the Company.

   
  On March 7, 2023 a business combination (the “Business Combination”) with Lionheart III Corp (“Lionheart”) was completed, following that the Company, which is newly-formed parent company – SMX (Security Matters) Public Limited Company, (formerly called Empatan Public Limited Company) was listed in the NASDAQ stock exchange under the ticker SMX.

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES:

 

The significant accounting policies followed in the preparation of the financial statements, on a consistent basis, are:

 

Basis of preparation

 

These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). Separate statements of comprehensive income, changes in equity, and cash flows have not been presented because the Corporation has not engaged in any activities except in connection with its formation.

 

Cash and cash equivalents

 

Cash equivalents are considered by the Company to be highly liquid investments, including, inter alia, short-term deposits with banks and the maturity of which do not exceed three months at the time of deposit, and which are not restricted.

 

Foreign currency

 

The financial statements are prepared in EURO which is the presentation and functional currency of the Company.

 

F-40
 

 

NOTE 3 – SHAREHOLDERS’ EQUITY

 

A.The ordinary shares in the Company confer upon their holders the right to receive notice to participate and vote in general meetings of the Company, and the right to receive dividends, if and when declared.

 

   Number of shares 
   December 31, 2022   July 1, 2022 
    

Authorized

    

Issued and outstanding

    

Authorized

    

Issued and outstanding

 

Ordinary shares

USD 0.0001 par value

   500,000,000    

1

    

500,000,000

    

1

 
Deferred Shares
EURO 1 par value
   

25,000

    

25,000

    

-

    

-

 

 

Ordinary shares

 

Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have no par value and the company does not have a limited amount of authorised capital.

 

Deferred shares

 

Deferred Ordinary Shares are non-voting shares and do not convey upon the holder the right to be paid a dividend or to receive notice of or to attend, vote or speak at a general meeting. The Deferred Shares confer the right on a return of capital, on a winding-up or otherwise, only to the repayment of the nominal value paid up on the Deferred Shares after repayment of the nominal value of the Ordinary Shares.

 

NOTE 4 – SUBSEQUENT EVENTS:

 

1.

In February 2023, the Company entered a Standby Equity Facility to raise up to USD 25,000 thousand of common stock over the course of 36 months. the Company will issue to the investor the common stock at a purchase price as one of two options (i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period. the Company issued in advance part of the common stocks for proceeds of USD 3,500 thousand as follows (i) USD 1,500 thousand at the initial closing (was received on March 2023) (ii) USD 2,000 thousand upon effectiveness of a registration statement that was filed on March 2023.

   
2.

On January 25, 2023, Security Matters Limited issued 250,000 convertible notes for an aggregate amount of USD 250 thousand. These convertible notes have a maturity date of the earlier between December 31, 2024 and the date of any change in control (excluding the Business Combination). The convertible notes have an interest rate of 15% per annum. The convertible notes shall be converted into common shares of the Company at a conversion price of USD 10.

 

F-41
 

 

NOTE 4 – SUBSEQUENT EVENTS (CONT.):

 

3.

Between August 2022 to January 2023, Security Matters Limited entered into bridge loan agreements (the “Bridge Loans”) with eleven lenders, which lent Security Matters Limited an aggregate amount of USD 3,860 thousand. The Bridge Loans have a maturity date of up to two years and bear interest rate of 10% per annum. The Bridge Loans were accounted for in accordance with amortized cost method.

 

As part of the Bridge Loans agreements, the lenders were granted with two types of warrants:

 

(i)Bonus Warrants – 243,000 warrants to purchase ordinary shares of the Company at an exercise price of USD 11.50 per share. The Bonus Warrants term is five years commencing upon the Business Combination.

 

(ii)

Redeemable Warrants – 597,000 warrants to purchase ordinary shares of the Company at a purchase price of USD 11.50 per share. The Redeemable Warrants term is five years commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD 5.00 per warrant.

 

Each investor has the option to decide that Security Matters Limited will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary.

 

In March 2023, Security Matters Limited signed an addendum to the Bridge Loans agreements which convert USD 1,350 thousand into common shares and defer the payments to March 31, 2024.

 

4.

The Company’s board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan, which was subsequently amended on April 25, 2023, which reserved for grant a number of Ordinary Shares equal to 15% of the number of issued and outstanding Ordinary Shares on a fully diluted basis immediately after the closing of the Business Combination, or 5,082,417 authorized ordinary shares. 

  
5.The financial statements were authorized for issuance on April 25, 2023.

 

F-42
 

 

SMX (SECURITY MATTERS)

PUBLIC LIMITED COMPANY

 

INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF JUNE 30, 2023

UNAUDITED

 

F-43
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

UNAUDITED INTERIM CONDENSED CONSOLIDATED

STATEMENTS OF FINANCIAL POSITION

 

         As of June 30,
2023
   As of December 31, 2022 
    Note    US$ in thousands 
Current assets                
Cash and cash equivalents         3,020    1,398 
Other current receivables         1,037    3,673 
Total current assets         4,057    5,071 
Non-current assets                
Property and equipment, net         820    969 
Intangible assets, net         5,269    5,027 
Investment in associated companies         112    221 
Total non-current assets         6,201    6,217 
                 
Total assets         10,258    11,288 
                 
Current liabilities                
Trade payables         7,281    2,972 
Lease liabilities         30    30 
Other payables         2,415    650 
Convertible notes   3     304    563 
Warrants         856    - 
Pre-paid advance   5.1     3,050    - 
Bridge loans and derivative financial liabilities   4     2,363    3,682 
Borrowings from related parties         689    710 
Total current liabilities         16,988    4,925 
Non-current liabilities                
Lease liabilities         403    440 
Bridge loans and derivative financial liabilities   4     938    - 
Long term payables         3,930    85 
Total non-current liabilities         5,271    4,207 
                 
Total liabilities         22,259    9,132 
                 
Shareholders’ equity (deficit)                
Issued capital and additional paid in capital   6     51,730    32,711 
Foreign currency translation reserve         (702)   (537)
Accumulated losses         (63,029)   (30,020)
Total Shareholders’ equity (deficit)         (12,001)   2,156 
Total liabilities and shareholders’ equity (deficit)         10,258    11,288 

 

/s/ Limor Moshe Lotker   /s/ Haggai Alon   /s/ Pauline Khoo   November 3, 2023

Limor Moshe Lotker

Chief Financial Officer

 

Haggai Alon

Chief Executive Officer

 

Pauline Khoo

Audit Committee Chairperson

  Date of approval of financial statements

 

The accompanying notes are an integral part of the financial statements.

 

F-44
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

UNAUDITED INTERIM CONDENSED CONSOLIDATED

STATEMENTS OF COMPREHENSIVE LOSS

 

               
         For the Six Months Ended 
         June 30, 2023   June 30, 2022 
    Note    US$ in thousands except share and per share data 
Research and development expenses, net         1,172    933 
Selling and marketing expenses         228    378 
General and administrative expenses   7     13,350    1,200 
Listing expenses         16,802    - 
Operating loss         31,552    2,511 
Finance income         1,143    105 
Finance expenses         2,496    36 
Share of net loss of associated companies         104    - 
Loss before income tax         33,009    2,442 
Income tax         -    - 
Loss after income tax for the period attributable to shareholders         33,009    2,442 
                 
Other comprehensive loss:                
Items that will be reclassified to profit or loss:                
Foreign currency translation         (165)   (639)
                 
Other comprehensive loss, net of tax         (165)   (639)
                 
Total comprehensive loss         33,174    3,081 
                 
Loss per share attributable to shareholders                 
                 
Basic and diluted loss per share attributable to shareholders (in dollars)   8     *(39.46)   **(3.36)

 

* After giving effect to the reverse stock split (see also Note 9.1)
** Restated as a result of the SPAC transaction and after giving effect to the reverse stock split (see also Note 1 and 9.1)

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-45
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

UNAUDITED INTERIM CONDENSED CONSOLIDATED CHANGES IN SHAREHOLDERS’ EQUITY

(US$ in thousands)

 

                     
  

Issued capital and

Additional

paid-in capital

   Foreign currency translation reserve   Accumulated loss   Total equity 
Balance as of January 1, 2023   32,713    (537)   (30,020)   2,156 
Comprehensive loss                    
Loss after income tax for the period   -    -    (33,009)   (33,009)
Other comprehensive loss for the period   -    (165)   -    (165)
Total comprehensive loss for the period   -    (165)   (33,009)   (33,174)
                     
Issuance of shares, net   170    -    -    170 
Recapitalization due to issuance of shares following the SPAC transaction, net   11,460    -    -    11,460 
Share-based compensation   2,092    -    -    2,092 
Conversion of convertible notes to shares   175    -    -    175 
Conversion of bridge loans to shares   2,983    -    -    2,983 
Exercise of options   10    -    -    10 
Conversion of warrants A to ordinary shares, net (See note 5.2)   290              290 
Issuance of Security Bundle, net (See note 5.2)   1,837    -    -    1,837 
Balance as of June 30, 2023   51,730    (702)   (63,029)   (12,001)

 

The accompanying notes are an integral part of the consolidated financial statements.

 

(*) Represents an amount lower than US$ 1 thousand, see Note 2D.

 

F-46
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

UNAUDITED INTERIM CONDENSED CONSOLIDATED CHANGES IN SHAREHOLDERS’ EQUITY

(US$ in thousands)

 

                     
  

Issued capital and

Additional

paid-in capital

   Foreign currency translation reserve   Accumulated loss   Total equity 
     
Balance as of January 1, 2022   31,504    223    (23,836)   7,891 
Comprehensive income                    
Loss after income tax for the period   -    -    (2,442)   (2,442)
Other comprehensive loss for the period   -    (639)   -    (639)
Total comprehensive loss for the period   -    (639)   (2,442)   (3,081)
                     
Issuance of shares, net   721    -    -    721 
Share-based compensation   219    -    -    219 
Balance as of June 30, 2022   32,444    (416)   (26,278)   5,750 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-47
 

 

 

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(US$ in thousands)

 

           
   For the Six Months Ended 
   June 30, 2023   June 30, 2022 
   US$ in thousands 
Cash flows from operating activities:          
Net Loss   (33,009)   (2,442)
Share-based compensation   2,052    165 
Depreciation and amortization   114    176 
Increase (decrease) in other receivables   2,575    (1,727)
Increase in trade payables   2,545    831 
Increase in other payables   70    110 
Decrease in other liabilities   13    32 
Revaluation of financial liabilities at fair value   (41)   - 
Financial expenses due to bridge loans principal amounts   1,421    - 
Interest on leases   7    28 
Provision of borrowing to related parties   14    (89)
Revaluation of convertible notes   (382)   - 
Share of net loss of associated companies   104    - 
Issuance of shares for directors   40    54 
SPAC transaction - listing costs   16,802    - 
Net cash flow used in operating activities   (7,675)   (2,862)
Cash flows from investing activities:          
Purchase of property, plant and equipment   (10)   (183)
Capitalized development cost   (383)   (783)
Net cash flow used in investing activities   (393)   (966)
Cash flows from financing activities:          
Payment of lease liabilities   (21)   (39)
Proceeds from issuance of convertible notes   250    581 
Proceeds from issuance of Security Bundle, net   914    - 
Issuance of warrants   923    - 
Issuance of derivative financial liability   974    - 
Proceeds from bridge loans   550    - 
Repayment of bridge loans   (30)   - 
Advance payment for equity, net (see Note 5.1)   3,220    - 
Issuance of shares in the SPAC transaction, net   2,923    - 
Net cash flow from financing activities   9,703    542 
           
Increase (decrease) in cash and cash equivalents   1,635    (3,286)
Cash and cash equivalents at beginning of period   1,398    4,171 
Exchange rate differences on cash and cash equivalent   (13)   (26)
Cash and cash equivalents at end of period   3,020    859 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-48
 

 

 

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(US$ in thousands)

 

   For the Six Months Ended 
   June 30, 2023   June 30, 2022 
   US$ in thousands 
Appendix A – Non-Cash transactions during the period:          
           
Conversion of liability to ordinary shares (see Note 5.1)   450    - 
Conversion of warrants to ordinary shares (see note 5.2)   290    - 
Conversion of bridge loans and derivative financial liability to ordinary shares   2,983    - 
Exercise of options and warrants to ordinary shares   2,229    - 
Conversion of convertible notes to ordinary shares   175    - 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-49
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 1 - GENERAL:

 

A. SMX (Security Matters) Public Limited Company (“Security Matters” or the “Company” and together with its subsidiaries, the “Group”) was incorporated in July 1, 2022 under the laws of Ireland with registered number 722009 and its registered office at Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6. The Company was incorporated in 2022 as part of the Business Combination (see Note 1.B).

 

The Group provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer. Its proprietary marker system embeds a permanent or removable (depending on the needs of the customer) mark on solid, liquid or gaseous objects or materials. Each marker is comprised of a combination of marker codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with an innovative patented reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers or on a blockchain ledger, to protect data integrity and custody.

 

B. The Business Combination - the SPAC transaction (“Business Combination”):

 

On March 7, 2023 (the “Closing Date”) the Company completed its Business Combination with Lionheart III Corp (“Lionheart”), following that Lionheart and Security Matters PTY Ltd. (formerly named Security Matters Limited, which was incorporated in May 2018 under Australian law) became the Company’s wholly-owned subsidiaries and the Company listed its ordinary shares and public warrants on the NASDAQ stock market under the tickers SMX and SMXWW, respectively. On July 26, 2022, Security Matters PTY Ltd. and Lionheart, a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (the “BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders received the Company’s shares and warrants in exchange for their existing Lionheart shares and warrants and all shares existed in Security Matters PTY Ltd were cancelled in return for the Company’s shares and resulting in Security Matters PTY Ltd. becoming a wholly owned subsidiary of the Company. Security Matters PTY Ltd. shareholders received consideration of 1 ordinary share per 10.3624 Security Matters PTY Ltd. shares, having an implied value of $10.00 per ordinary share and the Company became the holder of all of the issued shares in Security Matters PTY Ltd. and Lionheart, with Security Matters PTY Ltd. being delisted from the Australian Stock Exchange.

 

The Business Combination resulted in 97.58% redemption by Lionheart’s public shareholders which resulted in leaving $3,061 of funds remaining in the trust account (See also Note 6 and Note 2.E as for the accounting treatment of the transaction in these financial statements).

 

F-50
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 1 – GENERAL (CONT.):

 

C. The Company operates primarily through 8 wholly owned subsidiaries, all of which have been consolidated in these consolidated financial statements.

 

Controlled entity  

Country of

Incorporation

   

Percentage Owned

June 30, 2023

   

Percentage Owned

December 31, 2022

 
Security Matters PTY Ltd.
(Formerly - Security Matters Limited)
    Australia       100 %     -  
Lionheart III Corp     USA       100 %     -**  
SMX Circular Economy Platform PTE, Ltd.     Singapore       100 %     *  
SMX (Security Matters) Ireland Limited     Ireland       100 %     *  
SMX (Security Matters) Israel Ltd.
(Formerly - Security Matters Ltd.)
    Israel       100 %     100 %***
Security Matters Canada Ltd.     Canada       100 %     100 %***
Security Matters France Ltd.     France       100 %     100 %***
SMX Beverages Pty Ltd.     Australia       100 %     100 %***

 

In addition, the Company’s has the following investments in associated companies:

 

Entity  

Country of

Incorporation

   

Percentage Owned

June 30, 2023

   

Percentage Owned

December 31, 2022

 
Yahaloma Technologies Inc.     Canada       50 %     50 %***
True Gold Consortium Pty Ltd     Australia       44.4 %     44.4 %***

 

The proportion of ownership interest is equal to the proportion of voting power held.

 

* Incorporated in 2023.
** Merger occurred in March 2023.
*** Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2022.

 

D. During the six months ended June 30, 2023, the Company incurred operating losses and negative cash flows from operating activities. The Company has not yet generated revenues. As discussed in Note 4, during the period, the Company entered into binding loan agreements with existing shareholders. As discussed in Note 5.1, the Company executed an equity line agreement to raise up to $25,000 in consideration of the issuance of common stock over the course of 36 months with YA II PN, LTD (“Yorkville”). As discussed in Notes 4 and 9.4, the Company signed agreements to convert indebtedness by issuance of shares. As discussed in Note 9.3 the Company is continuing with additional capital raising, and post balance sheet date it received an additional $2,500 in funding. The Company has also the ability to decrease its expenses in order to meet its existing cash flow streams. Management believes that the proceeds from the recent funding agreements, combined with its cash on hand, equity line and the Company’s plans, are sufficient to meet the Company’s obligations as they come due in the foreseeable future. There are no assurances, however, that the Company will be able to obtain an adequate level of financial resources that are required for its long-term business plan.

 

F-51
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES:

 

A. Basis of preparation

 

These interim consolidated financial statements have been prepared in a condensed format in accordance with IAS 34 Interim Financial Reporting. They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the annual consolidated financial statements as of December 31, 2022 of the Company and of Security Matters PTY Ltd. (formerly - Security Matters Limited).

 

B. Functional currency

 

The consolidated financial statements are prepared in US Dollars, which is the functional and presentation currency of the Company.

 

C. Application of accounting policies

 

The Group has applied the same accounting policies and methods of computation in its interim condensed consolidated financial statements as in its 2022 annual financial statements and as in the 2022 annual financial statements of Security Matters PTY Ltd, except as stated below in note 2D and 2E.

 

Several amendments to IFRS Standards apply for the first time in 2023, but do not have an impact on the interim condensed consolidated financial statements.

 

D. Issue of a unit of financial instruments

 

The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.

 

E. Reverse acquisition transaction

 

The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.

 

Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($11,599), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $16,802, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.

 

F-52
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

E. Reverse acquisition transaction (Cont.)

 

The Company is initially consolidated in the financial statements from the Closing Date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($4,921) and trade and other payables and warrants ($10,127) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:

 

1. The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.

 

2. The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.

 

3. The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.

 

4. The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.

 

F. Reverse stock split

 

The presentation of loss per share amounts has been retrospectively adjusted to give effect to the reverse share split which occurred on August 8, 2023. Except otherwise specifically provided, no other adjustments have been made in these notes to reflect the reverse share split. See also Note 9.1.

 

F-53
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 3 – CONVERTIBLE NOTES

 

On January 25, 2023, the Company received an amount of $250 in consideration for issuance of convertible notes (the “Convertible Notes”) and two types of warrants. The Convertible Notes principal amount is $250 and maturity date is the earlier between December 31, 2024, and the date of any change in control (excluding the Business Combination). The Convertible Notes have an interest rate of 15% per annum and shall be converted into ordinary shares: (1) at the note holder’s discretion, at a fixed conversion price of USD 10 per ordinary share, or (2) through issuance of the Company’s ordinary shares at a 20% discount.

 

As part of the Convertible Note agreements, the investor was granted two types of warrants:

 

(i) Bonus Warrants – 12,500 warrants to purchase ordinary shares of the Company at an exercise price of USD 11.50 per share. The Bonus Warrants term is five years commencing upon the Business Combination.

 

(ii) Redeemable Warrants – 12,500 warrants to purchase ordinary shares of the Company at a purchase price of USD 11.50 per share. The Redeemable Warrants term is five years commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD 5.00 per warrant. The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.

 

The Convertible Notes are recorded in accordance with their fair value. The Redeemable Warrants are accounted for as a derivative financial liability. Management utilized a third-party appraiser to assist them in valuing the Convertible Notes and Redeemable Warrants.

 

In order to calculate the fair value of the Convertible Notes, the Company discounted the payment schedule by a discount rate of 30.7%.

 

The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model with expected volatility of 71.54% and the risk-free interest rate used is 4.19%. As of June 30, 2023, the fair value of the Convertible Notes was $218 and the fair value of the Redeemable Warrants was $71.

 

NOTE 4 – BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY:

 

Between August 2022 to January 2023, Security Matters PTY Ltd. entered into bridge loan agreements (the “Bridge Loans”) with eleven lenders, which lent Security Matters PTY Ltd. an aggregate amount of $3,860. The Bridge Loans have a maturity date of up to two years and bear an interest rate of 10% per annum. The Bridge Loans were accounted for in accordance with the amortized cost method.

 

As part of the Bridge Loans agreements, the lenders were granted two types of warrants:

 

(iii) Bonus Warrants – 243,000 warrants to purchase ordinary shares of the Company at an exercise price of USD 11.50 per share. The Bonus Warrants term is five years commencing upon the Business Combination.

 

(iv) Redeemable Warrants – 572,000 warrants to purchase ordinary shares of the Company at a purchase price of USD 11.50 per share. The Redeemable Warrants term is five years commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD 5.00 per warrant.

 

Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.

 

Management with the assistance of a third-party appraiser valued the Bonus and the Redeemable Warrants. The fair value of the Bonus Warrants was calculated using the Black-Scholes model. As of June 30, 2023, the fair value of the Bonus Warrants was less than $1 (December 31, 2022 - the fair value of the Bonus Warrants was $24).

 

The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model. As of June 30, 2023, the fair value of the Redeemable Warrants was 2,133 (December 31, 2022, the fair value of the Redeemable Warrants was $2,669).

 

The main assumptions used in the three valuation models described above were: (1) risk free rate 3.99%; (2) volatility of assets 81.03%; and (3) excepted terms of the warrants -5.18 years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.

 

During 2023, the Company entered into an additional bridge loan agreement (the “Additional Bridge Loans”), in which the Company raised an aggregate amount of $550. The Additional Bridge Loans have a maturity date of up to two years and bear interest rate of 10% per annum. In March 2023, the Company signed an addendum to the Bridge Loans agreements which convert principal amount of $1,350 and redeemable warrants at the amount of $1,000 into 872,418 ordinary shares and defer the remaining cash payments to March 31, 2024.

 

F-54
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 5 – MATERIAL EVENTS DURING THE PERIOD

 

1. The Company entered in February 2023 into a Standby Equity Purchase Agreement (“SEPA”) to raise up to $25,000 in consideration of the issuance of ordinary shares over the course of 36 months with Yorkville. According to the SEPA, the Company may issue Yorkville the ordinary shares at a purchase price as one of two options (i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period.

 

Yorkville advanced to the Company an aggregate principal amount of $3,500 (the “Pre-Paid Advance”). The Pre-Paid Advance was disbursed in two separate installments evidenced as convertible loans, the first for $1,500 at the closing of the Business Combination, and the second, as subsequently amended, for $2,000 upon the effectiveness of the Initial Yorkville Registration Statement. The purchase price for the Pre-Paid Advance is 92.0% of the Pre-Paid Advance. Such Pre-Paid Advances will be offset upon the issuance of ordinary shares to Yorkville at a price per share equal to the lower of (a) 100% of the daily VWAP of the Ordinary Shares on The Nasdaq Stock Market as of the trading day immediately prior to the date of the disbursement of the Pre-Paid Advance (the “Fixed Price”) (in the case of the first Pre-Paid Advance, $3.65), or (b) 93.0% of the lowest daily VWAP of the Ordinary Shares on Nasdaq during the seven trading days immediately prior to each purchase (the “Variable Price” and the lower of the Fixed Price and the Variable Price shall be referred to as the “Purchase Price”); however, in no event shall the Purchase Price be less than $1.10 (the “Floor Price”). On July 27, 2023, the Company amended the promissory note evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (as adjusted for reverse stock split which occurred on August 21, 2023, see also Note 9.1), after the Company was required to repay in cash $500 of principal amount as a result of the Company’s share price being below the original Floor Price. The maturity date will be 12-months after the initial closing of each Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $1,500. In the period, the Company issued ordinary shares in consideration of $450 in accordance with the terms of the SEPA.

 

2. On June 22, 2023, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with EF Hutton, LLC (the “Underwriter”) relating to the public offering of (i) 13,333,333 ordinary shares of the Company, at a subscription price per share of $0.24 (the “Firm Shares”), (ii) 13,333,333 warrants in the form of Warrant A to subscribe for 13,333,333 ordinary shares, at an exercise price of $0.24 per share (“Warrant A”), and (iii) 13,333,333 warrants in the form of Warrant B to subscribe for 13,333,333 ordinary shares, at an exercise price of $0.24 per share (“Warrant B” and together with Warrant A, the “Firm Warrants” and, collectively with the Firm Shares, the “Firm Securities”).

 

The Company also granted the Underwriter a 45-day option to subscribe for, in the aggregate, (a) up to 1,999,999 additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $0.24 (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to 1,999,999 ordinary shares at a price per share of $0.2399 (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $0.0001 per share, and/or (b) 1,999,999 warrants in the form of Warrant A to subscribe for an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at an exercise price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) 1,999,999 warrants in the form of Warrant B to purchase an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at a purchase price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants. The Option Shares and the Option Warrants are referred to as the “Option Securities”.

 

The offering closed on June 27, 2023. The Company delivered the Firm Shares (or Firm Share equivalents in the form of Pre-Funded Warrants), the Firm Warrants and the Option Warrants to the Underwriter on the same day.

 

The Warrant A terms specify that the warrants may be exercised at any time on or before June 27, 2028. On or after the earlier of (i) the thirty day anniversary of the date of the Underwriting Agreement and (ii) the date on which the aggregate composite trading volume of the Company’s ordinary shares as reported by Bloomberg LP beginning on the date of the Underwriting Agreement exceeds 15,000,000 ordinary shares, a holder of Warrant A warrants may also provide notice and elect a “cashless exercise” pursuant to which the holder would receive an aggregate number of ordinary shares equal to the product of (x) the aggregate number of ordinary shares that would be issuable upon a cash exercise and (y) $0.50. As of the date of publication of these financial statements, an aggregate of 15,195,332 Warrant A warrants were cashless exercised into an aggregate of 7,597,665 ordinary shares.

 

F-55
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 5 – MATERIAL EVENTS DURING THE PERIOD (CONT.)

 

The Warrant B terms specify that the warrants may be exercised at any time on or before June 27, 2028. All of such Warrant B warrants remain outstanding as of the end of period.

 

Warrant A was valued at $0.0635 which is half of the share market price at the end of the period, assuming cashless exercise. Warrants A were considered to be a derivative financial liability. The terms of warrants B specify that each warrant has a cash exercise price of $0.24. Warrant B was valued at $0.0602 by using the Black-Scholes option-pricing model, with expected volatility of 70.39% and the risk-free interest rate used is 4.13%. Warrants A and B expire in June 2028.

 

The net proceeds to the Company upon the closing of this offering were approximately $2,580. The capital raise fee amounted to $660.

 

The Company also granted to the Underwriter, 666,667 warrants at an exercise price of $0.264 per share, which expires after 5 years. The Underwriter’s warrants were valued at $0.0575 per option by using the Black & Scholes option-pricing, with expected volatility of 70.39% and the risk-free interest rate used is 4.13%.

 

3.

In January 2023, the Company signed an amendment to the agreement with Isorad that determine the following: (1) for the BCA with Lionheart, (a) Isorad was issued 864,000 options to purchase shares of the Company, which options were issued in January 2023 and valued using the Black-Scholes pricing model, with the main parameters used are: (1) risk-free rate: 3.42%; (2) expected volatility: 81.92%: (3) expected term: up to 3 years; and (4) expected dividend yield: 0%; and (b) Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of $27 million, or at the end of such 13 months, the earlier thereof). In the period, based on the funds the Company actually received, the Company recognized a technology license intellectual property at the amount of $101 against a liability that reflects the due amount; and

 

(2) Exit fee - in the occurrence of the first M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA, the Company is to pay a cash amount equal to 1.5% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

4. On March 2, 2023, the Company amended its loan agreement dated September 7, 2015, between the Company, its Shareholders and Kamea Fund that postponed the repayment of the borrowings from related party (Bonus Payment) to March 31, 2024 (refer also to Note 9.4 – Subsequent Events).

 

F-56
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 6 - SHAREHOLDERS’ EQUITY

 

A. Share capital:

 

    Number of shares  
    June 30, 2023     December 31, 2022  
    Authorized     Issued and outstanding     Authorized     Issued and outstanding  
Ordinary shares
USD 0.0001 par value
    800,000,000,000       38,364,447       500,000,000       1  
Preferred shares
USD 0.0001 par value
    200,000,000,000       -       -       -  
Deferred shares
Euro 1 par value
    25,000       25,000       25,000       25,000  

 

Ordinary shares

 

Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the Company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have a par value per share of $0.0001 (before the reverse split) and par value per share of $0.0022 (post reverse split) and the Company does not have a limited amount of authorised capital.

 

Preferred shares

 

preferred shares with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors.

 

Deferred shares

 

Deferred Ordinary Shares are non-voting shares and do not convey upon the holder the right to be paid a dividend or to receive notice of or to attend, vote or speak at a general meeting. The Deferred Shares confer the right on a return of capital, on a winding-up or otherwise, only to the repayment of the nominal value paid up on the Deferred Shares after repayment of the nominal value of the Ordinary Shares.

 

Changes in Share capital

 

A. On March 7, 2023 (the “Closing Date”), the Company consummated the Business Combination pursuant the BCA, dated July 26, 2022, and also consummated the SID, dated July 26, 2022.

 

Beginning on the day immediately prior to the Closing Date and ending on the day immediately after the Closing Date, the following transactions occurred:

 

  1. The AUD 828,240 of the 2022 Convertible Notes have been cancelled in consideration for the issuance of 1,000,000 ordinary shares in Security Matters PTY Ltd.

 

  2. Security Matters PTY Ltd. performed acceleration of vesting for all unvested warrants and options, the expense for the acceleration amounted to $186.

 

  3. 32,211,716 warrants have been exercised on cashless basis to 24,568,773 shares in Security Matters PTY Ltd.

 

  4. 18,673,253 ordinary shares of the Company have been issued to Security Matters PTY Ltd.’s shareholders in return for their 193,500,379 ordinary shares in Security Matters PTY Ltd. that were cancelled. Security Matters PTY Ltd.’s shareholders received as consideration 1 ordinary share of the Company per 10.3624 Security Matters PTY Ltd.’s ordinary shares.

 

  5. The Company issued 3,525,000 ordinary shares, 2,200,000 private warrants and 6,250,000 public warrants to Lionheart’s stockholders, in exchange for their existing Lionheart shares and warrants. The warrants exercise price is $11.5 per share, expiring in March 2028. The warrants are considered to be a derivative financial liability and measured at fair value, which is the market price as of the end of the period, amounted to $0.0204 per warrant.

 

F-57
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 6 – SHAREHOLDERS’ EQUITY (CONT.)

 

  6. The Company issued 303,053 ordinary shares for an aggregate of $3,110 net proceeds.

 

  7. The Company issued 872,418 ordinary shares for the conversion of bridge loan at principal amount of $1,350 and 200,000 redeemable warrants ($5 per warrant, 5 years, exercise price of $11.5 per share).

 

B. In May and June 2023, the Company issued 675,168 ordinary shares to Yorkville, for an aggregate of $450 net proceeds (see also Note 5.1).

 

C. In June 2023, the Company raised capital as part of issuance of a unit of financial instruments in consideration of an aggregate of $2,580 net proceeds. As part of this issuance, the Company issued 13,333,333 shares, 15,333,332 warrants A and 15,333,332 warrants B (see also Note 5.2).

 

D. After the balance sheet date, on August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis, after consolidating every twenty-two ordinary shares of the Company into one ordinary share (see also Note 9.1).

 

Incentive Equity Plan

 

In April 25, 2023, the Company’s board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan, which was subsequently amended the Company’s board of directors, subject to applicable Nasdaq requirements, which reserved for grant a number of ordinary shares equal to 15% of the number of issued and outstanding ordinary shares on a fully diluted basis immediately after the closing of the Business Combination, or 5,082,417 authorized ordinary shares.

 

1. During the six-month period ended June 30, 2023, the Company granted 4,334,000 RSUs to employees, directors and service providers. The fair value at grant date of RSUs granted in the period were $1-$1.09. The related share-based expenses that were recognized in the period amounted to $1,738.

 

RSUs granted to employees, directors and service providers:

 

 SCHEDULE OF RESTRICTED STOCK UNIT

  

Six months period ended

June 30, 2023

(in thousands)

  

Six months period ended

June 30, 2022
(in thousands)

 
Outstanding at beginning of period   -    - 
Granted   4,334    - 
Vested   (945)   - 
           
Outstanding at June 30, 2023   3,389    - 

 

2. During the six-month period ended June 30, 2023, the Company granted 790,408 options to employees and service providers. These grants carry an exercise price of between $1.04 - $4.0, vesting period up to 4 years from the grant date, contractual life of the options under the plan is 5 years. The fair value of the grant at grant date is $185. The related share based expenses that were recognized in the six months period ended June 30, 2023 amounted to $168.

 

F-58
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 6 - SHAREHOLDERS’ EQUITY (CONT.)

 

Options granted to employees and service providers:

 

 SCHEDULE OF SHARE OPTION GRANTED

 

   

Six months period ended

June 30, 2023

 
   

Number

of options

(in thousands)

   

Weighted average

exercise price per share (US$)

 
Outstanding at beginning of period     1,251       2.01  
Granted     790       3.47  
Exercised     (7 )     1.39  
Expired     -       -  
                 
Outstanding at June 30, 2023     2,034       2.58  
Exercisable options at June 30, 2023     1,825       2.48  

 

   

Six months period ended

June 30, 2022

 
   

Number

of options

(in thousands)

   

Weighted average

exercise price per share (US$)

 
Outstanding at beginning of period     3,346       2.02  
Granted     989       2.86  
Exercised     -          
Expired     (375 )     2.16  
                 
Outstanding at June 30, 2022     3,960       2.21  
Exercisable options at June 30, 2022     2,703       2.33  

 

The options to employees and service providers outstanding as of June 30, 2023, are comprised, as follows:

 

 SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING

Exercise price (US$)    

Outstanding as of

June 30, 2023

(in thousands)

   

Weighted average remaining

contractual term

   

Exercisable as of

June 30, 2023

(in thousands)

   

Weighted average remaining

contractual term

 
            (years)           (years)  
0.84-1.39       845       1.18       845       1.18  
1.81-2.51       335       2.59       335       2.59  
3.57-4.0       707       4.89       498       4.86  
4.18       10       1.74       10       1.74  
4.87       137       3.51       137       3.51  
        2,034               1,825          

 

NOTE 7 – GENERAL AND ADMINISTRATIVE EXPENSES

 

 SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES

    June 30, 2023     June 30, 2022  
    Six Months Ended  
    June 30, 2023     June 30, 2022  
    US$ in thousands     US$ in thousands  
Transaction cost     7,792       -  
Advertising, Public and Investors Relations     1,526       -  
Share based compensation     1,805       82  
Professional services     718       545  
Wages and salaries related     664       429  
Travel expenses     379       4  
Insurance     329       19  
Office and maintenance     37       80  
Depreciation and amortization     15       15  
Others     86       26  
Total     13,350       1,200  

 

NOTE 8 - LOSS PER SHARE

 

 SCHEDULE OF LOSS PER SHARE

    June 30, 2023     June 30, 2022  
    Six months ended  
    June 30, 2023     June 30, 2022  
Net loss attributable to the owners of the Company   $ (33,009 )   $ (2,442 )
                 
Basic and diluted loss per share   $ (39.46 )   $ *(3.36)  
Weighted average number of ordinary shares                
Weighted average number of ordinary shares used in calculating basic and diluted loss per share (in thousands)     837       *727  

 

As a result of the reverse share split described in Note 9.1, the calculation of the basic and diluted loss per share for all periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.

 

* Restated as a result of the SPAC transaction

 

F-59
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 9 – SUBSEQUENT EVENTS

 

Since the reporting date, the following significant events have occurred:

 

1. Reverse Stock Split - On August 8, 2023, at the Extraordinary General Meeting of Shareholders of the Company, the Company’s shareholders voted in favor of consolidating every twenty-two ordinary shares in the authorized but unissued and in the authorized and issued share capital of the Company into one ordinary share (the “Reverse Stock Split”).

 

On August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis under the current symbol “SMX”.

 

Following is a table which presents the loss per share before the change (see also Note 8).

 

Loss per share have been calculated using the weighted average number of shares in issue during the relevant financial periods, the weighted average number of equity shares in issue and loss for the period as follows:

 

 SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE

   June 30, 2023   June 30, 2022 
   Six months ended 
   June 30, 2023   June 30, 2022 
Net loss attributable to the owners of the Company   (33,009)   (2,442)
           
Basic and diluted loss per share   (1.79)   (0.15)
Weighted average number of ordinary shares          
Weighted average number of ordinary shares used in calculating basic and diluted loss per share   18,404    15,984 

 

2. On July 27, 2023, the Company amended its Pre-Paid Advance agreement with Yorkville (see also Note 5.1) evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (as adjusted for the Reverse Stock Split which occurred on August 21, 2023, see also Note 9.1), after the Company was required to repay in cash $500 of principal amount as a result of the Company’s share price being below the original Floor Price. The maturity date will be 12-months after the initial closing of the Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $1,500. In the period, the Company repaid approximately $450 principal amount by ordinary share issuance in accordance with the terms of the SEPA and subsequent to the period, the Company repaid approximately $1,350 through September 30, 2023.

 

3. On September 6, 2023, the Company consummated the transactions pursuant to a Securities Purchase Agreement dated as of September 5, 2023 and issued and sold to an institutional investor a promissory note with a fixed conversion price of $1.6378 and warrants, for gross proceeds to SMX of approximately $2,500, before deducting fees and other offering expenses payable by the Company to their service providers. The note is in the principal amount of $4,290. The actual amount loaned by the investor pursuant to the Note is $2,574 after a 40% original issue discount. The maturity date of the note is the 12-month anniversary of the Effective Date, and is the date upon which the principal amount, as well as any accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of 12% per year and shall be payable on the maturity date. The investor has the right, at any time, to convert all or any portion of the then outstanding and unpaid principal amount and interest (including any costs, fees and charges) into the Company’s ordinary shares, at a fixed conversion price of $1.6378 per share. Any such conversion is subject to customary conversion limitations set forth in the Purchase Agreement so the investor beneficially owns less than 4.99% of the Company’s ordinary shares. Additionally, the Company has the right to convert in whole or in part the note into ordinary shares; provided that in no case shall the Company so convert the note if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of 4.99%.

  

4. On September 15, 2023, the Company paid $250 to EF Hutton, division of Benchmark Investments, LLC, pursuant to a Satisfaction and Discharge of Indebtedness Pursuant to Promissory Note Dated March 7, 2023. Upon paying such amount, the promissory note dated March 7, 2023 in the principal sum of $900 was deemed fully paid and satisfied and the Note was thereafter canceled, discharged and no longer of any further force or effect.

 

5. On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund (the “Loan Agreements”). Pursuant to the amendment to the Loan Agreements, Kamea agreed to convert $657 of indebtedness under the Loan Agreements (the “Indebtedness Amount”) into 487,281 ordinary shares (post Reverse Stock Split) of the Company, as payment in full for the Indebtedness Amount; provided however, that in the event the proceeds received from Kamea with respect to any sales of such shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount.
   
6.

On October 3, 2023, the Company has signed an agreement with True Gold Consortium Pty Ltd (“TrueGold”) (see also Note 1C) shareholders to acquire an additional 7.5% which will increase the Company’s holdings to 51.9% in TrueGold and result in the Company’s gain control over TrueGold. As part of the agreement and in consideration for the additional 7.5%, it was agreed that the outstanding payables from TrueGold to the Company which amounted to AU$ 475 as of June 30, 2023 (approximately $307) would be forgiven in full.

 

The transaction is based on past valuation, which was prepared in October 2021, which evaluates TrueGold’s fair value in the range of $78.5 million to $90 million and at a mean of $84.3 million. This past valuation was not audited or reviewed.

 

As of the agreement’s closing date, both parties agreed to engage an independent third party appraiser to prepare an updated TrueGold valuation as of closing date by November 30, 2023. Accordingly, the Company will recognize in its financial statements the fair value of TrueGold’s assets & liabilities at closing date as will be valued by the independent third party appraiser. Once this valuation will be completed, there may be material differences between TrueGold’s past valuation from October 2021 to the updated valuation.

 

F-60
 

 

 

 Up to 4,000,000 Ordinary Shares

 

 

 SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

 

 

PRELIMINARY PROSPECTUS

 

 

, 2024

 

 

 
 

 

PART II. INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 6. Indemnification of Directors and Officers

 

The Company will be subject to the ICA. Subject to exceptions, the ICA does not permit a company to exempt a director or certain officers from, or indemnify a director against, liability in connection with any negligence, default, breach of duty or breach of trust by a director in relation to the company. The exceptions allow a company to (i) purchase and maintain director and officer insurance against any liability attaching in connection with any negligence, default, breach of duty or breach of trust owed to the company; and (ii) indemnify a director or other officer against any liability incurred in defending proceedings, whether civil or criminal (a) in which judgement is given in his or her favor or in which he or she is acquitted or (b) in respect of which an Irish court grants him or her relief from any such liability on the grounds that he or she acted honestly and reasonably and that, having regard to all the circumstances of the case, he or she ought fairly to be excused for the wrong concerned.

 

Under the Company’s Amended and Restated Memorandum and Articles of Association, subject to certain limitations and so far as may be permitted by the ICA, each director, officer or employee of the Company, and each person who is or was serving at the request of the Company as a director, officer or employee of another company, or of a partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans maintained or sponsored by the Company, shall be entitled to be indemnified by the Company against all costs, charges, losses, expenses and liabilities incurred by him or her in the execution and discharge of his or her duties or in relation thereto, including any liability incurred by him or her in defending any proceedings, civil or criminal, which relate to anything done or omitted or alleged to have been done or omitted by him or her as a director, officer or employee of the Company or such other company, partnership, joint venture, trust or other enterprise, and in which judgment is given in his or her favor (or the proceedings are otherwise disposed of without any finding or admission of any material breach of duty on his or her part) or in which he or she is acquitted or in connection with any application under any statute for relief from liability in respect of any such act or omission in which relief is granted to him or her by the court. However, any such indemnity shall not be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable for fraud or dishonesty in the performance of his or her duty to the Company unless and only to the extent that the courts of Ireland or the court in which such action or suit was brought shall determine upon application that despite the adjudication of liability, but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses as the court shall deem proper.

 

The Company on closing entered into indemnification agreements with each of the directors of the Company to provide contractual indemnification providing for indemnification and advancements by the Company of certain expenses and costs relating to claims, suits or proceedings arising from his or her service to the Company, and to Lionheart if applicable or, at Lionheart’s request, service to other entities, as officers or directors occurring at or prior to the Merger Effective Time to the maximum extent permitted by applicable law.

 

The Company is also anticipated to maintain standard policies of insurance under which coverage is provided (1) to its directors and officers against loss arising from claims made by reason of breach of duty or other wrongful act, while acting in their capacity as directors and officers of the Company, and (2) to the Company with respect to payments which may be made by the Company to such officers and directors pursuant to any indemnification provision contained in the Company’s Amended and Restated Memorandum and Articles of Association or otherwise as a matter of law.

 

Item 7. Recent Sales of Unregistered Securities

 

The following list sets forth information as to all of the Company’s securities sold in the last three years which were not registered under the Securities Act. The descriptions of these issuances are historical and have not been adjusted to give effect to the Business Combination.

 

All of the below issuances reflect the number of Ordinary Shares issued at the time of issuance and do not reflect an adjustment pursuant to the Reverse Stock Split.

 

In connection with the Company’s initial formation, the Company issued one ordinary share at a price of US$0.0001 each to Doron Afik, and subsequently issued 25,000 deferred ordinary shares at a price of €1.00 per share, to Doron Afik. Immediately prior to consummation of the Transactions, the Company had paid up capital of €25,000 and US$0.0001.

 

II-1
 

 

In March 2023, in connection with the Standby Equity Purchase Agreement, by and between YA II PN, LTD (“Yorkville”) and the Company, dated February 23, 2023 (the “SEPA”),, the Company issued 92,315 Ordinary Shares to Yorkville as a 1.5% commitment fee.

 

In April 2023, the Company granted, pursuant to its 2022 Incentive Equity Plan, (a) an aggregate of 4,361,920 restricted stock units that settle into ordinary shares of the Company and (b) options to purchase an aggregate of 597,030 ordinary shares, in each case to certain of the Company’s executives, directors, employees, consultants and agents.

 

On May 4, 2023, the Company issued (a) an aggregate of 872,418 ordinary shares, (b) redeemable warrants to purchase an aggregate of 384,500 ordinary shares and (c) warrants to purchase an aggregate of 255,500 ordinary shares, in each case to certain holders of outstanding convertible bridge promissory notes of the Company, upon the conversions thereof in accordance with their terms.

 

In May 2023, in connection with the SEPA, the Company issued 109,397 Ordinary Shares to Yorkville upon the conversion of $100,000 in principal amount of its convertible promissory note.

 

In June 2023, in connection with the SEPA, the Company issued 214,523 Ordinary Shares to Yorkville upon the conversion of $200,000 in principal amount of its convertible promissory note.

 

On June 16, 2023, in connection with the SEPA, the Company issued 258,933 Ordinary Shares to Yorkville upon the conversion of $150,000 in principal amount of its convertible promissory note.

 

On June 27, 2023, the Company issued to EF Hutton, a division of Benchmark Investments, LLC warrants to subscribe for 766,667 number of Ordinary Shares as set forth in the Registration Statement on Form F-1 as filed with the SEC on June 28, 2023.

 

On July 19, 2023, in connection with the SEPA, the Company issued 2,682,141 Ordinary Shares to Yorkville upon the conversion of $550,000 in principle amount of its convertible promissory note.

 

On August 7, 2023, in connection with the SEPA, the Company issued 1,159,155 Ordinary Shares to Yorkville upon the conversion of $132,723.25 in principle amount of its convertible promissory note.

 

On September 6, 2023, in connection with a Securities Purchase Agreement dated September 5, 2023 (“Securities Purchase Agreement”), the Company issued (i) a convertible promissory note to an institutional investor in the principal amount of $4,290,000, and (ii) two (2) warrants to the institutional investor, an “A” warrant and a “B” warrant. The A Warrant for 3,929,051 Ordinary Shares has a conversion price of $0.0022 per shares and the B Warrant for 2,619,367 Ordinary Shares has an exercise price of $1.6378 per share.

 

On September 20, 2023, in connection with the SEPA, the Company issued 129,421 Ordinary Shares to Yorkville upon the conversion of $167,246.75 in principal amount of its convertible promissory note.

 

On September 28, 2023, in connection with amendments to loan agreements dated September 19, 2023, the Company issued 487,281 Ordinary Shares to Kamea-the United Kibbutz Movement Ltd.

 

On September 29, 2023, in connection with the SEPA, the Company issued 86,497 Ordinary Shares to Yorkville upon the conversion of $100,000 in principal amount of its convertible promissory note.

 

On November 9, 2023, in connection with the Independent Contractor Engagement, dated August 11, 2023, by and between Holger and SMX Circular Economy Platform Pte. Ltd., the Company issued 38,640 Ordinary Shares to Holger.

 

II-2
 

 

On November 9, 2023, in connection with the Independent Contractor Engagement, dated August 23, 2023, by and between Mauro and SMX Circular Economy Platform Pte. Ltd., the Company issued 22,325 Ordinary Shares to Mauro.

 

On November 15, 2023, in connection with the Securities Purchase Agreement, the Company issued 146,223 Ordinary Shares to an institutional investor upon the conversion of $239,484.02 in principal amount of its convertible promissory note.

 

On November 20, 2023, in connection with the SEPA, the Company issued 89,269 Ordinary Shares to Yorkville upon the conversion of $100,000 in principal amount of its convertible promissory note.

 

On November 28, 2023, in connection with the SEPA, the Company issued 727,270 Ordinary Shares to Yorkville upon the conversion of $800,000 in principal amount of its convertible promissory note.

 

On November 28, 2023, in connection with the Securities Purchase Agreement, the Company issued 161,046 Ordinary Shares to an institutional investor upon the conversion of $263,761.14 in principal amount of its convertible promissory note.

 

On December 8, 2023, in connection with the Securities Purchase Agreement, the Company issued of 205,462 Ordinary Shares to an institutional investor upon the conversion of $336,505.66 in principal amount of its convertible promissory note.

 

On December 8, 2023, in connection with an inducement offer letter agreement with certain holders of existing warrants, dated December 7, 2023, the Company issued an aggregate of 909,090 new warrants to purchase, in the aggregate, up to 909,090 Ordinary Shares at an exercise price of either (i) $0.0022 per share in an amount not to exceed 75% of the New Warrant Shares, or (ii) $1.15 per share, in the discretion of the warrantholders.

 

On December 8, 2023, in connection with an inducement offer letter agreement, dated December 7, 2023, the Company issued an aggregate of 606,060 ordinary shares to certain holders of existing warrants.

 

On December 11, 2023, in connection with the Securities Purchase Agreement, the Company issued 247,568 Ordinary Shares to an institutional investor upon the conversion of $405,466.87 in principal amount of its convertible promissory note.

 

On December 13, 2023, in connection with the Securities Purchase Agreement, the Company issued 258,417 Ordinary Shares to an institutional investor upon the conversion of $423,235.36 in principal amount of its convertible promissory note.

 

On December 18, 2023, in connection with the Securities Purchase Agreement, the Company issued 271,337 Ordinary Shares to an institutional investor upon the conversion of $444,393.7 in principal amount of its convertible promissory note.

 

On January 12, 2024, in connection with the Securities Purchase Agreement, the Company issued 301,267 Ordinary Shares to an institutional investor upon the conversion of $493,415.09 in principal amount of its convertible promissory note.

 

On January 12, 2024, the Company issued an aggregate of 4,032,256 Ordinary Shares and warrants to purchase an aggregate of 4,032,256 ordinary shares, to holders (the “Note Holders”) of existing convertible notes (the “Existing Notes”) and Redeemable Warrants (the “Redeemable Warrants”), in exchange for the cancellation of an aggregate of (a) approximately $750,000 owed to the Note Holders under the Notes and (b) $1,450,000 cash value of Redeemable Warrants.

 

On January 12, 2024, the Company issued 457,682 Ordinary Shares to a service provider (the “Service Provider”) as payment in full for $260,000 worth of services previously provided to the Company by the Service Provider.

 

II-3
 

 

On January 19, 2024, in connection with the Securities Purchase Agreement, the Company issued 552,181 Ordinary Shares to an institutional investor upon the conversion of $904,362.04 in principal amount of its convertible promissory note.

 

On January 25, 2024, in connection with the SEPA, the Company issued 500,000 Ordinary Shares to Yorkville as advances under the SEPA.

 

On February 2, 2024, the Company issued 500,000 Ordinary Shares to EF Hutton, LLC in lieu of paying a cash fee of $155,000 to EF Hutton, LLC for underwriting services.

 

On February 7, 2024, in connection with the SEPA, the Company issued 500,000 Ordinary Shares to Yorkville as advances under the SEPA.

 

On February 7, 2024, in connection with the Securities Purchase Agreement, the Company issued 475,866 Ordinary Shares to an institutional investor upon the conversion of $779,374.08 in principal amount of its convertible promissory note.

 

On February 16, 2024, in connection with the SEPA, the Company issued 500,000 Ordinary Shares to Yorkville as advances under the SEPA.

 

On February 21, 2024, a warrant holder exercised 653,595 Ordinary Shares underlying a Warrant A at an exercise price per share of $0.0022.

 

On February 27, 2024, a warrant holder exercised 736,274 Ordinary Shares underlying a Warrant A at an exercise price per share of $0.0022.

 

None of the foregoing transactions involved any underwriters, underwriting discounts or commissions, or any public offering. The Registrant believes these transactions were exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act (or Regulation D or Regulation S promulgated thereunder), or Rule 701 promulgated under Section 3(b) of the Securities Act as transactions by an issuer not involving any public offering or pursuant to benefit plans and contracts relating to compensation as provided under Rule 701. The recipients of the securities in each of these transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the stock certificates issued in these transactions. All recipients had adequate access, through their relationships with us, to information about the Registrant.

 

II-4
 

 

Item 8. Exhibits.

 

Item 8. Exhibits and Financial Statement Schedules

 

Exhibit

No.

  Description
     
2.1   Business Combination Agreement, dated as of July 26, 2022, by and among Empatan Public Limited Company, Lionheart III Corp., Security Matters PTY and Aryeh Merger Sub, Inc. (incorporated by reference to Annex A to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, initially filed with the SEC on September 6, 2022).
     
2.2   Scheme Implementation Deed, dated July 26, 2022, by and among Lionheart III Corp., Empatan Public Limited Company and Security Matters PTY (incorporated by reference to Annex B-1 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, initially filed with the SEC on September 6, 2022).
     
3.1   Articles of Association of the Company (incorporated by reference to Exhibit 3.2 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, initially filed with the SEC on September 6, 2022).
     
3.2   Form of Amended and Restated Memorandum and Articles of Association of the Company (incorporated by reference to Annex C to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, initially filed with the SEC on September 6, 2022).
     
3.3   Deed of Variation-Scheme Implementation Deed, dated January 8, 2023, by and among Lionheart III Corp., Empatan Public Limited Company and Security Matters PTY (incorporated by reference to Annex B-2 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on January 12, 2023).
     
3.4   Constitution True Gold Consortium Pty Ltd. (incorporated by reference to Exhibit 10.19 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
3.5   Certificate of Incorporation on Change of Name (incorporated by reference to Exhibit 3.5 to the Registration Statement on Form F-1 (Reg. No. 333-270674), as amended, initially filed with the SEC on March 17, 2023).
     
3.6   Amended Public Limited Company Constitution of SMX (Security Matters) Public Limited Company Memorandum of Association (incorporated by reference to Exhibit 1.1 to the Company’s Current Report on Form 6-K filed with the SEC on August 18, 2023).
     
3.7   Further Amended Public Limited Company Constitution of SMX (Security Matters) Public Limited Company Memorandum of Association (incorporated by reference to Exhibit 3.7 to the Registration Statement on Form F-1 (Reg. No. 333-274774), as amended, initially filed with the SEC on September 29, 2023).
     
4.1   Promissory Note between the Company and EF Hutton, dated March 7, 2023 (incorporated by reference to Exhibit 4.1 to the Registration Statement on Form F-1 (Reg. No. 333-270674), as amended, initially filed with the SEC on March 17, 2023).
     
4.2   Warrant Agreement, dated November 3, 2021, by and between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 4.1 of the Current Report on Form 8-K filed by Lionheart III Corp with the SEC on November 9, 2021)
     
4.3   Form of Warrant A (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023)
     
4.4   Form of Warrant B (incorporated by reference to Exhibit 4.4 to the Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023)

 

II-5
 

 

4.5   Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.5 to the Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023)
     
4.6   Form of Underwriter’s Warrant (incorporated by reference to Exhibit 4.6 to the Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023)
     
4.7   Form of Warrant Agent Agreement with Respect to Warrant A, by and between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 4.7 to the Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023)
     
4.8   Form of Warrant Agent Agreement with Respect to Warrant B, by and between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 4.8 to the Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023)
     
4.9   Form of A Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 6-K filed with the SEC on September 6, 2023)
     
4.10   Form of B Warrant (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 6-K filed with the SEC on September 6, 2023)
     
4.11   Form of New Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 6-K filed with the SEC on December 7, 2023).
     
4.12   Warrant to YAII PN, Ltd. (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 6-K filed with the SEC on February 2, 2024).
     
4.13   Form of New Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 6-K filed with the SEC on December 7, 2023).
     
4.14   Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.14 to the Company’s Registration Statement on Form F-1 (Reg. No. 333-276760), as amended, initially filed with the SEC on February 8, 2024).
     
5.1**   Opinion of Arthur Cox
     
10.1   Registration Rights Agreement, dated November 3, 2021, by and between Lionheart III Corp, Lionheart Equities, LLC and certain securityholders (incorporated by reference to Exhibit 10.3 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, initially filed with the SEC on September 6, 2022).
     
10.2   Private Placement Securities Subscription Agreement, dated November 3, 2021, by and between Lionheart III Corp and Lionheart Equities, LLC (incorporated by reference to Exhibit 10.5 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, initially filed with the SEC on September 6, 2022).
     
10.3   Form of Indemnity Agreement (incorporated by reference to Exhibit 10.6 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, initially filed with the SEC on September 6, 2022).
     
10.4   Amended and Restated Sponsor Agreement, dated July 26, 2022, by and among Lionheart III Corp, Lionheart Equities, LLC, and certain insiders (incorporated by reference herein to Exhibit 10.9 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, initially filed with the SEC on September 6, 2022).
     
10.5  

Amended and Restated Registration Rights Agreement, by and between the Company, Lionheart Equities, LLC and Holders, dated February 23, 2023 (incorporated by reference to Exhibit 4.10 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

 

II-6
 

 

10.6   Employment Agreement, dated June 1, 2021, by and between Security Matters Ltd. and Haggai Alon (incorporated by reference to Exhibit 10.12 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.7   Employment Agreement, dated April 25, 2021, by and between Security Matters Ltd. and Limor Moshe Lotker (incorporated by reference to Exhibit 10.13 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.8   Amendment I, dated June 9, 2022, to Employment Agreement dated June 1, 2021, by and between Security Matters Ltd. and Haggai Alon (incorporated by reference to Exhibit 10.14 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.9   Amendment I, dated June 9, 2022, to Employment Agreement dated April 25, 2021, by and between Security Matters Ltd. and Limor Moshe Lotker (incorporated by reference to Exhibit 10.15 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.10   License Agreement, dated January 1, 2015, by and between Isorad Ltd. and Security Matters Ltd. (incorporated by reference to Exhibit 10.16 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.11   Amendment to License Agreement, dated July 10, 2018, by and between Isorad Ltd. and Security Matters Ltd. (incorporated by reference to Exhibit 10.17 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.12   Addendum to License Agreement, dated April 30, 2019, by and between Isorad Ltd. and Security Matters Ltd. (incorporated by reference to Exhibit 10.18 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.13   TrueGold Licensing Agreement dated July 26, 2020, by and between Security Matters Ltd. and True Gold Consortium Pty Ltd. (incorporated by reference to Exhibit 10.20 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.14   Shareholders Agreement dated July 27, 2020 by and among Security Matters PTY, W.A. Mint Pty Ltd. and True Gold Consortium Pty Ltd. (incorporated by reference to Exhibit 10.21 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.15   True Gold R&D Services Agreement dated November 16, 2022, by and between Security Matters Ltd. and True Gold Consortium Pty Ltd. (incorporated by reference to Exhibit 10.22 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.16   Services Agreement dated June 16, 2021, by and between Security Matters PTY and True Gold Consortium Pty Ltd. (incorporated by reference to Exhibit 10.23 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).

 

II-7
 

 

10.17   Amendment, dated May 26, 2022, to True Gold R&D Services Agreement, by and between Security Matters, Ltd. and True Gold Consortium Pty. Ltd. (incorporated by reference to Exhibit 10.24 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.18   Shareholders Agreement dated April 30, 2019, by and among Security Matters Ltd., Trifecta Industries Ltd. and Newco (incorporated by reference to Exhibit 10.25 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.19   Chairman Agreement dated July 26, 2022, by and among Ophir Sternberg and the Company (incorporated by reference to Exhibit 10.26 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.20   Independent Contractor Agreement dated July 26, 2022, by and among Faquiry Diaz and the Company (incorporated by reference to Exhibit 10.27 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.21   Form of Assignment, Assumption and Amendment Agreement with respect to the Warrant Agreement (incorporated by reference to Exhibit 4.4 to the Registration Statement on Form F-4 (Reg. No. 333-267301), as amended, filed with the SEC on December 28, 2022).
     
10.22   Reciprocal Standby Equity Purchase Agreement with YA II PN, LTD., dated February 23, 2023 (incorporated by reference to Exhibit 4.27 to the Shell Company Report on Form 20-F (File No. 001-41639), as amended, filed with the SEC on March 7, 2023).
     
10.23   Convertible Promissory Note with YA II PN, LTD., dated March 9, 2023 (incorporated by reference to Exhibit 4.28 to the Shell Company Report on Form 20-F (File No. 001-41639), as amended, filed with the SEC on March 7, 2023).
     
10.24   Form of Senior Secured Promissory Note (incorporated by reference to Exhibit 4.29 to the Shell Company Report on Form 20-F (File No. 001-41639), as amended, filed with the SEC on March 7, 2023).
     
10.25   Form of Specific Security Deed (incorporated by reference to Exhibit 4.30 to the Shell Company Report on Form 20-F (File No. 001-41639), as amended, filed with the SEC on March 7, 2023).
     
10.26   Form of 15% Senior Convertible Note due 2024 Growth Financing Termsheet (incorporated by reference to Exhibit 4.31 to the Shell Company Report on Form 20-F (File No. 001-41639), as amended, filed with the SEC on March 7, 2023).
     
10.27   Amended and Restated Promissory Note with Lionheart Management, LLC and Lionheart Equities, LLC, dated March 7, 2023 (incorporated by reference to Exhibit 4.32 to the Shell Company Report on Form 20-F (File No. 001-41639), as amended, filed with the SEC on March 7, 2023).
     
10.28   2022 Incentive Equity Plan (incorporated by reference to Exhibit 4.33 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.29   Lock-Up Agreement, dated February 23, 2023, by and between the Company and Ophir Sternberg (incorporated by reference to Exhibit 4.34 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.30   Lock-Up Agreement, dated February 23, 2023, by and between the Company and Thomas Hawkins (incorporated by reference to Exhibit 4.35 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.31   Lock-Up Agreement, dated February 23, 2023, by and between the Company and Faquiry Diaz Cala (incorporated by reference to Exhibit 4.36 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).

 

II-8
 

 

10.32   Lock-Up Agreement, dated February 23, 2023, by and between the Company and Haggai Alon (incorporated by reference to Exhibit 4.37 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.33   Lock-Up Agreement, dated February 23, 2023, by and between the Company and James Anderson (incorporated by reference to Exhibit 4.38 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.34   Lock-Up Agreement, dated February 23, 2023, by and between the Company and Lionheart Equities, LLC (incorporated by reference to Exhibit 4.39 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.35   Lock-Up Agreement, dated February 23, 2023, by and between the Company and Roger Meltzer (incorporated by reference to Exhibit 4.40 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.36   Lock-Up Agreement, dated February 23, 2023, by and between the Company and Thomas Byrne (incorporated by reference to Exhibit 4.41 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.37   Lock-Up Agreement, dated February 23, 2023, by and between the Company and Benguy Escrow Co. Ltd. A/C. (incorporated by reference to Exhibit 4.42 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.38   Lock-Up Agreement, dated February 23, 2023, by and between the Company and Paul Rapisarda (incorporated by reference to Exhibit 4.43 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.39   Form of 2022 Incentive Equity Plan, Option Award Agreement (incorporated by reference to Exhibit 4.44 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.40   Form of 2022 Incentive Equity Plan, RSU Award Agreement (incorporated by reference to Exhibit 4.45 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.41   Amendment to Binding Terms of Agreement, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.46 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.42   Amendment to 10% Secured Notes, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.47 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.43   Amendment to Binding Terms of Agreement, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.48 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.44   Amendment to Senior Secured Promissory Note Due August 24, 2024, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.49 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.45   Amendment to Senior Secured Promissory Note, dated March 2, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.50 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022 filed with the SEC on April 28, 2023).

 

II-9
 

 

10.46   Amendment to 10% Secured Notes Due July 1st, 2023, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.51 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.47   Amendment to 10% Secured Notes, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.52 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.48   Amendment to 10% Secured Bridge Notes, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.53 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.49   Amendment to Binding Terms of Agreement, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.54 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.50   Amendment to Loan Agreement, dated March 2, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.55 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.51   Amendment to Senior Secured Promissory Note Due July 31, 2023, dated March 5, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.56 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.52   Amendment to Senior Secured Promissory Note Due December 19, 2023, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.57 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.53   Conversion and Exchange Rights Agreement, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.58 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.54   Conversion and Exchange Rights Agreement, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.59 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.55   Amendment to Senior Secured Promissory Note Due December 19, 2023, dated March 1, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.60 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.56   Amendment to Senior Secured Promissory Note Due July 31, 2023, dated March 5, 2023, by and between the Company and Subscriber (incorporated by reference to Exhibit 4.61 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.57   Amended and Restated Promissory Note dated as of March 7, 2023, in favor of Lionheart Management, LLC and Lionheart Equities, LLC (incorporated by reference to Exhibit 4.62 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on April 28, 2023).
     
10.58   Amendment dated April 27, 2023 to Amended and Restated Promissory Note dated as of March 7, 2023 (incorporated by reference to Exhibit 4.63 to the Company’s Annual Report on Form 20-F filed with the SEC on April 28, 2023),
     
10.59   Convertible Promissory Note with YA II PN, LTD., dated May 22, 2023 (incorporated by reference to Exhibit 10.59 to the Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023).

 

II-10
 

 

10.60   Letter Agreement by and between the Company and YA II PN, Ltd., dated July 27, 2023 (incorporated by reference to Exhibit 10.60 to the Company’s Registration Statement on Form F-1 (Reg. No. 333-274378), as amended, initially filed with the SEC on September 6, 2023).
     
10.61   Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 6-K filed with the SEC on September 6, 2023).
     
10.62   Form of Promissory Note (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 6-K filed with the SEC on September 6, 2023).
     
10.63   Form of Registration Rights Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 6-K filed with the SEC on September 6, 2023).
     
10.64*   Employment Agreement by and between Security Matters Pty and Zeren Browne, dated July 21, 2022. (incorporated by reference to Exhibit 10.64 to the Company’s Registration Statement on Form F-1 (Reg No. 333-276258), as amended, initially filed with the SEC on December 22, 2023).
     
10.65   Form of Conversion and Exchange Rights Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 6-K filed with the SEC on January 25, 2024).
     
10.66   Form of Conversion and Exchange Rights Agreement (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 6-K filed with the SEC on January 25, 2024).
     
10.67   Letter Agreement with YAII PN, Ltd. (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 6-K filed with the SEC on February 2, 2024).
     
10.68   Form of Inducement Letter (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 6-K filed with the SEC on December 7, 2023).
     
10.69   Investment Agreement dated as of October 3, 2023 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 6-K filed with the SEC on October 10, 2023).
     
21.1   List of Subsidiaries of the Company (incorporated by reference to Exhibit 21.1 to the Company’s Registration Statement on Form F-1 (Reg. No. 333-272503), as amended, initially filed with the SEC on June 7, 2023).
   
23.1**   Consent of Arthur Cox (included as part of Exhibit 5.1)
   
23.2*   Consent of BDO Ziv Haft
     
23.3*   Consent of BDO Ziv Haft
     
24.1*   Power of Attorney (included on signature page to the initial filing of the Registration Statement)
   
99.1   Relevant Territories for withholding Tax on Dividends (incorporated by reference to Exhibit 99.1 to the Company’s Registration Statement on Form F-1 (Reg. No. 333-270674), as amended, initially filed with the SEC on March 17, 2023).
     
101.INS*   Inline XBRL Instance Document
     
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104*   Cover Page Interactive Data File (embedded within the Inline XBRL document).
     
107*   Filing Fee Table

 

 

* Filed herewith

** To be filed by amendment

 

II-11
 

 

 

(b) Financial Statement Schedules

 

Schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes thereto.

 

(d) Filing Fee Table.

 

The Filing Fee Table and related disclosure is filed herewith as Exhibit 107.

 

Item 9. Undertakings.

 

(a) The undersigned hereby undertakes:

 

(1) to file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

 

(i) to include any prospectus required by Section 10(a)(3) of the Securities Act;

 

(ii) to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) that, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

 

(iii) to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

 

(2) that for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof;

 

(3) to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering;

 

(4) to file a post-effective amendment to the registration statement to include any financial statements required by “Item 8.A. of Form 20-F” at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Securities Act need not be furnished; provided, that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements; and

 

II-12
 

 

(5) that, for the purpose of determining liability under the Securities Act to any purchaser:

 

(i) if the registrant is relying on Rule 430B:

 

(A) each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

 

(B) each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or

 

(ii) if the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness; provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

 

(b) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 

(c) The undersigned hereby undertakes:

 

(1) that for purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective; and

 

(2) for the purpose of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

II-13
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused and authorized this registration statement to be signed on its behalf by the undersigned.

 

  SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY
     
February 28, 2024 By: /s/ Haggai Alon
  Name: Haggai Alon
  Title: CEO

 

POWER OF ATTORNEY

 

Each of the undersigned individuals hereby severally constitutes and appoints each of Haggai Alon and Limor Moshe Lotker as the attorneys-in-fact for the undersigned, in any and all capacities, with full power of substitution, to sign on such person’s behalf, individually and in each capacity stated below, any and all amendments to this registration statement, and any subsequent registration statement filed by the registrant pursuant to Rule 462(b) of the Securities Act, and to file or cause to be filed the same, with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorneys-in-fact, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in connection therewith, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact, and each of them, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ Haggai Alon   Chief Executive Officer and Director   February 28, 2024
Haggai Alon   (Principal Executive Officer)    
         
/s/ Limor Moshe Lotker   Chief Financial Officer   February 28, 2024
Limor Moshe Lotker   (Principal Financial and Accounting Officer)    
         
/s/ Zeren Browne   Executive Vice President, Chief Strategy Officer   February 28, 2024
Zeren Browne   and Director    
         
/s/ Ophir Sternberg   Chairman of the Board of Directors   February 28, 2024
Ophir Sternberg        
         
/s/ Amir Bader   Director   February 28, 2024
Amir Bader        
         
/s/ Pauline Khoo   Director   February 28, 2024
Pauline Khoo        
         
/s/ Roger Meltzer   Director   February 28, 2024
Roger Meltzer        
         
/s/ Thomas Hawkins   Director   February 28, 2024
Thomas Hawkins        

 

II-14
 

 

AUTHORIZED REPRESENTATIVE

 

Pursuant to the requirements of the Securities Act, this registration statement on Form F-1 has been signed on behalf of the registrant by the undersigned, solely in his capacity as the duly authorized representative of the registrant in the United States, on February 28, 2024.

 

Puglisi & Associates  
     
By: /s/ Donald J. Puglisi  
Name: Donald J. Puglisi  
Title Managing Director  

 

II-15

 

 

EX-23.2 2 ex23-2.htm

 

Exhibit 23.2

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the use in this Prospectus constituting a part of the Registration Statement on Form F-1 of SMX (Security Matters) Public Limited Company (the “Company”) of our report dated April 25, 2023, relating to the financial statements of the Company which is contained in that Registration Statement.

 

We also consent to the reference to us under the caption “Experts” in the Prospectus.

 

  /s/ Ziv Haft
 

Certified Public Accountants (Isr.)

BDO Member Firm

 

Tel Aviv, Israel

February 28, 2024

 

 

 

 

EX-23.3 3 ex23-3.htm

 

Exhibit 23.3

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the use in this Prospectus constituting a part of the Registration Statement on Form F-1 of SMX (Security Matters) Public Limited Company of our report dated April 25, 2023, relating to the consolidated financial statements of Security Matters PTY (formerly Security Matters Limited), which is contained in that Prospectus.

 

We also consent to the reference to us under the caption “Experts” in the Prospectus.

 

  /s/ Ziv Haft
 

Certified Public Accountants (Isr.)

BDO Member Firm

 

Tel Aviv, Israel

February 28, 2024

 

 

 

 

EX-FILING FEES 4 ex107.htm

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form F-1

(Form Type)

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

   Security
Type
  Security
Class
Title
  Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Unit
  Maximum
Aggregate
Offering Price
   Fee
Rate
   Amount of
Registration
Fee
 
Newly Registered Securities  
Fees to Be
Paid
  Equity  Ordinary
Shares
  Other  4,000,000 (1)  $0.29795 (2)   $ 1,191,800     0.00014760   $ 175.91  
Total Offering Amounts          $ 1,191,800         $ 175.91  
Total Fees Previously Paid                    $0 
Total Fee Offsets                 $0 
Net Fee Due                  $ 175.91  

 

(1) Consists of an aggregate of 4,000,000 of the registrant (“Ordinary Shares”) that are available to be issued and sold by the registrant to the selling securityholder named herein, from time to time at the registrant’s election pursuant to a standby equity purchase agreement, effective as of March 7, 2023, between the registrant and the selling securityholder, subject to satisfaction of the conditions set forth therein.
(2) Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the Ordinary Shares on The Nasdaq Stock Market LLC on February 26, 2024 ($0.29795 per Ordinary Share). This calculation is in accordance with Rule 457(c).
(3) In the event of a stock split, stock dividend or other similar transaction involving the Ordinary Shares, in order to prevent dilution, the number of Ordinary Shares registered hereby shall be automatically increased to cover the additional Ordinary Shares in accordance with Rule 416(a) under the Securities Act.

 

 

 

 

GRAPHIC 5 formf-1_001.jpg begin 644 formf-1_001.jpg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end GRAPHIC 6 formf-1_002.jpg begin 644 formf-1_002.jpg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formf-1_003.jpg begin 644 formf-1_003.jpg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end GRAPHIC 8 formf-1_004.jpg begin 644 formf-1_004.jpg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end GRAPHIC 9 fin1_001.jpg begin 644 fin1_001.jpg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end GRAPHIC 10 fin_001.jpg begin 644 fin_001.jpg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end EX-101.SCH 11 smx-20230630.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Interim Condensed Consolidated Statements of Financial Position link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Interim Condensed Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Interim Condensed Consolidated Changes In Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Interim Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 995511 - Disclosure - GENERAL link:presentationLink link:calculationLink link:definitionLink 995512 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 995513 - Disclosure - CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS link:presentationLink link:calculationLink link:definitionLink 995514 - Disclosure - OTHER CURRENT ASSETS link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - PROPERTY AND EQUIPMENT, NET link:presentationLink link:calculationLink link:definitionLink 995516 - Disclosure - CONVERTIBLE NOTES link:presentationLink link:calculationLink link:definitionLink 995517 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES link:presentationLink link:calculationLink link:definitionLink 995518 - Disclosure - INTANGIBLE ASSETS, NET link:presentationLink link:calculationLink link:definitionLink 995519 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 995520 - Disclosure - OTHER PAYABLES link:presentationLink link:calculationLink link:definitionLink 995521 - Disclosure - BORROWINGS FROM RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 995522 - Disclosure - BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY link:presentationLink link:calculationLink link:definitionLink 995523 - Disclosure - SHAREHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 995524 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES link:presentationLink link:calculationLink link:definitionLink 995526 - Disclosure - TAXES ON INCOME link:presentationLink link:calculationLink link:definitionLink 995527 - Disclosure - LOSS PER SHARE link:presentationLink link:calculationLink link:definitionLink 995528 - Disclosure - RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 995529 - Disclosure - GOVERNMENT GRANTS link:presentationLink link:calculationLink link:definitionLink 995530 - Disclosure - CONTROLLED ENTITIES link:presentationLink link:calculationLink link:definitionLink 995531 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 995532 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT link:presentationLink link:calculationLink link:definitionLink 995533 - Disclosure - FAIR VALUE MEASUREMENT link:presentationLink link:calculationLink link:definitionLink 995534 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - MATERIAL EVENTS DURING THE PERIOD link:presentationLink link:calculationLink link:definitionLink 995536 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 995537 - Disclosure - GENERAL (Tables) link:presentationLink link:calculationLink link:definitionLink 995538 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995539 - Disclosure - OTHER CURRENT ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 995540 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 995541 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995542 - Disclosure - INTANGIBLE ASSETS, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 995543 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 995544 - Disclosure - OTHER PAYABLES (Tables) link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - BORROWINGS FROM RELATED PARTIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995546 - Disclosure - SHAREHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 995547 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 995548 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 995549 - Disclosure - TAXES ON INCOME (Tables) link:presentationLink link:calculationLink link:definitionLink 995550 - Disclosure - LOSS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 995551 - Disclosure - RELATED PARTIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995552 - Disclosure - GOVERNMENT GRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 995553 - Disclosure - CONTROLLED ENTITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 995554 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - FAIR VALUE MEASUREMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 995556 - Disclosure - SUBSEQUENT EVENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 995557 - Disclosure - GENERAL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995558 - Disclosure - SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 995559 - Disclosure - SCHEDULE OF OTHER CURRENT ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 995560 - Disclosure - SCHEDULE OF OTHER RECEIVABLES (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995561 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 995562 - Disclosure - CONVERTIBLE NOTES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995563 - Disclosure - SCHEDULE OF INFORMATION ABOUT CONSOLIDATED STRUCTURED ENTITIES (Details) link:presentationLink link:calculationLink link:definitionLink 995564 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - SUMMARY OF INTANGIBLE ASSETS NET (Details) link:presentationLink link:calculationLink link:definitionLink 995566 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995567 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 995568 - Disclosure - SCHEDULE OF LEASE LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 995569 - Disclosure - SCHEDULE OF CARRYING AMOUNTS OF LEASE LIABILITIES RECOGNIZED IN PROFIT OR LOSS (Details) link:presentationLink link:calculationLink link:definitionLink 995570 - Disclosure - SCHEDULE OF OTHER PAYABLES (Details) link:presentationLink link:calculationLink link:definitionLink 995571 - Disclosure - LEASES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995572 - Disclosure - SCHEDULE OF BORROWINGS FROM RELATED PARTIES (Details) link:presentationLink link:calculationLink link:definitionLink 995573 - Disclosure - BORROWINGS FROM RELATED PARTIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995574 - Disclosure - SCHEDULE OF ORDINARY SHARES (Details) link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995576 - Disclosure - SCHEDULE OF SHARE OPTION GRANTED (Details) link:presentationLink link:calculationLink link:definitionLink 995577 - Disclosure - SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 995578 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 995579 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 995580 - Disclosure - SHAREHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995581 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 995582 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995583 - Disclosure - TAXES ON INCOME (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995584 - Disclosure - SCHEDULE OF LOSS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - SCHEDULE OF KEY MANAGEMENT PERSONNEL (Details) link:presentationLink link:calculationLink link:definitionLink 995586 - Disclosure - SCHEDULE OF BALANCE WITH RELATED PARTIES (Details) link:presentationLink link:calculationLink link:definitionLink 995587 - Disclosure - SCHEDULE OF GOVERNMENT GRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 995588 - Disclosure - GOVERNMENT GRANTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995589 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 995590 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995591 - Disclosure - SCHEDULE OF FOREIGN CURRENCY RISK (Details) link:presentationLink link:calculationLink link:definitionLink 995592 - Disclosure - SCHEDULE OF SENSITIVITY ANALYSIS PROFIT AND OTHER EQUITY (Details) link:presentationLink link:calculationLink link:definitionLink 995593 - Disclosure - SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE (Details) link:presentationLink link:calculationLink link:definitionLink 995594 - Disclosure - SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 995596 - Disclosure - SCHEDULE OF ORDINARY SHARES (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995597 - Disclosure - SCHEDULE OF COMPANIES SUBSIDIARIES (Details) link:presentationLink link:calculationLink link:definitionLink 995598 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995599 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995600 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) link:presentationLink link:calculationLink link:definitionLink 995601 - Disclosure - SCHEDULE OF RESTRICTED STOCK UNIT (Details) link:presentationLink link:calculationLink link:definitionLink 995602 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 995603 - Disclosure - MATERIAL EVENTS DURING THE PERIOD (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 12 smx-20230630_cal.xml XBRL CALCULATION FILE EX-101.DEF 13 smx-20230630_def.xml XBRL DEFINITION FILE EX-101.LAB 14 smx-20230630_lab.xml XBRL LABEL FILE Entity Addresses, Address Type [Axis] Business Contact [Member] Consolidated Entities [Axis] Security matters limited [member] Components of equity [axis] Issued capital [member] Additional paid-in capital [member] Foreign Currency Translation [Member] Retained earnings [member] Issued And Additional Paid In Capital [Member] Business combinations [axis] Lionheart [Member] Types of contracts [axis] Business Combination Agreement [Member] Classes of share capital [axis] Ordinary shares [member] Security matters pty ltd [member] Equity line agreement [member] Classes of property, plant and equipment [axis] Computer equipment [member] Machinery [member] Furniture and Office Equipment [Member] Leasehold improvements [member] Special Purpose Acquisition Company [Member] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Gross carrying amount [member] Right-of-use assets [member] Accumulated Depreciation [Member] Convertible Notes Agreements [Member] Non-adjusting events after reporting period [axis] Major ordinary share transactions [member] Classes of financial liabilities [axis] Convertible notes [member] Convertible Note Agreements [Member] Bonus warrants [member] Redeemable warrants [member] Associates [axis] Yahaloma technologies inc [member] True gold consortium pty ltd [member] SMX beverages pty ltd [member] Joint ventures [axis] Global BevCo Pty Ltd. [member] Consulting agreement [member] Categories of financial assets [axis] Security Matters Limited's share of net assets [member] Company's share in net profits (losses) of associated companies [member] Classes of intangible assets other than goodwill [axis] Capitalised development expenditure [member] Licences [member] Accumulated Depreciation Amortisation [Member] Other intangible assets [member] Office equipment [member] Motor vehicles [member] Categories of related parties [axis] Lender two [member] Bridge loan agreements [member] Measurement [axis] Black and scholes model [member] Redeemable warrants type 1 [member] Creation date [axis] Third anniversary [member] Fourth anniversary [member] Monte carlo simulation model [member] Redeemable warrants type 2 [member] First anniversary [member] Second anniversary [member] Three valuation models [member] Eleven lenders [member] Range [axis] Top of range [member] Nonadjusting event [member] Deferred Shares [Member] Employees [member] Consultants [member] Bottom of range [member] Board members [member] Black scholes pricing model [member] Two Executive Director [Member] Executive director [member] Key management personnel of entity or parent [member] Warrants [member] Types of antidilutive instruments [axis] Private warrants [member] Public warrants [member] Ordinary Shares Two [Member] Bridge loans [member] Yorkville [Member] Underwriting agreement [member] Warrant A [member] Warrant B [member] Incentive equity plan [member] Employees directors and service [member] Restricted share units [member] Ranges of exercise prices for outstanding share options [axis] Exercise price one [member] Exercise price two [member] Exercise price three [member] Exercise price four [member] Exercise price five [member] Attribution of expenses by nature to their function [axis] Research and development expenses [member] General and administrative expenses [member] Directors [member] Shareholders [member] Joint ventures [member] Related parties [member] Counterparties [axis] Security Matters Ltd [member] Security matters canada ltd [member] Security matters france ltd [member] Geographical areas [axis] United states dollar [member] Types of risks [axis] Currency risk [member] EUR [member] Credit risk [member] Trade and other payables [member] Maturity [axis] Not later than one year [member] Later than one year and not later than five years [member] Later than five years [member] Government grants [member] Lease liabilities [member] Borrowing [member] Levels of fair value hierarchy [axis] Level 1 of fair value hierarchy [member] Classes of liabilities [axis] Derivatives [member] Level 2 of fair value hierarchy [member] Level 3 of fair value hierarchy [member] Isorad Ltd [member] SMX Public Limited Company [member] Prepaid advance agreement [member] Securities purchase agreement [member] Benchmark investments LLC [member] Loan agreement [member] Loan agreements [member] Subsidiaries [axis] Lion heart III corp [member] SMX circular economy platform pte ltd [member] SMX ireland limited [member] SMX israel ltd [member] Standby equity purchase agreement [member] Borrowings by name [axis] First installment [member] Second installment [member] EF hutton llc [member] Public offering [member] Prefunded warrant [member] Underwriter warrant [member] Technology-based intangible assets [member] Preference shares [member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Contact Personnel Name Statement [Table] IfrsStatementLineItems [Line Items] Current assets Cash and cash equivalents Other current receivables Total current assets Non-current assets Property and equipment, net Intangible assets, net Investment in associated companies Total non-current assets Total assets Current liabilities Trade payables Lease liabilities Other payables Convertible notes Warrants Pre-paid advance Bridge loans and derivative financial liabilities Borrowings from related parties Total current liabilities Non-current liabilities Lease liabilities Bridge loans and derivative financial liabilities Long term payables Other liabilities Total non-current liabilities Total liabilities Shareholders’ equity (deficit) Issued capital Additional paid-in capital Issued capital and additional paid in capital Foreign currency translation reserve Accumulated losses Total Shareholders’ equity (deficit) Total liabilities and shareholders’ equity (deficit) Revenue Cost of sales Gross profit Research and development expenses, net Selling and marketing expenses General and administrative expenses Listing expenses Operating loss Finance expenses Finance income Share of net loss of associated companies Loss before income tax Income tax Loss after income tax for the year attributable to shareholders Other comprehensive loss: Items that will be reclassified to profit or loss: Foreign currency translation Items that will or may be reclassified to profit or loss: Exchange gains arising on translation of foreign operations Other comprehensive loss, net of tax Total comprehensive loss Loss per share attributable to shareholders Basic loss per share attributable to shareholders Diluted loss per share attributable to shareholders Loss after income tax for the period attributable to shareholders Total comprehensive loss Statement of changes in equity [table] Beginning balance, value Beginning balance, shares Loss after income tax for the period Other comprehensive loss for the period Total comprehensive loss for the period Issuance of shares, net Share-based compensation Issuance of options to acquire intangible asset Exercise of warrants Recapitalization due to issuance of shares following the SPAC transaction, net Conversion of convertible notes to shares Conversion of bridge loans to shares Exercise of options Conversion of warrants A to ordinary shares, net (See note 5.2) Issuance of Security Bundle, net (See note 5.2) Ending balance, value Ending balance, shares Cash flows from operating activities: Net Loss Share-based compensation Increase in other current assets Depreciation and amortization Increase (decrease) in other receivables Increase in trade payables Increase in other payables Decrease in other liabilities Financial expenses due to bridge loans principal amounts Revaluation of financial liabilities at fair value Decrease in provision Interest on leases Provision of borrowing to related parties Revaluation of convertible notes SPAC transaction - listing costs Share of net loss of associated companies Issuance of shares for directors Net cash flow used in operating activities Cash flows from investing activities: Purchase of property, plant and equipment Capitalized development cost Net cash flow used in investing activities Cash flows from financing activities: Payments of borrowings to related parties Payment of lease liabilities Exercise of warrants Proceeds from issuance of convertible notes Proceeds from issuance of shares, net Proceeds from issuance of Security Bundle, net Issuance of warrants Issuance of derivative financial liability Proceeds from bridge loans Repayment of bridge loans Advance payment for equity, net (see Note 5.1) Issuance of shares in the SPAC transaction, net Proceeds from bridge loans and warrants Net cash flow from financing activities Increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of period Exchange rate differences on cash and cash equivalent Cash and cash equivalents at end of period Appendix A – Non-Cash transactions during the period: Conversion of liability to ordinary shares (see Note 5.1) Conversion of warrants to ordinary shares (see note 5.2) Conversion of bridge loans and derivative financial liability to ordinary shares Exercise of options and warrants to ordinary shares Conversion of convertible notes to ordinary shares Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance [Table Text Block] Company Selected Measure Name Named Executive Officers, Footnote [Text Block] Peer Group Issuers, Footnote [Text Block] Changed Peer Group, Footnote [Text Block] PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote [Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Equity Valuation Assumption Difference, Footnote [Text Block] Compensation Actually Paid vs. Total Shareholder Return [Text Block] Compensation Actually Paid vs. Net Income [Text Block] Compensation Actually Paid vs. Company Selected Measure [Text Block] Total Shareholder Return Vs Peer Group [Text Block] Compensation Actually Paid vs. Other Measure [Text Block] Tabular List [Table Text Block] Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Attributable to Parent Company Selected Measure Amount Other Performance Measure Amount Adjustment to Compensation Amount PEO Name Measure Name Non-GAAP Measure Description [Text Block] Additional 402(v) Disclosure [Text Block] Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis [Text Block] Stock Price or TSR Estimation Method [Text Block] Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined [Text Block] Forgone Recovery, Individual Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability [Text Block] Outstanding Recovery, Individual Name Outstanding Recovery Compensation Amount Restatement Does Not Require Recovery [Text Block] Awards Close in Time to MNPI Disclosures [Table] Award Type [Axis] Award Timing MNPI Disclosure [Text Block] Award Timing Method [Text Block] Award Timing Predetermined [Flag] Award Timing MNPI Considered [Flag] Award Timing, How MNPI Considered [Text Block] MNPI Disclosure Timed for Compensation Value [Flag] Awards Close in Time to MNPI Disclosures [Table Text Block] Awards Close in Time to MNPI Disclosures, Individual Name Award Underlying Securities Amount Award Exercise Price Award Grant Date Fair Value Underlying Security Market Price Change, Percent Trading Arrangements, by Individual [Table] Trading Arrangement [Axis] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted [Flag] Insider Trading Policies and Procedures Not Adopted [Text Block] GENERAL SIGNIFICANT ACCOUNTING POLICIES CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS OTHER CURRENT ASSETS PROPERTY AND EQUIPMENT, NET CONVERTIBLE NOTES INVESTMENTS IN ASSOCIATED COMPANIES INTANGIBLE ASSETS, NET LEASES OTHER PAYABLES BORROWINGS FROM RELATED PARTIES BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY SHAREHOLDERS’ EQUITY RESEARCH AND DEVELOPMENT EXPENSES, NET GENERAL AND ADMINISTRATIVE EXPENSES TAXES ON INCOME LOSS PER SHARE RELATED PARTIES GOVERNMENT GRANTS CONTROLLED ENTITIES COMMITMENTS AND CONTINGENT LIABILITIES FINANCIAL INSTRUMENTS AND RISK MANAGEMENT FAIR VALUE MEASUREMENT SUBSEQUENT EVENTS Material Events During Period MATERIAL EVENTS DURING THE PERIOD Basis of preparation Principles of consolidation Accounting Estimates and Assumptions Cash and cash equivalents Foreign currency Investments in associated companies Loss per share Governmental grants Fair value measurement Classification of financial instruments by fair value hierarchy Financial assets Financial liabilities Impairment of financial assets Impairment of non-financial assets Property, plant and equipment Reimbursement of research and development expenses Right-of-use assets Lease liabilities Employee benefits Intangible assets Share-based compensation New standards, interpretations and amendments not yet effective Functional currency Application of accounting policies Issue of a unit of financial instruments Reverse acquisition transaction Reverse stock split SCHEDULE OF COMPANIES SUBSIDIARIES SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT SCHEDULE OF OTHER CURRENT ASSETS SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT SCHEDULE OF INFORMATION ABOUT CONSOLIDATED STRUCTURED ENTITIES SUMMARY OF INTANGIBLE ASSETS NET SCHEDULE OF RIGHT OF USE ASSETS SCHEDULE OF LEASE LIABILITY SCHEDULE OF CARRYING AMOUNTS OF LEASE LIABILITIES RECOGNIZED IN PROFIT OR LOSS SCHEDULE OF OTHER PAYABLES SCHEDULE OF BORROWINGS FROM RELATED PARTIES SCHEDULE OF SHARE CAPITAL SCHEDULE OF SHARE OPTION GRANTED SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING SCHEDULE OF RESTRICTED STOCK UNIT SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE SCHEDULE OF LOSS PER SHARE SCHEDULE OF KEY MANAGEMENT PERSONNEL SCHEDULE OF BALANCE WITH RELATED PARTIES SCHEDULE OF GOVERNMENT GRANTS SCHEDULE OF ASSETS AND LIABILITIES SCHEDULE OF FOREIGN CURRENCY RISK SCHEDULE OF SENSITIVITY ANALYSIS PROFIT AND OTHER EQUITY SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE Disclosure of detailed information about business combination [table] Redemption percentage of business combination Remaining funds in trust account Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination Number of shares issued Share price Implied value Consideration of issuance of common stock Additional capital raising Disclosure of detailed information about property, plant and equipment [table] Depreciation rate, property, plant and equipment Prepaid expenses Tax authorities Proof of concept receivables Other Total Current prepaid expenses Property and equipment, beginning balance Additions Deductions Depreciation Currency translation adjustments Property and equipment, ending balance Number of convertible notes issued Face value of convertible notes Proceeds from borrowings Convertible notes maturity period Convertible note conversion price description Convertible note Convertible notes convered into ordinary shares Principal amount Maturity date Interest rate Fixed conversion price Discount rate Warrants to purchase ordinary shares Exercise price Warrants term Share purchase price Par value per share Description of approach used to determine discount rates Volatility rate Risk-free interest rate Fair value of convertible notes Fair value of the redeemable warrants Closing carrying amount Company’s share in net profits (losses) of associated companies Disclosure of associates [table] Country of incorporation Proportion of ownership interest in associate Proportion of ownership interest in joint venture Exercise of stock options shares Exercise price of outstanding share options Weighted average remaining contractual life of outstanding share options Consideration transferred, acquisition-date fair value Description of risk free interest rate percentage Options expected life Consulting fees Percentage of entitys revenue Disclosure of reconciliation of changes in goodwill [table] Cost, beginning balance Capitalized development cost Currency translation adjustments Cost, ending balance Accumulated amortization, beginning balance Amortization Accumulated amortization, ending balance Net book value Currency translation adjustments Amortisation, intangible assets other than goodwill Intangible assets under development Right-of-use assets, beginning balance Additions Foreign currency translation Deductions Depreciation expense Right-of-use assets, ending balance Lease liability, beginning balance Additions Deductions Accretion of interest Foreign exchange differences Lease Payments Lease liability, ending balance Current Non current Depreciation expense of right-of-use assets Interest expense on lease liabilities Foreign Exchange different Expense relating to short-term leases Total amount recognized in profit or loss Employees, salaries and related liabilities Related party Liabilities for grants received (Note 19) Accrued expenses Derivative financial liability (Note 13) Other Total Lease expiration Borrowings from related parties, beginning balance Payment of borrowings Provision for bonus (include interest) Exchange rate differences Borrowings from related parties, ending balance Cash advances and loans from related parties Borrowings, interest rate Bonus payments Carrying amount of liability Current borrowings Number of shares authorized Number of shares issued and outstanding Disclosure of disaggregation of revenue from contracts with customers [table] Warrants to purchase shares Exercise price, share options granted Borrowings maturity Fair value of warrants Weighted average share price, share options granted Percentage of voting equity interests acquired Term warrants Proceeds from loans and warrants Exercise price of warrants Excepted terms Par value Fair value of the bonus Warrants Fair value of redeemable warrants Proceeds from borrowings, classified as financing activities Aggregate amount of convertible instruments issued Redeemable warrants Number of shares Number of options outstanding Beginning balance Weighted average exercise price, outstanding beginning balance Granted Weighted average exercise price, Granted Number of options, Expired Weighted average exercise price, Expired Number of options outstanding Beginning balance Weighted average exercise price, outstanding beginning balance Number of options, Exercisable Weighted average exercise price, Exercisable Exercised Weighted average exercise price, Expired Number of options, Expired Disclosure of number and weighted average remaining contractual life of outstanding share options [table] Number of outstanding shares Weighted average remaining contractual life of outstanding share options Number of exercisable shares Weighted average remaining contractual life of exercisable share options Salaries and related expenses Subcontractors and consultants Research expenses Depreciation and amortization Share based compensation Travel expenses Freight Other Reimbursement from paid pilots and proof of concept projects Total Transaction cost Advertising, Public and Investors Relations Share based compensation Professional services Wages and salaries related Office and maintenance Insurance Others Total Proceeds from issuing other equity instruments Payments for share issue costs Proceeds from issuing shares Number of shares issued warrants Warrants exercise price Warrants expiration date Converted shares description Proceeds from exercise of warrants Option life, share options granted Description of vesting requirements for share-based payment arrangement Weighted average fair value at measurement date, share options granted Expenses of options Risk free interest rate, share options granted Expected volatility, share options granted Expected dividend as percentage, share options granted Date of grant of share-based payment arrangement Par value per share before reserve split Par value per share, post reserve split Convertible notes Stock expense Warrants exercised Number of shares issued Number of shares cancelled Conversion of stock, description Warrants exercise price Warrants exercise price per share Proceeds from ordinary shares Debt principal amount Warrants price per share Shares issued percent Number of shares granted Fair value grant Share based expenses Exercise price Stock option vesting period Exercise price Loss before income tax Theoretical tax rate of 27.5% Tax effect amounts which are not deductible/(taxable) in calculating taxable income: Non-deductible expenditure and others Unrecognized temporary differences and tax losses for which deferred tax weren’t recognized Income tax / (benefit) Applicable tax rate Tax effect of tax losses Net loss attributable to the owners of the Company Basic loss per share Weighted average number of ordinary shares Weighted average number of ordinary shares used in calculating basic loss per share Diluted loss per share Weighted average number of ordinary shares used in calculating diluted loss per share Issuance of options to related party Short-term salary and fees Loan repayment Share based payments Post-employment retirement benefits Payment for Administrative services Non-monetary benefits Proof of Concept projects paid by affiliated companies Key management personnel compensation Disclosure of transactions between related parties [table] Salary and related Borrowings from related parties Other accounts payable Other receivables Investment in subsidiary Total Short term liability at year end Long term liability at year end Total Government grants received Percentage of revenue Government grants Disclosure of offsetting of financial assets [table] Ownership percentage Percentage of royalty Consideration percentage Granted Convertible percentage Consideration paid (received) Payment of cash percent Unpaid contingent liability governance Assets Liabilities Assets Percentage of financial risk management Amount of financial impact of financial instrument Other receivables Disclosure of financial liabilities [table] Financial liabilities at amortized cost Disclosure of fair value measurement of assets [table] Derivative financial liabilities Disclosure of events after reporting period [text block] Disclosure of subsidiaries [table] Country of Incorporation Percentage Owned Disclosure of non-adjusting events after reporting period [table] Ordinary shares Loans maturity date Percentage of convertible notes Description of expected term warrants Description for equity or other funding convertible Payments for proceed from receiving equity or other funding convertible into equity Percentage of cash on exit fee Issued capital, ordinary shares Percentage of weighted average price of common stock Percentage of common stock Proceeds from offering Description for common stock received and effectiveness of resgistration Number of value converted Number of shares converted Conversion price Warrants to purchase, shares Exercise price of share Exercise price of share warrants Number of issued and outstanding ordinary shares percentage Pre-Paid Advance to decrease price per shares Payment of debt Prepaid advance amount Debt principal amount Loan borrowing Original issue discount Interest accrued percent Conversion of shares, description Debt conversion amount Percentage of interests acquired additional Percentage of interests acquired increase Outstanding payables Fair value Fair value based on the quoted opening share price Fair value of the shares Marketable securities held in a trust account Trade, other payables and warrants Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table] Number of outstanding, Beginning Number of outstanding, Granted Number of outstanding, Vested Number of outstanding, Ending Ordinary shares Description of share-based payment arrangement Notional amount Prepaid advance percentage Purchase price of per share Floor price per share Repayments of borrowings Warrants price per share Warrant term description Warrant cashless exercised Warrant exercise description Warrant cash exercise price Warrant exercise price Expected volatility Net proceeds from offering Capital raise fee Warrants issued Expected term Expected dividend Proceeds from issuing equity Investment property Convertible note. Convertible Notes Agreements [Member] Foreign Currency Translation [Member] Disclosure O fInvestment In Associated Companies Explanatory. Yahaloma technologies inc [member] True gold consortium pty ltd [member] SMX beverages pty ltd [member] Options expected life. Provision of borrowing to related parties. Share in earnings losses of associated companies net. Issuance of shares for directors. Accumulated Depreciation Amortisation [Member] Description of accounting policy for basis of preparation explanatory. Principles of consolidation explanatory. Lease expiration. Description of accounting policy for right of use assets explanatory. Disclosure of detailed information about property plant and equipment depreciation rate explanatory. Disclosure of detailed information about right of use assets text block. Special Purpose Acquisition Company [Member] Deductions other than through business combinations property plant and equipment. Deductions to right of use assets. Deductions in lease liabilities. Lease liabilities accretion of interest. Lease liabilities exchange rate of differences. Liabilities for grants received. Lease recognized in profit or loss. Bonus payments. Increase in carrying amount of liability. Proceeds from loans and warrants. Bridge loan agreements [member] Disclosure of controlled entities explanatory. Security Matters Ltd [member] Security matters canada ltd [member] Disclosure of detailed information about research and development expense explanatory. Security matters france ltd [member] Warrants to purchase shares. Disclosure of detailed information about general and administrative expense explanatory. Percentage of royalty. Contingent of consideration percentage. Description of expected expected term options granted. Bonus warrants [member] Addtional equity fund of convertible percent. Payment of cash percent. Fair value of warrants. Redeemable warrants type 1 [member] Third anniversary [member] Fourth anniversary [member] Disclosure of financial instrument and risk management explanatory. Black and scholes model [member] Monte carlo simulation model [member] Redeemable warrants type 2 [member] First anniversary [member] Disclosure of detailed information about government grants explanatory. Second anniversary [member] Description of expected term warrants. United states dollar [member] Key management personnel compensation payment for administrative services. Key management personnel compensation non monetary benefits. Proof of concept projects paid by affiliated companies. Key management personnel compensation loan repayment. Shareholders [member] Directors [member] Disclosure of detailed information about components of income tax expense explanatory. Subcontractors and consultants. General and administrative expenses [member] Research and development expenses [member] Freight expense. Reimbursement from paid pilots and proof of concept projects. Research expense. EUR [member] Balance with related parties. Number of shares issued and outstanding. Details information about balance with related parties explanatory. Percentage of financial risk management. Number of shares issued warrants. Amount of financial impact of financial instrument. Trade and other payables [member] Percentage of revenue. Bridge loans [member] Borrowing [member] Exercise price one [member] Exercise price two [member] Exercise price three [member] Exercise price four [member] Exercise price five [member] Employees [member] Consultants [member] Board members [member] Weighted average remaining contractual life of exercisable share options 2019. Expenses of options. Black scholes pricing model [member] Executive director [member] Nonadjusting event [member] Percentage of convertible notes. Isorad Ltd [member] Payments for proceed from receiving equity or other funding convertible into equity. Percentage of cash on exit fee. SMX Public Limited Company [member] Percentage of weighted average price of common stock. Percentage of common stock. Number of shares converted. Convertible notes [member] Bridge loans and derivative financial liabilities noncurrent. Adjustments for interest on leases. Capitalized development cost classified as investing activities. Redemption percentage of business combination. Remaining funds in trust account. Lionheart [Member] Business Combination Agreement [Member] Description of accounting policy new standards interpretations and amendments not yet effective [Explanatory] Furniture and Office Equipment [Member] Proof of concept receivables current. Number of convertible notes issued. Convertible note conversion price description. Convertible notes maturity period. Convertible notes convered into ordinary shares. Face value of convertible notes. Security Matters Limited's share of net assets [member] Company's share in net profits (losses) of associated companies [member] Shares issued for exercise of stock options, shares. Consulting fees. Global BevCo Pty Ltd. [member] Consulting agreement [member] Intangible assets other than goodwill, gross. Accumulated depreciation of intangible assets other than goodwill. Disclosure of detailed information about operating lease liabilities. Right-of-use assets effect of foreign exchange. Additions of lease liabilities. Lease liabilities foreign exchange differences. Disclosure of detailed information about trade and other payables explanatory. Lender two [member] Three valuation models [member] Warrants exercise price. Warrants expiration date. Warrants to purchase shares in converted shares, description. Two Executive Director [Member] Tax effect amounts which are not deductible taxable in calculating taxable income [Abstract] Disclosure of detailed information about controlled entities assets and liabilities explanatory. Weighted average number of ordinary shares [Abstract] Unpaid contingent liability governance. Proceeds from government grants received. Payments for government grants. Description for equity or other funding convertible. Description for common stock received and effectiveness of resgistration. Disclosure of detailed information about sensitivity analysis profit and other equity explanatory. Disclosure of detailed information about financial instrument and risk management foreign currency explanatory. Government grants [member] Weighted average remaining contractual life of outstanding share options. Accumulated Depreciation [Member] Security matters limited [member] Increase in other current assets. Disclosure of detailed information about other current assets explanatory. Issuance of options to related party. Deferred Shares [Member] Eleven lenders [member] Conversion price. Redeemable warrants [member] Issuance of options to acquire intangible asset. Number of value converted. Investment in subsidiaries joint ventures and associates. Number of issued and outstanding ordinary shares percentage. Disclosure of summary of significant accounting policies explanatory. Description of Other Accounting Policies Relevant to Understanding of Financial Statements. Share issued price per share. Security matters pty ltd [member] Lion heart III corp [member] SMX circular economy platform pte ltd [member] SMX ireland limited [member] SMX israel ltd [member] Stock issued during period value consideration of issuance of common stock. Equity line agreement [member] Fair value based on quoted opening share price. Marketable securities held in trust account. Fixed conversion price. Discount rate. Warrants to purchase ordinary shares. Convertiable note agreements [member] Warrants term. Exercise price of warrants. Share purchase price. Fair value of redeemable warrants. Fair value of convertible notes. Fair value of bonus warrants. Redeemable warrants. Non cash transactions during period abstract. Conversion of liability to ordinary shares. Exercise of options and warrants to ordinary shares. Conversion of convertible notes to ordinary shares. Issued capital and additional paid in capital. Bridge loans and derivative financial liabilities current. Prepaid advance. Issued And Additional Paid In Capital [Member] Conversion of warrants to ordinary shares. Issuance of security bundle. Financial expenses principal amounts. Revaluation of convertible notes. Description of accounting policy for application of accounting policies explanatory. Listing costs. Description of accounting policy for reverse acquisition transaction explanatory. Description of accounting policy for reverse stock split explanatory. Proceed from issuance of warrants. Proceeds from issuance of derivative financial liability. Repayment of bridge loans. Advance payment for equity. Conversion of bridge loans and derivative financial liability to ordinary shares. Disclosure of material events during period explanatory. Standby equity purchase agreement [member] Purchase price of per share. Underwriting agreement [member] Warrant A [member] EF hutton llc [member] Warrants exercise price per share. Warrant B [member] Par value per share before reverse split. Par value per share post reverse split. Transaction cost. Disclosure of restricted stock unit explanatory. Employees directors and service [member] Incentive equity plan [member] Private warrants [member] Public warrants [member] Prepaid advance agreement [member] Prepaid advance to decrease price per shares Loan agreements [member] Securities purchase agreement [member] Benchmark investments LLC [member] Warrants price per share. Capital raise fee. Warrant exercise description. Listing expenses. Proceeds from issuance of security bundle net. Yorkville [Member] Additional paid in capital in funding. Fair value of equity transaction. First installment [member] Second installment [member] Prepaid advance percentage. Floor price per share. Prefunded warrant [member] Public offering [member] Warrant term description. Warrant cashless exercised. Warrant cash exercise price. Expected term. Warrants issued. Underwriter warrant [member] Proceeds from issuing equity. Ordinary shares two [member] Warrant price per share. Shares issued and outstanding period. Stock option vesting period. Disclosure of weighted average loss per share [text block] Original issue discount. Interest accrued percent. Loan agreement [member] Convertible Note Agreements [Member] Percentage of interests acquired increase. Current assets [Default Label] Non-current assets [Default Label] Current liabilities [Default Label] Bridge loans and derivative financial liabilities noncurrent Non-current liabilities [Default Label] Liabilities Equity Equity and liabilities Gross profit Profit (loss) from operating activities Profit (loss) before tax Other comprehensive income that will be reclassified to profit or loss, net of tax Number of shares outstanding Adjustments for interest on leases RevaluationOfConvertibleNotes ShareInEarningsLossesOfAssociatedCompaniesNet IssuanceOfSharesForDirectors Cash flows from (used in) operating activities Purchase of property, plant and equipment, classified as investing activities Capitalized development cost classified as investing activities Cash flows from (used in) investing activities Cash repayments of advances and loans from related parties Payments of lease liabilities, classified as financing activities RepaymentOfBridgeLoans Cash flows from (used in) financing activities Increase (decrease) in cash and cash equivalents after effect of exchange rate changes Description of accounting policy for determining components of cash and cash equivalents [text block] Description of accounting policy for leases [text block] Description of accounting policy for share-based payment transactions [text block] InvestmentInSubsidiariesJointVenturesAndAssociates IntangibleAssetsOtherThanGoodwillGross Increase (decrease) through net exchange differences, intangible assets other than goodwill AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill Right-of-use assets [Default Label] Additions to right-of-use assets RightofuseAssetsEffectofForeignExchange DeductionsToRightofuseAssets Lease liabilities [Default Label] AdditionsOfLeaseLiabilities DeductionsInLeaseLiabilities LeaseLiabilitiesExchangeRateDifferences LeaseLiabilitiesForeignExchangeDifferences LeaseRecognizedInProfitOrLoss Weighted average exercise price of share options outstanding in share-based payment arrangement Weighted average exercise price of share options exercisable in share-based payment arrangement Number of share options exercised in share-based payment arrangement Weighted average exercise price of share options exercised in share-based payment arrangement Weighted average remaining contractual life of outstanding share options [Default Label] Depreciation and amortisation expense Notes and debentures issued Number of instruments granted in share-based payment arrangement Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement Key management personnel compensation Amounts payable, related party transactions Receivables due from related parties Government grants [Default Label] DescriptionOfExpectedExpectedTermOptionsGranted Assets less current liabilities Current trade receivables Net debt FairValueBasedOnQuotedOpeningSharePrice MarketableSecuritiesHeldInTrustAccount Number of other equity instruments outstanding in share-based payment arrangement WarrantsPricePerShare EX-101.PRE 15 smx-20230630_pre.xml XBRL PRESENTATION FILE XML 16 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
6 Months Ended
Jun. 30, 2023
Entity Addresses [Line Items]  
Document Type F-1
Amendment Flag false
Entity Registrant Name SMX (Security Matters) Public Limited Company
Entity Central Index Key 0001940674
Entity Incorporation, State or Country Code L2
Entity Address, Address Line One Mespil Business Centre
Entity Address, Address Line Two Mespil House
Entity Address, Address Line Three Sussex Road
Entity Address, City or Town Dublin 4
Entity Address, Country IE
City Area Code +353-1
Local Phone Number 920-1000
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Business Contact [Member]  
Entity Addresses [Line Items]  
Entity Address, Address Line One 850 Library Avenue
Entity Address, Address Line Two Suite 204
Entity Address, City or Town Newark
Entity Address, State or Province DE
Entity Address, Postal Zip Code 19711
Contact Personnel Name Puglisi & Associates
XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Interim Condensed Consolidated Statements of Financial Position
€ in Thousands, $ in Thousands
Jun. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
EUR (€)
Jul. 01, 2022
EUR (€)
Dec. 31, 2021
USD ($)
Current assets          
Cash and cash equivalents $ 3,020 $ 1,398     $ 4,171
Other current receivables 1,037 3,673      
Total current assets 4,057 5,071      
Non-current assets          
Property and equipment, net 820 969      
Intangible assets, net 5,269 5,027      
Investment in associated companies 112 221      
Total non-current assets 6,201 6,217      
Total assets 10,258 11,288      
Current liabilities          
Trade payables 7,281 2,972      
Lease liabilities 30 30      
Other payables 2,415 650      
Convertible notes 304 563      
Warrants 856      
Pre-paid advance 3,050      
Bridge loans and derivative financial liabilities 2,363 3,682      
Borrowings from related parties 689 710      
Total current liabilities 16,988 4,925      
Non-current liabilities          
Lease liabilities 403 440      
Bridge loans and derivative financial liabilities 938      
Long term payables 3,930 85      
Total non-current liabilities 5,271 4,207      
Total liabilities 22,259 9,132      
Shareholders’ equity (deficit)          
Issued capital and additional paid in capital 51,730 32,711      
Foreign currency translation reserve (702) (537)      
Accumulated losses (63,029) (30,020)      
Total Shareholders’ equity (deficit) (12,001) 2,156     7,891
Total liabilities and shareholders’ equity (deficit) $ 10,258 11,288      
Security matters limited [member]          
Current assets          
Cash and cash equivalents   1,398 € 25 [1] [1] 4,171
Other current receivables   3,673     920
Total current assets   5,071     5,091
Non-current assets          
Property and equipment, net   969     1,192
Intangible assets, net   5,027     3,908
Investment in associated companies   221     147
Total non-current assets   6,217     5,247
Total assets   11,288 25 [1] [1] 10,338
Current liabilities          
Trade payables   2,972     916
Lease liabilities   30     37
Other payables   650     673
Convertible notes   563    
Borrowings from related parties   710     270
Total current liabilities   4,925     1,896
Non-current liabilities          
Lease liabilities   440     466
Bridge loans and derivative financial liabilities   3,682    
Other liabilities   85     85
Total non-current liabilities   4,207     551
Total liabilities   9,132     2,447
Shareholders’ equity (deficit)          
Issued capital  
Additional paid-in capital   32,713 25 [1] [1] 31,504
Foreign currency translation reserve   (537)     223
Accumulated losses   (30,020)     (23,836)
Total Shareholders’ equity (deficit)   2,156 € 25 [1] [1] 7,891
Total liabilities and shareholders’ equity (deficit)   $ 11,288     $ 10,338
[1] Less than 1 thousand.
XML 18 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Interim Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]          
Research and development expenses, net $ 1,172 $ 933      
Selling and marketing expenses 228 378      
General and administrative expenses 13,350 1,200      
Listing expenses 16,802      
Operating loss 31,552 2,511      
Finance expenses 2,496 36      
Finance income 1,143 105      
Share of net loss of associated companies 104      
Loss before income tax 33,009 2,442      
Income tax      
Loss after income tax for the year attributable to shareholders (33,009) (2,442)      
Items that will be reclassified to profit or loss:          
Foreign currency translation (165) (639)      
Items that will or may be reclassified to profit or loss:          
Other comprehensive loss, net of tax (165) (639)      
Total comprehensive loss $ (33,174) $ (3,081)      
Loss per share attributable to shareholders          
Basic loss per share attributable to shareholders $ (39.46) [1] $ (3.36) [2],[3]      
Diluted loss per share attributable to shareholders $ (39.46) [1] $ (3.36) [2],[3]      
Loss after income tax for the period attributable to shareholders $ 33,009 $ 2,442      
Total comprehensive loss $ 33,174 $ 3,081      
Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Revenue     $ 13
Cost of sales     10
Gross profit     3
Research and development expenses, net     1,898 2,039 1,689
Selling and marketing expenses     569 453 427
General and administrative expenses     2,723 2,482 2,447
Operating loss     (5,190) (4,974) (4,560)
Finance expenses     1,128 101 79
Finance income     28 237 67
Share of net loss of associated companies     106 (101) (1)
Loss before income tax     (6,184) (4,939) (4,573)
Income tax    
Loss after income tax for the year attributable to shareholders     (6,184) (4,939) (4,573)
Items that will be reclassified to profit or loss:          
Foreign currency translation     (522) (7) 388
Items that will or may be reclassified to profit or loss:          
Exchange gains arising on translation of foreign operations     (238) (375)
Other comprehensive loss, net of tax     (760) (382) 388
Total comprehensive loss     $ (6,944) $ (5,321) $ (4,185)
Loss per share attributable to shareholders          
Basic loss per share attributable to shareholders     $ (0.04) $ (0.03) $ (0.04)
Diluted loss per share attributable to shareholders     $ (0.04) $ (0.03) $ (0.04)
Loss after income tax for the period attributable to shareholders     $ 6,184 $ 4,939 $ 4,573
Total comprehensive loss     $ 6,944 $ 5,321 $ 4,185
[1] After giving effect to the reverse stock split (see also Note 9.1)
[2] Restated as a result of the SPAC transaction
[3] Restated as a result of the SPAC transaction and after giving effect to the reverse stock split (see also Note 1 and 9.1)
XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Interim Condensed Consolidated Changes In Shareholders' Equity
€ in Thousands, $ in Thousands
Issued capital [member]
Security matters limited [member]
USD ($)
shares
Additional paid-in capital [member]
Security matters limited [member]
USD ($)
Foreign Currency Translation [Member]
Security matters limited [member]
USD ($)
Foreign Currency Translation [Member]
USD ($)
Retained earnings [member]
Security matters limited [member]
USD ($)
Retained earnings [member]
USD ($)
Issued And Additional Paid In Capital [Member]
USD ($)
Security matters limited [member]
USD ($)
Security matters limited [member]
EUR (€)
[1]
USD ($)
Beginning balance, value at Dec. 31, 2019 $ 17,357 $ 217   $ (14,324)     $ 3,250    
Beginning balance, shares at Dec. 31, 2019 | shares                  
IfrsStatementLineItems [Line Items]                    
Loss after income tax for the period   (4,573)     (4,573)    
Other comprehensive loss for the period 388       388    
Total comprehensive loss for the period 388   (4,573)     (4,185)    
Issuance of shares, net 6,857       6,857    
Share-based compensation 519       519    
Exercise of warrants          
Ending balance, value at Dec. 31, 2020 24,733 605   (18,897)     6,441    
Ending balance, shares at Dec. 31, 2020 | shares                  
IfrsStatementLineItems [Line Items]                    
Loss after income tax for the period   (4,939)     (4,939)    
Other comprehensive loss for the period (382)       (382)    
Total comprehensive loss for the period (382)   (4,939)     (5,321)    
Issuance of shares, net 5,892       5,892    
Share-based compensation 484       484    
Exercise of warrants 395       395    
Ending balance, value at Dec. 31, 2021 31,504 223 $ 223 (23,836) $ (23,836) $ 31,504 7,891   $ 7,891
Ending balance, shares at Dec. 31, 2021 | shares                  
IfrsStatementLineItems [Line Items]                    
Loss after income tax for the period         (2,442)     (2,442)
Other comprehensive loss for the period       (639)       (639)
Total comprehensive loss for the period       (639)   (2,442)     (3,081)
Issuance of shares, net         721     721
Share-based compensation         219     219
Conversion of warrants A to ordinary shares, net (See note 5.2)                  
Ending balance, value at Jun. 30, 2022       (416)   (26,278) 32,444     5,750
Beginning balance, value at Dec. 31, 2021 31,504 223 223 (23,836) (23,836) 31,504 7,891   7,891
Beginning balance, shares at Dec. 31, 2021 | shares                  
IfrsStatementLineItems [Line Items]                    
Loss after income tax for the period   (6,184)     (6,184)    
Other comprehensive loss for the period (760)       (760)    
Total comprehensive loss for the period   (760)   (6,184)     (6,944)    
Issuance of shares, net 182       182    
Share-based compensation 306       306    
Issuance of options to acquire intangible asset 721       721    
Ending balance, value at Dec. 31, 2022 $ 32,713 $ (537) (537) $ (30,020) (30,020) 32,713 $ 2,156 € 25 2,156
IfrsStatementLineItems [Line Items]                    
Loss after income tax for the period         (33,009)     (33,009)
Other comprehensive loss for the period       (165)       (165)
Total comprehensive loss for the period       (165)   (33,009)     (33,174)
Issuance of shares, net         170     170
Share-based compensation         2,092     2,092
Recapitalization due to issuance of shares following the SPAC transaction, net         11,460     11,460
Conversion of convertible notes to shares         175     175
Conversion of bridge loans to shares         2,983     2,983
Exercise of options         10     10
Conversion of warrants A to ordinary shares, net (See note 5.2)             290     290
Issuance of Security Bundle, net (See note 5.2)         1,837     1,837
Ending balance, value at Jun. 30, 2023       $ (702)   $ (63,029) $ 51,730     $ (12,001)
[1] Less than 1 thousand.
XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Interim Condensed Consolidated Statements of Cash Flows
€ in Thousands, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Cash flows from operating activities:          
Net Loss $ (33,009) $ (2,442)      
Share-based compensation 2,052 165      
Depreciation and amortization 114 176      
Increase (decrease) in other receivables 2,575 (1,727)      
Increase in trade payables 2,545 831      
Increase in other payables 70 110      
Decrease in other liabilities 13 32      
Financial expenses due to bridge loans principal amounts 1,421      
Revaluation of financial liabilities at fair value (41)      
Interest on leases 7 28      
Provision of borrowing to related parties 14 (89)      
Revaluation of convertible notes (382)      
SPAC transaction - listing costs 16,802      
Share of net loss of associated companies 104      
Issuance of shares for directors 40 54      
Net cash flow used in operating activities (7,675) (2,862)      
Cash flows from investing activities:          
Purchase of property, plant and equipment (10) (183)      
Capitalized development cost (383) (783)      
Net cash flow used in investing activities (393) (966)      
Cash flows from financing activities:          
Payment of lease liabilities (21) (39)      
Proceeds from issuance of convertible notes 250 581      
Proceeds from issuance of Security Bundle, net 914      
Issuance of warrants 923      
Issuance of derivative financial liability 974      
Proceeds from bridge loans 550      
Repayment of bridge loans (30)      
Advance payment for equity, net (see Note 5.1) 3,220      
Issuance of shares in the SPAC transaction, net 2,923      
Net cash flow from financing activities 9,703 542      
Increase (decrease) in cash and cash equivalents 1,635 (3,286)      
Cash and cash equivalents at beginning of period 1,398 4,171 $ 4,171    
Exchange rate differences on cash and cash equivalent (13) (26)      
Cash and cash equivalents at end of period 3,020 859 1,398 $ 4,171  
Appendix A – Non-Cash transactions during the period:          
Conversion of liability to ordinary shares (see Note 5.1) 450      
Conversion of warrants to ordinary shares (see note 5.2) 290      
Conversion of bridge loans and derivative financial liability to ordinary shares 2,983      
Exercise of options and warrants to ordinary shares 2,229      
Conversion of convertible notes to ordinary shares 175      
Security matters limited [member]          
Cash flows from operating activities:          
Net Loss     (6,184) (4,939) $ (4,573)
Share-based compensation     252 431 483
Increase in other current assets     (2,936) (463) (162)
Depreciation and amortization     290 315 219
Increase in trade payables     2,217 401 323
Increase in other payables     114 60 150
Decrease in other liabilities     17 (3) (15)
Revaluation of financial liabilities at fair value     387
Decrease in provision     (6)
Interest on leases     51 47 29
Provision of borrowing to related parties     621 89
Share of net loss of associated companies     (106) 101 1
Issuance of shares for directors     54 53 36
Net cash flow used in operating activities     (5,223) (3,908) (3,515)
Cash flows from investing activities:          
Purchase of property, plant and equipment     (152) (297) (235)
Capitalized development cost     (975) (1,468) (723)
Net cash flow used in investing activities     (1,127) (1,765) (958)
Cash flows from financing activities:          
Payments of borrowings to related parties     (172) (103) (144)
Payment of lease liabilities     (55) (98) (12)
Exercise of warrants     395
Proceeds from issuance of convertible notes     581
Proceeds from issuance of shares, net     182 5,892 6,857
Proceeds from bridge loans and warrants     3,310 32
Net cash flow from financing activities     3,846 6,118 6,701
Increase (decrease) in cash and cash equivalents     (2,504) 445 2,228
Cash and cash equivalents at beginning of period $ 1,398 $ 4,171 4,171 4,341 1,708
Exchange rate differences on cash and cash equivalent     (269) (615) 405
Cash and cash equivalents at end of period     $ 1,398 $ 4,171 $ 4,341
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
GENERAL
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
GENERAL

NOTE 1 - GENERAL:

 

A. SMX (Security Matters) Public Limited Company (“Security Matters” or the “Company” and together with its subsidiaries, the “Group”) was incorporated in July 1, 2022 under the laws of Ireland with registered number 722009 and its registered office at Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6. The Company was incorporated in 2022 as part of the Business Combination (see Note 1.B).

 

The Group provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer. Its proprietary marker system embeds a permanent or removable (depending on the needs of the customer) mark on solid, liquid or gaseous objects or materials. Each marker is comprised of a combination of marker codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with an innovative patented reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers or on a blockchain ledger, to protect data integrity and custody.

 

B. The Business Combination - the SPAC transaction (“Business Combination”):

 

On March 7, 2023 (the “Closing Date”) the Company completed its Business Combination with Lionheart III Corp (“Lionheart”), following that Lionheart and Security Matters PTY Ltd. (formerly named Security Matters Limited, which was incorporated in May 2018 under Australian law) became the Company’s wholly-owned subsidiaries and the Company listed its ordinary shares and public warrants on the NASDAQ stock market under the tickers SMX and SMXWW, respectively. On July 26, 2022, Security Matters PTY Ltd. and Lionheart, a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (the “BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders received the Company’s shares and warrants in exchange for their existing Lionheart shares and warrants and all shares existed in Security Matters PTY Ltd were cancelled in return for the Company’s shares and resulting in Security Matters PTY Ltd. becoming a wholly owned subsidiary of the Company. Security Matters PTY Ltd. shareholders received consideration of 1 ordinary share per 10.3624 Security Matters PTY Ltd. shares, having an implied value of $10.00 per ordinary share and the Company became the holder of all of the issued shares in Security Matters PTY Ltd. and Lionheart, with Security Matters PTY Ltd. being delisted from the Australian Stock Exchange.

 

The Business Combination resulted in 97.58% redemption by Lionheart’s public shareholders which resulted in leaving $3,061 of funds remaining in the trust account (See also Note 6 and Note 2.E as for the accounting treatment of the transaction in these financial statements).

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 1 – GENERAL (CONT.):

 

C. The Company operates primarily through 8 wholly owned subsidiaries, all of which have been consolidated in these consolidated financial statements.

 

Controlled entity  

Country of

Incorporation

   

Percentage Owned

June 30, 2023

   

Percentage Owned

December 31, 2022

 
Security Matters PTY Ltd.
(Formerly - Security Matters Limited)
    Australia       100 %     -  
Lionheart III Corp     USA       100 %     -**  
SMX Circular Economy Platform PTE, Ltd.     Singapore       100 %     *  
SMX (Security Matters) Ireland Limited     Ireland       100 %     *  
SMX (Security Matters) Israel Ltd.
(Formerly - Security Matters Ltd.)
    Israel       100 %     100 %***
Security Matters Canada Ltd.     Canada       100 %     100 %***
Security Matters France Ltd.     France       100 %     100 %***
SMX Beverages Pty Ltd.     Australia       100 %     100 %***

 

In addition, the Company’s has the following investments in associated companies:

 

Entity  

Country of

Incorporation

   

Percentage Owned

June 30, 2023

   

Percentage Owned

December 31, 2022

 
Yahaloma Technologies Inc.     Canada       50 %     50 %***
True Gold Consortium Pty Ltd     Australia       44.4 %     44.4 %***

 

The proportion of ownership interest is equal to the proportion of voting power held.

 

* Incorporated in 2023.
** Merger occurred in March 2023.
*** Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2022.

 

D. During the six months ended June 30, 2023, the Company incurred operating losses and negative cash flows from operating activities. The Company has not yet generated revenues. As discussed in Note 4, during the period, the Company entered into binding loan agreements with existing shareholders. As discussed in Note 5.1, the Company executed an equity line agreement to raise up to $25,000 in consideration of the issuance of common stock over the course of 36 months with YA II PN, LTD (“Yorkville”). As discussed in Notes 4 and 9.4, the Company signed agreements to convert indebtedness by issuance of shares. As discussed in Note 9.3 the Company is continuing with additional capital raising, and post balance sheet date it received an additional $2,500 in funding. The Company has also the ability to decrease its expenses in order to meet its existing cash flow streams. Management believes that the proceeds from the recent funding agreements, combined with its cash on hand, equity line and the Company’s plans, are sufficient to meet the Company’s obligations as they come due in the foreseeable future. There are no assurances, however, that the Company will be able to obtain an adequate level of financial resources that are required for its long-term business plan.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 1 – GENERAL:

 

A. SMX (Security Matters) Public Limited Company (the “Company”) was incorporated in July 1, 2022 under the laws of Ireland with registered number 722009 and its registered office at Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6.
   
B. The Corporation has not engaged in any activities except in connection with its formation.
   
C.

On July 26, 2022, Security Matters Limited and Lionheart III Corp (“Lionheart”), a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (“BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders receiving Security Matters Limited shares and warrants in exchange for their existing Lionheart shares and warrants and all shares in Security Matters Limited being cancelled in return for the Company’s shares and resulting in that Security Matters Limited becoming a wholly owned subsidiary of the Company.

   
  On March 7, 2023 a business combination (the “Business Combination”) with Lionheart III Corp (“Lionheart”) was completed, following that the Company, which is newly-formed parent company – SMX (Security Matters) Public Limited Company, (formerly called Empatan Public Limited Company) was listed in the NASDAQ stock exchange under the ticker SMX.

 

Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
GENERAL  

NOTE 1 – GENERAL:

 

A.Security Matters Limited (“Security Matters” or the “Company”, and together with its subsidiaries, the “Group”) was incorporated in May 2018 under Australian law. Security Matters’ registered address is Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6.

 

The Group engages in research and development to permanently and irrevocably “mark” any object either solid, liquid or gas, allowing identification, circularity, proof of authenticity, tracking supply chain movements and quality assurance for countless products in virtually every industry.

 

 

Security Matters’ technology comprises a chemical-based hidden “barcode” system, alongside a unique “reader” to identify these codes, and a blockchain record to store and protect ownership data. Security Matters offers a business-to-business (B2B), “white-label” solution that serves market leaders’ needs for authentication, supply chain integrity and quality assurance.

 

B.On March 7, 2023 the business combination (the “Business Combination”) with Lionheart III Corp (“Lionheart”) was completed, following that a newly-formed parent company – SMX (Security Matters) Public Limited Company (“SMX PLC”), (formerly called Empatan Public Limited Company) is listed in the NASDAQ stock exchange under the ticker SMX.

 

On July 26, 2022, the Company and Lionheart, a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (“BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders receiving SMX PLC Shares and warrants in exchange for their existing Lionheart shares and warrants and all shares in the Company being cancelled in return for SMX PLC shares and resulting in the Company becoming a wholly owned subsidiary of SMX PLC.

 

The Business Combination resulted in 97.58% redemption and with 3,061 remaining funds in the trust account. The transaction cost amounted to 17,300.

 

C.During the 12 months ended December 31, 2022, the Company incurred operating losses and negative cash flows from operating activities. The Company has not yet generated significant revenues. As discussed in Note 12, during the fourth quarter of 2022 the Company entered into binding loan agreements with existing shareholders. As discussed in Note 24 (4), the Company executed an equity line agreement. The Company has also the ability to decrease its expenses in order to meet its existing cash flow streams. Management believes that the proceeds from the recent funding agreements, combined with its cash on hand, equity line and the Company’s plans, are sufficient to meet the Company’s obligations as they come due in the foreseeable future. There are no assurances, however, that the Company will be able to obtain an adequate level of financial resources that are required for its long-term business plan.

 

XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES:

 

A. Basis of preparation

 

These interim consolidated financial statements have been prepared in a condensed format in accordance with IAS 34 Interim Financial Reporting. They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the annual consolidated financial statements as of December 31, 2022 of the Company and of Security Matters PTY Ltd. (formerly - Security Matters Limited).

 

B. Functional currency

 

The consolidated financial statements are prepared in US Dollars, which is the functional and presentation currency of the Company.

 

C. Application of accounting policies

 

The Group has applied the same accounting policies and methods of computation in its interim condensed consolidated financial statements as in its 2022 annual financial statements and as in the 2022 annual financial statements of Security Matters PTY Ltd, except as stated below in note 2D and 2E.

 

Several amendments to IFRS Standards apply for the first time in 2023, but do not have an impact on the interim condensed consolidated financial statements.

 

D. Issue of a unit of financial instruments

 

The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.

 

E. Reverse acquisition transaction

 

The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.

 

Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($11,599), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $16,802, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

E. Reverse acquisition transaction (Cont.)

 

The Company is initially consolidated in the financial statements from the Closing Date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($4,921) and trade and other payables and warrants ($10,127) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:

 

1. The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.

 

2. The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.

 

3. The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.

 

4. The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.

 

F. Reverse stock split

 

The presentation of loss per share amounts has been retrospectively adjusted to give effect to the reverse share split which occurred on August 8, 2023. Except otherwise specifically provided, no other adjustments have been made in these notes to reflect the reverse share split. See also Note 9.1.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES:

 

The significant accounting policies followed in the preparation of the financial statements, on a consistent basis, are:

 

Basis of preparation

 

These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). Separate statements of comprehensive income, changes in equity, and cash flows have not been presented because the Corporation has not engaged in any activities except in connection with its formation.

 

Cash and cash equivalents

 

Cash equivalents are considered by the Company to be highly liquid investments, including, inter alia, short-term deposits with banks and the maturity of which do not exceed three months at the time of deposit, and which are not restricted.

 

Foreign currency

 

The financial statements are prepared in EURO which is the presentation and functional currency of the Company.

 

 

Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
SIGNIFICANT ACCOUNTING POLICIES  

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES:

 

The significant accounting policies followed in the preparation of the financial statements, on a consistent basis, are:

 

Basis of preparation

 

These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). The financial statements have been prepared under the historical cost convention except for certain financial liabilities which are measured at fair value until conversion. The Company has elected to present the statement of comprehensive income using the function of expense method.

 

Principles of consolidation

 

The consolidated financial statements incorporate the assets and liabilities of all subsidiaries of Security Matters Limited as of December 31, 2022 and 2021 and the results of all subsidiaries for the three years in the period then ended. Security Matters Limited and its subsidiaries together are referred to in these financial statements as the Group or the “consolidated entity”.

 

Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is obtained by the Company and until the date that control is lost.

 

Intercompany transactions between entities in the consolidated entity are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of the impairment of the asset transferred.

 

Accounting Estimates and Assumptions

 

The preparation of the consolidated financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities and expenses. These estimates and underlying assumptions are reviewed regularly. Changes in accounting estimates are reported in the period of the change in estimate. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements, are disclosed in note 3.

 

Cash and cash equivalents

 

Cash equivalents are considered by the Group to be highly liquid investments, including, inter alia, short-term deposits with banks and the maturity of which do not exceed three months at the time of deposit, and which are not restricted.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Foreign currency

 

The consolidated financial statements are prepared in US Dollars which is the presentation currency of the Group. Security Matters Limited’s functional currency is Australian Dollars.

 

The functional currency of Security Matters Ltd. (Israel) is New Israeli Shekels. The functional currency of Security Matters Canada Ltd. Is Canadian Dollars. The functional currency of Security Matters France Ltd. Is Euro. The functional currency of SMX Beverages Pty Ltd. Is Australian Dollars.

 

Transactions and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting Standard (IAS) 21 (“The Effects of Changes in Foreign Exchange Rates”). Accordingly, transactions and balances have been converted as follows:

 

Assets and liabilities – at the rate of exchange applicable at the reporting date;
Expense items – at annual average rate at the statements of financial position date.
Share capital, capital reserve and other capital movement items were at rate of exchange as of the date of recognition of those items.
Accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned above.
Exchange gains and losses from the aforementioned conversion are recognized in the statement of other comprehensive lose in Foreign Currency Translation Reserve.

 

Investments in associated companies

 

Investments in associated companies are accounted under the equity method and are initially recognized at cost. The investment’s cost includes transaction costs. The consolidated financial statements include the Group’s share in net income or loss, in other comprehensive income or loss, and in the net assets of associated companies accounted by the equity method from the date when significant influence or joint control materialized, until the date on which the conditions for significant influence or joint control are no longer met.

 

Losses of an associate in amounts which exceed its equity are recognized by the Company to the extent of its investment in the associate plus any losses that the Company may incur as a result of a guarantee or other financial support provided in respect of the associate.

 

Loss per share

 

Basic loss per share

 

Basic loss per share is calculated by dividing the net loss attributable to the owners of Security Matters Limited, by the weighted average number of ordinary shares outstanding during the financial year, adjusted for bonus elements in ordinary shares issued during the financial year.

 

Diluted earnings per share

 

Potential ordinary shares are included in the computation of diluted earnings per share when their conversion decreases earnings per share. Potential Ordinary shares that are converted during the period are included in diluted earnings per share only until the conversion date and from that date in basic earnings per share.

 

Governmental grants

 

Government grants received for the use of research and development activities, for which the Group undertook to pay royalties to the state, contingent on future sales arising from this financing, were treated as forgivable loans. The grant was recognized as a liability in the financial statements, except when there is reasonable assurance that the Group will comply with the conditions for the forgiveness of the loan, then it would be recognized as a government grant. When the loan bears a below-market rate of interest, the liability is recognized at its fair value in accordance with the market interest rate prevailing at the time of receiving the grant. The difference between the consideration received and the liability recognized at inception was treated as a government grant and recognized as a reimbursement of research expenses. The repayment of the liability to the state is reviewed every reporting period, with changes in the liability resulting from a change in the expected royalties recognized in profit or loss.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Fair value measurement

 

Fair value is the price that would be received when selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:

 

A.In the principal market for the asset or liability; or
B.In the absence of a principal market, in the most advantageous market for the asset or liability.

 

The principal or the most advantageous market must be accessible to the Group.

 

The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.

 

A fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.

 

The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.

 

Classification of financial instruments by fair value hierarchy

 

The financial instruments presented in the statements of financial position at fair value are grouped into classes with similar characteristics using the following fair value hierarchy which is determined based on the source of input used in measuring fair value:

 

  Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities.
  Level 2 - Inputs other than quoted prices included within Level 1 that are observable either directly or indirectly.
  Level 3 - Inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).

 

Financial assets

 

The Group classifies its financial assets into one of the following categories, depending on the purpose for which the asset was acquired. The Group’s accounting policy for each category is as follows:

 

Other receivables: These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They arise principally through the provision of goods and services, but also incorporate other types of contractual monetary asset. These assets are carried at amortized cost less any provision for impairment.

 

The Group has no financial assets classified at Fair value through profit or loss.

 

Financial liabilities

 

financial liabilities measured at amortized cost:

 

Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.

 

After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, which ensures that any interest expense over the period is at a constant interest rate on the balance of the liability carried in the statement of financial position, except for

 

measured at fair value through profit or loss:

 

These financial liabilities comprise of derivatives that are options which are to be settled in equity instruments but nevertheless do not meet the definitions of equity instrument. At initial recognition, the Group measures those financial liabilities at fair value. Transaction costs are recognized in profit or loss. After initial recognition, changes in fair value are recognized in profit or loss.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Impairment of financial assets

 

The Group recognizes a loss allowance for expected credit losses on financial assets which are either measured at amortized cost or fair value through other comprehensive income. The measurement of the loss allowance depends upon the Group’s assessment at the end of each reporting period as to whether the financial instrument’s credit risk has increased significantly since initial recognition, based on reasonable and supportable information that is available, without undue cost or effort to obtain.

 

Where there has not been a significant increase in exposure to credit risk since initial recognition, a 12-month expected credit loss allowance is estimated. This represents a portion of the asset’s lifetime expected credit losses that is attributable to a default event that is possible within the next 12 months. Where a financial asset has become credit impaired or where it is determined that credit risk has increased significantly, the loss allowance is based on the asset’s lifetime expected credit losses. The amount of expected credit loss recognized is measured on the basis of the probability weighted present value of anticipated cash shortfalls over the life of the instrument discounted at the original effective interest rate. The loss allowance is recognized in profit or loss.

 

Impairment of non-financial assets

 

Intangible assets that have an indefinite useful life are not subject to amortization and are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired. Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount. Recoverable amount is the higher of an asset’s fair value less costs of disposal and value-in-use. The value-in-use is the present value of the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.

 

Property, plant and equipment

 

Items of property, plant and equipment are initially recognized at cost. Cost includes directly attributable costs and the estimated present value of any future costs of dismantling and removing items. Depreciation is computed by the straight-line method, based on the estimated useful lives of the assets, as follows:

 

   % 
Computers   33 
Machines and equipment   20 
Furniture and office equipment   10 
Leasehold improvements   5 

 

Leasehold improvements are depreciated over the term of the expected lease including optional extension, or the estimated useful lives of the improvements, whichever is shorter.

 

Reimbursement of research and development expenses

 

Reimbursements in proof of concept (POC) agreements of expenditures on research and development in order to achieve commercial agreement once this activity will be result successful, are offset in profit or loss against the related expenses (research and development expenses). Any IP generated from this activity remains at the ownership of the Group.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Right-of-use assets

 

All leases are accounted for by recognizing a right-of-use asset and a lease liability, excluding leases where the lease term is 12 months or less, or where the underlying asset is of low-value. These leases expenditures are recognized on a straight-line basis over the lease term.

 

A right-of-use asset is recognized at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of any lease incentives received.

 

Right-of-use assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever is the shorter. Where the Group expects to obtain ownership of the leased asset at the end of the lease term, the depreciation is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.

 

Lease liabilities

 

All leases are accounted for by recognizing a right-of-use asset and a lease liability. Lease liabilities are measured at the present value of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the rate implicit in the lease unless (as is typically the case) this is not readily determinable, in which case the Group’s incremental borrowing rate on commencement of the lease is used. Variable lease payments are only included in the measurement of the lease liability if they depend on an index or rate. In such cases, the initial measurement of the lease liability assumes the variable element will remain unchanged throughout the lease term. Other variable lease payments are expensed in the period to which they relate.

 

On initial recognition, the carrying value of the lease liability also includes:

 

  amounts expected to be payable under any residual value guarantee.
  the exercise price of any purchase option granted in favor of the Group if it is reasonably certain to exercise that option.
  any penalties payable for terminating the lease, if the term of the lease has been estimated on the basis of termination option being exercised.

 

Subsequent to initial measurement lease liabilities increase as a result of interest charged at a constant rate on the balance outstanding and are reduced for lease payments made. Lease liabilities are remeasured when there is a change in future lease payments arising from a change in an index or rate or when there is a change in the assessment of the term of any lease the remeasurement being recognized in front of the right of use assets.

 

Employee benefits

 

The Group has several employee benefit plans as to Israeli employees:

 

1.Short-term employee benefits: Short-term employee benefits include salaries, paid annual leave, paid sick leave, recreation and social security contributions and are recognized as expenses as the services are rendered. A liability in respect of a cash bonus or a profit-sharing plan is recognized when the Group has a legal or constructive obligation to make such payment as a result of past service rendered by an employee and a reliable estimate of the amount can be made.
2.Post-employment benefits: The plans are normally financed by contributions to insurance companies and classified as defined contribution plans or as defined benefit plans. The Group has defined for most of its employees contribution plans pursuant to Section 14 to the Israel Severance Pay Law since 2004 under which the Group pays fixed contributions and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient amounts to pay all employee benefits relating to employee service in the current and prior periods.

 

Contributions to the defined contribution plan in respect of severance or retirement pay are recognized as an expense simultaneously with receiving the employee’s services and no additional provision is required in the financial statements except for the unpaid contribution.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Intangible assets

 

Intangible assets include capitalized technology development costs. Expenditures on research activities are recognized in profit or loss as incurred. Expenditures on internally developed products are mainly employee salaries and legal fees for filing of patents and are capitalized when the Group demonstrates all the following criteria:

 

  a. The technical feasibility of completing the intangible asset so that it will be available for use or sale.
  b. The intention to complete the intangible asset and use or sell it.
  c. The ability to use or sell the intangible asset.
  d. The probability of the intangible asset to generate future economic benefits. Among other things, the Group considers the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset.
  e. The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.
  f. The ability to measure reliably the expenditures attributable to the intangible asset during its development.

 

The recognition criteria above are considered by the Group at each stage of development to determine when the criteria have been initially met in full.

 

The technical feasibility criteria is determined to be met when the milestone of initial marking and reading capabilities is satisfied. The milestone’s identification occurs only following a detailed broad mapping of the raw material characteristics and establishing the formula for the chemical marker architecture to be embedded into the raw material based on industry standards and regulations. The result is the initial evidence that the x-ray algorithm of the designated reader is in a stage that can identify the marker and convey information. At this stage, the Group believes that the technical feasibility of completing the development for use is probable.

 

The Group notes that technical feasibility has been established and the achieved technology is ready for the next stage which consists of performing a proof-of-concept pilot with an industry partner, in order to adapt the technology for the relevant industry and adjust the development to meet the industry’s needs.

 

Currently, the Group’s capitalized development activities focus on:

 

  1. Development of marker architecture to be embedded topically or in-situ (application) for each material/product within the optimal industrial manufacturing phase, based on industry standards and regulations.
  2. Semi Industrial scale – technology implementation in semi-industrial production.
  3. Development of a digital platform to support the end-to-end traceability from raw material to final product to recycling.

 

The Group’s management has the full intention to complete the development of the technology and ultimately to sell it. This intention is demonstrated by initiating partnerships with industry market leaders and continuing the development into the next phase. The Group’s intention is also reflected in the Group’s approved budget.

 

The Group’s management intends to concentrate its future sales and marketing efforts in the U.S. market, including recruitment of sales and marketing personnel. It plans to advance successful proof-of-concept pilots performed with industry leading partners, and further advance its innovative technology and commercialization efforts and collaborations in the segments relevant to its technology.

 

The Group’s business model targets leading brands and manufacturers in order to create a new market standard for circular economy solutions, brand authentication and supply chain integrity. The Group’s technology is applicable for multiple industries such as gold, fashion, electronics and circular economy – plastic and rubber. The Group is able to provide an adaptive solution for multiple market segments, based on a unified technology solution, through collaborative relationships with leading market companies which provide it with access to various potential entities to sell its solution. This is part of the Group’s strategy to create strategic partnerships with market leaders across its main segments of activity. The Group believes that this close collaboration with market leaders, and developing a product that meets their requests, suggest that there is a strong potential market for its development.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Intangible assets (Cont.)

 

Adequate technical and financial resources are available to complete the development; the development will be completed by the Group’s technology team which consists of professional experienced scientists and engineers, with a track record in the industrial sector and with financial resources successfully raised through the issuance of ordinary shares and loans. The Group has already accomplished its core technology development and is currently focused on development of specific adjustments for different market segments. This stage is focused and short-termed, therefore, management believes that limited financial resources are required for completing the development and that there is high probability for commencing commercial agreements following the successful proof-of-concept pilots.

 

The Group has financial systems in place that allow it to maintain records in sufficient detail that enable it to measure reliably the expenditures attributable to the intangible asset during its development.

 

Development expenditures not satisfying all the above criteria are recognized in the consolidated statement of comprehensive income as incurred.

 

Subsequent measurement

 

In subsequent periods, capitalized development expenditures are measured at cost less accumulated amortization and accumulated impairment losses.

 

An asset is ready for its intended use, when the developed technology becomes operational and the Group completes an initial customization for a client’s specific needs, which means that the technology is fully implemented in the customer’s manufacturing processes and ready for its intended use. The management estimates that in approximately two years such customization will be completed, and amortization will commence.

 

Intangible assets with a finite useful life are amortized over their estimated useful lives and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for intangible assets are reviewed at least at each year end.

 

The carrying amount of these assets is reviewed whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. An expenditure incurred in development activities, including the Group’s software development is capitalized only where it clearly increases the economic benefits to be derived from the asset to which it relates, the expenditure will lead to new or substantially improved products, the products are technically and commercially feasible and the Group has sufficient resources to complete the development and reach the stage for which the product is ready for use.

 

All other expenditure, including those incurred in order to maintain an intangible assets current level of performance, is expensed as incurred.

 

Share-based compensation

 

The Group measures the share-based expense and the cost of equity-settled transactions with employees and service providers by reference to the fair value of the equity instruments at the date at which they are granted. The Group selected the Black-Scholes model as the Group’s option pricing model to estimate the fair value of the Group’s options awards. The model is based on share price, grant date and on assumptions regarding expected volatility, expected life of the options, expected dividend, and a no risk interest rate. As for granted options which are settled in equity instruments, the fair value of the options at the grant date is charged to the statement of comprehensive loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting period is based on the number of options that eventually vest.

 

New standards, interpretations and amendments not yet effective

 

The Group has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective. There are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future accounting periods that the Group has decided not to adopt early.

 

The following amendments are effective for the period beginning January 1, 2023:

 

Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2);
Definition of Accounting Estimates (Amendments to IAS 8); and
Deferred Tax Related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12).

 

The following amendments are effective for the period beginning January 1, 2024:

 

IFRS 16 Leases (Amendment – Liability in a Sale and Leaseback)
IAS 1 Presentation of Financial Statements (Amendment – Classification of Liabilities as Current or Non-current)
IAS 1 Presentation of Financial Statements (Amendment – Non-current Liabilities with Covenants)

 

The Group is currently assessing the impact of these new accounting standards and amendments.

 

The Group does not expect any other standards issued by the IASB, but not yet effective, to have a material impact on the Group.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

XML 23 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS

NOTE 3 – CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS:

 

In the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant effect on the amounts recognized in the financial statements.

 

The preparation of the financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities, revenues and expenses. Changes in accounting estimates are reported in the period of the change in estimate. The key assumptions made in the financial statements are discussed below.

 

Share based payments

 

The Group has a share-based remuneration scheme for employees. The fair value of share options is estimated by using the Black-Scholes model, which was derived to model the value of the firm’s equity over time. The simulation model was designed to take into account the unique terms and conditions of the performance shares and share options, as well as the capital structure of the firm and the volatility of its assets, on the date of grant based on certain assumptions. Those conditions are described in the share-based compensation note and include, among others, the dividend growth rate, expected share price volatility and expected life of the options. The fair value of the equity settled options granted is charged to statement of profit or loss over the vesting period of each tranche and the credit is taken to equity, based on the consolidated entity’s estimate of shares that will eventually vest.

 

Intangible assets

 

The Group capitalizes costs for its developed projects when specific criteria are met. Initial capitalization of costs is based on management’s judgement that technological and economic feasibility is achievable, usually when a product development project has reached a defined milestone according to an established project management model. The management makes assumptions regarding the expected future economic benefit to be derived from the intangible asset and therefore whether the capitalized costs are expected to be recovered.

 

This amount of capitalized costs includes significant investment in the development of marking and reading capabilities in the subject material. Prior to being marketed, the Group will obtain a proof-of-concept pilot with an industry leading partner. The innovative nature of the product gives rise to some judgement as to whether the proof-of-concept will be successful such that it will lead to obtaining commercial contracts with customers. See also Note 2 – Intangible Assets.

 

The Management bases its estimates on historical experience, assumptions, and information currently available and deemed to be reasonable at the time the financial statements are prepared. However, actual amounts may differ from the estimated amounts as more detailed information becomes available. Estimates and assumptions are reviewed on an ongoing basis and, if necessary, changes are recognized in the period in which the estimate is revised.

 

Financial liability at fair value

 

The fair value of financial liabilities at fair value was estimated by using a Black Scholes model and Monte-Carlo simulation approach, which was aimed to model the value of the Company’s assets over time. The simulation approach was designed to take into account the terms and conditions financial liability, which are described in Note 12 and Note 23, as well as the capital structure of the Company and the volatility of its assets. The valuation was performed based on management’s assumptions and projections.

 

XML 24 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER CURRENT ASSETS
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
OTHER CURRENT ASSETS

NOTE 4 – OTHER CURRENT ASSETS:

 

  

December 31,

2022

  

December 31,

2021

 
Prepaid expenses (*)   3,157    454 
Tax authorities   358    280 
Proof of concept receivables   86    116 
Other   72    70 
Total   3,673    920 

 

*The prepaid expenses include 3,123 for December 31, 2022, which related to the anticipated SPAC transaction costs (refer to Note 1).

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

XML 25 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY AND EQUIPMENT, NET
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
PROPERTY AND EQUIPMENT, NET

NOTE 5 – PROPERTY AND EQUIPMENT, NET:

 

   Leasehold improvements   Machines and Equipment   Furniture and Office Equipment   Computers   Right of use assets   Total 
                         
Cost                              
At January 1, 2022   81    1,233    83    99    628    2,124 
Additions   -    135    -    17    49    201 
Deductions                       (21)   (21)
Depreciation   4    202    7    19    39    271 
Currency translation adjustments   (18)   (221)   (18)   (14)   (64)   (335)
At December 31, 2022   63    1,147    65    102    592    1,969 
Accumulated depreciation                              
At January 1, 2022   20    645    33    72    162    932 
Depreciation   4    202    7    19    39    271 
Currency translation adjustments   (6)   (148)   (9)   (17)   (23)   (203)
At December 31, 2022   18    699    31    74    178    1,000 
Net book value at December 31, 2022   45    448    34    28    414    969 

 

   Leasehold improvements   Machines and Equipment   Furniture and Office Equipment   Computers   Right of use assets   Total 
     
Cost                              
At January 1, 2021   69    847    73    72    606    1,667 
Additions   3    275    1    18    -    297 
Depreciation   5    187    7    16    72    287 
Currency translation adjustments   9    111    9    9    22    160 
At December 31, 2021   81    1,233    83    99    628    2,124 
Accumulated depreciation                              
At January 1, 2021   13    399    23    49    85    

569

 
Depreciation   5    187    7    16    72    287 
Currency translation adjustments   2    59    3    7    5    76 
At December 31, 2021   20    645    33    72    162    932 
Net book value at December 31, 2021   61    588    50    27    466    1,192 

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

XML 26 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONVERTIBLE NOTES
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
CONVERTIBLE NOTES

NOTE 3 – CONVERTIBLE NOTES

 

On January 25, 2023, the Company received an amount of $250 in consideration for issuance of convertible notes (the “Convertible Notes”) and two types of warrants. The Convertible Notes principal amount is $250 and maturity date is the earlier between December 31, 2024, and the date of any change in control (excluding the Business Combination). The Convertible Notes have an interest rate of 15% per annum and shall be converted into ordinary shares: (1) at the note holder’s discretion, at a fixed conversion price of USD 10 per ordinary share, or (2) through issuance of the Company’s ordinary shares at a 20% discount.

 

As part of the Convertible Note agreements, the investor was granted two types of warrants:

 

(i) Bonus Warrants – 12,500 warrants to purchase ordinary shares of the Company at an exercise price of USD 11.50 per share. The Bonus Warrants term is five years commencing upon the Business Combination.

 

(ii) Redeemable Warrants – 12,500 warrants to purchase ordinary shares of the Company at a purchase price of USD 11.50 per share. The Redeemable Warrants term is five years commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD 5.00 per warrant. The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.

 

The Convertible Notes are recorded in accordance with their fair value. The Redeemable Warrants are accounted for as a derivative financial liability. Management utilized a third-party appraiser to assist them in valuing the Convertible Notes and Redeemable Warrants.

 

In order to calculate the fair value of the Convertible Notes, the Company discounted the payment schedule by a discount rate of 30.7%.

 

The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model with expected volatility of 71.54% and the risk-free interest rate used is 4.19%. As of June 30, 2023, the fair value of the Convertible Notes was $218 and the fair value of the Redeemable Warrants was $71.

 

 
Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
CONVERTIBLE NOTES  

NOTE 6 – CONVERTIBLE NOTE:

CONVERTIBLE NOTES

 

In May 2022, the Company issued 828,240 convertible notes (the “Convertible Notes”), with a face value of AUD 1 (USD 0.7) per each Convertible Note, for an aggregate amount of AUD 828 thousand (569). The Convertible Notes have a maturity date of six months from issuance date. The conversion price is as follows: (i) if the Company executes a binding agreement for an M&A transaction or receives USD $20 million or more in return for the issuance of shares on or before December 31, 2022, the principal amount of each Convertible Note will automatically be converted into shares in the Company. The issuance price per share will be calculated at a 20% discount to the higher of the offer price or price paid by the investors participating in the qualified transaction, as such term is defined in the Convertible Notes agreement, subject to a floor cap of no lower than AUD 0.15 (USD 0.11) per share. In July 2022, the Company entered into a Business Combination Agreement that will be subject to de-listing of the Company’s ordinary share capital from the Australian Stock Exchange following receiving an Australian court approval of the future merger (ii) if the Company has not executed a binding agreement for a qualified transaction until December 31, 2022, the Convertible Notes balance will automatically convert into ordinary shares at that date. The issuance price per share will be calculated at a 20% discount to the 5-21 day volume weighted average price to December 31, 2022, as such term is defined in the Convertible Notes agreement, subject to a cap of no lower than AUD 0.15 (USD 0.11) per share, and on December 31, 2022 the investors will also be issued unlisted two year options on a 1:2 basis with an exercise price of AUD 0.45 (USD 0.32) per share. As of December 31, 2022, the Convertible Note amounted to 563.

 

In July 2022, an amendment to the Convertible Notes agreements was signed between the Company and the investors which prescribes a cancellation of the Convertible Notes and replacing them with the issuance of 1,000,000 ordinary shares of the Company (with the occurrence of the Business Combination).

 

On March 7, 2023, the Convertible Notes were converted to 1,000,000 ordinary shares of the Company.

 

XML 27 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS IN ASSOCIATED COMPANIES
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
INVESTMENTS IN ASSOCIATED COMPANIES

NOTE 7 – INVESTMENTS IN ASSOCIATED COMPANIES:

 

 SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES

Entity  

Country of

Incorporation

 

Percentage Owned

December 31, 2022

 

Percentage Owned

December 31, 2021

Yahaloma Technologies Inc.   Canada   50%   50%
True Gold Consortium Pty Ltd   Australia   44.4%   45.5%
SMX Beverages Pty Ltd   Australia   100%   50%

 

The proportion of ownership interest is equal to the proportion of voting power held.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 7 – INVESTMENTS IN ASSOCIATED COMPANIES (CONT.):

 

Yahaloma Technologies Inc.

 

On April 30, 2019, Security Matters Ltd. Signed an agreement with Trifecta Industries Inc. (“Trifecta”) for the commercialization of Security Matters Ltd.’s trace technology in the diamonds and precious stone industry.

 

Under the terms of the agreement, Security Matters Ltd. And Trifecta established a new entity – Yahaloma Technologies Inc. (“Yahaloma”), which is equally held by Security Matters Limited and Trifecta.

 

Yahaloma will have the exclusive rights and responsibility to commercialize the Group’s intellectual property in the area of diamonds or precious stone. Management has assessed the transaction and reached the conclusion that the new entity is jointly controlled by Security Matters Limited and Trifecta. Management has further determined that the contractual arrangement provides the parties to the joint arrangement with rights to the net assets of the arrangement. The contractual arrangement establishes each party’s share in the profit or loss relating to the activities of the arrangement. The arrangement is a joint venture and the Company’s interests in this joint venture is accounted for using the equity method of accounting.

 

SMX Beverages Pty Ltd

 

On February 10, 2020, the Company signed an agreement with Global BevCo Pty Ltd. (“Global BevCo”), an Australian company for the commercialization of Group’s trace technology in the alcoholic beverages industry. Under the terms of the agreement, the Company and Global BevCo established a new private entity, SMX Beverages Pty Ltd (“SMX-B”), which is equally held by the above two-mentioned entities. The Company has the exclusive rights and responsibility to commercialize the Group’s intellectual property in the area of alcoholic beverages.

 

The joint arrangement is a joint venture and the Company’s interests in its associate is accounted for using the equity method of accounting.

 

On December 24, 2021, the Company signed an agreement with Global BevCo to acquire the remaining 50% shares in SMX-B in exchange for 8,000,001 options of the Company at exercise price of AUD 0.4, with an expiration date of March 25, 2027. Total fair value is AUD 960,000 (USD 721,424), and the acquisition was settled on March 25, 2022. The Company assigned the consideration to technology license intellectual property. The total fair value of the options was determined according to Black & Scholes model, free rate interest of 2.5%, expected life 5 years. The acquisition agreement also provides a five-year consulting agreement to Global BevCo including AUD 13,500 per month and a 5% revenue share for referred clients.

 

True Gold Consortium Pty Ltd

 

On July 29, 2020, the Company signed a shareholders’ agreement with W.A. Mint Pty Ltd. And True Gold Consortium Pty Ltd. (“True Gold”). The purpose of the agreement is to set the framework for True Gold’s activity. True Gold’s goal is to establish an industry standard with the development of an innovative system that can mark (at a molecular level), track and trace gold bars and gold through every stage of the supply chain with blockchain technology. Under the terms of the agreement, True Gold will be equally held by the above two-mentioned entities, with the goal of adding other shareholders.

 

The Company’s management has assessed the transaction and reached the conclusion that the new entity is jointly controlled by Security Matters Limited, and W.A. Mint Pty Ltd. The Company’s management has further determined that the contractual arrangement provides the parties to the joint arrangement with rights to the net assets of the arrangement. The contractual arrangement establishes each party’s share in the profit or loss relating to the activities of the arrangement. The arrangement is a joint venture and the Company’s interests in this joint venture is accounted for using the equity method of accounting.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 7 – INVESTMENTS IN ASSOCIATED COMPANIES (CONT.):

 

Reconciliation of the consolidated entity’s carrying amount

 

 SCHEDULE OF INFORMATION ABOUT CONSOLIDATED STRUCTURED ENTITIES

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
Security Matters Limited’s share of net assets   115    248    249 
Company’s share in net profits (losses) of associated companies   106    (101)   (1)
Closing carrying amount   221    147    248 

 

XML 28 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTANGIBLE ASSETS, NET
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
INTANGIBLE ASSETS, NET

NOTE 8 – INTANGIBLE ASSETS, NET:

 

 SUMMARY OF INTANGIBLE ASSETS NET

                
  

Capitalization of

development cost

  

Purchased

license

   Total 
   US$ in thousands   US$ in thousands   US$ in thousands 
COST               
As of January 1, 2022   4,024    -    4,024 
Capitalized development cost   975    721    1,696 
Currency translation adjustments   (500)   (66)   (566)
As of December 31, 2022   4,499    655    5,154 
                
Accumulated amortization               
As of January 1, 2022   116    -    116 
Amortization   14    -    14 
Currency translation adjustments   (3)   -    (3)
As of December 31, 2022   127    -    127 
                
Net book value as of December 31, 2022   4,372    655    5,027 

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 8 – Intangible assets, NET (CONT.):

 

      
   Capitalization of development cost 
   US$ in thousands 
COST     
As of January 1, 2021   2,332 
Capitalized development cost   1,468 
Currency translation adjustments   224 
As of December 31, 2021   4,024 
      
Accumulated amortization     
As of January 1, 2021   88 
Amortization   28 
As of December 31, 2021   116 
      
Net book value as of December 31, 2021   3,908 

 

An intangible asset at the amount of 145 is being amortized, the amortization completed by December 31, 2022. The rest of the intangible asset balance has not yet been amortized.

 

Intangible assets as of December 31, 2022, consist of capitalized technology development costs of the Group’s core technology as well as the cost of the exclusive license intellectual property (721) which includes the addition amount as a result of the acquisition of additional 50% interest in SMX Beverages Pty Ltd (Note 7). The acquired rights have not yet commenced amortization as the license was not yet commenced usage.

 

XML 29 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
LEASES

NOTE 9 – LEASES:

 

The Group has lease contracts for office facilities (including a lab) and motor vehicles used in its operations. Leases of office and lab facilities generally have lease term of 12 years, motor vehicles generally have lease terms of 3 years.

 

Set out below are the carrying amounts of right-of-use assets recognized and the movements during the period:

 

 SCHEDULE OF RIGHT OF USE ASSETS

                
  

Office and lab

facilities

  

Motor

vehicles

  

Total

 
At January 1, 2022   446    20    466 
Additions   49        49 
Foreign currency translation   (35)   (6)   (41)
Deductions   (7)   (14)   (21)
Depreciation expense   (39)       (39)
As at December 31, 2022   414        414 

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 9 – LEASES (CONT.):

 

Set out below are the carrying amounts of lease liabilities and the movements during the period:

 

 SCHEDULE OF LEASE LIABILITY

           
  

December 31,

2022

  

December 31,

2021

 
At January 1,   503    589 
Additions   49     
Deductions   (21)    
Accretion of interest   51    47 
Foreign exchange differences   (57)   (35)
Lease Payments   (55)   (98)
As at December 31,   470    503 
           
Current   30    37 
Non-current   440    466 

 

The following are the amounts recognized in profit or loss:

 

 SCHEDULE OF CARRYING AMOUNTS OF LEASE LIABILITIES RECOGNIZED IN PROFIT OR LOSS

           
  

December 31,

2022

  

December 31,

2021

 
Depreciation expense of right-of-use assets   39    72 
Interest expense on lease liabilities   51    47 
Foreign Exchange different   16    (35)
Expense relating to short-term leases   -    - 
Total amount recognized in profit or loss   106    84 

 

XML 30 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER PAYABLES
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
OTHER PAYABLES

NOTE 10 – OTHER PAYABLES:

 

 SCHEDULE OF OTHER PAYABLES

           
  

December 31,

2022

  

December 31,

2021

 
         
Employees, salaries and related liabilities   392    500 
Related party   56    24 
Liabilities for grants received (Note 19)   50    30 
Accrued expenses       49 
Derivative financial liability (Note 13)       32 
Other   152    38 
Total   650    673 

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

XML 31 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
BORROWINGS FROM RELATED PARTIES
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
BORROWINGS FROM RELATED PARTIES

NOTE 11 BORROWINGS FROM RELATED PARTIES:

 

In 2015, the Group signed an agreement to receive a loan of ILS 2 million (approximately 513) from its shareholders.

 

These loan bears interest at an annual rate of 4%.

 

  

December 31,

2022

  

December 31,

2021

 
Balance at January 1,   270    280 
Payment of borrowings   (172)   (103)
Provision for bonus (include interest)   621    89 
Exchange rate differences   (9)   4 
Balance at December 31,   710    270 

 

In consideration of providing funding as a seed capitalist, the Company agreed to provide, as additional consideration, a bonus payments (the “Bonus Payments”) on the occurrence of an exit or major liquidity event. In any way, the Bonus Payments are capped at ILS 3 million (approximately 965) per each of the two lenders.

 

The Bonus Payments are intended to operate in one of the two trigger events:

 

(i)dividend distributions paid by the Company; or

 

(ii)the sale of shares by a lender in Security Matters Ltd. (either in the event of a takeover or otherwise)

 

Only if the aggregate amounts of one of the two trigger events exceeds the investment of the lenders in the Company (in a way of loan or shares), then the lender would be entitled the Bonus Payments based on a formula set forth in the agreement.

 

The amount of the Bonus Payments is the amount that exceeds the aggregate sum invested in the Company (in a way of loan or shares) by the lender divided by several factors according to the formula as set forth in the agreement.

 

There is no time limit to pay the Bonus Payments. Once the Company has paid each Bonus Payment in its entirety (i.e., the cap of ILS 3 million has been paid to each Lender), then the Company has fulfilled its obligations. When the Bonus Payments are not expected to be made, the resulting cash flows will not affect profit and loss until the point in which the Company estimates that the liquidity events will take place. As of December 31, 2021, the Company estimated that is more likely than not that the shareholders will sell their shares in 2022 which will entitle them to the Bonus Payments. The amount of the Bonus Payment is subject to assumptions that were made with the assistance of external appraisal. As a result, the increase in the carrying amount of the liability was charged as expense of $87 to profit and loss in 2021. In August 2022 the loan from related party has been fully repaid. In August 2022, the Company signed an addendum to the loan agreement that reduces the total amount of the Bonus Payments to ILS 2.5 million (approximately $710), to be paid upon the completion of the business combination (refer also to Note 24 – Subsequent Events). As of December 31, 2022, the Company estimated that is more likely than not that the business combination will be completed in the foreseeable future, as a result, the Company updated the liability according to the addendum which described above, the carrying amount of the liability was increased to $710 and charged as expense of $621 to profit and loss in 2022.

 

XML 32 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY

NOTE 4 – BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY:

 

Between August 2022 to January 2023, Security Matters PTY Ltd. entered into bridge loan agreements (the “Bridge Loans”) with eleven lenders, which lent Security Matters PTY Ltd. an aggregate amount of $3,860. The Bridge Loans have a maturity date of up to two years and bear an interest rate of 10% per annum. The Bridge Loans were accounted for in accordance with the amortized cost method.

 

As part of the Bridge Loans agreements, the lenders were granted two types of warrants:

 

(iii) Bonus Warrants – 243,000 warrants to purchase ordinary shares of the Company at an exercise price of USD 11.50 per share. The Bonus Warrants term is five years commencing upon the Business Combination.

 

(iv) Redeemable Warrants – 572,000 warrants to purchase ordinary shares of the Company at a purchase price of USD 11.50 per share. The Redeemable Warrants term is five years commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD 5.00 per warrant.

 

Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.

 

Management with the assistance of a third-party appraiser valued the Bonus and the Redeemable Warrants. The fair value of the Bonus Warrants was calculated using the Black-Scholes model. As of June 30, 2023, the fair value of the Bonus Warrants was less than $1 (December 31, 2022 - the fair value of the Bonus Warrants was $24).

 

The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model. As of June 30, 2023, the fair value of the Redeemable Warrants was 2,133 (December 31, 2022, the fair value of the Redeemable Warrants was $2,669).

 

The main assumptions used in the three valuation models described above were: (1) risk free rate 3.99%; (2) volatility of assets 81.03%; and (3) excepted terms of the warrants -5.18 years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.

 

During 2023, the Company entered into an additional bridge loan agreement (the “Additional Bridge Loans”), in which the Company raised an aggregate amount of $550. The Additional Bridge Loans have a maturity date of up to two years and bear interest rate of 10% per annum. In March 2023, the Company signed an addendum to the Bridge Loans agreements which convert principal amount of $1,350 and redeemable warrants at the amount of $1,000 into 872,418 ordinary shares and defer the remaining cash payments to March 31, 2024.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

 
Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY  

NOTE 12 – BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY:

 

Between August to December 2022, the Company entered into bridge loan agreements (the “Bridge Loans”) with seven lenders, which lent the Company an aggregate amount of 3,310. The Bridge Loans have a maturity date of up to two years and bears interest rate of 10% per annum. The Bridge Loans were accounted for in accordance with amortized cost method.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 12 – BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (CONT.):

 

As part of the Bridge Loans agreements, the lenders were granted with three types of warrants:

 

(i)Bonus Warrants – 215,500 warrants to purchase ordinary shares of SMX PLC (refer to Note 1) at an exercise price of USD 11.50 per share. The Bonus Warrants term is five years commencing upon the Business Combination (refer to Note 1).

 

Management utilized a third-party appraiser to assist them in valuing the Bonus Warrants. The fair value of the Bonus Warrants was calculated using the Black and Scholes model. As of December 31, 2022, the fair value of the Bonus Warrants was 24.

 

(ii)Redeemable Warrants Type 1 – 342,000 warrants to purchase ordinary shares of SMX PLC (refer to Note 1) at a purchase price of USD 11.50 per share. The Redeemable Warrants Type 1 term is five years commencing upon the Business Combination (refer to Note 1).

 

50.00% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the Business Combination for USD 5.00 per warrant.
25.00% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder for the 30 days following the third anniversary of the Business Combination for USD 5.00 per warrant.
25.00% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder for the 30 days following the fourth anniversary of the Business Combination for USD 5.00 per warrant.

 

Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of SMX PLC based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary.

 

Management utilized a third-party appraiser to assist them in valuing the Redeemable Warrants Type 1. The fair value of the Redeemable Warrants Type 1 was calculated using Monte-Carlo simulation model. As of December 31, 2022, the fair value of the Redeemable Warrants Type 1 was 1,973.

 

(iii)Redeemable Warrants Type 2 – 120,000 warrants to purchase ordinary shares of SMX PLC (refer to Note 1) at a purchase price of USD 11.50 per share. The Redeemable Warrants Type 2 term is five years commencing upon the Business Combination (refer to Note 1).

 

50.00% of the Redeemable Warrants Type 2 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the first anniversary of the Business Combination for USD 5.00 per warrant.
50.00% of the Redeemable Warrants Type 2 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the second anniversary of the Business Combination for USD 5.00 per warrant.

 

Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of SMX PLC based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary.

 

Management utilized a third-party appraiser to assist them in valuing the Redeemable Warrants Type 2. The fair value of the Redeemable Warrants Type 2 was calculated using Monte-Carlo simulation model. As of December 31, 2022, the fair value of the Redeemable Warrants Type 1 was 696.

 

The main assumptions used in the three valuation models described above were: (1) risk free rate 3.99%; (2) volatility of assets 81.03%; and (3) excepted terms of the warrants -5.18 years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.

 

In the event that the Business Combination shall not be consummated, the Bonus Warrants and the Redeemable Warrants type 1 and 2 shall be exchanged for such number of warrants for the Company’s ordinary shares.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

XML 33 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHAREHOLDERS’ EQUITY
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
SHAREHOLDERS’ EQUITY

NOTE 6 - SHAREHOLDERS’ EQUITY

 

A. Share capital:

 

    Number of shares  
    June 30, 2023     December 31, 2022  
    Authorized     Issued and outstanding     Authorized     Issued and outstanding  
Ordinary shares
USD 0.0001 par value
    800,000,000,000       38,364,447       500,000,000       1  
Preferred shares
USD 0.0001 par value
    200,000,000,000       -       -       -  
Deferred shares
Euro 1 par value
    25,000       25,000       25,000       25,000  

 

Ordinary shares

 

Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the Company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have a par value per share of $0.0001 (before the reverse split) and par value per share of $0.0022 (post reverse split) and the Company does not have a limited amount of authorised capital.

 

Preferred shares

 

preferred shares with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors.

 

Deferred shares

 

Deferred Ordinary Shares are non-voting shares and do not convey upon the holder the right to be paid a dividend or to receive notice of or to attend, vote or speak at a general meeting. The Deferred Shares confer the right on a return of capital, on a winding-up or otherwise, only to the repayment of the nominal value paid up on the Deferred Shares after repayment of the nominal value of the Ordinary Shares.

 

Changes in Share capital

 

A. On March 7, 2023 (the “Closing Date”), the Company consummated the Business Combination pursuant the BCA, dated July 26, 2022, and also consummated the SID, dated July 26, 2022.

 

Beginning on the day immediately prior to the Closing Date and ending on the day immediately after the Closing Date, the following transactions occurred:

 

  1. The AUD 828,240 of the 2022 Convertible Notes have been cancelled in consideration for the issuance of 1,000,000 ordinary shares in Security Matters PTY Ltd.

 

  2. Security Matters PTY Ltd. performed acceleration of vesting for all unvested warrants and options, the expense for the acceleration amounted to $186.

 

  3. 32,211,716 warrants have been exercised on cashless basis to 24,568,773 shares in Security Matters PTY Ltd.

 

  4. 18,673,253 ordinary shares of the Company have been issued to Security Matters PTY Ltd.’s shareholders in return for their 193,500,379 ordinary shares in Security Matters PTY Ltd. that were cancelled. Security Matters PTY Ltd.’s shareholders received as consideration 1 ordinary share of the Company per 10.3624 Security Matters PTY Ltd.’s ordinary shares.

 

  5. The Company issued 3,525,000 ordinary shares, 2,200,000 private warrants and 6,250,000 public warrants to Lionheart’s stockholders, in exchange for their existing Lionheart shares and warrants. The warrants exercise price is $11.5 per share, expiring in March 2028. The warrants are considered to be a derivative financial liability and measured at fair value, which is the market price as of the end of the period, amounted to $0.0204 per warrant.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 6 – SHAREHOLDERS’ EQUITY (CONT.)

 

  6. The Company issued 303,053 ordinary shares for an aggregate of $3,110 net proceeds.

 

  7. The Company issued 872,418 ordinary shares for the conversion of bridge loan at principal amount of $1,350 and 200,000 redeemable warrants ($5 per warrant, 5 years, exercise price of $11.5 per share).

 

B. In May and June 2023, the Company issued 675,168 ordinary shares to Yorkville, for an aggregate of $450 net proceeds (see also Note 5.1).

 

C. In June 2023, the Company raised capital as part of issuance of a unit of financial instruments in consideration of an aggregate of $2,580 net proceeds. As part of this issuance, the Company issued 13,333,333 shares, 15,333,332 warrants A and 15,333,332 warrants B (see also Note 5.2).

 

D. After the balance sheet date, on August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis, after consolidating every twenty-two ordinary shares of the Company into one ordinary share (see also Note 9.1).

 

Incentive Equity Plan

 

In April 25, 2023, the Company’s board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan, which was subsequently amended the Company’s board of directors, subject to applicable Nasdaq requirements, which reserved for grant a number of ordinary shares equal to 15% of the number of issued and outstanding ordinary shares on a fully diluted basis immediately after the closing of the Business Combination, or 5,082,417 authorized ordinary shares.

 

1. During the six-month period ended June 30, 2023, the Company granted 4,334,000 RSUs to employees, directors and service providers. The fair value at grant date of RSUs granted in the period were $1-$1.09. The related share-based expenses that were recognized in the period amounted to $1,738.

 

RSUs granted to employees, directors and service providers:

 

 SCHEDULE OF RESTRICTED STOCK UNIT

  

Six months period ended

June 30, 2023

(in thousands)

  

Six months period ended

June 30, 2022
(in thousands)

 
Outstanding at beginning of period   -    - 
Granted   4,334    - 
Vested   (945)   - 
           
Outstanding at June 30, 2023   3,389    - 

 

2. During the six-month period ended June 30, 2023, the Company granted 790,408 options to employees and service providers. These grants carry an exercise price of between $1.04 - $4.0, vesting period up to 4 years from the grant date, contractual life of the options under the plan is 5 years. The fair value of the grant at grant date is $185. The related share based expenses that were recognized in the six months period ended June 30, 2023 amounted to $168.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 6 - SHAREHOLDERS’ EQUITY (CONT.)

 

Options granted to employees and service providers:

 

 SCHEDULE OF SHARE OPTION GRANTED

 

   

Six months period ended

June 30, 2023

 
   

Number

of options

(in thousands)

   

Weighted average

exercise price per share (US$)

 
Outstanding at beginning of period     1,251       2.01  
Granted     790       3.47  
Exercised     (7 )     1.39  
Expired     -       -  
                 
Outstanding at June 30, 2023     2,034       2.58  
Exercisable options at June 30, 2023     1,825       2.48  

 

   

Six months period ended

June 30, 2022

 
   

Number

of options

(in thousands)

   

Weighted average

exercise price per share (US$)

 
Outstanding at beginning of period     3,346       2.02  
Granted     989       2.86  
Exercised     -          
Expired     (375 )     2.16  
                 
Outstanding at June 30, 2022     3,960       2.21  
Exercisable options at June 30, 2022     2,703       2.33  

 

The options to employees and service providers outstanding as of June 30, 2023, are comprised, as follows:

 

 SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING

Exercise price (US$)    

Outstanding as of

June 30, 2023

(in thousands)

   

Weighted average remaining

contractual term

   

Exercisable as of

June 30, 2023

(in thousands)

   

Weighted average remaining

contractual term

 
            (years)           (years)  
0.84-1.39       845       1.18       845       1.18  
1.81-2.51       335       2.59       335       2.59  
3.57-4.0       707       4.89       498       4.86  
4.18       10       1.74       10       1.74  
4.87       137       3.51       137       3.51  
        2,034               1,825          

 

NOTE 3 – SHAREHOLDERS’ EQUITY

 

A.The ordinary shares in the Company confer upon their holders the right to receive notice to participate and vote in general meetings of the Company, and the right to receive dividends, if and when declared.

 

   Number of shares 
   December 31, 2022   July 1, 2022 
    

Authorized

    

Issued and outstanding

    

Authorized

    

Issued and outstanding

 

Ordinary shares

USD 0.0001 par value

   500,000,000    

1

    

500,000,000

    

1

 
Deferred Shares
EURO 1 par value
   

25,000

    

25,000

    

-

    

-

 

 

Ordinary shares

 

Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have no par value and the company does not have a limited amount of authorised capital.

 

Deferred shares

 

Deferred Ordinary Shares are non-voting shares and do not convey upon the holder the right to be paid a dividend or to receive notice of or to attend, vote or speak at a general meeting. The Deferred Shares confer the right on a return of capital, on a winding-up or otherwise, only to the repayment of the nominal value paid up on the Deferred Shares after repayment of the nominal value of the Ordinary Shares.

 

Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
SHAREHOLDERS’ EQUITY  

NOTE 13 – SHAREHOLDERS’ EQUITY

 

A.The ordinary shares in the Company confer upon their holders the right to receive notice to participate and vote in general meetings of the Company, and the right to receive dividends, if and when declared.

 SCHEDULE OF ORDINARY SHARES

    Number of shares 
    December 31, 2022   December 31, 2021 
    Authorized  

Issued and

outstanding

   Authorized  

Issued and

outstanding

 
Ordinary shares    167,854,581    167,854,581    165,532,264    165,532,264 

 

Ordinary shares

 

Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have no par value and the company does not have a limited amount of authorised capital.

 

B.Increase in issued share capital:

 

1)In August 2022, the Company raised capital, in consideration of an aggregate of 254 net proceeds. An amount of 22 capital raise fee was paid in cash to the financial advisor. The Company issued 2,000,000 shares.

 

2)In October 2021, the Company raised capital, in consideration of an aggregate of 1,890 net proceeds. An amount of 115 capital raise fee was paid in cash to the financial advisor. The Company issued 8,938,666 shares and 4,469,333 warrants. The terms of the warrants specify that each warrant has an exercise price of AUD 0.4 and expires in March 2022. Upon exercise the holder would receive one ordinary share and another unlisted warrant that bears an exercise price of AUD 0.7, converted to one ordinary share and expired on January 20, 2023. The warrants were considered to be a derivative financial liability and measured at fair value. The fair value of the warrant derivative is not material.

 

3)In May 2021, the Company issued 15,270,249 shares in consideration of an aggregate of 4,034 net proceeds.

 

4)During 2021, 1,774,744 warrants were exercised to 1,774,744 ordinary shares, for aggregate net proceeds of 395.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 13 – SHAREHOLDERS’ EQUITY (CONT.):

 

C.Options granted to employees and service providers:

 

1)In June 2018, the Company has adopted a Share Option Plan (the “Plan”) to provide an incentive to retain, in the employment or service or directorship of the Company and provide the ability to attract new employees, directors or consultants whose services are considered valuable. The persons eligible to participate in the Share Option Plan include employees, directors and consultants of the Company or any subsidiary of the Company.

 

2)A summary of the status of the Company’s Share Option Plan granted to employees (including performance-based awards) and changes during the relevant period ended on that date is presented below:

 

 SCHEDULE OF SHARE OPTION GRANTED

  

Year ended

December 31, 2022

  

Year ended

December 31, 2021

 
  

Number

of options (in thousands)

  

Weighted average

Exercise price (AUD)

  

Number

of options

(in thousands)

  

Weighted average

Exercise price (AUD)

 
Outstanding at beginning of year   11,280    0.27    9,530    0.23 
Issue of options   1,000    0.27    1,850    0.45 
Expired   (7,600)   0.22    (100)   0.34 
                     
Outstanding at end of year   4,680    0.35    11,280    0.27 
Exercisable options   2,835    0.28    4,318    0.27 

 

The options to employees outstanding as of December 31, 2022, are comprised, as follows:

 

 SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING

Exercise price (AUD) 

Outstanding

as of

December 31, 2022

  

Weighted average remaining

contractual term

  

Exercisable

as of

December 31, 2022

  

Weighted average remaining

contractual term

 
       (years)       (years) 
0.12-0.2   800   4.59    400    4.64 
0.2   955   0.67    878    0.67 
0.31-0.357   2075   2.56    1432    2.15 
0.6   100   2.24    100    2.24 
0.7   750   3.97    25    3.74 
    4,680        2,835      

 

1.In 2022, the Company granted 600,000 options to employees and 1,600,000 options to consultants. These grants carry an exercise price of between AUD 0.03-0.14, vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years. The fair value at grant date is 154.

 

2.In 2021, the Company granted 250,000 options to employees and 5,400,000 options to consultants. These grants carry an exercise price of between AUD 0.35-0.70, vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years. The fair value at grant date is 622.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 13 – SHAREHOLDERS’ EQUITY (CONT.):

 

D.Options granted to employees and service providers (cont.):

 

3.In 2020, the Company granted 1,055,000 options to employees, 750,000 options to consultants and 2,500,000 options to a board member. These grants carry an exercise price of between AUD 0.20-0.70, vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years. The fair value at grant date is 533.

 

4.The Company granted 322,317 shares in 2022 and 257,562 shares in 2021 to its Board members in lieu of cash remuneration. The fair value at grant date is 54 in 2022 and 53 in 2021.

 

5.The expenses for the options that were not recognized as of December 31, 2022, amount to 152.

 

6.The options issued in 2022 and 2021, were valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: 0.11-3.55%; (2) expected volatility: 64-118%: (3) expected term: up to 5 years; and (4) expected dividend yield: 0%.

 

E.Performance options:

 

1)In August 2018, two Executive Directors were granted 10,000,000 Performance Options with an exercise price of AUD 0.2, for which their remuneration will be dependent on the Company satisfying several commercial and technological milestones. These milestones are reviewed by the Board of Directors and need to be achieved in 4 years since the date it was granted. If the milestones are not reached in 4 years, the options will expire. As of December 31, 2022, the Company did not reach the milestones. The Performance Options were expired.

 

2)In August 2021, Executive Director was granted 167,000 options and a key management was granted 500,000 options based on a non-market condition for which if the Company raises an aggregated amount of at least 10 million in one raise (including by way of a merger with a company with such amount in its treasury) 80% of the options will become vested. If an amount of 20 million or more is raised in one raise all options will become vested. The exercise price is AUD 0.7 and the expiration date is December 6, 2026. The Company believes it is probable that the milestone will be reached. The fair value at grant date is 98.

 

3)In July 2021, several employees were granted 1,100,000 options based on a non-market condition for which the options shall vest upon meeting the following conditions: (1) Company raised an aggregated amount of at least 20 million (including by way of a merger with a company with such amount in its treasury) (2) 25% of the options shall vest after one year and thereafter 6.25% at the end of every three months (3) the employees must continue to provide services to Company. The exercise price is AUD 0.351 and the expiration date is by July – September 2026. The Company believes it is probable that the milestone will be reached. The fair value at grant date is 214.

 

4)In July 2022, several employees were granted 200,000 options based on a non-market condition for which the options shall vest upon meeting the following conditions: 25% on the first anniversary of the Vesting Commencement Date and additional 6.25% at the end of each three months of continuous services thereafter. However, if Company or a parent thereof commences trading on NASDAQ, all options shall become fully vested. The exercise price is AUD 0.7-0.8 and the expiration date is by July 2027. The options became fully vested on the consummation of the Business Combination in 2023. The fair value at grant date is 10.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 13 – SHAREHOLDERS’ EQUITY (CONT.):

 

E. Performance options (cont.):

 

5)In June 2022, a key management was granted 200,000 options based on a non-market condition for which the options shall vest upon meeting the following conditions: The options will vest upon successful listing on NASDAQ/merger with SPAC. The exercise price is AUD 0.4 and the expiration date is by June 2027. The options became fully vested on the consummation of the Business Combination in 2023. The fair value at grant date is 5.

 

6)In May 2022, a consultant was granted 250,000 options based on a non-market condition for which if the options will vest upon successful IPO of the Company on NASDAQ. The exercise price is AUD 0.11 and the expiration date is May 26, 2027. The options became fully vested on the consummation of the Business Combination in 2023. The fair value at grant date is 19.

 

XML 34 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESEARCH AND DEVELOPMENT EXPENSES, NET
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
RESEARCH AND DEVELOPMENT EXPENSES, NET

NOTE 14 – RESEARCH AND DEVELOPMENT EXPENSES, NET:

 

 SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
Salaries and related expenses   2,166    1,795    1,186 
Subcontractors and consultants   374    631    509 
Research expenses   316    252    155 
Depreciation and amortization   255    287    243 
Share based compensation   127    100    47 
Travel expenses   50    42    11 
Freight   30    23    33 
Other   6    -    53 
Reimbursement from paid pilots and proof of concept projects   (1,426)   (1,091)   (548)
Total   1,898    2,039    1,689 

 

XML 35 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
GENERAL AND ADMINISTRATIVE EXPENSES
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
GENERAL AND ADMINISTRATIVE EXPENSES

NOTE 7 – GENERAL AND ADMINISTRATIVE EXPENSES

 

 SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES

    June 30, 2023     June 30, 2022  
    Six Months Ended  
    June 30, 2023     June 30, 2022  
    US$ in thousands     US$ in thousands  
Transaction cost     7,792       -  
Advertising, Public and Investors Relations     1,526       -  
Share based compensation     1,805       82  
Professional services     718       545  
Wages and salaries related     664       429  
Travel expenses     379       4  
Insurance     329       19  
Office and maintenance     37       80  
Depreciation and amortization     15       15  
Others     86       26  
Total     13,350       1,200  

 

 
Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
GENERAL AND ADMINISTRATIVE EXPENSES  

NOTE 15 – GENERAL AND ADMINISTRATIVE EXPENSES:

 

 SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
Professional services   1,105    1,089    1,257 
Wages and salaries related   935    752    409 
Travel expenses   223    -    65 
Office and maintenance   145    116    120 
Share based compensation   137    331    436 
Insurance   60    102    101 
Depreciation and amortization   35    28    16 
Other   83    64    43 
Total   2,723    2,482    2,447 

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

XML 36 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
TAXES ON INCOME
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
TAXES ON INCOME

NOTE 16 – TAXES ON INCOME:

 

1.The Company is incorporated and domiciled in Australia where the applicable tax rate is 27.5%.
  
2.Theoretical tax:

 

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
Reconciliation of income tax at the statutory rate               
Loss before income tax   (6,184)   (4,939)   (4,573)
                
Theoretical tax rate of 27.5%   (1,701)   (1,358)   (1,257)
                
Tax effect amounts which are not deductible/(taxable) in calculating taxable income:               
Non-deductible expenditure and others   335    118    132 
Unrecognized temporary differences and tax losses for which deferred tax weren’t recognized   1,366    1,240    1,125 
Income tax / (benefit)            

 

3.As of December 31, 2022, the Group has estimated carry forward tax losses of approximately 24,106 (2021: 17,659 2020:13,151) which may be carried forward and offset against taxable income for an indefinite period in the future. The Group did not recognize deferred tax assets relating to carry forward losses in the financial statements because their utilization in the foreseeable future is not probable.

 

XML 37 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
LOSS PER SHARE
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
LOSS PER SHARE

NOTE 8 - LOSS PER SHARE

 

 SCHEDULE OF LOSS PER SHARE

    June 30, 2023     June 30, 2022  
    Six months ended  
    June 30, 2023     June 30, 2022  
Net loss attributable to the owners of the Company   $ (33,009 )   $ (2,442 )
                 
Basic and diluted loss per share   $ (39.46 )   $ *(3.36)  
Weighted average number of ordinary shares                
Weighted average number of ordinary shares used in calculating basic and diluted loss per share (in thousands)     837       *727  

 

As a result of the reverse share split described in Note 9.1, the calculation of the basic and diluted loss per share for all periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.

 

* Restated as a result of the SPAC transaction

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

 
Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
LOSS PER SHARE  

NOTE 17 – LOSS PER SHARE

 

 SCHEDULE OF LOSS PER SHARE

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
             
Net loss attributable to the owners of the company   (6,184)   (4,939)   (4,573)
                
Basic and diluted loss per share   (0.04)   (0.03)   (0.04)
Weighted average number of ordinary shares               
Weighted average number of ordinary shares used in calculating basic and diluted loss per share   167,855    151,850    125,960 

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

XML 38 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
RELATED PARTIES
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
RELATED PARTIES

NOTE 18 – RELATED PARTIES:

 

Key Management Personnel Compensation and other related party transactions and balances:

 

The key management personnel, among others includes board members, CEO and CFO.

 

The totals of remuneration paid to Key Management Personnel and related parties during the years are as follows:

 

 SCHEDULE OF KEY MANAGEMENT PERSONNEL

1. Transactions with related parties: 

December 31,

2022

  

December 31,

2021

 

Issuance of options to related party

 

721

   - 
Short-term salary and fees   508    475 
Loan repayment   172    103 
Share based payments   98    105 
Post-employment retirement benefits   94    92 
Payment for Administrative services   36    39 
Non-monetary benefits   29    11 
Proof of Concept projects paid by affiliated companies   (1,064)   (695)
   (594)   130 

 

2. Balance with related parties:    

December 31,

2022

  

December 31,

2021

 
Key management  Salary and related   (99)   (86)
Directors  Salary and related   (82)    (11)
Shareholders  Borrowings from related parties   (710)   (270)
Shareholders  Other accounts payable   (56)   (24)
Joint Ventures  Other receivables   59    74 
Joint Ventures  Investment in subsidiary   221    147 
       (667)   (170)

 

XML 39 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOVERNMENT GRANTS
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
GOVERNMENT GRANTS

NOTE 19 – GOVERNMENT GRANTS

 

The Government of Israel encourages research and development projects oriented towards products for export or projects which will otherwise benefit the Israeli economy. This is conducted via the Israel Innovation Authority (IIA), which replaced the former Office of the Chief Scientist (OCS).

 

The Group has an approved project with the IIA under which it received a total of 162 in prior years.

 

The Group is subject to paying 3% of its relevant revenues until repayment of the entire grant. As of December 31, 2022, the Group paid an amount of 3.

 

The difference between the consideration received and the liability recognized at inception (present value) was treated as a government grant according to IAS 20 and recognized as a reimbursement of research expenses.

 

 SCHEDULE OF GOVERNMENT GRANTS

  

December 31,

2022

  

December 31,

2021

 
Short term liability at year end   50    30 
Long term liability at year end   85    85 
Total   135    115 

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

XML 40 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONTROLLED ENTITIES
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
CONTROLLED ENTITIES

NOTE 20 – CONTROLLED ENTITIES

 

The ultimate legal parent entity of the Group is Security Matters Limited, incorporated and domiciled in Australia. The consolidated financial statements incorporate the assets, liabilities and results of the following subsidiaries in accordance with the accounting policies described in Note 2.

 

Controlled entity 

Country of

Incorporation

  

Percentage Owned

December 31, 2022

  

Percentage Owned

December 31, 2021

 
Security Matters Ltd.   Israel    100%   100%
Security Matters Canada Ltd.   Canada    100%   100%
Security Matters France Ltd.   France    100%   100%
SMX Beverages Pty Ltd.   Australia    100%   50%

 

Security Matters Canada

 

Security Matters Canada was founded in March 2021 for commercializing the group’s activity in Canada. During the period Security Matters Canada has not yet started its operations.

 

Security Matters France

 

Security Matters France was founded in June 2021 for commercializing the group’s activity in EU. During the period Security Matters France has not yet started its operations.

 

SMX Beverages Pty Ltd

 

SMX Beverages Pty Ltd was founded in February 2020 as a joint venture for commercializing the group’s alcoholic beverages activity. Since March 2022, SMX Beverages Pty Ltd has been a wholly owned subsidiary (Note 7). During the period SMX Beverages Pty Ltd has not yet started its operations.

 

XML 41 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMITMENTS AND CONTINGENT LIABILITIES
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
COMMITMENTS AND CONTINGENT LIABILITIES

NOTE 21 – COMMITMENTS AND CONTINGENT LIABILITIES:

 

As part of the Board’s ongoing regulatory compliance process, the Board continues to monitor legal and regulatory developments and their potential impact on the Company. Management is not aware of any contingencies that may have a significant impact on the financial position of the Company.

 

1.In January 2015, the Company entered an agreement with Isorad Ltd. (a company wholly owned by the State of Israel with rights to exclusively commercialize the Soreq Research Center technology for civilian uses), according to which the Company was granted technological license in return for future royalties based on 2.2% of Gross sales by the Company and its affiliates and after 25 years the license becomes royalty-free. Upon the occurrence of an M&A event (as such event is defined in the agreement to include mergers, sale of all or substantially all the assets of ours and similar event), in the first M&A event, the Company is to pay a consideration equal to 1% of the amount received or transferred and in the second M&A event, a consideration equal to 2% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

On January 2023, the Company signed an amendment to the agreement that determine the following: (1) for the BCA with Lionheart, Isorad was issued (a) 864,000 options to purchase shares of the Company, the options were issued in January 2023 and valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: 3.42%; (2) expected volatility: 81.92%: (3) expected term: up to 3 years; and (4) expected dividend yield: 0%; (b) Additionally, Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of 27 million, or at the end of such 13 months, the earlier thereof). (2) Exit fee - in the occurrence of the first M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA with SPAC, the Company is to pay a cash amount equal to 1.5% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 21 – COMMITMENTS AND CONTINGENT LIABILITIES (CONT.):

 

2.The Group leases its offices and laboratory under an operating lease agreement, as well as two company cars which are all recognized within lease balances in the financial statements.

 

3.As Described in Note 11 borrowings from related parties, the Company is committed to pay a bonus payment upon achieving certain goals. The Bonus Payments were examined by an external valuator and based on management’s projections and insights it has estimated that the value of the Lender’s Bonus is estimated at the amount of 87 as of December 31, 2021. In August 2022, the Company signed an addendum to the loan agreement that reduces the maximum total amount of the Bonus Payments to ILS 2.5 million (approximately 710), to be paid upon the completion of the business combination. As of December 31, 2022, the bonus was recorded in the amount of 710.

 

4.As Described in Note 19 Government grants, the Company has a contingent liability of 166 (unpaid governance grant dependent on the Company’s future revenues) for the Israel Innovation Authority (IIA), which replaced the former Office of the Chief Scientist (OCS) for grants received to fund an approved research and development project.

 

XML 42 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT

NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT:

 

Financial risk management objectives

 

The Group’s activities expose it to a variety of financial risks: foreign currency risk, credit risk and liquidity risk. The Group’s overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the financial performance of the Group. The Group uses different methods to measure different types of risk to which it is exposed. These methods include sensitivity analysis in the case of interest rate, foreign exchange and other price risks, ageing analysis for credit risk and beta analysis in respect of investment portfolios to determine market risk.

 

Foreign currency risk

 

Currency risk is the risk that the value of financial instruments will fluctuate due to changes in foreign exchange rates. Currency risk arises when future commercial transactions and recognized assets and liabilities are denominated in a currency that is not the Group’s functional currency. The Group is exposed to foreign exchange risk arising from currency exposure primarily with respect to the USD and Euro. The Group’s policy is not to enter into any currency hedging transactions.

 

The carrying amounts of the Group foreign currency denominated monetary liability at the reporting date are as follows:

 

 SCHEDULE OF FOREIGN CURRENCY RISK

   Assets   Liabilities 
  

December 31,

2022

  

December 31,

2021

  

December 31,

2022

  

December 31,

2021

 
USD   1,214    481    (99)    
EUR   28    135    (73)    
    1,242    616    (172)    

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT.):

 

Sensitivity analysis

 

A 10% strengthening of the United States Dollar against the following currencies would have increased (decreased) equity and the income statement by the amounts shown below. This analysis assumes that all other variables, in particular interest rates, remain constant. For a 10% weakening of the United States Dollar against the relevant currency, there would be an equal and opposite impact on the profit and other equity.

 

  

December 31,

2022

  

December 31,

2021

 
Assets less liabilities   1,115    481 
    10%   10%
    112    48 

 

Price risk

 

The consolidated entity is not exposed to any significant price risk.

 

Interest rate risk

 

The consolidated entity is not exposed to any significant interest rate risk.

 

Credit risk

 

Credit risk arises when a failure by counterparties to discharge their obligations could reduce the amount of future cash inflows from financial assets on hand at the balance sheet date. The Group closely monitors the activities of its counterparties and controls the access to its intellectual property which enables it to ensure the prompt collection. The Group’s main financial assets are cash and cash equivalents as well as other receivables and represent the Group’s maximum exposure to credit risk in connection with its financial assets. Wherever possible and commercially practical, the Group holds cash with major financial institutions in Israel and Australia.

 

The carrying amount of financial assets represents the maximum credit exposure. The maximum exposure to credit risk at the reporting date was:

 

 SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE

  

December 31,

2022

  

December 31,

2021

 
Cash and cash equivalents   1,398    4,171 
Other receivables   158    920 
Total   1,556    5,091 

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT.):

 

Liquidity risk

 

Liquidity risk is the risk that arises when the maturity of assets and the maturity of liabilities do not match. An unmatched position potentially enhances profitability but can also increase the risk of loss. The Group has procedures to minimize such loss by maintaining sufficient cash and other highly liquid current assets and by having available an adequate amount of committed credit facilities. As of the balance sheet date, the Group has a positive working capital.

 

The following tables detail the Group’s remaining contractual maturity for its financial liabilities. The tables have been drawn up based on the undiscounted cash flows of financial liabilities based on the earliest date on which the Group can be required to pay.

 

 SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES

As of December 31, 2022 

Less than 1

year

   1-5 years   Over 5 years 
             
Financial liabilities at amortized cost               
Trade and other payables   3,622         
Bridge loans (Note 23)       989     
Government grants   75    84     
Lease liability   72    371    270 
Borrowings   710         
Total   4,479    1,444    270 

 

As of December 31, 2021 

Less than 1

year

   1-5 years   Over 5 years 
             
Financial liabilities at amortized cost               
Trade and other payables   1,589         
Lease liability   37    272    193 
Borrowings   270         
Total   1,896    272    193 


 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

XML 43 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENT
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
FAIR VALUE MEASUREMENT

NOTE 23 – FAIR VALUE MEASUREMENT:

 

Fair value hierarchy

 

The following tables detail the consolidated entity’s assets and liabilities, measured or disclosed at fair value, using a three-level hierarchy, based on the lowest level of input that is significant to the entire fair value measurement, being:

 

Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date

 

Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly

 

Level 3: Unobservable inputs for the asset or liability

 

As of December 31, 2022  Level 1   Level 2   Level 3   Total 
   US$ in thousands 
Liabilities                    
Derivative financial liabilities (Note 22)           2,693    2,693 
Total           2,693    2,693 

 

As of December 31, 2021  Level 1   Level 2   Level 3   Total 
   US$ in thousands 
Liabilities                    
Derivative financial liability       32        32 
Total       32        32 

 

XML 44 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUBSEQUENT EVENTS
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
SUBSEQUENT EVENTS

NOTE 9 – SUBSEQUENT EVENTS

 

Since the reporting date, the following significant events have occurred:

 

1. Reverse Stock Split - On August 8, 2023, at the Extraordinary General Meeting of Shareholders of the Company, the Company’s shareholders voted in favor of consolidating every twenty-two ordinary shares in the authorized but unissued and in the authorized and issued share capital of the Company into one ordinary share (the “Reverse Stock Split”).

 

On August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis under the current symbol “SMX”.

 

Following is a table which presents the loss per share before the change (see also Note 8).

 

Loss per share have been calculated using the weighted average number of shares in issue during the relevant financial periods, the weighted average number of equity shares in issue and loss for the period as follows:

 

 SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE

   June 30, 2023   June 30, 2022 
   Six months ended 
   June 30, 2023   June 30, 2022 
Net loss attributable to the owners of the Company   (33,009)   (2,442)
           
Basic and diluted loss per share   (1.79)   (0.15)
Weighted average number of ordinary shares          
Weighted average number of ordinary shares used in calculating basic and diluted loss per share   18,404    15,984 

 

2. On July 27, 2023, the Company amended its Pre-Paid Advance agreement with Yorkville (see also Note 5.1) evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (as adjusted for the Reverse Stock Split which occurred on August 21, 2023, see also Note 9.1), after the Company was required to repay in cash $500 of principal amount as a result of the Company’s share price being below the original Floor Price. The maturity date will be 12-months after the initial closing of the Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $1,500. In the period, the Company repaid approximately $450 principal amount by ordinary share issuance in accordance with the terms of the SEPA and subsequent to the period, the Company repaid approximately $1,350 through September 30, 2023.

 

3. On September 6, 2023, the Company consummated the transactions pursuant to a Securities Purchase Agreement dated as of September 5, 2023 and issued and sold to an institutional investor a promissory note with a fixed conversion price of $1.6378 and warrants, for gross proceeds to SMX of approximately $2,500, before deducting fees and other offering expenses payable by the Company to their service providers. The note is in the principal amount of $4,290. The actual amount loaned by the investor pursuant to the Note is $2,574 after a 40% original issue discount. The maturity date of the note is the 12-month anniversary of the Effective Date, and is the date upon which the principal amount, as well as any accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of 12% per year and shall be payable on the maturity date. The investor has the right, at any time, to convert all or any portion of the then outstanding and unpaid principal amount and interest (including any costs, fees and charges) into the Company’s ordinary shares, at a fixed conversion price of $1.6378 per share. Any such conversion is subject to customary conversion limitations set forth in the Purchase Agreement so the investor beneficially owns less than 4.99% of the Company’s ordinary shares. Additionally, the Company has the right to convert in whole or in part the note into ordinary shares; provided that in no case shall the Company so convert the note if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of 4.99%.

  

4. On September 15, 2023, the Company paid $250 to EF Hutton, division of Benchmark Investments, LLC, pursuant to a Satisfaction and Discharge of Indebtedness Pursuant to Promissory Note Dated March 7, 2023. Upon paying such amount, the promissory note dated March 7, 2023 in the principal sum of $900 was deemed fully paid and satisfied and the Note was thereafter canceled, discharged and no longer of any further force or effect.

 

5. On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund (the “Loan Agreements”). Pursuant to the amendment to the Loan Agreements, Kamea agreed to convert $657 of indebtedness under the Loan Agreements (the “Indebtedness Amount”) into 487,281 ordinary shares (post Reverse Stock Split) of the Company, as payment in full for the Indebtedness Amount; provided however, that in the event the proceeds received from Kamea with respect to any sales of such shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount.
   
6.

On October 3, 2023, the Company has signed an agreement with True Gold Consortium Pty Ltd (“TrueGold”) (see also Note 1C) shareholders to acquire an additional 7.5% which will increase the Company’s holdings to 51.9% in TrueGold and result in the Company’s gain control over TrueGold. As part of the agreement and in consideration for the additional 7.5%, it was agreed that the outstanding payables from TrueGold to the Company which amounted to AU$ 475 as of June 30, 2023 (approximately $307) would be forgiven in full.

 

The transaction is based on past valuation, which was prepared in October 2021, which evaluates TrueGold’s fair value in the range of $78.5 million to $90 million and at a mean of $84.3 million. This past valuation was not audited or reviewed.

 

As of the agreement’s closing date, both parties agreed to engage an independent third party appraiser to prepare an updated TrueGold valuation as of closing date by November 30, 2023. Accordingly, the Company will recognize in its financial statements the fair value of TrueGold’s assets & liabilities at closing date as will be valued by the independent third party appraiser. Once this valuation will be completed, there may be material differences between TrueGold’s past valuation from October 2021 to the updated valuation.

NOTE 4 – SUBSEQUENT EVENTS:

 

1.

In February 2023, the Company entered a Standby Equity Facility to raise up to USD 25,000 thousand of common stock over the course of 36 months. the Company will issue to the investor the common stock at a purchase price as one of two options (i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period. the Company issued in advance part of the common stocks for proceeds of USD 3,500 thousand as follows (i) USD 1,500 thousand at the initial closing (was received on March 2023) (ii) USD 2,000 thousand upon effectiveness of a registration statement that was filed on March 2023.

   
2.

On January 25, 2023, Security Matters Limited issued 250,000 convertible notes for an aggregate amount of USD 250 thousand. These convertible notes have a maturity date of the earlier between December 31, 2024 and the date of any change in control (excluding the Business Combination). The convertible notes have an interest rate of 15% per annum. The convertible notes shall be converted into common shares of the Company at a conversion price of USD 10.

 

 

NOTE 4 – SUBSEQUENT EVENTS (CONT.):

 

3.

Between August 2022 to January 2023, Security Matters Limited entered into bridge loan agreements (the “Bridge Loans”) with eleven lenders, which lent Security Matters Limited an aggregate amount of USD 3,860 thousand. The Bridge Loans have a maturity date of up to two years and bear interest rate of 10% per annum. The Bridge Loans were accounted for in accordance with amortized cost method.

 

As part of the Bridge Loans agreements, the lenders were granted with two types of warrants:

 

(i)Bonus Warrants – 243,000 warrants to purchase ordinary shares of the Company at an exercise price of USD 11.50 per share. The Bonus Warrants term is five years commencing upon the Business Combination.

 

(ii)

Redeemable Warrants – 597,000 warrants to purchase ordinary shares of the Company at a purchase price of USD 11.50 per share. The Redeemable Warrants term is five years commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD 5.00 per warrant.

 

Each investor has the option to decide that Security Matters Limited will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary.

 

In March 2023, Security Matters Limited signed an addendum to the Bridge Loans agreements which convert USD 1,350 thousand into common shares and defer the payments to March 31, 2024.

 

4.

The Company’s board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan, which was subsequently amended on April 25, 2023, which reserved for grant a number of Ordinary Shares equal to 15% of the number of issued and outstanding Ordinary Shares on a fully diluted basis immediately after the closing of the Business Combination, or 5,082,417 authorized ordinary shares. 

  
5.The financial statements were authorized for issuance on April 25, 2023.
Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
SUBSEQUENT EVENTS  

NOTE 24 – SUBSEQUENT EVENTS:

 

Since the reporting date the following significant events have occurred:

 

1.On January 25, 2023, the Company issued 250,000 in principal amount of convertible notes for an aggregate amount of 250. These convertible notes have a maturity date of the earlier between December 31, 2024 and the date of any change in control (excluding the Business Combination). The convertible notes has an interest rate of 15% per annum. The convertible notes shall be converted into common shares at a conversion price of USD 10.
2.In January 2023, the Company signed an amendment to the agreement with Isorad that determine the following: (1) for the BCA with Lionheart, Isorad was issued (a) 864,000 options to purchase shares of the Company, the options were issued in January 2023 and valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: 3.42%; (2) expected volatility: 81.92%: (3) expected term: up to 3 years; and (4) expected dividend yield: 0%; (b) Additionally, Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of 27 million, or at the end of such 13 months, the earlier thereof). (2) Exit fee - in the occurrence of the first M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA with SPAC, the Company is to pay a cash amount equal to 1.5% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.
3.On March 2, 2023, the Group signed an amendment that postponed the Bonus payment from borrowing from related party to March 31, 2024 (see Note 11).
4.In February 2023, SMX PLC entered a Standby Equity Facility to raise up to USD $25,000 of common stock over the course of 36 months. SMX PLC will issue to the investor the common stock at a purchase price as one of two options (i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period. SMX PLC issued in advance part of the common stocks for proceeds of $3,500 as follows (i) $1,500 at the initial closing (was received on March 2023) (ii) $2,000 upon effectiveness of a registration statement that was initially filed in March 2023.
5.During 2023, the Company entered into an additional bridge loan agreement (the “Additional Bridge Loans”), in which the Company raised an aggregate amount of $550. The Additional Bridge Loans have a maturity date of up to two years and bears interest rate of 10% per annum.
6.In March 2023, the Group signed an addendum to the Bridge Loans agreements (see also Note 12) which converted $1,350 into common shares and deferred the remaining cash payments to March 31, 2024.
7.On March 7, 2023, certain of the Company’s Convertible Notes (see also Note 6) were converted to 1,000,000 ordinary shares of the Company.
8.The financial statements were authorized for issuance on April 25, 2023.

XML 45 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
MATERIAL EVENTS DURING THE PERIOD
6 Months Ended
Jun. 30, 2023
Material Events During Period  
MATERIAL EVENTS DURING THE PERIOD

NOTE 5 – MATERIAL EVENTS DURING THE PERIOD

 

1. The Company entered in February 2023 into a Standby Equity Purchase Agreement (“SEPA”) to raise up to $25,000 in consideration of the issuance of ordinary shares over the course of 36 months with Yorkville. According to the SEPA, the Company may issue Yorkville the ordinary shares at a purchase price as one of two options (i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period.

 

Yorkville advanced to the Company an aggregate principal amount of $3,500 (the “Pre-Paid Advance”). The Pre-Paid Advance was disbursed in two separate installments evidenced as convertible loans, the first for $1,500 at the closing of the Business Combination, and the second, as subsequently amended, for $2,000 upon the effectiveness of the Initial Yorkville Registration Statement. The purchase price for the Pre-Paid Advance is 92.0% of the Pre-Paid Advance. Such Pre-Paid Advances will be offset upon the issuance of ordinary shares to Yorkville at a price per share equal to the lower of (a) 100% of the daily VWAP of the Ordinary Shares on The Nasdaq Stock Market as of the trading day immediately prior to the date of the disbursement of the Pre-Paid Advance (the “Fixed Price”) (in the case of the first Pre-Paid Advance, $3.65), or (b) 93.0% of the lowest daily VWAP of the Ordinary Shares on Nasdaq during the seven trading days immediately prior to each purchase (the “Variable Price” and the lower of the Fixed Price and the Variable Price shall be referred to as the “Purchase Price”); however, in no event shall the Purchase Price be less than $1.10 (the “Floor Price”). On July 27, 2023, the Company amended the promissory note evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (as adjusted for reverse stock split which occurred on August 21, 2023, see also Note 9.1), after the Company was required to repay in cash $500 of principal amount as a result of the Company’s share price being below the original Floor Price. The maturity date will be 12-months after the initial closing of each Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $1,500. In the period, the Company issued ordinary shares in consideration of $450 in accordance with the terms of the SEPA.

 

2. On June 22, 2023, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with EF Hutton, LLC (the “Underwriter”) relating to the public offering of (i) 13,333,333 ordinary shares of the Company, at a subscription price per share of $0.24 (the “Firm Shares”), (ii) 13,333,333 warrants in the form of Warrant A to subscribe for 13,333,333 ordinary shares, at an exercise price of $0.24 per share (“Warrant A”), and (iii) 13,333,333 warrants in the form of Warrant B to subscribe for 13,333,333 ordinary shares, at an exercise price of $0.24 per share (“Warrant B” and together with Warrant A, the “Firm Warrants” and, collectively with the Firm Shares, the “Firm Securities”).

 

The Company also granted the Underwriter a 45-day option to subscribe for, in the aggregate, (a) up to 1,999,999 additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $0.24 (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to 1,999,999 ordinary shares at a price per share of $0.2399 (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $0.0001 per share, and/or (b) 1,999,999 warrants in the form of Warrant A to subscribe for an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at an exercise price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) 1,999,999 warrants in the form of Warrant B to purchase an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at a purchase price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants. The Option Shares and the Option Warrants are referred to as the “Option Securities”.

 

The offering closed on June 27, 2023. The Company delivered the Firm Shares (or Firm Share equivalents in the form of Pre-Funded Warrants), the Firm Warrants and the Option Warrants to the Underwriter on the same day.

 

The Warrant A terms specify that the warrants may be exercised at any time on or before June 27, 2028. On or after the earlier of (i) the thirty day anniversary of the date of the Underwriting Agreement and (ii) the date on which the aggregate composite trading volume of the Company’s ordinary shares as reported by Bloomberg LP beginning on the date of the Underwriting Agreement exceeds 15,000,000 ordinary shares, a holder of Warrant A warrants may also provide notice and elect a “cashless exercise” pursuant to which the holder would receive an aggregate number of ordinary shares equal to the product of (x) the aggregate number of ordinary shares that would be issuable upon a cash exercise and (y) $0.50. As of the date of publication of these financial statements, an aggregate of 15,195,332 Warrant A warrants were cashless exercised into an aggregate of 7,597,665 ordinary shares.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 5 – MATERIAL EVENTS DURING THE PERIOD (CONT.)

 

The Warrant B terms specify that the warrants may be exercised at any time on or before June 27, 2028. All of such Warrant B warrants remain outstanding as of the end of period.

 

Warrant A was valued at $0.0635 which is half of the share market price at the end of the period, assuming cashless exercise. Warrants A were considered to be a derivative financial liability. The terms of warrants B specify that each warrant has a cash exercise price of $0.24. Warrant B was valued at $0.0602 by using the Black-Scholes option-pricing model, with expected volatility of 70.39% and the risk-free interest rate used is 4.13%. Warrants A and B expire in June 2028.

 

The net proceeds to the Company upon the closing of this offering were approximately $2,580. The capital raise fee amounted to $660.

 

The Company also granted to the Underwriter, 666,667 warrants at an exercise price of $0.264 per share, which expires after 5 years. The Underwriter’s warrants were valued at $0.0575 per option by using the Black & Scholes option-pricing, with expected volatility of 70.39% and the risk-free interest rate used is 4.13%.

 

3.

In January 2023, the Company signed an amendment to the agreement with Isorad that determine the following: (1) for the BCA with Lionheart, (a) Isorad was issued 864,000 options to purchase shares of the Company, which options were issued in January 2023 and valued using the Black-Scholes pricing model, with the main parameters used are: (1) risk-free rate: 3.42%; (2) expected volatility: 81.92%: (3) expected term: up to 3 years; and (4) expected dividend yield: 0%; and (b) Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of $27 million, or at the end of such 13 months, the earlier thereof). In the period, based on the funds the Company actually received, the Company recognized a technology license intellectual property at the amount of $101 against a liability that reflects the due amount; and

 

(2) Exit fee - in the occurrence of the first M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA, the Company is to pay a cash amount equal to 1.5% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

4. On March 2, 2023, the Company amended its loan agreement dated September 7, 2015, between the Company, its Shareholders and Kamea Fund that postponed the repayment of the borrowings from related party (Bonus Payment) to March 31, 2024 (refer also to Note 9.4 – Subsequent Events).

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

XML 46 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Basis of preparation

A. Basis of preparation

 

These interim consolidated financial statements have been prepared in a condensed format in accordance with IAS 34 Interim Financial Reporting. They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the annual consolidated financial statements as of December 31, 2022 of the Company and of Security Matters PTY Ltd. (formerly - Security Matters Limited).

 

Basis of preparation

 

These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). Separate statements of comprehensive income, changes in equity, and cash flows have not been presented because the Corporation has not engaged in any activities except in connection with its formation.

 

Cash and cash equivalents  

Cash and cash equivalents

 

Cash equivalents are considered by the Company to be highly liquid investments, including, inter alia, short-term deposits with banks and the maturity of which do not exceed three months at the time of deposit, and which are not restricted.

 

Foreign currency  

Foreign currency

 

The financial statements are prepared in EURO which is the presentation and functional currency of the Company.

 

 

Functional currency

B. Functional currency

 

The consolidated financial statements are prepared in US Dollars, which is the functional and presentation currency of the Company.

 

 
Application of accounting policies

C. Application of accounting policies

 

The Group has applied the same accounting policies and methods of computation in its interim condensed consolidated financial statements as in its 2022 annual financial statements and as in the 2022 annual financial statements of Security Matters PTY Ltd, except as stated below in note 2D and 2E.

 

Several amendments to IFRS Standards apply for the first time in 2023, but do not have an impact on the interim condensed consolidated financial statements.

 

 
Issue of a unit of financial instruments

D. Issue of a unit of financial instruments

 

The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.

 

 
Reverse acquisition transaction

E. Reverse acquisition transaction

 

The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.

 

Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($11,599), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $16,802, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

E. Reverse acquisition transaction (Cont.)

 

The Company is initially consolidated in the financial statements from the Closing Date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($4,921) and trade and other payables and warrants ($10,127) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:

 

1. The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.

 

2. The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.

 

3. The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.

 

4. The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.

 

 
Reverse stock split

F. Reverse stock split

 

The presentation of loss per share amounts has been retrospectively adjusted to give effect to the reverse share split which occurred on August 8, 2023. Except otherwise specifically provided, no other adjustments have been made in these notes to reflect the reverse share split. See also Note 9.1.

 
Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Basis of preparation  

Basis of preparation

 

These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). The financial statements have been prepared under the historical cost convention except for certain financial liabilities which are measured at fair value until conversion. The Company has elected to present the statement of comprehensive income using the function of expense method.

 

Principles of consolidation  

Principles of consolidation

 

The consolidated financial statements incorporate the assets and liabilities of all subsidiaries of Security Matters Limited as of December 31, 2022 and 2021 and the results of all subsidiaries for the three years in the period then ended. Security Matters Limited and its subsidiaries together are referred to in these financial statements as the Group or the “consolidated entity”.

 

Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is obtained by the Company and until the date that control is lost.

 

Intercompany transactions between entities in the consolidated entity are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of the impairment of the asset transferred.

 

Accounting Estimates and Assumptions  

Accounting Estimates and Assumptions

 

The preparation of the consolidated financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities and expenses. These estimates and underlying assumptions are reviewed regularly. Changes in accounting estimates are reported in the period of the change in estimate. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements, are disclosed in note 3.

 

Cash and cash equivalents  

Cash and cash equivalents

 

Cash equivalents are considered by the Group to be highly liquid investments, including, inter alia, short-term deposits with banks and the maturity of which do not exceed three months at the time of deposit, and which are not restricted.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Foreign currency  

Foreign currency

 

The consolidated financial statements are prepared in US Dollars which is the presentation currency of the Group. Security Matters Limited’s functional currency is Australian Dollars.

 

The functional currency of Security Matters Ltd. (Israel) is New Israeli Shekels. The functional currency of Security Matters Canada Ltd. Is Canadian Dollars. The functional currency of Security Matters France Ltd. Is Euro. The functional currency of SMX Beverages Pty Ltd. Is Australian Dollars.

 

Transactions and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting Standard (IAS) 21 (“The Effects of Changes in Foreign Exchange Rates”). Accordingly, transactions and balances have been converted as follows:

 

Assets and liabilities – at the rate of exchange applicable at the reporting date;
Expense items – at annual average rate at the statements of financial position date.
Share capital, capital reserve and other capital movement items were at rate of exchange as of the date of recognition of those items.
Accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned above.
Exchange gains and losses from the aforementioned conversion are recognized in the statement of other comprehensive lose in Foreign Currency Translation Reserve.

 

Investments in associated companies  

Investments in associated companies

 

Investments in associated companies are accounted under the equity method and are initially recognized at cost. The investment’s cost includes transaction costs. The consolidated financial statements include the Group’s share in net income or loss, in other comprehensive income or loss, and in the net assets of associated companies accounted by the equity method from the date when significant influence or joint control materialized, until the date on which the conditions for significant influence or joint control are no longer met.

 

Losses of an associate in amounts which exceed its equity are recognized by the Company to the extent of its investment in the associate plus any losses that the Company may incur as a result of a guarantee or other financial support provided in respect of the associate.

 

Loss per share  

Loss per share

 

Basic loss per share

 

Basic loss per share is calculated by dividing the net loss attributable to the owners of Security Matters Limited, by the weighted average number of ordinary shares outstanding during the financial year, adjusted for bonus elements in ordinary shares issued during the financial year.

 

Diluted earnings per share

 

Potential ordinary shares are included in the computation of diluted earnings per share when their conversion decreases earnings per share. Potential Ordinary shares that are converted during the period are included in diluted earnings per share only until the conversion date and from that date in basic earnings per share.

 

Governmental grants  

Governmental grants

 

Government grants received for the use of research and development activities, for which the Group undertook to pay royalties to the state, contingent on future sales arising from this financing, were treated as forgivable loans. The grant was recognized as a liability in the financial statements, except when there is reasonable assurance that the Group will comply with the conditions for the forgiveness of the loan, then it would be recognized as a government grant. When the loan bears a below-market rate of interest, the liability is recognized at its fair value in accordance with the market interest rate prevailing at the time of receiving the grant. The difference between the consideration received and the liability recognized at inception was treated as a government grant and recognized as a reimbursement of research expenses. The repayment of the liability to the state is reviewed every reporting period, with changes in the liability resulting from a change in the expected royalties recognized in profit or loss.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Fair value measurement  

Fair value measurement

 

Fair value is the price that would be received when selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:

 

A.In the principal market for the asset or liability; or
B.In the absence of a principal market, in the most advantageous market for the asset or liability.

 

The principal or the most advantageous market must be accessible to the Group.

 

The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.

 

A fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.

 

The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.

 

Classification of financial instruments by fair value hierarchy  

Classification of financial instruments by fair value hierarchy

 

The financial instruments presented in the statements of financial position at fair value are grouped into classes with similar characteristics using the following fair value hierarchy which is determined based on the source of input used in measuring fair value:

 

  Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities.
  Level 2 - Inputs other than quoted prices included within Level 1 that are observable either directly or indirectly.
  Level 3 - Inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).

 

Financial assets  

Financial assets

 

The Group classifies its financial assets into one of the following categories, depending on the purpose for which the asset was acquired. The Group’s accounting policy for each category is as follows:

 

Other receivables: These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They arise principally through the provision of goods and services, but also incorporate other types of contractual monetary asset. These assets are carried at amortized cost less any provision for impairment.

 

The Group has no financial assets classified at Fair value through profit or loss.

 

Financial liabilities  

Financial liabilities

 

financial liabilities measured at amortized cost:

 

Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.

 

After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, which ensures that any interest expense over the period is at a constant interest rate on the balance of the liability carried in the statement of financial position, except for

 

measured at fair value through profit or loss:

 

These financial liabilities comprise of derivatives that are options which are to be settled in equity instruments but nevertheless do not meet the definitions of equity instrument. At initial recognition, the Group measures those financial liabilities at fair value. Transaction costs are recognized in profit or loss. After initial recognition, changes in fair value are recognized in profit or loss.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Impairment of financial assets  

Impairment of financial assets

 

The Group recognizes a loss allowance for expected credit losses on financial assets which are either measured at amortized cost or fair value through other comprehensive income. The measurement of the loss allowance depends upon the Group’s assessment at the end of each reporting period as to whether the financial instrument’s credit risk has increased significantly since initial recognition, based on reasonable and supportable information that is available, without undue cost or effort to obtain.

 

Where there has not been a significant increase in exposure to credit risk since initial recognition, a 12-month expected credit loss allowance is estimated. This represents a portion of the asset’s lifetime expected credit losses that is attributable to a default event that is possible within the next 12 months. Where a financial asset has become credit impaired or where it is determined that credit risk has increased significantly, the loss allowance is based on the asset’s lifetime expected credit losses. The amount of expected credit loss recognized is measured on the basis of the probability weighted present value of anticipated cash shortfalls over the life of the instrument discounted at the original effective interest rate. The loss allowance is recognized in profit or loss.

 

Impairment of non-financial assets  

Impairment of non-financial assets

 

Intangible assets that have an indefinite useful life are not subject to amortization and are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired. Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount. Recoverable amount is the higher of an asset’s fair value less costs of disposal and value-in-use. The value-in-use is the present value of the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.

 

Property, plant and equipment  

Property, plant and equipment

 

Items of property, plant and equipment are initially recognized at cost. Cost includes directly attributable costs and the estimated present value of any future costs of dismantling and removing items. Depreciation is computed by the straight-line method, based on the estimated useful lives of the assets, as follows:

 

   % 
Computers   33 
Machines and equipment   20 
Furniture and office equipment   10 
Leasehold improvements   5 

 

Leasehold improvements are depreciated over the term of the expected lease including optional extension, or the estimated useful lives of the improvements, whichever is shorter.

 

Reimbursement of research and development expenses  

Reimbursement of research and development expenses

 

Reimbursements in proof of concept (POC) agreements of expenditures on research and development in order to achieve commercial agreement once this activity will be result successful, are offset in profit or loss against the related expenses (research and development expenses). Any IP generated from this activity remains at the ownership of the Group.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Right-of-use assets  

Right-of-use assets

 

All leases are accounted for by recognizing a right-of-use asset and a lease liability, excluding leases where the lease term is 12 months or less, or where the underlying asset is of low-value. These leases expenditures are recognized on a straight-line basis over the lease term.

 

A right-of-use asset is recognized at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of any lease incentives received.

 

Right-of-use assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever is the shorter. Where the Group expects to obtain ownership of the leased asset at the end of the lease term, the depreciation is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.

 

Lease liabilities  

Lease liabilities

 

All leases are accounted for by recognizing a right-of-use asset and a lease liability. Lease liabilities are measured at the present value of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the rate implicit in the lease unless (as is typically the case) this is not readily determinable, in which case the Group’s incremental borrowing rate on commencement of the lease is used. Variable lease payments are only included in the measurement of the lease liability if they depend on an index or rate. In such cases, the initial measurement of the lease liability assumes the variable element will remain unchanged throughout the lease term. Other variable lease payments are expensed in the period to which they relate.

 

On initial recognition, the carrying value of the lease liability also includes:

 

  amounts expected to be payable under any residual value guarantee.
  the exercise price of any purchase option granted in favor of the Group if it is reasonably certain to exercise that option.
  any penalties payable for terminating the lease, if the term of the lease has been estimated on the basis of termination option being exercised.

 

Subsequent to initial measurement lease liabilities increase as a result of interest charged at a constant rate on the balance outstanding and are reduced for lease payments made. Lease liabilities are remeasured when there is a change in future lease payments arising from a change in an index or rate or when there is a change in the assessment of the term of any lease the remeasurement being recognized in front of the right of use assets.

 

Employee benefits  

Employee benefits

 

The Group has several employee benefit plans as to Israeli employees:

 

1.Short-term employee benefits: Short-term employee benefits include salaries, paid annual leave, paid sick leave, recreation and social security contributions and are recognized as expenses as the services are rendered. A liability in respect of a cash bonus or a profit-sharing plan is recognized when the Group has a legal or constructive obligation to make such payment as a result of past service rendered by an employee and a reliable estimate of the amount can be made.
2.Post-employment benefits: The plans are normally financed by contributions to insurance companies and classified as defined contribution plans or as defined benefit plans. The Group has defined for most of its employees contribution plans pursuant to Section 14 to the Israel Severance Pay Law since 2004 under which the Group pays fixed contributions and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient amounts to pay all employee benefits relating to employee service in the current and prior periods.

 

Contributions to the defined contribution plan in respect of severance or retirement pay are recognized as an expense simultaneously with receiving the employee’s services and no additional provision is required in the financial statements except for the unpaid contribution.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Intangible assets  

Intangible assets

 

Intangible assets include capitalized technology development costs. Expenditures on research activities are recognized in profit or loss as incurred. Expenditures on internally developed products are mainly employee salaries and legal fees for filing of patents and are capitalized when the Group demonstrates all the following criteria:

 

  a. The technical feasibility of completing the intangible asset so that it will be available for use or sale.
  b. The intention to complete the intangible asset and use or sell it.
  c. The ability to use or sell the intangible asset.
  d. The probability of the intangible asset to generate future economic benefits. Among other things, the Group considers the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset.
  e. The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.
  f. The ability to measure reliably the expenditures attributable to the intangible asset during its development.

 

The recognition criteria above are considered by the Group at each stage of development to determine when the criteria have been initially met in full.

 

The technical feasibility criteria is determined to be met when the milestone of initial marking and reading capabilities is satisfied. The milestone’s identification occurs only following a detailed broad mapping of the raw material characteristics and establishing the formula for the chemical marker architecture to be embedded into the raw material based on industry standards and regulations. The result is the initial evidence that the x-ray algorithm of the designated reader is in a stage that can identify the marker and convey information. At this stage, the Group believes that the technical feasibility of completing the development for use is probable.

 

The Group notes that technical feasibility has been established and the achieved technology is ready for the next stage which consists of performing a proof-of-concept pilot with an industry partner, in order to adapt the technology for the relevant industry and adjust the development to meet the industry’s needs.

 

Currently, the Group’s capitalized development activities focus on:

 

  1. Development of marker architecture to be embedded topically or in-situ (application) for each material/product within the optimal industrial manufacturing phase, based on industry standards and regulations.
  2. Semi Industrial scale – technology implementation in semi-industrial production.
  3. Development of a digital platform to support the end-to-end traceability from raw material to final product to recycling.

 

The Group’s management has the full intention to complete the development of the technology and ultimately to sell it. This intention is demonstrated by initiating partnerships with industry market leaders and continuing the development into the next phase. The Group’s intention is also reflected in the Group’s approved budget.

 

The Group’s management intends to concentrate its future sales and marketing efforts in the U.S. market, including recruitment of sales and marketing personnel. It plans to advance successful proof-of-concept pilots performed with industry leading partners, and further advance its innovative technology and commercialization efforts and collaborations in the segments relevant to its technology.

 

The Group’s business model targets leading brands and manufacturers in order to create a new market standard for circular economy solutions, brand authentication and supply chain integrity. The Group’s technology is applicable for multiple industries such as gold, fashion, electronics and circular economy – plastic and rubber. The Group is able to provide an adaptive solution for multiple market segments, based on a unified technology solution, through collaborative relationships with leading market companies which provide it with access to various potential entities to sell its solution. This is part of the Group’s strategy to create strategic partnerships with market leaders across its main segments of activity. The Group believes that this close collaboration with market leaders, and developing a product that meets their requests, suggest that there is a strong potential market for its development.

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

Intangible assets (Cont.)

 

Adequate technical and financial resources are available to complete the development; the development will be completed by the Group’s technology team which consists of professional experienced scientists and engineers, with a track record in the industrial sector and with financial resources successfully raised through the issuance of ordinary shares and loans. The Group has already accomplished its core technology development and is currently focused on development of specific adjustments for different market segments. This stage is focused and short-termed, therefore, management believes that limited financial resources are required for completing the development and that there is high probability for commencing commercial agreements following the successful proof-of-concept pilots.

 

The Group has financial systems in place that allow it to maintain records in sufficient detail that enable it to measure reliably the expenditures attributable to the intangible asset during its development.

 

Development expenditures not satisfying all the above criteria are recognized in the consolidated statement of comprehensive income as incurred.

 

Subsequent measurement

 

In subsequent periods, capitalized development expenditures are measured at cost less accumulated amortization and accumulated impairment losses.

 

An asset is ready for its intended use, when the developed technology becomes operational and the Group completes an initial customization for a client’s specific needs, which means that the technology is fully implemented in the customer’s manufacturing processes and ready for its intended use. The management estimates that in approximately two years such customization will be completed, and amortization will commence.

 

Intangible assets with a finite useful life are amortized over their estimated useful lives and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for intangible assets are reviewed at least at each year end.

 

The carrying amount of these assets is reviewed whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. An expenditure incurred in development activities, including the Group’s software development is capitalized only where it clearly increases the economic benefits to be derived from the asset to which it relates, the expenditure will lead to new or substantially improved products, the products are technically and commercially feasible and the Group has sufficient resources to complete the development and reach the stage for which the product is ready for use.

 

All other expenditure, including those incurred in order to maintain an intangible assets current level of performance, is expensed as incurred.

 

Share-based compensation  

Share-based compensation

 

The Group measures the share-based expense and the cost of equity-settled transactions with employees and service providers by reference to the fair value of the equity instruments at the date at which they are granted. The Group selected the Black-Scholes model as the Group’s option pricing model to estimate the fair value of the Group’s options awards. The model is based on share price, grant date and on assumptions regarding expected volatility, expected life of the options, expected dividend, and a no risk interest rate. As for granted options which are settled in equity instruments, the fair value of the options at the grant date is charged to the statement of comprehensive loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting period is based on the number of options that eventually vest.

 

New standards, interpretations and amendments not yet effective  

New standards, interpretations and amendments not yet effective

 

The Group has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective. There are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future accounting periods that the Group has decided not to adopt early.

 

The following amendments are effective for the period beginning January 1, 2023:

 

Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2);
Definition of Accounting Estimates (Amendments to IAS 8); and
Deferred Tax Related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12).

 

The following amendments are effective for the period beginning January 1, 2024:

 

IFRS 16 Leases (Amendment – Liability in a Sale and Leaseback)
IAS 1 Presentation of Financial Statements (Amendment – Classification of Liabilities as Current or Non-current)
IAS 1 Presentation of Financial Statements (Amendment – Non-current Liabilities with Covenants)

 

The Group is currently assessing the impact of these new accounting standards and amendments.

 

The Group does not expect any other standards issued by the IASB, but not yet effective, to have a material impact on the Group.

XML 47 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
GENERAL (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
SCHEDULE OF COMPANIES SUBSIDIARIES
Controlled entity  

Country of

Incorporation

   

Percentage Owned

June 30, 2023

   

Percentage Owned

December 31, 2022

 
Security Matters PTY Ltd.
(Formerly - Security Matters Limited)
    Australia       100 %     -  
Lionheart III Corp     USA       100 %     -**  
SMX Circular Economy Platform PTE, Ltd.     Singapore       100 %     *  
SMX (Security Matters) Ireland Limited     Ireland       100 %     *  
SMX (Security Matters) Israel Ltd.
(Formerly - Security Matters Ltd.)
    Israel       100 %     100 %***
Security Matters Canada Ltd.     Canada       100 %     100 %***
Security Matters France Ltd.     France       100 %     100 %***
SMX Beverages Pty Ltd.     Australia       100 %     100 %***

 

In addition, the Company’s has the following investments in associated companies:

 

Entity  

Country of

Incorporation

   

Percentage Owned

June 30, 2023

   

Percentage Owned

December 31, 2022

 
Yahaloma Technologies Inc.     Canada       50 %     50 %***
True Gold Consortium Pty Ltd     Australia       44.4 %     44.4 %***

 

The proportion of ownership interest is equal to the proportion of voting power held.

 

* Incorporated in 2023.
** Merger occurred in March 2023.
*** Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2022.
 
Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
SCHEDULE OF COMPANIES SUBSIDIARIES  
XML 48 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT

 

   % 
Computers   33 
Machines and equipment   20 
Furniture and office equipment   10 
Leasehold improvements   5 
XML 49 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER CURRENT ASSETS (Tables)
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF OTHER CURRENT ASSETS

 

  

December 31,

2022

  

December 31,

2021

 
Prepaid expenses (*)   3,157    454 
Tax authorities   358    280 
Proof of concept receivables   86    116 
Other   72    70 
Total   3,673    920 

 

*The prepaid expenses include 3,123 for December 31, 2022, which related to the anticipated SPAC transaction costs (refer to Note 1).
XML 50 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY AND EQUIPMENT, NET (Tables)
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT

 

   Leasehold improvements   Machines and Equipment   Furniture and Office Equipment   Computers   Right of use assets   Total 
                         
Cost                              
At January 1, 2022   81    1,233    83    99    628    2,124 
Additions   -    135    -    17    49    201 
Deductions                       (21)   (21)
Depreciation   4    202    7    19    39    271 
Currency translation adjustments   (18)   (221)   (18)   (14)   (64)   (335)
At December 31, 2022   63    1,147    65    102    592    1,969 
Accumulated depreciation                              
At January 1, 2022   20    645    33    72    162    932 
Depreciation   4    202    7    19    39    271 
Currency translation adjustments   (6)   (148)   (9)   (17)   (23)   (203)
At December 31, 2022   18    699    31    74    178    1,000 
Net book value at December 31, 2022   45    448    34    28    414    969 

 

   Leasehold improvements   Machines and Equipment   Furniture and Office Equipment   Computers   Right of use assets   Total 
     
Cost                              
At January 1, 2021   69    847    73    72    606    1,667 
Additions   3    275    1    18    -    297 
Depreciation   5    187    7    16    72    287 
Currency translation adjustments   9    111    9    9    22    160 
At December 31, 2021   81    1,233    83    99    628    2,124 
Accumulated depreciation                              
At January 1, 2021   13    399    23    49    85    

569

 
Depreciation   5    187    7    16    72    287 
Currency translation adjustments   2    59    3    7    5    76 
At December 31, 2021   20    645    33    72    162    932 
Net book value at December 31, 2021   61    588    50    27    466    1,192 
XML 51 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS IN ASSOCIATED COMPANIES (Tables)
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF INFORMATION ABOUT CONSOLIDATED STRUCTURED ENTITIES

Reconciliation of the consolidated entity’s carrying amount

 

 SCHEDULE OF INFORMATION ABOUT CONSOLIDATED STRUCTURED ENTITIES

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
Security Matters Limited’s share of net assets   115    248    249 
Company’s share in net profits (losses) of associated companies   106    (101)   (1)
Closing carrying amount   221    147    248 
XML 52 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTANGIBLE ASSETS, NET (Tables)
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
SUMMARY OF INTANGIBLE ASSETS NET

 SUMMARY OF INTANGIBLE ASSETS NET

                
  

Capitalization of

development cost

  

Purchased

license

   Total 
   US$ in thousands   US$ in thousands   US$ in thousands 
COST               
As of January 1, 2022   4,024    -    4,024 
Capitalized development cost   975    721    1,696 
Currency translation adjustments   (500)   (66)   (566)
As of December 31, 2022   4,499    655    5,154 
                
Accumulated amortization               
As of January 1, 2022   116    -    116 
Amortization   14    -    14 
Currency translation adjustments   (3)   -    (3)
As of December 31, 2022   127    -    127 
                
Net book value as of December 31, 2022   4,372    655    5,027 

 

 

 

SECURITY MATTERS LIMITED

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

(US$ in thousands, except per share data)

 

 

NOTE 8 – Intangible assets, NET (CONT.):

 

      
   Capitalization of development cost 
   US$ in thousands 
COST     
As of January 1, 2021   2,332 
Capitalized development cost   1,468 
Currency translation adjustments   224 
As of December 31, 2021   4,024 
      
Accumulated amortization     
As of January 1, 2021   88 
Amortization   28 
As of December 31, 2021   116 
      
Net book value as of December 31, 2021   3,908 
XML 53 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES (Tables) - Security matters limited [member]
12 Months Ended
Dec. 31, 2022
IfrsStatementLineItems [Line Items]  
SCHEDULE OF RIGHT OF USE ASSETS

Set out below are the carrying amounts of right-of-use assets recognized and the movements during the period:

 

 SCHEDULE OF RIGHT OF USE ASSETS

                
  

Office and lab

facilities

  

Motor

vehicles

  

Total

 
At January 1, 2022   446    20    466 
Additions   49        49 
Foreign currency translation   (35)   (6)   (41)
Deductions   (7)   (14)   (21)
Depreciation expense   (39)       (39)
As at December 31, 2022   414        414 
SCHEDULE OF LEASE LIABILITY

Set out below are the carrying amounts of lease liabilities and the movements during the period:

 

 SCHEDULE OF LEASE LIABILITY

           
  

December 31,

2022

  

December 31,

2021

 
At January 1,   503    589 
Additions   49     
Deductions   (21)    
Accretion of interest   51    47 
Foreign exchange differences   (57)   (35)
Lease Payments   (55)   (98)
As at December 31,   470    503 
           
Current   30    37 
Non-current   440    466 
SCHEDULE OF CARRYING AMOUNTS OF LEASE LIABILITIES RECOGNIZED IN PROFIT OR LOSS

The following are the amounts recognized in profit or loss:

 

 SCHEDULE OF CARRYING AMOUNTS OF LEASE LIABILITIES RECOGNIZED IN PROFIT OR LOSS

           
  

December 31,

2022

  

December 31,

2021

 
Depreciation expense of right-of-use assets   39    72 
Interest expense on lease liabilities   51    47 
Foreign Exchange different   16    (35)
Expense relating to short-term leases   -    - 
Total amount recognized in profit or loss   106    84 
XML 54 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER PAYABLES (Tables)
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF OTHER PAYABLES

 SCHEDULE OF OTHER PAYABLES

           
  

December 31,

2022

  

December 31,

2021

 
         
Employees, salaries and related liabilities   392    500 
Related party   56    24 
Liabilities for grants received (Note 19)   50    30 
Accrued expenses       49 
Derivative financial liability (Note 13)       32 
Other   152    38 
Total   650    673 
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
BORROWINGS FROM RELATED PARTIES (Tables)
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF BORROWINGS FROM RELATED PARTIES

 

  

December 31,

2022

  

December 31,

2021

 
Balance at January 1,   270    280 
Payment of borrowings   (172)   (103)
Provision for bonus (include interest)   621    89 
Exchange rate differences   (9)   4 
Balance at December 31,   710    270 
XML 56 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHAREHOLDERS’ EQUITY (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
SCHEDULE OF SHARE CAPITAL

 

    Number of shares  
    June 30, 2023     December 31, 2022  
    Authorized     Issued and outstanding     Authorized     Issued and outstanding  
Ordinary shares
USD 0.0001 par value
    800,000,000,000       38,364,447       500,000,000       1  
Preferred shares
USD 0.0001 par value
    200,000,000,000       -       -       -  
Deferred shares
Euro 1 par value
    25,000       25,000       25,000       25,000  

 

   Number of shares 
   December 31, 2022   July 1, 2022 
    

Authorized

    

Issued and outstanding

    

Authorized

    

Issued and outstanding

 

Ordinary shares

USD 0.0001 par value

   500,000,000    

1

    

500,000,000

    

1

 
Deferred Shares
EURO 1 par value
   

25,000

    

25,000

    

-

    

-

 
SCHEDULE OF SHARE OPTION GRANTED

 SCHEDULE OF SHARE OPTION GRANTED

 

   

Six months period ended

June 30, 2023

 
   

Number

of options

(in thousands)

   

Weighted average

exercise price per share (US$)

 
Outstanding at beginning of period     1,251       2.01  
Granted     790       3.47  
Exercised     (7 )     1.39  
Expired     -       -  
                 
Outstanding at June 30, 2023     2,034       2.58  
Exercisable options at June 30, 2023     1,825       2.48  

 

   

Six months period ended

June 30, 2022

 
   

Number

of options

(in thousands)

   

Weighted average

exercise price per share (US$)

 
Outstanding at beginning of period     3,346       2.02  
Granted     989       2.86  
Exercised     -          
Expired     (375 )     2.16  
                 
Outstanding at June 30, 2022     3,960       2.21  
Exercisable options at June 30, 2022     2,703       2.33  
 
SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING

The options to employees and service providers outstanding as of June 30, 2023, are comprised, as follows:

 

 SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING

Exercise price (US$)    

Outstanding as of

June 30, 2023

(in thousands)

   

Weighted average remaining

contractual term

   

Exercisable as of

June 30, 2023

(in thousands)

   

Weighted average remaining

contractual term

 
            (years)           (years)  
0.84-1.39       845       1.18       845       1.18  
1.81-2.51       335       2.59       335       2.59  
3.57-4.0       707       4.89       498       4.86  
4.18       10       1.74       10       1.74  
4.87       137       3.51       137       3.51  
        2,034               1,825          
 
SCHEDULE OF RESTRICTED STOCK UNIT

 SCHEDULE OF RESTRICTED STOCK UNIT

  

Six months period ended

June 30, 2023

(in thousands)

  

Six months period ended

June 30, 2022
(in thousands)

 
Outstanding at beginning of period   -    - 
Granted   4,334    - 
Vested   (945)   - 
           
Outstanding at June 30, 2023   3,389    - 
 
Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
SCHEDULE OF SHARE CAPITAL  

 SCHEDULE OF ORDINARY SHARES

    Number of shares 
    December 31, 2022   December 31, 2021 
    Authorized  

Issued and

outstanding

   Authorized  

Issued and

outstanding

 
Ordinary shares    167,854,581    167,854,581    165,532,264    165,532,264 
SCHEDULE OF SHARE OPTION GRANTED  

 SCHEDULE OF SHARE OPTION GRANTED

  

Year ended

December 31, 2022

  

Year ended

December 31, 2021

 
  

Number

of options (in thousands)

  

Weighted average

Exercise price (AUD)

  

Number

of options

(in thousands)

  

Weighted average

Exercise price (AUD)

 
Outstanding at beginning of year   11,280    0.27    9,530    0.23 
Issue of options   1,000    0.27    1,850    0.45 
Expired   (7,600)   0.22    (100)   0.34 
                     
Outstanding at end of year   4,680    0.35    11,280    0.27 
Exercisable options   2,835    0.28    4,318    0.27 
SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING  

The options to employees outstanding as of December 31, 2022, are comprised, as follows:

 

 SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING

Exercise price (AUD) 

Outstanding

as of

December 31, 2022

  

Weighted average remaining

contractual term

  

Exercisable

as of

December 31, 2022

  

Weighted average remaining

contractual term

 
       (years)       (years) 
0.12-0.2   800   4.59    400    4.64 
0.2   955   0.67    878    0.67 
0.31-0.357   2075   2.56    1432    2.15 
0.6   100   2.24    100    2.24 
0.7   750   3.97    25    3.74 
    4,680        2,835      
XML 57 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables)
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE

 SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
Salaries and related expenses   2,166    1,795    1,186 
Subcontractors and consultants   374    631    509 
Research expenses   316    252    155 
Depreciation and amortization   255    287    243 
Share based compensation   127    100    47 
Travel expenses   50    42    11 
Freight   30    23    33 
Other   6    -    53 
Reimbursement from paid pilots and proof of concept projects   (1,426)   (1,091)   (548)
Total   1,898    2,039    1,689 
XML 58 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
GENERAL AND ADMINISTRATIVE EXPENSES (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES

 SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES

    June 30, 2023     June 30, 2022  
    Six Months Ended  
    June 30, 2023     June 30, 2022  
    US$ in thousands     US$ in thousands  
Transaction cost     7,792       -  
Advertising, Public and Investors Relations     1,526       -  
Share based compensation     1,805       82  
Professional services     718       545  
Wages and salaries related     664       429  
Travel expenses     379       4  
Insurance     329       19  
Office and maintenance     37       80  
Depreciation and amortization     15       15  
Others     86       26  
Total     13,350       1,200  
 
Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES  

 SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
Professional services   1,105    1,089    1,257 
Wages and salaries related   935    752    409 
Travel expenses   223    -    65 
Office and maintenance   145    116    120 
Share based compensation   137    331    436 
Insurance   60    102    101 
Depreciation and amortization   35    28    16 
Other   83    64    43 
Total   2,723    2,482    2,447 
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
TAXES ON INCOME (Tables)
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE

 

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
Reconciliation of income tax at the statutory rate               
Loss before income tax   (6,184)   (4,939)   (4,573)
                
Theoretical tax rate of 27.5%   (1,701)   (1,358)   (1,257)
                
Tax effect amounts which are not deductible/(taxable) in calculating taxable income:               
Non-deductible expenditure and others   335    118    132 
Unrecognized temporary differences and tax losses for which deferred tax weren’t recognized   1,366    1,240    1,125 
Income tax / (benefit)            
XML 60 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
LOSS PER SHARE (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
SCHEDULE OF LOSS PER SHARE

 SCHEDULE OF LOSS PER SHARE

    June 30, 2023     June 30, 2022  
    Six months ended  
    June 30, 2023     June 30, 2022  
Net loss attributable to the owners of the Company   $ (33,009 )   $ (2,442 )
                 
Basic and diluted loss per share   $ (39.46 )   $ *(3.36)  
Weighted average number of ordinary shares                
Weighted average number of ordinary shares used in calculating basic and diluted loss per share (in thousands)     837       *727  

 

As a result of the reverse share split described in Note 9.1, the calculation of the basic and diluted loss per share for all periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.

 

* Restated as a result of the SPAC transaction
 
Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
SCHEDULE OF LOSS PER SHARE  

 SCHEDULE OF LOSS PER SHARE

  

December 31,

2022

  

December 31,

2021

  

December 31,

2020

 
             
Net loss attributable to the owners of the company   (6,184)   (4,939)   (4,573)
                
Basic and diluted loss per share   (0.04)   (0.03)   (0.04)
Weighted average number of ordinary shares               
Weighted average number of ordinary shares used in calculating basic and diluted loss per share   167,855    151,850    125,960 

XML 61 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
RELATED PARTIES (Tables) - Security matters limited [member]
12 Months Ended
Dec. 31, 2022
IfrsStatementLineItems [Line Items]  
SCHEDULE OF KEY MANAGEMENT PERSONNEL

The totals of remuneration paid to Key Management Personnel and related parties during the years are as follows:

 

 SCHEDULE OF KEY MANAGEMENT PERSONNEL

1. Transactions with related parties: 

December 31,

2022

  

December 31,

2021

 

Issuance of options to related party

 

721

   - 
Short-term salary and fees   508    475 
Loan repayment   172    103 
Share based payments   98    105 
Post-employment retirement benefits   94    92 
Payment for Administrative services   36    39 
Non-monetary benefits   29    11 
Proof of Concept projects paid by affiliated companies   (1,064)   (695)
   (594)   130 
SCHEDULE OF BALANCE WITH RELATED PARTIES

2. Balance with related parties:    

December 31,

2022

  

December 31,

2021

 
Key management  Salary and related   (99)   (86)
Directors  Salary and related   (82)    (11)
Shareholders  Borrowings from related parties   (710)   (270)
Shareholders  Other accounts payable   (56)   (24)
Joint Ventures  Other receivables   59    74 
Joint Ventures  Investment in subsidiary   221    147 
       (667)   (170)
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOVERNMENT GRANTS (Tables)
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF GOVERNMENT GRANTS

 SCHEDULE OF GOVERNMENT GRANTS

  

December 31,

2022

  

December 31,

2021

 
Short term liability at year end   50    30 
Long term liability at year end   85    85 
Total   135    115 
XML 63 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONTROLLED ENTITIES (Tables)
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF ASSETS AND LIABILITIES

Controlled entity 

Country of

Incorporation

  

Percentage Owned

December 31, 2022

  

Percentage Owned

December 31, 2021

 
Security Matters Ltd.   Israel    100%   100%
Security Matters Canada Ltd.   Canada    100%   100%
Security Matters France Ltd.   France    100%   100%
SMX Beverages Pty Ltd.   Australia    100%   50%
XML 64 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables) - Security matters limited [member]
12 Months Ended
Dec. 31, 2022
IfrsStatementLineItems [Line Items]  
SCHEDULE OF FOREIGN CURRENCY RISK

The carrying amounts of the Group foreign currency denominated monetary liability at the reporting date are as follows:

 

 SCHEDULE OF FOREIGN CURRENCY RISK

   Assets   Liabilities 
  

December 31,

2022

  

December 31,

2021

  

December 31,

2022

  

December 31,

2021

 
USD   1,214    481    (99)    
EUR   28    135    (73)    
    1,242    616    (172)    
SCHEDULE OF SENSITIVITY ANALYSIS PROFIT AND OTHER EQUITY

  

December 31,

2022

  

December 31,

2021

 
Assets less liabilities   1,115    481 
    10%   10%
    112    48 
SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE

The carrying amount of financial assets represents the maximum credit exposure. The maximum exposure to credit risk at the reporting date was:

 

 SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE

  

December 31,

2022

  

December 31,

2021

 
Cash and cash equivalents   1,398    4,171 
Other receivables   158    920 
Total   1,556    5,091 
SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES

 SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES

As of December 31, 2022 

Less than 1

year

   1-5 years   Over 5 years 
             
Financial liabilities at amortized cost               
Trade and other payables   3,622         
Bridge loans (Note 23)       989     
Government grants   75    84     
Lease liability   72    371    270 
Borrowings   710         
Total   4,479    1,444    270 

 

As of December 31, 2021 

Less than 1

year

   1-5 years   Over 5 years 
             
Financial liabilities at amortized cost               
Trade and other payables   1,589         
Lease liability   37    272    193 
Borrowings   270         
Total   1,896    272    193 


XML 65 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENT (Tables)
12 Months Ended
Dec. 31, 2022
Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY

 

As of December 31, 2022  Level 1   Level 2   Level 3   Total 
   US$ in thousands 
Liabilities                    
Derivative financial liabilities (Note 22)           2,693    2,693 
Total           2,693    2,693 

 

As of December 31, 2021  Level 1   Level 2   Level 3   Total 
   US$ in thousands 
Liabilities                    
Derivative financial liability       32        32 
Total       32        32 
XML 66 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUBSEQUENT EVENTS (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE

Loss per share have been calculated using the weighted average number of shares in issue during the relevant financial periods, the weighted average number of equity shares in issue and loss for the period as follows:

 

 SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE

   June 30, 2023   June 30, 2022 
   Six months ended 
   June 30, 2023   June 30, 2022 
Net loss attributable to the owners of the Company   (33,009)   (2,442)
           
Basic and diluted loss per share   (1.79)   (0.15)
Weighted average number of ordinary shares          
Weighted average number of ordinary shares used in calculating basic and diluted loss per share   18,404    15,984 
 
Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE  

XML 67 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
GENERAL (Details Narrative)
$ / shares in Units, $ in Thousands
6 Months Ended
Jul. 26, 2022
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
$ / shares
Jun. 30, 2023
€ / shares
Mar. 07, 2023
shares
Jan. 31, 2023
shares
Dec. 31, 2022
$ / shares
Dec. 31, 2022
€ / shares
Aug. 31, 2022
shares
Dec. 31, 2021
shares
Oct. 31, 2021
shares
May 31, 2021
shares
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares       1,000,000 864,000            
Implied value | (per share)     € 1,000     $ 0.0001 € 1        
Ordinary shares [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares       3,525,000              
Implied value | $ / shares   $ 0.0001                  
Security matters limited [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares               2,000,000 1,774,744 8,938,666 15,270,249
Implied value | $ / shares           $ 0          
Security matters pty ltd [member] | Ordinary shares [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares 1                    
Share price | $ / shares $ 10.3624                    
Implied value | $ / shares $ 10.00                    
Equity line agreement [member]                      
IfrsStatementLineItems [Line Items]                      
Consideration of issuance of common stock   $ 25,000                  
Additional capital raising   $ 2,500                  
Lionheart [Member] | Business Combination Agreement [Member]                      
IfrsStatementLineItems [Line Items]                      
Redemption percentage of business combination 97.58%                    
Remaining funds in trust account $ 3,061                    
Lionheart [Member] | Business Combination Agreement [Member] | Security matters limited [member]                      
IfrsStatementLineItems [Line Items]                      
Redemption percentage of business combination 97.58%                    
Remaining funds in trust account $ 3,061                    
Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination $ 17,300                    
XML 68 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT (Details) - Security matters limited [member]
12 Months Ended
Dec. 31, 2022
Computer equipment [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate, property, plant and equipment 33.00%
Machinery [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate, property, plant and equipment 20.00%
Furniture and Office Equipment [Member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate, property, plant and equipment 10.00%
Leasehold improvements [member]  
IfrsStatementLineItems [Line Items]  
Depreciation rate, property, plant and equipment 5.00%
XML 69 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF OTHER CURRENT ASSETS (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Total $ 1,037 $ 3,673  
Security matters limited [member]      
IfrsStatementLineItems [Line Items]      
Prepaid expenses [1]   3,157 $ 454
Tax authorities   358 280
Proof of concept receivables   86 116
Other   72 70
Total   $ 3,673 $ 920
[1] The prepaid expenses include
XML 70 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF OTHER RECEIVABLES (Details) (Parenthetical)
$ in Thousands
Dec. 31, 2022
USD ($)
Special Purpose Acquisition Company [Member] | Security matters limited [member]  
IfrsStatementLineItems [Line Items]  
Current prepaid expenses $ 3,123
XML 71 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Property and equipment, ending balance $ 969  
Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 1,192  
Property and equipment, ending balance 969 $ 1,192
Gross carrying amount [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 2,124 1,667
Additions 201 297
Deductions (21)  
Depreciation 271 287
Currency translation adjustments (335) 160
Property and equipment, ending balance 1,969 2,124
Accumulated Depreciation [Member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 932 569
Depreciation 271 287
Currency translation adjustments (203) 76
Property and equipment, ending balance 1,000 932
Leasehold improvements [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 61  
Property and equipment, ending balance 45 61
Leasehold improvements [member] | Gross carrying amount [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 81 69
Additions 3
Depreciation 4 5
Currency translation adjustments (18) 9
Property and equipment, ending balance 63 81
Leasehold improvements [member] | Accumulated Depreciation [Member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 20 13
Depreciation 4 5
Currency translation adjustments (6) 2
Property and equipment, ending balance 18 20
Machinery [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 588  
Property and equipment, ending balance 448 588
Machinery [member] | Gross carrying amount [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 1,233 847
Additions 135 275
Depreciation 202 187
Currency translation adjustments (221) 111
Property and equipment, ending balance 1,147 1,233
Machinery [member] | Accumulated Depreciation [Member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 645 399
Depreciation 202 187
Currency translation adjustments (148) 59
Property and equipment, ending balance 699 645
Furniture and Office Equipment [Member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 50  
Property and equipment, ending balance 34 50
Furniture and Office Equipment [Member] | Gross carrying amount [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 83 73
Additions 1
Depreciation 7 7
Currency translation adjustments (18) 9
Property and equipment, ending balance 65 83
Furniture and Office Equipment [Member] | Accumulated Depreciation [Member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 33 23
Depreciation 7 7
Currency translation adjustments (9) 3
Property and equipment, ending balance 31 33
Computer equipment [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 27  
Property and equipment, ending balance 28 27
Computer equipment [member] | Gross carrying amount [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 99 72
Additions 17 18
Depreciation 19 16
Currency translation adjustments (14) 9
Property and equipment, ending balance 102 99
Computer equipment [member] | Accumulated Depreciation [Member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 72 49
Depreciation 19 16
Currency translation adjustments (17) 7
Property and equipment, ending balance 74 72
Right-of-use assets [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 466  
Property and equipment, ending balance 414 466
Right-of-use assets [member] | Gross carrying amount [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 628 606
Additions 49
Deductions (21)  
Depreciation 39 72
Currency translation adjustments (64) 22
Property and equipment, ending balance 592 628
Right-of-use assets [member] | Accumulated Depreciation [Member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Property and equipment, beginning balance 162 85
Depreciation 39 72
Currency translation adjustments (23) 5
Property and equipment, ending balance $ 178 $ 162
XML 72 R57.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONVERTIBLE NOTES (Details Narrative)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended
Mar. 07, 2023
shares
Jan. 25, 2023
USD ($)
$ / shares
shares
Jan. 31, 2023
shares
May 31, 2022
USD ($)
shares
May 31, 2022
AUD ($)
shares
Jun. 30, 2023
USD ($)
$ / shares
Jun. 30, 2023
€ / shares
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2022
€ / shares
Aug. 31, 2022
shares
Jul. 31, 2022
shares
May 31, 2022
AUD ($)
Dec. 31, 2021
USD ($)
shares
Oct. 31, 2021
shares
May 31, 2021
shares
IfrsStatementLineItems [Line Items]                              
Proceeds from borrowings | $           $ 2,983,000                  
Convertible note | $           304,000   $ 563,000              
Number of shares issued 1,000,000   864,000                        
Par value per share | (per share)             € 1,000 $ 0.0001 € 1            
Volatility rate     81.92%                        
Risk-free interest rate     3.42%                        
Fair value of convertible notes | $           218,000                  
Fair value of the redeemable warrants | $           $ 71,000                  
Redeemable warrants [member]                              
IfrsStatementLineItems [Line Items]                              
Warrants term 5 years                            
Volatility rate           71.54%                  
Risk-free interest rate           4.19%                  
Ordinary shares [member]                              
IfrsStatementLineItems [Line Items]                              
Number of shares issued 3,525,000                            
Fixed conversion price | $ / shares   $ 10                          
Par value per share | $ / shares           $ 0.0001                  
Convertible notes [member]                              
IfrsStatementLineItems [Line Items]                              
Proceeds from borrowings | $   $ 250,000                          
Principal amount | $   $ 250,000                          
Maturity date   December 31, 2024                          
Interest rate   15.00%                          
Discount rate   20.00%       30.70%                  
Convertible Note Agreements [Member] | Bonus warrants [member]                              
IfrsStatementLineItems [Line Items]                              
Warrants to purchase ordinary shares   12,500                          
Exercise price | $ / shares   $ 11.50                          
Warrants term   5 years                          
Convertible Note Agreements [Member] | Redeemable warrants [member]                              
IfrsStatementLineItems [Line Items]                              
Discount rate   20.00%                          
Warrants to purchase ordinary shares   12,500                          
Warrants term   5 years                          
Share purchase price | $ / shares   $ 11.50                          
Par value per share | $ / shares   $ 5.00                          
Description of approach used to determine discount rates   The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.                          
Security matters limited [member]                              
IfrsStatementLineItems [Line Items]                              
Number of convertible notes issued       828,240 828,240                    
Face value of convertible notes       $ 700               $ 1      
Proceeds from borrowings       $ 569,000 $ 828                    
Convertible notes maturity period       6 months 6 months                    
Convertible note conversion price description       (i) if the Company executes a binding agreement for an M&A transaction or receives USD $20 million or more in return for the issuance of shares on or before December 31, 2022, the principal amount of each Convertible Note will automatically be converted into shares in the Company. The issuance price per share will be calculated at a 20% discount to the higher of the offer price or price paid by the investors participating in the qualified transaction, as such term is defined in the Convertible Notes agreement, subject to a floor cap of no lower than AUD 0.15 (USD 0.11) per share. In July 2022, the Company entered into a Business Combination Agreement that will be subject to de-listing of the Company’s ordinary share capital from the Australian Stock Exchange following receiving an Australian court approval of the future merger (ii) if the Company has not executed a binding agreement for a qualified transaction until December 31, 2022, the Convertible Notes balance will automatically convert into ordinary shares at that date. The issuance price per share will be calculated at a 20% discount to the 5-21 day volume weighted average price to December 31, 2022, as such term is defined in the Convertible Notes agreement, subject to a cap of no lower than AUD 0.15 (USD 0.11) per share, and on December 31, 2022 the investors will also be issued unlisted two year options on a 1:2 basis with an exercise price of AUD 0.45 (USD 0.32) per share (i) if the Company executes a binding agreement for an M&A transaction or receives USD $20 million or more in return for the issuance of shares on or before December 31, 2022, the principal amount of each Convertible Note will automatically be converted into shares in the Company. The issuance price per share will be calculated at a 20% discount to the higher of the offer price or price paid by the investors participating in the qualified transaction, as such term is defined in the Convertible Notes agreement, subject to a floor cap of no lower than AUD 0.15 (USD 0.11) per share. In July 2022, the Company entered into a Business Combination Agreement that will be subject to de-listing of the Company’s ordinary share capital from the Australian Stock Exchange following receiving an Australian court approval of the future merger (ii) if the Company has not executed a binding agreement for a qualified transaction until December 31, 2022, the Convertible Notes balance will automatically convert into ordinary shares at that date. The issuance price per share will be calculated at a 20% discount to the 5-21 day volume weighted average price to December 31, 2022, as such term is defined in the Convertible Notes agreement, subject to a cap of no lower than AUD 0.15 (USD 0.11) per share, and on December 31, 2022 the investors will also be issued unlisted two year options on a 1:2 basis with an exercise price of AUD 0.45 (USD 0.32) per share                    
Convertible note | $               $ 563,000            
Number of shares issued                   2,000,000     1,774,744 8,938,666 15,270,249
Interest rate               4.00%              
Par value per share | $ / shares               $ 0              
Security matters limited [member] | Major ordinary share transactions [member]                              
IfrsStatementLineItems [Line Items]                              
Convertible notes convered into ordinary shares 1,000,000                            
Security matters limited [member] | Convertible Notes Agreements [Member]                              
IfrsStatementLineItems [Line Items]                              
Number of shares issued                     1,000,000        
XML 73 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF INFORMATION ABOUT CONSOLIDATED STRUCTURED ENTITIES (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]        
Closing carrying amount $ 112 $ 221    
Security matters limited [member]        
IfrsStatementLineItems [Line Items]        
Closing carrying amount   221 $ 147 $ 248
Security matters limited [member] | Security Matters Limited's share of net assets [member]        
IfrsStatementLineItems [Line Items]        
Closing carrying amount   115 248 249
Security matters limited [member] | Company's share in net profits (losses) of associated companies [member]        
IfrsStatementLineItems [Line Items]        
Company’s share in net profits (losses) of associated companies   $ 106 $ (101) $ (1)
XML 74 R59.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS IN ASSOCIATED COMPANIES (Details Narrative)
1 Months Ended 12 Months Ended
Dec. 24, 2021
AUD ($)
shares
Jan. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 24, 2021
USD ($)
Dec. 24, 2021
AUD ($)
$ / shares
IfrsStatementLineItems [Line Items]            
Description of risk free interest rate percentage   3.42%        
Security matters limited [member] | SMX beverages pty ltd [member]            
IfrsStatementLineItems [Line Items]            
Proportion of ownership interest in joint venture 50.00%          
Exercise of stock options shares | shares 8,000,001          
Exercise price of outstanding share options | $ / shares           $ 0.4
Weighted average remaining contractual life of outstanding share options Mar. 25, 2027          
Consideration transferred, acquisition-date fair value         $ 721,424 $ 960,000
Description of risk free interest rate percentage 2.50%          
Options expected life 5 years          
Security matters limited [member] | Global BevCo Pty Ltd. [member] | Consulting agreement [member]            
IfrsStatementLineItems [Line Items]            
Consulting fees | $ $ 13,500          
Percentage of entitys revenue 5.00%          
Yahaloma technologies inc [member] | Security matters limited [member]            
IfrsStatementLineItems [Line Items]            
Country of incorporation     Canada      
Proportion of ownership interest in associate     50.00% 50.00%    
True gold consortium pty ltd [member] | Security matters limited [member]            
IfrsStatementLineItems [Line Items]            
Country of incorporation     Australia      
Proportion of ownership interest in associate     44.40% 45.50%    
SMX beverages pty ltd [member] | Security matters limited [member]            
IfrsStatementLineItems [Line Items]            
Country of incorporation     Australia      
Proportion of ownership interest in associate     100.00% 50.00%    
XML 75 R60.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF INTANGIBLE ASSETS NET (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Net book value $ 5,027  
Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Amortization 145  
Net book value 5,027 $ 3,908
Capitalised development expenditure [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Net book value 4,372 3,908
Licences [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Net book value 655  
Gross carrying amount [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Cost, beginning balance 4,024  
Capitalized development cost 1,696  
Currency translation adjustments (566)  
Cost, ending balance 5,154 4,024
Currency translation adjustments 566  
Gross carrying amount [member] | Capitalised development expenditure [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Cost, beginning balance 4,024 2,332
Capitalized development cost 975 1,468
Currency translation adjustments (500) (224)
Cost, ending balance 4,499 4,024
Currency translation adjustments 500 224
Gross carrying amount [member] | Licences [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Cost, beginning balance  
Capitalized development cost 721  
Currency translation adjustments (66)  
Cost, ending balance 655
Currency translation adjustments 66  
Accumulated Depreciation Amortisation [Member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Currency translation adjustments (3)  
Accumulated amortization, beginning balance 116  
Amortization 14  
Accumulated amortization, ending balance 127 116
Currency translation adjustments 3  
Accumulated Depreciation Amortisation [Member] | Capitalised development expenditure [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Currency translation adjustments (3)  
Accumulated amortization, beginning balance 116 88
Amortization 14 28
Accumulated amortization, ending balance 127 116
Currency translation adjustments 3  
Accumulated Depreciation Amortisation [Member] | Licences [member] | Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Currency translation adjustments  
Accumulated amortization, beginning balance  
Amortization  
Accumulated amortization, ending balance
Currency translation adjustments  
XML 76 R61.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTANGIBLE ASSETS, NET (Details Narrative) - Security matters limited [member] - USD ($)
12 Months Ended
Dec. 24, 2021
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Amortisation, intangible assets other than goodwill   $ 145,000
SMX beverages pty ltd [member]    
IfrsStatementLineItems [Line Items]    
Proportion of ownership interest in joint venture 50.00%  
Other intangible assets [member] | SMX beverages pty ltd [member]    
IfrsStatementLineItems [Line Items]    
Intangible assets under development   $ 721
Proportion of ownership interest in joint venture   50.00%
XML 77 R62.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF RIGHT OF USE ASSETS (Details) - Security matters limited [member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Right-of-use assets, beginning balance $ 466  
Additions 49  
Foreign currency translation (41)  
Deductions (21)  
Depreciation expense (39) $ (72)
Right-of-use assets, ending balance 414 466
Office equipment [member]    
IfrsStatementLineItems [Line Items]    
Right-of-use assets, beginning balance 446  
Additions 49  
Foreign currency translation (35)  
Deductions (7)  
Depreciation expense (39)  
Right-of-use assets, ending balance 414 446
Motor vehicles [member]    
IfrsStatementLineItems [Line Items]    
Right-of-use assets, beginning balance 20  
Additions  
Foreign currency translation (6)  
Deductions (14)  
Depreciation expense  
Right-of-use assets, ending balance $ 20
XML 78 R63.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF LEASE LIABILITY (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]          
Lease Payments $ (21) $ (39)      
Current 30   $ 30    
Non current 403   440    
Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Lease liability, beginning balance $ 470 $ 503 503 $ 589  
Additions     49  
Deductions     (21)  
Accretion of interest     51 47  
Foreign exchange differences     (57) (35)  
Lease Payments     (55) (98) $ (12)
Lease liability, ending balance     470 503 $ 589
Current     30 37  
Non current     $ 440 $ 466  
XML 79 R64.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF CARRYING AMOUNTS OF LEASE LIABILITIES RECOGNIZED IN PROFIT OR LOSS (Details) - Security matters limited [member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Depreciation expense of right-of-use assets $ 39 $ 72
Interest expense on lease liabilities 51 47
Foreign Exchange different 16 (35)
Expense relating to short-term leases
Total amount recognized in profit or loss $ 106 $ 84
XML 80 R65.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF OTHER PAYABLES (Details) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Total $ 2,415 $ 650  
Security matters limited [member]      
IfrsStatementLineItems [Line Items]      
Employees, salaries and related liabilities   392 $ 500
Related party   56 24
Liabilities for grants received (Note 19)   50 30
Accrued expenses   49
Derivative financial liability (Note 13)   32
Other   152 38
Total   $ 650 $ 673
XML 81 R66.htm IDEA: XBRL DOCUMENT v3.24.0.1
LEASES (Details Narrative) - Security matters limited [member]
12 Months Ended
Dec. 31, 2022
Office equipment [member]  
IfrsStatementLineItems [Line Items]  
Lease expiration 12 years
Motor vehicles [member]  
IfrsStatementLineItems [Line Items]  
Lease expiration 3 years
XML 82 R67.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF BORROWINGS FROM RELATED PARTIES (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]          
Borrowings from related parties, beginning balance $ 710        
Provision for bonus (include interest) 14 $ (89)      
Borrowings from related parties, ending balance 689   $ 710    
Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Borrowings from related parties, beginning balance $ 710 $ 270 270 $ 280  
Payment of borrowings     (172) (103) $ (144)
Provision for bonus (include interest)     621 89
Exchange rate differences     (9) 4  
Borrowings from related parties, ending balance     $ 710 $ 270 $ 280
XML 83 R68.htm IDEA: XBRL DOCUMENT v3.24.0.1
BORROWINGS FROM RELATED PARTIES (Details Narrative)
$ in Thousands, ₪ in Millions
1 Months Ended 12 Months Ended
Aug. 31, 2022
USD ($)
Aug. 31, 2022
ILS (₪)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
ILS (₪)
Dec. 31, 2021
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2015
ILS (₪)
Jun. 30, 2023
USD ($)
Dec. 31, 2020
USD ($)
IfrsStatementLineItems [Line Items]                  
Current borrowings     $ 710         $ 689  
Security matters limited [member]                  
IfrsStatementLineItems [Line Items]                  
Cash advances and loans from related parties           $ 513 ₪ 2.0    
Borrowings, interest rate     4.00%            
Bonus payments $ 710 ₪ 2.5              
Carrying amount of liability     $ 621   $ 87        
Current borrowings     710   $ 270       $ 280
Security matters limited [member] | Lender two [member]                  
IfrsStatementLineItems [Line Items]                  
Bonus payments     $ 965 ₪ 3.0          
XML 84 R69.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF ORDINARY SHARES (Details) - shares
Dec. 31, 2022
Jul. 01, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Number of shares authorized 500,000,000 500,000,000  
Number of shares issued and outstanding 1 1  
Deferred Shares [Member]      
IfrsStatementLineItems [Line Items]      
Number of shares authorized 25,000    
Number of shares issued and outstanding 25,000    
Security matters limited [member]      
IfrsStatementLineItems [Line Items]      
Number of shares authorized 167,854,581   165,532,264
Number of shares issued and outstanding 167,854,581   165,532,264
XML 85 R70.htm IDEA: XBRL DOCUMENT v3.24.0.1
BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (Details Narrative)
$ / shares in Units, $ / shares in Units, $ in Thousands, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 07, 2023
shares
Jan. 30, 2023
shares
Mar. 31, 2023
USD ($)
shares
Jan. 31, 2023
$ / shares
shares
Jun. 30, 2022
$ / shares
May 31, 2022
USD ($)
May 31, 2022
AUD ($)
$ / shares
Aug. 31, 2021
$ / shares
Jul. 31, 2021
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
Jan. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
$ / shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2021
$ / shares
shares
Dec. 31, 2020
USD ($)
Dec. 31, 2020
$ / shares
Jun. 30, 2023
€ / shares
Dec. 31, 2022
€ / shares
Aug. 31, 2022
shares
Oct. 31, 2021
shares
May 31, 2021
shares
Jan. 31, 2015
IfrsStatementLineItems [Line Items]                                                  
Risk-free interest rate       3.42%                                          
Volatility rate       81.92%                                          
Par value | (per share)                   $ 0.0001       $ 0.0001 $ 0.0001         € 1,000 € 1        
Fair value of redeemable warrants | $                     $ 71                            
Aggregate amount of convertible instruments issued | $                     $ 2,983                            
Number of shares | shares 1,000,000     864,000               864,000                          
Redeemable warrants [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Risk-free interest rate                     4.19%                            
Volatility rate                     71.54%                            
Excepted terms 5 years                                                
Security matters limited [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Exercise price, share options granted | $ / shares         $ 0.4   $ 0.11 $ 0.7 $ 0.351                                
Percentage of voting equity interests acquired                                                 2.00%
Proceeds from loans and warrants | $                           $ 3,310   $ 32                
Borrowings, interest rate                   4.00%       4.00% 4.00%                    
Par value | $ / shares                   $ 0       $ 0 $ 0                    
Aggregate amount of convertible instruments issued           $ 569 $ 828                                    
Number of shares | shares                               1,774,744 1,774,744         2,000,000 8,938,666 15,270,249  
Security matters limited [member] | Nonadjusting event [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Risk-free interest rate   3.42%                                              
Volatility rate   81.92%                                              
Number of shares | shares   864,000                                              
Security matters limited [member] | Top of range [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Exercise price, share options granted | $ / shares         $ 0.8                   $ 0.14   $ 0.70   $ 0.70            
Security matters limited [member] | Three valuation models [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Risk-free interest rate                           3.99%                      
Volatility rate                           81.03%                      
Term warrants                           5 years 2 months 4 days                      
Bridge loan agreements [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Description of approach used to determine discount rates                       Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.                          
Risk-free interest rate                     3.99%                            
Volatility rate                     81.03%                            
Borrowings, interest rate       10.00%               10.00%                          
Excepted terms                     5 years 2 months 4 days                            
Fair value of the bonus Warrants | $                   $ 24       $ 24 $ 24                    
Aggregate amount of convertible instruments issued | $     $ 1,350                                            
Redeemable warrants | $     $ 1,000                                            
Number of shares | shares     872,418                                            
Bridge loan agreements [member] | Nonadjusting event [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Description of approach used to determine discount rates                       Each investor has the option to decide that Security Matters Limited will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary                          
Borrowings, interest rate       10.00%               10.00% 10.00%                        
Proceeds from borrowings, classified as financing activities | $                         $ 550                        
Bridge loan agreements [member] | Bonus warrants [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Warrants to purchase ordinary shares | shares                       243,000                          
Exercise price of warrants | $ / shares                       $ 11.50                          
Excepted terms                       5 years                          
Bridge loan agreements [member] | Redeemable warrants [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Warrants to purchase ordinary shares | shares                       572,000                          
Exercise price of warrants | $ / shares                       $ 11.50                          
Excepted terms                       5 years                          
Par value | $ / shares       $ 5.00               $ 5.00                          
Fair value of redeemable warrants | $                   $ 2,669 $ 2,133     2,669 $ 2,669                    
Bridge loan agreements [member] | Top of range [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Borrowings maturity                       two years                          
Fair value of the bonus Warrants | $                     $ 1                            
Bridge loan agreements [member] | Top of range [member] | Nonadjusting event [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Borrowings maturity                       two years P2Y                        
Bridge loan agreements [member] | Eleven lenders [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Proceeds from loans and warrants | $                       $ 3,860                          
Bridge loan agreements [member] | Eleven lenders [member] | Nonadjusting event [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Proceeds from loans and warrants | $                       $ 3,860                          
Bridge loan agreements [member] | Security matters limited [member] | Nonadjusting event [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Borrowings, interest rate                         10.00%                        
Proceeds from borrowings, classified as financing activities | $                         $ 550                        
Bridge loan agreements [member] | Bonus warrants [member] | Nonadjusting event [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Warrants to purchase shares | shares                       243,000                          
Exercise price, share options granted | $ / shares                       $ 11.50                          
Borrowings maturity                       five years                          
Bridge loan agreements [member] | Bonus warrants [member] | Security matters limited [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Warrants to purchase shares | shares                   215,500                              
Exercise price, share options granted | $ / shares                   $ 11.50                              
Borrowings maturity                   five years                              
Bridge loan agreements [member] | Bonus warrants [member] | Security matters limited [member] | Black and scholes model [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Fair value of warrants | $                           $ 24                      
Bridge loan agreements [member] | Redeemable warrants type 1 [member] | Security matters limited [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Warrants to purchase shares | shares                   342,000                              
Exercise price, share options granted | $ / shares                           $ 5.00                      
Borrowings maturity                   five years                              
Weighted average share price, share options granted | $ / shares                   $ 11.50                              
Percentage of voting equity interests acquired                   50.00%       50.00% 50.00%                    
Description of approach used to determine discount rates                           Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of SMX PLC based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary                      
Bridge loan agreements [member] | Redeemable warrants type 1 [member] | Security matters limited [member] | Third anniversary [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Exercise price, share options granted | $ / shares                           $ 5.00                      
Percentage of voting equity interests acquired                   25.00%       25.00% 25.00%                    
Bridge loan agreements [member] | Redeemable warrants type 1 [member] | Security matters limited [member] | Fourth anniversary [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Exercise price, share options granted | $ / shares                           $ 5.00                      
Percentage of voting equity interests acquired                   25.00%       25.00% 25.00%                    
Bridge loan agreements [member] | Redeemable warrants type 1 [member] | Security matters limited [member] | Monte carlo simulation model [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Fair value of warrants | $                           $ 1,973                      
Bridge loan agreements [member] | Redeemable warrants type 2 [member] | Security matters limited [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Warrants to purchase shares | shares                   120,000                              
Borrowings maturity                   five years                              
Weighted average share price, share options granted | $ / shares                   $ 11.50                              
Description of approach used to determine discount rates                           Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of SMX PLC based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary                      
Bridge loan agreements [member] | Redeemable warrants type 2 [member] | Security matters limited [member] | First anniversary [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Exercise price, share options granted | $ / shares                           $ 5.00                      
Percentage of voting equity interests acquired                   50.00%       50.00% 50.00%                    
Bridge loan agreements [member] | Redeemable warrants type 2 [member] | Security matters limited [member] | Second anniversary [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Exercise price, share options granted | $ / shares                           $ 5.00                      
Percentage of voting equity interests acquired                   50.00%       50.00% 50.00%                    
Bridge loan agreements [member] | Redeemable warrants type 2 [member] | Security matters limited [member] | Monte carlo simulation model [member]                                                  
IfrsStatementLineItems [Line Items]                                                  
Fair value of warrants | $                           $ 696                      
XML 86 R71.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF SHARE OPTION GRANTED (Details)
shares in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
shares
$ / shares
Jun. 30, 2023
shares
$ / shares
Jun. 30, 2022
shares
$ / shares
Jun. 30, 2022
shares
$ / shares
Dec. 31, 2022
shares
$ / shares
Dec. 31, 2022
shares
$ / shares
Dec. 31, 2021
shares
$ / shares
Dec. 31, 2021
shares
$ / shares
IfrsStatementLineItems [Line Items]                
Number of options outstanding Beginning balance 1,251 1,251 3,346 3,346 3,346 3,346    
Weighted average exercise price, outstanding beginning balance | $ / shares $ 2.01   $ 2.02   $ 2.02      
Granted 790 790 989 989        
Weighted average exercise price, Granted | $ / shares $ 3.47   $ 2.86          
Number of options, Expired (375) (375)        
Weighted average exercise price, Expired | $ / shares   $ 2.16          
Number of options outstanding Beginning balance 2,034 2,034 3,960 3,960 1,251 1,251 3,346 3,346
Weighted average exercise price, outstanding beginning balance | $ / shares $ 2.58   $ 2.21   $ 2.01   $ 2.02  
Number of options, Exercisable 1,825 1,825 2,703 2,703        
Weighted average exercise price, Exercisable | $ / shares $ 2.48   $ 2.33          
Exercised (7) (7)        
Weighted average exercise price, Expired | $ / shares $ 1.39              
Number of options, Expired 375 375        
Security matters limited [member]                
IfrsStatementLineItems [Line Items]                
Number of options outstanding Beginning balance 4,680 4,680 11,280 11,280 11,280 11,280 9,530 9,530
Weighted average exercise price, outstanding beginning balance | $ / shares   $ 0.35   $ 0.27   $ 0.27   $ 0.23
Granted         1,000 1,000 1,850 1,850
Weighted average exercise price, Granted | $ / shares           $ 0.27   $ 0.45
Number of options, Expired         (7,600) (7,600) (100) (100)
Weighted average exercise price, Expired | $ / shares           $ 0.22   $ 0.34
Number of options outstanding Beginning balance         4,680 4,680 11,280 11,280
Weighted average exercise price, outstanding beginning balance | $ / shares           $ 0.35   $ 0.27
Number of options, Exercisable         2,835 2,835 4,318 4,318
Weighted average exercise price, Exercisable | $ / shares           $ 0.28   $ 0.27
Number of options, Expired         7,600 7,600 100 100
XML 87 R72.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING (Details)
shares in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
shares
$ / shares
Dec. 31, 2022
shares
$ / shares
Jun. 30, 2022
shares
Dec. 31, 2021
shares
Dec. 31, 2020
shares
IfrsStatementLineItems [Line Items]          
Number of outstanding shares 2,034 1,251 3,960 3,346  
Weighted average remaining contractual life of outstanding share options 5 years        
Number of exercisable shares 1,825   2,703    
Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Number of outstanding shares   4,680   11,280 9,530
Number of exercisable shares   2,835   4,318  
Exercise price one [member]          
IfrsStatementLineItems [Line Items]          
Number of outstanding shares 845        
Weighted average remaining contractual life of outstanding share options 1 year 2 months 4 days        
Number of exercisable shares 845        
Weighted average remaining contractual life of exercisable share options 1 year 2 months 4 days        
Exercise price one [member] | Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Number of outstanding shares   800      
Weighted average remaining contractual life of outstanding share options   4 years 7 months 2 days      
Number of exercisable shares   400      
Weighted average remaining contractual life of exercisable share options   4 years 7 months 20 days      
Exercise price one [member] | Bottom of range [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares $ 0.84        
Exercise price one [member] | Bottom of range [member] | Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares   $ 0.12      
Exercise price one [member] | Top of range [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares $ 1.39        
Exercise price one [member] | Top of range [member] | Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares   0.2      
Exercise price two [member]          
IfrsStatementLineItems [Line Items]          
Number of outstanding shares 335        
Weighted average remaining contractual life of outstanding share options 2 years 7 months 2 days        
Number of exercisable shares 335        
Weighted average remaining contractual life of exercisable share options 2 years 7 months 2 days        
Exercise price two [member] | Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares   $ 0.2      
Number of outstanding shares   955      
Weighted average remaining contractual life of outstanding share options   8 months 1 day      
Number of exercisable shares   878      
Weighted average remaining contractual life of exercisable share options   8 months 1 day      
Exercise price two [member] | Bottom of range [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares $ 1.81        
Exercise price two [member] | Top of range [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares $ 2.51        
Exercise price three [member]          
IfrsStatementLineItems [Line Items]          
Number of outstanding shares 707        
Weighted average remaining contractual life of outstanding share options 4 years 10 months 20 days        
Number of exercisable shares 498        
Weighted average remaining contractual life of exercisable share options 4 years 10 months 9 days        
Exercise price three [member] | Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Number of outstanding shares   2,075      
Weighted average remaining contractual life of outstanding share options   2 years 6 months 21 days      
Number of exercisable shares   1,432      
Weighted average remaining contractual life of exercisable share options   2 years 1 month 24 days      
Exercise price three [member] | Bottom of range [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares $ 3.57        
Exercise price three [member] | Bottom of range [member] | Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares   $ 0.31      
Exercise price three [member] | Top of range [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares 4.0        
Exercise price three [member] | Top of range [member] | Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares   0.357      
Exercise price four [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares $ 4.18        
Number of outstanding shares 10        
Weighted average remaining contractual life of outstanding share options 1 year 8 months 26 days        
Number of exercisable shares 10        
Weighted average remaining contractual life of exercisable share options 1 year 8 months 26 days        
Exercise price four [member] | Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares   $ 0.6      
Number of outstanding shares   100      
Weighted average remaining contractual life of outstanding share options   2 years 2 months 26 days      
Number of exercisable shares   100      
Weighted average remaining contractual life of exercisable share options   2 years 2 months 26 days      
Exercise price five [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares $ 4.87        
Number of outstanding shares 137        
Weighted average remaining contractual life of outstanding share options 3 years 6 months 3 days        
Number of exercisable shares 137        
Weighted average remaining contractual life of exercisable share options 3 years 6 months 3 days        
Exercise price five [member] | Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Exercise price of outstanding share options | $ / shares   $ 0.7      
Number of outstanding shares   750      
Weighted average remaining contractual life of outstanding share options   3 years 11 months 19 days      
Number of exercisable shares   25      
Weighted average remaining contractual life of exercisable share options   3 years 8 months 26 days      
XML 88 R73.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]          
Share based compensation $ 2,052 $ 165      
Total $ 1,172 $ 933      
Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Share based compensation     $ 252 $ 431 $ 483
Total     1,898 2,039 1,689
Security matters limited [member] | Research and development expenses [member]          
IfrsStatementLineItems [Line Items]          
Salaries and related expenses     2,166 1,795 1,186
Subcontractors and consultants     374 631 509
Research expenses     316 252 155
Depreciation and amortization     255 287 243
Share based compensation     127 100 47
Travel expenses     50 42 11
Freight     30 23 33
Other     6 53
Reimbursement from paid pilots and proof of concept projects     (1,426) (1,091) (548)
Total     $ 1,898 $ 2,039 $ 1,689
XML 89 R74.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]          
Total $ 13,350 $ 1,200      
General and administrative expenses [member]          
IfrsStatementLineItems [Line Items]          
Transaction cost 7,792      
Advertising, Public and Investors Relations 1,526      
Share based compensation 1,805 82      
Professional services 718 545      
Wages and salaries related 664 429      
Travel expenses 379 4      
Office and maintenance 37 80      
Insurance 329 19      
Depreciation and amortization 15 15      
Others 86 26      
Total $ 13,350 $ 1,200      
Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Total     $ 2,723 $ 2,482 $ 2,447
Security matters limited [member] | General and administrative expenses [member]          
IfrsStatementLineItems [Line Items]          
Share based compensation     137 331 436
Professional services     1,105 1,089 1,257
Wages and salaries related     935 752 409
Travel expenses     223 65
Office and maintenance     145 116 120
Insurance     60 102 101
Depreciation and amortization     35 28 16
Others     83 64 43
Total     $ 2,723 $ 2,482 $ 2,447
XML 90 R75.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHAREHOLDERS’ EQUITY (Details Narrative)
$ / shares in Units, $ / shares in Units, $ in Thousands, $ in Thousands
1 Months Ended 6 Months Ended 12 Months Ended
Mar. 07, 2023
USD ($)
shares
$ / shares
Jun. 30, 2023
USD ($)
$ / shares
shares
May 31, 2023
USD ($)
shares
Jan. 31, 2023
shares
Aug. 31, 2022
USD ($)
shares
Jul. 31, 2022
USD ($)
shares
Jun. 30, 2022
USD ($)
shares
$ / shares
May 31, 2022
USD ($)
shares
$ / shares
Oct. 31, 2021
USD ($)
Aug. 31, 2021
shares
$ / shares
Jul. 31, 2021
USD ($)
shares
$ / shares
May 31, 2021
USD ($)
shares
Aug. 31, 2018
shares
$ / shares
Jun. 30, 2023
USD ($)
shares
$ / shares
Jun. 30, 2022
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
$ / shares
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2020
USD ($)
$ / shares
Jul. 03, 2023
shares
Jun. 30, 2023
€ / shares
Jun. 27, 2023
$ / shares
Jun. 22, 2023
shares
Apr. 25, 2023
shares
Mar. 07, 2023
AUD ($)
shares
Dec. 31, 2022
€ / shares
Jul. 01, 2022
shares
Oct. 31, 2021
$ / shares
shares
IfrsStatementLineItems [Line Items]                                                            
Par value per share | (per share)                               $ 0.0001 $ 0.0001           € 1,000         € 1    
Proceeds from issuing other equity instruments | $                           $ 2,923                              
Number of shares issued 1,000,000     864,000                                             1,000,000      
Proceeds from issuing shares | $   $ 2,580                                                        
Risk free interest rate, share options granted       3.42%                                                    
Expected volatility, share options granted       81.92%                                                    
Par value per share before reserve split | $ / shares   $ 0.0001                       $ 0.0001                                
Par value per share, post reserve split | $ / shares   $ 0.0022                       $ 0.0022                                
Convertible notes | $                                                     $ 828,240      
Stock expense | $ $ 186                         $ 11,460                                
Number of shares issued 18,673,253                                                          
Number of shares cancelled 193,500,379                                                          
Conversion of stock, description Security Matters PTY Ltd.’s shareholders received as consideration 1 ordinary share of the Company per 10.3624 Security Matters PTY Ltd.’s ordinary shares.                                                          
Number of shares authorized                               500,000,000 500,000,000                       500,000,000  
Exercise price                           5 years                                
Bridge loans [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Number of shares issued 872,418                                                   872,418      
Debt principal amount | $ $ 1,350                                                          
Underwriting agreement [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Number of shares issued   13,333,333                       13,333,333                                
Private warrants [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Number of shares issued                                           2,200,000                
Public warrants [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Number of shares issued 6,250,000                                                   6,250,000      
Warrants [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Risk free interest rate, share options granted                           4.13%                                
Expected volatility, share options granted                           70.39%                                
Warrants exercise price per share | $ / shares                                               $ 0.0204            
Warrant A [member] | Underwriting agreement [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Number of shares issued   15,333,332                       15,333,332                                
Warrant B [member] | Underwriting agreement [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Number of shares issued   15,333,332                       15,333,332                                
Ordinary shares [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Par value per share | $ / shares   $ 0.0001                       $ 0.0001                                
Number of shares issued 3,525,000                                                   3,525,000      
Number of shares authorized   800,000,000,000                       800,000,000,000   500,000,000 500,000,000                          
Ordinary shares [member] | Underwriting agreement [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Number of shares issued                                                 7,597,665          
Ordinary Shares Two [Member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Number of shares issued 303,053                                                   303,053      
Proceeds from ordinary shares | $ $ 3,110                                                          
Warrants [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Number of shares issued 24,568,773                                                   24,568,773      
Warrants exercised 32,211,716                                                          
Warrants exercise price | $ / shares $ 11.5                                                          
Redeemable warrants [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Risk free interest rate, share options granted                           4.19%                                
Expected volatility, share options granted                           71.54%                                
Warrants exercised 200,000                                                          
Warrants exercise price | $ / shares $ 11.5                                                          
Warrants price per share | $ / shares $ 5                                                          
Warrants term 5 years                                                          
Incentive equity plan [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Shares issued percent                                                   15.00%        
Number of shares authorized                                                   5,082,417        
Employees [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Option life, share options granted                           790,408                                
Weighted average fair value at measurement date, share options granted | $   $ 185                       $ 185                                
Share based expenses | $                           $ 168                                
Stock option vesting period                           4 years                                
Employees [member] | Bottom of range [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Exercise price | $ / shares   $ 1.04                       $ 1.04                                
Employees [member] | Top of range [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Exercise price | $ / shares   $ 4.0                       $ 4.0                                
Yorkville [Member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Number of shares issued   675,168 675,168                     675,168                                
Proceeds from issuing shares | $   $ 450 $ 450                                                      
Employees directors and service [member] | Restricted share units [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Warrants exercised                           945,000                              
Number of shares granted                           4,334,000                              
Share based expenses | $                           $ 1,738                                
Employees directors and service [member] | Bottom of range [member] | Restricted share units [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Fair value grant | $ / shares                           $ 1                                
Employees directors and service [member] | Top of range [member] | Restricted share units [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Fair value grant | $ / shares                           $ 1.09                                
Security matters limited [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Par value per share | $ / shares                               $ 0 $ 0                          
Proceeds from issuing other equity instruments | $         $ 254                                                  
Payments for share issue costs | $         $ 22       $ 115                                          
Number of shares issued         2,000,000             15,270,249           1,774,744 1,774,744                     8,938,666
Proceeds from issuing shares | $                 $ 1,890     $ 4,034       $ 182   $ 5,892   $ 6,857                    
Number of shares issued warrants                                   1,774,744 1,774,744                     4,469,333
Warrants exercise price | $ / shares                                                           $ 0.4
Warrants expiration date                 March 2022                                          
Converted shares description                 Upon exercise the holder would receive one ordinary share and another unlisted warrant that bears an exercise price of AUD 0.7, converted to one ordinary share and expired on January 20, 2023                                          
Proceeds from exercise of warrants | $                                 $ 395                      
Option life, share options granted           200,000 200,000 250,000     1,100,000                                      
Exercise price, share options granted | $ / shares             $ 0.4 $ 0.11   $ 0.7 $ 0.351                                      
Description of vesting requirements for share-based payment arrangement           25% on the first anniversary of the Vesting Commencement Date and additional 6.25% at the end of each three months of continuous services thereafter. However, if Company or a parent thereof commences trading on NASDAQ, all options shall become fully vested       the Company raises an aggregated amount of at least 10 million in one raise (including by way of a merger with a company with such amount in its treasury) 80% of the options will become vested. If an amount of 20 million or more is raised in one raise all options will become vested. (1) Company raised an aggregated amount of at least 20 million (including by way of a merger with a company with such amount in its treasury) (2) 25% of the options shall vest after one year and thereafter 6.25% at the end of every three months (3) the employees must continue to provide services to Company         vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years   vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years   vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years                    
Weighted average fair value at measurement date, share options granted | $         $ 98 $ 10 $ 5 $ 19     $ 214       $ 5 $ 154 $ 154 $ 622 $ 622 $ 533 $ 533                  
Expenses of options | $                               $ 152                            
Date of grant of share-based payment arrangement           July 2027 June 2027 May 26, 2027   December 6, 2026 July – September 2026                                      
Number of shares authorized                               167,854,581 167,854,581 165,532,264 165,532,264                      
Security matters limited [member] | Black scholes pricing model [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Term warrants                                   5 years                        
Expected dividend as percentage, share options granted                                   0.00%                        
Security matters limited [member] | Bottom of range [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Exercise price, share options granted | $ / shares             $ 0.7                   $ 0.03   $ 0.35   $ 0.20                  
Security matters limited [member] | Bottom of range [member] | Black scholes pricing model [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Risk free interest rate, share options granted                                   0.11%                        
Expected volatility, share options granted                                   64.00%                        
Security matters limited [member] | Top of range [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Exercise price, share options granted | $ / shares             $ 0.8                   $ 0.14   $ 0.70   $ 0.70                  
Security matters limited [member] | Top of range [member] | Black scholes pricing model [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Risk free interest rate, share options granted                                   3.55%                        
Expected volatility, share options granted                                   118.00%                        
Security matters limited [member] | Employees [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Option life, share options granted                               600,000   250,000   1,055,000                    
Security matters limited [member] | Consultants [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Option life, share options granted                               1,600,000   5,400,000   750,000                    
Security matters limited [member] | Board members [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Option life, share options granted                               322,317   257,562   2,500,000                    
Weighted average fair value at measurement date, share options granted | $                               $ 54 $ 54 $ 53 $ 53                      
Security matters limited [member] | Two Executive Director [Member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Option life, share options granted                         10,000,000                                  
Exercise price, share options granted | $ / shares                         $ 0.2                                  
Date of grant of share-based payment arrangement                         These milestones are reviewed by the Board of Directors and need to be achieved in 4 years since the date it was granted. If the milestones are not reached in 4 years, the options will expire                                  
Security matters limited [member] | Executive director [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Option life, share options granted                   167,000                                        
Security matters limited [member] | Key management personnel of entity or parent [member]                                                            
IfrsStatementLineItems [Line Items]                                                            
Option life, share options granted                   500,000                                        
XML 91 R76.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]          
Loss before income tax $ 33,009 $ 2,442      
Tax effect amounts which are not deductible/(taxable) in calculating taxable income:          
Income tax / (benefit)      
Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Loss before income tax     $ (6,184) $ (4,939) $ (4,573)
Theoretical tax rate of 27.5%     (1,701) (1,358) (1,257)
Tax effect amounts which are not deductible/(taxable) in calculating taxable income:          
Non-deductible expenditure and others     335 118 132
Unrecognized temporary differences and tax losses for which deferred tax weren’t recognized     1,366 1,240 1,125
Income tax / (benefit)    
XML 92 R77.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) (Parenthetical)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2020
Security matters limited [member]    
IfrsStatementLineItems [Line Items]    
Applicable tax rate 27.50% 27.50%
XML 93 R78.htm IDEA: XBRL DOCUMENT v3.24.0.1
TAXES ON INCOME (Details Narrative) - Security matters limited [member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]      
Applicable tax rate 27.50%   27.50%
Tax effect of tax losses $ 24,106 $ 17,659 $ 13,151
XML 94 R79.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF LOSS PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]          
Net loss attributable to the owners of the Company $ (33,009) $ (2,442)      
Basic loss per share $ (39.46) [1] $ (3.36) [2],[3]      
Weighted average number of ordinary shares          
Weighted average number of ordinary shares used in calculating basic loss per share 837 727 [2]      
Diluted loss per share $ (39.46) [1] $ (3.36) [2],[3]      
Weighted average number of ordinary shares used in calculating diluted loss per share 837 727 [2]      
Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Net loss attributable to the owners of the Company     $ (6,184) $ (4,939) $ (4,573)
Basic loss per share     $ (0.04) $ (0.03) $ (0.04)
Weighted average number of ordinary shares          
Weighted average number of ordinary shares used in calculating basic loss per share     167,855 151,850 125,960
Diluted loss per share     $ (0.04) $ (0.03) $ (0.04)
[1] After giving effect to the reverse stock split (see also Note 9.1)
[2] Restated as a result of the SPAC transaction
[3] Restated as a result of the SPAC transaction and after giving effect to the reverse stock split (see also Note 1 and 9.1)
XML 95 R80.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF KEY MANAGEMENT PERSONNEL (Details) - Security matters limited [member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Issuance of options to related party $ 721
Short-term salary and fees 508 475
Loan repayment 172 103
Share based payments 98 105
Post-employment retirement benefits 94 92
Payment for Administrative services 36 39
Non-monetary benefits 29 11
Proof of Concept projects paid by affiliated companies (1,064) (695)
Key management personnel compensation $ (594) $ 130
XML 96 R81.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF BALANCE WITH RELATED PARTIES (Details) - Security matters limited [member] - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Other accounts payable $ (152) $ (38)
Key management personnel of entity or parent [member]    
IfrsStatementLineItems [Line Items]    
Salary and related (99) (86)
Directors [member]    
IfrsStatementLineItems [Line Items]    
Salary and related (82) (11)
Shareholders [member]    
IfrsStatementLineItems [Line Items]    
Borrowings from related parties (710) (270)
Other accounts payable (56) (24)
Joint ventures [member]    
IfrsStatementLineItems [Line Items]    
Other receivables 59 74
Investment in subsidiary 221 147
Related parties [member]    
IfrsStatementLineItems [Line Items]    
Total $ (667) $ (170)
XML 97 R82.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF GOVERNMENT GRANTS (Details) - Security matters limited [member] - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Short term liability at year end $ 50 $ 30
Long term liability at year end 85 85
Total $ 135 $ 115
XML 98 R83.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOVERNMENT GRANTS (Details Narrative) - Security matters limited [member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Government grants received   $ 162
Percentage of revenue 3.00%  
Government grants $ 3  
XML 99 R84.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF ASSETS AND LIABILITIES (Details) - Security matters limited [member]
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Security Matters Ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation Israel  
Ownership percentage 100.00% 100.00%
Security matters canada ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation Canada  
Ownership percentage 100.00% 100.00%
Security matters france ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation France  
Ownership percentage 100.00% 100.00%
SMX beverages pty ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of incorporation Australia  
Ownership percentage 100.00% 50.00%
XML 100 R85.htm IDEA: XBRL DOCUMENT v3.24.0.1
COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)
$ in Thousands, ₪ in Millions
1 Months Ended 12 Months Ended
Jan. 30, 2023
USD ($)
shares
Jan. 31, 2023
shares
Aug. 31, 2022
USD ($)
shares
Aug. 31, 2022
ILS (₪)
shares
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
shares
Jun. 30, 2023
USD ($)
Mar. 07, 2023
shares
Oct. 31, 2021
shares
May 31, 2021
shares
Dec. 31, 2020
USD ($)
Jan. 31, 2015
IfrsStatementLineItems [Line Items]                        
Number of shares issued | shares   864,000           1,000,000        
Risk free interest rate, share options granted   3.42%                    
Expected volatility, share options granted   81.92%                    
Current borrowings         $ 710   $ 689          
Security matters limited [member]                        
IfrsStatementLineItems [Line Items]                        
Percentage of royalty                       2.20%
Consideration percentage                       1.00%
Percentage of voting equity interests acquired                       2.00%
Number of shares issued | shares     2,000,000 2,000,000   1,774,744     8,938,666 15,270,249    
Carrying amount of liability         621 $ 87            
Bonus payments     $ 710 ₪ 2.5                
Current borrowings         710 $ 270         $ 280  
Unpaid contingent liability governance         $ 166              
Security matters limited [member] | Nonadjusting event [member]                        
IfrsStatementLineItems [Line Items]                        
Number of shares issued | shares 864,000                      
Risk free interest rate, share options granted 3.42%                      
Expected volatility, share options granted 81.92%                      
Granted 3 years                      
Expected dividend as percentage, share options granted 0.00%                      
Convertible percentage 1.00%                      
Consideration paid (received) $ 27,000                      
Payment of cash percent 1.50%                      
XML 101 R86.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF FOREIGN CURRENCY RISK (Details)
€ in Thousands, $ in Thousands
Jun. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
EUR (€)
[1]
Jul. 01, 2022
EUR (€)
[1]
Dec. 31, 2021
USD ($)
IfrsStatementLineItems [Line Items]          
Assets $ 10,258 $ 11,288      
Liabilities $ (22,259) (9,132)      
Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Assets   11,288 € 25 $ 10,338
Liabilities   (9,132)     (2,447)
Currency risk [member] | Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Assets   1,242     616
Liabilities   (172)    
United states dollar [member] | Currency risk [member] | Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Assets   1,214     481
Liabilities   (99)    
EUR [member] | Currency risk [member] | Security matters limited [member]          
IfrsStatementLineItems [Line Items]          
Assets   28     135
Liabilities   $ (73)    
[1] Less than 1 thousand.
XML 102 R87.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF SENSITIVITY ANALYSIS PROFIT AND OTHER EQUITY (Details) - Security matters limited [member] - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Assets $ 1,115 $ 481
Percentage of financial risk management 10.00% 10.00%
Amount of financial impact of financial instrument $ 112 $ 48
XML 103 R88.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE (Details)
€ in Thousands, $ in Thousands
Jun. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
EUR (€)
[1]
Jul. 01, 2022
EUR (€)
[1]
Jun. 30, 2022
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
IfrsStatementLineItems [Line Items]                
Cash and cash equivalents $ 3,020 $ 1,398     $ 859 $ 4,171    
Total current assets $ 4,057 5,071            
Security matters limited [member]                
IfrsStatementLineItems [Line Items]                
Cash and cash equivalents   1,398 € 25   4,171 $ 4,341 $ 1,708
Total current assets   5,071       5,091    
Security matters limited [member] | Credit risk [member]                
IfrsStatementLineItems [Line Items]                
Cash and cash equivalents   1,398       4,171    
Other receivables   158       920    
Total current assets   $ 1,556       $ 5,091    
[1] Less than 1 thousand.
XML 104 R89.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES (Details) - Security matters limited [member] - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Not later than one year [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost $ 4,479 $ 1,896
Later than one year and not later than five years [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 1,444 272
Later than five years [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Trade and other payables [member] | Not later than one year [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 3,622 1,589
Trade and other payables [member] | Later than one year and not later than five years [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Trade and other payables [member] | Later than five years [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Bridge loans [member] | Not later than one year [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Bridge loans [member] | Later than one year and not later than five years [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 989  
Bridge loans [member] | Later than five years [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Government grants [member] | Not later than one year [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 75  
Government grants [member] | Later than one year and not later than five years [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 84  
Government grants [member] | Later than five years [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost  
Lease liabilities [member] | Not later than one year [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 72 37
Lease liabilities [member] | Later than one year and not later than five years [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 371 272
Lease liabilities [member] | Later than five years [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 270 193
Borrowing [member] | Not later than one year [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost 710 270
Borrowing [member] | Later than one year and not later than five years [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost
Borrowing [member] | Later than five years [member]    
IfrsStatementLineItems [Line Items]    
Financial liabilities at amortized cost $ 270 $ 193
XML 105 R90.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY (Details) - Security matters limited [member] - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities $ 2,693 $ 32
Derivatives [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities 2,693 32
Level 1 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities
Level 1 of fair value hierarchy [member] | Derivatives [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities
Level 2 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities 32
Level 2 of fair value hierarchy [member] | Derivatives [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities 32
Level 3 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities 2,693
Level 3 of fair value hierarchy [member] | Derivatives [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities $ 2,693
XML 106 R91.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF ORDINARY SHARES (Details) (Parenthetical)
Jun. 30, 2023
€ / shares
Dec. 31, 2022
$ / shares
Dec. 31, 2022
€ / shares
Par value per share | (per share) € 1,000 $ 0.0001 € 1
XML 107 R92.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF COMPANIES SUBSIDIARIES (Details)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Security matters pty ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Australia  
Percentage Owned 100.00%
Lion heart III corp [member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation USA  
Percentage Owned 100.00% [1]
SMX circular economy platform pte ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Singapore  
Percentage Owned 100.00% [2]
SMX ireland limited [member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Ireland  
Percentage Owned 100.00% [2]
SMX israel ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Israel  
Percentage Owned 100.00% 100.00% [3]
Security matters canada ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Canada  
Percentage Owned 100.00% 100.00% [3]
Security matters france ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation France  
Percentage Owned 100.00% 100.00% [3]
SMX beverages pty ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Australia  
Percentage Owned 100.00% 100.00% [3]
Yahaloma technologies inc [member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Canada  
Percentage Owned 50.00% 50.00% [3]
True gold consortium pty ltd [member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Australia  
Percentage Owned 44.40% 44.40% [3]
[1] Merger occurred in March 2023.
[2] Incorporated in 2023.
[3] Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2022.
XML 108 R93.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUBSEQUENT EVENTS (Details Narrative)
$ / shares in Units, $ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
Sep. 15, 2023
USD ($)
Sep. 06, 2023
USD ($)
$ / shares
Jul. 27, 2023
USD ($)
$ / shares
Apr. 25, 2023
shares
Mar. 07, 2023
shares
Mar. 07, 2023
shares
Jan. 30, 2023
shares
Jan. 25, 2023
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
shares
Feb. 28, 2023
USD ($)
Jan. 31, 2023
USD ($)
$ / shares
shares
Jun. 30, 2022
$ / shares
May 31, 2022
USD ($)
May 31, 2022
AUD ($)
$ / shares
Oct. 31, 2021
USD ($)
shares
Aug. 31, 2021
$ / shares
Jul. 31, 2021
$ / shares
May 31, 2021
USD ($)
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
Jan. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
$ / shares
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
Dec. 31, 2020
$ / shares
Oct. 03, 2023
Sep. 19, 2023
USD ($)
shares
Jun. 30, 2023
AUD ($)
Jun. 30, 2023
€ / shares
Dec. 31, 2022
€ / shares
Aug. 31, 2022
shares
Jul. 01, 2022
shares
Jan. 31, 2015
IfrsStatementLineItems [Line Items]                                                                            
Ordinary shares | shares           1,000,000 1,000,000           864,000                   864,000                              
Aggregate amount of convertible instruments issued                                           $ 2,983,000                                
Risk free interest rate, share options granted                         3.42%                                                  
Expected volatility, share options granted                         81.92%                                                  
Proceeds from offering                   $ 2,580,000                                                        
Implied value | (per share)                                         $ 0.0001       $ 0.0001 $ 0.0001               € 1,000 € 1      
Number of shares authorized | shares                                         500,000,000       500,000,000 500,000,000                     500,000,000  
Conversion of shares, description             Security Matters PTY Ltd.’s shareholders received as consideration 1 ordinary share of the Company per 10.3624 Security Matters PTY Ltd.’s ordinary shares.                                                              
Fair value based on the quoted opening share price                                           11,599,000                                
Fair value of the shares                                           16,802,000                                
Marketable securities held in a trust account                   4,921,000                       4,921,000                                
Trade, other payables and warrants                   10,127,000                       $ 10,127,000                                
Bridge loan agreements [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Ordinary shares | shares                     872,418                                                      
Aggregate amount of convertible instruments issued                     $ 1,350,000                                                      
Risk free interest rate, share options granted                                           3.99%                                
Expected volatility, share options granted                                           81.03%                                
Borrowings, interest rate                         10.00%                   10.00%                              
Description of approach used to determine discount rates                                             Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.                              
Top of range [member] | Bridge loan agreements [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Loans maturity date                                             two years                              
Eleven lenders [member] | Bridge loan agreements [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Proceeds from loans and warrants                                             $ 3,860,000                              
True gold consortium pty ltd [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Outstanding payables                   $ 307,000                       $ 307,000                     $ 475          
Fair value                                 $ 84,300,000                                          
True gold consortium pty ltd [member] | Bottom of range [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Fair value                                 78,500,000                                          
True gold consortium pty ltd [member] | Top of range [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Fair value                                 $ 90,000,000                                          
Security matters limited [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Ordinary shares | shares                                 8,938,666     15,270,249             1,774,744 1,774,744               2,000,000    
Aggregate amount of convertible instruments issued                             $ 569,000 $ 828                                            
Proceeds from offering                                 $ 1,890,000     $ 4,034,000         $ 182,000   $ 5,892,000   $ 6,857,000                  
Borrowings, interest rate                                         4.00%       4.00% 4.00%                        
Proceeds from loans and warrants                                                 $ 3,310,000   $ 32,000                    
Exercise price of share | $ / shares                           $ 0.4   $ 0.11   $ 0.7 $ 0.351                                      
Implied value | $ / shares                                         $ 0       $ 0 $ 0                        
Number of shares authorized | shares                                         167,854,581       167,854,581 167,854,581 165,532,264 165,532,264                    
Percentage of interests acquired additional                                                                           2.00%
Outstanding payables                                         $ 152,000       $ 152,000 $ 152,000 $ 38,000 $ 38,000                    
Security matters limited [member] | Bridge loan agreements [member] | Bonus warrants [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Loans maturity date                                         five years                                  
Warrants to purchase, shares | shares                                         215,500                                  
Exercise price of share | $ / shares                                         $ 11.50                                  
Security matters limited [member] | Bottom of range [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Exercise price of share | $ / shares                           0.7                       $ 0.03   $ 0.35   $ 0.20                
Security matters limited [member] | Top of range [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Exercise price of share | $ / shares                           $ 0.8                       $ 0.14   $ 0.70   $ 0.70                
Security matters limited [member] | Black scholes pricing model [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Description of expected term warrants                                                     5 years                      
Expected dividend as percentage, share options granted                                                     0.00%                      
Security matters limited [member] | Black scholes pricing model [member] | Bottom of range [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Risk free interest rate, share options granted                                                     0.11%                      
Expected volatility, share options granted                                                     64.00%                      
Security matters limited [member] | Black scholes pricing model [member] | Top of range [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Risk free interest rate, share options granted                                                     3.55%                      
Expected volatility, share options granted                                                     118.00%                      
Convertible notes [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Aggregate amount of convertible instruments issued                 $ 250,000                                                          
Loans maturity date                 December 31, 2024                                                          
Borrowings, interest rate                 15.00%                                                          
Nonadjusting event [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Issued capital, ordinary shares                       $ 25,000                                                    
Percentage of weighted average price of common stock                       96.00%                                                    
Proceeds from offering                       $ 3,500,000                                                    
Description for common stock received and effectiveness of resgistration                       (i) USD 1,500 thousand at the initial closing (was received on March 2023) (ii) USD 2,000 thousand upon effectiveness of a registration statement that was filed on March 2023                                                    
Number of issued and outstanding ordinary shares percentage         15.00%                                                                  
Number of shares authorized | shares         5,082,417                                                                  
Pre-Paid Advance to decrease price per shares | $ / shares       $ 1.10                                                                    
Payment of debt       $ 500,000                                                                    
Nonadjusting event [member] | Benchmark investments LLC [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Payment of debt   $ 250,000                                                                        
Debt principal amount   $ 900,000                                                                        
Nonadjusting event [member] | Bridge loan agreements [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Proceeds from borrowings, classified as financing activities                                               $ 550,000                            
Borrowings, interest rate                         10.00%                   10.00% 10.00%                            
Description of approach used to determine discount rates                                             Each investor has the option to decide that Security Matters Limited will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary                              
Nonadjusting event [member] | Bridge loan agreements [member] | Bonus warrants [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Loans maturity date                                             five years                              
Warrants to purchase, shares | shares                                             243,000                              
Exercise price of share | $ / shares                                             $ 11.50                              
Nonadjusting event [member] | Bridge loan agreements [member] | Redeemable warrants [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Loans maturity date                                             five years                              
Warrants to purchase, shares | shares                                             597,000                              
Exercise price of share warrants | $ / shares                                             $ 11.50                              
Implied value | $ / shares                         $ 5.00                   $ 5.00                              
Nonadjusting event [member] | Prepaid advance agreement [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Payment of debt $ 1,350,000     450,000                                                                    
Prepaid advance amount       $ 1,500,000                                                                    
Nonadjusting event [member] | Securities purchase agreement [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Proceeds from offering     $ 2,500,000                                                                      
Conversion price | $ / shares     $ 1.6378                                                                      
Debt principal amount     $ 4,290,000                                                                      
Loan borrowing     $ 2,574,000                                                                      
Original issue discount     40.00%                                                                      
Interest accrued percent     12.00%                                                                      
Conversion of shares, description     Any such conversion is subject to customary conversion limitations set forth in the Purchase Agreement so the investor beneficially owns less than 4.99% of the Company’s ordinary shares. Additionally, the Company has the right to convert in whole or in part the note into ordinary shares; provided that in no case shall the Company so convert the note if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of 4.99%                                                                      
Nonadjusting event [member] | Loan agreement [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Debt conversion amount                                                               $ 657,000            
Nonadjusting event [member] | Loan agreements [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Ordinary shares | shares                                                               487,281            
Nonadjusting event [member] | Bottom of range [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Percentage of common stock                       97.00%                                                    
Nonadjusting event [member] | Top of range [member] | Bridge loan agreements [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Loans maturity date                                             two years P2Y                            
Nonadjusting event [member] | Eleven lenders [member] | Bridge loan agreements [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Proceeds from loans and warrants                                             $ 3,860,000                              
Nonadjusting event [member] | True gold consortium pty ltd [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Percentage of interests acquired additional                                                             7.50%              
Percentage of interests acquired increase                                                             51.90%              
Nonadjusting event [member] | Security matters limited [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Ordinary shares | shares               864,000                                                            
Risk free interest rate, share options granted               3.42%                                                            
Expected volatility, share options granted               81.92%                                                            
Expected dividend as percentage, share options granted               0.00%                                                            
Nonadjusting event [member] | Security matters limited [member] | Bridge loan agreements [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Proceeds from borrowings, classified as financing activities                                               $ 550,000                            
Borrowings, interest rate                                               10.00%                            
Nonadjusting event [member] | Security matters limited [member] | Isorad Ltd [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Ordinary shares | shares                         864,000                   864,000                              
Description for equity or other funding convertible                         Additionally, Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter                                                  
Payments for proceed from receiving equity or other funding convertible into equity                         $ 27,000,000                                                  
Percentage of cash on exit fee                         1.50%                                                  
Nonadjusting event [member] | Security matters limited [member] | Isorad Ltd [member] | Black scholes pricing model [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Risk free interest rate, share options granted                         3.42%                                                  
Expected volatility, share options granted                         81.92%                                                  
Description of expected term warrants                         3 years                                                  
Expected dividend as percentage, share options granted                         0.00%                                                  
Nonadjusting event [member] | Security matters limited [member] | SMX Public Limited Company [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Issued capital, ordinary shares                       $ 25,000,000                                                    
Percentage of weighted average price of common stock                       96.00%                                                    
Proceeds from offering                       $ 3,500,000                                                    
Description for common stock received and effectiveness of resgistration                       (i) $1,500 at the initial closing (was received on March 2023) (ii) $2,000 upon effectiveness of a registration statement that was initially filed in March 2023.                                                    
Nonadjusting event [member] | Security matters limited [member] | SMX Public Limited Company [member] | Bottom of range [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Percentage of common stock                       97.00%                                                    
Nonadjusting event [member] | Convertible notes [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Ordinary shares | shares                 250,000                                                          
Aggregate amount of convertible instruments issued                 $ 250,000                                                          
Loans maturity date                 December 31, 2024                                                          
Percentage of convertible notes                 1500.00%                                                          
Conversion price | $ / shares                 $ 10                                                          
Nonadjusting event [member] | Convertible notes [member] | Bridge loan agreements [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Aggregate amount of convertible instruments issued                     1,350,000                                                      
Nonadjusting event [member] | Convertible notes [member] | Security matters limited [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Ordinary shares | shares                 250,000                                                          
Aggregate amount of convertible instruments issued                 $ 250,000                                                          
Loans maturity date                 December 31, 2024                                                          
Percentage of convertible notes                 15.00%                                                          
Nonadjusting event [member] | Convertible notes [member] | Security matters limited [member] | Bridge loan agreements [member]                                                                            
IfrsStatementLineItems [Line Items]                                                                            
Number of value converted                     $ 1,350,000                                                      
Number of shares converted | shares           1,000,000                                                                
XML 109 R94.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical)
Jun. 30, 2023
$ / shares
Jun. 30, 2023
€ / shares
Dec. 31, 2022
$ / shares
Dec. 31, 2022
€ / shares
IfrsStatementLineItems [Line Items]        
Par value per share | (per share)   € 1,000 $ 0.0001 € 1
Ordinary shares [member]        
IfrsStatementLineItems [Line Items]        
Par value per share $ 0.0001      
Preference shares [member]        
IfrsStatementLineItems [Line Items]        
Par value per share $ 0.0001      
XML 110 R95.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF SHARE CAPITAL (Details) - shares
Jun. 30, 2023
Dec. 31, 2022
Jul. 01, 2022
IfrsStatementLineItems [Line Items]      
Number of shares authorized   500,000,000 500,000,000
Number of shares issued and outstanding   1 1
Ordinary shares [member]      
IfrsStatementLineItems [Line Items]      
Number of shares authorized 800,000,000,000 500,000,000  
Number of shares issued and outstanding 38,364,447 1  
Preference shares [member]      
IfrsStatementLineItems [Line Items]      
Number of shares authorized 200,000,000,000  
Number of shares issued and outstanding  
Deferred Shares [Member]      
IfrsStatementLineItems [Line Items]      
Number of shares authorized 25,000 25,000  
Number of shares issued and outstanding 25,000 25,000  
XML 111 R96.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF RESTRICTED STOCK UNIT (Details) - Restricted share units [member] - Employees directors and service [member] - shares
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
IfrsStatementLineItems [Line Items]    
Number of outstanding, Beginning
Number of outstanding, Granted 4,334,000
Number of outstanding, Vested (945,000)
Number of outstanding, Ending 3,389,000
XML 112 R97.htm IDEA: XBRL DOCUMENT v3.24.0.1
SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
IfrsStatementLineItems [Line Items]    
Net loss attributable to the owners of the Company $ (33,009) $ (2,442)
Basic loss per share $ (39.46) [1] $ (3.36) [2],[3]
Diluted loss per share $ (39.46) [1] $ (3.36) [2],[3]
Weighted average number of ordinary shares    
Weighted average number of ordinary shares used in calculating basic loss per share 837 727 [2]
Weighted average number of ordinary shares used in calculating diluted loss per share 837 727 [2]
Ordinary shares [member]    
IfrsStatementLineItems [Line Items]    
Net loss attributable to the owners of the Company $ (33,009) $ (2,442)
Basic loss per share $ (1.79) $ (0.15)
Diluted loss per share $ (1.79) $ (0.15)
Weighted average number of ordinary shares    
Weighted average number of ordinary shares used in calculating basic loss per share 18,404 15,984
Weighted average number of ordinary shares used in calculating diluted loss per share 18,404 15,984
[1] After giving effect to the reverse stock split (see also Note 9.1)
[2] Restated as a result of the SPAC transaction
[3] Restated as a result of the SPAC transaction and after giving effect to the reverse stock split (see also Note 1 and 9.1)
XML 113 R98.htm IDEA: XBRL DOCUMENT v3.24.0.1
MATERIAL EVENTS DURING THE PERIOD (Details Narrative)
1 Months Ended 6 Months Ended
Jul. 27, 2023
USD ($)
$ / shares
Jun. 22, 2023
$ / shares
shares
Jul. 31, 2023
USD ($)
Feb. 28, 2023
USD ($)
$ / shares
Jan. 31, 2023
USD ($)
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2023
€ / shares
Jun. 27, 2023
$ / shares
Mar. 07, 2023
shares
Dec. 31, 2022
$ / shares
Dec. 31, 2022
€ / shares
IfrsStatementLineItems [Line Items]                      
Par value per share | (per share)             € 1,000     $ 0.0001 € 1
Floor price per share $ 1.10                    
Number of shares issued | shares         864,000       1,000,000    
Warrant exercise description           Warrant A was valued at $0.0635 which is half of the share market price at the end of the period, assuming cashless exercise. Warrants A were considered to be a derivative financial liability. The terms of warrants B specify that each warrant has a cash exercise price of $0.24. Warrant B was valued at $0.0602 by using the Black-Scholes option-pricing          
Expected volatility         81.92%            
Risk-free interest rate         3.42%            
Net proceeds from offering | $           $ 2,580,000          
Capital raise fee | $           $ 660,000          
Expected term         3 years            
Expected dividend | $         $ 0            
Proceeds from issuing equity | $         27,000,000            
Technology-based intangible assets [member]                      
IfrsStatementLineItems [Line Items]                      
Investment property | $         $ 101,000            
Warrants [member]                      
IfrsStatementLineItems [Line Items]                      
Warrants exercise price per share               $ 0.0204      
Expected volatility           70.39%          
Risk-free interest rate           4.13%          
Ordinary shares [member]                      
IfrsStatementLineItems [Line Items]                      
Par value per share           $ 0.0001          
Number of shares issued | shares                 3,525,000    
Warrant B [member]                      
IfrsStatementLineItems [Line Items]                      
Warrant cash exercise price           0.24          
Warrant exercise price           0.0602          
Underwriter warrant [member]                      
IfrsStatementLineItems [Line Items]                      
Warrants price per share           0.0575          
Warrant exercise price           $ 0.264          
Expected volatility           70.39%          
Risk-free interest rate           4.13%          
Warrants issued | shares           666,667          
Standby equity purchase agreement [member]                      
IfrsStatementLineItems [Line Items]                      
Ordinary shares | $     $ 450,000 $ 25,000,000              
Description of share-based payment arrangement       (i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period.              
Notional amount | $       $ 3,500,000              
Par value per share       $ 3.65              
Purchase price of per share       $ 1.10              
Repayments of borrowings | $ $ 500,000   $ 1,500,000                
Standby equity purchase agreement [member] | First installment [member]                      
IfrsStatementLineItems [Line Items]                      
Notional amount | $       $ 1,500,000              
Standby equity purchase agreement [member] | Second installment [member]                      
IfrsStatementLineItems [Line Items]                      
Notional amount | $       $ 2,000,000              
Prepaid advance percentage       92.00%              
Underwriting agreement [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares           13,333,333          
Warrant term description   (i) the thirty day anniversary of the date of the Underwriting Agreement and (ii) the date on which the aggregate composite trading volume of the Company’s ordinary shares as reported by Bloomberg LP beginning on the date of the Underwriting Agreement exceeds 15,000,000 ordinary shares, a holder of Warrant A warrants may also provide notice and elect a “cashless exercise” pursuant to which the holder would receive an aggregate number of ordinary shares equal to the product of (x) the aggregate number of ordinary shares that would be issuable upon a cash exercise and (y) $0.50. As of the date of publication of these financial statements, an aggregate of 15,195,332 Warrant A warrants were cashless exercised into an aggregate of 7,597,665 ordinary shares.                  
Underwriting agreement [member] | Public offering [member]                      
IfrsStatementLineItems [Line Items]                      
Description of share-based payment arrangement   (a) up to 1,999,999 additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $0.24 (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to 1,999,999 ordinary shares at a price per share of $0.2399 (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $0.0001 per share, and/or (b) 1,999,999 warrants in the form of Warrant A to subscribe for an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at an exercise price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) 1,999,999 warrants in the form of Warrant B to purchase an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at a purchase price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants.                  
Underwriting agreement [member] | Ordinary shares [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares   7,597,665                  
Underwriting agreement [member] | Ordinary shares [member] | Warrant A [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares   13,333,333                  
Underwriting agreement [member] | Ordinary shares [member] | Public offering [member]                      
IfrsStatementLineItems [Line Items]                      
Par value per share   $ 0.24                  
Number of shares issued | shares   1,999,999                  
Underwriting agreement [member] | Prefunded warrant [member] | Public offering [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares   1,999,999                  
Warrants exercise price per share   $ 0.0001                  
Warrants price per share   $ 0.2399                  
Underwriting agreement [member] | Warrant A [member]                      
IfrsStatementLineItems [Line Items]                      
Warrant cashless exercised | shares   15,195,332                  
Underwriting agreement [member] | Warrant A [member] | Public offering [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares   1,999,999                  
Warrants exercise price per share   $ 0.24                  
Underwriting agreement [member] | Warrant B [member] | Public offering [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares   1,999,999                  
Warrants price per share   $ 0.24                  
Underwriting agreement [member] | EF hutton llc [member] | Warrant A [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares   13,333,333                  
Warrants exercise price per share   $ 0.24                  
Underwriting agreement [member] | EF hutton llc [member] | Warrant B [member]                      
IfrsStatementLineItems [Line Items]                      
Number of shares issued | shares   13,333,333                  
Warrants exercise price per share   $ 0.24                  
Underwriting agreement [member] | EF hutton llc [member] | Ordinary shares [member]                      
IfrsStatementLineItems [Line Items]                      
Par value per share   $ 0.24                  
Number of shares issued | shares   13,333,333                  
EXCEL 115 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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ፆ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

M %196F(A<^_%@5)9?NX>KAVZ#3@C=0[_3; M\(;5VWTW"YL!G%!T>Z_H]D\K>C2\&SYNCY1WFO$X5BOI'WSC:C_4VQWO M0 _*?E>")/:)V*^H"&P]B":*9]\GH-V';NNEV40^H[%>G4)2OU\8D0B7(1%E M3MCJLGJGT_7A.%+'!-,XZ&@%ZJ7OVP8\TZJY[5?WGP;#JB-^-Z^^*^ZY7@I* MXQQ3<@W.NZ007?7J:F)5Z?OC0EGJMGZ8T><-:F= ^ZE2=C=Q!^P_F ;_ %!+ M P04 " "SBUQ80F>!L8," -!@ &0 'AL+W=O8%T50=(I:4M4M\$M/M0[<.1&')J M[H[=F=+^^]U=(&,;Y-LD1&R?_?CQQ7:Z:Z5?3(%(\"9*:7I!0;0\#4.3%2B8 M.5)+E/9DKK1@9%6]",U2(\M]D"C#)(J.0\&X#/I=;WO0_:Y:4,\EX0.4)88D8.@=G'*YYC63H@2^/G!C.H4[K 77F+ M?NEKM[7,F,%S57[G.16]X"2 '.=L5=)8K:]Q4X\GF*G2^']85[[MXP"RE2$E M-L&6@>"R>K*WS3WL!)Q$!P*234#B>5>)/,L+1JS?U6H-VGE;-"?X4GVT)<>E M>RD3TO:4VSCJ7]T_#<=WM\.[*5R-S^ZF$_@T9;,2S>=N2!;?>879!FM0824' ML.($;I6DPL!0YIC_"1!:8C6[9,MND#0B7F!V!.WX"R11DC3@M>MJVQZOCMP\0'LVUF1 CM'- -_9P9$4#STX$+^^EW/D/E-.:!O2]R:%$I3RS:!L$W M9KQT;<$(WI%I0)E#&D$[:MTHN6CR.DGMKS55Q$J(VRG$<0K[+C'<&5&!>N$7 MD8%,K215TUI;ZUUW5HWX;_=J4=XRO>#2]B[.;6AT]-5>H*Z63Z606OJ!GRFR MZ\.+A=W7J)V#/9\K15O%):B_ /U?4$L#!!0 ( +.+7%CT_E-[R ( *D& M 9 >&PO=V]R:W-H965TK3?&+@2]3D'7 MD(!Y*.8*9T'-DK$L]^XV#&6)=4PE/PKR\RFZU_Y)(,5 MW7)S+W>W4,7C!*:2:S>278EM7OHDW6HC\\H9%>1,E%_Z7-W#@<-5>,(AJAPB MI[L\R*D<44-['25W1%DTLEG#A>J\41P3-BF)4;C+T,_TAK.[Q?UL,AF/R/AN M$2_B<4+>+^B2@_[0"0R>8'%!6K$-2K;H!%LC(E,IS$:3L<@@>TT0H+1:7[37 M-XC.,HX@O2#-QD<2A5%TAJ]9Q]MT?*T3? FD6\7,"]ZA,: TX2QG!C+RF$.^ M!/7]6-!G*>VSN=8%3:'KX[O0H)[ [[U[T[@,/Y\1W*H%MQQ[\X3@>*5T8J@! M? EF@ILQFIH\6I,X^ZCDUG^0W*XEM\_?\?!V/'J8C,GLAO239+Q(2/]N1"9Q M?Q!/7(D=4_QOG-Y)3F^(E:%4VQT.YQ:473ZY(+%*I"JFHZP5S4"EB ML.MXLYW [&.9N?1[^U+[.Z3A[6O)FU:U-#'9!8FUHL!)(PS)VW+\$SBD@F:T MQ%?V6?R-HB*%$E_9K_#3;]X GD"A6DWF&+E#]K%]*,K9GKR-P['T!@?M(P>U M=DU2D]3>7ME)ZM6Z#_?+]O,;7C;Q*55K)O!5P0I=PXM/F%55-L9R8F3AFM%2 M&FQMSMS@OP24!>#^2DJSG]@#ZK]3[Q=02P,$% @ LXM<6';@<.'B! MEPP !D !X;"]W;W)K&ULO5?;66J^N2B45+'G"U*58\11WYD(F3.-4+DIJ M)3D+,Z4D+EGE1P;0PCCQ\YF(3_2*!Z.]]:'F>_HRP-3 MO"_B/Z)0+]N%1@%"/F?K6$_%YH;O_*D:>X&(5?8-FYULN0#!6FF1[)0101*E MVU_VO(O#.0K63L'*<&\/RE .F&:=EA0;D$8:K9E!YFJFC>"BU"3%TQ)W(]33 MG:$[[H[[;G<$[MCSI[-;9^Q[T!T/8.IZ7^&V.^Y>.V81+GSV$'/U"3Z#QX.U MC/0+ M&:2P5QE$2:A_ ]X@<'M>!6I'JIP$E# M'OYLH(1.Y9Y9>\]ZUDF+ QY<0H46P2I;U@E[E3Q2EY1U[[EPJ3S/-D9)Z MA)LN#A5\-T/(QD?=WAJUCQLU)7>E5BS@[0+6E.+RB1H*]OZ1]_PC7:4X8AGM#$=<$>1%1E*RYP:\ M7:'_6CDB0V;> &C1HC;8#0H7S29\@H\?&A:UOA!G-@6K ;12A8MZY6 #%6P+ M:K0&%[1NO6[ B6Q7\VQ7S\ZVYXP]UW>_N?X]%G-W=.^Y'MQ-)T/7SXI[XM\X M4W!^GZ' ,1* %$27K! +)PT@#?UX)M9;\$OR#S?TJ M:+$7E)%Z/%Y[9,/>%MPOQ>.L)/>96A*6AA#@ /B/=?3$XLPI6JPT&V 7:9V2 M":*31*(V;ILK"6BU 4VK3'RA,22T6*W6H%HL-^DI#M1S#M3/YL!L/'"]_F0V M]IW!00!&;K?GCI#OCGC<,%)+%BJX&(LL(=;E=>FUVPT<]%K@7A2<[>2A60FY_4J M-.Q\?\3Q[45>;PCLGI4Z!:M>)CTA,:?(5-3!!O 6Q)85=M&N-Y$;MFUG2L%RD3V)%8+% MWK)]-^:K^:N[NWULOHIOG^RW3"XBS&S,YZA:OJSCM2&WS^#M1(M5]O1\$!H? MLMEPB?\&ULM57;;N(P$'W/5XS2 M5=5*54,"[?8"2*$-*A*T%8&N5M4^F&1"K"8Q:QMH_WYM)V3I"M"^],6>\/+N+UF_$VDB!+>\ZP0'3N5TL+MML_;,NVVVE!DM\)F#6.8YX1\]S-BZ8[OV9F%,YZG4"TZW MO2!S#%%.%\]<:4Z-$M,<"T%9 1R3CNV[-[T+[6\<7BBNQ98,NI(98V]:&<0= MNZ$)88:1U A$32N\PRS30(K&[PK3KE/JP&UY@]XWM:M:9D3@'[4/6P%7C3T! M7A7@&=YE(L/RGDC2;7.V!JZ]%9H63*DF6I&CA3Z44')EI2I.=OO^8 PO_G : MP"CPP^DX& 6/$SB9D%F&XK3M2)5$NSI1!=@K ;T]@*X'(U;(5$!0Q!A_!G 4 MNYJBMZ'8\PXBWF-T#DWW#+R&YQW :]8E-PU>:P]>B-&24_FAME%*Y (RFE.) M,;SFF,^0_]I5]$%(_7)NQ()$V+'5TQ#(5VAWCX_6+PWM\]Q#<3XO]I#'X8!I,0E#0<^+W!<##YN8O_P0R[^<,FK_6?>2U?6"P!=<7,T=?7 M#(:XPLQRJWFC-V'"),FL:?C-H@7(E"T%*6)A#2F9T8Q*BL*Z1TY71#<;*Z$% M*2)*,G7':@602P?-.X?CHRG.]VWKVSBZOF^5HF4P'/79S=[^,^T?-HNEM MB?\P_62#77?)V6I7.?*Y:\+4652*3E#_AMT_4$L#!!0 M ( +.+7%CO(X,BJ0, (L+ 9 >&PO=V]R:W-H965TI',\ M/;3VSN"&XT8_&8-5,I?RFYV$)W"^@ZH:5G3M8I,VP\5'(# MREH3FQVXV#@TJ>'"WF)L%.URPIEQ?'T21W]?1Y^O(+JAWQCVKM@\0[T_] WQ M6RL_V7*=E%SA"UP#^"2%66F(1(II#7[:C.^$#00^":O4A3MU)V$CX\="'$ W M:$,8A-TZAYKAIY@0O./@88,[W2K87:Q1W:$W_O./SB#XJT[Q&Y$]T]^K]/>:V,?Q M]"PZO;Z(X,M[N(W./YQ=1:M=OY!: MM]9(96O%%,**W2',$04D+$N*C*XBA4)SL02S0MBXI*#H+6S&_;^5EUJ'-ND;CSVA: MSC%FC.+SPMA2 48Z)^5&H-)6EIU-9;YFX@'VNMUV$+R#?=@+V[U>"/NM$Z9Y MTK(B4YX5-MZ.\_&:]CH'APX1''3Z!+A].8)2I11UM8OA*TSIWNED_O@4['W. MK6O0X%KGJ-T+>M#IM]\=]: NP?['*_UI@O6K!.LW)Q@F]"[I1='_F[&7D?&< M6Q5?<[1AJ"TOC92O+2]O1/9,_:!2/_@=Y77PEOK?B.R9_L-*_^'O+*^-Y*^- MPZ]Y^@O%JRXN_I-^)T>U=&V@AD06PI2M3[5:=9H3UV#YC^9EF_J)J247E"BX M(&AP<$@/6)6M7SDQ&ULM=UK;^+&&@?PKV+1JMI*V^ +UVV"E,1W.]M5VHC27_HJCA%WU5GF^ M_M3OLV!%8\(NTC5-^"V+-(M)SB]FRSY;9Y3,RT%QU%=E>=2/29CT9I?E=5^R MV66ZR:,PH5\RB6WBF&0O-S1*GZ]Z2N_UBOMPN:?UU_R?BE M?JW,PY@F+$P3*:.+J]ZU\LG7R@'E&O\-Z3/;69:*77E,TV_%!6=^U9.+&=&( M!GE!$/[CB=[2*"HD/H_O%=JKMUD,W%U^U1I7@_D,XC#9_B1_5;^(G0&# M4P/4:H"Z-T#33@S0J@':W@!U>&+ H!HPV!^@G!@PK 8,SQTPJ@:,SIW2N!HP M/G? I!HP.7=*TVK ]-P!BOQZS\EG#ZGO[/U[6SWY\'B]NY7R_NYO'UCEHU(G M.9E=9NFSE!7K<9O#?FX?&89GXW[:U_ZH-.19XB].Y)=2/*X\DXJ MYANS(L6LE+<42ZSH-*@55?Q;LKM(9_R6'+%WO5GN>"<5]_Q9*:<53ZS\$>3G M*/Y;]_N+&&D%2:N?"K12U4ZHSB)C#SG)*3_(YCZ_T>&+3/JS6)3*Y?\?F>K- M%AT<1XL7$9_8F@3TJL=?)3":/='>[)>?E)'\^[%$(C$=B1E(S$1B%A*SD9B# MQ%PDYB$Q'X2U0CNH0SL0Z;//F_B19E*ZJ(_4C&WH7/K[])/+C5#LFE@DIB,Q M8XN-2JPH1IYFBES^N^P_[8;Q<+W):'"PFH6"\4[8>Z@=RBB<2L M+3;=F;Y\P>>OM'? /K*7[34)B1[>3TR M_1G3XEAU]$6D4.H:&"2F(S$#B9E(S$)B-A)SD)B+Q#PDYH.P5E+'=5+'[U'Y MC9&A16(Z$C.0F(G$+"1F(S$'B;E(S$-B/@AKA792AW8"K_R$8M?$(C$=B1F3 M@XI.&ZK#P\H/N5$+B=E(S$%B+A+SD)@/PEIAG-9AG':J#X7O?]\(K:XQG)Y5 M$NG(;1I(S$1B%A*SD9B#Q%PDYB$Q'X2U4JC(S:>9LC"'#S389&'^(L4DSVG& MI"B,PYP'4U1\BLVN>81J.E0SH)H)U2RH9D,U!ZJY4,V#:CY*:^=WIQM!>8]* MM%)1"49J.E0SH)H)U2RH9D,U!ZJY4,V#:CY*:R=8;1*LPLM2,=DYODA-AVH& M5#.AF@75;*CF5-IN2:\>^S#7/;*B,AX/QH-!>T7OR(J3J389C4;M%?UCXE = MR^I@6J_9SDK3<*,(6P,Z5HUBK'-*H*TV4,V :B94LRIMN%MO[WWZ"-V@ ]5< MJ.9!-1^EM=/8=-(HXE::@]IQS9>CO*D=>4*[?*8IWESGO$(;;:": =5,J&9! M-1NJ.5#-A6H>5/-16CO:3?>.,GR7LA+:QP/5=*AF0#43JEE0S89J#E1SH9H' MU7R4UDYPTTNDB)N)?JBL'!V^X(ZOJ$T.7@K0Y'WXPCM\H%J!E0SH9H% MU6RHYD U%ZIY4,U':>TX-DU!BK@KR/B^*=Y/*JZ6R#*C9?DI?L\(VAH$U72H M9D U$ZI94,V&:@Y4321T"ZA2MM/Y'X@H=T_4,V$:A94 MLZ&: ]5 MI9R%-C%!-1VJ&5#-A&H65+.AF@/57*CF034?I;43W#0QJ>+O(+JGSO/6+/_')F[\5G8Z'D[T/?<03Z1Q3:*<25#.A MF@75;*CF0#47JGE0S4=I[9@VG4JJN%/IGA9??LUK6&FQ2>;E5^?FV8;E$@F" M=)/D1Y,Y.BA&-7FTWZPDWG#G6$*;E:":"=4LJ&9#-0>JN5#-@VH^2FO'LFE6 M4L7-2O^FM.5K_M ?EHNGU/G%,[0S"JH94,V$:A94LZ&: ]5/? M=$:IDW, M1J0H78.4Y4Q:I!E/*$D8V9X7+:-!NDQ"QE=@=$TROFKT(BVR-.81KI'BP$L8 MHQP@R;Q8W%0'9WY#%)+',.+K;<\<=>X!6CMLDE+&VGY/QJUX3SL_#T!;KJ": M"=4LJ&9#-0>JN5#-@VH^2ML^#_1WSOP6TVQ9GL^P"!H_TFY/H59?6Y\S\;H\ M<]S>]9;RR=Z>^;!AMB=BO"/9,DR8%-$%)^6+,<]GMCVWX?9"GJ[+\\L]IGF> MQN7BBI(YS8H5^.V+-,U?+Q0;J,\P.?L'4$L#!!0 ( +.+7%CSP::O, , M *@+ 9 >&PO=V]R:W-H965T@*%J#NLYG GEVIA"R!5#*>$@'+GC5P+R[=IC8P*WXRV,B=-M&N/'+^5W?& M8<]R-!'$$"@M0?%O#4.(8ZV$'$^EJ%7MJ0UWVZ_J5\9Y=.:12ACR^!<+5=2S M.A8)84GS6,WYYAI*AUI:+^"Q-+]D4ZYU+!+D4O&D-$:"A*7%/WTN [%CX+8/ M&'BE@6>XBXT,Y8@JVN\*OB%"KT8UW3"N&FN$8ZD^E842.,O03O47PVM_='_C MD^D5&?FSN3\<#^[&TULR']SY"STZFT]G_OSN]PF9W0QN[\C@=D3\'_?CV<3' MWI<1*,IB^95\(PL($D@>0?SIV@J1]<9V4.)=%GC> M 3S7(Q.>JD@2/PTA_%_ 1E\KA[U7AR^]6L41!*>DX9X0S_&\&KU&%<"&T6L> MT!OR),O16P)/.R(P&T+/PCDD0:[#ZGS^Y;>=[#6JS0FT: M]<8!U/%2R(6B"C3E#4Z.L2G)@VX2T]Z+W#P"'9,4[[[ C(G0JY<_33[NP[;6__89]77.>U7%>Y2)G*!9CM MI\LE"X#XV_L^.9P!M<+O#*?K;#_NSC%RH%3]8.J=)\D]>AJ46[S) W=_'KC> M%LVK1;L!K B'H>$))[@[E]GMS&45+@& ^5NWVIW-I7Y6-2 MH+DO!9S6FQRP=XJG!,3*E(B2!#Q/55%'5:-5&3HHBJ_M\J*&G5"Q8BG6/;!$ M4^?T#)\>492%14?QS)1BCUQA86>:$9;2(/0"G%]RKEX[>H.J..__ U!+ P04 M " "SBUQ8IL3YKID# "=#@ &0 'AL+W=OLC3G(R,1HK@R31XE MD&%^00O(Y$A+D9(<[AGB M999A]OT:4KH9&;;Q/# CJT2H 7,\+/ *0A /Q3V3/;-EB4D&.2WAM1H MUU3 [?8S^\=*O!2SP!PF-/V7Q"(9&0,#Q;#$92IF=',#C2!/\44TY=5?M*EC M^[Z!HI(+FC5@N8.,Y/4G?FJ,V +8[A& TP",;A!3T9)--2KW*[3TB^3JH(2"R5DB<6(<3FZ"ZHK=3$)BD_!UZCQ["*7K[YAUZ@TB.Y@DM.;N_" M3>E>:Z'36NA4?.X1OMLEXZ' N3]$9_EY*ULSJ";MZ4E5?KCB M!8Y@9,@$P(&MP1C_\;OM6W_I##LG67 FLATSW=9,MXM]/*<"ISJ[:IA7P53V M6X]MR^T/S?6V#8=!KM]W=X."S@W\HKQ>*Z_7*2^$J&1$?)=76 A@'*4D(P)B M])A!M@"F/2F=E*>>E'.2!6S,,89V#I90Y:F8.?' )*ETC^ M1C2/H!"R$(R K/$BU6ON9#M5\^! S\#?DWP88MN^7O)E*_FR4_*=2(#IM'7" M3M5V>;#QOK.G31-RY+]I6R^EG?5KWZ7=N%/5-6P_^=;51%TZQR2JZG5WY*48 MLSO+$Y6'Y@G\AD[X*?:2GZQNH[2,09=7S:U2.P.VJMXX7-Z8,A=UE=..MN^H MZ^JY<3!N7TUM_8PC9ZH7A_FR1/UP^QNS%&ULM53?3]LP$/Y7 M3AF:0)I(FA0VL302_8&H!*)J@#V@/;C)M;%PXF!?6I#VQ\]V0M1)E+>]Q'?V MW7??%_LNWDGUK M$@M=25'KD%43UA>_KK,"2Z5-98V5.UE*5C(RK-KZN%;+< M)97"#X/@W"\9K[PD=GL+E<2R(<$K7"C035DR]39&(78F5YK("A>N1=SFX& ]MO MXY+C3>S98)2LIGZTSST=> M8 FAP(PL C/+%B^VD&,Y9<226,D=*!MMT*SAI+IL0XY7]E)24N:4FSQ*TLGU;/IP,X.[*[B[ MOYXM83F;S.:/E^.;60K'4R3&A3Z!XP536%&!Q#,F3N (> 7WA6PTJW(=^V2X M6$0_Z^J.V[KA@;I3S$XA&GR#, A#>$BG<'QT\B^,;Z3T>L)>3^APAX?TU)AQ M)F#1J%IJA,OLI>&:NQHW_($4LT9Q>C._E B5!L%+3IC# M4]G&?*3L4P:VBRYTS3(<>:9--*HM>LG7+X/SX.7^30HP/ZYFNE4V*$ MIC'HQAS.C:GAR9K@[ \I1_^!\K"G//ST2B:-LD\'#'3-> [X:B:*Q@\?38MT MYI#L/-DFT2",8G^[7]_?>^YV&5N3MY@H $%= M 9 >&PO=V]R:W-H965T7I%Z&RYT=2=3NEX22 MAL/9\>[,LR^<\Y>\^+V<<5Y9?R[F67DQFE75\MUX7$YF?)&4;_,ES^I?'O-B MD53UQ^)I7"X+GDS;FQ;S,;/M8+Q(TFQT>=Y^=U]K:IYF_+ZPRM5BD12O M[_D\?[D8.:/M%U_2IUG5?#&^/%\F3_R!5]^6]T7]:;S3,DT7/"O3/+,*_G@Q MNG+>73MVU-S1BOPSY2]EY]IJVO(CSW]O/GR<7HSLQB0^YY.JT9'4_SWS:SZ? M-ZIJ0_[8:!WM'MK:O_0MKYNS8^DY-?Y_%_IM)I=C**1->6/R6I>?-K#VR)JNRRA>;FVL+%FFV_C_Y<^.)S@U.H+B!;6Y@ M_1L\Q0WNY@:W;>C:LK99-TF57)X7^8M5--*UMN:B]4U[=]V:-&O^C@]54?^: MUO=5EP_7O][>?/MT:WW^8-U_^7Q_^^7KO]]8]Y^N?OMJ7?UV8]W^X]O'^[O; M^M//-[Q*TGGYBW5F?7NXL7[^Z1?K)RO-K*^S?%4FV;0\'U>U18W>\63S]/?K MIS/%TQUFW>59-2NMVVS*IZ*"<=V477O8MCWO&:GQAD_>6J[SQF(V8XA!UX?? M[A#FN#OWNJT^5Z'OXV-1/E1)Q>NN7WVJ?_Q87Y;6]^;2:J__@WEMK=3#E39# M^UVY3";\8E2/W9(7SWQT^=>_.(']-ZS%FI0)[?=V[?@/,DFW#,!6N]?JNW"4;/EW$0GX^?NRTCGSVP9?ZN M93[9L@<^615IW;(ZE%2\**UYND@K/K6^+_CB!R_0ORNI\MB_JR9E0NN#7>L# M$_TZT-E^3[]H>#^O4/_I1FV9ZNO58==+JVX\2LU[?)YP]L7;1K761H MU$92T^11&TDC6VB^8'&\LS@F+?Y[D9>E-4F*XK6Q,%GDJZS:#47K?]:@X4H^ M\]CNJDF9X!['AC1OFQBP&ZV:7*!+F^B##NHXY@;M1G>W:S.'>;V^C4@Y01#B MG=MA8#DC+;^:3M.&>G'$8K)EMM,W#!&*578!W3@D/-2X-%U-U(:YTC//F&28 M"3QQ@$\<&E!N>*UVDB9-(] V>++?0JD-B%"D;6J(LG* M>;*>]DS_6T\*FGZ+N]R77>ZZ?M]>6:IVJ,)>0 *'S+@G9(V-8L$>.6\@4L(( M%,V&3.[0J?QJ,EDM5K5[ZV30[0W6][O3L@?]W*-CIPD@<( (G,A(_B!!XV@? M:-(F^@ 8PZ$AX[3\$4B,8W*./6.VV[=7E@H#A;F0AQF=AX>'.";G7\>V[;[1LE2WDXA60Y9F M=);^Q).2S_+YU$H7RR)_;L=P>3(=TT\]=FSKTB;Z"#B >2;B&].T!+'Q@8D% M#0; P6C@."F^,9DI BF&F%BR8 HS!2@,!D]O#Y4(3(=!X@F YPP&D[V#UTS M,U_:K*/[M0EV8< NS B[,*WLHDN;Z -@%V:079B,)9$TMF49%;FX0"XN32[D MO)>^%_>HA2Z0RVCC*BP'L'%IL-G'7*Z,)_VU!$3$5Y@% ./2 #.$MUP92LZ< MJ&\L0BX*8SM[)S2W#(_7KKSR$/0!$9&)%/':!8QPZ>6$_?':V'23MNSH32,3 M*.("BKB^D7TSK1LLNK2)/@!<<8?ARD$AVT462_JS#43&404^(!:7)I:]@4_> M_9 "GRRB"GS "Z]I3$H\,F[&6=!WU991C%?8R*,>21;'.T#3=I$'P!R M>,/63 X*8YZ,%7[4[]&T 4,;")CBF<(43T80SY-:)PMU72 :W3F708,*.F#- MS"5I2X[NS2; Q ,P\8R B:<53'1I$WT 8.(9!!,/@0[F]N$S2)# MN,F3">.,21N_B)3C*"9@/H"(3X/(\&#LRZL CM/I4" M-!P;FRK2QAQ]#LT$7_C %SXS$9%]3="P\8$)!/$!0?QA"')01/:1Q1)I=1L1 M\1&Y4!0CH*RX%S IIS]B%8(--*?TY$ MBHAF==XOH7EF"'X%,J3(&Y6(D *^ N"88-C;( ?$;7D](>BC-R(3J3HLX$1 M+SD<'K>-S4)I"X\.6R;0) T"6(CH5OK*R:ZM(FO1 &^A,/PY;"7HA""Z8=N M1(8I1D((!!.>=E(C1 Z2]NVB1$2S@ 5"_2P(#2RSQ%JW>?0 MI4WT 3!(:'"?(T0.8$AQP\@KK)UW6$UA2XAL@_1!"Y-1147 EG#/,0YRV)J9 M8M(F'=VG37!*")P2&N&44"NGZ-(FOMP,G!(9Y)1(9A!IM121"16G@B+@E(CF M%'**&2'OG?:C#2:C.$<0 :9$-*;LHZ<(>>]%#1(R%!N;-=)6'1N) M=&D3?0B$$1DIHQ%IK:.A2YOH Z"0R& IC4B&C%#J_"5V BOQ%IY191Z2<,+K_5K;]U6A&.[?WB";M^?1!$ M2(4TCMTIC&7K+\.QU2F^'B45Q$*DF-)BUK'85"6.K6;Q_)U4B061ZH[4GN&= MBEDVC09[DI"Y:D2T7<>7#+!4I3G\Z=J=@F$UOL.R/B?(F"A(392%U3.R4!;/I/#\L)LJI^XSU MM[$Q*:4W.Q6Z;%-5.[>:A9J<81]+4*F@[^EQIQ;U@A=/;8GN&JL;F%Z7<=Y] MNZL#?M46O^Y]_[ZI#][6N 8UZ^+B=TE1=^TZ[/''6J7]MMDF+-;ENMQ_'[O J-VZ>3SK0Q$N!#FF0F"3H?IVG:B\YS(8-L:Q>0MR3B9*8O?B\) M82$0RR;[FYL]S46",>NS=.(7'=9?>G6?Y7\5MTE2*I\7\V7Q^N2V+.]>GIX6 MT]MD$16+N!0_YC>GQ5V>Q+.ZT6)^J@T&9Z>+.%V>O'E5OQ?E M;UYEJW*>+I,H5XK58A'G7]XE\^S^]8EZLGGCU_3FMJS>.'WSZBZ^23XDY<>[ M*!<_G3XHLW21+(LT6RIY)O?%UFNEFI6K+/NK^L&> MO3X95%.4S)-I61&Q^.=3\CZ9SRM)3,>_&_3DH<^JX?;KC6[4,R]FYBHNDO?9 M_(]T5MZ^/KDX46;)=;R:E[]F]U;2S-"X\J;9O*C_5N[7GSV_/%&FJZ+,%DUC M,06+=+G^-_[<+(BM!IIZH('6--!V&EP,#C08-@V&3^UAU#08/;6'<=-@_-0& M9TV#LYT&P^&!!N=-@_/=>1@?:'#1-+AX:@^738/+I_:@#C9K;O#4!:L^K.PG MKVUUL[K5W?5]N,EFA:M[:_S@1KA9Y>KN.C_]:+^FM;MQ13Y(R3N>%$L1Y'E??]Q^5[Y53I;B-\Z10TJ7R<9F6Q4_B M3?'ZM]ML5<3+6?'JM!234Z>Z;KR;IK[4#7JN)GR_*V4/3E+)GUM#?E[<\D M[4_%8GA8%MIF6;S3I* ?YR^4P?E/BC;0ALW\]DS6>[GBQ,L7BC9NE(\?)LKS M[SM+\" \>0(\5!^;//VQF?RR0;2'J3N(&4=@;S\^@IF/S-^JFK_!P077(UK' MB#]\=S$\&_TB\VRY-TFF+_87GG0*G6/$)TRA*_?>KFZVO(.*]]ARFS]%\8_? M.'J4X.E+2'U\@PWE6C@MM[2#2O3D.>M'.O$S?(CB8:T.#ZCV=5Y\*.,R$3ML MI2=^:8N7A?)G]5*I7_]_SZ2^6Z.C?K3:(7U9W,73Y/6)V.,LDOQ3DD9I"8N<;&-5:= MHOCT1KN\& X&@U>GG[;#B^S4)C&'Q%P2\TC,)[& Q$(2BR"L$U[CA_ :2\/K M?;;\E.1E>C5/E&56)H="2ZH<&UHD-B$QG<0,$C/7V-E6: T'H_W,(ONTQWM! M.3[;STF'[-,E,8_$?!(+2"PDL0C".FET]I!&9](T"E:+JR17LNN'TW-%L>H] MF?;N;._[H [J/]V-\[VTPV.S9K_3B[/]+Z%.]FF0F$EB%HG9).:0F$MB'HGY M)!:06$AB$81U$NG\(9'.Y0=W<:Y\BN>K1+D3P52GDMA%>O[P0]\IP'=2\MB= M)1*;D)A.8@:)F21FK;'SG?]INI%OKS]TN?6AP0OQ*75G5ZG'ZG[")2?=(S&? MQ (2"TDL@K!.VEP\I,V%-&U^S^9QF<[3\HN2QV72ERU2X-AL(;')&JNN@6]] M!R[42VUG[XCLU" QD\0L$K-)S"$QE\0\$O-)+""QD,0B".ODU>5#7EU*\^K7 MM/CKY^L\291T62;"+P_FEA0Z-K=(;'+9EUN#X6@WM\A.#1(S2 MD6GE;:+DR2Q)%G$5:_?5\-=E>3C9I/;1R49J$U334^?;;+0 M3FU4.SC)2 MFZ":CFH&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%E%:-_+:P?/J-QD]KZ+#YU%M M@FHZJAFH9J*:A6HVJCFHYJ*:AVH^J@6H%J):1&G=Y&M'TU>5I9*=O3\V>WAE MDB]Z,T[>?JQ\2>*\M])1WO+H/",U'=4,5#-1S4(U&]4<5'-1S4,U']4"5 M1 M+:*T;IZU ^Q5^0C[)XSID M'[[6AP^M134[9]_00?:H MYJ":BVH>JOFH%J!:B&H1I74#K!V3K\H'Y1\QR$,N'1UDZ-A]5--1S4 UL]%V M1[2,U,O=($-'\*.:@VHNJGFHYJ-:@&HAJD64U@VR=BB_*A_+'^:S=!GG7S;% M1=)+".@8?E2;H)J.:@:JF:AFH9J-:@ZJN:CFH9J/:@&JA:@645HW[MI: O7B MFUQ"0"L,4&V":CJJ&:AFHIJ%:C:J.:CFHIJ':CZJ!:@6HEI$:=WD:ZL25'E9 MPA%EY(W4N:_"6!OOUY'+NSPZR$A-1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4 MBRBM>P/7MDI!>Z1*(?V8[N7KL+ERC;8])57?2 M<8+VJ*.:@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD64ULVSMD)!DUYE_.'1UYH[V35%"E*?+:7H7SY5XD:V6Y<$00RL3M/T;RO>'&%IS M@&H&JIFH9J&:C6H.JKFHYJ&:CVH!JH6H%E%:-\3:P@1-7IC@Q^4JK^JJ9@?* M$>3MCTXO^=1,DFE]YF_S*+U1[[$F6H2 :@:JF:AFH9J-:@ZJN:CFH9J/:@&J MA:@645HWV=I*!4U>J6 _5F@E;W]TLJTU5>U=I=)>8='QQA:7X!J.JH9 MJ&:BFH5J-JHYJ.:BFH=J/JH%J!:B6D1IG5 [EQ#0/G54,U#- M1#4+U6Q41^_![B\_='9)9^:PW<4 MGZ#3H:.:@6HFJEFH9J.:@VHNJGFHYJ-:@&HAJD64ULVSMG9 O 0N/AS[G"MY MKT>G(*E-4$U'-0/53%2S4,U&-0?57%3S4,U'M0#50E2+**V;C&TAPG#\3:Y MH'4)J#9!-1W5#%0S4[VOJ$ MH;P^X:NOGJ)E"XWVZ-53M&P!U0Q4,U'-0C4;U1Q4U -5" M5(LHK9MG;<'#4%[P\*&^N^[#WMD3QX2@-0V-]MB8$+16 =4,5#-1S4(U&]4< M5'-1S4,U']4"5 M1+:*T3IZ-VEJ%D?Q9"%]S[W Y>6RD;JZ9ZFLT2\&9?5;YXIXL_[;'$7+[\H]^E\KA1QF1;77Y3J#2$D MU4SGR2Q9-,1MGJUN;FNU>F97O!3[K&(![9Q:K-ZJ/K*AK^)JN:WNA! KVN#_ MVJ4FIFDS'=K@YS*/A7.CS.(ORN]_O(W$3G$R3>JWZBDI5N*O>+E,J\?MB.Y> M]!U^H\M;1S4#U4Q4LU#-1C4'U5Q4\U#-1[4 U4)4BRBM&_%:&_'R8HP/R71] M<[I%7(HP+Y1YNDA+$5.R 7UR\^@L1Q\0@6HZJAFH9J*:A6HVJCFHYJ*:AVH^ MJ@6H%J):1&G=W&M+-T;?Y $1([2@ ]4FJ*:CFH%J)JI9J&:CFH-J+JIYJ.:C M6H!J(:I%E-9-OK;(0[R4[?&U3YV>[CT5[/ #J.7HT<%':A-4TQMM>[C.A7:A MC7;&ZQA/_)R)3IV%:C:J.:CFHIJ':CZJ!:@6HEI$:=VP:NLN1O('0!B";BZG M] 56;U*A-1>H-D$U?;3_G(KSW6&%!MJEB6H6JMFHYJ":BVH>JOD]F]'.XW(# MM,,0U2)*ZR946Q\QDM='''K>5F\TH:42J#9!-;W1.M>@SR[W'J%C]'Q.[$3M M[D&A-1"H9J.:@VHNJGFHYJ-:@&HAJD64ULVGM@9B)*^!V'_T\V+S/)J[)$^S M_J,]M "U2:HIC^R],Z41;8L;_O2W/CZIB8Z#Q:JV:CFH)J+:AZJ^:@6H%J( M:A&E=1.MK8 8R6L.=A.M.2PLJI$9Z^'#LW;<2F^ZH142J#9!-?V1)?D\_5%) M.V-4GB6?D^FJ^E\B5J[293WF)-[W2IG'RR*>KH<' MY4HU2"7]))I^_#!1OM<&RB*=SYO?+;*\&I$C/B/^[UG6T.[@FKSSZZ2 MZZK%[L/*M)_J9G>[CX44S>N1,7LWL*E'\\2K,A/_Z:73>#[_HEQM-ICJ*G>Z M++--S^ER>TF\4'Z[39X]3.!ZPVJ'=-9P1<7SZ6H>5U9<]@_K46[3F]OU&==Z M&-+UM?AA[66;%W=Q.E.NOJP72C-PJ1#OBGFI9K04Z^%9,WW_7L7S]#JM1F"U MR_\G)2[6XX*J$5EBN8KOP+58V[-VKKI+IFA7ZT^BX=6_DFD]O;%R/<_$9$WC MNVJ"EYDRS^Z3:FV)%?_VX^19]< EY7FUBL4K]<=VD;Q0[*7BK,02;E?49N13 M4C\HJEG0^MQ69L%O#5ML^3G>5K4RZ([LNJ' M[RXT]?R78F< 5C43:2FVDOK0K/K\VU4A%MH\%?/RH7W@UFS&]8:_W&X@5FE>KL? ?1)F=OVL$J]78H-.E$62WX@%\3S=^T;5P\]$ M3"G--VMV^)O5OVH5L26E\T-?A:WU^FR]7J_B>;W%]FSZS7:_7@V[@]7B9L%7 M3RFL-W[E:S;^9[L;__AG3:U'LGW*YJN%:)N(;T/=0DQ*?+/!Q:=[YO"_V*B? M=3;J0YNSN)&SU,W%#;FKC>W=%_LOZ?K/\G MZ__)^G^R_G\]ZTWT*,%"-1O5'%1S4/3T1ZS5 MYP_^5K[O/4V %AFCV@35=%0S4,U$-0O5[$;K7N4:[EWE753S4,U'M>!K M-*4WO] *8TKKY->XK3 >RRN,VP%\FX.9@Z/VY-*Q$89J$U3347 XOSL[.NA^, M^L2Q=C[01IU -5"5(LHK9ME;7GJ6/XLKT?+ M\D6R^?&_LGSW,LC6Q03Y0WGD$W!T\J&5K*BFHYJ!:B:J6:AFHYJ#:BZJ>:CF MHUJ :B&J1936#0CM0FJZ:AFH)J):A:JV:CFH)J+:AZJ M^:@6H%J(:A&E=9.O+8L=R\MB]XLZUL,]-L-NGO",BZ:'SEG$OI.K[^63[#5 M1+6(TM9! M=EK<)DDYBO3]03 MY2HKRVQ1O[Q-XEF25Q\0O[_.Q.%S\T/5P7V6_U7/SIO_ %!+ P04 " "S MBUQ8NV->M-T# #9% &0 'AL+W=O)&)XLAT+*MKQI@DACO(?KMC[H!N1$02N&.(;^(8L\=+ MB.AV:-C&TP]3LEH+]8/I#E*\@@#$/+UC\L@L*0L20\()31"#Y="XL,]]VU&" MK.(K@2W?&2-U*?>4_E0'X\70L-2,(()0* 267P\P@BA2)#F/7P74*/]3"7?' M3_2K[.+EQ=QC#B,:?2,+L1X:?0,M8(DWD9C2[6"&->/:)MD6M9:!P MPP6-"[&<04R2_!O_+AJQ([#;+PB<0N <*F@5@M:A@G8A:!\JZ!2"[-+-_-JS MQGE88'? Z!8Q52UI:I!U/U/+?I%$W2B!8/(LD3KA!J//OC>_]M'D"HUOKR;3 MFXO9>'*++BXG\QD:36Z#R?78NYCY'@IFT_EH-I_*H7\[&\_&?H!./!"81/P# M^HCF@8=.WGY ;Q%)T&Q--QPG"SXPA9RF^C,S+*9TF4_)>6%*7S;)*6I9_R#' M6FM*;TQRG]<3)>ZP7>>,EX(+ M^7"*:WER+(<3IBO"59QIE4ZTVJBNZ.(U0#'---(NK;_&4???;HW7.*%C>Z<)5NE=N^Q=N[%W 80;1L2C3#(A@'$4D9@(6*#O M,<3WP&KOZ4;DL?>T3IBG$^9K@E5\Z92^=%XC;3HZG=$)\W3"?$VPBC/=TIFN MKK1I!!WK1@[K-L92=S_>VKUJC;]?X[3[94VE);VR);V_"Q'T+RIK;HJ:Z[SF M/4=\C1D@ND2)?!W'G(/@C?'3.)ECVZH3YNF$^9I@%4?[I:/]UXB?ODYG=,(\ MG3!?$ZSBS%GIS)FN^&D$'>O&V5[\V';G6?SLU^Q&2]Z[NIJS^OBQK3]+)^NO M VA$XQ0GCV7>R*61RIN4T261@7,B^\I!+I]D#LD,HB'!"A!F*@+-B=0\O6-; MK97F::7YNFA5HW?6R/9KY%)!U>6/3IJGE>;KHE7]^;-&MAL7>F[QD+U[TW?L MWJ?_^:C5.JAU'5W0*B]*5O=9FM44?;2M9Z]%)?NQ: M#$_X4B5QQJX%D+;.4OX[6G+:=T?>!O/YLH<: ]/%G3&QDR]7UP+O==> M4R9QRC(9\XP(-CUMG3G'H7MD O(2'V)V*S>VB>G*#>=?S,[%Y+35,2UB"8N4 M05#]9\5&+$D,2;?C:PEMK>LT@9O;]_0@[[SNS V5;,23C_%$S4];KUIDPJ9T MF:BW_/8O5G:H;W@13V3^F]R693LM$BVEXFD9K%N0QEGQE]Z5)V(C0'>T.< M M ]RM %UQZ.@,,R MX# ?K.+LYD/C446')X+?$F%*:YK9R,QCE/#BZL/_OC= MI7_U;DPNKLC9>/QF=''VSO?(Z,WE]=G5A3\FSSVF:)Q( _&N!=#6O5YWW;WO^KEK)7HL.B!N M[R5Q.ZY#SMY[Y/FS%T3.J6"RJ7]VVM\T.R!=)Z=UF[KWB,:4X6Y#N/_X<*B 1/^S!E]1MJ-9[4V:-VU7KMY%=U=>IT*.594,3T=JM?ZPPN] M*=SR<2*M8:__^8,.G\V"0$)\Y P M'PD+D+ 0!*MIIK?63,]&U[*4D8@7^=+'IT3$\@N9"L9(G"FFJU-$SVJ,+)B( MM*CT MRD(&L5^RJH@#F=G&:RA=6P<]#I]O0W?[4I#F2E/A(6(&$A"%831W\M MCKY5'&,6+46LONE%56DU2)+$::S8A'Q*67K#Q&?RG8PO_R$W;,6$UH8D"UTX M456!)K58Z]Q7+4B8AX3Y2%B A(4@6$U2@[6D!D^Q1@V0FD'"/"3,1\(")"P$ MP6J:.5QKYM Z#5T+ON#B?HGBMYF>BN;QHEJBXHS\Q_4>66E1+47C&E54X3BU M9:5?7U-&UG;LJPPDS$?" B0L!,%JRGBU5L8KJS+\.YV7Q)(97>C+P>@+X7DJ M(\ND6J]/.Z]9S@OT8$,0KSKFQ]D2A;4)^XH""?.1L )"T&PFBB.UJ(X>IPH M%B*.0, \)\Y&P D+"YCCUJ;M MWOH;6A.(TZF,G8Y5(A]S%TXGLK1(7(E@QIHT^HAXI@2-U)(F.MV=VO73))D' MJKZDXH"X_9?$& &'C5Z1%;"O3J T'TH+H+001:MK:L,L=*P#.])ZB"?,F( Z M4=$:RN24"<$F+PF-OBYC&9L/_IB8R^DIC059T639F*K8*]IWUH'2/"C-A]*" MDM;?F"L.7:?G]NH+>MA0[FA@5OX=TXI;2C.EK&/; '&W5R3- MA]("*"U$T>H:J3Q:QVKG#=^4F0>[6[#(+$%FD6G4@9W3)]\8%8UFO#UR;V5 M75@H+8#20A2MKHS*B77L5NQCW+8PX39W^4[AR#M3*A=(\*,V' MT@(H+431ZMJI#%W'ZOT--V:<*-6AG\D'0YW?Y&SE6* &K.0FD^E!9 M:2&*5A=!Y= Z#UBTZY36)+YZ2Z]C4E]5KUBVXQJGT8_M_)#D0AU9*,V'T@(H M+431ZG*H;%G'[LO^2^9 M$M_,,J7G(RX6O'#LF@1C1^TK&"C->ZB;-*,3VOBP'-3"A=)"%*VNCT6 M[F-N-%,I>13KN:=1,%#G%DKS2IK]#KC_J%(!M&4ABE8?]VN[3NQ9&3& MDXFY]R/-^"_3'QYD^ME\Q5[WWHJ >KY0F@^E!5!:B*+5%59YONZ3/)CK0I_, MA=(\*,V'T@(H+431ZMJI7&'7[@KOE:] O5PHS7N@FV=+J01-XN:4!>K<0FDA MBE:71^7KWMI*6Y7/^'M 7JNZ)H]9&O?%?7 M[KO:'[S^Z7P%^J0ME.9!:3Z4%D!I(8I6EU;EYKJ'3Y*O("W,$93F06D^E!9 M:2&*5M=.9?VZ=NMWKWP%:N9":=X#W;3G*U#K%DH+4;2Z/"KKUK4_G/OK^0K4 MQ(72O))6,T^<[5REH4R#P0*U7%&T8LS;&V]4ITS,\I?E)8G,%[]X675]=/U" M_EG^&OK6<<\Y]IV&XX%S'!:OVU?XXNW_2RIF<:8S&3;5574.#G4*)HH7ZHL= MQ1?Y^]PW7"F>YIMS1B=,F +Z\RGGZG['5+#^MP;#_P%02P,$% @ LXM< M6"DI*#/W!@ N30 !D !X;"]W;W)K&ULO9MK M;]LV%(;_"N$50PNTM7F1'6>)@=S:!6BRHDXW#,4^,#(3:]7%I>BD*?;C1UTB M2J),6S+5+XEDDX?G/2)Y'A])1X\1_QHO&1/@>^"'\?%@*<3J<#B,W24+:/PV M6K%0?G,7\8 *>/QP,X>/[@DW>_%,D'P]G1BMZS.1.?5Q^Y/!L65A9>P,+8BT+ MV=WQX 0>GCGCI$/:XD^//<:E8Y!(N8VBK\G)Y>)X,$H\8CYS16*"RG\/[(SY M?F))^O$M-SHHQDPZEH^?K;]+Q4LQMS1F9Y'_E[<0R^/!P0 LV!U=^^)3]/@[ MRP4YB3TW\N/T+WC,VXX&P%W'(@KRSM*#P NS__1['HA2!SC>T 'E'5"] ]G0 M ><=<"HT\RR5=4X%G1WQZ!'PI+6TEARDL4E[2S5>F%S&N>#R6T_V$[/YYZNK MDT]_@S_>@G'R[ R7Q^<3,'UQWF#O\H['?)!? M7LK#&'Q)#D%Z_$]3U#*CI-EHLJ /XQ5UV?% KMB8\0J+]F35*S_D[:/]EJ'F;."$V.A@]E"<9!.DIP"@F. M4<*YV(1@/ :^%WB"+<"7@ 6WC#=>0*/)MA?0DK&*^G&A?MS'!![; MU&_)6$7_I- _,5[]DR#BPOM!DU33)#3K/2Y-7TBG,[GWP7!:Z+-Y[VIK':7W1+%FK1D4A$.R%@:!5"+)E MK1H#A4%P7P[*#92GY-BI9Q+S*%U5*!*"9A1ZSZ,X!B[E_,D+[P$-HK7> M[%9AR9:U:H@4+L%>> E:!29;UJHQ4,@$S0>5'#51 1]5)A0IH"RITB6I3!48+JMYHFRNOV4ER5ZFRL,UC=M54NC]E3-V=-JS<9&6#UT#4/&Y770H9\"[( ML#U;X%W*+N:Q=IK 51F**/ 6HNAR>71@T*].'U42K. #F^'CQ'77P5K*D2OI MG,DA7"^3EMUNB;.3+U?[Y1RS$ZWWVSZ**ECA#Y[TDG,LE4[R&/11B,&*KK!] MNL(Z.+W!]=701RD&*PK#9@HKKP9:NM^X:WK5JS(0:@N^#V(BBIB(N2BS[38J MT(@9>#9?I>U9ANBE&Z@_Y-#0J'0=JVXK:"%;H*7#FB$Z MN-27C'G4KA=#80LQ8TOK!/(SZDYFG]ONM;:L52-<>G"'])%OB*4[5'D,^KC? M111]$?OT173ZTO*->=BNLA1]D=WIJT.^(7I]1\\W#8T.-M2LB&(@LM_#.*3I M:9RZ8WH;M,DQ!2;$#"9[Y8:&NT5Z;FAHM#$W*/ @]N\!$9TVM.G=!VLXBC6< M+:S1-C=8*W*9'6O]V%\?O.,HWG%@'PG L52CR6/01\7'4?#DV()P?Z&JO(5$SGV;X>93;:1;;6T-"R]!!(P?I^^&Q,#-[FWD[U(47Q:O']S MDKYU4OO\%!Z>96_1*#/92SU7E,LM0"9%=B=-CMY.Y'7CV7LRV8F(5NFK)K>1 M$%&0'BX973">-)#?WT61>#Y)!BC>5IK]#U!+ P04 " "SBUQ8",/G1&8# M #!# &0 'AL+W=O9X4>.REB>>JZ.DXAY_I0EE#0RERJG",-U<+5 MI0*>6*<\

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

  • S]UOO3.W_",+\TTFE6SNOW2/;/;?S3: MAU/IOQ7C_[=G)3^]H!?[T<5!A5^G3]6@_NN[I_9=ULUS_>[#O_U+[^KL MO_;5=A*324PA,97$-!+32S\HO_;^^?MRDT.JI&83F(&B9DD9I&8 M36(.B;DDYI&83V(!B84D%I%83&()B:4DEI%83F(%B940UJG3 MAVHV>AC-OKU9L87 J16;Q&024R[W5>R;WNUNQ28'U4A,)S&#Q$P2LTC,)C&' MQ%P2\TC,)[& Q$(2BT@L)K&$Q%(2RT@L)[&"Q$H(ZU3LJ^\5^TI8L?VJD9ZK MAWDM_5WZ]Z>Z>3G>O^]4S2L%NNP=. MSLYZW3;,)L=T2,PE,>^X3\,_[F4!N6HAB44D%I-8\H)=;WVTO?:3[7ZPZ9X7 M=5^1D>N4DUA!8B6$=2KC]??*>"VLC&HU6I?&R1>IJ8=U_5A]?JBEKXL)>N/9 MM*V8?]E7)X7LJ762Q&024TA,)3&-Q'02,TC,)#&+Q.P7[')K_W6]LP-SR/%< M$O-(S">Q@,1"$HM(+":QA,12$LM(+">Q@L1*".N4\)OO)?Q&6,(_WMTU]5TU MJZ7J<3(?SQ:%?# 9/]?-;+2HY*/Q=-;,%Q/*IM)H.IW7P[=JNG"<4VLZB
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
  •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end XML 116 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 117 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 119 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 519 428 1 true 141 0 false 10 false false R1.htm 00000001 - Document - Cover Sheet http://smxpublicltd.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Interim Condensed Consolidated Statements of Financial Position Sheet http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition Interim Condensed Consolidated Statements of Financial Position Statements 2 false false R3.htm 00000003 - Statement - Interim Condensed Consolidated Statements of Comprehensive Loss Sheet http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss Interim Condensed Consolidated Statements of Comprehensive Loss Statements 3 false false R4.htm 00000004 - Statement - Interim Condensed Consolidated Changes In Shareholders' Equity Sheet http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity Interim Condensed Consolidated Changes In Shareholders' Equity Statements 4 false false R5.htm 00000005 - Statement - Interim Condensed Consolidated Statements of Cash Flows Sheet http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows Interim Condensed Consolidated Statements of Cash Flows Statements 5 false false R6.htm 995511 - Disclosure - GENERAL Sheet http://smxpublicltd.com/role/General GENERAL Notes 6 false false R7.htm 995512 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://smxpublicltd.com/role/SignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 995513 - Disclosure - CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS Sheet http://smxpublicltd.com/role/CriticalAccountingEstimatesAndJudgements CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS Notes 8 false false R9.htm 995514 - Disclosure - OTHER CURRENT ASSETS Sheet http://smxpublicltd.com/role/OtherCurrentAssets OTHER CURRENT ASSETS Notes 9 false false R10.htm 995515 - Disclosure - PROPERTY AND EQUIPMENT, NET Sheet http://smxpublicltd.com/role/PropertyAndEquipmentNet PROPERTY AND EQUIPMENT, NET Notes 10 false false R11.htm 995516 - Disclosure - CONVERTIBLE NOTES Notes http://smxpublicltd.com/role/ConvertibleNotes CONVERTIBLE NOTES Notes 11 false false R12.htm 995517 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES Sheet http://smxpublicltd.com/role/InvestmentsInAssociatedCompanies INVESTMENTS IN ASSOCIATED COMPANIES Notes 12 false false R13.htm 995518 - Disclosure - INTANGIBLE ASSETS, NET Sheet http://smxpublicltd.com/role/IntangibleAssetsNet INTANGIBLE ASSETS, NET Notes 13 false false R14.htm 995519 - Disclosure - LEASES Sheet http://smxpublicltd.com/role/Leases LEASES Notes 14 false false R15.htm 995520 - Disclosure - OTHER PAYABLES Sheet http://smxpublicltd.com/role/OtherPayables OTHER PAYABLES Notes 15 false false R16.htm 995521 - Disclosure - BORROWINGS FROM RELATED PARTIES Sheet http://smxpublicltd.com/role/BorrowingsFromRelatedParties BORROWINGS FROM RELATED PARTIES Notes 16 false false R17.htm 995522 - Disclosure - BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY Sheet http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiability BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY Notes 17 false false R18.htm 995523 - Disclosure - SHAREHOLDERS??? EQUITY Sheet http://smxpublicltd.com/role/ShareholdersEquity SHAREHOLDERS??? EQUITY Notes 18 false false R19.htm 995524 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET Sheet http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNet RESEARCH AND DEVELOPMENT EXPENSES, NET Notes 19 false false R20.htm 995525 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES Sheet http://smxpublicltd.com/role/GeneralAndAdministrativeExpenses GENERAL AND ADMINISTRATIVE EXPENSES Notes 20 false false R21.htm 995526 - Disclosure - TAXES ON INCOME Sheet http://smxpublicltd.com/role/TaxesOnIncome TAXES ON INCOME Notes 21 false false R22.htm 995527 - Disclosure - LOSS PER SHARE Sheet http://smxpublicltd.com/role/LossPerShare LOSS PER SHARE Notes 22 false false R23.htm 995528 - Disclosure - RELATED PARTIES Sheet http://smxpublicltd.com/role/RelatedParties RELATED PARTIES Notes 23 false false R24.htm 995529 - Disclosure - GOVERNMENT GRANTS Sheet http://smxpublicltd.com/role/GovernmentGrants GOVERNMENT GRANTS Notes 24 false false R25.htm 995530 - Disclosure - CONTROLLED ENTITIES Sheet http://smxpublicltd.com/role/ControlledEntities CONTROLLED ENTITIES Notes 25 false false R26.htm 995531 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES Sheet http://smxpublicltd.com/role/CommitmentsAndContingentLiabilities COMMITMENTS AND CONTINGENT LIABILITIES Notes 26 false false R27.htm 995532 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT Sheet http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagement FINANCIAL INSTRUMENTS AND RISK MANAGEMENT Notes 27 false false R28.htm 995533 - Disclosure - FAIR VALUE MEASUREMENT Sheet http://smxpublicltd.com/role/FairValueMeasurement FAIR VALUE MEASUREMENT Notes 28 false false R29.htm 995534 - Disclosure - SUBSEQUENT EVENTS Sheet http://smxpublicltd.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 29 false false R30.htm 995535 - Disclosure - MATERIAL EVENTS DURING THE PERIOD Sheet http://smxpublicltd.com/role/MaterialEventsDuringPeriod MATERIAL EVENTS DURING THE PERIOD Notes 30 false false R31.htm 995536 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 31 false false R32.htm 995537 - Disclosure - GENERAL (Tables) Sheet http://smxpublicltd.com/role/GeneralTables GENERAL (Tables) Tables http://smxpublicltd.com/role/General 32 false false R33.htm 995538 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://smxpublicltd.com/role/SignificantAccountingPoliciesTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://smxpublicltd.com/role/SignificantAccountingPolicies 33 false false R34.htm 995539 - Disclosure - OTHER CURRENT ASSETS (Tables) Sheet http://smxpublicltd.com/role/OtherCurrentAssetsTables OTHER CURRENT ASSETS (Tables) Tables http://smxpublicltd.com/role/OtherCurrentAssets 34 false false R35.htm 995540 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) Sheet http://smxpublicltd.com/role/PropertyAndEquipmentNetTables PROPERTY AND EQUIPMENT, NET (Tables) Tables http://smxpublicltd.com/role/PropertyAndEquipmentNet 35 false false R36.htm 995541 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES (Tables) Sheet http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesTables INVESTMENTS IN ASSOCIATED COMPANIES (Tables) Tables http://smxpublicltd.com/role/InvestmentsInAssociatedCompanies 36 false false R37.htm 995542 - Disclosure - INTANGIBLE ASSETS, NET (Tables) Sheet http://smxpublicltd.com/role/IntangibleAssetsNetTables INTANGIBLE ASSETS, NET (Tables) Tables http://smxpublicltd.com/role/IntangibleAssetsNet 37 false false R38.htm 995543 - Disclosure - LEASES (Tables) Sheet http://smxpublicltd.com/role/LeasesTables LEASES (Tables) Tables http://smxpublicltd.com/role/Leases 38 false false R39.htm 995544 - Disclosure - OTHER PAYABLES (Tables) Sheet http://smxpublicltd.com/role/OtherPayablesTables OTHER PAYABLES (Tables) Tables http://smxpublicltd.com/role/OtherPayables 39 false false R40.htm 995545 - Disclosure - BORROWINGS FROM RELATED PARTIES (Tables) Sheet http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesTables BORROWINGS FROM RELATED PARTIES (Tables) Tables http://smxpublicltd.com/role/BorrowingsFromRelatedParties 40 false false R41.htm 995546 - Disclosure - SHAREHOLDERS??? EQUITY (Tables) Sheet http://smxpublicltd.com/role/ShareholdersEquityTables SHAREHOLDERS??? EQUITY (Tables) Tables http://smxpublicltd.com/role/ShareholdersEquity 41 false false R42.htm 995547 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables) Sheet http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNetTables RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables) Tables http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNet 42 false false R43.htm 995548 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables) Sheet http://smxpublicltd.com/role/GeneralAndAdministrativeExpensesTables GENERAL AND ADMINISTRATIVE EXPENSES (Tables) Tables http://smxpublicltd.com/role/GeneralAndAdministrativeExpenses 43 false false R44.htm 995549 - Disclosure - TAXES ON INCOME (Tables) Sheet http://smxpublicltd.com/role/TaxesOnIncomeTables TAXES ON INCOME (Tables) Tables http://smxpublicltd.com/role/TaxesOnIncome 44 false false R45.htm 995550 - Disclosure - LOSS PER SHARE (Tables) Sheet http://smxpublicltd.com/role/LossPerShareTables LOSS PER SHARE (Tables) Tables http://smxpublicltd.com/role/LossPerShare 45 false false R46.htm 995551 - Disclosure - RELATED PARTIES (Tables) Sheet http://smxpublicltd.com/role/RelatedPartiesTables RELATED PARTIES (Tables) Tables http://smxpublicltd.com/role/RelatedParties 46 false false R47.htm 995552 - Disclosure - GOVERNMENT GRANTS (Tables) Sheet http://smxpublicltd.com/role/GovernmentGrantsTables GOVERNMENT GRANTS (Tables) Tables http://smxpublicltd.com/role/GovernmentGrants 47 false false R48.htm 995553 - Disclosure - CONTROLLED ENTITIES (Tables) Sheet http://smxpublicltd.com/role/ControlledEntitiesTables CONTROLLED ENTITIES (Tables) Tables http://smxpublicltd.com/role/ControlledEntities 48 false false R49.htm 995554 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables) Sheet http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables) Tables http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagement 49 false false R50.htm 995555 - Disclosure - FAIR VALUE MEASUREMENT (Tables) Sheet http://smxpublicltd.com/role/FairValueMeasurementTables FAIR VALUE MEASUREMENT (Tables) Tables http://smxpublicltd.com/role/FairValueMeasurement 50 false false R51.htm 995556 - Disclosure - SUBSEQUENT EVENTS (Tables) Sheet http://smxpublicltd.com/role/SubsequentEventsTables SUBSEQUENT EVENTS (Tables) Tables http://smxpublicltd.com/role/SubsequentEvents 51 false false R52.htm 995557 - Disclosure - GENERAL (Details Narrative) Sheet http://smxpublicltd.com/role/GeneralDetailsNarrative GENERAL (Details Narrative) Details http://smxpublicltd.com/role/GeneralTables 52 false false R53.htm 995558 - Disclosure - SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT (Details) Sheet http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT (Details) Details 53 false false R54.htm 995559 - Disclosure - SCHEDULE OF OTHER CURRENT ASSETS (Details) Sheet http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails SCHEDULE OF OTHER CURRENT ASSETS (Details) Details 54 false false R55.htm 995560 - Disclosure - SCHEDULE OF OTHER RECEIVABLES (Details) (Parenthetical) Sheet http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical SCHEDULE OF OTHER RECEIVABLES (Details) (Parenthetical) Details 55 false false R56.htm 995561 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) Sheet http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details) Details 56 false false R57.htm 995562 - Disclosure - CONVERTIBLE NOTES (Details Narrative) Notes http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative CONVERTIBLE NOTES (Details Narrative) Details http://smxpublicltd.com/role/ConvertibleNotes 57 false false R58.htm 995563 - Disclosure - SCHEDULE OF INFORMATION ABOUT CONSOLIDATED STRUCTURED ENTITIES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfInformationAboutConsolidatedStructuredEntitiesDetails SCHEDULE OF INFORMATION ABOUT CONSOLIDATED STRUCTURED ENTITIES (Details) Details 58 false false R59.htm 995564 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES (Details Narrative) Sheet http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative INVESTMENTS IN ASSOCIATED COMPANIES (Details Narrative) Details http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesTables 59 false false R60.htm 995565 - Disclosure - SUMMARY OF INTANGIBLE ASSETS NET (Details) Sheet http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails SUMMARY OF INTANGIBLE ASSETS NET (Details) Details 60 false false R61.htm 995566 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative) Sheet http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative INTANGIBLE ASSETS, NET (Details Narrative) Details http://smxpublicltd.com/role/IntangibleAssetsNetTables 61 false false R62.htm 995567 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS (Details) Sheet http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails SCHEDULE OF RIGHT OF USE ASSETS (Details) Details 62 false false R63.htm 995568 - Disclosure - SCHEDULE OF LEASE LIABILITY (Details) Sheet http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails SCHEDULE OF LEASE LIABILITY (Details) Details 63 false false R64.htm 995569 - Disclosure - SCHEDULE OF CARRYING AMOUNTS OF LEASE LIABILITIES RECOGNIZED IN PROFIT OR LOSS (Details) Sheet http://smxpublicltd.com/role/ScheduleOfCarryingAmountsOfLeaseLiabilitiesRecognizedInProfitOrLossDetails SCHEDULE OF CARRYING AMOUNTS OF LEASE LIABILITIES RECOGNIZED IN PROFIT OR LOSS (Details) Details 64 false false R65.htm 995570 - Disclosure - SCHEDULE OF OTHER PAYABLES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails SCHEDULE OF OTHER PAYABLES (Details) Details 65 false false R66.htm 995571 - Disclosure - LEASES (Details Narrative) Sheet http://smxpublicltd.com/role/LeasesDetailsNarrative LEASES (Details Narrative) Details http://smxpublicltd.com/role/LeasesTables 66 false false R67.htm 995572 - Disclosure - SCHEDULE OF BORROWINGS FROM RELATED PARTIES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails SCHEDULE OF BORROWINGS FROM RELATED PARTIES (Details) Details 67 false false R68.htm 995573 - Disclosure - BORROWINGS FROM RELATED PARTIES (Details Narrative) Sheet http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative BORROWINGS FROM RELATED PARTIES (Details Narrative) Details http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesTables 68 false false R69.htm 995574 - Disclosure - SCHEDULE OF ORDINARY SHARES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetails SCHEDULE OF ORDINARY SHARES (Details) Details 69 false false R70.htm 995575 - Disclosure - BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (Details Narrative) Sheet http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (Details Narrative) Details http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiability 70 false false R71.htm 995576 - Disclosure - SCHEDULE OF SHARE OPTION GRANTED (Details) Sheet http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails SCHEDULE OF SHARE OPTION GRANTED (Details) Details 71 false false R72.htm 995577 - Disclosure - SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING (Details) Sheet http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING (Details) Details 72 false false R73.htm 995578 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE (Details) Sheet http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE (Details) Details 73 false false R74.htm 995579 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details) Details 74 false false R75.htm 995580 - Disclosure - SHAREHOLDERS??? EQUITY (Details Narrative) Sheet http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative SHAREHOLDERS??? EQUITY (Details Narrative) Details http://smxpublicltd.com/role/ShareholdersEquityTables 75 false false R76.htm 995581 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) Sheet http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) Details 76 false false R77.htm 995582 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) (Parenthetical) Sheet http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetailsParenthetical SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) (Parenthetical) Details 77 false false R78.htm 995583 - Disclosure - TAXES ON INCOME (Details Narrative) Sheet http://smxpublicltd.com/role/TaxesOnIncomeDetailsNarrative TAXES ON INCOME (Details Narrative) Details http://smxpublicltd.com/role/TaxesOnIncomeTables 78 false false R79.htm 995584 - Disclosure - SCHEDULE OF LOSS PER SHARE (Details) Sheet http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails SCHEDULE OF LOSS PER SHARE (Details) Details 79 false false R80.htm 995585 - Disclosure - SCHEDULE OF KEY MANAGEMENT PERSONNEL (Details) Sheet http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails SCHEDULE OF KEY MANAGEMENT PERSONNEL (Details) Details 80 false false R81.htm 995586 - Disclosure - SCHEDULE OF BALANCE WITH RELATED PARTIES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails SCHEDULE OF BALANCE WITH RELATED PARTIES (Details) Details 81 false false R82.htm 995587 - Disclosure - SCHEDULE OF GOVERNMENT GRANTS (Details) Sheet http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails SCHEDULE OF GOVERNMENT GRANTS (Details) Details 82 false false R83.htm 995588 - Disclosure - GOVERNMENT GRANTS (Details Narrative) Sheet http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative GOVERNMENT GRANTS (Details Narrative) Details http://smxpublicltd.com/role/GovernmentGrantsTables 83 false false R84.htm 995589 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails SCHEDULE OF ASSETS AND LIABILITIES (Details) Details 84 false false R85.htm 995590 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative) Sheet http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative) Details http://smxpublicltd.com/role/CommitmentsAndContingentLiabilities 85 false false R86.htm 995591 - Disclosure - SCHEDULE OF FOREIGN CURRENCY RISK (Details) Sheet http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails SCHEDULE OF FOREIGN CURRENCY RISK (Details) Details 86 false false R87.htm 995592 - Disclosure - SCHEDULE OF SENSITIVITY ANALYSIS PROFIT AND OTHER EQUITY (Details) Sheet http://smxpublicltd.com/role/ScheduleOfSensitivityAnalysisProfitAndOtherEquityDetails SCHEDULE OF SENSITIVITY ANALYSIS PROFIT AND OTHER EQUITY (Details) Details 87 false false R88.htm 995593 - Disclosure - SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE (Details) Sheet http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE (Details) Details 88 false false R89.htm 995594 - Disclosure - SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES (Details) Details 89 false false R90.htm 995595 - Disclosure - SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY (Details) Sheet http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY (Details) Details 90 false false R91.htm 995596 - Disclosure - SCHEDULE OF ORDINARY SHARES (Details) (Parenthetical) Sheet http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetailsParenthetical SCHEDULE OF ORDINARY SHARES (Details) (Parenthetical) Details 91 false false R92.htm 995597 - Disclosure - SCHEDULE OF COMPANIES SUBSIDIARIES (Details) Sheet http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails SCHEDULE OF COMPANIES SUBSIDIARIES (Details) Details 92 false false R93.htm 995598 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://smxpublicltd.com/role/SubsequentEventsTables 93 false false R94.htm 995599 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical) Sheet http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical) Details 94 false false R95.htm 995600 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) Sheet http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails SCHEDULE OF SHARE CAPITAL (Details) Details 95 false false R96.htm 995601 - Disclosure - SCHEDULE OF RESTRICTED STOCK UNIT (Details) Sheet http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails SCHEDULE OF RESTRICTED STOCK UNIT (Details) Details 96 false false R97.htm 995602 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE (Details) Sheet http://smxpublicltd.com/role/ScheduleOfWeightedAverageLossPerShareDetails SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE (Details) Details 97 false false R98.htm 995603 - Disclosure - MATERIAL EVENTS DURING THE PERIOD (Details Narrative) Sheet http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative MATERIAL EVENTS DURING THE PERIOD (Details Narrative) Details http://smxpublicltd.com/role/MaterialEventsDuringPeriod 98 false false All Reports Book All Reports formf-1.htm smx-20230630.xsd smx-20230630_cal.xml smx-20230630_def.xml smx-20230630_lab.xml smx-20230630_pre.xml fin1_001.jpg fin_001.jpg formf-1_001.jpg formf-1_002.jpg formf-1_003.jpg formf-1_004.jpg http://xbrl.sec.gov/dei/2023 https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full true true JSON 122 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "formf-1.htm": { "nsprefix": "SMX", "nsuri": "http://smxpublicltd.com/20230630", "dts": { "inline": { "local": [ "formf-1.htm" ] }, "schema": { "local": [ "smx-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "smx-20230630_cal.xml" ] }, "definitionLink": { "local": [ "smx-20230630_def.xml" ] }, "labelLink": { "local": [ "smx-20230630_lab.xml" ] }, "presentationLink": { "local": [ "smx-20230630_pre.xml" ] } }, "keyStandard": 262, "keyCustom": 166, "axisStandard": 29, "axisCustom": 0, "memberStandard": 35, "memberCustom": 88, "hidden": { "total": 225, "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 181, "http://smxpublicltd.com/20230630": 40, "http://xbrl.sec.gov/dei/2023": 4 }, "contextCount": 519, "entityCount": 1, "segmentCount": 141, "elementCount": 784, "unitCount": 10, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 1414, "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://smxpublicltd.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R2": { "role": "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "longName": "00000002 - Statement - Interim Condensed Consolidated Statements of Financial Position", "shortName": "Interim Condensed Consolidated Statements of Financial Position", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R3": { "role": "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "longName": "00000003 - Statement - Interim Condensed Consolidated Statements of Comprehensive Loss", "shortName": "Interim Condensed Consolidated Statements of Comprehensive Loss", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:ResearchAndDevelopmentExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:SalesAndMarketingExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R4": { "role": "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity", "longName": "00000004 - Statement - Interim Condensed Consolidated Changes In Shareholders' Equity", "shortName": "Interim Condensed Consolidated Changes In Shareholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "AsOf2019-12-31_ifrs-full_AdditionalPaidinCapitalMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:Equity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2019-12-31_ifrs-full_AdditionalPaidinCapitalMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:Equity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R5": { "role": "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "longName": "00000005 - Statement - Interim Condensed Consolidated Statements of Cash Flows", "shortName": "Interim Condensed Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R6": { "role": "http://smxpublicltd.com/role/General", "longName": "995511 - Disclosure - GENERAL", "shortName": "GENERAL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R7": { "role": "http://smxpublicltd.com/role/SignificantAccountingPolicies", "longName": "995512 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R8": { "role": "http://smxpublicltd.com/role/CriticalAccountingEstimatesAndJudgements", "longName": "995513 - Disclosure - CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS", "shortName": "CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R9": { "role": "http://smxpublicltd.com/role/OtherCurrentAssets", "longName": "995514 - Disclosure - OTHER CURRENT ASSETS", "shortName": "OTHER CURRENT ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R10": { "role": "http://smxpublicltd.com/role/PropertyAndEquipmentNet", "longName": "995515 - Disclosure - PROPERTY AND EQUIPMENT, NET", "shortName": "PROPERTY AND EQUIPMENT, NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R11": { "role": "http://smxpublicltd.com/role/ConvertibleNotes", "longName": "995516 - Disclosure - CONVERTIBLE NOTES", "shortName": "CONVERTIBLE NOTES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R12": { "role": "http://smxpublicltd.com/role/InvestmentsInAssociatedCompanies", "longName": "995517 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES", "shortName": "INVESTMENTS IN ASSOCIATED COMPANIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R13": { "role": "http://smxpublicltd.com/role/IntangibleAssetsNet", "longName": "995518 - Disclosure - INTANGIBLE ASSETS, NET", "shortName": "INTANGIBLE ASSETS, NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R14": { "role": "http://smxpublicltd.com/role/Leases", "longName": "995519 - Disclosure - LEASES", "shortName": "LEASES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfLeasesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R15": { "role": "http://smxpublicltd.com/role/OtherPayables", "longName": "995520 - Disclosure - OTHER PAYABLES", "shortName": "OTHER PAYABLES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R16": { "role": "http://smxpublicltd.com/role/BorrowingsFromRelatedParties", "longName": "995521 - Disclosure - BORROWINGS FROM RELATED PARTIES", "shortName": "BORROWINGS FROM RELATED PARTIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R17": { "role": "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiability", "longName": "995522 - Disclosure - BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY", "shortName": "BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R18": { "role": "http://smxpublicltd.com/role/ShareholdersEquity", "longName": "995523 - Disclosure - SHAREHOLDERS\u2019 EQUITY", "shortName": "SHAREHOLDERS\u2019 EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R19": { "role": "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNet", "longName": "995524 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET", "shortName": "RESEARCH AND DEVELOPMENT EXPENSES, NET", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R20": { "role": "http://smxpublicltd.com/role/GeneralAndAdministrativeExpenses", "longName": "995525 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES", "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R21": { "role": "http://smxpublicltd.com/role/TaxesOnIncome", "longName": "995526 - Disclosure - TAXES ON INCOME", "shortName": "TAXES ON INCOME", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R22": { "role": "http://smxpublicltd.com/role/LossPerShare", "longName": "995527 - Disclosure - LOSS PER SHARE", "shortName": "LOSS PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R23": { "role": "http://smxpublicltd.com/role/RelatedParties", "longName": "995528 - Disclosure - RELATED PARTIES", "shortName": "RELATED PARTIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R24": { "role": "http://smxpublicltd.com/role/GovernmentGrants", "longName": "995529 - Disclosure - GOVERNMENT GRANTS", "shortName": "GOVERNMENT GRANTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R25": { "role": "http://smxpublicltd.com/role/ControlledEntities", "longName": "995530 - Disclosure - CONTROLLED ENTITIES", "shortName": "CONTROLLED ENTITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfControlledEntitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfControlledEntitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R26": { "role": "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilities", "longName": "995531 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES", "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R27": { "role": "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagement", "longName": "995532 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT", "shortName": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R28": { "role": "http://smxpublicltd.com/role/FairValueMeasurement", "longName": "995533 - Disclosure - FAIR VALUE MEASUREMENT", "shortName": "FAIR VALUE MEASUREMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R29": { "role": "http://smxpublicltd.com/role/SubsequentEvents", "longName": "995534 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R30": { "role": "http://smxpublicltd.com/role/MaterialEventsDuringPeriod", "longName": "995535 - Disclosure - MATERIAL EVENTS DURING THE PERIOD", "shortName": "MATERIAL EVENTS DURING THE PERIOD", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfMaterialEventsDuringPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfMaterialEventsDuringPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R31": { "role": "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies", "longName": "995536 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R32": { "role": "http://smxpublicltd.com/role/GeneralTables", "longName": "995537 - Disclosure - GENERAL (Tables)", "shortName": "GENERAL (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R33": { "role": "http://smxpublicltd.com/role/SignificantAccountingPoliciesTables", "longName": "995538 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R34": { "role": "http://smxpublicltd.com/role/OtherCurrentAssetsTables", "longName": "995539 - Disclosure - OTHER CURRENT ASSETS (Tables)", "shortName": "OTHER CURRENT ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R35": { "role": "http://smxpublicltd.com/role/PropertyAndEquipmentNetTables", "longName": "995540 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)", "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R36": { "role": "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesTables", "longName": "995541 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES (Tables)", "shortName": "INVESTMENTS IN ASSOCIATED COMPANIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfInformationAboutConsolidatedStructuredEntitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfInformationAboutConsolidatedStructuredEntitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R37": { "role": "http://smxpublicltd.com/role/IntangibleAssetsNetTables", "longName": "995542 - Disclosure - INTANGIBLE ASSETS, NET (Tables)", "shortName": "INTANGIBLE ASSETS, NET (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R38": { "role": "http://smxpublicltd.com/role/LeasesTables", "longName": "995543 - Disclosure - LEASES (Tables)", "shortName": "LEASES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R39": { "role": "http://smxpublicltd.com/role/OtherPayablesTables", "longName": "995544 - Disclosure - OTHER PAYABLES (Tables)", "shortName": "OTHER PAYABLES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R40": { "role": "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesTables", "longName": "995545 - Disclosure - BORROWINGS FROM RELATED PARTIES (Tables)", "shortName": "BORROWINGS FROM RELATED PARTIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R41": { "role": "http://smxpublicltd.com/role/ShareholdersEquityTables", "longName": "995546 - Disclosure - SHAREHOLDERS\u2019 EQUITY (Tables)", "shortName": "SHAREHOLDERS\u2019 EQUITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R42": { "role": "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNetTables", "longName": "995547 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables)", "shortName": "RESEARCH AND DEVELOPMENT EXPENSES, NET (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R43": { "role": "http://smxpublicltd.com/role/GeneralAndAdministrativeExpensesTables", "longName": "995548 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)", "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R44": { "role": "http://smxpublicltd.com/role/TaxesOnIncomeTables", "longName": "995549 - Disclosure - TAXES ON INCOME (Tables)", "shortName": "TAXES ON INCOME (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R45": { "role": "http://smxpublicltd.com/role/LossPerShareTables", "longName": "995550 - Disclosure - LOSS PER SHARE (Tables)", "shortName": "LOSS PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R46": { "role": "http://smxpublicltd.com/role/RelatedPartiesTables", "longName": "995551 - Disclosure - RELATED PARTIES (Tables)", "shortName": "RELATED PARTIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R47": { "role": "http://smxpublicltd.com/role/GovernmentGrantsTables", "longName": "995552 - Disclosure - GOVERNMENT GRANTS (Tables)", "shortName": "GOVERNMENT GRANTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R48": { "role": "http://smxpublicltd.com/role/ControlledEntitiesTables", "longName": "995553 - Disclosure - CONTROLLED ENTITIES (Tables)", "shortName": "CONTROLLED ENTITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutControlledEntitiesAssetsAndLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfControlledEntitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutControlledEntitiesAssetsAndLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfControlledEntitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R49": { "role": "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables", "longName": "995554 - Disclosure - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables)", "shortName": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "49", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutFinancialInstrumentAndRiskManagementForeignCurrencyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:DisclosureOfDetailedInformationAboutFinancialInstrumentAndRiskManagementForeignCurrencyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R50": { "role": "http://smxpublicltd.com/role/FairValueMeasurementTables", "longName": "995555 - Disclosure - FAIR VALUE MEASUREMENT (Tables)", "shortName": "FAIR VALUE MEASUREMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "50", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R51": { "role": "http://smxpublicltd.com/role/SubsequentEventsTables", "longName": "995556 - Disclosure - SUBSEQUENT EVENTS (Tables)", "shortName": "SUBSEQUENT EVENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "51", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfWeightedAverageLossPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfWeightedAverageLossPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R52": { "role": "http://smxpublicltd.com/role/GeneralDetailsNarrative", "longName": "995557 - Disclosure - GENERAL (Details Narrative)", "shortName": "GENERAL (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "AsOf2023-03-07", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-07-26_ifrs-full_OrdinarySharesMember_custom_SecurityMattersPTYLtdMember", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R53": { "role": "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "longName": "995558 - Disclosure - SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT (Details)", "shortName": "SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_ifrs-full_ComputerEquipmentMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DepreciationRatePropertyPlantAndEquipment", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_ifrs-full_ComputerEquipmentMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DepreciationRatePropertyPlantAndEquipment", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R54": { "role": "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails", "longName": "995559 - Disclosure - SCHEDULE OF OTHER CURRENT ASSETS (Details)", "shortName": "SCHEDULE OF OTHER CURRENT ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:OtherCurrentAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory", "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R55": { "role": "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical", "longName": "995560 - Disclosure - SCHEDULE OF OTHER RECEIVABLES (Details) (Parenthetical)", "shortName": "SCHEDULE OF OTHER RECEIVABLES (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_SpecialPurposeAcquisitionCompanyMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:CurrentPrepaidExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory", "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_SpecialPurposeAcquisitionCompanyMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:CurrentPrepaidExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory", "ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R56": { "role": "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "longName": "995561 - Disclosure - SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "shortName": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R57": { "role": "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "longName": "995562 - Disclosure - CONVERTIBLE NOTES (Details Narrative)", "shortName": "CONVERTIBLE NOTES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:IssueOfConvertibleInstruments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-06-30", "name": "SMX:FairValueOfConvertibleNotes", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R58": { "role": "http://smxpublicltd.com/role/ScheduleOfInformationAboutConsolidatedStructuredEntitiesDetails", "longName": "995563 - Disclosure - SCHEDULE OF INFORMATION ABOUT CONSOLIDATED STRUCTURED ENTITIES (Details)", "shortName": "SCHEDULE OF INFORMATION ABOUT CONSOLIDATED STRUCTURED ENTITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfInformationAboutConsolidatedStructuredEntitiesExplanatory", "SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R59": { "role": "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "longName": "995564 - Disclosure - INVESTMENTS IN ASSOCIATED COMPANIES (Details Narrative)", "shortName": "INVESTMENTS IN ASSOCIATED COMPANIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "From2023-01-012023-01-31", "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "td", "tr", "table", "SMX:DisclosureOfMaterialEventsDuringPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2021-12-232021-12-24_custom_SMXBeveragesPtyLtdMember_custom_SecurityMattersLimitedMember", "name": "SMX:SharesIssuedForExerciseOfStockOptionsShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "SMX:DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R60": { "role": "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails", "longName": "995565 - Disclosure - SUMMARY OF INTANGIBLE ASSETS NET (Details)", "shortName": "SUMMARY OF INTANGIBLE ASSETS NET (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_ifrs-full_CapitalisedDevelopmentExpenditureMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R61": { "role": "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "longName": "995566 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)", "shortName": "INTANGIBLE ASSETS, NET (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_ifrs-full_OtherIntangibleAssetsMember_custom_SMXBeveragesPtyLtdMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:IntangibleAssetsUnderDevelopment", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R62": { "role": "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails", "longName": "995567 - Disclosure - SCHEDULE OF RIGHT OF USE ASSETS (Details)", "shortName": "SCHEDULE OF RIGHT OF USE ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "AsOf2021-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:RightofuseAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:AdditionsToRightofuseAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R63": { "role": "http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails", "longName": "995568 - Disclosure - SCHEDULE OF LEASE LIABILITY (Details)", "shortName": "SCHEDULE OF LEASE LIABILITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:AdditionsOfLeaseLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R64": { "role": "http://smxpublicltd.com/role/ScheduleOfCarryingAmountsOfLeaseLiabilitiesRecognizedInProfitOrLossDetails", "longName": "995569 - Disclosure - SCHEDULE OF CARRYING AMOUNTS OF LEASE LIABILITIES RECOGNIZED IN PROFIT OR LOSS (Details)", "shortName": "SCHEDULE OF CARRYING AMOUNTS OF LEASE LIABILITIES RECOGNIZED IN PROFIT OR LOSS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DepreciationRightofuseAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:InterestExpenseOnLeaseLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R65": { "role": "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails", "longName": "995570 - Disclosure - SCHEDULE OF OTHER PAYABLES (Details)", "shortName": "SCHEDULE OF OTHER PAYABLES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:OtherCurrentPayables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:ShorttermEmployeeBenefitsAccruals", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R66": { "role": "http://smxpublicltd.com/role/LeasesDetailsNarrative", "longName": "995571 - Disclosure - LEASES (Details Narrative)", "shortName": "LEASES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_ifrs-full_OfficeEquipmentMember_custom_SecurityMattersLimitedMember", "name": "SMX:LeaseExpiration", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_ifrs-full_OfficeEquipmentMember_custom_SecurityMattersLimitedMember", "name": "SMX:LeaseExpiration", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfLeasesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R67": { "role": "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails", "longName": "995572 - Disclosure - SCHEDULE OF BORROWINGS FROM RELATED PARTIES (Details)", "shortName": "SCHEDULE OF BORROWINGS FROM RELATED PARTIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:ShorttermBorrowings", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R68": { "role": "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "longName": "995573 - Disclosure - BORROWINGS FROM RELATED PARTIES (Details Narrative)", "shortName": "BORROWINGS FROM RELATED PARTIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:ShorttermBorrowings", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2015-01-012015-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:CashAdvancesAndLoansFromRelatedParties", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R69": { "role": "http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetails", "longName": "995574 - Disclosure - SCHEDULE OF ORDINARY SHARES (Details)", "shortName": "SCHEDULE OF ORDINARY SHARES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:NumberOfSharesAuthorised", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_DeferredSharesMember", "name": "ifrs-full:NumberOfSharesAuthorised", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R70": { "role": "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "longName": "995575 - Disclosure - BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (Details Narrative)", "shortName": "BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "From2023-01-012023-01-31", "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "td", "tr", "table", "SMX:DisclosureOfMaterialEventsDuringPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_ThreeValuationModelsMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R71": { "role": "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails", "longName": "995576 - Disclosure - SCHEDULE OF SHARE OPTION GRANTED (Details)", "shortName": "SCHEDULE OF SHARE OPTION GRANTED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R72": { "role": "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "longName": "995577 - Disclosure - SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING (Details)", "shortName": "SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-06-30_custom_OptionsOutstandingOneMember", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R73": { "role": "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails", "longName": "995578 - Disclosure - SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE (Details)", "shortName": "SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:AdjustmentsForSharebasedPayments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember_custom_ResearchAndDevelopmentExpensesMember", "name": "ifrs-full:EmployeeBenefitsExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory", "ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R74": { "role": "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "longName": "995579 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)", "shortName": "SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:GeneralAndAdministrativeExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-06-30_custom_GeneralAndAdministrativeExpensesMember", "name": "SMX:TransactionCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory", "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R75": { "role": "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "longName": "995580 - Disclosure - SHAREHOLDERS\u2019 EQUITY (Details Narrative)", "shortName": "SHAREHOLDERS\u2019 EQUITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:ParValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-03-07", "name": "ifrs-full:NotesAndDebenturesIssued", "unitRef": "AUD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R76": { "role": "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails", "longName": "995581 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details)", "shortName": "SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:ProfitLossBeforeTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:TaxExpenseIncomeAtApplicableTaxRate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R77": { "role": "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetailsParenthetical", "longName": "995582 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) (Parenthetical)", "shortName": "SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:ApplicableTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": null }, "R78": { "role": "http://smxpublicltd.com/role/TaxesOnIncomeDetailsNarrative", "longName": "995583 - Disclosure - TAXES ON INCOME (Details Narrative)", "shortName": "TAXES ON INCOME (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:ApplicableTaxRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:TaxEffectOfTaxLosses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R79": { "role": "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails", "longName": "995584 - Disclosure - SCHEDULE OF LOSS PER SHARE (Details)", "shortName": "SCHEDULE OF LOSS PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:WeightedAverageShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R80": { "role": "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails", "longName": "995585 - Disclosure - SCHEDULE OF KEY MANAGEMENT PERSONNEL (Details)", "shortName": "SCHEDULE OF KEY MANAGEMENT PERSONNEL (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:KeyManagementIssuanceOfOptionsToRelatedParty", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:KeyManagementIssuanceOfOptionsToRelatedParty", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R81": { "role": "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "longName": "995586 - Disclosure - SCHEDULE OF BALANCE WITH RELATED PARTIES (Details)", "shortName": "SCHEDULE OF BALANCE WITH RELATED PARTIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:OtherPayables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory", "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_ifrs-full_KeyManagementPersonnelOfEntityOrParentMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:AmountsPayableRelatedPartyTransactions", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutBalanceWithRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R82": { "role": "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails", "longName": "995587 - Disclosure - SCHEDULE OF GOVERNMENT GRANTS (Details)", "shortName": "SCHEDULE OF GOVERNMENT GRANTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:CurrentGovernmentGrants", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory", "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:CurrentGovernmentGrants", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory", "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R83": { "role": "http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative", "longName": "995588 - Disclosure - GOVERNMENT GRANTS (Details Narrative)", "shortName": "GOVERNMENT GRANTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "From2021-01-012021-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:ProceedsFromGovernmentGrantsReceived", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2021-01-012021-12-31_custom_SecurityMattersLimitedMember", "name": "SMX:ProceedsFromGovernmentGrantsReceived", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfGovernmentGrantsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R84": { "role": "http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails", "longName": "995589 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES (Details)", "shortName": "SCHEDULE OF ASSETS AND LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLtdMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:CountryOfIncorporation", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutControlledEntitiesAssetsAndLiabilitiesExplanatory", "SMX:DisclosureOfControlledEntitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_SecurityMattersLtdMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:CountryOfIncorporation", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutControlledEntitiesAssetsAndLiabilitiesExplanatory", "SMX:DisclosureOfControlledEntitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R85": { "role": "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "longName": "995590 - Disclosure - COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)", "shortName": "COMMITMENTS AND CONTINGENT LIABILITIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "AsOf2023-01-31", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "td", "tr", "table", "SMX:DisclosureOfMaterialEventsDuringPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2015-01-31_custom_SecurityMattersLimitedMember", "name": "SMX:PercentageOfRoyalty", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R86": { "role": "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails", "longName": "995591 - Disclosure - SCHEDULE OF FOREIGN CURRENCY RISK (Details)", "shortName": "SCHEDULE OF FOREIGN CURRENCY RISK (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:Assets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_ifrs-full_CurrencyRiskMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:Assets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutFinancialInstrumentAndRiskManagementForeignCurrencyExplanatory", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R87": { "role": "http://smxpublicltd.com/role/ScheduleOfSensitivityAnalysisProfitAndOtherEquityDetails", "longName": "995592 - Disclosure - SCHEDULE OF SENSITIVITY ANALYSIS PROFIT AND OTHER EQUITY (Details)", "shortName": "SCHEDULE OF SENSITIVITY ANALYSIS PROFIT AND OTHER EQUITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:AssetsLessCurrentLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutSensitivityAnalysisProfitAndOtherEquityExplanatory", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:AssetsLessCurrentLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutSensitivityAnalysisProfitAndOtherEquityExplanatory", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R88": { "role": "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "longName": "995593 - Disclosure - SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE (Details)", "shortName": "SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_SecurityMattersLimitedMember_ifrs-full_CreditRiskMember", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfCreditRiskExposureExplanatory", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R89": { "role": "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails", "longName": "995594 - Disclosure - SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES (Details)", "shortName": "SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "AsOf2022-12-31_ifrs-full_NotLaterThanOneYearMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:FinancialLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_ifrs-full_NotLaterThanOneYearMember_custom_SecurityMattersLimitedMember", "name": "ifrs-full:FinancialLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "SMX:DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R90": { "role": "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails", "longName": "995595 - Disclosure - SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY (Details)", "shortName": "SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DerivativeFinancialLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_custom_SecurityMattersLimitedMember", "name": "ifrs-full:DerivativeFinancialLiabilities", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "ifrs-full:DisclosureOfFairValueMeasurementExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R91": { "role": "http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetailsParenthetical", "longName": "995596 - Disclosure - SCHEDULE OF ORDINARY SHARES (Details) (Parenthetical)", "shortName": "SCHEDULE OF ORDINARY SHARES (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:ParValuePerShare", "unitRef": "EuroPerShare", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": null }, "R92": { "role": "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails", "longName": "995597 - Disclosure - SCHEDULE OF COMPANIES SUBSIDIARIES (Details)", "shortName": "SCHEDULE OF COMPANIES SUBSIDIARIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "From2023-01-012023-06-30_custom_SecurityMattersPTYLtdMember", "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-06-30_custom_SecurityMattersPTYLtdMember", "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true, "unique": true } }, "R93": { "role": "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative", "longName": "995598 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "AsOf2023-03-07", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:FairValueBasedOnQuotedOpeningSharePrice", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "SMX:DescriptionOfAccountingPolicyForReverseAcquisitionTransactionExplanatory", "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R94": { "role": "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical", "longName": "995599 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical)", "shortName": "SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:ParValuePerShare", "unitRef": "EuroPerShare", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-06-30_ifrs-full_PreferenceSharesMember", "name": "ifrs-full:ParValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R95": { "role": "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "longName": "995600 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details)", "shortName": "SCHEDULE OF SHARE CAPITAL (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:NumberOfSharesAuthorised", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-06-30_ifrs-full_OrdinarySharesMember", "name": "SMX:NumberOfSharesIssuedAndOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R96": { "role": "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "longName": "995601 - Disclosure - SCHEDULE OF RESTRICTED STOCK UNIT (Details)", "shortName": "SCHEDULE OF RESTRICTED STOCK UNIT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "From2023-01-012023-06-30_custom_EmployeesDirectorsAndServiceMember_ifrs-full_RestrictedShareUnitsMember", "name": "ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-06-30_ifrs-full_RestrictedShareUnitsMember_custom_EmployeesDirectorsAndServiceMember", "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfRestrictedStockUnitExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R97": { "role": "http://smxpublicltd.com/role/ScheduleOfWeightedAverageLossPerShareDetails", "longName": "995602 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE (Details)", "shortName": "SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-06-30_ifrs-full_OrdinarySharesMember", "name": "ifrs-full:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfWeightedAverageLossPerShareExplanatory", "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } }, "R98": { "role": "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "longName": "995603 - Disclosure - MATERIAL EVENTS DURING THE PERIOD (Details Narrative)", "shortName": "MATERIAL EVENTS DURING THE PERIOD (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:ParValuePerShare", "unitRef": "EuroPerShare", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-07-27", "name": "SMX:FloorPricePricePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "SMX:DisclosureOfMaterialEventsDuringPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "formf-1.htm", "unique": true } } }, "tag": { "ifrs-full_AccrualsClassifiedAsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccrualsClassifiedAsCurrent", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails": { "parentTag": "ifrs-full_OtherCurrentPayables", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued expenses" } }, "en": { "role": { "documentation": "The amount of accruals classified as current. [Refer: Accruals]" } } }, "auth_ref": [ "r360" ] }, "SMX_AccumulatedDepreciationAmortisationMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "AccumulatedDepreciationAmortisationMember", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Depreciation Amortisation [Member]", "documentation": "Accumulated Depreciation Amortisation [Member]" } } }, "auth_ref": [] }, "SMX_AccumulatedDepreciationMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "AccumulatedDepreciationMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated Depreciation [Member]", "documentation": "Accumulated Depreciation [Member]" } } }, "auth_ref": [] }, "SMX_AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Accumulated amortization, beginning balance", "periodEndLabel": "Accumulated amortization, ending balance", "documentation": "Accumulated depreciation of intangible assets other than goodwill.", "label": "AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill" } } }, "auth_ref": [] }, "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consideration transferred, acquisition-date fair value" } }, "en": { "role": { "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r170" ] }, "ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination" } }, "en": { "role": { "documentation": "The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r171" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r309" ] }, "SMX_AdditionalPaidInCapitalinFunding": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "AdditionalPaidInCapitalinFunding", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Additional capital raising", "documentation": "Additional paid in capital in funding." } } }, "auth_ref": [] }, "ifrs-full_AdditionalPaidinCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionalPaidinCapitalMember", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital [member]" } }, "en": { "role": { "documentation": "This member stands for amounts received from issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r354" ] }, "SMX_AdditionsOfLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "AdditionsOfLeaseLiabilities", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Additions", "documentation": "Additions of lease liabilities.", "label": "AdditionsOfLeaseLiabilities" } } }, "auth_ref": [] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Capitalized development cost" } }, "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r78" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Additions" } }, "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } } }, "auth_ref": [ "r43" ] }, "ifrs-full_AdditionsToRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsToRightofuseAssets", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Additions", "label": "Additions to right-of-use assets" } }, "en": { "role": { "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r138" ] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AddressTypeDomain", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "SMX_AddtionalEquityFundOfConvertiblePercent": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "AddtionalEquityFundOfConvertiblePercent", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible percentage", "documentation": "Addtional equity fund of convertible percent." } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r315" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r315" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r315" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r315" ] }, "ifrs-full_AdjustedWeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustedWeightedAverageShares", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails", "http://smxpublicltd.com/role/ScheduleOfWeightedAverageLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares used in calculating diluted loss per share" } }, "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r74" ] }, "SMX_AdjustmentsForDecreaseIncreaseInIncreaseInOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "AdjustmentsForDecreaseIncreaseInIncreaseInOtherCurrentAssets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase in other current assets", "documentation": "Increase in other current assets." } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in other receivables" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r368" ] }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDepreciationAndAmortisationExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization" } }, "en": { "role": { "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]" } } }, "auth_ref": [ "r369" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Revaluation of financial liabilities at fair value" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in derivative financial liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Derivative financial liabilities; Profit (loss)]" } } }, "auth_ref": [ "r370" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInOtherLiabilities", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Decrease in other liabilities" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in other liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other liabilities; Profit (loss)]" } } }, "auth_ref": [ "r370" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInOtherOperatingPayables", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase in other payables" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in other operating payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r368" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase in trade payables" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]" } } }, "auth_ref": [ "r370" ] }, "SMX_AdjustmentsForInterestOnLeases": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "AdjustmentsForInterestOnLeases", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest on leases", "documentation": "Adjustments for interest on leases.", "label": "Adjustments for interest on leases" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForProvisions", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Decrease in provision" } }, "en": { "role": { "documentation": "Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]" } } }, "auth_ref": [ "r369" ] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation", "label": "Share based compensation" } }, "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r369" ] }, "SMX_AdvancePaymentForEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "AdvancePaymentForEquity", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Advance payment for equity, net (see Note 5.1)", "documentation": "Advance payment for equity." } } }, "auth_ref": [] }, "ifrs-full_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdvertisingExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Advertising, Public and Investors Relations" } }, "en": { "role": { "documentation": "The amount of expense arising from advertising." } } }, "auth_ref": [ "r355" ] }, "ifrs-full_AggregatedMeasurementMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AggregatedMeasurementMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used." } } }, "auth_ref": [ "r85", "r89", "r124" ] }, "ifrs-full_AggregatedTimeBandsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AggregatedTimeBandsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } } }, "auth_ref": [ "r16", "r131", "r141", "r142", "r145", "r146", "r148", "r154", "r179", "r225", "r254", "r256" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r279", "r291", "r301", "r326" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r282", "r294", "r304", "r329" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r315" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r322" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r286", "r295", "r305", "r322", "r330", "r334", "r342" ] }, "ifrs-full_AllLevelsOfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AllLevelsOfFairValueHierarchyMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "auth_ref": [ "r50", "r125" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "auth_ref": [ "r340" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Amortization", "verboseLabel": "Amortisation, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r79" ] }, "SMX_AmountOfFinancialImpactOfFinancialInstrument": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "AmountOfFinancialImpactOfFinancialInstrument", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfSensitivityAnalysisProfitAndOtherEquityDetails" ], "lang": { "en-us": { "role": { "label": "Amount of financial impact of financial instrument", "documentation": "Amount of financial impact of financial instrument." } } }, "auth_ref": [] }, "ifrs-full_AmountsPayableRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmountsPayableRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Salary and related", "label": "Amounts payable, related party transactions" } }, "en": { "role": { "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r58", "r62" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r287" ] }, "ifrs-full_AntidilutiveInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AntidilutiveInstrumentsMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for antidilutive instruments. Instruments are antidilutive when their conversion to ordinary shares would increase earnings per share or decrease loss per share from continuing operations. The calculation of diluted earnings per share does not assume conversion, exercise, or other issue of potential ordinary shares that would have an antidilutive effect on earnings per share. It also represents the standard value for the \u2018Types of antidilutive instruments' axis if no other member is used." } } }, "auth_ref": [ "r75" ] }, "ifrs-full_ApplicableTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ApplicableTaxRate", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetailsParenthetical", "http://smxpublicltd.com/role/TaxesOnIncomeDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Applicable tax rate" } }, "en": { "role": { "documentation": "The applicable income tax rate." } } }, "auth_ref": [ "r39" ] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r14", "r124", "r125", "r126", "r198", "r201" ] }, "ifrs-full_AssetsLessCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AssetsLessCurrentLiabilities", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfSensitivityAnalysisProfitAndOtherEquityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Assets", "label": "Assets less current liabilities" } }, "en": { "role": { "documentation": "The amount of assets less the amount of current liabilities." } } }, "auth_ref": [ "r357" ] }, "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Attribution of expenses by nature to their function [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r352", "r355" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r287" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price" } } }, "auth_ref": [ "r337" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r338" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r333" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r333" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r333" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r333" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r333" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r333" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]" } } }, "auth_ref": [] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r336" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r335" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r334" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r334" ] }, "SMX_BalanceWithRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "BalanceWithRelatedParties", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Total", "documentation": "Balance with related parties." } } }, "auth_ref": [] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails", "http://smxpublicltd.com/role/ScheduleOfWeightedAverageLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Basic loss per share attributable to shareholders", "verboseLabel": "Basic loss per share" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r72", "r73" ] }, "ifrs-full_BasicEarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BasicEarningsPerShareAbstract", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Loss per share attributable to shareholders" } } }, "auth_ref": [] }, "SMX_BenchmarkInvestmentsLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "BenchmarkInvestmentsLLCMember", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Benchmark investments LLC [member]", "documentation": "Benchmark investments LLC [member]" } } }, "auth_ref": [] }, "SMX_BlackAndScholesModelMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "BlackAndScholesModelMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Black and scholes model [member]", "documentation": "Black and scholes model [member]" } } }, "auth_ref": [] }, "SMX_BlackScholesPricingModelMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "BlackScholesPricingModelMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Black scholes pricing model [member]", "documentation": "Black scholes pricing model [member]" } } }, "auth_ref": [] }, "SMX_BoardMembersMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "BoardMembersMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Board members [member]", "documentation": "Board members [member]" } } }, "auth_ref": [] }, "SMX_BonusPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "BonusPayments", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bonus payments", "documentation": "Bonus payments." } } }, "auth_ref": [] }, "SMX_BonusWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "BonusWarrantsMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bonus warrants [member]", "documentation": "Bonus warrants [member]" } } }, "auth_ref": [] }, "ifrs-full_BorrowingCostsIncurred": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingCostsIncurred", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan borrowing" } }, "en": { "role": { "documentation": "The amount of interest and other costs that an entity incurs in connection with the borrowing of funds." } } }, "auth_ref": [ "r355" ] }, "SMX_BorrowingMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "BorrowingMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Borrowing [member]", "documentation": "Borrowing [member]" } } }, "auth_ref": [] }, "ifrs-full_BorrowingsByNameAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameAxis", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r372" ] }, "ifrs-full_BorrowingsByNameMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } } }, "auth_ref": [ "r372" ] }, "ifrs-full_BorrowingsInterestRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsInterestRate", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest rate", "verboseLabel": "Borrowings, interest rate" } }, "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r372" ] }, "ifrs-full_BorrowingsMaturity": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsMaturity", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maturity date", "verboseLabel": "Borrowings maturity", "terseLabel": "Loans maturity date" } }, "en": { "role": { "documentation": "The maturity of borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r372" ] }, "ifrs-full_BottomOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BottomOfRangeMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bottom of range [member]" } }, "en": { "role": { "documentation": "This member stands for the bottom of a range." } } }, "auth_ref": [ "r129", "r148", "r164", "r239", "r241", "r372" ] }, "SMX_BridgeLoanAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "BridgeLoanAgreementsMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bridge loan agreements [member]", "documentation": "Bridge loan agreements [member]" } } }, "auth_ref": [] }, "SMX_BridgeLoansAndDerivativeFinancialLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "BridgeLoansAndDerivativeFinancialLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Bridge loans and derivative financial liabilities", "documentation": "Bridge loans and derivative financial liabilities current." } } }, "auth_ref": [] }, "SMX_BridgeLoansAndDerivativeFinancialLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "BridgeLoansAndDerivativeFinancialLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "verboseLabel": "Bridge loans and derivative financial liabilities", "documentation": "Bridge loans and derivative financial liabilities noncurrent.", "label": "Bridge loans and derivative financial liabilities noncurrent" } } }, "auth_ref": [] }, "SMX_BridgeLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "BridgeLoansMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bridge loans [member]", "documentation": "Bridge loans [member]" } } }, "auth_ref": [] }, "SMX_BusinessCombinationAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "BusinessCombinationAgreementMember", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Combination Agreement [Member]", "documentation": "Business Combination Agreement [Member]" } } }, "auth_ref": [] }, "ifrs-full_BusinessCombinationsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BusinessCombinationsAxis", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business combinations [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r173" ] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "BusinessContactMember", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r274", "r287" ] }, "SMX_CapitalRaiseFee": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "CapitalRaiseFee", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Capital raise fee", "documentation": "Capital raise fee." } } }, "auth_ref": [] }, "ifrs-full_CapitalisedDevelopmentExpenditureMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CapitalisedDevelopmentExpenditureMember", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Capitalised development expenditure [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets arising from development expenditure capitalised before the start of commercial production or use. An intangible asset shall only be recognised if the entity can demonstrate all of the following: (a) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (b) its intention to complete the intangible asset and use or sell it; (c) its ability to use or sell the intangible asset; (d) how the intangible asset will generate probable future economic benefits. Among other things, the entity can demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset; (e) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (f) its ability to measure reliably the expenditure attributable to the intangible asset during its development." } } }, "auth_ref": [ "r366" ] }, "SMX_CapitalizedDevelopmentCostClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "CapitalizedDevelopmentCostClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Capitalized development cost", "documentation": "Capitalized development cost classified as investing activities.", "label": "Capitalized development cost classified as investing activities" } } }, "auth_ref": [] }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r42", "r46", "r77", "r81", "r86", "r87", "r88", "r89", "r90", "r174", "r183", "r184" ] }, "ifrs-full_CarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r46", "r81", "r86", "r88", "r89", "r174", "r183", "r184" ] }, "ifrs-full_CashAdvancesAndLoansFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAdvancesAndLoansFromRelatedParties", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash advances and loans from related parties" } }, "en": { "role": { "documentation": "The cash inflow from advances and loans from related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r367" ] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 }, "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r12", "r96", "r117" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flow from financing activities", "label": "Cash flows from (used in) financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } } }, "auth_ref": [ "r91", "r98" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flow used in investing activities", "label": "Cash flows from (used in) investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } } }, "auth_ref": [ "r91", "r98" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flow used in operating activities", "label": "Cash flows from (used in) operating activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } } }, "auth_ref": [ "r91", "r98" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "ifrs-full_CashRepaymentsOfAdvancesAndLoansFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashRepaymentsOfAdvancesAndLoansFromRelatedParties", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments of borrowings to related parties", "negatedTerseLabel": "Payment of borrowings", "label": "Cash repayments of advances and loans from related parties" } }, "en": { "role": { "documentation": "The cash outflow for repayments of advances and loans from related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r367" ] }, "ifrs-full_CategoriesOfFinancialAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfFinancialAssetsAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfInformationAboutConsolidatedStructuredEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Categories of financial assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r190" ] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r61" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r313" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfFinancialLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialLiabilitiesAxis", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of financial liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r187", "r188", "r208", "r209" ] }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Classes of intangible assets other than goodwill [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r82" ] }, "ifrs-full_ClassesOfLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfLiabilitiesAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Classes of liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r127" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "presentation": [ "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r47" ] }, "ifrs-full_ClassesOfShareCapitalAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalAxis", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfWeightedAverageLossPerShareDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of share capital [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r24" ] }, "ifrs-full_ClassesOfShareCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfWeightedAverageLossPerShareDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } } }, "auth_ref": [ "r24" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r314" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r314" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r319" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r318" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r320" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r317" ] }, "SMX_CompanysShareInNetProfitsLossesOfAssociatedCompaniesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "CompanysShareInNetProfitsLossesOfAssociatedCompaniesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfInformationAboutConsolidatedStructuredEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Company's share in net profits (losses) of associated companies [member]", "documentation": "Company's share in net profits (losses) of associated companies [member]" } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Items that will or may be reclassified to profit or loss:" } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Items that will be reclassified to profit or loss:" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive loss", "negatedTotalLabel": "Total comprehensive loss", "label": "Total comprehensive loss for the period" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r2", "r28", "r103", "r105", "r114", "r237" ] }, "ifrs-full_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComputerEquipmentMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Computer equipment [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r363" ] }, "ifrs-full_ConsiderationPaidReceived": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ConsiderationPaidReceived", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consideration paid (received)" } }, "en": { "role": { "documentation": "The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r95" ] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedParties", "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesTables", "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiability", "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilities", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ControlledEntities", "http://smxpublicltd.com/role/ControlledEntitiesTables", "http://smxpublicltd.com/role/ConvertibleNotes", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/CriticalAccountingEstimatesAndJudgements", "http://smxpublicltd.com/role/FairValueMeasurement", "http://smxpublicltd.com/role/FairValueMeasurementTables", "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagement", "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables", "http://smxpublicltd.com/role/General", "http://smxpublicltd.com/role/GeneralAndAdministrativeExpenses", "http://smxpublicltd.com/role/GeneralAndAdministrativeExpensesTables", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/GeneralTables", "http://smxpublicltd.com/role/GovernmentGrants", "http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative", "http://smxpublicltd.com/role/GovernmentGrantsTables", "http://smxpublicltd.com/role/IntangibleAssetsNet", "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/IntangibleAssetsNetTables", "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompanies", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesTables", "http://smxpublicltd.com/role/Leases", "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/LeasesTables", "http://smxpublicltd.com/role/LossPerShare", "http://smxpublicltd.com/role/LossPerShareTables", "http://smxpublicltd.com/role/OtherCurrentAssets", "http://smxpublicltd.com/role/OtherCurrentAssetsTables", "http://smxpublicltd.com/role/OtherPayables", "http://smxpublicltd.com/role/OtherPayablesTables", "http://smxpublicltd.com/role/PropertyAndEquipmentNet", "http://smxpublicltd.com/role/PropertyAndEquipmentNetTables", "http://smxpublicltd.com/role/RelatedParties", "http://smxpublicltd.com/role/RelatedPartiesTables", "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNet", "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNetTables", "http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfCarryingAmountsOfLeaseLiabilitiesRecognizedInProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails", "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails", "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails", "http://smxpublicltd.com/role/ScheduleOfInformationAboutConsolidatedStructuredEntitiesDetails", "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails", "http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails", "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails", "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetails", "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails", "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails", "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails", "http://smxpublicltd.com/role/ScheduleOfSensitivityAnalysisProfitAndOtherEquityDetails", "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails", "http://smxpublicltd.com/role/ShareholdersEquity", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityTables", "http://smxpublicltd.com/role/SignificantAccountingPolicies", "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies", "http://smxpublicltd.com/role/SignificantAccountingPoliciesTables", "http://smxpublicltd.com/role/SubsequentEvents", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsTables", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails", "http://smxpublicltd.com/role/TaxesOnIncome", "http://smxpublicltd.com/role/TaxesOnIncomeDetailsNarrative", "http://smxpublicltd.com/role/TaxesOnIncomeTables" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedParties", "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesTables", "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiability", "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilities", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ControlledEntities", "http://smxpublicltd.com/role/ControlledEntitiesTables", "http://smxpublicltd.com/role/ConvertibleNotes", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/CriticalAccountingEstimatesAndJudgements", "http://smxpublicltd.com/role/FairValueMeasurement", "http://smxpublicltd.com/role/FairValueMeasurementTables", "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagement", "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables", "http://smxpublicltd.com/role/General", "http://smxpublicltd.com/role/GeneralAndAdministrativeExpenses", "http://smxpublicltd.com/role/GeneralAndAdministrativeExpensesTables", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/GeneralTables", "http://smxpublicltd.com/role/GovernmentGrants", "http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative", "http://smxpublicltd.com/role/GovernmentGrantsTables", "http://smxpublicltd.com/role/IntangibleAssetsNet", "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/IntangibleAssetsNetTables", "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompanies", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesTables", "http://smxpublicltd.com/role/Leases", "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/LeasesTables", "http://smxpublicltd.com/role/LossPerShare", "http://smxpublicltd.com/role/LossPerShareTables", "http://smxpublicltd.com/role/OtherCurrentAssets", "http://smxpublicltd.com/role/OtherCurrentAssetsTables", "http://smxpublicltd.com/role/OtherPayables", "http://smxpublicltd.com/role/OtherPayablesTables", "http://smxpublicltd.com/role/PropertyAndEquipmentNet", "http://smxpublicltd.com/role/PropertyAndEquipmentNetTables", "http://smxpublicltd.com/role/RelatedParties", "http://smxpublicltd.com/role/RelatedPartiesTables", "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNet", "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNetTables", "http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfCarryingAmountsOfLeaseLiabilitiesRecognizedInProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails", "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails", "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails", "http://smxpublicltd.com/role/ScheduleOfInformationAboutConsolidatedStructuredEntitiesDetails", "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails", "http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails", "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails", "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetails", "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails", "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails", "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails", "http://smxpublicltd.com/role/ScheduleOfSensitivityAnalysisProfitAndOtherEquityDetails", "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails", "http://smxpublicltd.com/role/ShareholdersEquity", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityTables", "http://smxpublicltd.com/role/SignificantAccountingPolicies", "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies", "http://smxpublicltd.com/role/SignificantAccountingPoliciesTables", "http://smxpublicltd.com/role/SubsequentEvents", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsTables", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails", "http://smxpublicltd.com/role/TaxesOnIncome", "http://smxpublicltd.com/role/TaxesOnIncomeDetailsNarrative", "http://smxpublicltd.com/role/TaxesOnIncomeTables" ], "auth_ref": [] }, "SMX_ConsultantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConsultantsMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consultants [member]", "documentation": "Consultants [member]" } } }, "auth_ref": [] }, "SMX_ConsultingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConsultingAgreementMember", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consulting agreement [member]", "documentation": "Consulting agreement [member]" } } }, "auth_ref": [] }, "SMX_ConsultingFees": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConsultingFees", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consulting fees", "documentation": "Consulting fees." } } }, "auth_ref": [] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContactPersonnelName", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "SMX_ContingentOfConsiderationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ContingentOfConsiderationPercentage", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consideration percentage", "documentation": "Contingent of consideration percentage." } } }, "auth_ref": [] }, "SMX_ConversionOfBridgeLoansAndDerivativeFinancialLiabilityToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConversionOfBridgeLoansAndDerivativeFinancialLiabilityToOrdinaryShares", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of bridge loans and derivative financial liability to ordinary shares", "documentation": "Conversion of bridge loans and derivative financial liability to ordinary shares." } } }, "auth_ref": [] }, "SMX_ConversionOfConvertibleNotesToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConversionOfConvertibleNotesToOrdinaryShares", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of convertible notes to ordinary shares", "documentation": "Conversion of convertible notes to ordinary shares." } } }, "auth_ref": [] }, "SMX_ConversionOfLiabilityToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConversionOfLiabilityToOrdinaryShares", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of liability to ordinary shares (see Note 5.1)", "documentation": "Conversion of liability to ordinary shares." } } }, "auth_ref": [] }, "SMX_ConversionOfWarrantsToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConversionOfWarrantsToOrdinaryShares", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of warrants A to ordinary shares, net (See note 5.2)", "verboseLabel": "Conversion of warrants to ordinary shares (see note 5.2)", "documentation": "Conversion of warrants to ordinary shares." } } }, "auth_ref": [] }, "SMX_ConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConversionPrice", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion price", "documentation": "Conversion price." } } }, "auth_ref": [] }, "SMX_ConvertibleNote": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConvertibleNote", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Convertible notes", "verboseLabel": "Convertible note", "documentation": "Convertible note." } } }, "auth_ref": [] }, "SMX_ConvertibleNoteAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConvertibleNoteAgreementsMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible Note Agreements [Member]", "documentation": "Convertible Note Agreements [Member]" } } }, "auth_ref": [] }, "SMX_ConvertibleNoteConversionPriceDescription": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConvertibleNoteConversionPriceDescription", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible note conversion price description", "documentation": "Convertible note conversion price description." } } }, "auth_ref": [] }, "SMX_ConvertibleNotesAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConvertibleNotesAgreementsMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible Notes Agreements [Member]", "documentation": "Convertible Notes Agreements [Member]" } } }, "auth_ref": [] }, "SMX_ConvertibleNotesConveredIntoOrdinaryShares": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConvertibleNotesConveredIntoOrdinaryShares", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible notes convered into ordinary shares", "documentation": "Convertible notes convered into ordinary shares." } } }, "auth_ref": [] }, "SMX_ConvertibleNotesMaturityPeriod": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConvertibleNotesMaturityPeriod", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible notes maturity period", "documentation": "Convertible notes maturity period." } } }, "auth_ref": [] }, "SMX_ConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ConvertibleNotesMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible notes [member]", "documentation": "Convertible notes [member]" } } }, "auth_ref": [] }, "ifrs-full_CostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CostOfSales", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Cost of sales" } }, "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } } }, "auth_ref": [ "r0", "r34" ] }, "ifrs-full_CounterpartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CounterpartiesAxis", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Counterparties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r191" ] }, "ifrs-full_CounterpartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CounterpartiesMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used." } } }, "auth_ref": [ "r191" ] }, "ifrs-full_CountryOfIncorporation": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CountryOfIncorporation", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Country of incorporation" } }, "en": { "role": { "documentation": "The country in which the entity is incorporated." } } }, "auth_ref": [ "r7" ] }, "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CountryOfIncorporationOrResidenceOfSubsidiary", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Country of Incorporation" } }, "en": { "role": { "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r66", "r69", "r106", "r107" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "ifrs-full_CreationDateAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CreationDateAxis", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Creation date [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r99", "r100", "r101" ] }, "ifrs-full_CreditRiskMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CreditRiskMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails" ], "lang": { "en-us": { "role": { "label": "Credit risk [member]" } }, "en": { "role": { "documentation": "This member stands for the risk that one party to a financial instrument will cause a financial loss for the other party by failing to discharge an obligation. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r149", "r150", "r151", "r250" ] }, "ifrs-full_CurrencyRiskMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrencyRiskMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Currency risk [member]" } }, "en": { "role": { "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r149", "r150", "r151", "r152", "r192" ] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 }, "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Current assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r17", "r110", "r237" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "auth_ref": [] }, "ifrs-full_CurrentDerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentDerivativeFinancialLiabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails": { "parentTag": "ifrs-full_OtherCurrentPayables", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Derivative financial liability (Note 13)" } }, "en": { "role": { "documentation": "The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]" } } }, "auth_ref": [ "r357" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_CurrentGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentGovernmentGrants", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails": { "parentTag": "ifrs-full_GovernmentGrants", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "label": "Short term liability at year end" } }, "en": { "role": { "documentation": "The amount of current government grants recognised in the statement of financial position as deferred income. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r357" ] }, "ifrs-full_CurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities", "verboseLabel": "Current" } }, "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r134" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Current liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r18", "r112", "r237" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "auth_ref": [] }, "ifrs-full_CurrentPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPrepaidExpenses", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Current prepaid expenses", "verboseLabel": "Prepaid advance amount" } }, "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } } }, "auth_ref": [ "r355" ] }, "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPrepaymentsAndOtherCurrentAssets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses" } }, "en": { "role": { "documentation": "The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments]" } } }, "auth_ref": [ "r357" ] }, "ifrs-full_CurrentTradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTradeReceivables", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other receivables", "label": "Current trade receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r213", "r215" ] }, "ifrs-full_CurrentValueAddedTaxReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentValueAddedTaxReceivables", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Tax authorities" } }, "en": { "role": { "documentation": "The amount of current value added tax receivables. [Refer: Value added tax receivables]" } } }, "auth_ref": [ "r358" ] }, "ifrs-full_CurrentWarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentWarrantLiability", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Warrants" } }, "en": { "role": { "documentation": "The amount of current warrant liabilities. [Refer: Warrant liability]" } } }, "auth_ref": [ "r357" ] }, "ifrs-full_DateOfGrantOfSharebasedPaymentArrangement": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DateOfGrantOfSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Date of grant of share-based payment arrangement" } }, "en": { "role": { "documentation": "The date on which share-based payment arrangements are granted. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r248", "r249" ] }, "ifrs-full_DebtInstrumentsHeld": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DebtInstrumentsHeld", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt principal amount" } }, "en": { "role": { "documentation": "The amount of instruments representing indebtedness held by the entity." } } }, "auth_ref": [ "r357" ] }, "ifrs-full_DebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DebtSecurities", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt conversion amount" } }, "en": { "role": { "documentation": "The amount of instruments issued by the entity that represent indebtedness." } } }, "auth_ref": [ "r357" ] }, "SMX_DeductionsInLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DeductionsInLeaseLiabilities", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Deductions", "documentation": "Deductions in lease liabilities.", "label": "DeductionsInLeaseLiabilities" } } }, "auth_ref": [] }, "SMX_DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Deductions", "documentation": "Deductions other than through business combinations property plant and equipment." } } }, "auth_ref": [] }, "SMX_DeductionsToRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DeductionsToRightofuseAssets", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Deductions", "documentation": "Deductions to right of use assets.", "label": "DeductionsToRightofuseAssets" } } }, "auth_ref": [] }, "ifrs-full_DefaultFinancialStatementsDateMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DefaultFinancialStatementsDateMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Creation date' axis if no other member is used." } } }, "auth_ref": [ "r99", "r100", "r101" ] }, "SMX_DeferredSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DeferredSharesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Shares [Member]", "documentation": "Deferred Shares [Member]" } } }, "auth_ref": [] }, "ifrs-full_DepreciationAndAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationAndAmortisationExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 4.0 }, "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Depreciation and amortization", "label": "Depreciation and amortisation expense" } }, "en": { "role": { "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives." } } }, "auth_ref": [ "r1", "r34", "r118", "r195", "r203", "r210" ] }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationPropertyPlantAndEquipment", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation" } }, "en": { "role": { "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]" } } }, "auth_ref": [ "r44", "r48" ] }, "ifrs-full_DepreciationRatePropertyPlantAndEquipment": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationRatePropertyPlantAndEquipment", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation rate, property, plant and equipment" } }, "en": { "role": { "documentation": "The depreciation rate used for property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r41" ] }, "ifrs-full_DepreciationRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationRightofuseAssets", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCarryingAmountsOfLeaseLiabilitiesRecognizedInProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Depreciation expense", "label": "Depreciation expense of right-of-use assets" } }, "en": { "role": { "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]" } } }, "auth_ref": [ "r135" ] }, "ifrs-full_DerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DerivativeFinancialLiabilities", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Derivative financial liabilities" } }, "en": { "role": { "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r357" ] }, "ifrs-full_DerivativesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DerivativesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Derivatives [member]" } }, "en": { "role": { "documentation": "This member stands for financial instruments or other contracts within the scope of IFRS 9 with all three of the following characteristics: (a) Their value changes in response to the change in a specified interest rate, financial instrument price, commodity price, foreign exchange rate, index of prices or rates, credit rating or credit index, or other variable, provided in the case of a non-financial variable that the variable is not specific to a party to the contract (sometimes called the \u2018underlying\u2019); (b) They require no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; (c) They are settled at a future date. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r238", "r240", "r252", "r258" ] }, "SMX_DescriptionForCommonStockReceivedAndEffectivenessOfResgistration": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DescriptionForCommonStockReceivedAndEffectivenessOfResgistration", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description for common stock received and effectiveness of resgistration", "documentation": "Description for common stock received and effectiveness of resgistration." } } }, "auth_ref": [] }, "SMX_DescriptionForEquityOrOtherFundingConvertible": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DescriptionForEquityOrOtherFundingConvertible", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description for equity or other funding convertible", "documentation": "Description for equity or other funding convertible." } } }, "auth_ref": [] }, "SMX_DescriptionOfAccountingPolicyForApplicationOfAccountingPoliciesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DescriptionOfAccountingPolicyForApplicationOfAccountingPoliciesExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Application of accounting policies", "documentation": "Description of accounting policy for application of accounting policies explanatory." } } }, "auth_ref": [] }, "SMX_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of preparation", "documentation": "Description of accounting policy for basis of preparation explanatory." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Loss per share" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for earnings per share." } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Employee benefits" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment." } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair value measurement" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for fair value measurement. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Financial assets" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Classification of financial instruments by fair value hierarchy" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial instruments at fair value through profit or loss. [Refer: At fair value [member]; Financial instruments, class [member]]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Issue of a unit of financial instruments" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Financial liabilities" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial liabilities. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Foreign currency" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for foreign currency translation." } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Functional currency" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for the currency of the primary economic environment in which the entity operates." } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForGovernmentGrants", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Governmental grants" } }, "en": { "role": { "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r51" ] }, "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of financial assets" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for the impairment of financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impairment of non-financial assets" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for the impairment of non-financial assets. [Refer: Financial assets]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible assets" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForInvestmentInAssociates": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForInvestmentInAssociates", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Investments in associated companies" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for investments in associates. [Refer: Associates [member]]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Lease liabilities", "label": "Description of accounting policy for leases [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time." } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reimbursement of research and development expenses" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for research and development expense. [Refer: Research and development expense]" } } }, "auth_ref": [ "r356" ] }, "SMX_DescriptionOfAccountingPolicyForReverseAcquisitionTransactionExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DescriptionOfAccountingPolicyForReverseAcquisitionTransactionExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reverse acquisition transaction", "documentation": "Description of accounting policy for reverse acquisition transaction explanatory." } } }, "auth_ref": [] }, "SMX_DescriptionOfAccountingPolicyForReverseStockSplitExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DescriptionOfAccountingPolicyForReverseStockSplitExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reverse stock split", "documentation": "Description of accounting policy for reverse stock split explanatory." } } }, "auth_ref": [] }, "SMX_DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets", "documentation": "Description of accounting policy for right of use assets explanatory." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation", "label": "Description of accounting policy for share-based payment transactions [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r356" ] }, "SMX_DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsNotYetEffectiveExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsNotYetEffectiveExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "New standards, interpretations and amendments not yet effective", "documentation": "Description of accounting policy new standards interpretations and amendments not yet effective [Explanatory]" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]" } }, "en": { "role": { "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r97" ] }, "ifrs-full_DescriptionOfApproachUsedToDetermineDiscountRates": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfApproachUsedToDetermineDiscountRates", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of approach used to determine discount rates" } }, "en": { "role": { "documentation": "The description of the approach used to determine discount rates when applying IFRS 17." } } }, "auth_ref": [ "r147" ] }, "ifrs-full_DescriptionOfConversionOfDebtToEquity": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfConversionOfDebtToEquity", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion of stock, description", "verboseLabel": "Conversion of shares, description" } }, "en": { "role": { "documentation": "The description of the non-cash conversion of debt to equity." } } }, "auth_ref": [ "r234" ] }, "SMX_DescriptionOfExpectedExpectedTermOptionsGranted": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DescriptionOfExpectedExpectedTermOptionsGranted", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Granted", "documentation": "Description of expected expected term options granted.", "label": "DescriptionOfExpectedExpectedTermOptionsGranted" } } }, "auth_ref": [] }, "SMX_DescriptionOfExpectedTerm": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DescriptionOfExpectedTerm", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected term", "documentation": "Expected term." } } }, "auth_ref": [] }, "SMX_DescriptionOfExpectedTermWarrants": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DescriptionOfExpectedTermWarrants", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Term warrants", "verboseLabel": "Description of expected term warrants", "documentation": "Description of expected term warrants." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Volatility rate", "verboseLabel": "Expected volatility, share options granted", "terseLabel": "Expected volatility" } }, "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } } }, "auth_ref": [ "r165" ] }, "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfOptionLifeShareOptionsGranted", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Option life, share options granted" } }, "en": { "role": { "documentation": "The option life of share options granted." } } }, "auth_ref": [ "r165" ] }, "SMX_DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounting Estimates and Assumptions", "documentation": "Description of Other Accounting Policies Relevant to Understanding of Financial Statements." } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Risk-free interest rate", "verboseLabel": "Description of risk free interest rate percentage", "terseLabel": "Risk free interest rate, share options granted" } }, "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } } }, "auth_ref": [ "r165" ] }, "ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfVestingRequirementsForSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of vesting requirements for share-based payment arrangement" } }, "en": { "role": { "documentation": "The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r155" ] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails", "http://smxpublicltd.com/role/ScheduleOfWeightedAverageLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Diluted loss per share attributable to shareholders", "verboseLabel": "Diluted loss per share" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r72", "r73" ] }, "SMX_DirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DirectorsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Directors [member]", "documentation": "Directors [member]" } } }, "auth_ref": [] }, "SMX_DisclosureControlledEntitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureControlledEntitiesAbstract", "auth_ref": [] }, "SMX_DisclosureFinancialInstrumentsAndRiskManagementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureFinancialInstrumentsAndRiskManagementAbstract", "auth_ref": [] }, "SMX_DisclosureInvestmentsInAssociatedCompaniesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureInvestmentsInAssociatedCompaniesAbstract", "auth_ref": [] }, "SMX_DisclosureMaterialEventsDuringPeriodAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureMaterialEventsDuringPeriodAbstract", "lang": { "en-us": { "role": { "label": "Material Events During Period" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "presentation": [ "http://smxpublicltd.com/role/CriticalAccountingEstimatesAndJudgements" ], "lang": { "en-us": { "role": { "label": "CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS" } }, "en": { "role": { "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]" } } }, "auth_ref": [ "r351" ] }, "ifrs-full_DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory", "presentation": [ "http://smxpublicltd.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF CARRYING AMOUNTS OF LEASE LIABILITIES RECOGNIZED IN PROFIT OR LOSS" } }, "en": { "role": { "documentation": "The disclosure of additional information about leasing activities of a lessee." } } }, "auth_ref": [ "r140" ] }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "presentation": [ "http://smxpublicltd.com/role/General" ], "lang": { "en-us": { "role": { "label": "GENERAL" } }, "en": { "role": { "documentation": "The disclosure of the basis used for the preparation of the financial statements." } } }, "auth_ref": [ "r351" ] }, "ifrs-full_DisclosureOfBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBorrowingsExplanatory", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedParties" ], "lang": { "en-us": { "role": { "label": "BORROWINGS FROM RELATED PARTIES" } }, "en": { "role": { "documentation": "The disclosure of borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r351" ] }, "ifrs-full_DisclosureOfBusinessCombinationsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBusinessCombinationsTable", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about business combination [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of business combinations." } } }, "auth_ref": [ "r173" ] }, "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalExplanatory", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF SHARE CAPITAL" } }, "en": { "role": { "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]" } } }, "auth_ref": [ "r24" ] }, "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilities" ], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENT LIABILITIES" } }, "en": { "role": { "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]" } } }, "auth_ref": [ "r351" ] }, "SMX_DisclosureOfControlledEntitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfControlledEntitiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/ControlledEntities" ], "lang": { "en-us": { "role": { "label": "CONTROLLED ENTITIES", "documentation": "Disclosure of controlled entities explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfCreditRiskExposureExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCreditRiskExposureExplanatory", "presentation": [ "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE" } }, "en": { "role": { "documentation": "The disclosure of the credit risk exposure. Credit risk exposure is the credit risk inherent in an entity\u2019s financial assets and commitments to extend credit." } } }, "auth_ref": [ "r185" ] }, "ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDerivativeFinancialInstrumentsExplanatory", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiability" ], "lang": { "en-us": { "role": { "label": "BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY" } }, "en": { "role": { "documentation": "The disclosure of derivative financial instruments. [Refer: Derivatives [member]]" } } }, "auth_ref": [ "r351" ] }, "SMX_DisclosureOfDetailedInformationAboutBalanceWithRelatedPartiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfDetailedInformationAboutBalanceWithRelatedPartiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/RelatedPartiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF BALANCE WITH RELATED PARTIES", "documentation": "Details information about balance with related parties explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF BORROWINGS FROM RELATED PARTIES" } }, "en": { "role": { "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r372" ] }, "SMX_DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory", "presentation": [ "http://smxpublicltd.com/role/TaxesOnIncomeTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE", "documentation": "Disclosure of detailed information about components of income tax expense explanatory." } } }, "auth_ref": [] }, "SMX_DisclosureOfDetailedInformationAboutControlledEntitiesAssetsAndLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfDetailedInformationAboutControlledEntitiesAssetsAndLiabilitiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/ControlledEntitiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF ASSETS AND LIABILITIES", "documentation": "Disclosure of detailed information about controlled entities assets and liabilities explanatory." } } }, "auth_ref": [] }, "SMX_DisclosureOfDetailedInformationAboutFinancialInstrumentAndRiskManagementForeignCurrencyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfDetailedInformationAboutFinancialInstrumentAndRiskManagementForeignCurrencyExplanatory", "presentation": [ "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF FOREIGN CURRENCY RISK", "documentation": "Disclosure of detailed information about financial instrument and risk management foreign currency explanatory." } } }, "auth_ref": [] }, "SMX_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory", "presentation": [ "http://smxpublicltd.com/role/GeneralAndAdministrativeExpensesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES", "documentation": "Disclosure of detailed information about general and administrative expense explanatory." } } }, "auth_ref": [] }, "SMX_DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory", "presentation": [ "http://smxpublicltd.com/role/GovernmentGrantsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF GOVERNMENT GRANTS", "documentation": "Disclosure of detailed information about government grants explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetTables" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF INTANGIBLE ASSETS NET" } }, "en": { "role": { "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r82" ] }, "SMX_DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities", "presentation": [ "http://smxpublicltd.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF LEASE LIABILITY", "documentation": "Disclosure of detailed information about operating lease liabilities." } } }, "auth_ref": [] }, "SMX_DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/OtherCurrentAssetsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OTHER CURRENT ASSETS", "documentation": "Disclosure of detailed information about other current assets explanatory." } } }, "auth_ref": [] }, "SMX_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT", "documentation": "Disclosure of detailed information about property plant and equipment depreciation rate explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://smxpublicltd.com/role/PropertyAndEquipmentNetTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT" } }, "en": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r47" ] }, "SMX_DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNetTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE", "documentation": "Disclosure of detailed information about research and development expense explanatory." } } }, "auth_ref": [] }, "SMX_DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock", "presentation": [ "http://smxpublicltd.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RIGHT OF USE ASSETS", "documentation": "Disclosure of detailed information about right of use assets text block." } } }, "auth_ref": [] }, "SMX_DisclosureOfDetailedInformationAboutSensitivityAnalysisProfitAndOtherEquityExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfDetailedInformationAboutSensitivityAnalysisProfitAndOtherEquityExplanatory", "presentation": [ "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF SENSITIVITY ANALYSIS PROFIT AND OTHER EQUITY", "documentation": "Disclosure of detailed information about sensitivity analysis profit and other equity explanatory." } } }, "auth_ref": [] }, "SMX_DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory", "presentation": [ "http://smxpublicltd.com/role/OtherPayablesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OTHER PAYABLES", "documentation": "Disclosure of detailed information about trade and other payables explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } } }, "auth_ref": [ "r130" ] }, "ifrs-full_DisclosureOfEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEarningsPerShareExplanatory", "presentation": [ "http://smxpublicltd.com/role/LossPerShareTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF LOSS PER SHARE" } }, "en": { "role": { "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r76" ] }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "lang": { "en-us": { "role": { "label": "Disclosure of events after reporting period [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } } }, "auth_ref": [ "r36" ] }, "ifrs-full_DisclosureOfFairValueMeasurementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementExplanatory", "presentation": [ "http://smxpublicltd.com/role/FairValueMeasurement" ], "lang": { "en-us": { "role": { "label": "FAIR VALUE MEASUREMENT" } }, "en": { "role": { "documentation": "The entire disclosure for fair value measurement." } } }, "auth_ref": [ "r128" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of assets." } } }, "auth_ref": [ "r127" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/FairValueMeasurementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY" } }, "en": { "role": { "documentation": "The disclosure of the fair value measurement of liabilities." } } }, "auth_ref": [ "r127" ] }, "SMX_DisclosureOfFinancialInstrumentAndRiskManagementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfFinancialInstrumentAndRiskManagementExplanatory", "presentation": [ "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagement" ], "lang": { "en-us": { "role": { "label": "FINANCIAL INSTRUMENTS AND RISK MANAGEMENT", "documentation": "Disclosure of financial instrument and risk management explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsExplanatory", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "CONVERTIBLE NOTES" } }, "en": { "role": { "documentation": "The entire disclosure for financial instruments." } } }, "auth_ref": [ "r193" ] }, "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES" } }, "en": { "role": { "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r189" ] }, "ifrs-full_DisclosureOfFinancialLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialLiabilitiesTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial liabilities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to financial liabilities." } } }, "auth_ref": [ "r189" ] }, "ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "presentation": [ "http://smxpublicltd.com/role/GeneralAndAdministrativeExpenses" ], "lang": { "en-us": { "role": { "label": "GENERAL AND ADMINISTRATIVE EXPENSES" } }, "en": { "role": { "documentation": "The disclosure of general and administrative expenses. [Refer: Administrative expenses]" } } }, "auth_ref": [ "r351" ] }, "ifrs-full_DisclosureOfGovernmentGrantsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGovernmentGrantsExplanatory", "presentation": [ "http://smxpublicltd.com/role/GovernmentGrants" ], "lang": { "en-us": { "role": { "label": "GOVERNMENT GRANTS" } }, "en": { "role": { "documentation": "The entire disclosure for government grants." } } }, "auth_ref": [ "r52" ] }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIncomeTaxExplanatory", "presentation": [ "http://smxpublicltd.com/role/TaxesOnIncome" ], "lang": { "en-us": { "role": { "label": "TAXES ON INCOME" } }, "en": { "role": { "documentation": "The entire disclosure for income taxes." } } }, "auth_ref": [ "r40" ] }, "ifrs-full_DisclosureOfInformationAboutConsolidatedStructuredEntitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInformationAboutConsolidatedStructuredEntitiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF INFORMATION ABOUT CONSOLIDATED STRUCTURED ENTITIES" } }, "en": { "role": { "documentation": "The disclosure of information about consolidated structured entities. [Refer: Consolidated structured entities [member]]" } } }, "auth_ref": [ "r123" ] }, "ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table]" } } }, "auth_ref": [ "r365" ] }, "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIntangibleAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNet" ], "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS, NET" } }, "en": { "role": { "documentation": "The entire disclosure for intangible assets." } } }, "auth_ref": [ "r84" ] }, "SMX_DisclosureOfInvestmentInAssociatedCompaniesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfInvestmentInAssociatedCompaniesExplanatory", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompanies" ], "lang": { "en-us": { "role": { "label": "INVESTMENTS IN ASSOCIATED COMPANIES", "documentation": "Disclosure O fInvestment In Associated Companies Explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfLeasesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfLeasesExplanatory", "presentation": [ "http://smxpublicltd.com/role/Leases" ], "lang": { "en-us": { "role": { "label": "LEASES" } }, "en": { "role": { "documentation": "The entire disclosure for leases." } } }, "auth_ref": [ "r143", "r144" ] }, "SMX_DisclosureOfMaterialEventsDuringPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfMaterialEventsDuringPeriodExplanatory", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriod" ], "lang": { "en-us": { "role": { "label": "MATERIAL EVENTS DURING THE PERIOD", "documentation": "Disclosure of material events during period explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "presentation": [ "http://smxpublicltd.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } }, "en": { "role": { "documentation": "The disclosure of non-adjusting events after the reporting period. [Refer: Non-adjusting events after reporting period [member]]" } } }, "auth_ref": [ "r35" ] }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period." } } }, "auth_ref": [ "r35" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF SHARE OPTION GRANTED" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r163" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r164" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the number and weighted average remaining contractual life of outstanding share options." } } }, "auth_ref": [ "r164" ] }, "ifrs-full_DisclosureOfOffsettingOfFinancialAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOffsettingOfFinancialAssetsTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of offsetting of financial assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the offsetting of financial assets." } } }, "auth_ref": [ "r177" ] }, "ifrs-full_DisclosureOfOtherCurrentAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherCurrentAssetsExplanatory", "presentation": [ "http://smxpublicltd.com/role/OtherCurrentAssets" ], "lang": { "en-us": { "role": { "label": "OTHER CURRENT ASSETS" } }, "en": { "role": { "documentation": "The disclosure of other current assets. [Refer: Other current assets]" } } }, "auth_ref": [ "r351" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://smxpublicltd.com/role/PropertyAndEquipmentNet" ], "lang": { "en-us": { "role": { "label": "PROPERTY AND EQUIPMENT, NET" } }, "en": { "role": { "documentation": "The entire disclosure for property, plant and equipment." } } }, "auth_ref": [ "r49" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "presentation": [ "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } } }, "auth_ref": [ "r47" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill." } } }, "auth_ref": [ "r174" ] }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRelatedPartyExplanatory", "presentation": [ "http://smxpublicltd.com/role/RelatedParties" ], "lang": { "en-us": { "role": { "label": "RELATED PARTIES" } }, "en": { "role": { "documentation": "The entire disclosure for related parties." } } }, "auth_ref": [ "r63" ] }, "ifrs-full_DisclosureOfResearchAndDevelopmentExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfResearchAndDevelopmentExpenseExplanatory", "presentation": [ "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNet" ], "lang": { "en-us": { "role": { "label": "RESEARCH AND DEVELOPMENT EXPENSES, NET" } }, "en": { "role": { "documentation": "The disclosure of research and development expense. [Refer: Research and development expense]" } } }, "auth_ref": [ "r351" ] }, "SMX_DisclosureOfRestrictedStockUnitExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfRestrictedStockUnitExplanatory", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF RESTRICTED STOCK UNIT", "documentation": "Disclosure of restricted stock unit explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS\u2019 EQUITY" } }, "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } } }, "auth_ref": [ "r25" ] }, "ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInAssociatesTable", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of associates [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to associates." } } }, "auth_ref": [ "r68", "r71", "r122" ] }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "presentation": [ "http://smxpublicltd.com/role/GeneralTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF COMPANIES SUBSIDIARIES" } }, "en": { "role": { "documentation": "The disclosure of subsidiaries. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r68", "r71", "r120" ] }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of subsidiaries [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to subsidiaries." } } }, "auth_ref": [ "r68", "r71", "r120" ] }, "SMX_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SIGNIFICANT ACCOUNTING POLICIES", "documentation": "Disclosure of summary of significant accounting policies explanatory." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTradeAndOtherPayablesExplanatory", "presentation": [ "http://smxpublicltd.com/role/OtherPayables" ], "lang": { "en-us": { "role": { "label": "OTHER PAYABLES" } }, "en": { "role": { "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]" } } }, "auth_ref": [ "r351" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "presentation": [ "http://smxpublicltd.com/role/RelatedPartiesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF KEY MANAGEMENT PERSONNEL" } }, "en": { "role": { "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r59" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } } }, "auth_ref": [ "r61" ] }, "SMX_DisclosureOfWeightedAverageLossPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureOfWeightedAverageLossPerShareExplanatory", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE", "documentation": "Disclosure of weighted average loss per share [text block]" } } }, "auth_ref": [] }, "SMX_DisclosureSignificantAccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DisclosureSignificantAccountingPoliciesAbstract", "auth_ref": [] }, "SMX_DiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "DiscountRate", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Discount rate", "documentation": "Discount rate." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r274" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r272", "r274", "r287" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r273" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r261" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r274" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r274" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r308" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r264" ] }, "SMX_EFHuttonLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "EFHuttonLLCMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "EF hutton llc [member]", "documentation": "EF hutton llc [member]" } } }, "auth_ref": [] }, "SMX_EURMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "EURMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "EUR [member]", "documentation": "EUR [member]" } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareExplanatory", "presentation": [ "http://smxpublicltd.com/role/LossPerShare" ], "lang": { "en-us": { "role": { "label": "LOSS PER SHARE" } }, "en": { "role": { "documentation": "The disclosure of earnings per share." } } }, "auth_ref": [ "r72" ] }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Exchange rate differences on cash and cash equivalent" } }, "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r93", "r94" ] }, "SMX_ElevenLendersMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ElevenLendersMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Eleven lenders [member]", "documentation": "Eleven lenders [member]" } } }, "auth_ref": [] }, "ifrs-full_EmployeeBenefitsExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EmployeeBenefitsExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Salaries and related expenses" } }, "en": { "role": { "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment." } } }, "auth_ref": [ "r1", "r34", "r210" ] }, "SMX_EmployeesDirectorsAndServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "EmployeesDirectorsAndServiceMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employees directors and service [member]", "documentation": "Employees directors and service [member]" } } }, "auth_ref": [] }, "SMX_EmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "EmployeesMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employees [member]", "documentation": "Employees [member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityAddressesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesLineItems", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesTable", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Table]", "documentation": "Container of address information for the entity" } } }, "auth_ref": [ "r263" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r267" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r263" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r263" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r350" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r263" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r347" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r287" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r263" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r263" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r263" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r263" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r348" ] }, "ifrs-full_EntitysTotalForAssociatesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForAssociatesMember", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Associates' axis if no other member is used." } } }, "auth_ref": [ "r68", "r71", "r122" ] }, "ifrs-full_EntitysTotalForBusinessCombinationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForBusinessCombinationsMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used." } } }, "auth_ref": [ "r173", "r175" ] }, "ifrs-full_EntitysTotalForJointVenturesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForJointVenturesMember", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Joint ventures' axis if no other member is used." } } }, "auth_ref": [ "r68", "r71", "r121" ] }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForRelatedPartiesMember", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r61" ] }, "ifrs-full_EntitysTotalForSubsidiariesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForSubsidiariesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } } }, "auth_ref": [ "r68", "r71", "r120" ] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Equity", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total Shareholders\u2019 equity (deficit)", "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Ending balance, value", "label": "Equity" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r14", "r20", "r102", "r104", "r124", "r125", "r126" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 equity (deficit)" } } }, "auth_ref": [] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and shareholders\u2019 equity (deficit)", "label": "Equity and liabilities" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r14" ] }, "SMX_EquityLineAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "EquityLineAgreementMember", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity line agreement [member]", "documentation": "Equity line agreement [member]" } } }, "auth_ref": [] }, "ifrs-full_EquityMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r6" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r316" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r279", "r291", "r301", "r326" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r276", "r288", "r298", "r323" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r322" ] }, "SMX_ExecutiveDirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ExecutiveDirectorMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Executive director [member]", "documentation": "Executive director [member]" } } }, "auth_ref": [] }, "SMX_ExerciseOfOptionsAndWarrantsToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ExerciseOfOptionsAndWarrantsToOrdinaryShares", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Exercise of options and warrants to ordinary shares", "documentation": "Exercise of options and warrants to ordinary shares." } } }, "auth_ref": [] }, "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExercisePriceOfOutstandingShareOptions2019", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise price of outstanding share options", "verboseLabel": "Exercise price" } }, "en": { "role": { "documentation": "The exercise price of outstanding share options." } } }, "auth_ref": [ "r164" ] }, "SMX_ExercisePriceOfWarrants": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ExercisePriceOfWarrants", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise price", "documentation": "Exercise price of warrants." } } }, "auth_ref": [] }, "ifrs-full_ExercisePriceShareOptionsGranted2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExercisePriceShareOptionsGranted2019", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise price, share options granted", "verboseLabel": "Exercise price of share" } }, "en": { "role": { "documentation": "The exercise price of share options granted." } } }, "auth_ref": [ "r165" ] }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected dividend as percentage, share options granted" } }, "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } } }, "auth_ref": [ "r165" ] }, "ifrs-full_ExpectedDividendShareOptionsGranted": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpectedDividendShareOptionsGranted", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected dividend" } }, "en": { "role": { "documentation": "The amount of an expected dividend used to calculate the fair value of share options granted." } } }, "auth_ref": [ "r165" ] }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Share based compensation", "label": "Share based expenses" } }, "en": { "role": { "documentation": "The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets." } } }, "auth_ref": [ "r168" ] }, "ifrs-full_ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCarryingAmountsOfLeaseLiabilitiesRecognizedInProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Expense relating to short-term leases" } }, "en": { "role": { "documentation": "The amount of the expense relating to short-term leases accounted for applying paragraph 6 of IFRS 16. This expense need not include the expense relating to leases with a lease term of one month or less. Short-term lease is a lease that, at the commencement date, has a lease term of 12 months or less. A lease that contains a purchase option is not a short-term lease." } } }, "auth_ref": [ "r137" ] }, "SMX_ExpensesOfOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ExpensesOfOptions", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expenses of options", "documentation": "Expenses of options." } } }, "auth_ref": [] }, "ifrs-full_ExplanationOfShareOptionsInSharebasedPaymentArrangement": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExplanationOfShareOptionsInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of share-based payment arrangement" } }, "en": { "role": { "documentation": "The description of a share-based payment arrangement that existed at any time during the reporting period. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r155" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "SMX_FaceValueOfConvertibleNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FaceValueOfConvertibleNotes", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Face value of convertible notes", "documentation": "Face value of convertible notes." } } }, "auth_ref": [] }, "SMX_FairValueBasedOnQuotedOpeningSharePrice": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FairValueBasedOnQuotedOpeningSharePrice", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Fair value based on the quoted opening share price", "documentation": "Fair value based on quoted opening share price.", "label": "FairValueBasedOnQuotedOpeningSharePrice" } } }, "auth_ref": [] }, "SMX_FairValueOfBonusWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FairValueOfBonusWarrants", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of the bonus Warrants", "documentation": "Fair value of bonus warrants." } } }, "auth_ref": [] }, "SMX_FairValueOfConvertibleNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FairValueOfConvertibleNotes", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of convertible notes", "documentation": "Fair value of convertible notes." } } }, "auth_ref": [] }, "SMX_FairValueOfEquityTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FairValueOfEquityTransaction", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of the shares", "documentation": "Fair value of equity transaction." } } }, "auth_ref": [] }, "SMX_FairValueOfRedeemableWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FairValueOfRedeemableWarrants", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of the redeemable warrants", "verboseLabel": "Fair value of redeemable warrants", "documentation": "Fair value of redeemable warrants." } } }, "auth_ref": [] }, "SMX_FairValueOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FairValueOfWarrants", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of warrants", "documentation": "Fair value of warrants." } } }, "auth_ref": [] }, "ifrs-full_FinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceCosts", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Finance expenses" } }, "en": { "role": { "documentation": "The amount of costs associated with financing activities of the entity." } } }, "auth_ref": [ "r30" ] }, "ifrs-full_FinanceIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceIncome", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Finance income" } }, "en": { "role": { "documentation": "The amount of income associated with interest and other financing activities of the entity." } } }, "auth_ref": [ "r362" ] }, "ifrs-full_FinancialAssetsCategoryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsCategoryMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfInformationAboutConsolidatedStructuredEntitiesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated categories of financial assets. It also represents the standard value for the 'Categories of financial assets' axis if no other member is used. [Refer: Financial assets]" } } }, "auth_ref": [ "r190" ] }, "SMX_FinancialExpensesPrincipalAmounts": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FinancialExpensesPrincipalAmounts", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Financial expenses due to bridge loans principal amounts", "documentation": "Financial expenses principal amounts." } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilities", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities at amortized cost" } }, "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r180" ] }, "ifrs-full_FinancialLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r187", "r188", "r208", "r209" ] }, "SMX_FirstAnniversaryMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FirstAnniversaryMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "First anniversary [member]", "documentation": "First anniversary [member]" } } }, "auth_ref": [] }, "SMX_FirstInstallmentMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FirstInstallmentMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "First installment [member]", "documentation": "First installment [member]" } } }, "auth_ref": [] }, "SMX_FixedConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FixedConversionPrice", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fixed conversion price", "documentation": "Fixed conversion price." } } }, "auth_ref": [] }, "SMX_FloorPricePricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FloorPricePricePerShare", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Floor price per share", "documentation": "Floor price per share." } } }, "auth_ref": [] }, "SMX_ForeignCurrencyTranslationMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ForeignCurrencyTranslationMember", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Foreign Currency Translation [Member]", "documentation": "Foreign Currency Translation [Member]" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r283", "r295", "r305", "r330" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r283", "r295", "r305", "r330" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r283", "r295", "r305", "r330" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r283", "r295", "r305", "r330" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r283", "r295", "r305", "r330" ] }, "SMX_FourthAnniversaryMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FourthAnniversaryMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fourth anniversary [member]", "documentation": "Fourth anniversary [member]" } } }, "auth_ref": [] }, "SMX_FreightExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FreightExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Freight", "documentation": "Freight expense." } } }, "auth_ref": [] }, "SMX_FurnitureAndOfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "FurnitureAndOfficeEquipmentMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and Office Equipment [Member]", "documentation": "Furniture and Office Equipment [Member]" } } }, "auth_ref": [] }, "ifrs-full_GainRecognisedInBargainPurchaseTransaction": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainRecognisedInBargainPurchaseTransaction", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value" } }, "en": { "role": { "documentation": "The amount of any gain recognised in a business combination in which the net of the identifiable assets acquired and the liabilities assumed exceeds the aggregate of the consideration transferred, non-controlling interest in the acquiree and fair value of the acquirer's previously held equity interest in the acquiree. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r172" ] }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Exchange rate differences" } }, "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r33" ] }, "ifrs-full_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 4.0 }, "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "General and administrative expenses", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of expense relating to general and administrative activities of the entity." } } }, "auth_ref": [ "r355" ] }, "SMX_GeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "GeneralAndAdministrativeExpensesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "General and administrative expenses [member]", "documentation": "General and administrative expenses [member]" } } }, "auth_ref": [] }, "ifrs-full_GeographicalAreasAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeographicalAreasAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Geographical areas [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r206", "r224", "r242", "r247" ] }, "ifrs-full_GeographicalAreasMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeographicalAreasMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } } }, "auth_ref": [ "r206", "r224", "r242", "r247" ] }, "SMX_GlobalBevCoPtyLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "GlobalBevCoPtyLtdMember", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Global BevCo Pty Ltd. [member]", "documentation": "Global BevCo Pty Ltd. [member]" } } }, "auth_ref": [] }, "ifrs-full_GovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GovernmentGrants", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Government grants [Default Label]" } }, "en": { "role": { "documentation": "The amount of assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity, recognised as deferred income. They exclude those forms of government assistance that cannot reasonably have a value placed upon them and transactions with government that cannot be distinguished from the normal trading transactions of the entity. [Refer: Deferred income other than contract liabilities; Government [member]]" } } }, "auth_ref": [ "r357" ] }, "SMX_GovernmentGrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "GovernmentGrantsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Government grants [member]", "documentation": "Government grants [member]" } } }, "auth_ref": [] }, "ifrs-full_GrossCarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossCarryingAmountMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Gross carrying amount [member]" } }, "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r42", "r77", "r87", "r90", "r174", "r184", "r185", "r251" ] }, "ifrs-full_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross profit" } }, "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } } }, "auth_ref": [ "r211" ] }, "SMX_IfrsStatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "IfrsStatementLineItems", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedParties", "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesTables", "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiability", "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilities", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ControlledEntities", "http://smxpublicltd.com/role/ControlledEntitiesTables", "http://smxpublicltd.com/role/ConvertibleNotes", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/CriticalAccountingEstimatesAndJudgements", "http://smxpublicltd.com/role/FairValueMeasurement", "http://smxpublicltd.com/role/FairValueMeasurementTables", "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagement", "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables", "http://smxpublicltd.com/role/General", "http://smxpublicltd.com/role/GeneralAndAdministrativeExpenses", "http://smxpublicltd.com/role/GeneralAndAdministrativeExpensesTables", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/GeneralTables", "http://smxpublicltd.com/role/GovernmentGrants", "http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative", "http://smxpublicltd.com/role/GovernmentGrantsTables", "http://smxpublicltd.com/role/IntangibleAssetsNet", "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/IntangibleAssetsNetTables", "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompanies", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesTables", "http://smxpublicltd.com/role/Leases", "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/LeasesTables", "http://smxpublicltd.com/role/LossPerShare", "http://smxpublicltd.com/role/LossPerShareTables", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/OtherCurrentAssets", "http://smxpublicltd.com/role/OtherCurrentAssetsTables", "http://smxpublicltd.com/role/OtherPayables", "http://smxpublicltd.com/role/OtherPayablesTables", "http://smxpublicltd.com/role/PropertyAndEquipmentNet", "http://smxpublicltd.com/role/PropertyAndEquipmentNetTables", "http://smxpublicltd.com/role/RelatedParties", "http://smxpublicltd.com/role/RelatedPartiesTables", "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNet", "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNetTables", "http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfCarryingAmountsOfLeaseLiabilitiesRecognizedInProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails", "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails", "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails", "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails", "http://smxpublicltd.com/role/ScheduleOfInformationAboutConsolidatedStructuredEntitiesDetails", "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails", "http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails", "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails", "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetails", "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails", "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails", "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails", "http://smxpublicltd.com/role/ScheduleOfSensitivityAnalysisProfitAndOtherEquityDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails", "http://smxpublicltd.com/role/ScheduleOfWeightedAverageLossPerShareDetails", "http://smxpublicltd.com/role/ShareholdersEquity", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityTables", "http://smxpublicltd.com/role/SignificantAccountingPolicies", "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies", "http://smxpublicltd.com/role/SignificantAccountingPoliciesTables", "http://smxpublicltd.com/role/SubsequentEvents", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsTables", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails", "http://smxpublicltd.com/role/TaxesOnIncome", "http://smxpublicltd.com/role/TaxesOnIncomeDetailsNarrative", "http://smxpublicltd.com/role/TaxesOnIncomeTables" ], "lang": { "en-us": { "role": { "label": "IfrsStatementLineItems [Line Items]" } } }, "auth_ref": [] }, "SMX_IncentiveEquityPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "IncentiveEquityPlanMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Incentive equity plan [member]", "documentation": "Incentive equity plan [member]" } } }, "auth_ref": [] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeStatementAbstract", "auth_ref": [] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 2.0 }, "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Income tax", "verboseLabel": "Income tax / (benefit)" } }, "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } } }, "auth_ref": [ "r32", "r37", "r38", "r39", "r64", "r119", "r197" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Increase (decrease) in cash and cash equivalents", "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r96" ] }, "ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughConversionOfConvertibleInstruments", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Conversion of convertible notes to shares" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the conversion of convertible instruments." } } }, "auth_ref": [ "r353" ] }, "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughExerciseOfOptions", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercise of options" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of options." } } }, "auth_ref": [ "r353" ] }, "ifrs-full_IncreaseDecreaseThroughExerciseOfWarrantsEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughExerciseOfWarrantsEquity", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Exercise of warrants" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of warrants." } } }, "auth_ref": [ "r353" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Currency translation adjustments", "verboseLabel": "Currency translation adjustments", "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r80" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Currency translation adjustments" } }, "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r45" ] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Share-based compensation" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r5" ] }, "SMX_IncreaseInCarryingAmountOfLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "IncreaseInCarryingAmountOfLiability", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Carrying amount of liability", "documentation": "Increase in carrying amount of liability." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r286", "r295", "r305", "r322", "r330", "r334", "r342" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "auth_ref": [ "r340" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r275", "r346" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r275", "r346" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r275", "r346" ] }, "ifrs-full_InsuranceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InsuranceExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Insurance" } }, "en": { "role": { "documentation": "The amount of expense arising from purchased insurance." } } }, "auth_ref": [ "r355" ] }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "periodEndLabel": "Net book value" } }, "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r10", "r81" ] }, "SMX_IntangibleAssetsOtherThanGoodwillGross": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "IntangibleAssetsOtherThanGoodwillGross", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cost, beginning balance", "periodEndLabel": "Cost, ending balance", "documentation": "Intangible assets other than goodwill, gross.", "label": "IntangibleAssetsOtherThanGoodwillGross" } } }, "auth_ref": [] }, "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwillMember", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r82", "r227", "r244" ] }, "ifrs-full_IntangibleAssetsUnderDevelopment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsUnderDevelopment", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Intangible assets under development" } }, "en": { "role": { "documentation": "The amount of intangible assets representing such assets under development. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r228" ] }, "SMX_InterestAccruedPercent": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "InterestAccruedPercent", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest accrued percent", "documentation": "Interest accrued percent." } } }, "auth_ref": [] }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpenseOnLeaseLiabilities", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCarryingAmountsOfLeaseLiabilitiesRecognizedInProfitOrLossDetails" ], "lang": { "en-us": { "role": { "label": "Interest expense on lease liabilities" } }, "en": { "role": { "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r136" ] }, "SMX_InvestmentInSubsidiariesJointVenturesAndAssociates": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "InvestmentInSubsidiariesJointVenturesAndAssociates", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfInformationAboutConsolidatedStructuredEntitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Company\u2019s share in net profits (losses) of associated companies", "documentation": "Investment in subsidiaries joint ventures and associates.", "label": "InvestmentInSubsidiariesJointVenturesAndAssociates" } } }, "auth_ref": [] }, "ifrs-full_InvestmentProperty": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentProperty", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment property" } }, "en": { "role": { "documentation": "The amount of property (land or a building - or part of a building - or both) held (by the owner or by the lessee as a right-of-use asset) to earn rentals or for capital appreciation or both, rather than for: (a) use in the production or supply of goods or services or for administrative purposes; or (b) sale in the ordinary course of business." } } }, "auth_ref": [ "r9", "r86", "r88" ] }, "ifrs-full_InvestmentsInSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentsInSubsidiaries", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Investment in subsidiary" } }, "en": { "role": { "documentation": "The amount of investments in subsidiaries in an entity's separate financial statements. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r65" ] }, "ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentsInSubsidiariesJointVenturesAndAssociates", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/ScheduleOfInformationAboutConsolidatedStructuredEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Investment in associated companies", "verboseLabel": "Closing carrying amount" } }, "en": { "role": { "documentation": "The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]" } } }, "auth_ref": [ "r65" ] }, "SMX_IsoradLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "IsoradLtdMember", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Isorad Ltd [member]", "documentation": "Isorad Ltd [member]" } } }, "auth_ref": [] }, "SMX_IssuanceOfOptionsToAcquireIntangibleAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "IssuanceOfOptionsToAcquireIntangibleAsset", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of options to acquire intangible asset", "documentation": "Issuance of options to acquire intangible asset." } } }, "auth_ref": [] }, "SMX_IssuanceOfSecurityBundle": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "IssuanceOfSecurityBundle", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of Security Bundle, net (See note 5.2)", "documentation": "Issuance of security bundle." } } }, "auth_ref": [] }, "SMX_IssuanceOfSharesForDirectors": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "IssuanceOfSharesForDirectors", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Issuance of shares for directors", "documentation": "Issuance of shares for directors.", "label": "IssuanceOfSharesForDirectors" } } }, "auth_ref": [] }, "ifrs-full_IssueOfConvertibleInstruments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssueOfConvertibleInstruments", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Conversion of bridge loans to shares", "verboseLabel": "Proceeds from borrowings", "terseLabel": "Aggregate amount of convertible instruments issued" } }, "en": { "role": { "documentation": "The change in equity resulting from the issuing of convertible instruments." } } }, "auth_ref": [ "r353" ] }, "ifrs-full_IssueOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssueOfEquity", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issuance of shares, net" } }, "en": { "role": { "documentation": "The increase in equity through the issue of equity instruments." } } }, "auth_ref": [ "r5" ] }, "SMX_IssuedAndAdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "IssuedAndAdditionalPaidInCapitalMember", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issued And Additional Paid In Capital [Member]", "documentation": "Issued And Additional Paid In Capital [Member]" } } }, "auth_ref": [] }, "ifrs-full_IssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapital", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Issued capital" } }, "en": { "role": { "documentation": "The nominal value of capital issued." } } }, "auth_ref": [ "r216" ] }, "SMX_IssuedCapitalAndAdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "IssuedCapitalAndAdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Issued capital and additional paid in capital", "documentation": "Issued capital and additional paid in capital." } } }, "auth_ref": [] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Issued capital [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_IssuedCapitalOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapitalOrdinaryShares", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issued capital, ordinary shares", "verboseLabel": "Ordinary shares" } }, "en": { "role": { "documentation": "The nominal value of capital arising from issuing ordinary shares. [Refer: Issued capital]" } } }, "auth_ref": [ "r359" ] }, "ifrs-full_JointVenturesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "JointVenturesAxis", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Joint ventures [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r68", "r71", "r121" ] }, "ifrs-full_JointVenturesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "JointVenturesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Joint ventures [member]" } }, "en": { "role": { "documentation": "This member stands for joint arrangements whereby the parties that have joint control of the arrangement have rights to the net assets of the arrangement." } } }, "auth_ref": [ "r68", "r71", "r121" ] }, "SMX_KeyManagementIssuanceOfOptionsToRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "KeyManagementIssuanceOfOptionsToRelatedParty", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Issuance of options to related party", "documentation": "Issuance of options to related party." } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelCompensation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensation", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Key management personnel compensation", "label": "Key management personnel compensation" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r57" ] }, "SMX_KeyManagementPersonnelCompensationLoanRepayment": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "KeyManagementPersonnelCompensationLoanRepayment", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Loan repayment", "documentation": "Key management personnel compensation loan repayment." } } }, "auth_ref": [] }, "SMX_KeyManagementPersonnelCompensationNonmonetaryBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "KeyManagementPersonnelCompensationNonmonetaryBenefits", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Non-monetary benefits", "documentation": "Key management personnel compensation non monetary benefits." } } }, "auth_ref": [] }, "SMX_KeyManagementPersonnelCompensationPaymentForAdministrativeServices": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "KeyManagementPersonnelCompensationPaymentForAdministrativeServices", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Payment for Administrative services", "documentation": "Key management personnel compensation payment for administrative services." } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Post-employment retirement benefits" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r55" ] }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Share based payments" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r56" ] }, "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Short-term salary and fees" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r54" ] }, "ifrs-full_KeyManagementPersonnelOfEntityOrParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelOfEntityOrParentMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Key management personnel of entity or parent [member]" } }, "en": { "role": { "documentation": "This member stands for those persons having authority and responsibility for planning, directing and controlling the activities of the entity, directly or indirectly, including any director (whether executive or otherwise) of that entity." } } }, "auth_ref": [ "r60" ] }, "ifrs-full_LaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanFiveYearsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than five years." } } }, "auth_ref": [ "r141", "r142", "r154", "r254", "r255", "r257" ] }, "ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanOneYearAndNotLaterThanFiveYearsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Later than one year and not later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than five years." } } }, "auth_ref": [ "r253", "r257" ] }, "SMX_LeaseExpiration": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "LeaseExpiration", "presentation": [ "http://smxpublicltd.com/role/LeasesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lease expiration", "documentation": "Lease expiration." } } }, "auth_ref": [] }, "ifrs-full_LeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilities", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Lease liability, beginning balance", "periodEndLabel": "Lease liability, ending balance", "label": "Lease liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } } }, "auth_ref": [ "r134" ] }, "SMX_LeaseLiabilitiesAccretionofInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "LeaseLiabilitiesAccretionofInterest", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Accretion of interest", "documentation": "Lease liabilities accretion of interest." } } }, "auth_ref": [] }, "SMX_LeaseLiabilitiesExchangeRateDifferences": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "LeaseLiabilitiesExchangeRateDifferences", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign exchange differences", "documentation": "Lease liabilities exchange rate of differences.", "label": "LeaseLiabilitiesExchangeRateDifferences" } } }, "auth_ref": [] }, "SMX_LeaseLiabilitiesForeignExchangeDifferences": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "LeaseLiabilitiesForeignExchangeDifferences", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCarryingAmountsOfLeaseLiabilitiesRecognizedInProfitOrLossDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign Exchange different", "documentation": "Lease liabilities foreign exchange differences.", "label": "LeaseLiabilitiesForeignExchangeDifferences" } } }, "auth_ref": [] }, "ifrs-full_LeaseLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilitiesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities [member]" } }, "en": { "role": { "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r235", "r236" ] }, "SMX_LeaseRecognizedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "LeaseRecognizedInProfitOrLoss", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCarryingAmountsOfLeaseLiabilitiesRecognizedInProfitOrLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total amount recognized in profit or loss", "documentation": "Lease recognized in profit or loss.", "label": "LeaseRecognizedInProfitOrLoss" } } }, "auth_ref": [] }, "ifrs-full_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Leasehold improvements [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement." } } }, "auth_ref": [ "r363" ] }, "SMX_LenderTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "LenderTwoMember", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lender two [member]", "documentation": "Lender two [member]" } } }, "auth_ref": [] }, "ifrs-full_Level1OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level1OfFairValueHierarchyMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Level 1 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } } }, "auth_ref": [ "r50", "r125" ] }, "ifrs-full_Level2OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level2OfFairValueHierarchyMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Level 2 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } } }, "auth_ref": [ "r125" ] }, "ifrs-full_Level3OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level3OfFairValueHierarchyMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Level 3 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability." } } }, "auth_ref": [ "r125" ] }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LevelsOfFairValueHierarchyAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r50", "r125" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "negatedLabel": "Liabilities", "label": "Liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r14", "r124", "r125", "r126", "r198", "r202" ] }, "SMX_LiabilitiesForGrantsReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "LiabilitiesForGrantsReceived", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails": { "parentTag": "ifrs-full_OtherCurrentPayables", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Liabilities for grants received (Note 19)", "documentation": "Liabilities for grants received." } } }, "auth_ref": [] }, "ifrs-full_LiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiabilitiesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of liabilities' axis if no other member is used. [Refer: Liabilities]" } } }, "auth_ref": [ "r127" ] }, "ifrs-full_LicencesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LicencesMember", "presentation": [ "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Licences [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r366" ] }, "ifrs-full_LineItemsByFunctionMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LineItemsByFunctionMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value of the \u2018Attribution of expenses by nature to their function' axis if no other member is used." } } }, "auth_ref": [ "r352", "r355" ] }, "SMX_LionheartIIICorpMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "LionheartIIICorpMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Lion heart III corp [member]", "documentation": "Lion heart III corp [member]" } } }, "auth_ref": [] }, "SMX_LionheartMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "LionheartMember", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lionheart [Member]", "documentation": "Lionheart [Member]" } } }, "auth_ref": [] }, "SMX_ListingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ListingCosts", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "SPAC transaction - listing costs", "documentation": "Listing costs." } } }, "auth_ref": [] }, "SMX_ListingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ListingExpenses", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Listing expenses", "documentation": "Listing expenses." } } }, "auth_ref": [] }, "SMX_LoanAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "LoanAgreementMember", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan agreement [member]", "documentation": "Loan agreement [member]" } } }, "auth_ref": [] }, "SMX_LoanAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "LoanAgreementsMember", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan agreements [member]", "documentation": "Loan agreements [member]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "ifrs-full_MachineryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MachineryMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Machinery [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing long-lived, depreciable machinery used in operations. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r221" ] }, "ifrs-full_MajorOrdinaryShareTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MajorOrdinaryShareTransactionsMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Major ordinary share transactions [member]" } }, "en": { "role": { "documentation": "This member stands for major ordinary share transactions. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r219" ] }, "SMX_MarketableSecuritiesHeldInTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "MarketableSecuritiesHeldInTrustAccount", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Marketable securities held in a trust account", "documentation": "Marketable securities held in trust account.", "label": "MarketableSecuritiesHeldInTrustAccount" } } }, "auth_ref": [] }, "ifrs-full_MaturityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MaturityAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Maturity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r16", "r131", "r141", "r142", "r145", "r146", "r148", "r154", "r179", "r186", "r225", "r254" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r314" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name" } } }, "auth_ref": [ "r314" ] }, "ifrs-full_MeasurementAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MeasurementAxis", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Measurement [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r85", "r89", "r124" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r333" ] }, "SMX_MonteCarloSimulationModelMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "MonteCarloSimulationModelMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Monte carlo simulation model [member]", "documentation": "Monte carlo simulation model [member]" } } }, "auth_ref": [] }, "ifrs-full_MotorVehiclesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MotorVehiclesMember", "presentation": [ "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Motor vehicles [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing self-propelled ground vehicles used in the entity's operations. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r222" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r341" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r315" ] }, "ifrs-full_NetDebt": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetDebt", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Debt principal amount", "label": "Net debt" } }, "en": { "role": { "documentation": "The amount of net debt of the entity." } } }, "auth_ref": [ "r355" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r314" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r312" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r311" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r341" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r341" ] }, "SMX_NonadjustingEventMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "NonadjustingEventMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Nonadjusting event [member]", "documentation": "Nonadjusting event [member]" } } }, "auth_ref": [] }, "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NonadjustingEventsAfterReportingPeriodAxis", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non-adjusting events after reporting period [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r35" ] }, "ifrs-full_NonadjustingEventsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NonadjustingEventsMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used." } } }, "auth_ref": [ "r35" ] }, "SMX_NoncashTransactionsDuringPeriodAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "NoncashTransactionsDuringPeriodAbstract", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Appendix A \u2013 Non-Cash transactions during the period:", "documentation": "Non cash transactions during period abstract." } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current assets", "label": "Non-current assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r17", "r111", "r237" ] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current assets" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentGovernmentGrants", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails": { "parentTag": "ifrs-full_GovernmentGrants", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails" ], "lang": { "en-us": { "role": { "label": "Long term liability at year end" } }, "en": { "role": { "documentation": "The amount of non-current government grants recognised on the statement of financial position as deferred income. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r357" ] }, "ifrs-full_NoncurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Lease liabilities", "label": "Non current" } }, "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r134" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current liabilities", "label": "Non-current liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r18", "r113", "r237" ] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current liabilities" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentPayables", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Long term payables" } }, "en": { "role": { "documentation": "The amount of non-current trade payables and non-current other payables. [Refer: Other non-current payables; Non-current trade payables]" } } }, "auth_ref": [ "r13" ] }, "ifrs-full_NotLaterThanOneYearMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotLaterThanOneYearMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Not later than one year [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of not later than one year." } } }, "auth_ref": [ "r15", "r141", "r142", "r154", "r254", "r257" ] }, "ifrs-full_NotesAndDebenturesIssued": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotesAndDebenturesIssued", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Convertible notes", "label": "Notes and debentures issued" } }, "en": { "role": { "documentation": "The amount of notes and debentures issued by the entity." } } }, "auth_ref": [ "r355" ] }, "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotesAndOtherExplanatoryInformationAbstract", "auth_ref": [] }, "ifrs-full_NotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotionalAmount", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Principal amount", "verboseLabel": "Notional amount" } }, "en": { "role": { "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument." } } }, "auth_ref": [ "r355" ] }, "SMX_NumberOfConvertibleNotesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "NumberOfConvertibleNotesIssued", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of convertible notes issued", "documentation": "Number of convertible notes issued." } } }, "auth_ref": [] }, "ifrs-full_NumberOfInstrumentsGrantedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfInstrumentsGrantedInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of shares issued", "label": "Number of instruments granted in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of instruments granted in share-based payment arrangement." } } }, "auth_ref": [ "r248", "r249" ] }, "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares granted", "verboseLabel": "Number of outstanding, Granted" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement." } } }, "auth_ref": [ "r167", "r371" ] }, "SMX_NumberOfIssuedAndOutstandingOrdinarySharesPercentage": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "NumberOfIssuedAndOutstandingOrdinarySharesPercentage", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of issued and outstanding ordinary shares percentage", "documentation": "Number of issued and outstanding ordinary shares percentage." } } }, "auth_ref": [] }, "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants exercised", "negatedLabel": "Number of outstanding, Vested" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement." } } }, "auth_ref": [ "r371" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of outstanding, Beginning", "periodEndLabel": "Number of outstanding, Ending", "label": "Number of other equity instruments outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r371" ] }, "ifrs-full_NumberOfOutstandingShareOptions": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOutstandingShareOptions", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of options outstanding Beginning balance", "periodEndLabel": "Number of options outstanding Beginning balance", "label": "Number of outstanding shares" } }, "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r156", "r161", "r164" ] }, "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Number of options, Exercisable", "label": "Number of exercisable shares" } }, "en": { "role": { "documentation": "The number of share options exercisable in a share-based payment arrangement." } } }, "auth_ref": [ "r162" ] }, "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Exercised", "label": "Number of share options exercised in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options exercised in a share-based payment arrangement." } } }, "auth_ref": [ "r159" ] }, "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of options, Expired", "label": "Number of options, Expired" } }, "en": { "role": { "documentation": "The number of share options expired in a share-based payment arrangement." } } }, "auth_ref": [ "r160" ] }, "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares cancelled" } }, "en": { "role": { "documentation": "The number of share options forfeited in a share-based payment arrangement." } } }, "auth_ref": [ "r158" ] }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Granted" } }, "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } } }, "auth_ref": [ "r157" ] }, "ifrs-full_NumberOfSharesAuthorised": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesAuthorised", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares authorized" } }, "en": { "role": { "documentation": "The number of shares authorised." } } }, "auth_ref": [ "r21" ] }, "SMX_NumberOfSharesConverted": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "NumberOfSharesConverted", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares converted", "documentation": "Number of shares converted." } } }, "auth_ref": [] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued", "verboseLabel": "Number of shares", "terseLabel": "Ordinary shares" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r353" ] }, "SMX_NumberOfSharesIssuedAndOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "NumberOfSharesIssuedAndOutstanding", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares issued and outstanding", "documentation": "Number of shares issued and outstanding." } } }, "auth_ref": [] }, "SMX_NumberOfSharesIssuedWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "NumberOfSharesIssuedWarrants", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued warrants", "documentation": "Number of shares issued warrants." } } }, "auth_ref": [] }, "ifrs-full_NumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesOutstanding", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance, shares", "periodEndLabel": "Ending balance, shares", "label": "Number of shares outstanding" } }, "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } } }, "auth_ref": [ "r23" ] }, "SMX_NumberOfValueConverted": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "NumberOfValueConverted", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of value converted", "documentation": "Number of value converted." } } }, "auth_ref": [] }, "ifrs-full_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OfficeEquipmentMember", "presentation": [ "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Office equipment [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing equipment used to support office functions, not specifically used in the production process. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r223" ] }, "SMX_OptionsExpectedLife": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "OptionsExpectedLife", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Options expected life", "documentation": "Options expected life." } } }, "auth_ref": [] }, "SMX_OptionsOutstandingFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "OptionsOutstandingFiveMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price five [member]", "documentation": "Exercise price five [member]" } } }, "auth_ref": [] }, "SMX_OptionsOutstandingFourMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "OptionsOutstandingFourMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price four [member]", "documentation": "Exercise price four [member]" } } }, "auth_ref": [] }, "SMX_OptionsOutstandingOneMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "OptionsOutstandingOneMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price one [member]", "documentation": "Exercise price one [member]" } } }, "auth_ref": [] }, "SMX_OptionsOutstandingThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "OptionsOutstandingThreeMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price three [member]", "documentation": "Exercise price three [member]" } } }, "auth_ref": [] }, "SMX_OptionsOutstandingTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "OptionsOutstandingTwoMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price two [member]", "documentation": "Exercise price two [member]" } } }, "auth_ref": [] }, "ifrs-full_OrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OrdinarySharesMember", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfWeightedAverageLossPerShareDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary shares [member]" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used." } } }, "auth_ref": [ "r72", "r361" ] }, "SMX_OrdinarySharesTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "OrdinarySharesTwoMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary Shares Two [Member]", "documentation": "Ordinary shares two [member]" } } }, "auth_ref": [] }, "SMX_OriginalIssueDiscount": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "OriginalIssueDiscount", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Original issue discount", "documentation": "Original issue discount." } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncome", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Other comprehensive loss for the period" } }, "en": { "role": { "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]" } } }, "auth_ref": [ "r4", "r27", "r33", "r116" ] }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeAbstract", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other comprehensive loss:" } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Exchange gains arising on translation of foreign operations" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r19", "r33" ] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, related to exchange differences on translation of the financial statements of a parent company or a stand-alone entity to a different presentation currency. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r33" ] }, "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive loss, net of tax", "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax" } }, "en": { "role": { "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r217", "r218" ] }, "ifrs-full_OtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentAssets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 }, "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Other current receivables", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]" } } }, "auth_ref": [ "r357" ] }, "ifrs-full_OtherCurrentFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentFinancialAssets", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Other" } }, "en": { "role": { "documentation": "The amount of current financial assets that the entity does not separately disclose in the same statement or note. [Refer: Other financial assets; Current financial assets]" } } }, "auth_ref": [ "r11" ] }, "ifrs-full_OtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentPayables", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 3.0 }, "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Other payables", "verboseLabel": "Total" } }, "en": { "role": { "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r357" ] }, "ifrs-full_OtherExpenseByNature": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherExpenseByNature", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 8.0 }, "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other", "label": "Others" } }, "en": { "role": { "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'nature of expense' form for its analysis of expenses. [Refer: Expenses, by nature]" } } }, "auth_ref": [ "r34", "r210" ] }, "ifrs-full_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other intangible assets [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r366" ] }, "ifrs-full_OtherNoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherNoncurrentLiabilities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other liabilities" } }, "en": { "role": { "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]" } } }, "auth_ref": [ "r357" ] }, "ifrs-full_OtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherPayables", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails": { "parentTag": "ifrs-full_OtherCurrentPayables", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Other", "negatedLabel": "Other accounts payable", "label": "Outstanding payables" } }, "en": { "role": { "documentation": "Amounts payable that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r357" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure Amount" } } }, "auth_ref": [ "r314" ] }, "ifrs-full_OtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherReceivables", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Other receivables" } }, "en": { "role": { "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r215" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r274" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r281", "r293", "r303", "r328" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r284", "r296", "r306", "r331" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r284", "r296", "r306", "r331" ] }, "ifrs-full_ParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ParValuePerShare", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Implied value", "verboseLabel": "Par value per share", "terseLabel": "Par value" } }, "en": { "role": { "documentation": "The nominal value per share." } } }, "auth_ref": [ "r22" ] }, "SMX_ParValuePerShareBeforeReverseSplit": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ParValuePerShareBeforeReverseSplit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Par value per share before reserve split", "documentation": "Par value per share before reverse split." } } }, "auth_ref": [] }, "SMX_ParValuePerSharePostReverseSplit": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ParValuePerSharePostReverseSplit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Par value per share, post reserve split", "documentation": "Par value per share post reverse split." } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r310" ] }, "SMX_PaymentOfCashPercent": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PaymentOfCashPercent", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payment of cash percent", "documentation": "Payment of cash percent." } } }, "auth_ref": [] }, "SMX_PaymentsForGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PaymentsForGovernmentGrants", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Government grants", "documentation": "Payments for government grants." } } }, "auth_ref": [] }, "SMX_PaymentsForProceedFromReceivingEquityOrOtherFundingConvertibleIntoEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PaymentsForProceedFromReceivingEquityOrOtherFundingConvertibleIntoEquity", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments for proceed from receiving equity or other funding convertible into equity", "documentation": "Payments for proceed from receiving equity or other funding convertible into equity." } } }, "auth_ref": [] }, "ifrs-full_PaymentsForShareIssueCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsForShareIssueCosts", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments for share issue costs" } }, "en": { "role": { "documentation": "The cash outflow for share issue costs." } } }, "auth_ref": [ "r367" ] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of lease liabilities", "negatedTerseLabel": "Lease Payments", "label": "Payments of lease liabilities, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r233" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r313" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r313" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r312" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r315" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r311" ] }, "SMX_PercentageOfCashOnExitFee": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PercentageOfCashOnExitFee", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of cash on exit fee", "documentation": "Percentage of cash on exit fee." } } }, "auth_ref": [] }, "SMX_PercentageOfCommonStock": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PercentageOfCommonStock", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of common stock", "documentation": "Percentage of common stock." } } }, "auth_ref": [] }, "SMX_PercentageOfConvertibleNotes": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PercentageOfConvertibleNotes", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of convertible notes", "documentation": "Percentage of convertible notes." } } }, "auth_ref": [] }, "ifrs-full_PercentageOfEntitysRevenue": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PercentageOfEntitysRevenue", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of entitys revenue" } }, "en": { "role": { "documentation": "The percentage of the entity's revenue. [Refer: Revenue]" } } }, "auth_ref": [ "r373" ] }, "SMX_PercentageOfFinancialRiskManagement": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PercentageOfFinancialRiskManagement", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfSensitivityAnalysisProfitAndOtherEquityDetails" ], "lang": { "en-us": { "role": { "label": "Percentage of financial risk management", "documentation": "Percentage of financial risk management." } } }, "auth_ref": [] }, "SMX_PercentageOfInterestsAcquiredIncrease": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PercentageOfInterestsAcquiredIncrease", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of interests acquired increase", "documentation": "Percentage of interests acquired increase." } } }, "auth_ref": [] }, "SMX_PercentageOfRevenue": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PercentageOfRevenue", "presentation": [ "http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of revenue", "documentation": "Percentage of revenue." } } }, "auth_ref": [] }, "SMX_PercentageOfRoyalty": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PercentageOfRoyalty", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of royalty", "documentation": "Percentage of royalty." } } }, "auth_ref": [] }, "ifrs-full_PercentageOfVotingEquityInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PercentageOfVotingEquityInterestsAcquired", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of voting equity interests acquired", "verboseLabel": "Percentage of interests acquired additional" } }, "en": { "role": { "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r169" ] }, "SMX_PercentageOfWeightedAveragePriceOfCommonStock": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PercentageOfWeightedAveragePriceOfCommonStock", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of weighted average price of common stock", "documentation": "Percentage of weighted average price of common stock." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r268" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r269" ] }, "SMX_PrePaidAdvanceAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PrePaidAdvanceAgreementMember", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prepaid advance agreement [member]", "documentation": "Prepaid advance agreement [member]" } } }, "auth_ref": [] }, "ifrs-full_PreferenceSharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PreferenceSharesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preference shares [member]" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are senior in some aspects to ordinary shares, but subordinate to debt instruments in terms of claim. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r361" ] }, "SMX_PrefundedWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PrefundedWarrantMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prefunded warrant [member]", "documentation": "Prefunded warrant [member]" } } }, "auth_ref": [] }, "SMX_PrepaidAdvance": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PrepaidAdvance", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Pre-paid advance", "documentation": "Prepaid advance." } } }, "auth_ref": [] }, "SMX_PrepaidAdvancePercentage": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PrepaidAdvancePercentage", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Prepaid advance percentage", "documentation": "Prepaid advance percentage." } } }, "auth_ref": [] }, "SMX_PrepaidAdvanceToDecreasePricePerShares": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PrepaidAdvanceToDecreasePricePerShares", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Pre-Paid Advance to decrease price per shares", "documentation": "Prepaid advance to decrease price per shares" } } }, "auth_ref": [] }, "SMX_PrinciplesOfConsolidationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PrinciplesOfConsolidationExplanatory", "presentation": [ "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Principles of consolidation", "documentation": "Principles of consolidation explanatory." } } }, "auth_ref": [] }, "SMX_PrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PrivateWarrantsMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Private warrants [member]", "documentation": "Private warrants [member]" } } }, "auth_ref": [] }, "SMX_ProceedFromIssuanceofWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ProceedFromIssuanceofWarrants", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance of warrants", "documentation": "Proceed from issuance of warrants." } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from borrowings, classified as financing activities" } }, "en": { "role": { "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]" } } }, "auth_ref": [ "r231" ] }, "SMX_ProceedsFromBridgeLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ProceedsFromBridgeLoans", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from bridge loans" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromExerciseOfOptions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromExerciseOfOptions", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net proceeds from offering" } }, "en": { "role": { "documentation": "The cash inflow from the exercise of options." } } }, "auth_ref": [ "r367" ] }, "ifrs-full_ProceedsFromExerciseOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromExerciseOfWarrants", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercise of warrants", "label": "Proceeds from exercise of warrants" } }, "en": { "role": { "documentation": "The cash inflow from the exercise of share purchase warrants." } } }, "auth_ref": [ "r367" ] }, "SMX_ProceedsFromGovernmentGrantsReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ProceedsFromGovernmentGrantsReceived", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Government grants received", "documentation": "Proceeds from government grants received." } } }, "auth_ref": [] }, "SMX_ProceedsFromIssuanceOfSecurityBundleNet": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ProceedsFromIssuanceOfSecurityBundleNet", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of Security Bundle, net", "documentation": "Proceeds from issuance of security bundle net." } } }, "auth_ref": [] }, "SMX_ProceedsFromIssuanceofDerivativeFinancialLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ProceedsFromIssuanceofDerivativeFinancialLiability", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance of derivative financial liability", "documentation": "Proceeds from issuance of derivative financial liability." } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssueOfBondsNotesAndDebentures", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of convertible notes" } }, "en": { "role": { "documentation": "The cash inflow from the issuing of bonds, notes and debentures." } } }, "auth_ref": [ "r367" ] }, "ifrs-full_ProceedsFromIssueOfOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssueOfOrdinaryShares", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from ordinary shares" } }, "en": { "role": { "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r367" ] }, "SMX_ProceedsFromIssuingEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ProceedsFromIssuingEquity", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuing equity", "documentation": "Proceeds from issuing equity." } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromIssuingOtherEquityInstruments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssuingOtherEquityInstruments", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issuance of shares in the SPAC transaction, net", "verboseLabel": "Proceeds from issuing other equity instruments" } }, "en": { "role": { "documentation": "The cash inflow from issuing equity instruments that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r230" ] }, "ifrs-full_ProceedsFromIssuingShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssuingShares", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of shares, net", "verboseLabel": "Proceeds from issuing shares", "terseLabel": "Proceeds from offering" } }, "en": { "role": { "documentation": "The cash inflow from issuing shares." } } }, "auth_ref": [ "r230" ] }, "SMX_ProceedsFromLoansAndWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ProceedsFromLoansAndWarrants", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from bridge loans and warrants", "verboseLabel": "Proceeds from loans and warrants", "documentation": "Proceeds from loans and warrants." } } }, "auth_ref": [] }, "ifrs-full_ProfessionalFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfessionalFeesExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Professional services" } }, "en": { "role": { "documentation": "The amount of fees paid or payable for professional services." } } }, "auth_ref": [ "r355" ] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 }, "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails", "http://smxpublicltd.com/role/ScheduleOfWeightedAverageLossPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Loss after income tax for the year attributable to shareholders", "negatedTotalLabel": "Loss after income tax for the period attributable to shareholders", "label": "Loss after income tax for the period", "verboseLabel": "Net Loss", "terseLabel": "Net loss attributable to the owners of the Company" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r3", "r26", "r92", "r103", "r105", "r198", "r200", "r237", "r245" ] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Loss before income tax", "negatedLabel": "Loss before income tax", "label": "Profit (loss) before tax" } }, "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r176", "r210", "r211", "r259", "r260" ] }, "ifrs-full_ProfitLossFromOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossFromOperatingActivities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Operating loss", "label": "Profit (loss) from operating activities" } }, "en": { "role": { "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r226", "r362" ] }, "SMX_ProofOfConceptProjectsPaidByAffiliatedCompanies": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ProofOfConceptProjectsPaidByAffiliatedCompanies", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails" ], "lang": { "en-us": { "role": { "label": "Proof of Concept projects paid by affiliated companies", "documentation": "Proof of concept projects paid by affiliated companies." } } }, "auth_ref": [] }, "SMX_ProofOfConceptReceivablesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ProofOfConceptReceivablesCurrent", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails": { "parentTag": "ifrs-full_OtherCurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Proof of concept receivables", "documentation": "Proof of concept receivables current." } } }, "auth_ref": [] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "periodStartLabel": "Property and equipment, beginning balance", "periodEndLabel": "Property and equipment, ending balance" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r8", "r46" ] }, "ifrs-full_PropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipmentMember", "presentation": [ "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r47", "r227", "r244" ] }, "ifrs-full_ProportionOfOwnershipInterestInAssociate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProportionOfOwnershipInterestInAssociate", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Proportion of ownership interest in associate", "verboseLabel": "Ownership percentage" } }, "en": { "role": { "documentation": "The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]" } } }, "auth_ref": [ "r67", "r70", "r109" ] }, "ifrs-full_ProportionOfOwnershipInterestInJointVenture": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProportionOfOwnershipInterestInJointVenture", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proportion of ownership interest in joint venture" } }, "en": { "role": { "documentation": "The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Joint ventures [member]]" } } }, "auth_ref": [ "r67", "r70", "r109" ] }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProportionOfOwnershipInterestInSubsidiary", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Percentage Owned" } }, "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r67", "r70", "r108" ] }, "SMX_ProvisionOfBorrowingToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ProvisionOfBorrowingToRelatedParties", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Provision of borrowing to related parties", "verboseLabel": "Provision for bonus (include interest)", "documentation": "Provision of borrowing to related parties." } } }, "auth_ref": [] }, "SMX_PublicOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PublicOfferingMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Public offering [member]", "documentation": "Public offering [member]" } } }, "auth_ref": [] }, "SMX_PublicWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PublicWarrantsMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Public warrants [member]", "documentation": "Public warrants [member]" } } }, "auth_ref": [] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property, plant and equipment", "label": "Purchase of property, plant and equipment, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r229" ] }, "SMX_PurchasePriceOfPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "PurchasePriceOfPerShare", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase price of per share", "documentation": "Purchase price of per share." } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r310" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r310" ] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Range [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r129", "r148", "r164", "r239", "r241", "r372" ] }, "ifrs-full_RangesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r129", "r148", "r164", "r239", "r241", "r372" ] }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r164" ] }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]" } } }, "auth_ref": [ "r164" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r276", "r288", "r298", "r323" ] }, "SMX_RedeemableWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "RedeemableWarrants", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Redeemable warrants", "documentation": "Redeemable warrants." } } }, "auth_ref": [] }, "SMX_RedeemableWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "RedeemableWarrantsMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Redeemable warrants [member]", "documentation": "Redeemable warrants [member]" } } }, "auth_ref": [] }, "SMX_RedeemableWarrantsTypeOneMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "RedeemableWarrantsTypeOneMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Redeemable warrants type 1 [member]", "documentation": "Redeemable warrants type 1 [member]" } } }, "auth_ref": [] }, "SMX_RedeemableWarrantsTypeTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "RedeemableWarrantsTypeTwoMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Redeemable warrants type 2 [member]", "documentation": "Redeemable warrants type 2 [member]" } } }, "auth_ref": [] }, "SMX_RedemptionPercentageOfBusinessCombination": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "RedemptionPercentageOfBusinessCombination", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Redemption percentage of business combination", "documentation": "Redemption percentage of business combination." } } }, "auth_ref": [] }, "SMX_ReimbursementFromPaidPilotsAndProofOfConceptProjects": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ReimbursementFromPaidPilotsAndProofOfConceptProjects", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Reimbursement from paid pilots and proof of concept projects", "documentation": "Reimbursement from paid pilots and proof of concept projects." } } }, "auth_ref": [] }, "ifrs-full_RelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RelatedPartiesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Related parties [member]" } }, "en": { "role": { "documentation": "This member stands for related parties. Related parties are persons or entities that are related to the entity that is preparing its financial statements (the reporting entity). (a) A person or a close member of that person\u2019s family is related to a reporting entity if that person: (i) has control or joint control over the reporting entity; (ii) has significant influence over the reporting entity; or (iii) is a member of the key management personnel of the reporting entity or of a parent of the reporting entity. (b) An entity is related to a reporting entity if any of the following conditions applies: (i) The entity and the reporting entity are members of the same group (which means that each parent, subsidiary and fellow subsidiary is related to the others). (ii) One entity is an associate or joint venture of the other entity (or an associate or joint venture of a member of a group of which the other entity is a member). (iii) Both entities are joint ventures of the same third party. (iv) One entity is a joint venture of a third entity and the other entity is an associate of the third entity. (v) The entity is a post-employment benefit plan for the benefit of employees of either the reporting entity or an entity related to the reporting entity. If the reporting entity is itself such a plan, the sponsoring employers are also related to the reporting entity. (vi) The entity is controlled or jointly controlled by a person identified in (a). (vii) A person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity). (viii) The entity, or any member of a group of which it is a part, provides key management personnel services to the reporting entity or to the parent of the reporting entity. [Refer: Joint ventures [member]; Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r61" ] }, "SMX_RemainingFundsInTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "RemainingFundsInTrustAccount", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Remaining funds in trust account", "documentation": "Remaining funds in trust account." } } }, "auth_ref": [] }, "ifrs-full_RepairsAndMaintenanceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepairsAndMaintenanceExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Office and maintenance" } }, "en": { "role": { "documentation": "The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts." } } }, "auth_ref": [ "r362" ] }, "SMX_RepaymentOfBridgeLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "RepaymentOfBridgeLoans", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of bridge loans", "documentation": "Repayment of bridge loans.", "label": "RepaymentOfBridgeLoans" } } }, "auth_ref": [] }, "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payment of debt", "verboseLabel": "Repayments of borrowings" } }, "en": { "role": { "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]" } } }, "auth_ref": [ "r232" ] }, "ifrs-full_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 2.0 }, "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Research and development expenses, net", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } } }, "auth_ref": [ "r83" ] }, "SMX_ResearchAndDevelopmentExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ResearchAndDevelopmentExpensesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Research and development expenses [member]", "documentation": "Research and development expenses [member]" } } }, "auth_ref": [] }, "SMX_ResearchExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ResearchExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Research expenses", "documentation": "Research expense." } } }, "auth_ref": [] }, "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfExchangeDifferencesOnTranslation", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation reserve" } }, "en": { "role": { "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r53" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r277", "r289", "r299", "r324" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r278", "r290", "r300", "r325" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r285", "r297", "r307", "r332" ] }, "ifrs-full_RestrictedShareUnitsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RestrictedShareUnitsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted share units [member]" } }, "en": { "role": { "documentation": "This member stands for a class of antidilutive instrument representing restricted share units." } } }, "auth_ref": [ "r365" ] }, "ifrs-full_RetainedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarnings", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Accumulated losses" } }, "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r216", "r218" ] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained earnings [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r6", "r212" ] }, "SMX_RevaluationOfConvertibleNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "RevaluationOfConvertibleNotes", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Revaluation of convertible notes", "documentation": "Revaluation of convertible notes.", "label": "RevaluationOfConvertibleNotes" } } }, "auth_ref": [] }, "ifrs-full_Revenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Revenue", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Revenue" } }, "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } } }, "auth_ref": [ "r29", "r115", "r176", "r194", "r199", "r204", "r205", "r207", "r210", "r211", "r237" ] }, "ifrs-full_RightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RightofuseAssets", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Right-of-use assets, beginning balance", "periodEndLabel": "Right-of-use assets, ending balance", "label": "Right-of-use assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } } }, "auth_ref": [ "r133", "r139" ] }, "SMX_RightofuseAssetsEffectofForeignExchange": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "RightofuseAssetsEffectofForeignExchange", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign currency translation", "documentation": "Right-of-use assets effect of foreign exchange.", "label": "RightofuseAssetsEffectofForeignExchange" } } }, "auth_ref": [] }, "ifrs-full_RightofuseAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RightofuseAssetsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets [member]" } }, "en": { "role": { "documentation": "This member stands for right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r132" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r341" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r341" ] }, "SMX_SMXBeveragesPtyLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SMXBeveragesPtyLtdMember", "presentation": [ "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "SMX beverages pty ltd [member]", "documentation": "SMX beverages pty ltd [member]" } } }, "auth_ref": [] }, "SMX_SMXCircularEconomyPlatformPTELtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SMXCircularEconomyPlatformPTELtdMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "SMX circular economy platform pte ltd [member]", "documentation": "SMX circular economy platform pte ltd [member]" } } }, "auth_ref": [] }, "SMX_SMXIrelandLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SMXIrelandLimitedMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "SMX ireland limited [member]", "documentation": "SMX ireland limited [member]" } } }, "auth_ref": [] }, "SMX_SMXIsraelLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SMXIsraelLtdMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "SMX israel ltd [member]", "documentation": "SMX israel ltd [member]" } } }, "auth_ref": [] }, "SMX_SMXPublicLimitedCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SMXPublicLimitedCompanyMember", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "SMX Public Limited Company [member]", "documentation": "SMX Public Limited Company [member]" } } }, "auth_ref": [] }, "ifrs-full_SalesAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SalesAndMarketingExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Selling and marketing expenses" } }, "en": { "role": { "documentation": "The amount of expense relating to the marketing and selling of goods or services." } } }, "auth_ref": [ "r362" ] }, "SMX_SecondAnniversaryMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SecondAnniversaryMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Second anniversary [member]", "documentation": "Second anniversary [member]" } } }, "auth_ref": [] }, "SMX_SecondInstallmentMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SecondInstallmentMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Second installment [member]", "documentation": "Second installment [member]" } } }, "auth_ref": [] }, "SMX_SecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SecuritiesPurchaseAgreementMember", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Securities purchase agreement [member]", "documentation": "Securities purchase agreement [member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r262" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r266" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r265" ] }, "SMX_SecurityMattersCanadaLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SecurityMattersCanadaLtdMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Security matters canada ltd [member]", "documentation": "Security matters canada ltd [member]" } } }, "auth_ref": [] }, "SMX_SecurityMattersFranceLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SecurityMattersFranceLtdMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Security matters france ltd [member]", "documentation": "Security matters france ltd [member]" } } }, "auth_ref": [] }, "SMX_SecurityMattersLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SecurityMattersLimitedMember", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedParties", "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesTables", "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiability", "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilities", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ControlledEntities", "http://smxpublicltd.com/role/ControlledEntitiesTables", "http://smxpublicltd.com/role/ConvertibleNotes", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/CriticalAccountingEstimatesAndJudgements", "http://smxpublicltd.com/role/FairValueMeasurement", "http://smxpublicltd.com/role/FairValueMeasurementTables", "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagement", "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables", "http://smxpublicltd.com/role/General", "http://smxpublicltd.com/role/GeneralAndAdministrativeExpenses", "http://smxpublicltd.com/role/GeneralAndAdministrativeExpensesTables", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/GeneralTables", "http://smxpublicltd.com/role/GovernmentGrants", "http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative", "http://smxpublicltd.com/role/GovernmentGrantsTables", "http://smxpublicltd.com/role/IntangibleAssetsNet", "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/IntangibleAssetsNetTables", "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompanies", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesTables", "http://smxpublicltd.com/role/Leases", "http://smxpublicltd.com/role/LeasesDetailsNarrative", "http://smxpublicltd.com/role/LeasesTables", "http://smxpublicltd.com/role/LossPerShare", "http://smxpublicltd.com/role/LossPerShareTables", "http://smxpublicltd.com/role/OtherCurrentAssets", "http://smxpublicltd.com/role/OtherCurrentAssetsTables", "http://smxpublicltd.com/role/OtherPayables", "http://smxpublicltd.com/role/OtherPayablesTables", "http://smxpublicltd.com/role/PropertyAndEquipmentNet", "http://smxpublicltd.com/role/PropertyAndEquipmentNetTables", "http://smxpublicltd.com/role/RelatedParties", "http://smxpublicltd.com/role/RelatedPartiesTables", "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNet", "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNetTables", "http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfCarryingAmountsOfLeaseLiabilitiesRecognizedInProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails", "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfDepreciationRatesOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails", "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails", "http://smxpublicltd.com/role/ScheduleOfInformationAboutConsolidatedStructuredEntitiesDetails", "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails", "http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails", "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails", "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetails", "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails", "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails", "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfPropertyPlantAndEquipmentDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails", "http://smxpublicltd.com/role/ScheduleOfRightOfUseAssetsDetails", "http://smxpublicltd.com/role/ScheduleOfSensitivityAnalysisProfitAndOtherEquityDetails", "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails", "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails", "http://smxpublicltd.com/role/ScheduleOfUnobservableForAssetsOrLiabilityDetails", "http://smxpublicltd.com/role/ShareholdersEquity", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityTables", "http://smxpublicltd.com/role/SignificantAccountingPolicies", "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies", "http://smxpublicltd.com/role/SignificantAccountingPoliciesTables", "http://smxpublicltd.com/role/SubsequentEvents", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsTables", "http://smxpublicltd.com/role/SummaryOfIntangibleAssetsNetDetails", "http://smxpublicltd.com/role/TaxesOnIncome", "http://smxpublicltd.com/role/TaxesOnIncomeDetailsNarrative", "http://smxpublicltd.com/role/TaxesOnIncomeTables" ], "lang": { "en-us": { "role": { "label": "Security matters limited [member]", "documentation": "Security matters limited [member]" } } }, "auth_ref": [] }, "SMX_SecurityMattersLimitedsShareOfNetAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SecurityMattersLimitedsShareOfNetAssetsMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfInformationAboutConsolidatedStructuredEntitiesDetails" ], "lang": { "en-us": { "role": { "label": "Security Matters Limited's share of net assets [member]", "documentation": "Security Matters Limited's share of net assets [member]" } } }, "auth_ref": [] }, "SMX_SecurityMattersLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SecurityMattersLtdMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfAssetsAndLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Security Matters Ltd [member]", "documentation": "Security Matters Ltd [member]" } } }, "auth_ref": [] }, "SMX_SecurityMattersPTYLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SecurityMattersPTYLtdMember", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Security matters pty ltd [member]", "documentation": "Security matters pty ltd [member]" } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r270" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "auth_ref": [] }, "SMX_ShareInEarningsLossesOfAssociatedCompaniesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ShareInEarningsLossesOfAssociatedCompaniesNet", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Share of net loss of associated companies", "documentation": "Share in earnings losses of associated companies net.", "label": "ShareInEarningsLossesOfAssociatedCompaniesNet" } } }, "auth_ref": [] }, "ifrs-full_ShareIssueRelatedCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShareIssueRelatedCost", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Recapitalization due to issuance of shares following the SPAC transaction, net", "verboseLabel": "Stock expense" } }, "en": { "role": { "documentation": "The amount of cost related to the issuance of shares." } } }, "auth_ref": [ "r353" ] }, "SMX_ShareIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ShareIssuedPricePerShare", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share price", "documentation": "Share issued price per share." } } }, "auth_ref": [] }, "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Share of net loss of associated companies" } }, "en": { "role": { "documentation": "The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]" } } }, "auth_ref": [ "r31", "r196", "r203" ] }, "ifrs-full_SharePremium": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SharePremium", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital" } }, "en": { "role": { "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value." } } }, "auth_ref": [ "r216" ] }, "SMX_SharePurchasePrice": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SharePurchasePrice", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share purchase price", "verboseLabel": "Exercise price of warrants", "documentation": "Share purchase price." } } }, "auth_ref": [] }, "SMX_ShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ShareholdersMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Shareholders [member]", "documentation": "Shareholders [member]" } } }, "auth_ref": [] }, "SMX_SharesIssuedAndOutstandingPercent": { "xbrltype": "percentItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SharesIssuedAndOutstandingPercent", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares issued percent", "documentation": "Shares issued and outstanding period." } } }, "auth_ref": [] }, "SMX_SharesIssuedForExerciseOfStockOptionsShares": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SharesIssuedForExerciseOfStockOptionsShares", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise of stock options shares", "documentation": "Shares issued for exercise of stock options, shares." } } }, "auth_ref": [] }, "ifrs-full_ShorttermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermBorrowings", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Borrowings from related parties", "periodStartLabel": "Borrowings from related parties, beginning balance", "periodEndLabel": "Borrowings from related parties, ending balance", "verboseLabel": "Current borrowings" } }, "en": { "role": { "documentation": "The amount of current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r357" ] }, "ifrs-full_ShorttermEmployeeBenefitsAccruals": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermEmployeeBenefitsAccruals", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails": { "parentTag": "ifrs-full_OtherCurrentPayables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Employees, salaries and related liabilities" } }, "en": { "role": { "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]" } } }, "auth_ref": [ "r360" ] }, "ifrs-full_SignificantInvestmentsInAssociatesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SignificantInvestmentsInAssociatesAxis", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Associates [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r68", "r71", "r122" ] }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r68", "r71", "r120" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r271" ] }, "SMX_SpecialPurposeAcquisitionCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SpecialPurposeAcquisitionCompanyMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherReceivablesDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Special Purpose Acquisition Company [Member]", "documentation": "Special Purpose Acquisition Company [Member]" } } }, "auth_ref": [] }, "SMX_StandbyEquityPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "StandbyEquityPurchaseAgreementMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Standby equity purchase agreement [member]", "documentation": "Standby equity purchase agreement [member]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/InterimCondensedConsolidatedChangesInShareholdersEquity", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetails", "http://smxpublicltd.com/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfWeightedAverageLossPerShareDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r6" ] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://smxpublicltd.com/role/BorrowingsFromRelatedParties", "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesDetailsNarrative", "http://smxpublicltd.com/role/BorrowingsFromRelatedPartiesTables", "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiability", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilities", "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative", "http://smxpublicltd.com/role/ControlledEntities", "http://smxpublicltd.com/role/ControlledEntitiesTables", "http://smxpublicltd.com/role/ConvertibleNotes", "http://smxpublicltd.com/role/CriticalAccountingEstimatesAndJudgements", "http://smxpublicltd.com/role/FairValueMeasurement", "http://smxpublicltd.com/role/FairValueMeasurementTables", "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagement", "http://smxpublicltd.com/role/FinancialInstrumentsAndRiskManagementTables", "http://smxpublicltd.com/role/General", "http://smxpublicltd.com/role/GeneralAndAdministrativeExpenses", "http://smxpublicltd.com/role/GeneralAndAdministrativeExpensesTables", "http://smxpublicltd.com/role/GeneralTables", "http://smxpublicltd.com/role/GovernmentGrants", "http://smxpublicltd.com/role/GovernmentGrantsDetailsNarrative", "http://smxpublicltd.com/role/GovernmentGrantsTables", "http://smxpublicltd.com/role/IntangibleAssetsNet", "http://smxpublicltd.com/role/IntangibleAssetsNetDetailsNarrative", "http://smxpublicltd.com/role/IntangibleAssetsNetTables", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompanies", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesTables", "http://smxpublicltd.com/role/Leases", "http://smxpublicltd.com/role/LeasesTables", "http://smxpublicltd.com/role/LossPerShare", "http://smxpublicltd.com/role/LossPerShareTables", "http://smxpublicltd.com/role/OtherCurrentAssets", "http://smxpublicltd.com/role/OtherCurrentAssetsTables", "http://smxpublicltd.com/role/OtherPayables", "http://smxpublicltd.com/role/OtherPayablesTables", "http://smxpublicltd.com/role/PropertyAndEquipmentNet", "http://smxpublicltd.com/role/PropertyAndEquipmentNetTables", "http://smxpublicltd.com/role/RelatedParties", "http://smxpublicltd.com/role/RelatedPartiesTables", "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNet", "http://smxpublicltd.com/role/ResearchAndDevelopmentExpensesNetTables", "http://smxpublicltd.com/role/ScheduleOfBorrowingsFromRelatedPartiesDetails", "http://smxpublicltd.com/role/ScheduleOfCarryingAmountsOfLeaseLiabilitiesRecognizedInProfitOrLossDetails", "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails", "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetailsParenthetical", "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfGovernmentGrantsDetails", "http://smxpublicltd.com/role/ScheduleOfInformationAboutConsolidatedStructuredEntitiesDetails", "http://smxpublicltd.com/role/ScheduleOfKeyManagementPersonnelDetails", "http://smxpublicltd.com/role/ScheduleOfLeaseLiabilityDetails", "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails", "http://smxpublicltd.com/role/ScheduleOfOrdinarySharesDetails", "http://smxpublicltd.com/role/ScheduleOfOtherCurrentAssetsDetails", "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails", "http://smxpublicltd.com/role/ScheduleOfSensitivityAnalysisProfitAndOtherEquityDetails", "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails", "http://smxpublicltd.com/role/ShareholdersEquity", "http://smxpublicltd.com/role/ShareholdersEquityTables", "http://smxpublicltd.com/role/SignificantAccountingPolicies", "http://smxpublicltd.com/role/SignificantAccountingPoliciesPolicies", "http://smxpublicltd.com/role/SignificantAccountingPoliciesTables", "http://smxpublicltd.com/role/SubsequentEvents", "http://smxpublicltd.com/role/SubsequentEventsTables", "http://smxpublicltd.com/role/TaxesOnIncome", "http://smxpublicltd.com/role/TaxesOnIncomeDetailsNarrative", "http://smxpublicltd.com/role/TaxesOnIncomeTables" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r280", "r292", "r302", "r327" ] }, "SMX_StockIssuedDuringPeriodValueConsiderationOfIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "StockIssuedDuringPeriodValueConsiderationOfIssuanceOfCommonStock", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consideration of issuance of common stock", "documentation": "Stock issued during period value consideration of issuance of common stock." } } }, "auth_ref": [] }, "SMX_StockOptionVestingPeriod": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "StockOptionVestingPeriod", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock option vesting period", "documentation": "Stock option vesting period." } } }, "auth_ref": [] }, "SMX_SubcontractorsAndConsultants": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "SubcontractorsAndConsultants", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Subcontractors and consultants", "documentation": "Subcontractors and consultants." } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r321" ] }, "ifrs-full_TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Unrecognized temporary differences and tax losses for which deferred tax weren\u2019t recognized" } }, "en": { "role": { "documentation": "The amount of benefit arising from a previously unrecognised tax loss, tax credit or temporary difference of a prior period that is used to reduce current tax expense. [Refer: Temporary differences [member]; Unused tax losses [member]; Unused tax credits [member]]" } } }, "auth_ref": [ "r220" ] }, "SMX_TaxEffectAmountsWhichAreNotDeductibletaxableInCalculatingTaxableIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "TaxEffectAmountsWhichAreNotDeductibletaxableInCalculatingTaxableIncomeAbstract", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Tax effect amounts which are not deductible/(taxable) in calculating taxable income:", "documentation": "Tax effect amounts which are not deductible taxable in calculating taxable income [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Non-deductible expenditure and others" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]" } } }, "auth_ref": [ "r38" ] }, "ifrs-full_TaxEffectOfTaxLosses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfTaxLosses", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/TaxesOnIncomeDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tax effect of tax losses" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]" } } }, "auth_ref": [ "r38" ] }, "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxExpenseIncomeAtApplicableTaxRate", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails": { "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfComponentsOfIncomeTaxExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Theoretical tax rate of 27.5%" } }, "en": { "role": { "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r38" ] }, "ifrs-full_TechnologybasedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TechnologybasedIntangibleAssetsMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Technology-based intangible assets [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing assets based on technology. Such assets may include patented and unpatented technology, databases as well as trade secrets. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r366" ] }, "SMX_ThirdAnniversaryMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ThirdAnniversaryMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Third anniversary [member]", "documentation": "Third anniversary [member]" } } }, "auth_ref": [] }, "SMX_ThreeValuationModelsMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "ThreeValuationModelsMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Three valuation models [member]", "documentation": "Three valuation models [member]" } } }, "auth_ref": [] }, "ifrs-full_TopOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TopOfRangeMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Top of range [member]" } }, "en": { "role": { "documentation": "This member stands for top of a range." } } }, "auth_ref": [ "r129", "r148", "r164", "r239", "r241", "r372" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r313" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r320" ] }, "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToRelatedParties", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails": { "parentTag": "ifrs-full_OtherCurrentPayables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOtherPayablesDetails" ], "lang": { "en-us": { "role": { "label": "Related party" } }, "en": { "role": { "documentation": "The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]" } } }, "auth_ref": [ "r360" ] }, "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers", "crdr": "credit", "calculation": { "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Trade payables" } }, "en": { "role": { "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]" } } }, "auth_ref": [ "r214", "r360" ] }, "ifrs-full_TradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherPayables", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Trade, other payables and warrants" } }, "en": { "role": { "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]" } } }, "auth_ref": [ "r13" ] }, "SMX_TradeAndOtherPayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "TradeAndOtherPayablesMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfUndiscountedFinancialLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Trade and other payables [member]", "documentation": "Trade and other payables [member]" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherReceivablesDueFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherReceivablesDueFromRelatedParties", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfBalanceWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Borrowings from related parties", "label": "Receivables due from related parties" } }, "en": { "role": { "documentation": "The amount of receivables due from related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r215" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r340" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r342" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "SMX_TransactionCost": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "TransactionCost", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Transaction cost", "documentation": "Transaction cost." } } }, "auth_ref": [] }, "ifrs-full_TravelExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TravelExpense", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails": { "parentTag": "ifrs-full_ResearchAndDevelopmentExpense", "weight": 1.0, "order": 6.0 }, "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smxpublicltd.com/role/ScheduleOfResearchAndDevelopmentExpenseDetails" ], "lang": { "en-us": { "role": { "label": "Travel expenses" } }, "en": { "role": { "documentation": "The amount of expense arising from travel." } } }, "auth_ref": [ "r355" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r343" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r344" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r342" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r342" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Aggregate Available" } } }, "auth_ref": [ "r345" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r343" ] }, "SMX_TrueGoldConsortiumPtyLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "TrueGoldConsortiumPtyLtdMember", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "True gold consortium pty ltd [member]", "documentation": "True gold consortium pty ltd [member]" } } }, "auth_ref": [] }, "SMX_TwoExecutiveDirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "TwoExecutiveDirectorMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Two Executive Director [Member]", "documentation": "Two Executive Director [Member]" } } }, "auth_ref": [] }, "ifrs-full_TypesOfAntidilutiveInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfAntidilutiveInstrumentsAxis", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfRestrictedStockUnitDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Types of antidilutive instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r75" ] }, "ifrs-full_TypesOfContractsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfContractsAxis", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Types of contracts [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r243", "r246" ] }, "ifrs-full_TypesOfContractsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfContractsMember", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/GeneralDetailsNarrative", "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of contracts with customers. It also represents the standard value for the 'Types of contracts' axis if no other member is used." } } }, "auth_ref": [ "r243", "r246" ] }, "ifrs-full_TypesOfRisksAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfRisksAxis", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "Types of risks [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r149", "r150", "r151", "r153", "r178", "r181", "r182" ] }, "ifrs-full_TypesOfRisksMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfRisksMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfFinancialAssetsAndImpactOfCreditExposureDetails", "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used." } } }, "auth_ref": [ "r149", "r150", "r151", "r153", "r178", "r181", "r182" ] }, "SMX_UnderwriterWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "UnderwriterWarrantMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwriter warrant [member]", "documentation": "Underwriter warrant [member]" } } }, "auth_ref": [] }, "SMX_UnderwritingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "UnderwritingAgreementMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwriting agreement [member]", "documentation": "Underwriting agreement [member]" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r339" ] }, "SMX_UnitedStatesDollarMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "UnitedStatesDollarMember", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfForeignCurrencyRiskDetails" ], "lang": { "en-us": { "role": { "label": "United states dollar [member]", "documentation": "United states dollar [member]" } } }, "auth_ref": [] }, "SMX_UnpaidContingentLiabilityGovernance": { "xbrltype": "monetaryItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "UnpaidContingentLiabilityGovernance", "crdr": "debit", "presentation": [ "http://smxpublicltd.com/role/CommitmentsAndContingentLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Unpaid contingent liability governance", "documentation": "Unpaid contingent liability governance." } } }, "auth_ref": [] }, "ifrs-full_WagesAndSalaries": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WagesAndSalaries", "crdr": "debit", "calculation": { "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smxpublicltd.com/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Wages and salaries related" } }, "en": { "role": { "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]" } } }, "auth_ref": [ "r364" ] }, "SMX_WarrantAMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantAMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant A [member]", "documentation": "Warrant A [member]" } } }, "auth_ref": [] }, "SMX_WarrantBMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantBMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant B [member]", "documentation": "Warrant B [member]" } } }, "auth_ref": [] }, "SMX_WarrantCashExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantCashExercisePrice", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant cash exercise price", "documentation": "Warrant cash exercise price." } } }, "auth_ref": [] }, "SMX_WarrantCashlessExercised": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantCashlessExercised", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant cashless exercised", "documentation": "Warrant cashless exercised." } } }, "auth_ref": [] }, "SMX_WarrantExerciseDescription": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantExerciseDescription", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant exercise description", "documentation": "Warrant exercise description." } } }, "auth_ref": [] }, "SMX_WarrantPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantPricePerShare", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants price per share", "documentation": "Warrant price per share." } } }, "auth_ref": [] }, "SMX_WarrantTermDescription": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantTermDescription", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant term description", "documentation": "Warrant term description." } } }, "auth_ref": [] }, "SMX_WarrantsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantsExercisePrice", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants exercise price", "verboseLabel": "Warrant exercise price", "documentation": "Warrants exercise price." } } }, "auth_ref": [] }, "SMX_WarrantsExercisePricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantsExercisePricePerShare", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants exercise price per share", "documentation": "Warrants exercise price per share." } } }, "auth_ref": [] }, "SMX_WarrantsExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantsExpirationDate", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants expiration date", "documentation": "Warrants expiration date." } } }, "auth_ref": [] }, "SMX_WarrantsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantsIssued", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants issued", "documentation": "Warrants issued." } } }, "auth_ref": [] }, "ifrs-full_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WarrantsMember", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants [member]" } }, "en": { "role": { "documentation": "This member stands for a class of antidilutive instrument representing warrants." } } }, "auth_ref": [ "r365" ] }, "SMX_WarrantsPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantsPricePerShare", "presentation": [ "http://smxpublicltd.com/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrants price per share", "documentation": "Warrants price per share.", "label": "WarrantsPricePerShare" } } }, "auth_ref": [] }, "SMX_WarrantsTerm": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantsTerm", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants term", "verboseLabel": "Excepted terms", "documentation": "Warrants term." } } }, "auth_ref": [] }, "SMX_WarrantsToPurchaseOrdinaryShares": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantsToPurchaseOrdinaryShares", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants to purchase ordinary shares", "documentation": "Warrants to purchase ordinary shares." } } }, "auth_ref": [] }, "SMX_WarrantsToPurchaseShares": { "xbrltype": "sharesItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantsToPurchaseShares", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants to purchase shares", "verboseLabel": "Warrants to purchase, shares", "documentation": "Warrants to purchase shares." } } }, "auth_ref": [] }, "SMX_WarrantsToPurchaseSharesInConvertedSharesDescription": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WarrantsToPurchaseSharesInConvertedSharesDescription", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Converted shares description", "documentation": "Warrants to purchase shares in converted shares, description." } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrants exercise price", "label": "Weighted average exercise price of other equity instruments exercised or vested in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r371" ] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value grant" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r371" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted average exercise price, Exercisable", "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r162" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average exercise price, Expired", "label": "Weighted average exercise price of share options exercised in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r159" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, Expired" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r160" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, Granted" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r157" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price, outstanding beginning balance", "periodEndLabel": "Weighted average exercise price, outstanding beginning balance", "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r156", "r161" ] }, "ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageFairValueAtMeasurementDateShareOptionsGranted", "crdr": "credit", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average fair value at measurement date, share options granted" } }, "en": { "role": { "documentation": "The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r166" ] }, "SMX_WeightedAverageNumberOfOrdinarySharesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WeightedAverageNumberOfOrdinarySharesAbstract", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails", "http://smxpublicltd.com/role/ScheduleOfWeightedAverageLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares", "documentation": "Weighted average number of ordinary shares [Abstract]" } } }, "auth_ref": [] }, "SMX_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019": { "xbrltype": "durationItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life of exercisable share options", "documentation": "Weighted average remaining contractual life of exercisable share options 2019." } } }, "auth_ref": [] }, "SMX_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions": { "xbrltype": "dateItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life of outstanding share options", "documentation": "Weighted average remaining contractual life of outstanding share options." } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfOptionsToEmployeesOutstandingDetails", "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average remaining contractual life of outstanding share options", "terseLabel": "Exercise price", "label": "Weighted average remaining contractual life of outstanding share options [Default Label]" } }, "en": { "role": { "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r164" ] }, "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageSharePriceShareOptionsGranted2019", "presentation": [ "http://smxpublicltd.com/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smxpublicltd.com/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average share price, share options granted", "verboseLabel": "Exercise price of share warrants" } }, "en": { "role": { "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]" } } }, "auth_ref": [ "r165" ] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://smxpublicltd.com/role/ScheduleOfLossPerShareDetails", "http://smxpublicltd.com/role/ScheduleOfWeightedAverageLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares used in calculating basic loss per share" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r74" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://smxpublicltd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r349" ] }, "SMX_YahalomaTechnologiesIncMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "YahalomaTechnologiesIncMember", "presentation": [ "http://smxpublicltd.com/role/InvestmentsInAssociatedCompaniesDetailsNarrative", "http://smxpublicltd.com/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Yahaloma technologies inc [member]", "documentation": "Yahaloma technologies inc [member]" } } }, "auth_ref": [] }, "SMX_YorkvilleMember": { "xbrltype": "domainItemType", "nsuri": "http://smxpublicltd.com/20230630", "localname": "YorkvilleMember", "presentation": [ "http://smxpublicltd.com/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Yorkville [Member]", "documentation": "Yorkville [Member]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard", "URIDate": "2023-03-23" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2023-03-23" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2023-03-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard", "URIDate": "2023-03-23" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2023-03-23" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2023-03-23" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_b&doctype=Standard", "URIDate": "2023-03-23" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2023-03-23" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_d&doctype=Standard", "URIDate": "2023-03-23" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2023-03-23" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2023-03-23" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61_a&doctype=Standard", "URIDate": "2023-03-23" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61&doctype=Standard", "URIDate": "2023-03-23" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard", "URIDate": "2023-03-23" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2023-03-23" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard", "URIDate": "2023-03-23" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2023-03-23" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2023-03-23" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard", "URIDate": "2023-03-23" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_c&doctype=Standard", "URIDate": "2023-03-23" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2023-03-23" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2023-03-23" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard", "URIDate": "2023-03-23" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&anchor=para_21&doctype=Standard", "URIDate": "2023-03-23" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2023-03-23" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2023-03-23" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_c&doctype=Standard", "URIDate": "2023-03-23" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2023-03-23" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2023-03-23" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73&doctype=Standard", "URIDate": "2023-03-23" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2023-03-23" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI", "URIDate": "2023-03-23" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_142&doctype=Standard", "URIDate": "2023-03-23" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "20", "IssueDate": "2023-01-01", "Paragraph": "39", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&anchor=para_39_a&doctype=Standard", "URIDate": "2023-03-23" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "20", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS20_g39-39_TI", "URIDate": "2023-03-23" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Paragraph": "52", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_b&doctype=Standard", "URIDate": "2023-03-23" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2023-03-23" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2023-03-23" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18&doctype=Standard", "URIDate": "2023-03-23" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_f&doctype=Standard", "URIDate": "2023-03-23" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard", "URIDate": "2023-03-23" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2023-03-23" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2023-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2023-03-23" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2023-03-23" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard", "URIDate": "2023-03-23" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2023-03-23" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2023-03-23" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI", "URIDate": "2023-03-23" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2023-03-23" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2023-03-23" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard", "URIDate": "2023-03-23" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard", "URIDate": "2023-03-23" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI", "URIDate": "2023-03-23" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "32A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_32A&doctype=Standard", "URIDate": "2023-03-23" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard", "URIDate": "2023-03-23" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2023-03-23" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2023-03-23" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard", "URIDate": "2023-03-23" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "40", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_40_a&doctype=Standard", "URIDate": "2023-03-23" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "46", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_46&doctype=Standard", "URIDate": "2023-03-23" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2023-03-23" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "f", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_f_i&doctype=Standard", "URIDate": "2023-03-23" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "29", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_29_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "49", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2023-en-r&anchor=para_49_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2023-03-23" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2023-03-23" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_b&doctype=Standard", "URIDate": "2023-03-23" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "19B", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_b&doctype=Standard", "URIDate": "2023-03-23" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "19B", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2023-03-23" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "21", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_21_a_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B4", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B4", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Section": "Nature of the risks associated with an entity's interests in consolidated structured entities", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS12_g14-17_TI", "URIDate": "2023-03-23" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2023-03-23" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2023-03-23" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2023-03-23" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93&doctype=Standard", "URIDate": "2023-03-23" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS13_g91-99_TI", "URIDate": "2023-03-23" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2023-03-23" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "114", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard", "URIDate": "2023-03-23" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "120", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2023-03-23" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2023-03-23" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2023-03-23" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_c&doctype=Standard", "URIDate": "2023-03-23" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_h&doctype=Standard", "URIDate": "2023-03-23" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2023-03-23" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "59", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_59&doctype=Standard", "URIDate": "2023-03-23" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard", "URIDate": "2023-03-23" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "97", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_97&doctype=Standard", "URIDate": "2023-03-23" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI", "URIDate": "2023-03-23" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Presentation", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI", "URIDate": "2023-03-23" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "109", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109&doctype=Standard", "URIDate": "2023-03-23" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "109A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2023-03-23" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "117", "Subparagraph": "c", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_117_c_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard", "URIDate": "2023-03-23" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "124", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_124&doctype=Standard", "URIDate": "2023-03-23" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "125", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_125&doctype=Standard", "URIDate": "2023-03-23" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "128", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "128", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a&doctype=Standard", "URIDate": "2023-03-23" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "132", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2023-03-23" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_a&doctype=Standard", "URIDate": "2023-03-23" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_v&doctype=Standard", "URIDate": "2023-03-23" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b&doctype=Standard", "URIDate": "2023-03-23" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2023-03-23" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2023-03-23" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "51", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_51_a&doctype=Standard", "URIDate": "2023-03-23" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "m", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_m&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "n", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_n_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "13C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_13C&doctype=Standard", "URIDate": "2023-03-23" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "21C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21C&doctype=Standard", "URIDate": "2023-03-23" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "23B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2023-03-23" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2023-03-23" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2023-03-23" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2023-03-23" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42E", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2023-03-23" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42I&doctype=Standard", "URIDate": "2023-03-23" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard", "URIDate": "2023-03-23" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8&doctype=Standard", "URIDate": "2023-03-23" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B52", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B52&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Defined terms", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI", "URIDate": "2023-03-23" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI", "URIDate": "2023-03-23" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2023-03-23" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_e&doctype=Standard", "URIDate": "2023-03-23" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_g&doctype=Standard", "URIDate": "2023-03-23" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2023-03-23" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2023-03-23" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2023-03-23" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2023-03-23" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2023-03-23" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard", "URIDate": "2023-03-23" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2023-03-23" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.34&doctype=Standard", "URIDate": "2023-03-23" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.42", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.42&doctype=Standard", "URIDate": "2023-03-23" }, "r210": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard", "URIDate": "2023-03-23" }, "r211": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r212": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r213": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard", "URIDate": "2023-03-23" }, "r214": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard", "URIDate": "2023-03-23" }, "r215": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r216": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r217": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82A&doctype=Standard", "URIDate": "2023-03-23" }, "r218": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r219": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "22", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&anchor=para_22_f&doctype=Standard", "URIDate": "2023-03-23" }, "r220": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "80", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_80_e&doctype=Standard", "URIDate": "2023-03-23" }, "r221": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_c&doctype=Standard", "URIDate": "2023-03-23" }, "r222": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_f&doctype=Standard", "URIDate": "2023-03-23" }, "r223": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_h&doctype=Standard", "URIDate": "2023-03-23" }, "r224": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2023-03-23" }, "r225": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "147", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2023-03-23" }, "r226": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "32", "IssueDate": "2023-01-01", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r227": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r228": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_g&doctype=Standard", "URIDate": "2023-03-23" }, "r229": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2023-03-23" }, "r230": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2023-03-23" }, "r231": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_c&doctype=Standard", "URIDate": "2023-03-23" }, "r232": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_d&doctype=Standard", "URIDate": "2023-03-23" }, "r233": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r234": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "44", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44_c&doctype=Standard", "URIDate": "2023-03-23" }, "r235": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "44C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44C&doctype=Standard", "URIDate": "2023-03-23" }, "r236": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Section": "C Reconciliation of liabilities arising from financing activities", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI", "URIDate": "2023-03-23" }, "r237": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r238": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard", "URIDate": "2023-03-23" }, "r239": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r240": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE60", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE60&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r241": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r242": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r243": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r244": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r245": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2023-03-23" }, "r246": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "96", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_a&doctype=Standard", "URIDate": "2023-03-23" }, "r247": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "96", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2023-03-23" }, "r248": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_a&doctype=Standard", "URIDate": "2023-03-23" }, "r249": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "IG23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_IG23&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r250": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard", "URIDate": "2023-03-23" }, "r251": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2023-03-23" }, "r252": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard", "URIDate": "2023-03-23" }, "r253": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r254": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r255": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r256": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r257": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "IG31A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r258": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "IG40B", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG40B&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r259": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r260": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r261": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r262": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r263": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r264": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r265": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r266": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r267": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r268": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r269": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r270": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r271": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r272": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r273": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r274": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r275": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r276": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r277": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r278": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r279": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r280": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r281": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r282": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r283": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r284": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r285": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r286": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r287": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r288": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r289": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r290": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r291": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r292": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r293": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r294": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r295": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r296": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r297": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r298": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r299": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r300": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r301": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r302": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r303": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r304": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r305": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r306": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r307": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r308": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r310": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r311": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r312": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r313": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r314": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r315": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r316": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r317": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r318": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r319": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r320": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r321": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r322": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r323": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r324": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r325": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r326": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r327": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r328": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r329": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r330": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r331": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r332": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r333": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r334": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r335": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r336": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r337": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r338": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r339": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r340": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r341": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r342": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r343": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r344": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r345": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r346": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r347": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r348": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r349": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r350": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r351": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2023-03-23" }, "r352": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard", "URIDate": "2023-03-23" }, "r353": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2023-03-23" }, "r354": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r355": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2023-03-23" }, "r356": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard", "URIDate": "2023-03-23" }, "r357": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r358": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r359": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r360": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard", "URIDate": "2023-03-23" }, "r361": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r362": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard", "URIDate": "2023-03-23" }, "r363": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard", "URIDate": "2023-03-23" }, "r364": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "9", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_9&doctype=Standard", "URIDate": "2023-03-23" }, "r365": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2023-03-23" }, "r366": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119&doctype=Standard", "URIDate": "2023-03-23" }, "r367": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r368": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2023-03-23" }, "r369": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2023-03-23" }, "r370": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r371": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r372": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r373": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" } } } ZIP 123 0001493152-24-008230-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-008230-xbrl.zip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

    +=%0Y1Z$(Y(1!%YRQR6TPO/JGVG- MFN)1[!%L7U\8*M:D#H"3@O?/*8TTJ=YI*2ZGN:)+731MM7+1LZ27I ^9H55R M^2J_P APHA]_Q2OB':@W=MTL ;)(R(94O!DIVZ$ZI6S$FXM+?FR:],A MG6).!CMV0)&@68H'^::I3T%D %/3/8PJBDE3>SDA8X]6A9!3,D$>WFS;MY@' M.>5+0/$\@>4Z7;1-OB+2T$=GEXNV7/G!Y).7#!,(+QC#AW='V.7VBS>+6"PT MH4>I\'@P!!EL9-!=T')RWJ)<*R,DN)(AG\:JZ2FI1.:_R-D["=477[*E2P1^ M,_EZ8C(YQLU@J2MP?&M>A90IU]0%?\[ES=%M+<=91!!Z;[F[O\*K?E*L6)W\ M4"QI@:1/CBF;^5@L+;9D,(^T@=M\O4O_5C4+MV5?87=\#]OX1ER5GYI54:6_ MD!7CU4DKOMRP,:,>6;9C[J>?2$='_>\W3*GAMD*7J#EUCOY/?W_3P9OUYEJ3 MJ:8]/T]/^8$V95UN^DWZ^/E?V/YI(8GQO.:R[@V^?\,/:J].)B>E/R;\%@3M M%W4^'9.__NW)G;(%10LWD4M@*/=@,X]_&SQY*%+;=YO0L&F>_Y MYCXLE?GSQ_\O19=)SY]_&?C$;,/=63)ZF9 M8_=3U/RPTW>6F1-3].8W.QSA*02!)99TPG;**58@OZX9_+.R8 B63!&?8B0N MHR$9+H?I9K$#U+X?=1??B M;EI_XF%G;0:Y/HQEZJAWCWE:7ZGES'X6NR;Q.9!6XH4O_A@&2 MB:?1P&M[I^V+D:()I'?JRG[,$*\@P-^#[.*-21 M!F1CM-06PA1D'F./H[67%U8L*#GB%V#+PG4]9T9\E>!&R@B :YZ\2?6,L?$Z M)OQL)+Q8$P!1A3#%5+B-X08%0P +;<5)LW;FC:M$;R6X^=_V% MDNA"1^G/G"@SY&84*JBG>=IPN!$[!$KZA@3&DIFF=L@KJ/196I4UVP^!B2_) M)VWJ&75[F_8IBK&1P!.'D3[=:;91*9J.Q0<$++KN%KT[Y6I/EM=QG*5:CT=I M)/D@I6RYG5%0Y^T.Z*\%;#+#H1 Y1V2;H]7'RS\ *SUJG3PZ>#.U!Y('??NI M-"Y<'!='):IV;UJ<[EV.ZNJJ\K.YJOQ)J\J/YZKRO:TJ?X$CYZZ+&GVQ8N9O M1R='R1F![@3DZF&A3>N;W/#31>V^^!2XPNJ@9X^R1?[RB"_H-S;93VHRRG M^OC1\&(BW$R=E=O@:&?T#<]PP^A9Y[:3]G;#7:DL]UYS6RIGQ([2_^%&')R0 MON 11\[>$?\V.UL\P<;"G0C/];EP TO(9PM7)YQH_ M$RIP%[6O^;%YIR= #]WD>SP4:/@8AYP$Z;:I*1_@BY'SO6 MZEVI<3N6HN[2)-JELA"UH]I3+USR&+DGD_*9G][!-[_1D8J<'>/>".<8O;4.+SW^X.:=G>C@\A)F _F9V@!NXW Y.IO;]Q):? M/.$?A$<>_4V?U^L?JWY,\0&4 )RV8EB3L#XW-3G4^/RJ6.RH?;+MB63\('+17]ELZJ M_:S*SJ^V+GE ^2XO\_9!.*=]E68I24BR5SKO5*UCK1%TJ%Z =]^LX8>#)JGK M)BU/S'#C28F[!;TC%:C4->V!?E.=$*F7D*-(!8Y\SPBHDI?9NC@ T'[!$W"4 MOIJV'^QX4*YGZ.GZ/HM]=LP2_;8%O1UU91EJ?:DRH?M@IQP/=FTE@6EB?' 0 MW_#@ CWV+(VTL-:K*;!V?]\D\,K#1W/PAO2[X?6PS>)CK8VFFL^?&WF" MAB "%[?G0&3YDWT+;3@=\HBT.?$4)$WN-G5WIG_5RUM2:*.A6!<0$,!"'8@@ M^ 7E@6S;G(X3JWA01AY*=L6@98.C[>:#=I2^R9U_:,>J.^,F<:@5H*ZVHZ.2 MON4"Q+)CP08!^$7',*]I:]+L=65,]@T^JJ5A*I5?BH_WNY:A^.*QX6?!5K=% M4I+S6W9_>!(:W\D&*@T"/VADQ\SJ0A##9F M2UJRWU0)5M 29]1-<7=_![2@,[65(Z;3XS OJ@E\IG1Q.]JQ-Q[JCW>BIS0,OJ^O5#)O']VW>O ML\F5%+C?$(Q_\SSRQIU92]PN)PE1LHJBMT.V1V\M?])0^_G8H<^%@TC:SYU] M]RYYR8Q8(*RSUY9?T7YAGHZ"N(UP[IT5UA1^CZ>U1!A2'$) MQ" >6 LKHLTRXFB;+@59HUIQCB)M_IM-"9PVS0I''U&D27:-;R1M%SD9*O)R M6"&3PUAKKTP60_8_A(4'R23\A:[$'A=%[DOOD4-?*_0ID0N6D[XY9>+HH5QH M $1O0K2>1^GW!;,!F3LNW:Y"MX076XYR6&[,:J7 F!ZRP9U2NE,&Q3BZDSH) M\/N<*VX#EGQ#R4#67[EM^$E\DTE$6K?CM9VF_9#4S>!3=0LPFOS?/"L]=, M(XU7R/28*'U>T%^],?>= JM_$2[2$Q:,],RE^6E;3)2F)#VQ&&2))IW<&V5 MYEKS0=6:IX7WY3'F&!WQ+<[SU2[ M9\U1OMFNMP?B+U#S5Z'6F/OLF#GLXX?79^SE,2)Z,I]\^TWS]0#'+Y0 M\KIA'=W'+[]]D='3H9_0/:CM L&'0A_+VQL\2$;>913PA;!I*88:P\%C(??1 M-@*UP]$0Z5WC4>'8$4X>]V[R).+9?ZO!K"S-$<(?>I-G2GPY2A((^Y[&6XX] M3T2V*!W:EMAS-@LQEUK]9;0D$[LDP7T\+G(-4_I3B(@KGI?Q.#9K.K5R>*&$ MKA53+Y(KJ",1TBYF8Y%PH/S!WEY?V>V=;&_[7V8V4.(WT)\QV'<^&WPU!/;Y M#(']I!#8)S,$=H; WBF3'H,!*=_KS[8'*S\#;]%6>?%VX);@,B$ ^/069&#*N_UX."8Y$AR ][S- M( ,Z2'WNO6C9>?P@P=LZ"QA:%9#+H:[54ZV*L%<\N#P[/B5>0=T7TX4CL "I M<6LXP$T]C$@S1!8A28(I[_KV,OG%W)WRM!Y^UQ:[MA$"4^YY?CAX#4(/R"/I M'/N')*;^6/=O;VHP\=&T"WA"?M#+U@MRE/*H@_[$O2XI>XU[YT;U/K0'BV^4 M1+B^SED25@Q?IT'0ED[%NM-Y-D2]./YF^!F\'S$:UK82::!TF54WER(6I8.1R+QSX#D:L M69ZI(NX>Y'",T_6P*7@LJI80M5937_L"F=1$\!S-)+L,MR;[AZ #XE(P3F#E M2GUBN 5_3L'[?/0P]R%FNZL;]Z0HDL_H/ T^F%[O/25C[RG*^#- PY_[J[); M]EUGZJX/E!+LQXCA'I#=E\EJ*3@\33'3 NCB0U48:&"+)&!'$Q.^*M<*YFW];[ MQ,,)F/"Q6F9S[>1P+/GO10*\E'%6-)(CY/@N]C@"S5.4@A>UJT!T &0EK; ! M-1]$",0YF5C5R7+"=Q)X@ZB?CH66.3X(])WKD<#,?]RQE1@RAC9#.,P@?O1+ M1EF^/:_F_K O _EOR/.9-.--;_QODA\,Z<:;/_)D*E/>X].#+_[;__7RQ3"^F<]YVAS%/![[M MABZJD !F4:6.N(V(][G8R:^HO-6X*S;M?9CE>3<>QCP=^&ZL0$7"KBG8C$Q^ MTF=QE-!BQ%$;*\70E;@DMVO:2Y/)A+ $J30G MQP\J:QG)X@::(LOFT:_*84-:)MKV1G ([*VY8((HO;F@%4-A6+\[$T$D)"XE MR8MF2A;KJ%:Y1 4;9B,1X*R MEJQ[+IX7WGY:8X/OP(N2FR(B*/E%(?0]=39<^K2Q(" MT,@1;JP<2A+Q9H*M*2@X.^,'1>0UQ.=W5*EQ%X", ^M;YR5=7HKZ5KK*<%5Y MZ2JIK6=R^&[S2V8_(I7O?%4DBV)W@>NZ)5Y6)1WT9#GSZ/!FU!NISP6'@-J7 MQY]B#R*G4("YM]I*Y8EH:P+2SKUUJ>TD]:6E"+_9 MUIVM]JTR1%/BK.]:,#7]F%_,1O;6'JF_&E*P55,P/AD!?TU3Z(Q-(.7PS"@X M;+NBH-*H4%+.9^FAG:4ZZSB6:F"^TU6Q=&<72P32&84_$Q%$6 (X)T&HDV]+ M\%\RRRV,^)[%,W$)Y3(-BRBQO*;Z7%RMZ1C:R-#K.$(E4D1B(0*00@43K5PC MGLN-Y(4[T80/2*DYW(D&^BN^H!)%T%&>C%;]'L6(> @\[1:?4\"\N:GW=4-=R_FAKM/VG#W=&ZXN[<-=_? F-P9 M[XP\Z(23942+H&!_G'3T MJ/_@O):(08]"ZK!(QFE;CL_T$\.F$2PH_D2 I!ZEVGY@EUKRL])!GPC1T7LH MTB[3W_.VS6LK\AP6(*=; I6\O,2^IU1O*U_^LR^9-:R3ITRZ7;[9IJM^=SE* MP_"7PP>$--EN(Z7;4FTQ$'5K)T%XVB"5"Q^W*KL=^\G$MBA$WLD/O[YFG]/3 M2A"K6]\NG9/M+OU7?YH^)A#VOA!<&Z^27@C#?*PC0-FYEK/H-_?X5%C"*)VX1O.JZ9EF&#"8W MY_&ZAL(D)\LV^1]<$0G; U_^T?W_K( .+;?DE.LU=L8N(T+RJMR4.TI0;K:[ M;K@3HT8["L*VSJV6/-ZF.9]N!'1#X]P?K. L#?>PUU+"?]% 1[S5+)@6+5WG MYVX%&!;O#Q53;'DE+2E':1Y6M,WR6E49:&:@+RR59JS9U M;ULUEX62V?BG3 (78.JY #F_/#!OQ $9F3A*1O_5]WI<9^;F=,E!';2?=A=C MP5'M@DSBV9U[A/J:Y5K(G&44 .[>AMR4N5?>5[/SKOU MPT -J'.KQ]SJ,2-WW N()HEB=Z;UHSC_%].,D0*72-/OF(2$>)E^36HKI,QN1+S.0P07-+1F'>(?X%($+N'"S>(/OV!I2>5:*< M/A;Z#,.6(*P'Q7 UF/*70/H(RJ@N+D!C(10Z_BMGY;8CP?3;NEMFK.J,53VP MB7*>X%FYD!UM@KM4X'TNVKEP\<^N8-%%Y#-PEC7]SL6O>5UNP.B4;^%0NA!/ MY/>,6.U$U/7%$*5W,73Z+$B/7RQ0JNS2GT4>X MGE>>)B4L&NT18YH*^:(. M$@ OYCIA K-PNHK&C"H6="[B"6RVZ M%L7*$&,D@MZ%&"I!@8_2MWV+](A'$>,I&;L\2[_)TB?'3Y[2"J#R:HB")N4'^R[>9M"'ZEL+ M)1DIGGQ%DKXGSP"OF/? 56_T>Y&$4I!/^;7$VT:"E)3.8SSM5#LZI>%S26-@1. MJ>B PV'C_ 9BC%V6S*E%1TZ\^"'EU F!4MW4^Y+QT38+AP7J!;R?1I=.K$7Q MHS5OI-N\D83J/['E5*G1; L1:Y*%1U@(M^3"4M+*ZN3*$4^DJ)0]$&[(J8-ME6DO9O7_15/UJ1%[DZU5ZMS$H\"HC^=6J)ARY(L M0A*Y>&&]BZ='&A2R95;$7+EF+UTA^;WJ8LM#>! ^&9QLD(#9,W9)]^!6QII1CH 8TR60KW9<3ZNZHB]-F5U)DU#6CE^/6ANH"6 T_(I.KPRP!(%>9 MB1IRUN01T!'A_B0KC60M5IYTZ?*F^% MXW0M/'74P^&6Q<2CR6QP57.CR[YQ)X4\D2BG&9YA?_XMW)&(_A8]X!BFPJ\D MP%P6SML]@.K=$+O,6]$N#JIMIF;-G30:B8 ',HB8>DE:K^]\ M<5:PP!Z!H( M_.MP[!)R&LQ=41=(:6-'A-B,TH#,]7M-R,1X3;^TPC[KKMU>R>3V(F>7?&6" MWJ+Z2O2FTB 9Z)0Y6L&T MDMFAF94GM)L^H2F="*-)"U@H2B34_W,F=4_0:D<\N>$)(%:)M17-B*[*JM<' M'<9:LV6ZU99)>,<1A0M6C7M\"94CI1.U3>-P?V"9RC5O-K_J182EI1,8*Z-9 MN->3^HE9B]#$3&C)&G:YM8N(NE7^3^K<"#1#@W20Z!3YA[>EGJE'UF>DO<'/ MQW5)[#A_;<4?)9R1(+AY1WOX-' M0!\<0A:(@MW]AI'NY!=RH3.G)A7B6/?.5')-Q3/3DE.^Z"A$%,LGV7FQWV:>UVPYS*?^V'1]8F8/LO=94NG$IY5K7]JK"R54+Y"CYP4:(5^M0:/#H M@Z%\"?*I[DK[<.V;/TFJT#%WF]I M]RM&BJT C();(;1Q;.F-8"R=_S-USKEK2;!:U"LAY)S.!R!6&4(YBNS:E*#N M,E[9B-6=2XM0 %\T]LH\M+LT7@[0K*UN6CZ_J*K9TJ/0CG+!OF_BU)IK)UQ' M-&I-^"+1Y6'?F3,GLGK)?JLW:17,QB4[!%D*H+]@=11=.>69E5$>U;.$IVRP$' M9-%23HAN0KY95?Z!%#2S8.G?&VKOK(%>87VHT6Z4U."W ME;@4^"GX^1R2=PV#T0(T)WRQ J^=](>*=TZ)@IK';$G0F$DG MGMCY]#J)5[#DPR&"Q"A%-I)Q.B*#!\K#P1I$S7P.P8>#Q648QNGQ2\+XA:F@ M6([];AEWSWS#_@Y5FA9MDZ\B^MMS.0W[SKL)-46,%GI#!65)$%Z="%00/ CG+YO> MXYGS4R95 \=] M%?$^;38X[P(QH/5:[])4WKW%^^C%024B%6!Q;OX0/8YD#*>"B[2A-+!SF<(5FG;N@N"W&8YS0&!-64[8M M".6[@/0"L\R?P%-D4VI4F>I/$9R+1:FHSSCOSI*U"VCGM.E7E#'Y&W?L)B"Y M2-]R87FF:OPRGCXYF+\7R(=HCQIG&A5Y26XGJ,!W"GPGN8$I";:Q[S+0L8F2Q#/3\4$Q M';_JDIQ;H*FGXOH%E$XLH'@QN(7=12N[Q(1'!=U5W3)D$AMF]=_)+\#*'ZR:PL7$_V"XXHYFU\W===OW,"];YV-8/*]5\+^ M<$&5JXZ!]PJX\![HP;' EN&MSR37;-!9(%[EL] MU5F7XR$<+<@364//CI_M7Y]Z1.C)Q:-.Z "B)G&[-*T:-[,(Q!-W<=B]4W7 M=&_F **ME2$(=_J?/W]_@NM_-E?F-DJ;O9PKA9^T4OABKA3.E<([83<.ZP5& M@_NNE@A'V[S4!!^IQA%N$CU'F5^)B-L!PA?AHE!4C?>#1Y^[?)4*O9AZ&^]81 I6BO=I%, MEP@9+S],3+!AXRCJLSXK"ZEX^M$QK^RO&3WZC79XPIAE^I;$C:>D.2'E?([B MBM5D[3-.:?A*<$@>N&_32+BKJDX9=4ARNKB,"#42KV1&&[VGRBY]54Y3(FCM M1J\U';^9[U&PV'%^1[+K6$S-ZG,5)@_G6/VBGA1+BU^E1:>&Z[Q!7N<+\*#/ M?M&G[JR^@>+@:)8M4)W[YIE[&6FWO@,,HZBZX@*5+=^O8.O9.,P9B1!ZN))K MGR#T;)M#N"(KZ3ZRA= ''J9&0A("'[XK>T,\%6LCHKHH+AM)<@Y\)3UM3/)Q M%IJ[T4O.0G/7SL6!R^[ _\JKBA[:'E?[G_^N MSM.!;SQNRJ)G)G2AXE%6_DPD7WN/&"N)N0KQ'Y[$(YLUZ&/-TX)M5 MJLKTT(I%\3F+;=O\@WW?+HK%X=\*J:\F;R1HEN2"0H?!N5\0FT)!;$C^;1G_C3QB+<3!UV2A7FG@K3-XG? MBS4ZVY+#F*<#MR5NH[$K8"@UN7(AC7[=&=+F0%R3:HSJB=5@QN927.EVMZ!? M1PR!$\FR>[$JYMU[&/-T1W;O\(3ET@@777>@,!/H*C[PY/B[.O^C6-&_'W\W MV.!*L8BL=+DE/"PIT,Y!^ $LAWG?'LA$M<6R[4MJAM*TV:H \%G:;_\ 0Y2B M&N[%A,X;[S#FZ< WGAZ8Q;*IF\TEXS]<]"K$\F,%WSU)Z[)> 4YW>2_F?-Z; MAS%/![XWZ^*"'ABXQ\QV8Q%C95>N"(3GCLHE1'QWY*NZ[S 2;]L6)E5$!,6F MLTQRUL-=K&W.]V)US+OX,.;IX'@AS/Z\30]DHMI^ _)S/+-Q?"&7(:O-(<;K8G/&-LSF)7$I@9%6+3%;0KEF^+7=,#[#A#-9\+M_^A3/O M\ .9* 2_?2F;>W=&K5,U:_% 27B5YJ=Y67=1J]3TO$JSNFT)L&WZQR-JA..P M3 B(?P4OP[/CF9?AD_(R?#/S,MQ;7H:Y">:CC?# JVK9IRX[$WK2)3?G! =GSMY!_F2R/ M HS#C%W8.\F[C'Y];!3P. /<;*]Z]J\J,H0;C)#E?N1";"H#;I*N\O.71A? M^D?OGG,E:GKX11"HEU-28$[\+0]CG@Y\6Y)(VE17WD@];;JI?9Q:FDKS M6F7;HRL#T4]-4_ 5& GN$?G"NSH)8G],- -,J;1/#VFHP'"T U.F0+]14SAO MJM[](NH!)?PXBT00F5.Q2I6VID03*,AI IFRI5Z@92H]W);T>\W\";X<<92> M!%Z0B;_SW3U9PXJE,]QG:N=E]K5ZL$#DE1U(A$#BT]3NEZJ7&=I31UWF+%7C MG^2=J"[FW2[C\5-*=HY7['A%-!@SH1MAE^-SI- MA?K"C@"YBS^(R L,6.=Y MM:^H;NUVE@CE$6N#0QJU8,F;YD*2_XRR*0(/\"40JZW0^(^$KB?.DYE\YZ#L MOUV;(*:\(!E5F7XM =?DUR!594UROR/O7H3?O=(MK<@/U.-77::/GZ7NP2I8 MMN$J?^ 3%0EQJOW[M_ZC]MIN]3V"#I$SG_IP#S,VOT(7]OC;[/&W+[+C)]^. ME>2QU?CP,='25O^Q8O'7-28QLLSYJF$UF* MX@^P";4K*IN98KFT5,J 2".UV><734N;5HIK64A@4&(E2F-,&HJ1/1CSYH%_ M^U^R,'S^4A8FZ8JZ1$XHK_\8R-ZN66 **)\.$]8R?[D[7OE$@YW*0#,(.D71 MRX(P2>9UB\YYQ@FJ;7P:1L+!0L'L6[I1ER2EO*(,! M],8R8V\@2!@ORW;9;W"E9?&9=:?NQ]EZ"\Q90*B8GL=_>4ND=DM5G0B;-VI23O8BN6L6>-./;6QU)W(VW&, M.>_: UD,\ZX]D(G274NI3G3WGS?"^MT6]2DSL!02R#>;\>R$3I?KTI%3:D9,NZ^++%N $B\FXF+[Y*80"0 MI5J96_;(Q2F7"XLC."^LADK& B$YR8>DY5HS:3V*=4: ,-*XBUMF]69)=#,O M^$M:@%.+D&0_\AVA/W"^$!F=<+?-58!#39M]W$(,\H7BU7OYPO0576?/!4;B MHTU=>4$1DI[Q/*0737I9Y-SADKO0@@B'/7=A!SD26=5(\N,RT5>TTML5%1>B MPW=7^2Z7,I=7J!'Q@+*I26B%Z0]+NE*DWRFR ZP;Y!6 C>1(V'N14,'HQ5E/ M.VB?- O:R?2F39L 4MD%*9B2T)=>IZCV^C0J";-7GB:C\LZ$9;!B1VUQFK?D M_05)*FHRJCOZ1")*K\.'1N;&_;)^M"C9>JYRA-?FJ\64-552:$.'!+RI62^?$,J6C+TJN MJ5677%1BC=^ /DAL 0A3K.L<,(;1H'0]BDU[AR4N)\GYL@4/@YN/B[."\N/> MR//YX-;:*IDZ']P#+(K1*3%0Z>8%+8JL+"(/Q/$'J00!7;%F)=IP6]QQZD1* MKKTCK; 0S.3R63F_A-50'# 55!J^ENH27^6@)7(#DLPULC1S7>D.')"B?K8A M,[W?!/CM[*+LMBJ1L&[6_Y$^*!_R+^N5+IZU,\;.5./(FH2TT[;>-3O2;J[! MP>]NU05*?7>9?W]\=/Q-NN#R^7?N)G*7*G>W7>5[.1?LK4/YBA]J[5[&W0]2 MSJ0P)I=8439>'C/YT=WOS'U[)Z+0&P9;D6Q629K,RB"^7A=08*:'DZ>++C4X M&+N^4,EI"(KA!?7],$@X; PP(4'I-UVQQC/OSL*=<_Q36Q2/Z W9R'T'*_^@ M/+_Y/"C\"JUP^T*RLZ):)8M+>C" V\JJ));CXL.R*)QU__=OCH\]OB'W:$R: M("6HT9G"\&V:#F?LDK7)62Q0(&0-"7C3L_ZS=T-?M/?!M%S=J?AX[E3\I)V* MW\Z=BO>V4_$>&).[ZJE([Y-Q=!Q"NAOVD;?/'8KG>8MZQ%A:E>/\\7-E MR(:ID&??6I0/'9P4722DYJFRGP2O"XSF8[]H%.M_WC-V8%$.>O%_E?PI37]= M(' WLR\L)C%V404IX&:%B;9Y$(KQ"-,*'"4^YUVTAD2EG5/LEOJKH$*K=U+I M8D27?F,!UI^?-RWOLJ+=2&/L#ID$79$L[XSUZO8 @OZI=>E.:Z)0FWR%9/@* MB$BBIY_3L@=ES:?7-[CU7;FX2N"\ MZ>P5ZZ,'=;")%@ DPN:<399%!IH",<(@J')O=NK6&RTO%X;U@@9OBX"D5\3W M$.%M. /,PL4OS;JUDOTA-,N[%W$T_\BS@=NGQ1Y.I\X&;ZE*D65ILWWR%]$PAB&/) MH/I&NU6D+@]:!;]7S=0?I3\B&J;T\-JY(58^KU#FI!JGH?UI2A/O6<@:$F_O:VEM>.5693X^8FE](@?KML:DK)YWP%[/U(PQF3YF=LW#4R M$+:GFD F51A^\J4SU>[1R2$H,)R$=O7SBPX330GY49,1N\R2L-O":MXV\+SQ M9;.NM:]WS\I8:_7#[U2[/PGWKMN3/0N_-5+:+]UG=Y#O1]SX)5WGUH5$[IH+ M+.(TA_&B4YTBMHN"'0[8(PD-N5K&&RE>296"N'TIRZVGO^?=*O\G[2!W,;]5 MQA>C0\@@$L;7C:(_+$5['WR;[Y6^%@/Q$S\J?RI?YW.T]4_6YP632\G-'05O(H=51[W>]?_$X[V"]0R'=678Y M[,GC<>>Q++IDE3G#LZ3ZC327I,+9=@G&S>0*4KCW=H=(&5= M;OJ-B5&CIDS>)1_VQL8.#ZA01 MN^>$ H+?N'2[J]C1SD$F#Y_^4=;G_P;[.QQ']B)^("$D\CX>X&,".#K9Y>NU MP(L>8D=AR\N.8L8'W: __O@Z?2#?X@_HUS(<-6Z$AJ36M-N/(PL0_ZDRS_[TMG;@@*\$M8VOX%&&8R/-"N ML3S<:[]P%XXP!@/#ES1J^)3?Y8JKIA?NJHL"RJVHI![3@ST]IJ*MXG)L%1)] MNIC ']P44Y/LX\>T I["?/E5\3Q+J&OZ"Z[Z>Q^:R='9W=%N55#Q]3$+L6WK]Q^\#K=/MHEM.O=D*5G8[-.7#1VU3[#7Z MRG?79;MA#."@1J,FC;%]&*UB-35>R=7C]37WP'P.?UR>;M44"L#\<[O#,GZ- M-L(@>>%BIE,B_E@#BQI2@MA45.HC39?U ,^KH:--?:@$^-7Q'>V>(=R&$43. M@!#&I@MN/GGC@DEDL-'8*<<%?]U_V/HA T['HC2O'D/.B$=VXNFWA@[ = M8304)65X!R][L47&;3+8)8'XF(EE(YMAYCC11QD? H"U79%PVJISGT8I%+F< MI;,OSDI1^!U-:P%6+P996E?C M]'\T%WA,>C!W 1?I$S3;#8/<\O([25SMY;+%W=P MIJDN%;^VMSXQY6VJJ_!G_6+R)^ABP858%/XZ.[X,^YN3Q^9=FHW;$49](1R$ M3B>[)-V^MI^_2@UU6%W@5*=T#Z$]84>P?Y(ZH/@#500+/"/@/R^=Q&3I+PHA M*FRC=+S4K]:Y6ZX6<3G" %"2@<\NHP(QDY#-)&0SP0)4]5AV&H@5Q*T,VBA5 MD5:2#O_L&Q68QLZEO>B#PGM!HS'3G1S&/!WX;I1.=-F3S@E;82/.>^X IW+> MV&V.D#6&)[EO//Q7^'GIQHE:R607L[J1 &60I\WT2 MUH,@Z=-W:$H]9X0&^L"!]GKY\H6V)I&KN"Y6SI0S(UL/.,FV#<*Q6Z@_;B6U M2IQMDC9MB],>]$@,?4BTD4 M]+VL3H.\;H);!:PXYX@S)N@B0/GX?NFK"JHCVI7$[XG/RON#?F[\UKY]*8Y\ MZ5;)8%@9_D,$9/8>GGL1K6^&'DP*]$P%D*==WVW+I8!KPBRG0T^MA86 M-_V0<\CK7:+^-3U7;>^.,HV\4H'97N1M]%[CD6)7'@C@DMG4:(:+]2$,>S]P[2/15T(J,.5$S1W[>D?PN42XL>N>F5#G52WF!N+#NID_+U 0S K5>:[J/XVT2&MI6A@ M @,G:J"=\ *86$7;"FJ4U%-T M\H&*(Q]/UCRDBF@5LG(1.$;':QC,C^@,&B+@3HL:QP_ ESEU.;M+N(LF_99D M*Y&WS9G(\P3@++OK($0F,%)N '+OND ;=.+P$O7U;GIX!*[DE!X3KK)2G:MW!6!6G('Y$+LLT>(.[CGNNG.T8C?GW MQ3(' TY#<[C-_V]5+Y'HV\:IH?V>,H6[['#262'8^99O( )DO83;%S9=6X7 MV_ 46HK7D<0=]$Q"Q%MC1]S=>MD)H69W5%7# R5"?C8US0RM0N>R=[!<;H%U M,8D 3T)"/IBU:$(IKRM-TZ97CK7O-H>)*(F::7(L=0"1;2;6 V;U=6=WO@3R M6M$[?1>H<;X@A\A=/3>_*!=3H&Y&@6'77MC[O)8]C'CQI[S! ?]P,O/B'ZSW9PF80O\X][R0 MC_.GN?)/1"?U"5I+'[]\J%TG)OE"Q'8YF&!7N!NQRQ+K7;_9NMBTW:7OW.K^ M7GW$$_RJWW::H'ER_/B)2= ,JN Q:"MYU\H1-U@E ^(FA8GX@]LL0 M<*@P"'7T:,6W@'I,L8'OX9XF_\H-@+>75/CIW&?Q*?LLGAW/?19SG\7=MS/W MXB4CURC.(*#16.%$&*[H9Z(,F-KOXG54"(2.>,2SB(@N%P M3*FQN;@^%ON(E%1"ADX("0F_=,HLA%X*)H^;?HFO&(TOS;(D507J/[G68TC@ M,]\#@Z3UY9R;Z5R\>H+II@X%O;5FA-N!7XU# MU+VT5Q62#R6Z$Z>ZK-!D4JZHLI;ON4#J>^,7NG79I<[3NBAR$&3L,OL'KY,UK?OF/>=\Y*#_8DZ?LX@4I(>WT M1&M\.[WH7)2U;SU/?X&W;%C=&FM=N[*G%-1H73/-@XN#.4SD!.NDUIU=\$F. MN)N<:60G."(&B?@6/^:=%709/JATT5_[1[*$BXM69;(7T)- M_>T/FHK00HY 04BM#.>N5:1;A]XVR.E(/(<-^FR_QVY.[WMU>OWKLW-DF4/4\L M0!:]_.3CTP6P)+2@D;SCE(C445X%=^?$<[1\W[C_C>9TN$6N75I(9T!:PM<* M,7GL0R;7+K0H0]+$)7MZL@T1H77[B*$6> <6NG=C#+\T U[$^8RM+Q*Z$=WF M552&HD&U5H1K0)HEPA?%IG5G[G>/.@ATJ2%SBW5-WC)A72Z9UJ3CUUZ'!?MB M:L$F-(XF=>4^4"(1U[K/=%+<02F*KA5(P@W6B:;?/4YUJ1XU+5YMANZNO"JH] M7SV>2K-*=&F71,14-&$_V[([2ZO\PI:95B6!SH"%9-6&)55XN1K/!QZMM'U: MSWN=G6ZO_Y[)EZ0KGOV9 T[/D.Z]B]<$'^4.YG5O'?,-P;=23-D7- MHH]/CI\\2=_5^![.VC>,C'A?Y0QKD>0'\=F%4##O=^YL;;G)SPV]S6$E+D!POSA)C]]+K9MZ.>1.N=*3)?/'W^8/607(&B^&/Z MSL0R4M=RSM(>UL5!TKKY4B58SIOJW*)]LU01BS&(P@,9E3=NF&MZT+0QJ"0 M3MQJ:1CB5+3+LLN%MF_J,@\)8"$I+=J_=-[*PR<>WB1DF!T!NS #Q9QE@* MK%>RD,044Z2739]&5/9>J0%%>^<.GK-]X?JCZ"*K#1IT.B0#%CWMH.35_R;>0^WCAI6 M,2+DE37K.<=X6#G&Q":C:0%1H#=]G%*WP4@[:HPA&ZH 1LI[G60PD->LNT+4 MTQ.&WWL'(D;]4#"Z!S@0G"("^"&XPB.PC1M$B'-.[Z"\Z5==.E/J'X+3'Z M_ZP\==[TB*9;LM_[$S2[H3+H5'U@LIQDNP)PE$P^*[)8<9')MM]2O.=.L1QE MA(0]/#?K'<$G)&\KEXC$I?>]SE'ZUN97Q@?\PIU5FZA=$Y^):P!)7M+@[[3O MF!K6I0I,"12W*K@-:EP)Z/:5 N)\C&UIBKCM@="]].&S;/0M%9$X1K3^R&G3 MK*:CPR'68VIN.NFTXLB?&H8X8;,R9.%8$@EG'8J13S[H?+'#'84&MH4#"7UJ M^1IB?6\L]F1R3]Y@1*MC7W$^7AQ_]TH_9!6N2&,I*Y%T< ?,L+L74+(9.IO0 M348)@-T9U,NSH;WV>;J=%'BT"D2FV/S5I_8:FI73,\)@N]$2T0^2"JV[G,>\ M;M3_2^**$9NBB7?: (+<=M?D;:>VS@ _P59\,D66#%)D^:(Y'Z8G7P6PM;U9 M!-C:9Z,#P-HD?OVR\"3YUV5$XBDBCUH'4-E7Q\4X7_FQ^W913,XATET[/$>8 MLI#(G:I,"DMP2[JD,#VT7P;K9S#+JE@_$;R(QJLN$A>-^+OCF.Z:/1,=!4 < MJ=!@Y%W9L3RSK[W2WIVLUZ;O7IU\KY%X%L7<28BY>9UV.,*FP^_AB5919?9Z MEXD0#^K?6*M)MC H! KF E M"MRQF)@OLB7QCD476Q@]7JK+2<+>^Y!.NQIM_VQ&VW]2M/WC&6T_H^V_4/OL M)TTQT)7*U?_S;__K_SL^_C;D'!;__?7//_WT[M=?W_R0O/G?O[W[]3_3M^_^ M_NKOK]_]_6^?,]7[F5_W()_ZTR^PKR9R^K98M#WI63YEC4MB1: 1(YR;A)LG M;]Z_4O4MYT#\!,J.]!M1Q207Y3^;]H]SY],544N^9P]BO^-,:"2XLNP<0/=_ M_\6DW^+G?W_R/#L^/L9_>RAG,NNM0#/+B.WHK54%NVD1_ M[:9+?]N=Y0$/OVMQQSS@X5R,K@,S9K\UKQK .3P?>"IZ74;W4$)?D&3T3!EQ MDN4[H4#A5Y?R-_["UZN;M%E4ZJSJ.HOA>U<]!R<(AMA1W-%?52$3X=%U@2/S MM(HT)P[&ILV6^(;/?A<$;KZTJ,B?%0C9PW7ZY^E(O4#(;=8'^S:P[)%^Y#O63*6G"/>>'A25F?PN_43DOY]X6<\+^4\NY&=/O_GV M"RSDQ]FSXQ?9M\^??HZ%?$)0AGD=W^=U_.+)\R^UCCDN^PSK^->SLEV98'#_ MD(1E_.EH\^>5_,FZ4WD9F8GS372"T:7. EHTW#0D%?E!'W/CU^V5JW;/BJ6G MX%4;:70[I^+XZC5,51*JDJ,)@OF.FXKKY6TA56-/)(]E/LQCF&5.CT%1Y1?E MB[\RFGCR#%6#PPS"OE1\]-NV8104"J#=FEL9-!UD,DMVVGU97KL(;1YB3PK* M1KV%J.3B5^&=IQ)LDKP)>RE%2;:21VJ[G4(Y\8N-FY4S MJ=EK^\C3%X_HUPG#>])\O1/3L"+Z];497%0YJ>QL+ .:G'5Z\A3O2^QR1J5E MU'/"=.B:AI;^?E=3;(*V@=1.07.E&]'SEV8D-KKY,Y%(HX_O>331W%#SS:'CASJ,' MY4,RCOQU;FH1%M4S9\&PAMPH$U/M P3QGJ8O9]D:_?&'W.VQ]-B>QK.)Y^3&E[]S M/=H&4?ISX+5PY[$ KGJ:?*I=\NB@P2? M)314U9#T^X@004^2[DA/*4RDXJ @D/\]'A M6;6GUL2ZD9Y$N6A"3@'/N2".3J#&* H]LH8$>]3Z1SE#JR/6+R. &>3UO7M; M@!A/TQ^/WL^GQJT^-2S'!GA^L!T)3G8!3G50;(C&GC6QW@U_=O3RY5_U+!K8OHXY;JE>B;(ZP44J3[%X1B/1! M>50<97I*81,]Y'WCK(#N,?7,VT+ FFY?]LX9SWU+KBTR)[Q3M!X;<=6;1W(> M+NT3O]O^W4W2B^7&#SSS.CI\\SIZXDPS](J%9;6@3 M3!++N@L"A?<14S*=.+M1])31R"-K135@[HH&F#XSGGL\&+FRT Q?/G$O?_SX M^,75+__L"674I(F"\F4R!+;=7 +#P72%R?2WF,W9K39G)\[JN//IRQ@S.;'W M^0ARBB=>0&>%]HEBY 98K^9*6S2CC1Y>_OCXVZO?_>D3RL!^E,U+;H?- M^ZH \>*!;\?XU5!5 MMIQ)N6>G"-G_Z*CCE)EW#>K&RY8A9S&X2Q(2C5$U<9_$F'HQX_ O.J+8;7! MN6>GI^Y$ER>-C\67Q]]DS[Y],O( A!6*6ZR-AXAWOIE/.%EY.DI?$;1VP1U8 MNVDHEMPS)S1VW"_G!X;&".VL MW D_J*\53;VZ;V,7Y6-U,>C9A:5D+)FHLN&^^!N1B0/ZCW%^3^.^"^JV' M& CR@;FRN"E,V4E]2UFQ4V]&!+8FU+5ONA<<+@U].X@62V\X<.DLQ"QB@\ZA M _&+J7"J7)UO41Y@I.= \S9;U7=$+!LQ\XTJ:L,2AQ #0P2H M%O4&(S,8CBO3V%P>73R\QA[3$"PNJ<3Q3@1$])8T&L/I]H7]QE:0Q6@1Z3JQ M"Y13Y9A0-!C,FZ8>>*Q11HBD$88/[0M]N,4_>W=ML>68B"LG/SS@!/NLWP^) M3+US9)6I%B-Y?/3T>#9SM]K,_2YP%%6;,[U#=(;ZLY7LVTU:DC)AP1REP0+? MB/,S<7+4)SJ@W;*K- $:X(."Y0 MY^DBKX1'9R."Z#;TX\U"JU'6I4OC< MS%L2/4+']<3A$\B]=;.K-[R#\&W(<*UZI@$B@05N 9<] MZA,S.H7:EHUH2]XHB=](JC4,/ O^UKS3;_5Y'5;W&1Q1%^/J*2SY.N+!6Z_+ MJB0"3H]:*^I3Y/<+V<5R:*$-@BP M<9',_/IWWZI0 $%9MF4)A"IKIA-))+#KMFM?GOWLU4("%-9H;.;NZ>$MO50# M&^MP.%#H4EQG3ZDFR#Y18;"&B.E0F"V'"-\KH9RT!.GK UC: K$L(JM^-:MZ"3@B7:T3B_[,MC1D'/ M-INM57;CGVP,UZUM(C E-;=A L&P6)3DPCMH[QQ6L4;0R01CD& M44TLX]4KXNM#1BDB:J&M"8H4QT=1/Y";'S"!;Q @Y)[;=3THIN+(8RKN%%.Q M[S$5'E-Q%YJ#UWJ(O&B-$^;^#N?\ =G33I$EE]OOZ]%3TUI9"9Y.[JX;PRU5%':8$-]Z34:)-',OJ MJ/E?1V2#<(Z0Y&O-.H'T6P _?B]$X$R7^#"0).*<3M]D1-_0S*1/))& M(LAY\!M=2]Y@X8I!G5;E1QOC\8[[L.]6)N:UTL2Z$6DPI#+(%R9:#4)-;&>3 M+#@9#_9'A\TWWM7ENA5'Y/$I!>O44+\)L+K"*;P9OIHA3_@2-@"\6$EJY5IE M8# 6U/;!J2HW].J+Q++:U\Q&T\]'K#7IZ%!_=E ]6^@0K\ A0!M:!..\+9T] MLHFERQ1:]N3(I(G06YN@F#VJSL<9745_X5+J*3E*.#3-L&*LA3"0%X8J%0WY M;2Z^\5S3,L+IM>E2/'*X@I2DZ!3* RH&,=RQ);L56^_Q';9_ZF"64DCJ0T*% MEA*(K(MA0LZ["A&"('8X61=LN.JH M(XE3:%:=2)F=E-* #>#[%Q_$8(W:JT$-=P.(G_OK#FK58 9W+29N SL_>K8[ MW*\ F0XV-6@#I:^]>NU&IMFZ8467_P39>*:8/YFMC5YM&72KN^7]<-:8J\:2O-\WEDU#.+. MH%QKMF 9%V9+FHES1*R=+.J79WHC MF4!/L#D&XM+2M7+G?R. _E;< X_OYGMO2Z:QA*= -Q^V;!;E'_*V_4HX4U.V M(FJ2]B0%&IQ(W&?0]=,9R'7 +Q7%S\Y7BM4V$=/+U02T9XHTJ=,X&SGKJ*&\ MJ;FAVFJZTG9A$OBYIJ %'UX@.5V%S_L=A C>,"86\7:[AJ3FK0QN8_C/5,O0 M@:7*=@-R4$2?5R5=*<&&;;NB6%]4#]0?01E1*LV9\$$@.&++ZH?Z.%U$4QKZ M5SUB#,4RGC#3\(F< MF"EU+)A7FR]H/FJ A^'H\*EE&SC9=U;JUHS/V+F&Y\'!7N7(3%+G>W:F(+!3 M0&$2NYGB;3D^?1 M6^1L2/>*K@E(^&]<4B7N;:PW?#WY+@[R5,\/C8Z=8* M-GDR$W*&S?6PDKTQQ;1K&X6:PDMTAV:I>C_A!UA -<.+ U38.B$AMW7GS7V^ MC*,"T[\4AKG6)F7]GS+*3,IM2<7HN/$NP[\>5M $1PW7@TP-.A[.'(N+7U#) M6W1!?2U!X.-C?/Z!J";F,./8P+[&NH>#P%(]'$$_NQXB7?:$^$HDG3@'\)3R MU3\\/K*)#%7%^5"+\=UE%&*#-.J3Y;F2>9.]?FO>T8'; 780,&%5F<31!U1A M-@Y:8T"?U'>$9-DP95OE_@9T@!QVSQ:NR#H8HD[VX63>D."2(ZYR'$'BK+05 M1FX0T=2>2UQU;66INAUKB/!ZH!O["7[/F@%> M,=-SA5M;+]:%*JA2E"\&,ZVC,94E/EH=:]'_'8^""QCAF0O6@Z8X;1RFRR0M;7&E^5>9*@$YXW>.Q;[ MKDPW%-B9QV[_C:#VZ2>JQ3*!!T87%SJS#!>UHDFGEL^@/[!3QL>I^!$G5:7 M6CF$P< XO;9??P3+*;F YZHEB&.;)]5^WQ"(3:I8Y7+32I%HU=2)BDDIZ(^! M?M.,D!]"+45L>Z6T(QS4ABSL5MC/@S0QVO%\CI$:$/9;XC0R&0V+ M2]?X=;2V*PEJ2'2FBR@IG6\3DV!C7#C#U'<)[KUDIC(6 A-SM$FJPL%:=WK4 M?8UF=[OA:WQD8PR!M8_7:T",09BSQ8+U)JYU5W&>F??( MHPUY6?!$_$A7XU;F8S1WC@1;-23GTWKC29YA]@CDFURL4JWL,BYS4P1C*GR7 M8 5&-,;@^'L:EC)V^>QMDLL.G9*]_Z2M.XYY$1EO>(0Q ;PB=B@B]=%/)=_K MZBS$L=3V[)/3IRVJRA#J66TU&E6N9,U\=Y3339W$+'V%L:J"NBDO,K%^>N'4 M=#?U5#J1Z@CR-#@ES8"S*][;QIQK9-5-.S+R3RH8=$TWP1KOI2VZ#-S$&+8^ MORBFZ*5R^9:TT^LX9">+&>\GB4^BFJ&7G/FS4,P@%1DT7(I MF]34E"$5+M?2R[)MWN]\?O SQ]\'C?/#Q=J.!]OP.RL^UH(Y7Y "?G@X/"*G M=+@[/ R?L).&WJ)XIRUT^>O>:<"V5JXSLMDRMD+A$ @Q&97-T*OI.+?,C3?) M>CWB&J%9[4 6ZS1EHJG_$ M>&,';5Q@EJ^@Q7_U:,3>C_BW)*@@U$Y-D]V-A#6HPEF_Z *O_E-3[L<;J=J" M,[JC["-'_,B:S=9\1$6PQTD/ND],S;3IB)[[#?DX1GPF.BP0'=;<+?7=:8BO MQ%2V]G$#@][D3ZWJ.%RJGV:I1I$&'.BNPF)Y"X\E_O6=:@DTDN%T)A;3F7@< MS&(Y-S6\YFU/!])-V890S0M!S0<8NEM)*$\2K^0 X#5#K34SC._21U2>)A1Q MG* 3HN<8(Z;YF*7@'J+7> I.5FQ.)CLA:Z?:Q-IKW$%U2C^RYZ@1I]#R(2.] M\21J[QBXC#8;9]O2_L$LP'Z@1<7)GR&&U0W56Q]Q4%L,$XBU#AA.4W/V;UXQ M*O,T28N!:Y2;9@0FF1JXJ;R;MZBMG*FWD!AMK*X@4]ATIY KVFY60\B82719 MSP*9IRJR^]>1/!EY'MKZOU9I$%ONA$]8:R7@)',2Q[-M/0*!&\;]K$36TEV! MS@!''D*UWPR:?.;QD?>,CSST^,A'BH]\2-C[NFW#RGFN&QP%#N,@*_Q!=4/8 M.\ &>^$A=-"97Q[#7\BP:).B-F@M-UO0=K/1/;#YT4WCHF;V2UGC^PS>AY$B M[< NJK[?-MG,'P^2X;IQ\$$#<779Y(;MAJF\ M>I02-:G9MT%+2SW^7K-M&E) 79/M7E72,]#H$^V3+(30R3%7'M'FFG_QG]S8 MYCHNXXD[VNJY-=3R36A2GF-V4VW1@I )2?>DTU8#) M-RTTV4RT"9VF6!4X6.9-,*Z_S04X]U)@5_R>)]3/:X[U_-PHC3^^.TT73QO@ M7SW5=E,>_9B7RY^*2]!O\&\W_]F@*#2;Y394A:Z%]=I&)USHP_/ZB9,9NWF$ M9B;782>;AV??3JEC;S3UH^:%Z[C>5WVA D>+^:*M'L6C_B L0L!<_5E%L4Z5 MTC8.7 ,;UVV2BI2]W@[@AB8 /W1F>K_USJF";&Y0K1ET^^SAUV)N&V-SWV%@ MR G W?;YWTE J8ISW5ZR3P;Y[+Z6,7P+M7QR='Q2+40QNX?QW.4 ,*R. G]= MBXQ--B@5V+B30]'*[NZ4;WA$MVYGK,O_J!:O)^?Z%GUIJJ9?GP@+H,E>RS$* M86&]=K.M24W[-I*D1:\OY7Y[)?_4 77-N6W_(0,&'K0W(QH\:#YG7.PEJG SZE\\"YHKW36-VAK>$./ M08;$5X_8U.0P:#8Y#%N;'#;K,%J"^0RWHG?#A"[+F$9!CZ\'YXDDM*6(,JCU M76OO^RM*<^#X!L1GO+1$ \T/3LJB8BI@[F-;?6D*=:6K PH6<*!\+>@]E7K@ MUIYYC4'B^DHY5%KF\2J\U/%,0&4BBW%8Z+D\QP^BU_MQI.])6W,8&*.$YZ:K M:&LM<-UZ39D[]-QADO2:O5>:_1341FN"48@31*-1DB8;F8<>$I$#Q@'F\NFR'?'O/X-LC#[Y]I)9J1WK2S-)&SX;/JKWD#&G=J4-.])A*? 9A M4ZT[OE8@; [.[4Z]^@KX#?6F2$S+F";_(G<;K5W^M8J62+@7P'&^=$"+9E46:5,333;::?LC-)(*7 &O69G:M2XHK6M LX(*WPI,J6=B #DU+.[:C ML B-@0-@*6$N(C<&6F[A@60!:C+!T?IT&*4(<'O15G@:X/)1#6!4,#(1=T(T MQ;ENV$'(6E:L" )&_[63Z9AP#GGE+1@F4EXBM&^QD"K*N+$36>"PV;C)Q6-2 MD8_O4GBA*[>DD4RKJ$;9W*?#M]:$:Z.]_KE]@?"@!N2NT%&:QR6>H +4!N4' M!6;CNDZW:9SL@#01^T<80"9MV5BI&GR23@W')NA9.%S(S4EHP5DD35D^T<_$ M:(M/SDC@*)(O7!SW:I+5D@I;]77]&+^@#5QP%VW@VC:).SV/21<]/NUKNB!5X1C3*M?5H0/3>ZJRF =M M0;-FC=O:'B<+()PA(8P MUJ$VKVNV=!ZL=04>,$9^LW)H#91^7;/6P&G6"@JOA>-UK5.E:2P^6S-R\?OQMONWHK'&MCY-+?U4 M:'37&T:3#B/BO+PDY+QP ^B$V0[S6_4.M168AM3'U9/M%9[V5[:4P^TY*A60 MYGV!W3#(#1&QQ]/L /?/RRC6:Q;#)H,!#97*X+CMT0KJ1VO@>D U)Z"QPS?= MV"V0IXTA7928X"]6[$%@.[Q6'H%9++;V8[=[P/J<;YS.0R>&-S/;[;R]?OWYUW@W 1'T*MGMQ'Q(O MLOW7E?>#=?=E(P+OJ > \%4 ^H\+.$ML>?//QVJ#;&/ H<;4WR@-7/6 M)/9WP[^9+BK7)N_!1M::V_()&YDT%\6'Z4$?ZECB]APVM_?63?D^H:[=)+\$ MTN89IQQ75:@W1T^%O0X3,+^Y+=&G',[U!LEK[9'/8D5\7*_0SHLFE.E :)24 M]P8ZSO4U,YHF:PL_-SYGE&!3+?5@$#IO_MTCZM\D7M*0:6@=TC[CE]@3N>Y1 M7RJT//(\]:J!%%O<"WTRE5,Z02T.5OPFA(;]6T037X M1H\0$W3.-'%I3+)4S5H!5J7MM957W'R[X9EF(PQ-L^HC^/+ OKS6)$:(O*\U M&;X,8>+LF?EB)76K:8YI8C&9=R9:8=AJX"0Y=RXR3"IB>[JL)%I,CY[]MC;> M^-O8>*_>_N/MJ]>_O@K.?OOE[/W3U\W"BIA_ [@$EC)BN-/L!C8M" MLP]OW='U_ ?!4Q,Q%3!S2,U1(B+99"TC6$"$,*CUOEHVH#5)539CJ 7:=&D& M>NR5?8X 5.U#R ZB[@&EK23 [I38O.:"2OTK["'EN4 !4U*-C$?&1Y8)87S% MUI2"+K@<"+E8@O;.B/N5_OC[WX9_[4O0;;^X[7=9_4&..;BSJ?0Y].RS!>YF* M]PX[J4Y,IY:HR'4\-[R!Q /#+CKG 5,!Q I6@I(@DXS#6&G!D:8!F5MH14Z5 M1<\6&=[_YK\0 #&]3&!D%]R*E3*V\(T=,MYT-M<(MJ3T\6[X%AQRE@\SH9C" M+2,LZDF3.9&_VP:C(&852KR@& -G@\ )IT0ZI>\Q#,#Q-.2*)Y<;G*T1K SK*ZR"5 ER(_(48D4!*JWI68UY6NID1%"XKBD7!.'SZANAZO-#N6X> <1 !9X/:/HV(5O$*P!^*TLXC!1 (^-HS\->H8B* C?P/RTOHBF9GO ZS"X\:?.4AA--H%? M:6P7P+REUPA4B2,M?;WLRD7MFYUH(>N+8B)&:Q/@M6C?QPR7YM\BA)^O_*WY MB&_-\W?_"M[FF=(Q=4 $C6<"UP1E'@]'!X3D^MPNFEDCCK!;7J M-OI(KCBF9.5;Q\4F4C;,?#0PO;-)*]E^/=&?RNVV(CV^G4N7_H)7,@'KY%;F MTF'6NCD&=M))KK,K\Q&\:W'R^6-P-8,6K]'P4X/$X.V9I18.8;9"GBT;&.)/ MA6_/9/Y0,IP\"UT[!]?S/^&O)5P"H&!_A^&J;'H9OB33'X/V\L0HO,# >6*J M;OACA+.LKLX 8]1141:@'E# M\F*^4,(G=MP@<#5F[).N$H;]#4>'@]#9,K669_P2V#NS\)<(/!M8UT;S,_/7 M8K9+C8UATC!V1SD4L=R0#0'?3Q3'L3R&I]',LS,E=(&YVT0+&M7N"W=!-PE7 MC?4/9[;:/\O(/.[C.7 $@VUB@G.V+1-&XN)%FG/-M]@-*Z%2(>;!E;%A.I]J M]'KY?J?B;1+ :7LV<%0.5GI=F,,F? VK\!U9OGEX]OY_29F* MBO:Y'U>HX$PQF$JL>>?C#@6$Y2RO*OSSU6*2QN8HG9[_ZP<4;=<8W&WRM-XH MV%@$1R::R7E_K*Y)PUK5ZD ZU6R6(>X M:S["9"LXIJ]*=)7"@T'X%BO8$%_[:G@0OC\X/=IMEQPY=XKK%(L_XWBU0W@T M*OB+9I%"V_^'8.U[K-9XK9YR-A87[X5F(G%X,'R8/V1'_91N0^RPB@!<3MYB M[#Z4CLR@#@^Y8_3_JDL5P]8)WSOJ/7B;3'>QH?M+E:B9L^;T]L.1X>'/2OTS M(EI>PA6+C&>7% ,P 1@GLSW/NRI M\#7\5( [9]Z2@H"0P]W-=? W>OZ;1BG8PR=06:V?:O>_7,6,8PWNB+8,&609G?.)/H3^%S6[A[\B!/Z;[;+_FB)H6,F[SF?IAL$=(\ZY;9OHJ M8O9'A >6R12A*N9,39UMW<"_!2]>GMJ]V_J4\[>O=L%(AJ#7& YVG M>VF/T3ZT;>B;X5MD;.Y:@ZX\BDQ1J[>O!NVN[S)+T2B88475]%(OF/W0H9-A MZ_M,945XN#NJ^KRQ>4%G%RDD;3B1'F+4'&6_4(B7 IK^79L<'B/%6MYPH M0FMK@P'DIE5%#)=,C*EN*@M.@C8D16U 4HRVWM])?$X0.:HH/?E%%,B9"0*J MHUW ?+>V[>C6YA6HFP[:Y+K42#KLD:V=0[>6UBK34>-8$Y_5:+B[?S0^V*19 ML&$7HWE(C&BQC"-XF>6?_2M\?SBD)S4>;B+#EL/;L^79,L/ M[FOA_2*IG1.)E^*:@='T"9J^24$L[Y9*S'E\T<9=S7 V3#\DI-8WOA6%*RA$S:WO6BK6$>"K%96:-X7<[5Z,UZ/V'QSC M$=5Z6PA33(64MV@(%8?8#))*DJC[(!&=F ]:Q.?IM-@-SR,,VKH&,D(43?H: MPZXP#T1IB"2J9!QG P,%98)/V/$+6 QKUF9E+,(GA2A)#)H,Z6.SGFK\T$@$SSJ @0R0EZ<\7%#ER.B)(KPQ-_+C44 MHZ.V56AKD@DZQQ+ 4N6%T.*>*6KD8>(M;L^*H+&*3%4F[2?AJ7,DM^61Y2:7 MKQ)$TSNS6N7(SE^_1/-'*+^*F+I#**+2@KE"Y9>'?^R>[QKH'F.($*IZS3&? M"F2,4]S:BZZ^%RU%6F,@:X.HRYB$ITE24H(1QT;TQ7 4@O%PYXU9!ES*UN&J MV]I),0PW68$%LS3]&/UT6Q?*'O;WK MZ^M=&/WN17H5("T9ERBF\B5W!1CAY!S=B@S4C!\'+*N29N9XP&^H14*&92!T M$UD.I)==JNA[?/"D!RWS^^T*BY[TM:_S\Q;#4FJ.N/B.L VF:AC9D=+X2H

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

    WIY%6OW"0]-,DN+%J29=*5VA-$398T1:(_B1 MK(@'::*S4SCC?-*&D8VH^>5Q0H2R_&^(@ =._N^*5_CW/NV M>JEHT.GO65;VY2+3%^ZUW-EM*18>?RPZ2?84G9.,SM>XCF%C&0-11$01;1=) M6">>L;VF**;+#$V"!D1(B9#&-]102I>+V<3+:+"*V?SC_.I6O&8*[]5L/Y?8 MBMGE+>Z_@K:G<@*HR$);'P'UFINAP]"\2V0S=&:I1)8^75LB^]%S'^=+T]Q3[,^SU>[54PQ-_=__*[(,\XM:JJ]DBX_SRO7[J0Q>P>VDD"ZW>^?U M#G5=>:B<7M87]9$+=NB'N+Z?KN='4+5J$C3,-2\I!'OANQ0(9 &<+%L#.B=* MR RX:[H#B4AVN8J<6;AL8;SL<7XJUBI3T/@+7D.N'?>0FS KDQ=JT2T\I[G' M^G=E:<;B]HN4HQ(BA%)32\1 M(R)&(8E1 FMZ]VYX=]TM*M9Q9P\-$I/@; *H&+L%D6.-[H;='=&T$]SJXXFD MS X!3(8B+I6X7EURDFXE^B8ZU7:U_/N5?5Q_N\M10<44_I!-.$7 MTH0X37F#B,4,7F21:Y5XG4>$B@A5C(!$[B &[_IH,&#%BZH2IVGB0 1"13,Q MWW)(XN7BM7OW,AF^3,&7#DE@DIDA";-C8K(*%F/+K_'39[]!X\?,".?3Y6P$_<3C8(1+7L/<:_"AKYP.X5!#E#F9 M%SEI:8:JTQS7@#)^:57>>^-HS7&"?/H% 0V7WJ*BG> PLUSZ#''I#U3[^;78 M>6*Q"<_&A&<_L-B^S$/,;#=JSA=!]DT<;'?19;M=5:/+-IIAF7$A^Z=P=BM\ M:9<9$RE1VHOT"XF3!G0)6SO[/MO(1[W_UO52$: 2W!3P@25I094([%H_!B*0MQJ M)_O1BDL"&2^T4J+3Y7S0=('XLQ&152*K41'& M24Y$9X.4#@[_3!_$C=T]UG1+V8$$[W9#R[WUG/RSS%^!E^5BK[5LN'UO/0^N M#*%(GLG%MGAU@U 5D$Q%Q#LA,WZW7KWM-'L/@?KW7%5ZO7JG2UTVKYJ]>FU9 M;((\RL^?!%!RB;&^)A',QKW=0'OOM:EJN]5M7S9K%W! M'US56[TN8;#U-NIKTN+[;?>_@;8NRI0^4J8:)POPR1"R +BM"8"&;L2I@!(X MG?NQ1-KH[(-AU2(C]!=E"U,^Q/&0TE0>/DR4F4>:9DZ>)L,TQ4G0,[=QTPB@ MD,-/BBV=L#FT-,MR%T[R\-_I?U888<6)/3RP&[]N^:>*JBIO$/.NZ__-%I9; MY!?7MLCW?-CCG'^[G/7?'Z3[XB@)L886;HW/4.CXUK7'KSW.M19+W^M5Y7Z. MOW7:[G3:]\W669=J=-I75*=^B:WM=:73:];=!M;X3S])'?-W&M:)9NWF#T59 M .BAM"A[[ 9U+E?'G.0KT-V44RS-Y(Z@X0/4F:I,)WB,,1 H^%!NJ (PAJ]" MTR_-FE>*HR0%_DX94,W+[A)7E6C&G;;,::.*\,JA*;$56;B$7]206ECJ;#*1 M\W+^<0J?]\BCU= ,?,XC^IO1Z+HV?SCCZ+.;RQ[G(Q?.USN]!LDP.4M5P;^% M'M+-VR'=O".D"_?L#NFRZ?)JJDAJ2>X^=>20U27XT-1W;C)1E7>X/AU(LY63 M/-WN)-'%LN3^ ?.Z,3-\5IAVV_.W-_UWUMZ+ M:ZJ,>YS.A[#;R3T)':I#)GB$> OA[#"]F R3QX-W+-1EZ>RWUV&QD)ED7EI/ MR_>+9$[!XL\!SRD@XSZBD[D:GL9DRYPYEVET.Q7K]'?;7P"W1['[.,\_=,]RS5@^D]EY^VU;W?05<:@>7?@)<>G@_="\F*6?IJ#RJX05:IX!QQII5OH8,4FF=$7 M!UTM6+-_)L9ERQ'5!Q UR_!#<+<8VR3(?XL?R(2( MV5<1L_U!CV*4T&,?>,.--FHK"1$=,.%F*#\&4MY'A3$QSD[>7HYJS \ M(PR3T_(G;))?&X3#BU,&Z/[)Y.E$M1R)!RV3T,'LNY^,GV#RY)7]L^WE>:AZ ML)0N,X6$]?LAW2Z)W'U&[AA;[O8%\XLT#>6.#E@-OV\>^N$KRF'-];E6E5=1 M@YMR)*JOS FXQ/7Y&G&O5=E'%1LIU" M1Y3@82K!]0-'_ A43'%&D4;=/]!5W^< MT[]+FEQHO)]VBU\WH&&1"Z\.9]\+"\(E2M^1/JJQ"C_<49)_7'^W&\-1UE5OX?0 M, X!EEAK/'4HWXOP?<7E,FERP7F0"[!B:@243W8 MM+ BG3^@M#!/-%/QA69J3V^S\]]J[47=II*'Y,?:^;% %A*='$LT:;(UZ?Y M3X& 'B*J1%23 'J*AP9Z? Z,J#S.^W_&!<-I@8^XC2*HS0 D1//340=+D?3C?Z#564,ES(S^@X* MJ.F@\6UPA+\D"")Z*B=1KK? 7YH)/5866^H[>AIJ?,G2OT[QK\Q\8PW_D/GU M@U)D_$J%Y_&$%QYWRX)T .^B3BDJI-P3_%])?)G"U>LS"KS"KY]03=1A:T:] M<3-CR>ZG4ZA-,-S5!/5/U%->#1+KBVPN_%WKJTM-$%N5=U!X?K1=<0D0*U-Z;8FB2Q[DV _0#?\9(^M.FVWK7PH)=)2V_ C8 M;B@3@',P1&B#9. \*!UBPB$Z0*3/M9_A;AW_+UL\R>26>W1[]X,\-C\;]9%& MU#7.-2[&U65GM<=.NASBQ)C/3(NA3]B<9QO.[5,XQ,^F!D0N,H*(8)0L!.JR M)$!@IHK]*5*G"%R) M6?.8':+PB45@"Y X\3<2+BM(TXQ5^>H! $$B4-PAAD MA7"K9@V)$6="!F2B++!$F6B)NM2%$^H[$-$$2F,J"3 ,%G92*)U[!@H\2BA^ M@5:AH.>]B1I8K3H)46H):/%:=%N69BG1P"'<$#JX0X1/N+$R1?@%'NM&G(*' MT0!!P[\6Y5>@Z6.3'=!/3/1IL8KE1W^'_^:0KXH^9W3M-V?9:#^.4O"3LN/; MU)LRE:"&AYPFZZ(N(2"UZN#V.0W^0D'/12!^*B%77D=_UT?6Z^VQ 00-[P@- M&VQD<<[N*F!3-JT[')6_"( ["2B0I2)A\96 -C!0URK\I) MU #Z9 KD3X[G%14'@2!&1X^W>(C3"!OMG8U4D(*\(L.3@1^E).2RXQ@<-_-@ MJQ.JC8)F3AX9<29*Q,ZQZ^/H3-&H J1:5* C?CH!)T8(C>@F6(4?H 6A_,+9#%,,,8U/B!F0)K@)23 ML>!A#N#7D69"]K(/!0%'?R$CWEN&S",H("M(VTT KQN! 6C>QAP***//0^4U ME72DCGA.&U$#27G3(*Z5)/PU;C" 7TM-5&4@HM$* M1[F@:)J8L2_OI$$0W. M?AN)# 5VK*CHZ<\H[@A_)N/%VZ]U#@P&G0ODP,7Q*O[@TJ''P8\(VZ03[X M&>AS4]49OF9PK4P2 MN;XH(>J_06;BX;Z'*$:O8>:0-?R^_RZKG\I"_33-US3EJOF""GY^>W!I/=D1 MRUUI"?W\=%%BU3]S57M*4YBR_TM75U=JKW*3PO&QE+AFCC.HE*ZP.X5CW""Y MQ-?@=0;?Y%2F0T@!@_I M+47X)8[)6D@45"!,>:PL0$I7=,3RFQ =?)*7M:RLMY8YM[4L6M:2+B+NG%[= MR=FGP6VG/;2Y\]1UH_9I UBT#"#\6[BDM 16SKEJ=LK>B8 MG)^;H:7SJE68&_V)_GU]*2;OO'QJBNP'*45AW^I :X+1 88DTXEY/-?M*?:J(,H"*!O^J+LG'/_5T% VBQX085))PM!7I3;):R1B]VIWT-O$R1 MN->Q[?^QSMBSAE';UMA[+@[;\[Z]EX5O!\\+: #@8.9@JD]5\Y[=95^MI4PG M@KD0IS%=<>AL;6=@"0%HO"KVD2;L*Z_@R+^)MNRZ@,YE16I\]*AO.B7('(9R M4YS*[W]N.\,#2+IC/JHTP/^APA,1:$)3/H%3?EO@M#J_A@&S]L5SIM4:[0TX MQ:#7!Y/_H-<'_D]J!\B)C30:$W;26*(&&=?@FU^ASGX%#:B[95[DI*:LP>]A M2[UF)EL.^?"NX<:U#3/9?+[@<5ZY:61.]=_,S0R$FRL7P0FW\+1CEEHWZ3C[ M.'\9U"H/\BWS5@#I\FFG63NK4Y?M2JM+55HUJE;O-.\JO>9=G6HT6Y56M5FY MI"Z;E=/F9;/WX)I+;/RUGZ2YQSN4J=A'.<-;[IJEG@+]#7F*IF,(U:@-\5:= M1#RV"2(<44;84Q6%X;)[J%&N5$;C([@OGYW(B(,G*- N6]= 1R;XD@S_TI%7 M*:]]PR-F'$[*9@S1:<3C/;>%&J&)Y B"[$T MB]0:/\K0WRB4+H6FDHZ-B)'K%3@&A$ D7 J$%=!DIM!% T:5. R$=P>7JNKP M%-$8+OCP,=!'BG""#_$KL=R^+B_PS%+PCGOEE?_]S_$QU1"!)/RDKKDA@-X- M=FUX](0<^XNZXZ0I^CMU?&R6+0CBJ_]L_Z5$ASPF8:"$"W^S++U.:I%1X9$G MX:E4%ZD)J_/8ED9G-HZ=I+.(]HOJS29P!145(E#^%]6"^, @;$M!%&2SSF_] M8WT-_6KU\O[??R"I/8@.4>_S<1\@?^\G='#1H3G32PZ'QA;S;B*,DYR(S@8I M'1S^&2G=.&1NS="^6!OF;3:TG"3EY)]E_OI"=!W!;R,/"5_G(1>-^+)$V.OM@6+7("/U% MV<*4#W$\I#25AP\39>:1IIF3I\DP37&2_K^TC9M& %4X_Z38T@F+D^0MRUTX MR:-$^']6&,'N%&(E_!*PN_> 9<" )/4=6IK>R8^?"0S )3(WLJ*E4"*(G8WA MC& M0G5'KE1L'-D:JAR.:YD)3O"3E [=?7SU^\:IZ+>1E*!EJ*>/.N8D7]TO2)V,KSJ9?[8K9_FHV";04>VN7BW0LHSTPB#&_-X4H34W M/R6:7=Q#6Y_M*==3E1]Q&NCBY,?'B2B8.0+TVAQB%*/3VH,JW!*Z>5W*'#;T M 5('%5L9F!F]SH>.+JF M-;=C)G-NN@!?1X,UM]X,[7G=N6&[UB<\]A'>E7FSU7#;PXSX939U;2+C0A\$RIZ\NJE7YD91XQ/U # M5MS+ JB\"+\[444CI?:V6UL1$L9U7UPWOW.-OH*)VS:2=L\,6\;23"GV,D./ M\]-NX^E^^#OS<::/GQTG64+@F5][24DQ76:8DUR,9 3ZL<&J*M&NS%M%G/ZX MT(M ':-TN2"^!JNEQ9?.*^D['V2]!>)#7AE#HB" &FAA=M:H=;Y4=35'=*&D3UP@+(K2 M^0!N /UY6!F%:V?]_PF$O;ZW<<7)W-#(KI_JHH02!U("[\I1KD67'RD20+G I#69Q(;.;[>[TNYWK>L)1T3!QOP^_A&OSVPON*S M9]$>-:7S"5> 0\EOZ 5+7T3TK,B"2U4LVYFZX*&G! MN4UPVX-VP?)+/Z6H-^QOY^FK+/3#V0TC(T+ #B&GI8881B&M1Q(94CGH_B4= M($!]@GAINX +4NX4LS;N0B98]HB,.QVPM#+L,S?S;+^/[61RA63S!&: )1I,ER3MU.;CW^'H0 M"!74AF-HL%I2 CL?"N7]Y'Z@/5_)+]<^RKF"4N)0Y'%-\(=E=Q'\V5HB/Q$( M6A!ZQ5JM"PKE$Q(4^E B]+/*>/9'NGO+#B(.$(7"S@QF5\&BK?EV)X$C MRX1$'S\J,/[]G_!Q-'%_/O)<"G%T?_[O_Y7RA5*XD\J7/"!7@RB'"KT&*DHT M@O:]/;A34&.?^LL4JI&F69:D57CX;Q4(N#H<0AUA\CB%.!PXBL3CJ->U\_=< M5;GYTT66/I0J@%&O1PA&C);1R@8 F^S$J.Y MU!$EP,,Q8]49FA*XF0:W*DG8HJ^W;O#8/&^ELY^XE=Y_5/I#D58?3L\GX_?G M5[!V$D,H-]1;1Y;CYK#DH#AZ26,B_14SXK"*X%(QP1:YC!'-_ARX8(IA!\0) MM A7#[D:9:H /Z+&Z<#]E!ZZ.JW(,C0:JL:I,TN)26>:?B-=9VIBYBOCDC7D MV0MJ03--/?4D02WNE1BH!<./]8@%YPR@Y@76T=J7Z!Y0)M JUL&>ZD'#GL^I MF],!M;19R^8JD@PE;^5^,)4 WRT.P55IP14K= MDAH"'ZY+FV3H=+D.OY RYC)!^X9F$2RL-,H*0 I* (LFX%:W1V/8!SPW;3## M0ZL5$;HJ9-K=$;WAEM*9319DP PRD+',72W]"82-X8 M+66T &=I"G(=;@H.S3]U=U^YIB8JX '^$5Z!-N5="&!=@D9H):"_-%BF'6M9\OH7[\R2^&<K=&'75KID$UWIXI0(!CS_.9MF-:Z_ETJ7@.P5.+'2ISYM,4=5TCXO,\V)#NY)_9X2;KY2-NF*)UI!G M'YD3F5Q":VC8V-;0#-#IDHS4N*B=\:&KEO\2J1,D M(S4VJ"I+4)7U%"CDBNR5=4\ST]+5ZSF3Z0M?&5:MH\]><%6!X"I_*_&-JS1\ MO#L%5H=8X1R:ULF^-*3:G_E%O1IM!^^HD=6.U,:'T*KX): 5R4K]3%9JXY"S M4AV7!T*A.^@.W9^WV%.:\JC2B'A.:W><'3[G-8_S9;0UXHOXGLVB3FM*T8C M=CFM63I=SI?RA]PI/J9:-W*0BZ9?C#FH0*$^G1J&7H-*#FHZ43:;;:#YB$B2 M'#I.@SR$H$H?Z>B^\@KP8,6?U'?F!Z6*VC,U0%]2H<;T:D*^#LYVX#<;\(M6 M2 E!' ^_T2/(MT'3K54K/;2Q.VM?6+[LF3Z7#U=WE6Q!Z$U]-#'>9@_!-,N& MI>XCT)5%K<-/2J6@^F#[<->OU'?V!_6J(%THP6TBG0X9%NBKR53U]?Q5?Y\ M'I+ESGZ.%W=%RUEJOM3,=VN5#.LC@A)\]Z1^6.?M>4P]^!@;E GZ0S3L-)R,Z=:,&Q0G-O)! M+UX%/-MXP2&RQ[$&^)_"5$7I<&D'Z/J0=&X&R:!X&5-<=@%34?$'SMZ#@!XZ MQS8GX!'"O(3\CX&([)\&W10!/N 5Q\A3 PB%95Z$H$$2N;ZAKA"3H4'P*C@> M&\W +UB92ACMPC] K\%0+:= %D# MU'=1YI4Q^'%$R4"/ DLE..@6^:*;<@HI"_"*"C+MV(IG,J5QTR(K.KIM@<(( M0=<8.99'7E/'$-NL\Q!UPT-$'UG:$.+\AN!6)& M?W")3.&7MAS)"9F-(A_@OF;R? JI0$@8:2J \K__.3ZF&B*0A)_4-3<$O^ # M7Z8 BA)\4"[SB\(N(/P[=7QLA.'_%<17:X5]2"&@VKF8QO WY@3Z&)2F2**P MDJV9QTL+E#5JOH-7)(F;:' IUM^6TD17*;!(8/!(2_"D_N(*W_E+=,\+5-?K MTN7&L9-T%M%^X4C%3ZJB0E7'_Z):4+,;A&TIB()LSOFM?ZROH5^MW@_\^P\D MM0?15< ]'_.[.'0V&+@381QDA/1V2"E@\,_(ZEFTC'2\\MI MQ\NZW]C ;B1XMQM:SO1V\L\R?WTNTWLM&Z;188>8D(0YYS/I1+EO$1IYR.[; MKW"#4!603$7$.R$S?K=>O>TT>P^!+ERO*KU>O=.E+IM7S5Z]MBPV01[EYT\" M*+F*'K\@$2 [M=J]>C?0WGMMJMIN==N7S5H%\A+5:+8JK6JS_ '5_56 MKTL8;+V-^IJT^'[;_6^@K>.@LC+5H-L"GVS$7*@)=$^PQX&<8.['$FFCLP^& M58N,T%^4+4SY$,=#2E-Y^#!19AYIFCEYF@S3%"?I_TO;N&F$JZ)_4FSIA,47 M-9;E+ISDS23H)48P&Z"W!)U"CQR442- MEQ04JFH/<*"YRDU$G9,Z0 /J*] JLM#61T!U9P'7WR<2)W.ZHCIJ9]E,(5?$ MDF:%3XMTT1VF_^S+'N?O[?Q\H@OYXO7S%K!\MX$*9)Y33&9-;Y(BVWB<=^]Z M%YGFQ: RRJ7+W?-*IW[>OJQ!M&<&:ZCZS2W$BS;GA.8Q.6-^1DWM7F)^I-#6 MT0 H=@V$( ]73EQ,%],F0NAZ.XA]7'BE74(XJLH RYQ '^V-L(!$N7%P O08H(&[-[]V^IJNA>!F4V M.:W(.J-4R+B-4JFRUBA]]-S'^7!0*\T4D'V]SH1K?[RE0A U^/(92E"1@()&J'I>K]U>UE/M!M7NU*!_V'F@L&7J+EV_ M1:K!_85NPPN@&>;@,S&T*,'$:B1MBR7N>$%]J#+WOBK[."'[H)_^+\UDEZ\' M-ESS!-I)U+Y$"]_PX1U!DV!8KOB?@.W)$2DE4NI;2O-)%5(K'1QOR4H)C_\) MQ'-5!\X73/Q/@&AOHKV#2RF;5"FM3/61HJ+DN_B3/9ZKVC\SV"'1'5^(-#5M M"H2@89_=7"[NF!3*5-=TN#GH_:]<[,22:^.YJOW+$E&LL5G5_IF!*%:B6&/@ M/_RB^I"]AZHRE044'U;4GY0Z[']GZ>P1FRD>L;G,^*EA^(J+2@=VZ33O9+3KD$KN@<6&F%@\XI*,PVKMNB+MVB'-U>O M^FJU]F?V]"S:=6,MNT[$O/OD;-/\B8OV[!*)\-UDJ%?1']10KJ.*GS9UNYA. MDLVFRTR^<%3,98]R169]Z2,1?2+Z"]&O+,I/W1QN@"*4,+6 !!X: +0>V)>W MTF6V,%JO 43\+)PPX 8R=,&J-+T8RK%1B/DB$8@&B&P1F #@P'&4 4:^-W6 M2N?ZCGCG(9]HC-9XGH$]'W(_JU;<& J0&D,R&7O6F] M"94L 0,;P, ^-$+A8#7"S4GJ<_Y&+KY6!FE-I?HGM4#:FR ?/ MM-QQYXHX+-..+BU%EI+1:2.1[4&62$X!&>M81ROTI11QE.UMYVS;:=T35>$! M@#\PA[6]B5A34=.)E0G.FVGJ\.OPP[BSC-'V%?W2[@."6QYQ8]2&58-O%07K M@>;R1D 2S$:9$#/-S(\L)<:/N-?5WFZ,>W #9_13O 8J5FSV? ;%Z8CRHE:G M9Y/!FR;Y&$*P],A073;V6*Z+"NIG36O@@QCM@:R.,0Z M?T&!#T(]9O I<91D[#EE'#INGF9#7XHWDMD3U>R%5 SMH>+G-!$5/W"A39E7 M :<%J[2!.M-$N$8ILBD6/U?V'')'>U)=%P]9B5N)'?,C[I+6#%9!5ID.X1H< MG;"MHCK93V97M^RBU9J1+B)@\E=X'E_(Y^/7VZP/8.+WC>L:=!:M MLCCXMU ]3+\MGDOI,IM;]2]C,8E$!GJ@=5A(^82JR-0"]&QN%7O-S? )-10# M6^*H0%71-G/)?6%T=UY]_?MPFO<#7]>](JYLD8-Z&I4IQ)$K3(41:"U8UU # M '!??^S9('7#:2/+35JT[^2$5U%35,,5LI25B1&66:FR(?ANA)=<=W &[YS> M3L^:Y^>G#=10.5CHVGCF&OI'8,]040ZSS4 V-NEOBI<_SE["A'/A<\L'^,Y MZ/$6CTJ9XE$^OSKU)Q;,8N"YP+UT/*;1;+HYMP09S(RN M_GAD@_DK/%P1+AJ84VZAE1*->8B5V]6IPLR"SZQ#=8W'M1AL"K]LWBTYF>UE M>#L>91\*_!.!>P28>\WSU7IAKL4TW@^739?HDIE$HJ#\"K0.\3T2S MAYB'>5EE!_AISIK'[(U."B]R]^U%T:]R?2\VL!Z 9XFD?32.W!*1>#&4<_'N M(RV@T8XJ/PI$.Z,YAO>@S]#G?0;CKH\ENZ=<3^&&.0V8RERN*C)R9H%@_, Q M]<;[H&>UN[98F8C%AR?[H.UG6,9%6#QEIX<=9'MN5BBFR[>3@'/:;>WFR)9X M4Z:28'>W4V2PE)Y@S-N1%12!ASI'$C5]884-5=Y'DWT"PH8)&K=F"1[ M/A(\)#3]*- B<#K$NB&OUOD[%B$::1)H H\J.G,@2'B0A =C$Q[,'%IX\(J; M>80&U[CBQ6"N.)U#!E1_+^1;3Y/G:XX+U16G<[MVN4KI,I,[8@OT$9M=G;@9 M"V"\A2^^3=B7"1[VI7,6KC+8XJQ2?3D]+5[WQMO=Z6\,^T+>,.%5V%SB,[J7 MIY%[3F=BZC]M'?:-WBI#"$>,,C'*08XM&WNC7(-J1QX&=2^@4=[@XOH/DN+D M[K8@]%]O7BI2:Q!V['/7A3AY!MVI%0K9HT(VI@K6/? MU&7"ZRX$G_RD=L86+R;/TWP_W+N0G9\[&_MS5YP-8_S^,4#;$9X%NX!=T$8[ MZDQ6,5AM+0:S8LKM@:T/G$",L0-<1M5'ZVU\05]5,Z<^\/GFUZQ#8XP=[ J9 M9?RBL0STW$JK=ZV1A6MVEZ4>R]F]63*[-^39O7DRNY?,[OVL!)/9O9_TG3#G MD-F],9UV2&;W1A<'^8)$(+-[R>Q>,KO7AWT@LWO)[-Y# KN[J@;WF#Z[?KHL M]1W:E=[)CY]1;W1W 05RM1)UFXAJ4MI$M'&&6K!H^1"%'(TP.1A/)&4&@-&@ M1P/J*\H)FZ@*ZMNC:J1QQ!>1GKA=3!Y^?I>.P0/$WG].FRG)I>B.:A*3P!V'=#?P3-=H'J M"E_X0JU^W.=0]@/WQJF"]L-0(R-.'J(R"YQ&@Y>G @F\HA1R^$U1$2@ I=7L MGLCIN.H&991/5* AGS.8)NT#27G[Z4O_?"A1EJAC&?^P,(2U[\H#=4X$&L]- MT,V8.@7IE3O[FJCQDH(R^=L#([VC(@OW.&0 A J47FX(7&5HFIG^8:+R^OL$ M'C<'E?IL<:O.9NDLG7;UA2VYFP&$^-K'>?UT/WT"=<.' MJI]>T1^"J,%50YV*S?R+WV:TO)I,O=ZGF]=GM9 M3[4;1GB :E_WFNT6==:IM/!UA2N'(5)C\O%];ZFP,#.(H LU3 ;4^E[BCNX( M/S&P>;N(\6>BQ)Z>=B3QQ ? !:MTPJ8GZHN, '^B(G+?/2#;[Y_%@/5^>?TD MO'U+1>P61,24B.D>Q)2)N9B26?LHXRW)XEG1.9X(>Y#AV"R)"M9DUK1!"L!L#(]Z01%&T8B0!"S;1E,3FM.B888D7BWN=00Z4T26F,J!F@%/)8-8= M#6;->9;..X[(>??X*';-DNFIHP,H:Y=.FP/S?E\]#S*3TFNAT/=H/&LYQ8X1 MK=2I??Y]3D*WW9](Z6#C,L)Y#1%WU#9@30VX5_^ +&JY?<065YNQ)WAV*U$: MT2D-=[^-3S/D)\3)I\NEHUR&(!RB,K9PBW:, M<%:4C5[/GYX5WS7A1B0(9Z<()WREY0_A%##"69U@DF!UM9N V/U(U$%<W@S05PYE1H[%9*?@)==VT.F.I];<#]*$'#L3] MPAUGO876C07,"TRZ=<."MZGB"!L*%E&W3*\IL*%6,<42_Q%EL:HLZELB/5]R M@%&>KR#6:?[]KE2M<:5^@""6.8\@N0HF G+O7/7X W2EJ$)61.DD4.EXW[J% M@5!6?$=Z=B<^3Q3I[2U/$,H'"&4//9D]=$6!QK.1;;N@&GQ"ED[S$JR@)5#5 M%+I?U](+JIBG\P'*$ULFT!/$S=$HMM?BNG>3F[?B:/VMY!%EOC7R)-S0E?7W M;>"@+QK'.&!58-/EPE$^:0&KSS8%(BIG&Y63WQ(K^A(2_]&L*B55+X6%(W\<0SRA7(8.C7&RR-%4"'==#45=LQ AIQ8D][=X.]:N[HCYD M"$+Z/$**2< ,); 3?$04SL<*I[87?+2BAC*3T5DV-R\^] +<]B56*<4%'^T_ MQH83USVF7\=:4Y%?LR7\ M1VZ>5PCDT>8#R$)(#3YB$/U@L:[UESJ?+V:-\%#U 8F_,B#+9Z5USP!K9NK\KY^>N6'^8 MZW\$[3GL&MG#T4J[+)W=UQTT+IW-)#^/D>BQ'>FQPN=!T8JRF5[-MK MR:OJ@H"B9'1&*Q2CZXQ&M,E7T"8[1D4K>JBEGH]?V\),?Y,(*HH#*MK7S?.A MU)^2FV>K?S*:96CT$DE@(Y?=^,ACMX_HHB]%7O*WYW'ZY.:W]&;>*FU,8 M[=<>H,K^%*%C%WPKTNDR>U0D3BO1.W[U3F;K1$:?0A(H^%9DF,)%K7+^C 8M M^\]G/&0-%=&1Q"G45L0EPVR1:"VBM?QIK8\[LWT2+:TXP(W!VU2\J/#='D%+ M(:*E?4;EBBRZJLPP1.\0O>-3[VS;0B44M+2BDQ11U9C2!=M_"-#.][ UU"[1 MTIY"<,7,@87@_M'1(913*6M'T,S I_!HZ)HE>L5*_7%^5=*T3N?A#K+\%NU_ M-HPG>X(G* YF(<\GL[;LFC(&=^G:9(CUUP":O0E$46EL2E \:9>:#Q6( MS[K5\WKM]K*>:C>H]G6OV6YUJ5Z;JE]=7[8?ZO4NU;[M=7N55JW9.K/)X:0* MUJH4#R1IP@F(8?Z7IM/XW_!3O/7OP)0SL0(/.8J;:'!/UM_LGO"EPC>+P,?( MC"S8(-P+E]5[%;^5K'U%$@);Q/!G6+H&6+H&4R8!VY,IK)Y6WV&=EDU_D#FE M(?]) N4X+=CDZ$$2A]9:YCK05BW3GHR)M7%;T*YZ4"1)2WUF5C2E6M \B0+( M+]R)8-/;@3I.IOSY1#OQAPV?@VTV;YK05%NYVD-15WSQ,J[J#V::0;' MQZM5:FT9&&D&JV\QONKXZ2FF2^3#@>U?Y )Y)^2 M?E*A-U'$?N>CU\ZCR@ZZ[7IG!V51=A"SOG5^:-)ZO,S)Q8/CY)XR66+CQM]Q M_^+OV5MNRL>3!5>6O&O^PZV)-TQN^&2.FJE>V6]Q;;EG+I#YMM],U6RP9A1- MKXK!'FVBYEUSZ?+I< MC&)TPE[%*?;::2'OIYLRTP/G4F*S+.@/GE5Z.]((W%WK[]73G\QY;\/L)SOJ M3#E"N)0$]^:I-CXQ/72=]H@@'KU]@G"8:N%8 _Q/8:HB7W$UG3@,#G-KD$*Z MG#W)E5:2P(D&(?CFH[KE3U8 [AW]S)@7]NRR\O9;'GB@'[#8R0&AG\A:+L0. M&Q6A9B/8B&@V?YJM_@@LG>';R#KD)VXP;MB<% ;]4O'IK[ MC%O1?Q' N*C4 M8!Q17/?JCW_\MH&UW%JNA/!;/GM ^"V!/<+6W3(T$A&;[;TIEMH0 7?'STZO MW@$XC/N"Q=YV')$MT1]$9.-X!1S/CGG!V@/$-.CJ$++,[+7P4AD^=U[[405= M8^%JA!IHC4*0_3L3)29=+N5(@[<=A%3IPPBI.N2=K_6R+_(#^SS.QR&DFJ P MZO9"O^,P:HE%UCY?"!V&$_V00$#B?0N%JT:O/IG/1G$(?"8GV!DNUHHD MV%G*'@;*2EYZM9]@9S(247LC%7PRJ?H<9/B+>?_B7,@>2)#409-8I567<%IK MAME#6G7A +EY-;$Z?Y/-YM_!VZF8C2L;[CNUNI0W)A)NZ/Q),&G(F+22B(B^ M@UWGU^WF[WR;XR8*0V+ZVPC\7ASA0KK,T@42UM]!6+]V(&%]I]#_'9QRM]*X M]5#:,#>%!/9#EOQ=A_:+4$FI,L;I3V] MK+R/2' _I.#^OE%-*5UFLIG04X^(QDJDQJ(/(;[O5%FR5&N4WM7JO,.0"/\^ M05<4,?X2C89IGC"YI,.M \IBSBL;G= MAC]+-)X2F2=YS-%;ZD(2HIY.,7MI%Z=M9G37>B")S/L59=_>08EFH7<015DD M<0Z60Y[5PPAY.B6>_9T!JCSNS#>,/B0!SW"E?K?QSA*=00"<#;^BD"B(!&*2 M>O+CG4[]=7'6:0' W=!3EH0[PPEW[AO/9 F>(>K*T9\F\<%.I[YJ"_ESK7BC M%=LY$NO<(]Z*)M29.PRD=9CIS$PRHI[_G[UO;4J=6=K^[J_(YMWW4ZXJ=9%P M=MV;*N2@* ("GM87*B0#1$."25#AU[\]DP/A*,$$$LQZGMJW(IG,]/35T]W3 M!^'=NAC17C[EF[A4OF$S!^+UG"YNUUY/$O3I>K-W?S; \*%(F3G4,X'PB]J MV$Q6GBI/=\]Q37#F%_5JQP[$<^J%.'!@::0BV50BM#1"S^DV,H&=R*7'0I?/ MW79"UZDS57Y[V._:=9J.9&-GF<#G)_I60AR88E,X .>J3<0IK_>?Q7(B_R0Y M=*X>G-JS2_?KGI6B3"3+A DTH??5"& )OO?5)M ZD\1;_>I9N679T/NZ1Y7- M$^\K'<7*6BKTONX[T/2'BO1#46*3;GGG)LKPXBXJ7\7O2J'7;%NOV4Z5/YJ. M9.,GR73H$_.G_N=3.1ON[H$>!='=^#,FKQ\IJ<;V"L)+Z&CPR-&PVW.$B629 MDW0L]"/X\QSQ)>$\1F P3SK3&/RM83&0/3I:L&Z'EKQ.YY+M2?*J)J0^7C.# M/MK"(S%@E9X *\-?C9+_9=)G,1"GQL(%B4=XK%/CXR6K/Z(5F&YQH]!]SN:>:/(0E6[^: MITD4YN>&$0[#@Z']G:8]T3,F(4B1W]_J_&,,XB*_TF>NPND%3BJA.W9SAF6) M",Q-_^%C\X32^HC*RP.8PYCJP2&+G8/SP62S94,*2.44@9S:8.R1_V+?E?TP MO]0'(I%D,QK0&E=HGM503U8$[ YM(!%^@\,?> O-.3V+@Z$HCQ%233]GX>.C M2S\E1*:[07OUS21%G)^55Q%?R_2/6"2;C$9/HDOBR!TQQ%Q%0-?XTO 9 M.YJ+)E/()"G%2HL\R?B))_,P_DC4X 465U9NKM[8QB3^7HSMCRL7Y[5+OL2Y M#2>'R)G.^4AK/< M2XKW1F-?U4UUC1<7:O@R^V**Q4*[0YF_^>RQUW<7+WOBB)W5T5W%#B2DFH[O MC!U.G G(.=ZY6'TZ/B!0/*5> [V-!(5X5/!]\UIOUC(VFGRRO)2Y:,K,/?NM M^]?U.[CVI'2^E-D]346R[_H0CH@]A#7*/#4:XK,@3N&[7I7JPC*),DU. HH' M7>%DZ9TZ_HYQ[@#7\4@AG]1%UIGV+JA40G_URBM@ESGRS-'\X%BDNJR@4.^L M.$(4J]D(@R>__@B)R<=HM8=:1O=@&&6J;A6CX93W.QA-J99$SZUAVM(T:/_X:$B@ MZ>%9PNM]-$D_\>02'XUPEQB7)@_H>;Q!_Q"ON'*O/AH&CI3$23STT7SMH\FY M8XZO8V4'/II,LW)/?^9BEY<;"-2M+?)%IO65CX:A]>8V^_/1K.FSY"U3+/IH M>LKKL#!1GVY?O?3:K>.(??MH&-+&.+4FGL]7/IHUI^.6/IIY-IK<-XH)[?T. M/=+")CZ:E6?4_GPT3"STT?C&1U/RR$=C<&O\N7"'Z,3ML[H'%XTCCG?31<. M[IEDUO0["%TTF[IHCC#7H$].'/$H^^]_3D^IDH!$_IRJ XO\@9'>1DCB\ B) MQ!^*\ O\3)V>&I%FO/"^>:SEG&\F2>*#'/F(C'=PLBBR0Q6F8OXTYQ1:C*^< M.H&6N':6AFU-72&+(=8SKXMD2Z=VTIE$^T.UQD.804YA.P+WAZH"('7"5F5, M029E?^JW^1C^TR*G_?L;2+V$Z IB7T\[". %8P_)IMD]8H=#8Y-YUQ'&3DY, M9YV4-@[_#EX-%R..=9MW,EKQ;]X56.A8!.C,!<+M=$'S?ET[_\SSU_?\NBO9 M,.):]IONU"6<\PV?+)WX)P@QO7.@2F%,><0[+C-^LYB_;Y1;SXX4M=M-DJ$W^!8"2BZ?_#R0"L%.UUBHVG2G]-2I?JS9KE7(A![Q$ ME1\H[O&H>*_"Z 1:A2Q]@7.8^;@_/, MA7CR?_!4[ "#IZ*;!4]%W0I4B5HW<%'W@J%25\:=6O(\S"5J'4%&/5- M\!23P(E$T43BX()4K,/A9($E4WYBR26Q4S?CMU)=>LD\3S9("?&**?<;.Y4D M%;4/CBEMD5-+H_J*?N+,"YE5C'VU6//^1GDY>62B>V2-U.X)DGB M ./Z6*J#*4L-"+U\%=JWCI\=A/8)K9;4K3;1>^_5PT"N1<;U5VA?&L=R,;N+ MY5H([8OMBRD60_LFE;\OA>?K_&L_M2>.V'MH7R90H7UK"F9L&=HWST:3-^X5 M->DRFWF?!@"O">U;>4[M+[0O%@U#^WP3VA?S*+3/X-9T+M6)7O?RE?$&*IGK ML7V.6-[-V+X8'6L%[FU6ET!2;S4O^,:SSI M1M;E,I[D,JE,O_P6G70S^TN[W#-/QG ^<.HDD5P,_ \V3])8*Q=E M^8(U$]BJ.Q36I$.C,30:]V@T)@[.:$2?0R2I\ H0.C/^1JT/FLT'4A ER1JH M0)SOD^^VT^X0Y .E49'3K62'I<3.SA?J5AVXUSE8_H7I0CJZVE708@" MLQ8^6U_A&'[9'=5"DOW31V!3N.24?D\>@ M3ETGSBVFC:%/;QFV<#$HOR0>7GFQX+3@^8:K=^C?6;_(G08[&$?5*6,[J_ 6 MSAY6*5)AF-Y?Q$/I8!AT,82B.*Z.J[4'II5R&A.V7^[T.O!B,]9,X^CPQ.[J M;/WSQY%T/F9^$:6;PUX"-JFD]54636(5C*=R:ATI..>;[2W59ST7J)/X ML'RE24\].I'<)+;7T?1=%8V>>._HM=(/U_/S;A?>."=UWOG'?N9LF7@Q* M/CM(#()2B=O*%[>;1'6&/HO-E^8PR+'0G#5**HJ$ HR@.A??D>.P]SSW*@' M^(*@@*'.(R=B5C)_*JT-*\2V%\=#J:UM46_-.6 M<2&M#]E:@#E_*W2)RQ4JW. OBGL>SD>G3Z-IHKSH/TV5ES43W&%87SP&K$QR M+OV;=[FM_#=V!V2 UE^>8KDLM3+A2A:=YSP\J%_D!@4VR;$;\/"V&7:^XMX5 MB7;Q.,F[]&F>'0ZHT._?M#X2E)DH4F!,4:0Z"%8\1$0YH&1IIOJ'"M]3NV-\ M%Z@B')\FPB8-!G@S6=&Q%:HAKB_)HMS#9RL%JT>P41)2S[Y*F <&K74)J]2Z M7^7]><[XA>?,!7W3>QPKO0T\']YQ\,(YL2F59KDW0>Z856>2;;IW^#(7F.I= M0!]P(G?&^FTR"63&\3G6P8WW7T)Z@2?@.);K"\!0Y(+:3$A4!:<"%K]+#WC6 MJ ]6-16#,ZJL9RW.35,/(8)7S[SW9";@B$ "?0YAXOY,4\RM"GRRXY87^.EJ MYTBAW^?;SC3SG'(T#:*(Z73BO7<#S!@WIAT31O8\8+Y!]GYI10O>+2A#NM"6;9?S)=3SY]^;N\V;\D-GPNG6YC-Q? M[9)X.I+5MLPE5UA!)>5@*;;74U /@]T,] =EF-4H$;%PPM)1K.>*>,- OP=E M5W^2.@;+0AQA10U;*!_LV)D;']Y :E[H&[KKAQL!).)D5_5$;"%,1MX+<[D MU!1RN3G^1:6C_\S74#&L;AC#&35PY1?#N,&4L);/3%<-7#J0%5*NA*R2C+C9 -*+'.RS=]Q;]V%<@ZG/,]?]Y_OW\;7&]U-;]]2 MY_4(I^4M'BYQG(/#2VQ2WF^ ME8LH <:FZ6]P1-@D<4TD_>E':=G<)1TD8F^4BOU( DY_D#O$PB?99S/>$\ME M:OB1EB3B.R][OI+EDEXEXNM,F+YAXN.WZ/O?^ 8%:3W(H'=;=&V8XY:@(]G, M[B($=^P="SUAA^,)BQV:)^QZ)(X-/YAYGS3M]K#V;G]-'H)3GT+*.HI36 KF MA0:;OJ&+5Z6=U-9)6>=XRDO%;8G2EF!P47CZYYKN=B-,[6-C"!LSU&@(WQH@ MI)G)D%U9%.4/IT4VK3>JBR&UM <>@CDV?A_>:8GGQ"!7XS;4*+?A1"\]!(E8 M)'M,_]K>0\!_[2&PV_L+LRI4P!G7S&)!<> C2?9KN9P$E@YQ?>9 M^DU['V0I&8-*GN$W&7HLCOJ&EV+1BV]J<>;M 'BCKY+$!/(-2QP/\)T%YAQ! M&CF\EI7-;CUF]QX5?V;LE7_-@22\P DRA>YP@[]!W/,4AI&8_''U^<:=JON3MIO MYS\ ?L:*GR.Z6OWST%#3(QU"5\+Z?^M="0FO"J?I_,@\EY^J.46H:!MT8/"@ MXIG;HFQ35T(RDF7HW>7 AN5R0E?"EH6F#]65P#AV);C6NHZQ3F5&EX)L*2V. M^[6_7&.#NH_?+QV=,HN%[=Z5@)LEA8Z$W3L2DJX[$A:8^.W]XYF]'W\FJO0F MJN66?.BI(R&-2T7_X]!\UG=,4+#U+4D"B!255<:FC6Y,">MY\#Y.#X+".HH> M'L7K.P9":-[>=AIJ8$3LVDQS7 !:-\/ED6JSJ"T;_XRZDC^P##S!T2FF)@K< MRN(J7'BBY+MRUR$;ZBO%C@N6N$F 1M5YJP\NA>HD4OFYP!B),6G).G,%U?-3E+K @\ MV%G1F8M]\<1BE9@KIG-7&8_DFX\- A4]88A]]SA+1C$W+%[E^D(%\.3G3L^39V$=)<= M#'2V,-21"URZ$ZDJ/NT[@J3_32_V&?.V[5G3WM($ 7C#TDFV9WVQT.C4WF74<8.SDQG752VCC\.W@U_* X=&S>$SH?3J8O MP.6Z.B8!;-5QACM?T+SSV?S2C:,X,UVT?-,..<;WF9:K6*C257*M^56L3 /&R=#;?(O M )1U!GJ&,X5%IGO\Z]7N6.(E)\/VE21/7(7LK'="<>8^>6)SL11@D= M<)10XO"BA"1D-@9T4L)D36,?IS%"LQ=]$^:>N59?44D64[N($9J[N]MAC% R M%L8([21&J#5?6V+Z(G7$<4A5@9BY/ I ]J+7@3D'3 M122]%2O\78EI38:[O?_>]24W29CP:5]O[RZYF6]=*/R M.5ONN4N7W"1=0G*&Q/"2^\M).+GD]J[P@JX#Q":-!Z["H@K]M>3RXI+;93FV MZ25WTM96)[SC#JT@GUI!R4.S@F[9L64$$4$K:NP7!M":C'6G!E#".HL3.,+G M5JA\ MZ]HR:,X M&24Z1UY^/B>?G[MB:8-SV0NCQ&5!MJ%1DL(-8S-^L$J"9)2LN="\WU3 ":(3O$<9;*""V1=(+*B3+F1%P>7$6LPO5S$E] [TB4AY@[<6=0 M247P'Y$%&,O*>,H73)RD]L..F/!+SU\);#%^>T)_=**Q%[:DQ%^V,,_V<>\; MM^Y]9\51FF':$Y5^3?/,QUNG"2=$H]@LYAKY*RI7+5"%XD.Q4JOC0"*J^%0O M5IO%Y@E5+;8L7IFR39_/C._9!;O)^^0%NV1PTLO8QGH%I+&"B/BRI,M$ M$%VYCCS2MF)Y[&FVLWR&L36A=O&E<-:\O%\I<6G\M^$Y#'A!A1<#*\$>(8-C MOB_U9K%P4<+UUZ2'W@O]>JL*D6PS?U4LW%>*1[42]14NEB#"4R?/9M'P[L4D MZQZC[<.2O0U%7IA01Q;YO<_*HA7L#?[T?Q$F8K%;/!/5#0FSMS9#>FM/BI,* MG[[[1!EN/O-A30:+HT6O").R).R.8\^V*DH=HT]V$\FY8V)@/E@(G_,E<_MS M5E] +M%>TLY^PC>>LZ+4#0JEET@"74%335L)<,YU[=],Z=IBM 9 MZ1=AQM?4BW&5U< D:\DMW-RW-)*(\VJV:=]:JTPU"G<,V$:N KD[6=[DN-N MQ%9#*-?>8UN8%\O5?S [ ),]11Y)/#8]9.6<4GJ=8R8:/V%BZ1,FD?CE0N9B M@OG'6[](DQ59W'..S!17?E+TUG/X_H#0\]LWQ\9*&-^F8)I&HL>4WN 0<90L/_:58_95Y=]RZ&^ZG[/N'?9A4Z#7#ZAD\G57O3O;E^@F"W$ M[@_&+FUAEPX$=DE3D%1F35Q>B-T0NS\#NU$+N]% 8#=&&OJD#^K<76HU1:<7 M4VQ MS*1IU.EW+22_BN< R.0]R&%\7[T.L0=A_L0CV5AJ31,(-_;+ERP58O'@L1@T MBT$S3W"Z7W1-:&U L+C4(DE-+1*3LKZXO.E_#*NC M#_Y5^A0"X/$KKV^B5?@?<0;)%T M%"M#P9?&(2Y#7*[%9<",E#0.S$ROZ989XC+$Y2'@,F#6"VZUR<1C@8!I%UHP/U!03,LTF#N!S]S:ZEAD9QFBY044CK?'V9%+$\GE:>_ ML?YK>/T!(QE[$TK4'R11<8#L+"8/PJ#(1+*QT* (P7<0X N8+9'!X9#!C^X( MP1>"+WAF1(:&DR_XX%MJ1ES,W$_4M#Y2#%*:]L%^[8EJ8M(L\0TVQGE;.=C7 MUQ1D6T)!^H,$Z=0ILPR2AV!.9)A(-DPU#W'H&QS:1SI5$7%^4DXT,Q,^7LV$?G\-%XFR M[2"98A>VD1K"/E)#LI$DGWN(MQ+W@>;TS<0?D-T,E-S>M%G2OC=EK63W:A&N MR_[C=64YG,N- !D3*A 4/EMW/N [Y,X$S#+XE<(]Q#N>X2[/V]#-H![ L,] MF@E8C$<(]Q#N^X2[/XV^#>".8YKCZ2"#?54O$IO5MI; ;:&U!T-/FQIZHUYW ME([+=&WD;7[[V@N9K;JNNIX\(FNL&*"6N XEH2]H[(I,WVHE.W?9K45B@(RT MU=([A96U=,:A_/8_'X9@#\'N.=C]::*M!CLN9GP2C3GLU>!_/@S!'H+=<[#[ MTT!;#79<.ODDF3X0L)LVVF^-[8@H>W1D+JLZ&L H7/;?H66\I7/Q]N0N=I^7 M;E/T^'F;#BD#5ND)L#+\U:BWB_VW8ZVW,]V;X;(ESOSJFO89H1#PTQ#6H2G8 M@%PHUB>HG"BK8+76NI=(0@HKXII]_$"0!%536$UX1P8GPW]$5F(U61E/F9%) M,+AWGGV#HNG9VM=;O:$]N1BWZBD^%QM=;7/!N=L]KM9:Q2,Z0?W?_TLS-/V' MT@>W*,)DVA.I\%2[KN=OTH]B)'M9K!8;N0J5JQ:H7.&V7"TW6XU0Q@HBXLN2 M+M^QOZPU(F,8U1U[R,[H91]6_*;S_HF-9)OYJV+AOE(\JI6H[1"G\Q*0 MY7E!ZOTO$HV0W^%;G/F[8PH:.AF6)BJ$R2W>)+9"<*-@?J M)@BL[%2$Z^@\U>0A0:@)5^O]BQ&8WR)< 7%$9A)R;?HO1I_8<>;DT4W^[8T8 MF!%L"_,Q=_MS5E]@+H611EN8HW7,7?.CC"2D49470\S]2,S1(>8\PUP,(RUJ M82ZJ8R[&TL4NVRN+[[$0W*; R9_CX)>[:MF" O*IM'QAE4MOE[!+;L&XE@[@Y MI!N3#&D7TN[[DUPJVA)S_3N(V%$%J6<&-=D%7"OU>'^'KF7A.GXX LZVYA.J M/NJ( D?R/\K2.P*9KZA4 XG$;Z:&/!CB-Z1=$&FW5/8Q,[+/$'CX(F"AEKM- M"5++TF-?X/J7LLRK-07>_BYP2&V OB^\([X@\%59NQO!3+KCDJS YW)/$HC; M7+D5('<_!GXSI+L9*Q>/ M1J,X5HZ.>M#:.I#L%J+W!Z/W6T'M>T$O31*.G4:Z'BR[A>C]P>C]5I3Z7M#+ M8/0R"0]ZS>V/W99:3;D9J^F1[2&<(MYD1581D+NEHK8PEU+/C^]73^.AP.\Q MAWC?B0=D4\C4\$6 :FP-I>![ ,0'JD*$/PAZ"'7[YI%Z(#9/+)+-Q#RP>'S/ M3B$.#QB'P;->XI%L*A&VI MQ>% X#)X=@AM>1SWP(?C!]&!VU/%Z"[NC5>I\ M9E*WS)/*!^::QM,*1F'[ZU#.[J+]]5Z$;#*29<*>62$(_0-"^TBK6TPDF&38 M8B+DUKUSZWZ[1>_ER$A%LLG@NZF6JN7T7(W1(2LHV+*Z9078.(F5..03+;TS MN=)8-B5<*=YJZ;Z^':AUNP*'K.N!P7270G'[(\7M.L0>B,*>CF3I>/#%;XC) M$),'$^^$*_O1 >NF$F(RQ.3FF R;9[**UM2 M+IA1->YMF^N@W$R0W2936Y;@%PKV'RC8=R8+#L.:HG&D>LR#2%??\VD(\!#@ MS@$>.-.,9B+96"Q@G>]"@(< WQ/ @V?GQ2+9>"SXOI<-TOK+DCI2?'0%="2;#+[S+(1A",- 6R^XD9'$. R^%V&ID9&<[?R%A@J0A]PA8!H/9%R1E?SJ$[/C4I!2 MDTRE-LAXFQ!7TE)28 MG!YP/_?:A&Q,H,3LIDW2]DW9M8+8JT7L7%0O _9AF#-,-))-APGY(9Q#.!^" M$<30D6PR'L(YA',(YP,PG1@&AYL%'LY+3:?2C.GT!77;0FLOAI0V-:2TV$WN ME1\5T9L_^LELU1[9]6IELL:* >I=[5#T^8+&K@CQK5:R-,VWWQK;$5'VZ,A<5G4T@%&X[+]#RZY+YS+MR?!Y='U1EQ/%FVUZ&P]8 MI2=(IYH\/*?@Z]8')@+(9W82< A81G&5BSL6'3K3/1OBI_2#1"?H=9UP:#S?Q'<98>SD MQ'3626GC<.#W82 !/"?%ACM?B?[**2/9&6>>L1Q/:X:O5O)?Q/2Y?=M9!>MW MH:LQG?!M8\(U:$IA,'G$.RX?6Q&*%<%0M_2F M/L).C'.*R9PQ"3PU\^1.G27A]\CO!498L&@#JN6N,5/G+?297UV[1HE02.78 M(;9'E!&*+(8X"RHGRNI(0;5N6>+D 6JQG\7/HQ^\?HW\]JO?D(JGPK]U1L4K4J5:[F:[=%:[.G^]YQ<8+G,^,OLYXV M]E7-D)7\;R)YEIK'Q@OPFM =&Q\*$H_P2T[UKWIM&#HR][>TTF:DQ:*LF/$& M?-=0^XZ1%@49*DA+*'Y.2=A#*F[DZ:?/7 U1,;CCN[-J]9&CLS0O#^!U8TI0 M0>7@9&4H*[@--,EXY>6!P DB_ ;:2&Z$OF>O,E[,> MG6@$?:0X%O\\,VA^5RE :1V,8_T0S(YTFSSC\\ MO"@(%?M?.]X7AG;O,GU#YWFY6K*\YZ>,S7U>)_%:=O\Y;A.6.EN39:G_YUO< M\,_9HI-[OR"<==JY!IIY3^#>5_F]?6/\*EMD!1$*.9(Q(!O.J05&M%VU[%)Q M:]X^S:AL!:2Q6,:5)1W@.(RN(X\T+!AE"8YH=585PQ=JJ[2[5&Q6N\N4VLB, MQG/QG>V)='/[&+TM,:^%;>K$?5.KMY9WD6M/:/7O;;KYGKKL]:R9\((*KS:)7RN*< M2M7Q6*W:[+[%/>>WOO/;^[]_=#0&[ W^]'\1)C(-_[[HWKQMQC+ MU+OSEVO>!#]8T+5LFQU[.0J((]+8T8D1HT]VXS/<,3$P(RPX:GS)W?Z8 MN\!(HRW,T3KF7H?QA*8'<[P).ROX8:YGGJMIN[4XXVZ=QO+JL;TY;4DJ!/&]#MARJYBO37J?M^W)\/U=^2LF M^C&%];<3UM,:G'.AYU:ZB=PUTDTXD555G?##OJ2U&Y?BY)GY?.=B#^._S9Q6 M+E4+S>)#\>'^LU0N9B[+Q6J]]7!1;[T^U!Y*M[U6]+G7O$\46E&Z5"XU+A[S M%Z7'TD6I)59+Y7R_^/>IT6MN:9?\(#P@_"=_=6 M^0:"=L_>8<86YWWN@-,!?#F&,2#LN([IM_0E]TZ(OQ ^%"7TS(?_[9VY#_0OX+ M^6_O9%SJBV:FI2BPWMCM(D[+#4"_T-3'OL#U6 MI3PKR._/H^Y=22T^]GZPDYK])!-#A+@4 MJU.7^L#DI7#51DG60%4V*?S[V*#Q+UQ?B9N2F3(^-\*+ST/AX@?@AL(EY+^0 M_P)(QI#_0O[S6+G*+5ST$Q7 :M@YHUF5I0+2D((;]5@JE1Y("K_@6-)E40#: M7?%SG,Q5:IHO&G/N>V.JLG0ZU:1TK0N3FA=P6U12O5+&'7/54';X 9<[;\'U M70CZ-;LJ%H]D8[$U,10!D:(A$D,D?@.)/LB-BB4B69H.V%5QB,00B>XBT0>9 M3;$D(#'FL/&L#QEJJ661GKPUJTK@JS489(R?X^?DAN8(5!^ MI, 7M&F$@6F3J#:;9""4^_35A5;ZW*8%YH$X?2V:3Q"OAR:;9*9XB\XJL4AP MT+((>P*_ O\;?F$>P7=@A\A?/_#72;N,U!^-F@X<*(GM9JKG0>2K[EOJ[TED M^-:&2I$POV0R\"=&* E"21!82> '&RY-@@_CT5 2A)(@E 3[D@1^L"$S6!+0 M3/ ]JZN"?VQ6Y'QKF3P,*T@CX(/:$"DL7K9U!Z79[+W^PVLEF;F^N!.]S43= M]!)JJT+A;F^!3DPK*?4W==S1H;4^+<,7Q:^WE=*^(+PKHGJKE;@OK^TCG:J( M.Q4^3_L"SR-X&R"8$3X[BD@G4AF\[#1#,]-U?Y_']JZLA%@(L> 8"^EHB(40 M"R$6"!;H@\#"?,?RQ0[?MMZ*N5Q[TLA=1:-WB=O,Y8N[S;!7-\SS-W7>[-'/-E_]2N&,U;8L/V1Z8QN+1!\XW*%V]J MA=[M8]?1%;0UN%^O">*X7DW\A(XNWA,XVL8ORMLXXJ!C["T]=_;ZN=V..=GM MA5YZ=;'W^<:-8!=$%W?;!Z[@.*ZWDCI))A9K'>]MM[%#['Q^_S).]F^ANE2' M2:=C?Z^8CX:;^^<#!UX($G"6E6E,%L* (+NZVI\%.V+TX\711 1)GXL@L1(G ,EQ_S T MP VO@4(<.U(1_H*@4"--$(4)<45:3\D*4A$B!-)70PDJ60$<;AW\\=EV2#55 M3YO>.715FW1;=5ZC2LXKS+OLK#X5'$56P4%D:ATIS3ZKK.J7GDDE(S,Z?30Y M(]S6#-.>T%JK\1:ME$IU8J5BGP\["Z_^=\"=A1G;PGS,W?Z< MU1>82[276?TON<'#>YWN?M3$$',_$G-TB#G/,)=K+_/4//U]4_\V^9=)-!UB M[D=B+AH0S+E?_3(P:O2^)[14LOAJAKXCF>\F%.YA\"?DQA[N/?1HWT31. M1?Z0D$)"!/!OG#R -X_=B1WR>=]4I^L(1/-4QXOR4P=5W[=DB<>VZFSN-TYS M)2\AQ'>(;S?P[:?V+_'X5MW._<9I(;Y#?/L&WWYJ-1-/;-4!W6^5[$ESM$H.YA\@4H^&$7,0S! MMNKV:\FMA.C.';-Z3_EE]ER=3$B=->N2D6ST+.J55];WKIH0OB%\'WCP]=*MZA"^Z0,Y?;]JFOF(,$\@/@?6!MM#U1$F::U; M4WA!8I6Q3AI[3TQBV-3R7#$U9*.59')_)=(%#9[G]DYODX*Z2:.3D9(('7$$ MBFQ04C=LPL9-OO >A!Z.D/]"_@L@&4/^"_G/8P]O8<;#.Z >;"]OZA?TF/9::<@PQY7AYU!%1<*O# MN[&*G9>'7PKE_7B!+?-SF>F):[8G4R?I1/"KMH<0#2'J#40]]_2N@V@B"A!- MT #1L,5*"-$0HKL/DOT:HKCP)9,XR22##]'% M+NEDCSIBSTUU7\[&6OH^U) MLDA??U[GTI+<#W#9:U+Y#7URXHA'V7__0C!0 M(OV'>F#%$?Z9.CTU)!\OO&]^%S17K"%)IN:H]-AF!<6646 :FKVD7/92C$RA MMEB@8ZY^6>G43CJ3:'^HUG@(,\@I;$?@_E!5D$TZ8:LRIF L:G_JM_D8_M-B M/SK:0?ANISGU)!LFKU(QN'0V&3@=82QDQ/362>EC<._(XS6 M5AU94<5E!PC>[8+FRP7:^6>>OQQ/:X:]5K*A>^4"]4+YWTT@IQ,[SL[:[N2? M U4*8\HCWG&9\9O%_'VCW'IV5%?H-M=J%1M-JE*^+;>*A7G8.!EJDW\!H.0< M8_U,(AAU@)N.UMZJ4?E:M5FKE LYX"6J5*[FJOERKD(U6_#!;;'::H8,MOJ, M^IFT.+YO_M=Y879YI+(2#R.#RH)@6=9E L6S&OMKCK3>G0_ZJ>89H7\H6QCX M$ 8]2E4X&$R0Z'8T2I^]#'L1BA6U_T4LO:E/7!?G%),Y8Q)X:N;)G3I+PN^1 MWPN,L&!Z'YZRZX_2^O8BXPW1*#X&^HDFK[Z975]N/MB3:*2_'T<_WO0(QD&\4*.5OKN4:K7&PN M*53?<7&"YT"!SPU/G9S M'3=H?'0+?-TC34>H.J!/EB0D4GEY@%LAL\232SJS:'TX_A0=$M008X+2%!:^ M0ERC*OE2AP60<$@]#U)?A@WVTF+. M.=C;H@([XAXU R)38>A\L49V+%^JG7FR=)-KHTN;U[FZ6?L_>%HV(%P@[0,A MR79X"$A==1KA-NLS'30N5IY&3M[1GHA_^30C%?_6'V,N'5$>;2CF94W66)%4 MW5/08"09+==!R @\+LP'0HI:*J0P ]LE$A"!XF%#<7>F/J+&B 4$8'V=5>'% MHBA_J'!TG7O6.&:&1":G[@94WKV5O$U<7PFQ;DYOB,W6;J^8N MB0&.&YPT:]5JL?(3&YQLFH>S[^M"6N\.9A_^M\!UY,/^Z9XA[GHTKXI3^67;I>="'0^%6+N1V(N M*'U3E@;XT]/L1]!)IRII655'V.ZM=6M#\_;IW F[^K7_>(*)9%/,LG;&;FZ\G[EG6 M4R"I&.&SHXATDJ8CV5-W-(GYB)\%T3C;J':&W2Q[W>Y3;/9E!3/,H#@8BO(8 MH0LDH:Z@F6T,["+S]EGNMS*?-Z\9F6(2+5"9:?X@8A"J0VQHT7X-*M\J,(E(EDXQ M@<\T"R$70FX3R/E! TD"Y)S6U_0AYRQ5.Z*._3"L@CJLBGU_J[2/<:7"W!6' MK=&[O]TOWKI<@$YD:H18E,'C856^GR0$G1EF<\#RK0:2BF0S'GA0?,]"(?9^ M-O;\H(JDL2H2_&I-KJ@B=5G5$/%BX:^LN0\JQ5YHX>^P7(]QH3<$1L*$.YU2 MSG",:(*BQ\MV#$J&XC(4EPZ YUM])0/ZBL/RZ@?!1R$ 0P#Z06E)1@& P?=8 M+M59BDYN;0SELB0K.7X@2 )N=: )[P@F\2YP:)GJJBZ]] M*0;=R.2 ,:E9ZE&J0;Y07/X@<;F9?_DKQ/E59TG2D6PL&7B1&8(P!.&6(/2# MWL( "#.!!Z&CS(2E&UB5I8$L(8U5QFN\+(-$L]=[?QS>--G0RP(C =5.3;+I M%T&A7R44D1LCS+>J22R298(O%4/O#;"^(TMLI*PU&52KST]C]1R2@- -EL!=WU [1&^(7L_0NSL5:0/T)B/99"9@83(; M=-.F'4;(M(5JR]"0>*$]T*9*TE]TF1NT8K$W(1,09XVK)D-PJN4XE#*^Z OO MBKQTK>"!%T+3R66];QTYJ4@VX30PQA?\M5[+"?$;XM?%6!O_*SLX)CCFL/>< M7_ELL0'=NE9NF?8D<<-<"E)4UEK(W=+J^F)GBK+NLFXP5LOMU7P+2&,%$?%E M26B\U5$"Y-G6]NO; ]:4YNWJ67WM\!VJ9C M^8:EL:>U9@OM2?ZN%+]O%/Z^*M.4=S>+W-K+UU[D*KEJOD@]EEM7U(KJ]^XK MJV$Q7/^X!!B]&*X!ABWJX/I-0?''K'RNS"VISA96(UWX=\#52,,*P"&,0AA] M&T8!+.H;"!^II:S%O*XHB?L X4D.+./YQ]2D8])>5^LDY3G)/&T-2WX,??=3 M\\^T)3/I_,PE2VX 4,5W86-L>-G+'ML;8;2%:GEZT<)932/:MI'R\&1/5L R MF.D4![_G/@5UYJO+O5*U;E'2!&U<4^ Y^(/N/FA/%%F]*8Y;LOH$EB]\ 5.H M.2WQ:O#/-WHZ>U[6\$LO^V:[,.NJRP&=;9X8:["V(^KNWBV/TU4]B*_<$;J^ M&X$0RJE-Y53<%3E%[TY.?;X,B\6GIT84YS*&*OJ\C1@N"@CA-5H(5 .H/VGFBL?]$0GYUYF7VI)M/+\@,D)AG6KC!RV7@/K "A_29 F. E7NU#NPU*7C8I]MB711Z%NNX6\[R0%47^$*2> MJM?C4>3!?.1#2%77SZW9-N\@0WF4D_B:UD=* W%(>,=B5BV,$(Y$FSV W-1_ M[=@Q3[!"[";:3\B7S#!MG6!3)EG*(($[SAP1?!.U> DA=W^PQ2+9%.TP<'3? M0 E6AIL_:+93X;*];KQ,N/!_2X_=V_JCD.F'PF6E<)D/0O>#<(E'LDPJT,(E M= J'NO+WYDD0K;N%.8X8Q+@/" 9W2$S73['9CL*$](;[P7,5.'HO/5V7N^R; M+%BG%)G PKX'[G":H6-@--M$))L(6/G,4+%U7R2DG(@$=Q77\EMO/,ZQK.(MNN^^T4VN@0:MCGOU'L M[S("[?XL(I4W@G46A1$)'LF&@@/9\*U@W:6R(1%+Q.K]QTYI^/K#9,-BO*T_ M9$,ZDDT%3$_=6^:ZR_ZS=_^6M!#D3SQ;22/^QKS;>WI\KY[4V?+H>#Y0O#X5,5.1R-9.IX*O. ) MFD/XA\MA?\S*GY56#K!Z**^//MG\]CZN& >RO=_\[(R#:1K MR1H6H+N@^2ZKV:\D\H;:\5("[J^^:YJ.9)-)A\>5+X 1UFG>K^").A8\WU*7 MEPN>FTDRE?_(5RK5>"AXUFO'?A,\./'-:0BO+X"Q/'!BLYK2Q?:D^%JX[C&U M3EY]\:YXL2OF6L>2 9VY.L'S2]QE[>JIO6@O*'TI@]$A8=OQ4F'!@%Q1H#K) MI&8+5$=G#?\-AVQ/Y,[3IU*YR,0*C.]WL5IK%8_H#/5__R\-,O@/-5??FJ'; M$Z'^UJE^EE]ON'0D>UE[*#:JM\5JB[ILY*HMJ^KT A\,75WZ"["$T!T;'PH2 MC_"@44%:0@]<=1NDDKC1&3]WE 5IZJT^.IHR(NZW5U85%HD4DCAYI+ ]>%A! M*F(5KD]RNGGTCD1Y2+YMM>3#1ZR$LU@T^8-5>!7_A1_AOX!LI]#G4%9@;&7Z MP$=?@/$^!%&D9'S?^2&HZ,AH,4S!!\8L! H!V.7!^(QJ]065@O^'W_'(\*YW M@;5]E2I+DOS.DD,M-]+Z,D8]=5PNYWZ=&*]3$ ",P[.$I_"A@Q2JUNT*',+K MQA_F^P+J'C4YO!I!U:CC6K[YZ\PO&^N6JA4X_E3DT9#JLRHP(,4.@8G><<*4 MSDMZ]7+"!^4/#&1-:I7#TNAI]N5,_-KK M-1T#S2NY6+3DR&) _3_?X@M!.AHJ HB4,8@F]8SR"W/_;(R"?%9''0)+3<8A MXH+46P"9>KF4L8&I#JKA+)KBD6QLM17C I3^.0*Z M"40PB>@=)(Q)1!6FI0DB/C?9L:D>8$F+3T<%Z?+LC,JI^'.S2CBN_$UAFIV0 MK^I\05KV8N%-"JLLD\(V-V-=?YE:DI5YT6?W,L[SAECMIP8HDQZW4JN%[UJ^ M6/U>OW9!2R>\9HZS([^(I)\J67FAVT4*PHU:.DC[0$@BP *&5 50=G2-=ZKH M2+IZ*PIL1Q"Q"@Q_DGL2T /^B*]X<9-4_,CQ$.OU@(QW5ARA7]0'Z%>:@D@R M.E:UJ-X<>(YP[H^"N_9@X5[.-0'F1IFGZ1OP@PH2!IV1HB)39E@&!%@"2%*1 MNB^5VO<-L39U,R02/W+(?8[ZBWO-)?K8GUFJ7A)U/#[Q]57C'N\%5B[W]B]7;.).V*2)# MZ3ZF2(^"ENJ$'6)6_SO@#C%AHR7OD):Q^5M ^YE(*MMXS8>]F'XFT@+8B\EB MY6ATYFHH/U)P1?P%D]>ZXAZPEY>3UL-[>_+2&BO-OX54J=+=0MW8:V^GI->] MG9I]6='3+0"I YL=!,8/]A522 J[$?DJD'&'+3"^BA!>@<&-*L?LSNF3C&03 M'M0F"R3/A!#\P1#WSRS5$')S2@H55GB-M=1WI-7W3?Z_:T7 MC7FJH_@ZB[8B2SUO=1%_!ICNF^YKA>+!Y#.M!J3/%)9T))M.!#YC*01G"$[/ MP+D_529S$.!N%5]$I).,AP!Y MC@\G'2:0229?B49_:RL9G& =U=SD3[[QP'37I28S.;A*]2! 6^N3$$8^R__[G])0J"4CDSZDZVT-_8,"W M$0Y\@X$2F3_4 PY4@Y^ITU-#AO#"^^;0F[N,3)*I.0KIV2Q09QD%IF$[\RJB M)@^7J KIUPE9E3,$8;7_J MM_D8_M.4)TV&_/P.V!E0IC"F/>,=EQF\6\_>-W*FS)/P>^;W " M&[.$IN_NL2S*?0I2'MRF@E"*^*&D"KKFS(EDHA6MP MS=+_PC+XE#UBHBM+DA3;D\%5)WDU*;)2.1W) MP@';:M0J%3A>X3@MM\K%YC2EW.VJ)&<)[)4P?ISG9P_\+UXD0.YZ#3@3T)G9QH]6+F92"EORNZG?#$-//1NWBX1:7TC/F,).W:3#$ MUH'_MG3.7+-9;#6I7+4 %GCNHEPA$OU')7/N)@_*S3-[RM=D+;I,XI\4,M:#IWGE\T"EC1_:9W/7:Z'?P;[>D[V3+E@(")X1.AU7) M<#X&2Y#F&@)[&UI.ZRXY0F?M0T+\#X;WMBF_E)Z('HJ#4!R$XL"[?T$2!W1P MQ4'0VL58UEXL_H_G?A/3TT$F:_F[-/[LVQ(US++U),LVO6:ZTYJ(F=GZ$+I= M5.O.Z/M+:R&VYQ]#RM#>]L#T-LU[R#3>['LP5%MR3Z9SEV]BQ!UDN^?'LV:Y MD9]O(;]X*1EG(TN92%8O*KUPX1/.7!5K8NU%47M M"\,R!B%2M;*44U69$UAM;:7;[R/XY?;Q<52+WI4ZXK0WMCD;?*]O*%_?")2; MEV([#U#?E-+?*]_J3-ZX7/XW@XMI1X-;:N"?4 CMIE5B>=<-N]*ND#H#*_;55 MF-ZQ5:BSA4VHYQ/16NQV4G^Z??&;;3@_5\\LQ$0DJ[_+=0O1]SP:@GM1][KP MBP&X -;Z'3-0>D^5$A]S6P,+KM;EJ3AQ6_=*>J1[^=GJ"V7,HHQ)^<6^6Y Q MPLO+3:5<&459.I0Q3BT[7\B85.!E3/#N!W=NW\&VXICRT+[SMWU7W+%]I[.% M39PG>O5&/C]\5J^3?K/OYN?JF7V7CF3U=X7VW<\%]U3W2OC%OEL JW!7E^N- MZ[]\3@AUKYV($[=UKTS@=:]0QOC#A^22?;<@8_(WE8)8+K;0 (4RQJE]YP,9 M ^(E\#(FO+3+-F^?R,0N$"P(X*92=6T+F@F3'!I,5QI##M$AJ1L7NJ/2F$A\XZKJ,'#^I!G M5 '>9'P9#@Y!YJGY6FM'QMO[\'9)QKT.-5@EG%AX%K@$&CQ'.$OUHF!9,'G% MYR@W;T-#E/L)Y49(QQS*KT<2VA;DQ?M- &Z\^&CG \DA_@(UK=/1PONXQ#4 M^P7ULCV9AW0)=901JXPQK*,4_(VE7F1!TJAWL-O 4M@4Z2(G]W']4*ICO=%$ M_]E14\#"Q-(1&)CS[=/B=0,YUCL(23")#QA-'%,R+LHR+60ZIHY)/=+4KZ7" M9.6@($J.#EN4[+. ]-1JGBWZ/( G22G;G,3C&HRP7?#;UX5,,ZG87%WITHSG M8_NWM">O]WPN]+ZY5.:^%T7)SW^82>>60_Z M0F85WA+4LM23L=A44&\D$DQ@Z3X4!:+O#1690RJ,;3U(1(<@C6 &FDP-9$F M9XPZV7KQ:6L<'D2O* _UXM7PMR,81%"H(0AL& *^+PR&<"; %,CP@%Q8\?@, MS@4)!#9^#)?7QEH?^X$;0\#\X>_&! #3I#:UUFWAF0Y6,T7&%DN,1;(N-K'Z M3O)W](Q)")*;%*>_7_?*8YXH2X[*MUVSDJ'\T8D3.S8H4H&-E+&GV)Z"='B2 MJO%E%0P GH2'4,.LRBY^<1,7OL<(U0LDZ>\B;G\B>4BG.U4 M"3.>44?UTOA-64%O5 .IB.B8>3)[H#77EV11[CF;#=%X07/%,I$:J4C]=6*4 MSB?ZI@Q+%;C^#+6P4MW#K4QA[=9;,3=3H!(C2458U580*-3.]@=/I3LB>K@B MCUF1U/SOL"J\!L39?$1(:5KN?5H#L=9MD"?';:%LNPJB$U$:=+Z)2%<4.BK\ M?;R>5O.9/HSW0W_Q>-65"2YMO^1MRUJZT@FL<[K:TM7!+4<\DF7.F-77'/I_ MW+NA<%AG&C>84%5*A:7 %H]GV L?M-AD8;M=S)4:TAL_L%W,Y4R"&@/;J^0) MD]TZ8*;C^1J;=]H%")\YFM']T#A'90YV22$=/,F)3-W^'SL8_LE1")N(( )@ MTB/ @_ZK@-M'P-&K6Y>DPX0E/@ Z8 CBAI6.9@)8[P%[G!#:D#F((@7 P%:A MQA+5 H0"_G#:)0-_31XI.IU48"R15?09_CHQ)]85%%5SUGS/OO)9>2D0*34$ MQ80EK3T$WK N*?0V CD ?YR':W0*UZG=0IKE3)^>(FLY?*_Z-W][MYQ:+[]8 M\)T9P'X%NP;!&TS ?XA.P(GL7SP39AS@2W60_!R"HXO'7*O!,:%VD:(8/6(, M9E0!L/#;'(\PV^4,6)HT MDK%R3*E?;7"GONFK_,=J23@\@LQJN.<0B*@/ :0DL;"&0Y"9P!Q8=AD:AMR% M[^+A2%\^]60+(4W$LBFE=4$,[G.G/;;4>00;/P!U8+8UU3EU M3/\BVBUQ-.1SNKI? 53U09 M,4.ATOV14KJ\RC6NV:]EX;*Y+A-[3(R(O:@I]E:]W66I:(E"?7ZSPC 5R::3 M\9/HDIC$(Z]DHCPDKGJB9(W Q@,;R)!3$[3(6-ZS'W*T(ZBO1NX]P![?S!=Y-SOJT2<^UH1YPUH!'2_"D>3 V8 "R M$35]69>ZJ6D>QR-\7IDW6=O2N#J"!2:S M-U1LIBND(]G867R'ZL*?HV/F%X4^AXC##HAW601M483U+C)=<373%8WG'ZS' M_<5R=5:LU90/5N-?'++<1BL+,,-E0![39YD=*K^D*/W.&[C(%YX!RL7/AT+2.2_DEOF MT@K&4SEU:EJN$EI[D%C%4N:A\CA,:[WNUQ++X9I\*:Y6RRB:CF37A)B[?B)2 MQYU?5([GR;T?]@].+0IL G>0W@42M^9=+[-@#'T(W551&DD\\9"1ZRJP78U- MLCE'9AC-2_9Z'N0?+W/QVWP&V7U_YLPV]/QMN$ ?V28;'8HTLUOGH'%9;7AA MX'4CXI6VW#%L#^P&5<,>/-)46J%D[!FAND!O;&%PMHT3)'SAI7^1U8A9@N-= M\-<,6X=X=HRMQ+(4=W 6*3IV-("9]>U.%^H8Q@)V'[*">6$ ?^'Z>#!RMP?V M>H_TH)Y.55\#O.JK"E)V/S&,WS!&: ^EI)3)BUV3]JX_;Y9F&5V,,*8U.Z,<7A*A!><8#8V&!2?W=AUB&^"Z!BE\Z%N MB\.1+PI(T9E2[OXZH["Y4OP4-*J+$'5JNL!G+YJL&QHG]TWD#TLOG+:]1)J_ MAIN]2S(0M02AED^K6<_E9[QG1S-71:S:-P&W\J(H9KO79<<#_9(&'EP\>W9P MZEQUZ.<)WTP_:-.$/V-6>.UD0<;)L_;*>,E" G?&X.X%9XG=GC+>^/J=^>]= MB9?:843G1@HQV"WF#+]NR#GGVT^2J3F*V-JL!_PR"DQ#LI8$6BW-U9Q&-RVV9IQK M.5\ZM9/.)-H?JC4>P@QR"ML1N#]4%<"O$[8J8PK&&/M3O\W'\)\6KXC^_0VD M7D)TX,W7TPX"9,/80[)I]CN5PZ&QR<#K"&,G)Z:S3DH;AWMX2;6/_IV>WKHM M7=!\E*6=?^;YZWM1EBO9,.):N2H]Q))PSG=Z["1\VT!K#:A2&%,>\8[+C-\L MYN\;Y=:SLU"E7*M5;#2I2OFVW"H6O.YK' !*+M[8_T B&"DE34=K;]5P'DFS M5BD7:2"F0TC M@\J"8%E@2NHV"L6S&OMKCK3>G0_ZJ>89H7\H6QCX$ 8]2E4X&$R0Z'8T2I^] M#'L1BA7!-K?TIC["P?_G%),Y8XB1:)[IIS\T=9>?X/3_#V T_%_M M0W8T#3,-C&.MF#A\:&.'NH(XN2?!$GGB$8=C7G]QAQ5QTJDZS<_]/1[\!(@0R:Q@XDA01; MJU17D0< 0Y'<\QH%'A?2ESA224'3(R+TVZF.+(VK6^=L'^#N,-J^_>Z>DE8%GB%"Q!RU*>590Q$#A''JMUS:H7X_90BDFQ MI34_)U?OG53WKMAKU*>=.\V!;!,0S;'67>-M,)7OM2??YM(\9MW?Q=9=FBT>CP?4T,5)_I2&BU'5L/?.N526D MTV;Y'/C)709.+(WZ@+7.,C!.2EMR_>P+#C9"1!S-Y9@=@E#^)!)1'"_PPL5J M7C!EW0(;7%[=#9\O6Y?/33YX;+"A'$M%LBEZ=\&5OYPE!MK"ST9F2CFI.(/L M)5DZ. ,'J40+Z8 =@/]V1N749:)-%V6.)D$4&5*E 1LC"F_+3E]YX*9G@MV: M?5G!.SFXL-0JG>/(F4HX\.NXLR6#+(UY<521RU5>2N^6ET+S+C3O7#?OXC_ MO,M0ES+LA42,+5)Y9LZ@ZY-2CE;M+&VJSB^3=;92%/<2EM6+A?3&^@NQQV;F MP)UM6#)YO4R]OG?O^QFI:QVX^I#+)].S1EUW$&\PJ6_U:_12I.(VC,FD/[6T MXQ$AK*.Y3'=,9SP@R1 1^3E7V*W4>JI+$GR.SGR'4TD M-]+@/,5,=%PNYWZ=&&Y'!0U%EB-F.ZE>.@#-H49\HE8\;U] 7:K)"3@'!,RC MXUJ^J4]*1Y*C65A!F*#HX&!^8E-A/?:=Q-0;%:FP@\%6'\]T/GA[_NVX[J#? MRI*2S#A;J="2Z5\N2RI\#^]#3N)Q/O*T N'RBJ0ITNUKIB)IRI;6N/T[P$Y- M#UYZHUP&C5[=K4?J=L<-Z[Z.H4X7RI#FVI-).LH-DM=ON2)&@E>)=->H.J#"I+ 4"Q]'N#R"S2U+R1WBC7U':O 7 MZED?AQVN =]#7BZKYH]+$*+/H8R+&I(4&Y9Z9Q4!Z9KE]!(/;[!ZCH]5!'.D MC-R>,?G\A.(4Q,/CA O(3:7P-A)X?)CCC_0K@IG7'V&U@UPGSC$.'*5P; _@ M11PNUF@J(:#9X%=PFDWMG4X.2/N*-*,\'$*O>G5;08)398)L)6M9'MX**T7= M+G G3&+^JG*(%*(MVK*6R+1M*R U)"E>P"D7>,(#!'H+K[\1L?C,$"Y%PH5O2<0'H(XY5P;I M"^_!.6-+],-4T"]==,$Q>K:P:1<.MB! CRTP_ JR2_21V!$Q*>8!] MP;KC@YT>(61U1JUP;>&@ "N,TU/:K2?LTG@J1XG)MK ^'"GRDH,,!* H<&-K_K)>:UG/^B8A-.;[ M^HCOD;I4-OH%7#0N0]T^;<("G%F"B/BRI/M\@,2YCCS2-K'C#,%H(F&5Z1B+ MSIJ.F?QRT]&;J;0G-S#B?>GA69O0KO0ZW%%#!JQ_J,AK6H6=H%QD"6 M@)[*V.9J-"2B8J8]XXARI$>IJ49I0O7<,W@%_4#;9/Z\H +CP=P!S\B8XC>7 M,^MHN(BU)V_]EY;2&;QTWR+99OZJ6+BO%(]J):I4:Q3+EU4J?]]H%*OY9^)J M6-J"RJ/KE\T21]U+W]/O)TED".:D_])[L]9'1 CV%I=^9_N5HY.* ']POC,CAG?4DIVG'QFQA$YNMZ+ MT2>[2>7<,3&P,;60/^=+AO7GK$(8A3#2842', IA%,(H/(U"&(4PVCN,@G(: MN6\&_J$ZP-FX+;G$8R>UUEXSZ#7/&8M;ZE MZK4TR7V\-3DKK%J?[C?R!)@YZI.*(*Y&#WR1#V.NX.L4F)54M09K+R';SH.] MF6@D2Y\P='QU!LTW(;T?Q(0":&\"B/:' +K.O?R=7%U?B2GA9P@@.I@"B(YD MX^DUC0]"\1.*GZGXN9@1/[:+I+90-840+_A)$7KBE _ZKCGZ_,M8,?*(4E0J72BS##.[2W: )HYF1<%^Y M4^'SM"_@8C#G%.P'(WQV%)%.Q5-XX](@_:<[%PS@[LWI]-@'7ON.I\E+JA3O M&]_;4)?K+WYI2K M*7%]IDWA5E]I][4IWQMUH=C91NRDW/22 (J+0O0Y*@_N@+?7&6^!D4)N^Y=\*XL2D6PJ M%BQ1]%TO4BB%MI%"M(<>)9>D$/?&ECZ;K>M'+7T84FA3QU(BX;ICZ2"]2>Z% M,/WHP,A=!$/Z+WA@4;=R+* N+V7ZM1JO"/&5D4>>$M5/QIJI(/E,'TJ2H*,X MXTPE\C&+AW+$9[[I1>W(L1S)5U!S..C>W7#?=C,'7H[0_I0CJ4@V22]6J@VE M2"A%-I B\>^X?!R+DTSFF63,D4?&K_PSWP1XL0BYK1A; MK@2[?E_XE#_K+?FVZV*!M-V4YQ0L"@BS1:Y(63WT20K#9O_]S^DI51*0R)]3 M=;:'_L" ;R/@?CQ0DOY#/> JD? S=7IJR!->>-^R&I-D:HZJ;&U6.VL9 M!:;>MR6]298RWY21U_7_)J6Z2J=VTIE$^T-AR7).Y100#=P?J@J'M$[8JHPI M&(O9G_IM/H;_M%CH_]_?0.HE1%<0^WK:0;C(W3DU))MFSR8]'!J;#+R.,'9R M8CKKI+1QN+NML0^NU_?7"YJOC&?GGWG^VCKBD[#72C9TKS*>WI7HV_'0"=]& M;*\!50ICRB/><9GQF\7\?:/<>G:4@'^;:[6*C295*=^66\7"/&RH:=N29@L^(%U+0@9;?4;]3%H< MWS?_ZVCII 6#/%)9B8>1065!L*PA@H.N3^J,O"KV-]*Y(>EM(^)(\0$)*PH&MV2< LL+)MA MU7#<#UELD([PW&<:+L%?%32 Q>"[&WB[I)T=E618((4)\H'85V?$4)"(WG$/ M3K,' FD""SJ%3I .[N>$UXX[6>'&3L.A#)" ]0_ O+?Z=0X5N2MH1]/63SJU MPE8C.VDU8A-3.8/)ZF1#;UC6&II+[&:^HY48#/TH"AM)LYJ,9]D M@JZC)6%4>Z_672P&.5]7>4\!V\O)L$F^[ [C*3,XXX.F/$UOB M78^IG%3Z;"[9D88?I96U.GX"WNE]X1VWD#VPJJZ!*,6V8XDG:+ @;N_SVC:@ M?./I[_%H\7@M,S+,$K_1Q-0E6T<*MBG9'JIUK<[.L\V[DW6-..]*=RM60)U%/&)E'K(P7- MBE0:5*BH,XGJ$P;_)Q0B/U&(T-\1(H8BU_L9 MA$C0O%4_V@=^B'E^Q:EPRY$8#)L0*)-@!?L'DJHI(TO*+7BGWJ2W1R9YH3&V MBB5DT%D!9P9!S'QF#1W49+^5 M8)7?WE[HK%0,S204P?#F6+#V1+Q@W98BA0 M;^HEGWONW-"94+:X*5OVYUJ+8]?:88@69YG/#)R4[\IGXZ_4>WV('T[F\TYB MX[U941TV"1UAP\O%5?DH_#*@.]/JHR,DK+ >'.MB\4"_^+\VOZ2*)8JLL*XDA!.%N& MPPH_4DBB"\Z&D2E>4+D^S!;AG!)!H>0.S)#%VK2*OPTJ,XP[XI MT8;81R,- M#\FQ:A]PVQ7E#Y7J*O)@:C@=L>2B'F>K]'&."JOGOG18D<555=0^0AI.HD4X M50=1EXH\&E(X[P&)8VH@@^8O*ZK^5HXD.N )PYL%39U?!AX>6R>*+)I/<#A& M39./\+>Q7!%%Q&DXH6:HR$.D@#SZZ M<'X032?^!43$QD(2S+LSLF@%L/ [. M1\2XL$V3E%M*_5$IDA,T-16-%;,F8MJ. M@C@$?R73P$\H: A2$*^"D,1@-=BI*IRA1'-EYW_.LI2I(^8^I#T/J$ M7O.;JK(Z,/ MV!=9F;.6!6VD\P_,IJPJ+-+3F'+ \PKP/QMPJ;[O#*5I*(P]44B'/[YY*1J\ ML2+U*/[_V7O7KL25;7_XO9\BA[/7>;K_0VT2[MUK,P97Q49 6W[#2.0 J(A MP22H\.F?JLH=PB680(+5XYR]NA62JEGS7G/^9B:SU'J4=I09[?S0WJ(X?TLM M6LWA[^Q@[T T!,X**\MSU+['NF2$=)$V95+3+X88ZJ)G2*.F(K;)*< 4XE MJ+[@>Y$2/'MGE9]'M$,&4_LMD;N=<_U,$]RM6'J/CM\(&<$9=.GU_&3)VRIL$BV MB[W%2[^::(]*9:&^AYMRVNUOB.YXE49,3]EB>M(0$\K^HN/WJK@+[6?+=.QC M I:$V>=;]A1J6$OD AA<'4F&(O+Y=>730ZG+X>0S'42H ?RCT5IM(+9':7:0VE'Y2-I;/,1X[OD+(6JZN M4=7--3*F@79\\(A4PR.:C*8WHX;\\IQ-AR(_%(J"[HZDLD*$TN:GTRIR0LT8 M*ZIVAVG6H5*P&-DHE2)3:(D$$PG>)L%A=)&2\5@^=1[/>4PEA96YO/54E7N+ M@*(;,C-RR7 MS(XDLR,C0$DR.U)CIP:9'4EF1Y+9D5OL YD=269'GI*S2V9''C*M$/Z%U_G7 M&<^A>9'!-*6?".4#:)]T4AY!/.#.1O1W;="BK0]=ZYM4<:H3]5@:S=+Z;$?[ MKVRS12A.PK 1\->#\255$*F9B/\.. I/140IV*FD(I )U+5\!L0QZB]7]/&( MVH/F5'^F4@.X:U90)'/8I+5:]%))4>RMZ&,6/V, N)FLM)&?P-U3RFPP MQI]'+?6H!UR%_X\Z.979<,@/>+B8,[,!7&OR'D,#(,SASA#!]+F/JIT&\$EC M]@VWH;ZQO,!J+=D4RZ$YD*J]]1XU:?,J0M;0NTJ',&[7J 4)I!A3*/5&^S.K MT=[1QPUWQ^H4?$.#)^47/)R3G2*D4Y\[M*,%XW"DMG+4BFQ-254U/ .CW]T M 0+0YI'B(X,/0KEZ!&Y@"M%0DIV-_W:9TKAOMH'4$ YF7V'XC4]Z[,( MH$6?,CH3$4($QEO0&Q\TL ='E[1=8!W?!JPL\ C2!?$?^J&&NF#Q(9+)/FJ& MAG(A:[ P4_8X,TP=+=#';^@W,?AL\RW6M/2GF?122W]E;4O_EL?V%IWRGZOKWJ?!\!'0Y_X>!+C>"IWN+A^0=__2;NZ,SC+,1O-LHU]JE9K?A3 W4:X5B MK5[KU"IMDS&/H&J^1)=Y5"K_"MHL-*@&C:9+U$A).=I[0UUI^8F9C)'KBT73 M@CSE**#W*E+T81)?!Z;%'-KDK6VQQ^;2T"WHJ&+CV[[HBQ3>".*!<+=QA&Y! MI\$ S3>]G2<5!1[P?[Y%6/NL(BX A(A171 YU5-<$#G5<)J?SW2[A&0"E9D_ MTD:!VQ)_*-\_09"&"Y0IE!0UU*=[PGY P 7P :PQE&0D_$?XC_!?! E'^"^J MD[O-NX94-F#@&=S+;@*Z:7?T4W;N![X)@8O:+"F.\9&V6TJWFTFW29&.;G4! ME5 H[M>:6F^[,40.GWA!Y#"D34L_:KW+SO[(6_T.?:4SOB&I=58%+NI"P^-Z=_:T\B<+U=UO1U?<9(_TUMQ;/@L-Z+OTK.\Z2BLAL?U M]#[XN+DD'YM3<22DZ^Y,N%#"XX#\NQCS' ?@V>*(,_]&7!3J32Z*CS\(SL\Z> MR#^1_^C+_XJDR[.XU/SSQ-?F@R\IZ>D3DO1P);*/'1P799X;:;&?(+&B0GV# M)@]03.([2=CXK@A+AU&$VIG6T7'Z%-)EEOT>- >;@1R]6A4$\1I;6GT@I]")F,Y;-)HLF()H.: M+'N8"-(7';8:1DZFJ+ MH):*1TA+>0TL.ZV;USDM_/W]]$Q4U_ZJ*_2Q93J63P0QI9DHM @JM$(4%=J* MZFIVG^Z+W=^T])E\L.)#86Z^?S.#KO6OIE@XEG%%V%D;9=/05/E%K MAU%KZ0.5U>VCT+P&WI-<@A=E85C[NW_#=G2TW(ZW*'3D;U&(*CB,*BA_0A7L M$6M*+PIS/[S/%(M#(JV&M#+QJ$MKN.X\0S'*NB.IK.#'Q.UPZK50T'B;UNV+K>1Y7GN^#C[OV.H;P!U_AC+)RL7SR/)GQV)P48DDAZNA4U)'7 MJ&E$UP?5^2#%%QFBHSY]-1#R2\L4]"_I\V328TULB&6***X08N <,PV^H896 M>&6>LO>#UR)'-%U J? 0J3IZCZO/L,K@\N#HZ$W"=)OF2:;>A2*+LW[J'1V- M1"R9>K?A#YEZ1^;(A$=L?-L7F7KWQ1F 3+T+9YU:Q 6 $#&J"R*G>HH+(J<: M3O-#IMZ%YG1/V \@4Y\BH%T(_X5HC:$D(^$_PG]1[^DNB,97XDQH1X]=-.!WQJ7:U[G$^*\]_O]+-W_U#8!V$;196-N%_IPF1_U.4_]T:WT,D_RN2_O[6*?SY MT_@SY0\Q)R9\DN[_. 8R]2X&P\]Z:IEZB/_\O#*KK^$HJ%)@+ MDX- :C*SR=9R@@4@BDYO&5F]?)T!Y4W(:X:]Q^+=-WR?H'"-XC M.3$0I]6T6YBBK RJ2\WFTJO M!L)^:9G=X](RQ!)%U-9!U58J]$GP]7IN6!2XU]HOV M'?_V^#SMMK*#/F"%&?H[=7&A&RZ.?]M=V2T!)J;QTCSAI.Z&?NI& M 2N_M)PU4J6I*_4M:5_%>EL"6ZU>V$EG$.T7U9E/X0H*,E27@U]4 ^I3C; - M"5$PD;)_ZX?Q-?0K2XX-(?[W!R2U"]%EP+Y<] '4A?#94WQH=J#*TZ&QP<"; M"&,G)Z*S1DH;AW]&.VU$_@P:$'"]!!]V0\O8QG;^6>:O_;N+$'NM94/_L(WA M_GW 0*!3H>VRVR!4&213 ?&.SXS?KI2Z][7.DR=LW]M"IU.Y;U/UVFVM4RDO MBXV71^WR)P*47 4I_X)$@.S4:'8J;4][[S2I4K/1;M9KY0+D):I::Q0:I5JA M3K4[\ >WE4:G31ALO8WZFK3XUFW_Q]/6>9%2Q]),844./AFZ+ !N:PJ@H1NS M,J X5F6_+Y$V./N@6;7 "/U%V4*7#WXRHA1Y !_&BW0O'JC&,4*ZG]C MIM\T!BC!\Y-B=F<6P+*@)VBL$2>@=A*)JS,*P-!4F8R: ZK+"_CN/@6L.@G$TB. MRL=48$56E>2YE65BLG0\&W,D$>+.OC8/C^TM$E?-:_:M/>GT0Y][0!;WC$E0 MN%*%_D5I#S>IP!1[B\[KK3HH?8PRW#,,IPNU>^JA4.]6J-M*H=V]QR;69 2+ M)_H^KO.GX_F^)+*.E=0)^\+Y/.+NLS?$WM28!S(K#\9S*-N1VH;;T!]_5QQ MKK,S!F=#&$CC?#R%S81"<4!E>0$Z'P!I4)RL8Z$NI*#*@0H22VWFET*AFQA5 MP4!\MNN/K4D-XRA0^Y7-JIJ 7LO E,@ 7 G@#PIEY M].=4GT7?D42\"+@ZH*@4_A":W,.+TYF*9KVH%*]0"J0-/X1QO A_)N$OH(5" M#\EZG[$FI#7APP%\]T_"6\&B=: 3I7]2=S,)\40'P/N.W)P MT;7*&T +>T&\-(0LPW/H^ :L8# 8_)G]>@V?NW'*ZIR"!P\? Q^.;][0+VR' MC;QD$"6Z1?6DF9]4#8FEHH-RXDE,KXZSYT6<=.6@XZJ.X=GC+U*T=J HHI'Z M"I#?<"X1,0(Z2LP"=@Z N@'P^ T<%/&!*LS1;WG1^%>4*!?5LT[\I+JB[;!X M[>#7GYESB^'TT9M#VS7V.H<]D7$Z[+F4)X=]W3MZ"[KPIF2JU[?J=!AZ]UUG M6Z?37LST%E?MR9!/S.I2Q]P#M/]PE_ ]\,1!+-\N75?*W7KEK%FENHUFL5VY M?R@4ZQ6JVKRG"NUVI=.FX-_JM4*Q5J]UGEQ\_ #%A QJ#%&[R?I!C4PTVGLB M/7!,4_1H*^$>BQFZ!9W:\8=;V$*WH%,[_D2HJ1VZ!9W&\6]O.#LVG0\X8C*L M19WAKEXW^9].QGR@I_\\;ES&VB]9PT_?D+7''ELL;-%TJ-55.*E'AC:%9XF$ M_PC_$?Z+(.$(_Q'^"\_9$OZ+$MRGGO=/)@,>+5*&/W]CT44[7NO0M6OU6T-2 M <4PWZ,Z;,C/_$I(QA$YT?6L8]P$KL6L]$SC;)YBNY&\-NIL7&"AX4=IMX^Z M-%&;O=B;@*:M19N=U%V6??RMW@JL#,Q.:NMC[NP92!8M=-.+$/KFR4PO(JHC M/'-\#J4ZF(!5QV.YD;KYFV5I)D=4AU-U9(GJ(*K#%]51]J@Z++R6SRN01, * MA&$?7[K@IK6X$[Z* MF"XK+Y?%WQ7!B7D19;SL[ZZ.JA'!S<)1V/Y9GS=!!S M+8C._)HZ,^VCSMQ7MSV)'_7X5>*]OD@3W>:?;@N#PJ)/4&&%ZRH[%&4>X2^\ MB5(F/<6AR-%.G(IH^X^#?5J(/J3_.1+] MS^'NR#V-%CC2_TR.G_0_D^,G_<]?\/C#?PU#^I_#V9]+^I\CQ_>D_YGDL$C_ MU;&72/B/\!_AOP@2CO ?X;_PG"WA/]+_O$?_\_S3!TPJZ?VZ.<[M<7.\.B)Q%>IS=^Q*BW#D,9%HCJ.7-CV>042=.=SZN;Y(5UL/3VR MS%=1(/[7T-#NE72;SBYOV7:.OHF7 M"@1?9LG7(O@R1'6$S]?:5]#3S/O;< HFOVO]KR+HA_")PN#HI$[-T0G7Q74H MBCK"7V83I;RYI9KCH^KQ6QQGWV);D_'CDY6-GYJ;9:A*/T)L2+; M)I"5D.:E%K6_0U$L/K3>NN-]Q7*O XBF7[25GH=WD]+>W:002PRQ_9]6-1 +A;HJU%WCW1,U&S_R2&=$-O_.8&L?M+V+^8UI9]]?']X;>P-%'3R M-OKPAC=S.H9WM2OZAV-"MV/@=:'86TBO]7EJ<;>XNLY%95;U2O_T\A://Y.\ M(8DL]PR?R8NCRAL05:4PA ^\!U-)1C]KP95)W)K!Y,DD$W.<4SR]=C"YYQ?U M%M5GI?#P)',I)>WOB>-E#.<^'WJCV:F<,4D*6V+Z%Z4]W*0- [7J0NZ_/][) M7;$(7>AVM]BNW'4KC0Y5>8#_V]9YY:?_??>7*91@UO\Z50.GQI*\1W(/;5X< M@#-U#"C9X%&*8U5 H1\-)4&0WM&/%/A^?L@/6%&E .9K:LQ""RD-H(#*@/L9 M;2JXG61 4 TV/ 9CTQ>J-/V)I%?_IW%M$H=;]".E#1\?RY]])JE+7YWW 'BB*6+/>-<_-ZPX8^4YQ:0PCD3B'$M029K ]&O8+>5Y[#3FH F,N4($'&N-JLW1U5;O]'6SL3R3BI_'X_$5A]<3^RU%Q+Y) M >]-"J8RM"?\%$9,[$2:06,A#7U?DJ<%#:PCID1TQNC@*+@2=C22P0A9.G.E M*^+IO(?';-<U 3V3WK(WE0JS==%9KM ;J1% MS,W'UR0S&3X9W34JS6%)71^6^LSEEY[8O#,&"G!A=NRDL="Q4#&9--<.=59E&09^X+*K?XPAUV*(,,O>+F0N7MOWKQ9%FA# MD'H,!EX6N]5#1/ M#<:L. ((8 &=E"P)U#?P,1!FR$_''R[.%%X$BH(\L#YD$22KWR^1G*Q*B:>5 MC%D%F0\>848 1:5D?54NML-@0,CC"&."'3DU)N8&+$2SUDP&41:E][K<:MQG MWS*+\3K;T;[]\W,3(:)E-+!CIUN-"\9F-M!).F62AL%.:L5L_!,*[V[J44^P M(J3(&BE"/KT@0&MB_ K&.U!*)/C/R02R@>[RLRJT1]HG%,0=T&,< $^+@,(& MC3/

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�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

    T_U'-!;3&=_-1K_@R]D\A3@/=O=9X+.UI0[F#D:5DI)*%9+T-SDPA.#9 M#7:AMU_Y,,XLAJ2;%Z8/_3."P,$7_9< V1]HP?W811R# +GON!6.&\#XG0O\ M BF^.8IX!Y(;.4>A<)2P,ZRZ3RV?J[X="[1 \2][E.]8UY,$O>> M6FY5==+P6\0'IJXF4:V_.W1\L_W &8XN\R)2OCEXZ[T:$+8S93)OTUU\OIA\O4;0<";]9)D)D=GTE#"=?T\-P M9Y&M\7#Q*'/U;U^ -0(A!Z%[CUM<.IGZARIL&H:?Q&=': M2>JAO';-X2_Z0A3Q=5(S[64LL.Y%@'3O?YZ_],69]>=9_;E:CG-7/06N^ZJ& MAE=["0/_+!HR#T+$7KR3X2'U&(,12Y$="&H[JLT&A(Q@W'M/AF07HK M]R9N]^IZ[7JG+9*+Y2D-I/MJC4J2K,BLWAT-'SL461Z.4S^[T9-H>Z)WS+8H MM^I$G8TTY;.^_-A9;Z+,U9G< V\,LI@=40I>>^MK;BE/,LO-HL?VS;E,4NTR M1)5.Z3ZS5$9&65N]TO&#" R05;/EQ<>:U7W:1UB"?.+[9A5*]DKF40G]T&OI M1MG%84E\'43UG4PS2H8)8-Z63!KJX\N2V7[L[;U'LMFX4?IP6'PN^HA^HREC M">P]5=\U,J93?7E\/!._$*K/[K$ B\CL0HHH\D'KPX_W1'N/7PPM%^)[9HG7 MG6%J^OTL>2!P]"5^*[1]OV2!G$PDLVU#-XPK*=(FU"<5>T5D4F>Q M)W0NM-D"">X3+M-39^KDRT)?I(\%8"G''?=S=7PM2O3T-2=$M(Y<9EQW$A_' M:R];0A:#?N8;-,>V@YE5JT_GZHB\CS$RM;%.NKP9^)W5_OIRLF\F]O952"O$ M=_CQ/UBQGRV/UR2G;$;W/IS@@X!,BH?AOZ5E+K@YOMRKCO24[CTWJ8<G SME)FK64FRFAFW"\TD;^MA7R$U'_A]G0Z?(BIL/\RKUGK/S-.4 M]B+N[!W!0]8,/T7N.BZY2,H0)#-?GO-?,BJA*8VNR1' MT+7)>XZ!_77EN^6/_;V]9D9*:%-8FOHH?K+1&/V*]D:]BZ?A/Q,S"QSU&4 + M=S$7*']\>\VL5/VLX8?R$&'J)\U42>OR3NHAIU8$(++2R1ZQ@RBBCXN-^?O% MVVLJ )JJ2\W$MCG9+<8K$_?J1I$>IDTWQN7[1^*XX/_#=0CH+_\/4$L#!!0 M ( +.+7%CU=PI6'8< &JE"@ 4 VJ,@!FYH.7!XE$XK__SX]5U'E ) EQ M_+=?7O[YMU\Z*/9Q$,:+O_UR-WWA3+O]_B^=)/7BP(MPC/[V2XQ_^3__W__[ M_W3H__[[?[UXT;D.413\I=/#_HM^/,=_[0R]%?I+YP;%B'@I)G_M?/*B#?L+ MO@XC1#I=O%I'*$7T'_(/_Z7SYL^O7G[MO'@AT>XG% >8W$WZ^W:7:;I._O+K MK]^_?_]SC!^\[YA\2_[LXY5<@]/42S?)OK7??ORV_5]>_;^C,/[V%_;_OGH) MZE![Q_OZ-];\?QR421_7M!LG(>N%OW1^/>/3_3A%)%QU<1R@.$$!_2'!41AX M*0I8MT(K%*?):'X=QM2DH1>-<1(R0Y:(>W:[[:O(!C5!2UHF?$ #G"2*5 3; M;4?%[M*+%RCIQ].E1\7 44"G+/>/39@^GJ&@1*L70-!+EM<1_JX,N>/VU*F4 MKRU1B:!'I=1]?AHNXG >^EZ<.KZ/-W%*E\LQM8$?HC+K2=55)VJ7T'G!]Z*G M;[E)&JXH2HD3!W_?!(L$*ZH0:$[Q& M)'VDNK-1NV:Z#U%:(EE)+86@XY@N=VGX-4)#G)9V2:BXRBGH 25IUD/Z,04% MTS6+38-T;O?B\C$C6UWIG$EG:&:1O N5@RNHH4ZL :+4J7&[:MC5G'O2%>.8N#BBME'BG](4*!2UFB MA(7@"BJ%6JW"G#[0P<.^2*=_^MMNRI214KH%=6+OI_9^3(?Z9O?U29A\N_5B M+V?<)8)7:D.AZ%Y(,G?:+>4B&R(EJ:"*PJ5L\S5!?VS83/\@L>V!BJL3Z-9C MFVDORMOO;0C;#=*_X*!$M/**+>UW5>Q[F]O_;A?-F0QIY99MR8I2 E9HH$4;VBO+CQ=^C7;V MS5)2RC?0Y/93;K(LJ=;B5E1*WHJMM+IRP4I-;6BGQRJJUO$^4DKE&2\WN&>6D+JW8W/Y1;B42 M5E(^D?=0ZH51,O1(/@7+S=Q0+86V\YGX:+;BV):MWH3568@=667CT/F*-^EAF C9^"F=J_>+8U4H MSFJ]O0U]1;SJ-J=R@5NM//+(#'RR:Y?$2+Z%1GT3E4TOW4(3HV42+I;I:'Z7 MH'JK1$G])D3./"C[8^>J @MK-R%NE\+X&,8+9\45&J=V]1[4N$!%5%X>R&F\ DL^9HS8A:YJ=!055< M2EMHI"MEWTMFV*6MXD=$]Y&;-+L%0[MYY9Y5H;%&R(7(M5R9:51HK EERCS- M5?6IV%Z3YQH5![Q\ XWP*;HIP7$>ZK]SIO^HV:IY/NHVW-#Y2,7^ M)56WD9U%X3"D\KX"KMN$J/] CT^NLGH3-LZ]"G21+.QCJ]I9HHU6@SXK.U-K MM]@$(M>8H' 1YR<#_B,[I*L*2'D3C>P(V%U.:IV0A5UYT6,2)KD7A%HU/*F!U45H:K7KM-J'A'MRY)%H&( M@I/]98VIH6)[S:B$OR:(9$=4=&#D-AZ1V@[.BNVUY@^I>88GW513!#T[ &%' MZ6$0>J1&'Y-II+E(@:I[.\GJC;ELNMXZ3/=A ?4ZC6Q#+2EQCMP-NV=2$OK9 MR27VO]W%8>63Z?(FFA#\,V*G3BAP*"_U%NB<;9M\4VW)+)M* M@OP_+_##K\@/MM'O#^L>73JC;.5GVR\G"+)4(%ZTC8>D.:82^R'3 M+8^.EV];J4)9@-0Y4A\TH%0T)_CW9GM"/\-L1:<SO-Z%)-W-)&U:E +;.) M/,I"DC2Y>G1_('_#^F67]N %)H^UM9!LMQ%%SN[G@K:4=AX5 [)1 8]Q"YG_ M+ZK?*\J;;&IPGBLVT)0Z%$ M0#QVC.;0%3;>9J$Y2]R#]AKL '1/N, Q8L$@E/.<7*"L(#'8DCIA"^>5"@06 MMJ9.Z*SC)5U*7] ,W\;KD)&9\[HQU)K*>8'N31'A].JK1SK6SY@G^.TFZ4&[ MZA3IH;FWB8ZO6%>0^+@!D6@>\7?2\0H?2_"7T_R$NS2)+#'AF^S[2]H$\3=? MT8L@9(;*^-CV0R?JLU;"./V5%OUU6^97;@/-R[W_V(L K[RPHM"GM5N0./O2 MBQ5:?659&BN)>UBU>5F]**HF85:A>;EBG#I51=O5:;5/YJ.Z=J?<53^4F?XY MC+.MZ8#^>B W^I&B.$#[&8XU6'IV5,P6&J:LPC8G[,O."Y9 -KL;17_,2VY% MV0D38?] @HAE3\5$8B(,4)A/A/2'IXF0_G*?1;(_TOTWI?X)2JB6J)^BU7YR MC+RO*,H^=4^+PZ5_;5_6@\VX4,YMR6,9G\!UR$[:;<^0''YY=_R+C^.4=@4AP"FF MU.BG:WZYQ2%38I'4D+E?_::WO>]?<@149?+=BG;^)%4#DTPS");7+<%RM4GH M])HD+*;"\]/;+9GC0<,MV@ \A[228WJX=V,)8<%YIZ6)9T=AF/A\0Q=+W/,Z M0L/VK;#^GH@*6;>M688*$S"!KB-O BCQ2;@NGI0 M9BZ4-,7:QR*#:V>[,\8$+;8A\CC>9WL73R'<*IK#4"X[N&BVBX<3QQLOFJ U M)B4P%$L:8OT3D2&C_]ZNT?^Y\4B*2/0H8_>CPH:8GB%#<& )S5D_0^7L+X;![*VWQ8URO)%F44. MYC8-?QTFOA?E\EW3OP%N9+"X(0#PY=;%D9-+]P5Y1!J"?6&C #B4&C1_2[OB M;5ZV)]&$\P]46G, A&*#"+2T#\[U8 ^+#C>PV_BXE.86YXH+6KJES6\NU,XA M$J?L]521M0]+&F%QCLB@U5O:].:"=>GX(RPO:X!^_ ,]BLQ^5-0(N_-D!@W? MTF8WEVQ,0I;-;AKZY=/+<5DC3,\5&K1]2SO<7+29]Z,?T)Z1/7G!+%8. 5#% M""1$LH. M+3%S25DF4#(&A>\X5UV99<\=G$@7 J$%8T IUP#$**6]L$'*FW_ MP_1Z*1'54RQN!!R0W. A64M[8DBZ5]5 >&4H"*_$(+2T)X:D>UT-A->&@O!: M#$)+.^,#Z;KTQQ&9X>_ .3U0V"0 CJ0&S=_JMG@K6[9>CDA,'F9&0ES3)^D610:NWNG7>"C;&2>I%_S=QR"/+AK%TOH;MYC44'K MMK3W'6!V[K/$L=##?%Q*0N/Q#?ZJ?E-#?0C V7U]S^)8*#.+2T]3P2KY\D&T2JHG%2 MRRQ,^.*#R+2T#9TB?T.GR\>7K[[.V*UF8#XZ*J6YY;GB@I9N:>LYQ-M$&]/' MU5<!. 4UMS9NH+D__"5+'@/' M?_!*:FYN4&30ZBWM/I^FMX74G+TP:\Y>2,S9+>T^=T+E@?YT[(V^1N'B( \C MW^B<"H;8'Y(<@N+WMF[09O>^"F]\7M,?^"!PBVIN?EAFT/!M7:W=!"'+PIL) MN$_$OK_X"/@-RFKI#H>,^" RK9ZG?D91](\8?X^GR$MPC()\HR$ZSP"J:(Y) MN>P@(*V>L'["T29./9(%ZQ)A!IVCHD8 P),9-'RKAZG;H/3]"L:&*W3O053# M"!@$HH-HM'K(VH]31#R?Y?GM>:FWE5>$!K^&$6@(1 ?1:#5H.1NLQZFWH0L1 M^X)&V/Y48M#DK<8J3U=>%.WR_8A,?E#0").?2@R:O-5H9'>%R().AC<$?T^7 MVXO!(M-S*Q@! 2PY"$6K4R6:?^ MXYA@'R%V=)3LQZ7$=DRJ 2, DM<$A*[=J[UXM6)7RK#_+7]"J\<)FB/V7BZ:H1_I%?W0-S'1*JVN.5K5] !!:RL6 M.L^UNW]$'3ZEYI74' I09-#JA1WY?_]ZI W]TK?=OW'^Z:#1&J\H9&ZR<$5E M#E"<(/9B=H*C,/"R5RIWARN%9XW'.-]<[=4Y>'GA5>=%9U^-_KQMOK-OOU/\ MP%/1I(/GG?TW.ON/U.F+IP]8WO[KOC\GR?YK)^@5^APM#)4]?V3,O>1KU@$W MR8N%YZVW#^I$:;+[R],XV?[A?B\)]$3#MN!Q.:4#I-8##0)3'@X:0 -HO#3X M.,,>H(2D!7#H;T_ T%_NB[TXFQI"E "/,]#B<&FE($D]RR"V-9:0&83ET@" MKP4 ZESHF089XXIQ:.>EAO:AT/(%!U5P-?.( W>QVT4.W7HI77XI65FQT GP MQ09:153COF6V)=?IL;3LC.\>HQ&RDO?GO]@HZ7^2:*[EF) MIY]>4'9^_U0D@RS[>U9BN_%U*,5,$^J&7D!M" M2\F4IA@M+UDZ<<#^X_ZQ"1^\"(B^>E*;6Z-UO.1A.,$-5L"@898YQ ]T%X%V M6MH@P #A0>:@'UC2.)D*D3PZ2HX&U*(SQ+%?==&"ZAB$F5 %"#XEAPUJX1L3 M3/>,Z>,X\MA#'@&;U-? 8S'[6F"ERP$H@\=?B#VX]2+%R'=Q^?* M9W/^;.G%-Q@'W\.(=]%J7[NTLEF@RJD#@:ODS$(UN \H2;>N_>GF:Q(&H<>> M8O\[IG;]1/^^(70W&@=47^R'E($+%\D:S9G6 >HI"'4))2%4\L<%PLDO.AP M13?TV#5K1*?LXF9V[#VRDXMDEMUT1]/->AV%_,L]^X:JM'/Q(5D"W#''URUEG6Z[\J9A!^H E?7P<,] M!>IB2H5)RO9"0\Q][8:6.BIDB(D!P4&[:NAYV>K[V2/L)9.=VKR@YV,3'5/#XF99IH<,RAMB8+S=HU+KN#JY1KT@8+- M>S';7?<0"1\\=OMR']554 &.=:8MU6C(''CJ*@=BJ*%_8KK$A!W%KZXP(?@[ M"^T636NZRB8T-8T30@RY4! M3[LU]'44M*FPVX5KZ>#PK0]HE6UO[9=KSJ8S3P*?SVB>VC('N?-4!/'4T(WQ M)+J,$^.TM#F8EBD!HJ9AD$KFB.$:H-0%Q:UE((HERH!H:N@YJ0SD<\&P!GP: M1JM(@J8%5/4(J30Z&H:;L""H]%%F#W%8TC2,.-*#,&GH8LE2+ 9=;QVFW!LF MX=_:+78&%K,5!)E-O&CLA4$_A@< BY>0JZRQ^2LJ 6&BYA$CM0-E@A)$'M!H MOLOEW@OGVU0%R2C.CCR#EM._$P#IB U"(>&KHOM_!$'DMLF7GDSH>+H )7\%+H MFD"%Y7XC:,ENHS^@ 7[*/WN80.7U.0E4#K[1R3YB$ZC8!"HV@8I-H&(3J-@$ M*C:!BDV@\LP3J$S0 XHWO$6^L$/+BAAP@ZA\#RG4,P /(ZE!5=R_?!@CCXJXC*+DWE $@0;!H&C]R@ M&)'M2.&PY]-*7(T58A>,5R M!N!T(BX$B8:Q(5O968)^;K;[8R7S@N: 4I 70D7#.S199,MH_C0!C.9/F8'H M2GF8-BA_U0H%UYC<)6S"SXZJ;E&ZY+ZF=A@_H^0K!O0'QU (I-UMZZ>>0W5A)K] $^9&7).$\1,$,YSUY1%A?'J)T-*>3CU0N MMN8^>[GXJ"J=X_1$HEF#@'U2PSM%D/X[Q)W5-P 9"&IP7@9#9VJ5UX2^KL+ M56-$,O^R#%\15C0 O'+Y01@U=+D>:,-FCIU&TA 6*YD&WXGL('0:>E1[8;1) MGRXURH(GJ&8 ?&72@P 6G+ ZW4;K9M2/O8K"5%CBB$J;'%[W/+R+]GNUNVC; M]FFQ3O$+_^FMK-QNT-6UIS/7LJH&W6:35TIT M--S0!;?FO#C;:Z_\2W#<;66Q1OL7X2K#)'*@G"IO1&S]+E@!N!BT+WA8KN7[ M$_%MRWH@NJ9;7N>?/XQ8TO*[A) M?I#C%$'EHX9?XYXW=U\<,1FAP<5(Z3C)IUDX9YIHM,C5O7^C(P+5Q(>P>'/Q M;!1FI .INPNJE2%$B6O09@B1P,%F"+$90FR&$%G9&YVOFG -E#L%:%_2_H2B M**E!N\?AAAE@-,]."9+1)DU2+Z8;JH4(%;"2"4"5"&_0\*E\M\( =(ZE!5<0 M_>" G?JQ#29 )58=@@X36]1G!E\9 !.=U+_="[@B:@PQ$8 MPD7# 'C:G0A['JZ'\O_.E@1O%LMLB?U*?P_&WF.6GY,Y##U?YD9GY?:,0+FV M7E!GJ!N"#GKI6/: T7RTSKX]PXY/>R2A\P4E20OVP+>3) AX6D^ZNL9055<# M0D;#"&V@^[D_$/'#A"J\?0<\D9A@JS6E,>+GJ02AKV&,=3;+9.O,!$59$!I. MA"&[W HF("D0'-R:ZWCVSN^071P_())D=^?RGU,V)?7C)"6;+/]\C8%;WJ@) MP)^IG/(SX^:I<(T.(*IH!,CE"H! :NC%*5UVMBSDK-5XVX81\%;2!42ZKH.( M2XR+$\B.!Y.DV7[E&I.34S\AAF5UGP.R4CJ" MY$7E2G@HR.GG_(HF/QMW>Q4$-@ZCH:QKX=*GI\2M)GJ0,#1$=)IC!=,2MV&\D&GU^7J:(XU%TT M#,DK4_)P7*CH+_P6?X8.(] E_#J/0=LJIM_32]Y%AGJ'_4 MC1[D9RG('H4*O6CW)MZ8A/3WM1=12K7A;SS9;?^R:@:C)JT>!)"& 7YE';"' M".4^[)')O>J*AK.X98.[B4H+B(XE]>Y*8X(?PJ0L" FJ\_S@/](-!%9I"HWC M'I@B@I)T% ]8!Y1R.AW7,1@8.=U 8)3Z"O>]832_PH3@[U2)&=Y&'H\] DRN MM*I,3;-!DM80A$II'-\$/7C19OON2"& =(A3""-A%;/!*5<-1$5I1-_VP6;H M?=RG)YTO\S*N4IN?: *:6.DCW_F-B+B8/QD5GP(-V.U0+Z;B#Z';796:,!ND MZJJ"*-;U#)6%OF9AM\SA&1+DT]I02**@AMD8E6H&0J*AZT7.(.?';1@,>1U- MP2Z@X=U,CEI]NB(G2D)X!"V9&<)3IA"(O(9NF_&&^$LOR5_IICTY?1Q'7IPZ M<< NFJZ9C;K[]WZ(F4H];6 M#ZV /0A:,I,]E"D$(J]AQ!E3;X+6VPA)NDD-'MBV**%+VP![<:9UJ2_RP%C5 M6M-J4I $EM=%:F@-=A,- \_&>^4R_WCA;*JX&G+L)^26=1M]#IWF/.7!OJ-A MY!FES#Y"06:RTVPX)1>8Z5 #)3&1.UW MTY0+E4' +VLV @*=0 "41CIM71C;3>HU)F!*URR4CEO8; A$2H$8Z.BY.66< MV4V"7!W)I(_2C1B,>4UEP;Z@- "K*%,V%]"-H13]X]8P&"49S4!(-/28R!GD M_!,7@R&OHRG8!33TDIS>!F&*TD[-_L,FG0S3CQ=?1.EM"+MFC4B( T%( ZTM65E?D"KJ $*B='-?S B]=_!43X<-5KT$ M'#6LS$^1+=8*!,BD=.4FPR-4"D1'Z76GHC@%YU!V4@@[4*OC5[]MHQ$^4VVP M#RAU!YR\9E#8 LLA7:4%X_"LK!R(FM+[5\ [,ME!?_7Q6=:"<:A55@Y$K;#) M;_LA@QL4(^)%>^'RYPD^?'CSYN7+SHM.+TQ8[O@-0?27&W?H3IR!?6W OC9@ M7QNPKPW8UP;L:P/VM8%+O3:@'I46GQL065W'UP>?:!#=<'E)F+"+E6CMD6TV MD?UFZ^F%)O?'.O)B)J7P8=GS6K[G.1^U\.2I5!#J*;]=CC9/PT4?13+]ZIA,3_LWP_YUO^L,9QVGVQW=#6?]X4UG/!KTNWUW M:DFV)=F69%N2;4FV)=F69%N2K0O)YEJ]R/&FF]7*(X_T!Q%%$K-CVN993>I+ MBY5HIB$?[M)>2*6/GH1WDS1<>?F5P+]O@@4Z"-HM4N/7Q]2X.^G/*#$>%'FQ M.YWU;YV9.^TXPU[G[W>]&_?6'N9<3YE4#:XL;,0P=ERNBX9\>)?> MO)C9O) +K$B*WQR3XO%D-'8GLR^91]G]YUU_S#S*_]49NC/+C2TWMMS8)FT_YCQYS2/([XX)_,&=YD3N$\HMB&3EB>:WFNY;F6YUJ>:WFNY;E:\=R67,/'9*J& M6UC0A+ZLN)8F&I+A['%[KM/WPS'_';C.U/IU+=^U?-?R73#O7D]%M9^(.LD#?L3.9V3!?RY8M M6[9LV;)ERY8M6[9L^>=CRT_TJL[[=[S*AO%B6 <=R;#TV_$\:GSRI-W5I-^[ M<3N#D3/,G^GHN9/^)V?6_^1VKOM#9]CM.X/.H.]<]0?]V1=+E2U5ME394F5+ ME2U5ME394N6?C"ISZ-9YZ22D&S2,4E?32T.:/5UZ!"UQ1.5(6*XX/IT^>09O M^M&9N!]' \JBI__Y'^]?O7SWURQ-L67.ECE;YFR9LV7.ECE;YFR9\T_'G#,^ MU?768>I%$Y0@\I"],IR%(N3\JD\[,4%)G7S%M1K7]\%IQ3IJR*Z9 E249>;! M?D 1WJ5BIC,< I)9O#IY(6_B3EUGTOVX]5M_<@>C[#F0CONOL3N MEGA;XFV)MR7>EGA;XOU3$F\AU:K!M67;,\QA74DM#1GU#8H1\2(JOA.L:+M) M2C+W^XY3\PCUR>MZ-^[0G3B#C$\[O=O^L#^=3?)8D!VEMFS:LFG+IBV;MFS: MLFG+IBV;_LG8= G-JL&GY5LTC%%75$Q#3CWS?J!D%/=C^I>G!;E H$\>W9LY M_W*GG=&PTQ]V1[>N)=L3O)(YXMT;5$UQ)=2W0MT;5$UQ)= M2W1_ J+K>B1F*2-VK$F2XPJJ&4!ORZ37D-F6IXL[>23/IH>SY-:26TMN+;FU MY-:26TMN?SYR>Q@9NR=0C[7BA;G5#2"[LEIH2'IO\ ,B,5/SAGAQRJ6])V_C MW8P^N9-A=H'N9N(,9Y;X6N)KB:\EOI;X6N)KB:\EOC\;\3TF476">^$F#"/ M99IH2()I+T[I#]%3'^;0X-/'W7'=W>]F?,J9L_[\'8;7]XPYR\NT<]+,&U!-<27$MP+<&U!-<2 M7$MP-2*X+7EZ)=OM5;UI=.JE-.09?,>)Z'J3,+DVRT5?8&*4U619Y^\ MH_?T5EY_.)U-[IX8]Z0__4?GUADZ-R[[HZ7:EFI;JFVIMJ7:EFI;JFVIMBY4 MN]27S.%*)U2IDG>Y8H/Z$F0%>NG(C;V0?/*B#;I%'E,,HL(G;^!=._U)YY,S MN',[MZXSO9M8WFMYK^6]EO=:WFMYK^6]EO=JQ7M;9<_3?7+M[3I+B"TAMH38$F)+ MB"TAMH3XYR/$0QQ[P;\W"8L;R&F4,Z<:3M :$_:W,2(A#FI0Y,H-&_80=#W] M-*31M$M34;TH5Z)'N_E.>!ZA/GFL[M:9N1,6<)'3Z4[O;M(?WG1F'UV6E[@_ MZA4T:V(3$"[B3%;5?%Z_6.&8: MTH'@)4MV_8/^Q_UC$SYX$="9GCP9RKZB;V=J2EF0+1G6F>AZ1O\/A8NXNR$$ MQ=06Q(N32&(ED3.M[ =,[T*5](1ZS^_F]9Y^_("2[/)9/W:2!-.)-T7UIQVP MQ6?0/P2*01WBC7D=HN9C+&T\^@<\AH"/65]P;V%=Z5\'1OA-F2X,UB.29X'J8CPMY-5=63 MSOGP<^AG9^L/]<(/!O="RMF0?.KAVJT^I_[#5TYT>FIL[ZB1H.2\II]3/Q%H MJ/R$Y)*;Y=6:SJ',=@4WI=)I1>X+SZ#K5% 4[$&F>7Z/U![B>-YX)Q)^Y)GU MHW)=P:YDH-^7TKO B_1MOY, OOF2V]^ ;CX'L81:HV,16^\PRZ4&5U MP3YEH(LV.S/]2J?68.P]9E<'6.R%Y[,*JF8@V6\\@[Y4254PK$YIM*M0Y"'Z M/F7A?QX)$CH.$%D3E&:!-RR#L$,U"+(CC"%.OZ#4G<\15>6A9)]21NW._ZB^ M/:4EW<&N8Z!K]WH39^/#BW;Q7ZI. 40-Z]N%%.H'=I.Z_MM:&UYGO:8_>=Q_ MEWK,25G[^H*N7DT0>P,=KKQ3]08#%HSH,4HU!#M+70]K/<\8>D D08[_QR9, M,OL6Z-/Y;C+)UO6%7+62(.KM^D-SD:'>>2N'&'[L09=/Z4U[$9(VS&")LQ0AHDFS'"9HRP M&2-LQ@B;,>*9))DK).EZN@B7]&.6P3<,0H_4>]FO8K.&966NHQW402Z9I5F4 MH VFU.\KIV>S5-M2;4NU+=6V5-M2;4NU+=76C&J7/NS70ZD71BCHQW-,5MDI MF?,5;U(PR+R'U@2Q1!*TY(1J7>G5/Y5?TY=8-ZVTAGP["_[*C]/3/!P,)MD? MCDGV:/;1G72Z=Y,)>R#%F4[=F676EEE;9FV9M676EEE;9FV9]3-BUJ=420F% M%C9K/%Q_WG77_,7M/^ MK\[0G5F"; FR)?!#ECB?2\6Q8/\_O*8D/>'G]SI[#9[<[ _9+[J4;?OS-Q>ISNZ'3M# M&Q-BB;DEYI:86V)NB;DEYI:8_\3$_)A!%JTRI4N>G])B>_O48.6U/V 8)3]/ M3RWY^&'F(*%/_-4I!9\YPYO^U<#=AHI8=[AEW99U6]9M6;=EW99U6];]4[-N MR'][S+D4>L$%31O&M.MJJ"''SO/^PK3Z]3&M'KC.U#JO+8VV--K2:$NC+8VV M--K2: UI=.VPZ^Q5##S?[%[%F-$N>$4_\8T/RUE-ZDM[E6@F07=;"J6GJZ[' M,GMD;+?PI%]]3,$FC<=4K%FCU**Y[:X3!&&>R_E87:8E5=9A>< S-;/'4&AO MEGXM2MUG].T[C6D+$J0+WU$>>X_9!A?>&?_.OYX\=KXX5P.[0[8[9+M#MCMD MNT.V.V2[0[8[Y.>T0YX1+T!.'!SP)"5WD\M:UIO38X^DPEL1;XX9\M5H,AE][@]OIIWKR>BV,W$'V9V(L3.9V1L1EC); MRFPILZ7,EC);RFPILXZ4^<*Q64\L3&%4%K=1?8FV(MTTY-C9V[9+'%$Y$G9K M.GV$F?7;D_SS'YV)^W$TZ+F3Z7_^Q_M7+]_]-"+>L(^7##+.;$ MP6?$XM10X#P@XBV0^X,N[6&"QB3T]ZJ/LF=AZ^RLSOR,81U&A;:-LI[V^],$ M,7O3;2:=:5/B^>G&BP;AG-88;=(D]>* _EM#G>R<;S^3GG>V"4#JU]3)Z@0E M*1TF65X&['^[BV4>Y9:NKR^LU=4 .=[E_#14:D1%6=*.V$,/*,*[]':4'"-Q MCHJ3E[@G[M1U)MV/6=[FGOO)'8RRS,T=]U]C=SAU;<-BNEN+J+B.\&*MDNW!E2Y M![0CUC"K/GF,^\8=NA-GD)%JIW?;'_:GLXDSZW]R][S:4FI+J2VEMI3:4FI+ MJ2VEMI3Z^5#J$AZEA%3+?\-X6EU150V)]VYXY_Z(\ M>33L](?=T:UK&;-ES)8Q6\9L&;-ES)8Q6\;\?!@S>]\-Q[2?)>P-C9PE_5!) MER4_8#Q7KJ*GAD1Y@)-DC$@6*03RY#I M'[$D-5'I<*/&4^(RW30\0 H>NJY,!<^>66\.QK.)J/!P.UU*!_NVY,$ MRX8M&[9LV+)ARX8M&[9L^'FQX5.FE+^F[<1!X?EE1:'H%3]E/'.NI[&&?/HZ MC+W8#]ECRPEE-LPV3(E)F'R[I:(OGA9N+L4^>:[XNC]TAMV^,^CTA]/9Y(XY MGJ=9SI1)?_J/SJTS=&[=]UWA*KD!]"7[>3A>:L@DM#1]HAW=B+WI,PF1,\#Q, M=Z\\YT^Y*>DVU;]E?%>IJ7*CI*C!-VH("L*4#02J4/:W.@_4B!K1MT/4U 4D M77HCO9\"I1T\7/N4-&,8VC+:@)3M@HX9+R2?O&B#;I''%!'[8=Z<^&&<_J3S MR1G3:S3Q3I=K-/%.EVLT\4Z7:S3Q3I=]'2ZM$64.>1J-#^3-5=H MTS0*754U#0\ZIYNO"?IC0R5W'Y#P"LW;8RX]O;N:NO^\RUY0^^3:*S261EL: M;6FTI=&61EL:;6FTCC2Z].#IZ+'C8I+22H=*B5# MC^2/2O X[LF;P;O7S?ZTK=W95W]V)+>Y;>75)J&")DD7K[Z&<7;>F$"LF+O1 M$C1@$%VNJMH%>+3:/L#3#6#;^TIPG?8Y=TW CN$N,X,1)^?9:OZ8S'#J1=>8 M\'0"BR89KB_2;CK>4.HH4^T>+F8D"_ND0>247[B:-" M]RWSTS,&%1;I8- \.Z-?34;S["*-YZ>EZR6_O+%KI4A](^*.CA4HGR2A&I=: M 840E.%EXE*G"C*]%S$%L+:X6G%F#F=!4*:M: $KKW>Q-:UDJ."*.JB>$[DP MY &_;$.N>KNI6%\L.]OJ+GYZ8<7QU'CVH=:[U^M+(V',M>ZYES[74 MGVN9?*PE%U2OW.3CV9=!6L7BQ0JF'22>R YN_S7.DR] MJ,P)(*ADVE(OHQ.$Y^^&P%F^P116NY1CH!P1*0Q-=!&HAU%+;M$,U,TPC0;1 M'I& SE'D,5-%PAW$*]_ZHEEIT!VC!VH +IU*0W F*$"K-;/+F*XOM&MZ"_Z: MP>7'#HQW*#="_;A473MPMJ92&#SMN&&V;X[6*7]*FF3[&! MO [(*V] KP#%;L>;P+Z:?W1,0A_M@C\!5P)06E\SEPEMT(9S[.57T@00[0L? ME]47(+'($#QOE(Z!%/O?\@[2VQ!*%*@((0XR:9BW*J2?]/(YEI5B;VJQ8Z?5 M"L=956"LG-FJOI"I4@X"]ZU*<)T@R.SET0X6!OUXNVL*8\8&J>!\\,IJ:0V. ME/"0\=]=\,*JOT3!)LK26*T)\L.L!TVHQG3+.R9XC4CZ.(Z\+,T9.]1=,TML MP_?W&A5B_M^?W&OM?G1[=P.W,[KN]-SQQ.WVG5E_-.Q,G)D[97\=3T9C=S+[ M\E^=\< 9SK(\ONX_[_KC/)G,]F/VAH#T#0$0MTK7!,I:,?VN@)R5#+XPL'== M@9I*GX24M*#)L8@DHJ"S5%K MR$E*(WW N*,5RN[7FS3/)"H)/U#E8G&2Q'+BC MHI<[$:N+&$^!=@[$KC>$6H52!)9Y=SX/?50^8&B]TFKWO*5!1PRDE0'70 W' MS@!Y"5KB*.BOU@0_9&N(Q/&RH-KEXJKKCJDR9<#%S 9:M[7-J!5MK>1HR$9; M2^!@HZUMM+6-MCXWVEK#H^QC?S8X:PO]H;*-W+_1]7"BIBX0TI=,KKD_J\B> MS\C?5TGSN S!B<0'T8G$:/;1G72Z=Y,).VMPIE.7)=Y\KD<.-O.FS;QI,V_J M1=0L9]8&"LN9+6=NCS-KZ%+;4JHQ06OO,?,E[=XJ.R!;PO,%N2;T3=992Q,) MMJP9QEG8F!-0!C[S?DR0C\*'@USU FRAJN9@*M1 ]7CE3I%T\X7G62(-'ZW3 M@@A;"?G39%DM?1&0%=X@!T-Q*M@__U8^00JJZ0N?M/0@P= ;OVJP&8F6!$B_ M:^/;*AY MU@<]&OHNBV<;8>#^6-/.*^7[/ZK1>@3\><.N6HL4 1MF$LS' F'X@OL21PRU]LO]LTA.(^8^*V6 7@FF^ =>@4QNV3 M.4J7=PZPTL7VR,(!>@R<4'S5DS@_VS*_=XJV6<(J]R_?ZVQY.?'!7>[[BT>/ M&!S7TT+F(_O.K WNL<$]-KC'E. >#2^VUJ?_/;<2X2'L-*30NWHU%3U 1=WQNVA8.,W@CYM75'C&@.O M6DF#7'#%;=#9B>Y,Q+Z.(@8MZ?W8)^P$OH?R_VX[]1"E[@^?=O(%ZH7S.2(H M]E&]94'-%TSH(2HU!<^-+A=!3%GO Y4XI!OR(4[W]^>''F&O@ST\[=(+<<.O MCN.&NZ/A)W:\@EACCV M@G]ODC2,%^X#4\29IRRWXIK%K>W>CR]C&%5:,9!W5#>2$0[C4[7*%S>XSJ48 M20UPRO$UD:FHA%-OMM(@Y,;%T]YZ_\9D1((P]LCC=.D1-"->G'B^9)X^F?J7 MN\93.C)/;S-*J@.>RFBX2.^O6N^S:0]"[VL8B7S,3_&RY94-7)*E32(\=],% M8)X2Y4-75.OBF2%*<3E&M-P&9BS#JK'4>REN N\+>A*J^ ^VPK;]J&.5 0-[ M#@K"0Y9^H_-*F"WM76\=IEXDO0*>5C)YY8-,P$'2$" E;@F*JEU\S0,1D<+0 MQ,5./8R&+'NQ3W;%8XWR6<685QRVL@I>+D31FX_QZ6R@F>)2M,#3%" T(K-HS)V MA4K??]#4N$*!(0M_4&KAX89],#MA/MB']Y-D\Q2Z?VAG<9W[EVU['JIVM(6;-N\HZ,+\JSJHE#QHHE-09, M*#&XK]8/FBM,"/X>QHL])Q'!F S@I).O&X)(&C=+&& M67"=2@[N,M5NZ\,?*#ABA$/\I9<@&:)45DMO6\M)#]I?Z2[:_8&('R8H&SRC^4XT MOMF!PGI;6R@T:&2E&^(]X(BL2CHT+:&W.4\E!6U8=R/,OX7/AL9NO B6L=-R M>ML3DA>TJH8'[V./9 [U,2*9.B(R=UQ68W1*9 81TG#;6G $CN;.>DVPYR_O M$A3,< ]19KJB-BA2 .'90>7&3,"XIE)@)]!P@WR@(GN\V4]1\ E'7LJBHG/R M,.Z006MP'Z@X0[\0,=)F'R[)@@5-ZCG] 3)]HSK"Y7T M D\>%1_9AZ3BD3U806,\9 0'#:[V(<8G,4Y#94I-?EK%&*-#HH-F+_@(VL[9 M.?67*-A$5.I^/,=DE3\I]!5O#O)@35.R\=E[DD\9L?*36F?5'PXYS-;J;L82?T]&@WW-F;J\SG4WNNK.["?W1 M'<[ZLWXA_^>SR_JY3W*W25XL/&]=2'2W_T*I/+<%C\L9E+<3 MT$#D ;9).FL&PHMM;3-RGKW V(R<-B.GS^PR10M,PH.+\/D#PN6O MYI94U72ID5< G.WTP_%(_JUJ$G=\2BI>["Z6)#9@;@:1',W" M?O%U,,G=4O,A2DM>I0<7%Z")B[TB*S?.RI9,@5:JYUX@/'2U]N+'7(Q^3,48 M$SP/TV2 \PO75"K,GMMA42VLJ"@C3A9F6;>]RZ5PK8KDF3J"XU##1;4?/Z D MS>ZO]./IYFL2!J'')J>_8VKM3_3O&T)Y>1SL51;?\*G>')VZ=/5'GJ\6U!64 MSLA/TIT!(3-*Y78TQNX,?23V-FW[EP\Z(&?VD7DCZO=CAW)_^,F=SF[=X6Q* M?^XXT^FHV\_\Q]W1[=@9]NVK437..0NO;4_#11S.0]]C/9 '8%+ZDE2MY@SR M4I^GZ 6'4BZXQ>=)$ M(GM)6=5+^38JPG22O$3.)&8X.9K#5V]'1[-]H$6/QQ=OZ46TQ\^0OXQQA!98+P(RNW3J$.D-'5)*E__D$3*OEA MK=@*)>XX&ULA@8.-K;"Q%3:VXMS8"@V/#PY=J26N"DYALU<=D6;@P-$/Q"-> M=*!,Y3TJM_:EW! P+B6[38$-C'0Z*,=4RY6O$=S;7 ;5;+#>:K+!$@TBB3W6 M6U$&+:4;VYL(?_4B*D47EYL=*'S!Y,5UK"[2 C*ZCD^DSAX-?VY=)0T1&4-= M^D4#WO.^'.,00F"?8(>UUIM0*("UW8?3$JIO&"_V3V"7O)W&+V[&D]\"V<&5 M3,.M=)2"/[ 8I+;?&Q /R"#]%$G-K:!R3)24YA)F&<]^8X.Q18W95?_0] M1B19ANO=7?W"LBT"4;8-$V"MIHOJH\/+ 5VDW&=@76SF&$B/-# MU6Q2XXZA1C70HZI?K] C99C^_:&^7E!GJ)M,DKL";#^\RVO'9B[^I,XIJ+'Y M10*#?H=FO#S72/"X1Z&,WM;DR0H94L,$AV-*OJB&=+T>S;=',A/T@.*->$L( MUM(8+&GIP2U^0;/64[5M5BLO]SU1ZK1@.?WR:\%#E K2L;TY2<=V=WOK3+[D MV=AFSO"F?S5PV24Z=S;M#-W9\TVXIGB5+QR 39"/8S^,0B]?S/:/2=]@''P/ MHZC2?3G9UDR_+E?-:@;?ENMZA#PR5W_V5I#C^YO5)F(A=SVT)LC/]:?_2-(P MR7^.@_YJ3?DQ,RK]Y8;@)#EJI30%4%/?U.30N6+O.)MQ:=HIDS\P;[!4?I\LX!5KK814'A #T&3BB^ MZDF<2XLE>JO8DO;: 5-8$W%SKN,)&7IYZZ7C7-DJ7B,PH9]G1E5)" M5[&E9T+3:MG/B#LHI1J5S\#235R,HM6#[S2/5253F<'%VL-?<\;6:A\QCIIU MO768>E&8L+7Q 45XS>S)?/=Q$+(8%1D6+]7$Q6A;U>%]2L&E]3-H?1B$/HI] MF6M/AR4;&.TMX!S55@[Z3XSC\W*4SDK#^M;B*2/X\C+;O:[ M?VS"M>@HF'M9HJP5@PZ*:^EW@6/DADX%0$VE3P-*6M#D>H\DHN 9@92=C%ER MN9J4[U-+JU[\+$ .)MZ"*V$2,UP1S>&KMQ.BV3Y@GF]_/@]]5 %\;H6+77^6 M'9(G;GQ("X-FZ%M,O_8)+2FGEO$>1 M>S9RST;N/>O(/0T/.#+/&9YO=IXS$0SOY[V*G^"DZRL,1I5E5 ][7$QZ:%@X\L/ M"%I%5$-OZY=+#J[N^DUDQ9O!568R43V-X:L@/P3B[SHTR;>[1$6MS2\KOVI/B!0* M._\7>S.WD,-.#@F@LE%HB'20<&OHLBJ/O4>F.6=*S0)^PGF( B>Y#F,O]MFC M.G0^>"A=OFLWJF\/4*0;U#,TS/O6W1#"+%*!M@%5#$!5)#F$6=V7OQO$;(AC MOSIL<"T#D"L1'@+OO0X>YL.GRCA3"GLU81&'_X."?CPF>!ZF(S+ B>B6QP>1 M,[KK3"9?^L.;CG,[NAO.IJ<.ZKX[[4S<[NAFV/^_;J_3'W;&D]%U?]8933J# MT?097PJQ_FOKO[;^:[V@D8P#MY@;0%S9 ##E=&C%CW[\Y:.XNLH^1;B^OKA45T.UQ[W) MG$UY'YN@B,X=\6*&ITM,V"JPRG1FFGY>AOYRN\=E4+@_T&K-?OCH)5<(Q7?) MT\::F]A)S2?T[2"-:-K>>0'DOA",:*B*OAA)22YQ(G Y-U26M6CL/;+=IL"U M].XWD6MI-/OH3CICYXMS-7"MF\BZB:R;R+J)K)O(NHFLF\BZB7XB-]&>F+NK M=80?$;I",;5TFH7O;+Q(Z&,HK:PO#:ZH@T%>HQGQ N3$04:3MX$".[8\P]F6 M# 5CCY0YD*JT8P#.E=5IQZUTX$JY(5Z(N%#]A#D-@#.BZJ%CHD;, !3>3TD M7$*ZH'O@(!*A>%#0 +1.Y850T3! D[?PEH)S5-X4C'AB0U"]O9Q/-7?&2SRQ M^^[EL2\U"\.;_@Q/ZBH^EK?9EVWV99M]V69?MMF7^2C;[,LV^[+-OFRS+VL" MGTQNC\GM,?FS/B97GX_#_;$.278G #A4.RRDKYL1D%7B M>/IR\9I7F!#\/8P7R355^/"D51"^^4H4OGDUFDQ&G_O#FVGG>C*Z[4S<@3-S M>YVQ,\GN!-MX3AO/:>,Y;3RG):J6J%JB:HGJSQ?/^<2Z1/XJ3G$#DNA 4DO0 M8%UPZGK)3]$ [)6@_K"KD OD+=N?^*G]$UVJ\ *3D 6''3*NTB#7DIJ:+C32\ANT7*# TW+%3%9GN_]E7".OM/>NU1!$8-<_4]NIET^ M2_8(BPA0?@T# !0(WHI;_@K'FV3WY E_MCLHHJ])N9*JIHA\/V+L$Q9BUH\/ MWWL8S?>/"P-.Q?**6MM;5GX)3[8N4X^"TV!M$2N5&L))CR26) ACCSQ.EQX1 MAD'^+LQB.>GUA\[D2V?ZT9G8L$=[K&"/%>RQ@CU6L,<*.KA2[+&"/59HS8F" M5VL O/T.(K=H9KIB+A/[L+18$+;+P;7;N_8#B M#6)'<'1CD1+/3Y//8;KL;I(4K^B6H5*BPKJM&^2/4ZKW!;QX:KO6C'Z5,J^] MDF5;,GYY3?+TG(GB23IZ@6V,V'$?*U"^;X!J7&IC)X2@#"\3-WBJ(--[TZ< MUA8W?T_TR:&32Z:D< L(E[]8>L"2H8$E93=H[KO:))0!)$D7K[Y2FLOL6[JX MP76>YP)79B,S/)6'$8D\G2J'PHH:N=126 I629AKN6',6"';Q5OO=;2Y/M'F M\LIBZ#XS5T#9NGI:\&(+:O7!A"^?W!<]%DM0+":$)H:OH[H;.W M.N->B_)=K;#:I?P6$ XG3Y>6ZVR&@T(]>%JN;BH!;M/;$'G^-R<.IOX2LZ=3 M<( BH=,!+'^Y1V-DA@J6U0#<3=5=Y;AFOV7=JNN1"$_#U2;//5=J^Y)*]Q_, M $!�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

  •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formf-1_htm.xml IDEA: XBRL DOCUMENT 0001940674 2023-01-01 2023-06-30 0001940674 dei:BusinessContactMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersLimitedMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember 2022-07-01 0001940674 2023-06-30 0001940674 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember 2020-01-01 2020-12-31 0001940674 2022-01-01 2022-06-30 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:IssuedCapitalMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:AdditionalPaidinCapitalMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ForeignCurrencyTranslationMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:RetainedEarningsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:IssuedCapitalMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:AdditionalPaidinCapitalMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ForeignCurrencyTranslationMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:RetainedEarningsMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:IssuedCapitalMember 2019-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:AdditionalPaidinCapitalMember 2019-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ForeignCurrencyTranslationMember 2019-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:RetainedEarningsMember 2019-12-31 0001940674 SMX:SecurityMattersLimitedMember 2019-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2022-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2022-12-31 0001940674 ifrs-full:RetainedEarningsMember 2022-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2021-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2021-12-31 0001940674 ifrs-full:RetainedEarningsMember 2021-12-31 0001940674 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:IssuedCapitalMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:AdditionalPaidinCapitalMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ForeignCurrencyTranslationMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:RetainedEarningsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:IssuedCapitalMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:AdditionalPaidinCapitalMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ForeignCurrencyTranslationMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:RetainedEarningsMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:IssuedCapitalMember 2020-01-01 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:AdditionalPaidinCapitalMember 2020-01-01 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ForeignCurrencyTranslationMember 2020-01-01 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:RetainedEarningsMember 2020-01-01 2020-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2023-01-01 2023-06-30 0001940674 ifrs-full:RetainedEarningsMember 2023-01-01 2023-06-30 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2022-01-01 2022-06-30 0001940674 ifrs-full:RetainedEarningsMember 2022-01-01 2022-06-30 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:IssuedCapitalMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:AdditionalPaidinCapitalMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ForeignCurrencyTranslationMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:RetainedEarningsMember 2022-12-31 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2023-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2023-06-30 0001940674 ifrs-full:RetainedEarningsMember 2023-06-30 0001940674 SMX:IssuedAndAdditionalPaidInCapitalMember 2022-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2022-06-30 0001940674 ifrs-full:RetainedEarningsMember 2022-06-30 0001940674 2022-06-30 0001940674 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:LionheartMember SMX:BusinessCombinationAgreementMember 2022-07-26 2022-07-26 0001940674 SMX:SecurityMattersPTYLtdMember ifrs-full:OrdinarySharesMember 2022-07-26 0001940674 SMX:LionheartMember SMX:BusinessCombinationAgreementMember 2022-07-26 2022-07-26 0001940674 SMX:EquityLineAgreementMember 2023-01-01 2023-06-30 0001940674 SMX:EquityLineAgreementMember 2023-06-30 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:ComputerEquipmentMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:MachineryMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:FurnitureAndOfficeEquipmentMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SpecialPurposeAcquisitionCompanyMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember SMX:FurnitureAndOfficeEquipmentMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember SMX:FurnitureAndOfficeEquipmentMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember SMX:FurnitureAndOfficeEquipmentMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:LeaseholdImprovementsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:MachineryMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember SMX:FurnitureAndOfficeEquipmentMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:ComputerEquipmentMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:RightofuseAssetsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:MachineryMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember SMX:FurnitureAndOfficeEquipmentMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:ComputerEquipmentMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:RightofuseAssetsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:LeaseholdImprovementsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:MachineryMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember SMX:FurnitureAndOfficeEquipmentMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:ComputerEquipmentMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:RightofuseAssetsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:LeaseholdImprovementsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:MachineryMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:FurnitureAndOfficeEquipmentMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:ComputerEquipmentMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:RightofuseAssetsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember SMX:FurnitureAndOfficeEquipmentMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LeaseholdImprovementsMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:MachineryMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember SMX:FurnitureAndOfficeEquipmentMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:LeaseholdImprovementsMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:MachineryMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember SMX:FurnitureAndOfficeEquipmentMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:ComputerEquipmentMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:RightofuseAssetsMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:LeaseholdImprovementsMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:MachineryMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember SMX:FurnitureAndOfficeEquipmentMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:ComputerEquipmentMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember ifrs-full:RightofuseAssetsMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:LeaseholdImprovementsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:MachineryMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:FurnitureAndOfficeEquipmentMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:ComputerEquipmentMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:RightofuseAssetsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember 2022-05-01 2022-05-31 0001940674 SMX:SecurityMattersLimitedMember 2022-05-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ConvertibleNotesAgreementsMember 2022-07-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:MajorOrdinaryShareTransactionsMember 2023-03-07 0001940674 SMX:ConvertibleNotesMember 2023-01-24 2023-01-25 0001940674 SMX:ConvertibleNotesMember 2023-01-25 0001940674 ifrs-full:OrdinarySharesMember 2023-01-25 0001940674 SMX:BonusWarrantsMember SMX:ConvertibleNoteAgreementsMember 2023-01-24 2023-01-25 0001940674 SMX:RedeemableWarrantsMember SMX:ConvertibleNoteAgreementsMember 2023-01-24 2023-01-25 0001940674 SMX:RedeemableWarrantsMember SMX:ConvertibleNoteAgreementsMember 2023-01-25 0001940674 SMX:ConvertibleNotesMember 2023-01-01 2023-06-30 0001940674 SMX:RedeemableWarrantsMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersLimitedMember SMX:YahalomaTechnologiesIncMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:YahalomaTechnologiesIncMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:TrueGoldConsortiumPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:TrueGoldConsortiumPtyLtdMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SMXBeveragesPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SMXBeveragesPtyLtdMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SMXBeveragesPtyLtdMember 2021-12-23 2021-12-24 0001940674 SMX:SecurityMattersLimitedMember SMX:SMXBeveragesPtyLtdMember 2021-12-24 0001940674 SMX:SecurityMattersLimitedMember SMX:GlobalBevCoPtyLtdMember SMX:ConsultingAgreementMember 2021-12-23 2021-12-24 0001940674 SMX:SecurityMattersLimitedMember SMX:SecurityMattersLimitedsShareOfNetAssetsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SecurityMattersLimitedsShareOfNetAssetsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SecurityMattersLimitedsShareOfNetAssetsMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:CompanysShareInNetProfitsLossesOfAssociatedCompaniesMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:CompanysShareInNetProfitsLossesOfAssociatedCompaniesMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:CompanysShareInNetProfitsLossesOfAssociatedCompaniesMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:LicencesMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationAmortisationMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationAmortisationMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationAmortisationMember ifrs-full:LicencesMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationAmortisationMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:LicencesMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:GrossCarryingAmountMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:AccumulatedDepreciationAmortisationMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:CapitalisedDevelopmentExpenditureMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:OtherIntangibleAssetsMember SMX:SMXBeveragesPtyLtdMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:OtherIntangibleAssetsMember SMX:SMXBeveragesPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:OfficeEquipmentMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:MotorVehiclesMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:OfficeEquipmentMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:MotorVehiclesMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:OfficeEquipmentMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:MotorVehiclesMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember 2015-01-01 2015-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:LenderTwoMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember 2022-08-01 2022-08-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BonusWarrantsMember SMX:BridgeLoanAgreementsMember 2022-10-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BonusWarrantsMember SMX:BlackAndScholesModelMember SMX:BridgeLoanAgreementsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeOneMember SMX:BridgeLoanAgreementsMember 2022-10-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeOneMember SMX:BridgeLoanAgreementsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeOneMember SMX:BridgeLoanAgreementsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeOneMember SMX:ThirdAnniversaryMember SMX:BridgeLoanAgreementsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeOneMember SMX:ThirdAnniversaryMember SMX:BridgeLoanAgreementsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeOneMember SMX:FourthAnniversaryMember SMX:BridgeLoanAgreementsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeOneMember SMX:FourthAnniversaryMember SMX:BridgeLoanAgreementsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeOneMember SMX:MonteCarloSimulationModelMember SMX:BridgeLoanAgreementsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeTwoMember SMX:BridgeLoanAgreementsMember 2022-10-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeTwoMember SMX:FirstAnniversaryMember SMX:BridgeLoanAgreementsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeTwoMember SMX:FirstAnniversaryMember SMX:BridgeLoanAgreementsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeTwoMember SMX:SecondAnniversaryMember SMX:BridgeLoanAgreementsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeTwoMember SMX:SecondAnniversaryMember SMX:BridgeLoanAgreementsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeTwoMember SMX:BridgeLoanAgreementsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:RedeemableWarrantsTypeTwoMember SMX:MonteCarloSimulationModelMember SMX:BridgeLoanAgreementsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ThreeValuationModelsMember 2022-01-01 2022-12-31 0001940674 SMX:ElevenLendersMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 ifrs-full:TopOfRangeMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-01-31 0001940674 SMX:BonusWarrantsMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:RedeemableWarrantsMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:RedeemableWarrantsMember SMX:BridgeLoanAgreementsMember 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 ifrs-full:TopOfRangeMember SMX:BridgeLoanAgreementsMember 2023-06-30 0001940674 SMX:BridgeLoanAgreementsMember 2022-12-31 0001940674 SMX:RedeemableWarrantsMember SMX:BridgeLoanAgreementsMember 2023-06-30 0001940674 SMX:RedeemableWarrantsMember SMX:BridgeLoanAgreementsMember 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-01-01 2023-06-30 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:NonadjustingEventMember ifrs-full:TopOfRangeMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-03-01 2023-03-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-03-31 0001940674 2022-07-01 0001940674 SMX:DeferredSharesMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember 2022-08-31 0001940674 SMX:SecurityMattersLimitedMember 2021-10-01 2021-10-31 0001940674 SMX:SecurityMattersLimitedMember 2021-10-31 0001940674 SMX:SecurityMattersLimitedMember 2021-05-31 0001940674 SMX:SecurityMattersLimitedMember 2021-05-01 2021-05-31 0001940674 SMX:SecurityMattersLimitedMember SMX:EmployeesMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ConsultantsMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:BottomOfRangeMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:TopOfRangeMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:EmployeesMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ConsultantsMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:BottomOfRangeMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:TopOfRangeMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:EmployeesMember 2020-01-01 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ConsultantsMember 2020-01-01 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BoardMembersMember 2020-01-01 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:BottomOfRangeMember 2020-01-01 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:TopOfRangeMember 2020-01-01 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BoardMembersMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BoardMembersMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BoardMembersMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BoardMembersMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BlackScholesPricingModelMember ifrs-full:BottomOfRangeMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BlackScholesPricingModelMember ifrs-full:TopOfRangeMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BlackScholesPricingModelMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:TwoExecutiveDirectorMember 2018-08-01 2018-08-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ExecutiveDirectorMember 2021-08-01 2021-08-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2021-08-01 2021-08-31 0001940674 SMX:SecurityMattersLimitedMember 2021-08-01 2021-08-31 0001940674 SMX:SecurityMattersLimitedMember 2021-07-01 2021-07-31 0001940674 SMX:SecurityMattersLimitedMember 2021-07-31 0001940674 SMX:SecurityMattersLimitedMember 2022-07-01 2022-07-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:BottomOfRangeMember 2022-06-01 2022-06-30 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:TopOfRangeMember 2022-06-01 2022-06-30 0001940674 SMX:SecurityMattersLimitedMember 2022-07-31 0001940674 SMX:SecurityMattersLimitedMember 2022-06-01 2022-06-30 0001940674 SMX:SecurityMattersLimitedMember 2022-06-30 0001940674 2023-03-07 0001940674 2023-03-07 2023-03-07 0001940674 ifrs-full:WarrantsMember 2023-03-07 2023-03-07 0001940674 ifrs-full:WarrantsMember 2023-03-07 0001940674 ifrs-full:OrdinarySharesMember 2023-03-07 0001940674 SMX:PrivateWarrantsMember 2023-07-03 0001940674 SMX:PublicWarrantsMember 2023-03-07 0001940674 ifrs-full:WarrantsMember 2023-06-27 0001940674 SMX:OrdinarySharesTwoMember 2023-03-07 0001940674 SMX:OrdinarySharesTwoMember 2023-03-07 2023-03-07 0001940674 SMX:BridgeLoansMember 2023-03-07 0001940674 SMX:RedeemableWarrantsMember 2023-03-07 2023-03-07 0001940674 SMX:RedeemableWarrantsMember 2023-03-07 0001940674 SMX:YorkvilleMember 2023-05-31 0001940674 SMX:YorkvilleMember 2023-06-30 0001940674 SMX:YorkvilleMember 2023-05-01 2023-05-31 0001940674 SMX:YorkvilleMember 2023-06-01 2023-06-30 0001940674 2023-06-01 2023-06-30 0001940674 SMX:UnderwritingAgreementMember 2023-06-30 0001940674 SMX:WarrantAMember SMX:UnderwritingAgreementMember 2023-06-30 0001940674 SMX:WarrantBMember SMX:UnderwritingAgreementMember 2023-06-30 0001940674 SMX:IncentiveEquityPlanMember 2023-04-25 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-06-30 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:BottomOfRangeMember ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-06-30 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:TopOfRangeMember ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-06-30 0001940674 SMX:EmployeesMember 2023-01-01 2023-06-30 0001940674 SMX:EmployeesMember ifrs-full:BottomOfRangeMember 2023-06-30 0001940674 SMX:EmployeesMember ifrs-full:TopOfRangeMember 2023-06-30 0001940674 SMX:EmployeesMember 2023-06-30 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:BottomOfRangeMember SMX:OptionsOutstandingOneMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:TopOfRangeMember SMX:OptionsOutstandingOneMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:OptionsOutstandingOneMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:OptionsOutstandingOneMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:OptionsOutstandingTwoMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:OptionsOutstandingTwoMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:BottomOfRangeMember SMX:OptionsOutstandingThreeMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:TopOfRangeMember SMX:OptionsOutstandingThreeMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:OptionsOutstandingThreeMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:OptionsOutstandingThreeMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:OptionsOutstandingFourMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:OptionsOutstandingFourMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:OptionsOutstandingFiveMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:OptionsOutstandingFiveMember 2022-01-01 2022-12-31 0001940674 ifrs-full:BottomOfRangeMember SMX:OptionsOutstandingOneMember 2023-06-30 0001940674 ifrs-full:TopOfRangeMember SMX:OptionsOutstandingOneMember 2023-06-30 0001940674 SMX:OptionsOutstandingOneMember 2023-06-30 0001940674 SMX:OptionsOutstandingOneMember 2023-01-01 2023-06-30 0001940674 ifrs-full:BottomOfRangeMember SMX:OptionsOutstandingTwoMember 2023-06-30 0001940674 ifrs-full:TopOfRangeMember SMX:OptionsOutstandingTwoMember 2023-06-30 0001940674 SMX:OptionsOutstandingTwoMember 2023-06-30 0001940674 SMX:OptionsOutstandingTwoMember 2023-01-01 2023-06-30 0001940674 ifrs-full:BottomOfRangeMember SMX:OptionsOutstandingThreeMember 2023-06-30 0001940674 ifrs-full:TopOfRangeMember SMX:OptionsOutstandingThreeMember 2023-06-30 0001940674 SMX:OptionsOutstandingThreeMember 2023-06-30 0001940674 SMX:OptionsOutstandingThreeMember 2023-01-01 2023-06-30 0001940674 SMX:OptionsOutstandingFourMember 2023-06-30 0001940674 SMX:OptionsOutstandingFourMember 2023-01-01 2023-06-30 0001940674 SMX:OptionsOutstandingFiveMember 2023-06-30 0001940674 SMX:OptionsOutstandingFiveMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersLimitedMember SMX:ResearchAndDevelopmentExpensesMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ResearchAndDevelopmentExpensesMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ResearchAndDevelopmentExpensesMember 2020-01-01 2020-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:GeneralAndAdministrativeExpensesMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:GeneralAndAdministrativeExpensesMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:GeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001940674 SMX:GeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001940674 SMX:GeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:KeyManagementPersonnelOfEntityOrParentMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:DirectorsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:DirectorsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ShareholdersMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ShareholdersMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:JointVenturesMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:JointVenturesMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:RelatedPartiesMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:RelatedPartiesMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SecurityMattersLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SecurityMattersLtdMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SecurityMattersCanadaLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SecurityMattersCanadaLtdMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SecurityMattersFranceLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SecurityMattersFranceLtdMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SMXBeveragesPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SMXBeveragesPtyLtdMember 2021-01-01 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember 2015-01-31 0001940674 SMX:SecurityMattersLimitedMember SMX:NonadjustingEventMember 2023-01-30 0001940674 SMX:SecurityMattersLimitedMember SMX:NonadjustingEventMember 2023-01-29 2023-01-30 0001940674 SMX:SecurityMattersLimitedMember SMX:UnitedStatesDollarMember ifrs-full:CurrencyRiskMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:UnitedStatesDollarMember ifrs-full:CurrencyRiskMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:EURMember ifrs-full:CurrencyRiskMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:EURMember ifrs-full:CurrencyRiskMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:CurrencyRiskMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:CurrencyRiskMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:CreditRiskMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:CreditRiskMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:TradeAndOtherPayablesMember ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:TradeAndOtherPayablesMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:TradeAndOtherPayablesMember ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BridgeLoansMember ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BridgeLoansMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BridgeLoansMember ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:GovernmentGrantsMember ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:GovernmentGrantsMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:GovernmentGrantsMember ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:LeaseLiabilitiesMember ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BorrowingMember ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BorrowingMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BorrowingMember ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:TradeAndOtherPayablesMember ifrs-full:NotLaterThanOneYearMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:TradeAndOtherPayablesMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:TradeAndOtherPayablesMember ifrs-full:LaterThanFiveYearsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:LeaseLiabilitiesMember ifrs-full:NotLaterThanOneYearMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:LeaseLiabilitiesMember ifrs-full:LaterThanFiveYearsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BorrowingMember ifrs-full:NotLaterThanOneYearMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BorrowingMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:LaterThanFiveYearsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:NotLaterThanOneYearMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:BorrowingMember ifrs-full:LaterThanFiveYearsMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:DerivativesMember ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:DerivativesMember ifrs-full:Level2OfFairValueHierarchyMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:DerivativesMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:Level2OfFairValueHierarchyMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:DerivativesMember ifrs-full:Level1OfFairValueHierarchyMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:DerivativesMember ifrs-full:Level2OfFairValueHierarchyMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:DerivativesMember ifrs-full:Level3OfFairValueHierarchyMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:DerivativesMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:Level1OfFairValueHierarchyMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:Level2OfFairValueHierarchyMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember ifrs-full:Level3OfFairValueHierarchyMember 2021-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ConvertibleNotesMember SMX:NonadjustingEventMember 2023-01-25 0001940674 SMX:SecurityMattersLimitedMember SMX:ConvertibleNotesMember SMX:NonadjustingEventMember 2023-01-24 2023-01-25 0001940674 SMX:SecurityMattersLimitedMember SMX:IsoradLtdMember SMX:NonadjustingEventMember 2023-01-31 0001940674 SMX:SecurityMattersLimitedMember SMX:IsoradLtdMember SMX:BlackScholesPricingModelMember SMX:NonadjustingEventMember 2023-01-01 2023-01-31 0001940674 SMX:SecurityMattersLimitedMember SMX:IsoradLtdMember SMX:NonadjustingEventMember 2023-01-01 2023-01-31 0001940674 SMX:SecurityMattersLimitedMember SMX:SMXPublicLimitedCompanyMember SMX:NonadjustingEventMember 2023-02-28 0001940674 SMX:SecurityMattersLimitedMember SMX:SMXPublicLimitedCompanyMember SMX:NonadjustingEventMember 2023-02-01 2023-02-28 0001940674 SMX:SecurityMattersLimitedMember SMX:SMXPublicLimitedCompanyMember SMX:NonadjustingEventMember ifrs-full:BottomOfRangeMember 2023-02-01 2023-02-28 0001940674 SMX:SecurityMattersLimitedMember SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-12-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ConvertibleNotesMember SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-03-01 2023-03-31 0001940674 SMX:SecurityMattersLimitedMember SMX:ConvertibleNotesMember SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-03-06 2023-03-07 0001940674 SMX:NonadjustingEventMember 2023-02-28 0001940674 SMX:NonadjustingEventMember 2023-02-01 2023-02-28 0001940674 SMX:NonadjustingEventMember ifrs-full:BottomOfRangeMember 2023-02-01 2023-02-28 0001940674 SMX:ConvertibleNotesMember SMX:NonadjustingEventMember 2023-01-25 0001940674 SMX:ConvertibleNotesMember SMX:NonadjustingEventMember 2023-01-24 2023-01-25 0001940674 SMX:ElevenLendersMember SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:NonadjustingEventMember ifrs-full:TopOfRangeMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-01-31 0001940674 SMX:BonusWarrantsMember SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:RedeemableWarrantsMember SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:RedeemableWarrantsMember SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-01-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:ConvertibleNotesMember SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-03-01 2023-03-31 0001940674 SMX:NonadjustingEventMember 2023-04-25 2023-04-25 0001940674 SMX:NonadjustingEventMember 2023-04-25 0001940674 SMX:NonadjustingEventMember 2023-07-27 0001940674 SMX:NonadjustingEventMember 2023-07-27 2023-07-27 0001940674 SMX:NonadjustingEventMember SMX:PrePaidAdvanceAgreementMember 2023-07-27 0001940674 SMX:NonadjustingEventMember SMX:PrePaidAdvanceAgreementMember 2023-07-27 2023-07-27 0001940674 SMX:NonadjustingEventMember SMX:PrePaidAdvanceAgreementMember 2023-09-30 2023-09-30 0001940674 SMX:NonadjustingEventMember SMX:SecuritiesPurchaseAgreementMember 2023-09-06 2023-09-06 0001940674 SMX:NonadjustingEventMember SMX:SecuritiesPurchaseAgreementMember 2023-09-06 0001940674 SMX:BenchmarkInvestmentsLLCMember SMX:NonadjustingEventMember 2023-09-15 2023-09-15 0001940674 SMX:BenchmarkInvestmentsLLCMember SMX:NonadjustingEventMember 2023-09-15 0001940674 SMX:NonadjustingEventMember SMX:LoanAgreementMember 2023-09-19 0001940674 SMX:NonadjustingEventMember SMX:LoanAgreementsMember 2023-09-19 0001940674 SMX:TrueGoldConsortiumPtyLtdMember SMX:NonadjustingEventMember 2023-10-03 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-06-30 0001940674 SMX:TrueGoldConsortiumPtyLtdMember ifrs-full:BottomOfRangeMember 2021-10-01 2021-10-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember ifrs-full:TopOfRangeMember 2021-10-01 2021-10-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2021-10-01 2021-10-31 0001940674 SMX:SecurityMattersPTYLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersPTYLtdMember 2022-01-01 2022-12-31 0001940674 SMX:LionheartIIICorpMember 2023-01-01 2023-06-30 0001940674 SMX:LionheartIIICorpMember 2022-01-01 2022-12-31 0001940674 SMX:SMXCircularEconomyPlatformPTELtdMember 2023-01-01 2023-06-30 0001940674 SMX:SMXCircularEconomyPlatformPTELtdMember 2022-01-01 2022-12-31 0001940674 SMX:SMXIrelandLimitedMember 2023-01-01 2023-06-30 0001940674 SMX:SMXIrelandLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:SMXIsraelLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SMXIsraelLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersCanadaLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersCanadaLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersFranceLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersFranceLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SMXBeveragesPtyLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SMXBeveragesPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:YahalomaTechnologiesIncMember 2023-01-01 2023-06-30 0001940674 SMX:YahalomaTechnologiesIncMember 2022-01-01 2022-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-01-01 2023-06-30 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-02-28 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-02-01 2023-02-28 0001940674 SMX:FirstInstallmentMember SMX:StandbyEquityPurchaseAgreementMember 2023-02-28 0001940674 SMX:SecondInstallmentMember SMX:StandbyEquityPurchaseAgreementMember 2023-02-28 0001940674 2023-07-27 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-07-27 2023-07-27 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-07-01 2023-07-31 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-07-31 0001940674 ifrs-full:OrdinarySharesMember SMX:EFHuttonLLCMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:WarrantAMember SMX:EFHuttonLLCMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:WarrantBMember SMX:EFHuttonLLCMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 ifrs-full:OrdinarySharesMember SMX:WarrantAMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:PublicOfferingMember SMX:UnderwritingAgreementMember 2023-06-22 2023-06-22 0001940674 ifrs-full:OrdinarySharesMember SMX:PublicOfferingMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:PrefundedWarrantMember SMX:PublicOfferingMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:WarrantAMember SMX:PublicOfferingMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:WarrantBMember SMX:PublicOfferingMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember 2023-06-22 2023-06-22 0001940674 SMX:WarrantAMember SMX:UnderwritingAgreementMember 2023-06-22 2023-06-22 0001940674 ifrs-full:OrdinarySharesMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:WarrantBMember 2023-06-30 0001940674 ifrs-full:WarrantsMember 2023-01-01 2023-06-30 0001940674 SMX:UnderwriterWarrantMember 2023-06-30 0001940674 SMX:UnderwriterWarrantMember 2023-01-01 2023-06-30 0001940674 2023-01-31 0001940674 2023-01-01 2023-01-31 0001940674 ifrs-full:TechnologybasedIntangibleAssetsMember 2023-01-31 0001940674 ifrs-full:OrdinarySharesMember 2023-06-30 0001940674 ifrs-full:PreferenceSharesMember 2023-06-30 0001940674 ifrs-full:OrdinarySharesMember 2022-12-31 0001940674 ifrs-full:PreferenceSharesMember 2022-12-31 0001940674 SMX:DeferredSharesMember 2023-06-30 0001940674 SMX:DeferredSharesMember 2022-12-31 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember 2022-12-31 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember 2021-12-31 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember 2022-01-01 2022-06-30 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember 2023-06-30 0001940674 SMX:EmployeesDirectorsAndServiceMember ifrs-full:RestrictedShareUnitsMember 2022-06-30 0001940674 ifrs-full:OrdinarySharesMember 2023-01-01 2023-06-30 0001940674 ifrs-full:OrdinarySharesMember 2022-01-01 2022-06-30 iso4217:USD shares iso4217:USD shares pure SMX:Integer iso4217:AUD iso4217:ILS iso4217:AUD shares iso4217:EUR iso4217:EUR shares false 0001940674 false 0001940674 P6M P2Y F-1 SMX (Security Matters) Public Limited Company L2 +353-1 920-1000 Mespil Business Centre Mespil House Sussex Road Dublin 4 IE Puglisi & Associates 850 Library Avenue Suite 204 Newark DE 19711 true false 1398000 4171000 3673000 920000 5071000 5091000 969000 1192000 5027000 3908000 221000 147000 6217000 5247000 11288000 10338000 2972000 916000 30000 37000 650000 673000 563000 710000 270000 4925000 1896000 440000 466000 3682000 85000 85000 4207000 551000 9132000 2447000 32713000 31504000 -537000 223000 -30020000 -23836000 2156000 7891000 11288000 10338000 13000 10000 3000 1898000 2039000 1689000 569000 453000 427000 2723000 2482000 2447000 5190000 4974000 4560000 1128000 101000 79000 28000 237000 67000 106000 -101000 -1000 6184000 4939000 4573000 -6184000 -4939000 -4573000 -522000 -7000 388000 -238000 -375000 -760000 -382000 388000 -6944000 -5321000 -4185000 -0.04 -0.04 -0.03 -0.03 -0.04 -0.04 31504000 223000 -23836000 7891000 -6184000 -6184000 -760000 -760000 -760000 -6184000 -6944000 182000 182000 306000 306000 721000 721000 32713000 -537000 -30020000 2156000 24733000 605000 -18897000 6441000 -4939000 -4939000 -382000 -382000 -382000 -4939000 -5321000 5892000 5892000 395000 395000 484000 484000 31504000 223000 -23836000 7891000 17357000 217000 -14324000 3250000 17357000 217000 -14324000 3250000 -4573000 -4573000 388000 388000 388000 388000 388000 -4573000 -4185000 6857000 6857000 519000 519000 24733000 605000 -18897000 6441000 24733000 605000 -18897000 6441000 -6184000 -4939000 -4573000 252000 431000 483000 -2936000 -463000 -162000 290000 315000 219000 2217000 401000 323000 114000 60000 150000 17000 -3000 -15000 387000 -6000 -51000 -47000 -29000 621000 89000 106000 -101000 -1000 -54000 -53000 -36000 -5223000 -3908000 -3515000 152000 297000 235000 975000 1468000 723000 -1127000 -1765000 -958000 172000 103000 144000 55000 98000 12000 395000 581000 182000 5892000 6857000 3310000 32000 3846000 6118000 6701000 -2504000 445000 2228000 4171000 4341000 1708000 -269000 -615000 405000 1398000 4171000 4341000 <p id="xdx_80B_eifrs-full--DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_zudOmOWMwaw" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_821_zVcOhSEW8Lbk">GENERAL</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters Limited (“Security Matters” or the “Company”, and together with its subsidiaries, the “Group”) was incorporated in May 2018 under Australian law. Security Matters’ registered address is Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group engages in research and development to permanently and irrevocably “mark” any object either solid, liquid or gas, allowing identification, circularity, proof of authenticity, tracking supply chain movements and quality assurance for countless products in virtually every industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_zjqW5hHGeqF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zOO48uwfaW1e">SCHEDULE OF COMPANIES SUBSIDIARIES</span></span></p> <p id="xdx_8A7_zO1Inih98bK3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters’ technology comprises a chemical-based hidden “barcode” system, alongside a unique “reader” to identify these codes, and a blockchain record to store and protect ownership data. Security Matters offers a business-to-business (B2B), “white-label” solution that serves market leaders’ needs for authentication, supply chain integrity and quality assurance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 7, 2023 the business combination (the “Business Combination”) with Lionheart III Corp (“Lionheart”) was completed, following that a newly-formed parent company – SMX (Security Matters) Public Limited Company (“SMX PLC”), (formerly called <span style="background-color: white">Empatan Public Limited Company</span>) is listed in the NASDAQ stock exchange under the ticker SMX.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 26, 2022, the Company and Lionheart, a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (“BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders receiving SMX PLC Shares and warrants in exchange for their existing Lionheart shares and warrants and all shares in the Company being cancelled in return for SMX PLC shares and resulting in the Company becoming a wholly owned subsidiary of SMX PLC.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Business Combination resulted in <span id="xdx_903_ecustom--RedemptionPercentageOfBusinessCombination_pid_dp_uPure_c20220726__20220726__ifrs-full--BusinessCombinationsAxis__custom--LionheartMember__ifrs-full--TypesOfContractsAxis__custom--BusinessCombinationAgreementMember_zk9wnDGiAn1j">97.58</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% redemption and with <span id="xdx_90A_ecustom--RemainingFundsInTrustAccount_pn3n3_c20220726__20220726__ifrs-full--BusinessCombinationsAxis__custom--LionheartMember__ifrs-full--TypesOfContractsAxis__custom--BusinessCombinationAgreementMember_zmejnE9tHIQ6">3,061 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">remaining funds in the trust account. The transaction cost amounted to <span id="xdx_903_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pn3n3_c20220726__20220726__ifrs-full--BusinessCombinationsAxis__custom--LionheartMember__ifrs-full--TypesOfContractsAxis__custom--BusinessCombinationAgreementMember_zAAvcEpRziQg">17,300</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the 12 months ended December 31, 2022, the Company incurred operating losses and negative cash flows from operating activities. The Company has not yet generated significant revenues. As discussed in Note 12, during the fourth quarter of 2022 the Company entered into binding loan agreements with existing shareholders. As discussed in Note 24 (4), the Company executed an equity line agreement. The Company has also the ability to decrease its expenses in order to meet its existing cash flow streams. Management believes that the proceeds from the recent funding agreements, combined with its cash on hand, equity line and the Company’s plans, are sufficient to meet the Company’s obligations as they come due in the foreseeable future. There are no assurances, however, that the Company will be able to obtain an adequate level of financial resources that are required for its long-term business plan.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_89D_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_zjqW5hHGeqF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zOO48uwfaW1e">SCHEDULE OF COMPANIES SUBSIDIARIES</span></span></p> 0.9758 3061000 17300000 <p id="xdx_80D_ecustom--DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_z4VyS6JDETTi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – <span id="xdx_821_zk3lJQCieyY9">SIGNIFICANT ACCOUNTING POLICIES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The significant accounting policies followed in the preparation of the financial statements, on a consistent basis, are:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_841_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zmOj35XaPLUa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_861_zYDNYFgn8Q4d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis of preparation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). The financial statements have been prepared under the historical cost convention except for certain financial liabilities which are measured at fair value until conversion. The Company has elected to present the statement of comprehensive income using the function of expense method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--PrinciplesOfConsolidationExplanatory_zTXNmVnBjY9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_864_zVX8TQJFGma7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principles of consolidation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements incorporate the assets and liabilities of all subsidiaries of Security Matters Limited as of December 31, 2022 and 2021 and the results of all subsidiaries for the three years in the period then ended. Security Matters Limited and its subsidiaries together are referred to in these financial statements as the Group or the “consolidated entity”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is obtained by the Company and until the date that control is lost.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intercompany transactions between entities in the consolidated entity are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of the impairment of the asset transferred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_848_ecustom--DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_ztrMa3dscoh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86B_zVq0SChf4RZj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting Estimates and Assumptions</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities and expenses. These estimates and underlying assumptions are reviewed regularly. Changes in accounting estimates are reported in the period of the change in estimate. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements, are disclosed in note 3.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_z69J4TMTqKbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span id="xdx_86E_z2eM7UnjnYz9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash and cash equivalents</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash equivalents are considered by the Group to be highly liquid investments, including, inter alia, short-term deposits with banks and the maturity of which do not exceed three months at the time of deposit, and which are not restricted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zRB5KX1e5w58" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_865_z0MxhYpLxIOj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign currency</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements are prepared in US Dollars which is the presentation currency of the Group. Security Matters Limited’s functional currency is Australian Dollars.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The functional currency of Security Matters Ltd. (Israel) is New Israeli Shekels. The functional currency of Security Matters Canada Ltd. Is Canadian Dollars. The functional currency of Security Matters France Ltd. Is Euro. The functional currency of SMX Beverages Pty Ltd. Is Australian Dollars.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting Standard (IAS) 21 (“The Effects of Changes in Foreign Exchange Rates”). Accordingly, transactions and balances have been converted as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.7pt; text-align: justify; text-indent: -14.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities – at the rate of exchange applicable at the reporting date;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense items – at annual average rate at the statements of financial position date. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share capital, capital reserve and other capital movement items were at rate of exchange as of the date of recognition of those items.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned above.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange gains and losses from the aforementioned conversion are recognized in the statement of other comprehensive lose in Foreign Currency Translation Reserve.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForInvestmentInAssociates_zE1YwqopBTbj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span id="xdx_865_zRDkqfEtHEy7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investments in associated companies</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in associated companies are accounted under the equity method and are initially recognized at cost. The investment’s cost includes transaction costs. The consolidated financial statements include the Group’s share in net income or loss, in other comprehensive income or loss, and in the net assets of associated companies accounted by the equity method from the date when significant influence or joint control materialized, until the date on which the conditions for significant influence or joint control are no longer met.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Losses of an associate in amounts which exceed its equity are recognized by the Company to the extent of its investment in the associate plus any losses that the Company may incur as a result of a guarantee or other financial support provided in respect of the associate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zOlFZ4JcEAi8" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_868_zCDkgqerI14f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss per share</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic loss per share</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Basic loss per share is calculated by dividing the net loss attributable to the owners of Security Matters Limited, by the weighted average number of ordinary shares outstanding during the financial year, adjusted for bonus elements in ordinary shares issued during the financial year</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted earnings per share</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Potential ordinary shares are included in the computation of diluted earnings per share when their conversion decreases earnings per share. Potential Ordinary shares that are converted during the period are included in diluted earnings per share only until the conversion date and from that date in basic earnings per share. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForGovernmentGrants_zuURK8dUmOL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_860_zszKg2XaGpDd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governmental grants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants received for the use of research and development activities, for which the Group undertook to pay royalties to the state, contingent on future sales arising from this financing, were treated as forgivable loans. The grant was recognized as a liability in the financial statements, except when there is reasonable assurance that the Group will comply with the conditions for the forgiveness of the loan, then it would be recognized as a government grant. When the loan bears a below-market rate of interest, the liability is recognized at its fair value in accordance with the market interest rate prevailing at the time of receiving the grant. The difference between the consideration received and the liability recognized at inception was treated as a government grant and recognized as a reimbursement of research expenses. The repayment of the liability to the state is reviewed every reporting period, with changes in the liability resulting from a change in the expected royalties recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_zEjcM85A6Zz" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_866_z4cAkgtb2GL1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair value measurement</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is the price that would be received when selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the principal market for the asset or liability; or</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the absence of a principal market, in the most advantageous market for the asset or liability.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The principal or the most advantageous market must be accessible to the Group.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_zY6k3cjPTyU" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_860_znsdv9lU5aH8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification of financial instruments by fair value hierarchy</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial instruments presented in the statements of financial position at fair value are grouped into classes with similar characteristics using the following fair value hierarchy which is determined based on the source of input used in measuring fair value:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs other than quoted prices included within Level 1 that are observable either directly or indirectly.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_zPTelSge5LX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_868_zNE1XhWX4aye" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group classifies its financial assets into one of the following categories, depending on the purpose for which the asset was acquired. The Group’s accounting policy for each category is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other receivables: These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They arise principally through the provision of goods and services, but also incorporate other types of contractual monetary asset. These assets are carried at amortized cost less any provision for impairment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has no financial assets classified at Fair value through profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_zW1nsOLqLxwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_862_zY3UvVOVFWQ2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial liabilities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>financial liabilities measured at amortized cost:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, which ensures that any interest expense over the period is at a constant interest rate on the balance of the liability carried in the statement of financial position, except for</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>measured at fair value through profit or loss:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These financial liabilities comprise of derivatives that are options which are to be settled in equity instruments but nevertheless do not meet the definitions of equity instrument. At initial recognition, the Group measures those financial liabilities at fair value. Transaction costs are recognized in profit or loss. After initial recognition, changes in fair value are recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_zmLs4pxn3AFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86F_zggT8hiFf6Tb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment of financial assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group recognizes a loss allowance for expected credit losses on financial assets which are either measured at amortized cost or fair value through other comprehensive income. The measurement of the loss allowance depends upon the Group’s assessment at the end of each reporting period as to whether the financial instrument’s credit risk has increased significantly since initial recognition, based on reasonable and supportable information that is available, without undue cost or effort to obtain.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where there has not been a significant increase in exposure to credit risk since initial recognition, a 12-month expected credit loss allowance is estimated. This represents a portion of the asset’s lifetime expected credit losses that is attributable to a default event that is possible within the next 12 months. Where a financial asset has become credit impaired or where it is determined that credit risk has increased significantly, the loss allowance is based on the asset’s lifetime expected credit losses. The amount of expected credit loss recognized is measured on the basis of the probability weighted present value of anticipated cash shortfalls over the life of the instrument discounted at the original effective interest rate. The loss allowance is recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_zQqDz2IQ9OMk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_860_zj5oW0cMvhQf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment of non-financial assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets that have an indefinite useful life are not subject to amortization and are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired. Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount. Recoverable amount is the higher of an asset’s fair value less costs of disposal and value-in-use. The value-in-use is the present value of the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_z15ZSL4XTf84" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_862_ziUjCNLWqJN7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property, plant and equipment</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items of property, plant and equipment are initially recognized at cost. Cost includes directly attributable costs and the estimated present value of any future costs of dismantling and removing items. Depreciation is computed by the straight-line method, based on the estimated useful lives of the assets, as follows:</span></p> <p id="xdx_89A_ecustom--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory_zXlyIQF833w7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_ztnVr45ncep" style="display: none">SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span id="xdx_904_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zW2TtsXojyB5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machines and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zG7WZu5iK1C2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and office equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zMyKSl9mosl5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zi1VLUTvAXUd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_zkxA0lBuyOod" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements are depreciated over the term of the expected lease including optional extension, or the estimated useful lives of the improvements, whichever is shorter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_zg5lI3UPJS75" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86F_zQhgWddmiz4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reimbursement of research and development expenses</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimbursements in proof of concept (POC) agreements of expenditures on research and development in order to achieve commercial agreement once this activity will be result successful, are offset in profit or loss against the related expenses (research and development expenses). Any IP generated from this activity remains at the ownership of the Group.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_847_ecustom--DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_zRxQe3ACh3b9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_861_zCXrsHZvcfK" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Right-of-use assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All leases are accounted for by recognizing a right-of-use asset and a lease liability, excluding leases where the lease term is 12 months or less, or where the underlying asset is of low-value. These leases expenditures are recognized on a straight-line basis over the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A right-of-use asset is recognized at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of any lease incentives received.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever is the shorter. Where the Group expects to obtain ownership of the leased asset at the end of the lease term, the depreciation is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_z2DIT5MeRE4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_866_zGOgwoliGo86" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease liabilities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All leases are accounted for by recognizing a right-of-use asset and a lease liability. Lease liabilities are measured at the present value of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the rate implicit in the lease unless (as is typically the case) this is not readily determinable, in which case the Group’s incremental borrowing rate on commencement of the lease is used. Variable lease payments are only included in the measurement of the lease liability if they depend on an index or rate. In such cases, the initial measurement of the lease liability assumes the variable element will remain unchanged throughout the lease term. Other variable lease payments are expensed in the period to which they relate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On initial recognition, the carrying value of the lease liability also includes:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amounts expected to be payable under any residual value guarantee.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the exercise price of any purchase option granted in favor of the Group if it is reasonably certain to exercise that option.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any penalties payable for terminating the lease, if the term of the lease has been estimated on the basis of termination option being exercised.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent to initial measurement lease liabilities increase as a result of interest charged at a constant rate on the balance outstanding and are reduced for lease payments made. Lease liabilities are remeasured when there is a change in future lease payments arising from a change in an index or rate or when there is a change in the assessment of the term of any lease the remeasurement being recognized in front of the right of use assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84E_eifrs-full--DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_ztttQi0tt4e7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86D_zc3lLVilGkA7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employee benefits</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has several employee benefit plans as to Israeli employees:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term employee benefits: Short-term employee benefits include salaries, paid annual leave, paid sick leave, recreation and social security contributions and are recognized as expenses as the services are rendered. A liability in respect of a cash bonus or a profit-sharing plan is recognized when the Group has a legal or constructive obligation to make such payment as a result of past service rendered by an employee and a reliable estimate of the amount can be made.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-employment benefits: The plans are normally financed by contributions to insurance companies and classified as defined contribution plans or as defined benefit plans. The Group has defined for most of its employees contribution plans pursuant to Section 14 to the Israel Severance Pay Law since 2004 under which the Group pays fixed contributions and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient amounts to pay all employee benefits relating to employee service in the current and prior periods.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contributions to the defined contribution plan in respect of severance or retirement pay are recognized as an expense simultaneously with receiving the employee’s services and no additional provision is required in the financial statements except for the unpaid contribution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_z6Pbsq0ElOxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86E_zgPQbIQtdhjj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets include capitalized technology development costs. Expenditures on research activities are recognized in profit or loss as incurred. Expenditures on internally developed products are mainly employee salaries and legal fees for filing of patents and are capitalized when the Group demonstrates all the following criteria:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The technical feasibility of completing the intangible asset so that it will be available for use or sale.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The intention to complete the intangible asset and use or sell it.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ability to use or sell the intangible asset.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The probability of the intangible asset to generate future economic benefits. Among other things, the Group considers the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ability to measure reliably the expenditures attributable to the intangible asset during its development.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The recognition criteria above are considered by the Group at each stage of development to determine when the criteria have been initially met in full.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The technical feasibility criteria is determined to be met when the milestone of initial marking and reading capabilities is satisfied. The milestone’s identification occurs only following a detailed broad mapping of the raw material characteristics and establishing the formula for the chemical marker architecture to be embedded into the raw material based on industry standards and regulations. The result is the initial evidence that the x-ray algorithm of the designated reader is in a stage that can identify the marker and convey information. At this stage, the Group believes that the technical feasibility of completing the development for use is probable.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group notes that technical feasibility has been established and the achieved technology is ready for the next stage which consists of performing a proof-of-concept pilot with an industry partner, in order to adapt the technology for the relevant industry and adjust the development to meet the industry’s needs.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Currently, the Group’s capitalized development activities focus on:</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">1.</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Development of marker architecture to be embedded topically or in-situ (application) for each material/product within the optimal industrial manufacturing phase, based on industry standards and regulations.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">2.</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Semi Industrial scale – technology implementation in semi-industrial production.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">3.</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Development of a digital platform to support the end-to-end traceability from raw material to final product to recycling.</span></td></tr> </table> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group’s management has the full intention to complete the development of the technology and ultimately to sell it. This intention is demonstrated by initiating partnerships with industry market leaders and continuing the development into the next phase. The Group’s intention is also reflected in the Group’s approved budget.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group’s management intends to concentrate its future sales and marketing efforts in the U.S. market, including recruitment of sales and marketing personnel. It plans to advance successful proof-of-concept pilots performed with industry leading partners, and further advance its innovative technology and commercialization efforts and collaborations in the segments relevant to its technology.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group’s business model targets leading brands and manufacturers in order to create a new market standard for circular economy solutions, brand authentication and supply chain integrity. The Group’s technology is applicable for multiple industries such as gold, fashion, electronics and circular economy – plastic and rubber. The Group is able to provide an adaptive solution for multiple market segments, based on a unified technology solution, through collaborative relationships with leading market companies which provide it with access to various potential entities to sell its solution. This is part of the Group’s strategy to create strategic partnerships with market leaders across its main segments of activity. The Group believes that this close collaboration with market leaders, and developing a product that meets their requests, suggest that there is a strong potential market for its development.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible assets (Cont.)</b></span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Adequate technical and financial resources are available to complete the development; the development will be completed by the Group’s technology team which consists of professional experienced scientists and engineers, with a track record in the industrial sector and with financial resources successfully raised through the issuance of ordinary shares and loans. The Group has already accomplished its core technology development and is currently focused on development of specific adjustments for different market segments. This stage is focused and short-termed, therefore, management believes that limited financial resources are required for completing the development and that there is high probability for commencing commercial agreements following the successful proof-of-concept pilots.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group has financial systems in place that allow it to maintain records in sufficient detail that enable it to measure reliably the expenditures attributable to the intangible asset during its development.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Development expenditures not satisfying all the above criteria are recognized in the consolidated statement of comprehensive income as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsequent measurement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">In subsequent periods, capitalized development expenditures are measured at cost less accumulated amortization and accumulated impairment losses.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">An asset is ready for its intended use, when the developed technology becomes operational and the Group completes an initial customization for a client’s specific needs, which means that the technology is fully implemented in the customer’s manufacturing processes and ready for its intended use. The management estimates that in approximately two years such customization will be completed, and amortization will commence.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Intangible assets with a finite useful life are amortized over their estimated useful lives and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for intangible assets are reviewed at least at each year end.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The carrying amount of these assets is reviewed whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. An expenditure incurred in development activities, including the Group’s software development is capitalized only where it clearly increases the economic benefits to be derived from the asset to which it relates, the expenditure will lead to new or substantially improved products, the products are technically and commercially feasible and the Group has sufficient resources to complete the development and reach the stage for which the product is ready for use.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">All other expenditure, including those incurred in order to maintain an intangible assets current level of performance, is expensed as incurred.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zVDa2wj2WqTa" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_863_zFfeGfeCNSQ4" style="font: normal 10pt Times New Roman, Times, Serif"><b>Share-based compensation</b></span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group measures the share-based expense and the cost of equity-settled transactions with employees and service providers by reference to the fair value of the equity instruments at the date at which they are granted. The Group selected the Black-Scholes model as the Group’s option pricing model to estimate the fair value of the Group’s options awards. The model is based on share price, grant date and on assumptions regarding expected volatility, expected life of the options, expected dividend, and a no risk interest rate. As for granted options which are settled in equity instruments, the fair value of the options at the grant date is charged to the statement of comprehensive loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting period is based on the number of options that eventually vest.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84D_ecustom--DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsNotYetEffectiveExplanatory_zNHcZ3qA8OTe" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_864_zWs0N0TILJyg" style="font: normal 10pt Times New Roman, Times, Serif"><b>New standards, interpretations and amendments not yet effective</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective. There are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future accounting periods that the Group has decided not to adopt early.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following amendments are effective for the period beginning January 1, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2);</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definition of Accounting Estimates (Amendments to IAS 8); and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred Tax Related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following amendments are effective for the period beginning January 1, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IFRS 16 Leases (Amendment – Liability in a Sale and Leaseback)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IAS 1 Presentation of Financial Statements (Amendment – Classification of Liabilities as Current or Non-current)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IAS 1 Presentation of Financial Statements (Amendment – Non-current Liabilities with Covenants)</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group is currently assessing the impact of these new accounting standards and amendments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group does not expect any other standards issued by the IASB, but not yet effective, to have a material impact on the Group.</span></p> <p id="xdx_85B_z9sZT4d6pNHg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_841_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zmOj35XaPLUa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_861_zYDNYFgn8Q4d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basis of preparation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). The financial statements have been prepared under the historical cost convention except for certain financial liabilities which are measured at fair value until conversion. The Company has elected to present the statement of comprehensive income using the function of expense method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--PrinciplesOfConsolidationExplanatory_zTXNmVnBjY9i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_864_zVX8TQJFGma7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principles of consolidation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements incorporate the assets and liabilities of all subsidiaries of Security Matters Limited as of December 31, 2022 and 2021 and the results of all subsidiaries for the three years in the period then ended. Security Matters Limited and its subsidiaries together are referred to in these financial statements as the Group or the “consolidated entity”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiaries are all those entities over which the Company has control. The Company controls an entity when it is exposed to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its power to direct the activities of the entity. Subsidiaries are fully consolidated from the date on which control is obtained by the Company and until the date that control is lost.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intercompany transactions between entities in the consolidated entity are eliminated. Unrealized losses are also eliminated unless the transaction provides evidence of the impairment of the asset transferred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_848_ecustom--DescriptionOfOtherAccountingPoliciesRelevantToUnderstandingOfFinancialStatements_ztrMa3dscoh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86B_zVq0SChf4RZj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Accounting Estimates and Assumptions</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities and expenses. These estimates and underlying assumptions are reviewed regularly. Changes in accounting estimates are reported in the period of the change in estimate. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements, are disclosed in note 3.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_z69J4TMTqKbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span id="xdx_86E_z2eM7UnjnYz9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cash and cash equivalents</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash equivalents are considered by the Group to be highly liquid investments, including, inter alia, short-term deposits with banks and the maturity of which do not exceed three months at the time of deposit, and which are not restricted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zRB5KX1e5w58" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_865_z0MxhYpLxIOj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign currency</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements are prepared in US Dollars which is the presentation currency of the Group. Security Matters Limited’s functional currency is Australian Dollars.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The functional currency of Security Matters Ltd. (Israel) is New Israeli Shekels. The functional currency of Security Matters Canada Ltd. Is Canadian Dollars. The functional currency of Security Matters France Ltd. Is Euro. The functional currency of SMX Beverages Pty Ltd. Is Australian Dollars.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting Standard (IAS) 21 (“The Effects of Changes in Foreign Exchange Rates”). Accordingly, transactions and balances have been converted as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.7pt; text-align: justify; text-indent: -14.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets and liabilities – at the rate of exchange applicable at the reporting date;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense items – at annual average rate at the statements of financial position date. </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share capital, capital reserve and other capital movement items were at rate of exchange as of the date of recognition of those items.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned above.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange gains and losses from the aforementioned conversion are recognized in the statement of other comprehensive lose in Foreign Currency Translation Reserve.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForInvestmentInAssociates_zE1YwqopBTbj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span id="xdx_865_zRDkqfEtHEy7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investments in associated companies</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in associated companies are accounted under the equity method and are initially recognized at cost. The investment’s cost includes transaction costs. The consolidated financial statements include the Group’s share in net income or loss, in other comprehensive income or loss, and in the net assets of associated companies accounted by the equity method from the date when significant influence or joint control materialized, until the date on which the conditions for significant influence or joint control are no longer met.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Losses of an associate in amounts which exceed its equity are recognized by the Company to the extent of its investment in the associate plus any losses that the Company may incur as a result of a guarantee or other financial support provided in respect of the associate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_zOlFZ4JcEAi8" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_868_zCDkgqerI14f" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss per share</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic loss per share</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Basic loss per share is calculated by dividing the net loss attributable to the owners of Security Matters Limited, by the weighted average number of ordinary shares outstanding during the financial year, adjusted for bonus elements in ordinary shares issued during the financial year</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Diluted earnings per share</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Potential ordinary shares are included in the computation of diluted earnings per share when their conversion decreases earnings per share. Potential Ordinary shares that are converted during the period are included in diluted earnings per share only until the conversion date and from that date in basic earnings per share. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForGovernmentGrants_zuURK8dUmOL" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_860_zszKg2XaGpDd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Governmental grants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants received for the use of research and development activities, for which the Group undertook to pay royalties to the state, contingent on future sales arising from this financing, were treated as forgivable loans. The grant was recognized as a liability in the financial statements, except when there is reasonable assurance that the Group will comply with the conditions for the forgiveness of the loan, then it would be recognized as a government grant. When the loan bears a below-market rate of interest, the liability is recognized at its fair value in accordance with the market interest rate prevailing at the time of receiving the grant. The difference between the consideration received and the liability recognized at inception was treated as a government grant and recognized as a reimbursement of research expenses. The repayment of the liability to the state is reviewed every reporting period, with changes in the liability resulting from a change in the expected royalties recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_zEjcM85A6Zz" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_866_z4cAkgtb2GL1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fair value measurement</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is the price that would be received when selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the principal market for the asset or liability; or</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the absence of a principal market, in the most advantageous market for the asset or liability.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The principal or the most advantageous market must be accessible to the Group.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory_zY6k3cjPTyU" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_860_znsdv9lU5aH8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Classification of financial instruments by fair value hierarchy</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial instruments presented in the statements of financial position at fair value are grouped into classes with similar characteristics using the following fair value hierarchy which is determined based on the source of input used in measuring fair value:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs other than quoted prices included within Level 1 that are observable either directly or indirectly.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs that are not based on observable market data (valuation techniques which use inputs that are not based on observable market data).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_zPTelSge5LX" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_868_zNE1XhWX4aye" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group classifies its financial assets into one of the following categories, depending on the purpose for which the asset was acquired. The Group’s accounting policy for each category is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other receivables: These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They arise principally through the provision of goods and services, but also incorporate other types of contractual monetary asset. These assets are carried at amortized cost less any provision for impairment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has no financial assets classified at Fair value through profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_zW1nsOLqLxwb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_862_zY3UvVOVFWQ2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial liabilities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>financial liabilities measured at amortized cost:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities are initially recognized at fair value less transaction costs that are directly attributable to the issue of the financial liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After initial recognition, the Group measures all financial liabilities at amortized cost using the effective interest rate method, which ensures that any interest expense over the period is at a constant interest rate on the balance of the liability carried in the statement of financial position, except for</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>measured at fair value through profit or loss:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These financial liabilities comprise of derivatives that are options which are to be settled in equity instruments but nevertheless do not meet the definitions of equity instrument. At initial recognition, the Group measures those financial liabilities at fair value. Transaction costs are recognized in profit or loss. After initial recognition, changes in fair value are recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfFinancialAssetsExplanatory_zmLs4pxn3AFi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86F_zggT8hiFf6Tb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment of financial assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group recognizes a loss allowance for expected credit losses on financial assets which are either measured at amortized cost or fair value through other comprehensive income. The measurement of the loss allowance depends upon the Group’s assessment at the end of each reporting period as to whether the financial instrument’s credit risk has increased significantly since initial recognition, based on reasonable and supportable information that is available, without undue cost or effort to obtain.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where there has not been a significant increase in exposure to credit risk since initial recognition, a 12-month expected credit loss allowance is estimated. This represents a portion of the asset’s lifetime expected credit losses that is attributable to a default event that is possible within the next 12 months. Where a financial asset has become credit impaired or where it is determined that credit risk has increased significantly, the loss allowance is based on the asset’s lifetime expected credit losses. The amount of expected credit loss recognized is measured on the basis of the probability weighted present value of anticipated cash shortfalls over the life of the instrument discounted at the original effective interest rate. The loss allowance is recognized in profit or loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84C_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory_zQqDz2IQ9OMk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_860_zj5oW0cMvhQf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Impairment of non-financial assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets that have an indefinite useful life are not subject to amortization and are tested annually for impairment, or more frequently if events or changes in circumstances indicate that they might be impaired. Other non-financial assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount. Recoverable amount is the higher of an asset’s fair value less costs of disposal and value-in-use. The value-in-use is the present value of the estimated future cash flows relating to the asset using a pre-tax discount rate specific to the asset or cash-generating unit to which the asset belongs. Assets that do not have independent cash flows are grouped together to form a cash-generating unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_843_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_z15ZSL4XTf84" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_862_ziUjCNLWqJN7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Property, plant and equipment</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Items of property, plant and equipment are initially recognized at cost. Cost includes directly attributable costs and the estimated present value of any future costs of dismantling and removing items. Depreciation is computed by the straight-line method, based on the estimated useful lives of the assets, as follows:</span></p> <p id="xdx_89A_ecustom--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory_zXlyIQF833w7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_ztnVr45ncep" style="display: none">SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span id="xdx_904_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zW2TtsXojyB5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machines and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zG7WZu5iK1C2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and office equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zMyKSl9mosl5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zi1VLUTvAXUd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_zkxA0lBuyOod" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements are depreciated over the term of the expected lease including optional extension, or the estimated useful lives of the improvements, whichever is shorter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89A_ecustom--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentDepreciationRateExplanatory_zXlyIQF833w7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B9_ztnVr45ncep" style="display: none">SCHEDULE OF DEPRECIATION RATES OF PROPERTY, PLANT AND EQUIPMENT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span id="xdx_904_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zW2TtsXojyB5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machines and equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zG7WZu5iK1C2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and office equipment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zMyKSl9mosl5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eifrs-full--DepreciationRatePropertyPlantAndEquipment_pid_dp_uPure_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zi1VLUTvAXUd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 0.33 0.20 0.10 0.05 <p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_zg5lI3UPJS75" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86F_zQhgWddmiz4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reimbursement of research and development expenses</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimbursements in proof of concept (POC) agreements of expenditures on research and development in order to achieve commercial agreement once this activity will be result successful, are offset in profit or loss against the related expenses (research and development expenses). Any IP generated from this activity remains at the ownership of the Group.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_847_ecustom--DescriptionOfAccountingPolicyForRightOfUseAssetsExplanatory_zRxQe3ACh3b9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_861_zCXrsHZvcfK" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Right-of-use assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All leases are accounted for by recognizing a right-of-use asset and a lease liability, excluding leases where the lease term is 12 months or less, or where the underlying asset is of low-value. These leases expenditures are recognized on a straight-line basis over the lease term.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A right-of-use asset is recognized at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date net of any lease incentives received.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever is the shorter. Where the Group expects to obtain ownership of the leased asset at the end of the lease term, the depreciation is over its estimated useful life. Right-of use assets are subject to impairment or adjusted for any remeasurement of lease liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_z2DIT5MeRE4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_866_zGOgwoliGo86" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease liabilities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All leases are accounted for by recognizing a right-of-use asset and a lease liability. Lease liabilities are measured at the present value of the contractual payments due to the lessor over the lease term, with the discount rate determined by reference to the rate implicit in the lease unless (as is typically the case) this is not readily determinable, in which case the Group’s incremental borrowing rate on commencement of the lease is used. Variable lease payments are only included in the measurement of the lease liability if they depend on an index or rate. In such cases, the initial measurement of the lease liability assumes the variable element will remain unchanged throughout the lease term. Other variable lease payments are expensed in the period to which they relate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On initial recognition, the carrying value of the lease liability also includes:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">amounts expected to be payable under any residual value guarantee.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the exercise price of any purchase option granted in favor of the Group if it is reasonably certain to exercise that option.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any penalties payable for terminating the lease, if the term of the lease has been estimated on the basis of termination option being exercised.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent to initial measurement lease liabilities increase as a result of interest charged at a constant rate on the balance outstanding and are reduced for lease payments made. Lease liabilities are remeasured when there is a change in future lease payments arising from a change in an index or rate or when there is a change in the assessment of the term of any lease the remeasurement being recognized in front of the right of use assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84E_eifrs-full--DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_ztttQi0tt4e7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86D_zc3lLVilGkA7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employee benefits</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has several employee benefit plans as to Israeli employees:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term employee benefits: Short-term employee benefits include salaries, paid annual leave, paid sick leave, recreation and social security contributions and are recognized as expenses as the services are rendered. A liability in respect of a cash bonus or a profit-sharing plan is recognized when the Group has a legal or constructive obligation to make such payment as a result of past service rendered by an employee and a reliable estimate of the amount can be made.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-employment benefits: The plans are normally financed by contributions to insurance companies and classified as defined contribution plans or as defined benefit plans. The Group has defined for most of its employees contribution plans pursuant to Section 14 to the Israel Severance Pay Law since 2004 under which the Group pays fixed contributions and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient amounts to pay all employee benefits relating to employee service in the current and prior periods.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contributions to the defined contribution plan in respect of severance or retirement pay are recognized as an expense simultaneously with receiving the employee’s services and no additional provision is required in the financial statements except for the unpaid contribution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_z6Pbsq0ElOxg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_86E_zgPQbIQtdhjj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets include capitalized technology development costs. Expenditures on research activities are recognized in profit or loss as incurred. Expenditures on internally developed products are mainly employee salaries and legal fees for filing of patents and are capitalized when the Group demonstrates all the following criteria:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The technical feasibility of completing the intangible asset so that it will be available for use or sale.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The intention to complete the intangible asset and use or sell it.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ability to use or sell the intangible asset.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">d.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The probability of the intangible asset to generate future economic benefits. Among other things, the Group considers the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">e.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">f.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ability to measure reliably the expenditures attributable to the intangible asset during its development.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The recognition criteria above are considered by the Group at each stage of development to determine when the criteria have been initially met in full.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The technical feasibility criteria is determined to be met when the milestone of initial marking and reading capabilities is satisfied. The milestone’s identification occurs only following a detailed broad mapping of the raw material characteristics and establishing the formula for the chemical marker architecture to be embedded into the raw material based on industry standards and regulations. The result is the initial evidence that the x-ray algorithm of the designated reader is in a stage that can identify the marker and convey information. At this stage, the Group believes that the technical feasibility of completing the development for use is probable.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group notes that technical feasibility has been established and the achieved technology is ready for the next stage which consists of performing a proof-of-concept pilot with an industry partner, in order to adapt the technology for the relevant industry and adjust the development to meet the industry’s needs.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Currently, the Group’s capitalized development activities focus on:</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">1.</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Development of marker architecture to be embedded topically or in-situ (application) for each material/product within the optimal industrial manufacturing phase, based on industry standards and regulations.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">2.</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Semi Industrial scale – technology implementation in semi-industrial production.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">3.</span></td> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Development of a digital platform to support the end-to-end traceability from raw material to final product to recycling.</span></td></tr> </table> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group’s management has the full intention to complete the development of the technology and ultimately to sell it. This intention is demonstrated by initiating partnerships with industry market leaders and continuing the development into the next phase. The Group’s intention is also reflected in the Group’s approved budget.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group’s management intends to concentrate its future sales and marketing efforts in the U.S. market, including recruitment of sales and marketing personnel. It plans to advance successful proof-of-concept pilots performed with industry leading partners, and further advance its innovative technology and commercialization efforts and collaborations in the segments relevant to its technology.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group’s business model targets leading brands and manufacturers in order to create a new market standard for circular economy solutions, brand authentication and supply chain integrity. The Group’s technology is applicable for multiple industries such as gold, fashion, electronics and circular economy – plastic and rubber. The Group is able to provide an adaptive solution for multiple market segments, based on a unified technology solution, through collaborative relationships with leading market companies which provide it with access to various potential entities to sell its solution. This is part of the Group’s strategy to create strategic partnerships with market leaders across its main segments of activity. The Group believes that this close collaboration with market leaders, and developing a product that meets their requests, suggest that there is a strong potential market for its development.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible assets (Cont.)</b></span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Adequate technical and financial resources are available to complete the development; the development will be completed by the Group’s technology team which consists of professional experienced scientists and engineers, with a track record in the industrial sector and with financial resources successfully raised through the issuance of ordinary shares and loans. The Group has already accomplished its core technology development and is currently focused on development of specific adjustments for different market segments. This stage is focused and short-termed, therefore, management believes that limited financial resources are required for completing the development and that there is high probability for commencing commercial agreements following the successful proof-of-concept pilots.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group has financial systems in place that allow it to maintain records in sufficient detail that enable it to measure reliably the expenditures attributable to the intangible asset during its development.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Development expenditures not satisfying all the above criteria are recognized in the consolidated statement of comprehensive income as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Subsequent measurement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">In subsequent periods, capitalized development expenditures are measured at cost less accumulated amortization and accumulated impairment losses.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">An asset is ready for its intended use, when the developed technology becomes operational and the Group completes an initial customization for a client’s specific needs, which means that the technology is fully implemented in the customer’s manufacturing processes and ready for its intended use. The management estimates that in approximately two years such customization will be completed, and amortization will commence.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Intangible assets with a finite useful life are amortized over their estimated useful lives and reviewed for impairment whenever there is an indication that the asset may be impaired. The amortization period and the amortization method for intangible assets are reviewed at least at each year end.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The carrying amount of these assets is reviewed whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. An expenditure incurred in development activities, including the Group’s software development is capitalized only where it clearly increases the economic benefits to be derived from the asset to which it relates, the expenditure will lead to new or substantially improved products, the products are technically and commercially feasible and the Group has sufficient resources to complete the development and reach the stage for which the product is ready for use.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">All other expenditure, including those incurred in order to maintain an intangible assets current level of performance, is expensed as incurred.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zVDa2wj2WqTa" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_863_zFfeGfeCNSQ4" style="font: normal 10pt Times New Roman, Times, Serif"><b>Share-based compensation</b></span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: normal 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group measures the share-based expense and the cost of equity-settled transactions with employees and service providers by reference to the fair value of the equity instruments at the date at which they are granted. The Group selected the Black-Scholes model as the Group’s option pricing model to estimate the fair value of the Group’s options awards. The model is based on share price, grant date and on assumptions regarding expected volatility, expected life of the options, expected dividend, and a no risk interest rate. As for granted options which are settled in equity instruments, the fair value of the options at the grant date is charged to the statement of comprehensive loss over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting period is based on the number of options that eventually vest.</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_84D_ecustom--DescriptionOfAccountingPolicyNewStandardsInterpretationsAndAmendmentsNotYetEffectiveExplanatory_zNHcZ3qA8OTe" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_864_zWs0N0TILJyg" style="font: normal 10pt Times New Roman, Times, Serif"><b>New standards, interpretations and amendments not yet effective</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective. There are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future accounting periods that the Group has decided not to adopt early.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following amendments are effective for the period beginning January 1, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2);</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definition of Accounting Estimates (Amendments to IAS 8); and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred Tax Related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following amendments are effective for the period beginning January 1, 2024:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IFRS 16 Leases (Amendment – Liability in a Sale and Leaseback)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IAS 1 Presentation of Financial Statements (Amendment – Classification of Liabilities as Current or Non-current)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IAS 1 Presentation of Financial Statements (Amendment – Non-current Liabilities with Covenants)</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group is currently assessing the impact of these new accounting standards and amendments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group does not expect any other standards issued by the IASB, but not yet effective, to have a material impact on the Group.</span></p> <p id="xdx_80A_eifrs-full--DisclosureOfAccountingJudgementsAndEstimatesExplanatory_zlFrrvKqbsre" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_82C_z7hLQic6Ha38">CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the process of applying the significant accounting policies, the Group has made the following judgments which have the most significant effect on the amounts recognized in the financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements requires management to make estimates and assumptions that have an effect on the application of the accounting policies and on the reported amounts of assets, liabilities, revenues and expenses. Changes in accounting estimates are reported in the period of the change in estimate. The key assumptions made in the financial statements are discussed below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share based payments </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has a share-based remuneration scheme for employees. The fair value of share options is estimated by using the Black-Scholes model, which was derived to model the value of the firm’s equity over time. The simulation model was designed to take into account the unique terms and conditions of the performance shares and share options, as well as the capital structure of the firm and the volatility of its assets, on the date of grant based on certain assumptions. Those conditions are described in the share-based compensation note and include, among others, the dividend growth rate, expected share price volatility and expected life of the options. The fair value of the equity settled options granted is charged to statement of profit or loss over the vesting period of each tranche and the credit is taken to equity, based on the consolidated entity’s estimate of shares that will eventually vest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible assets</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group capitalizes costs for its developed projects when specific criteria are met. Initial capitalization of costs is based on management’s judgement that technological and economic feasibility is achievable, usually when a product development project has reached a defined milestone according to an established project management model. The management makes assumptions regarding the expected future economic benefit to be derived from the intangible asset and therefore whether the capitalized costs are expected to be recovered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This amount of capitalized costs includes significant investment in the development of marking and reading capabilities in the subject material. Prior to being marketed, the Group will obtain a proof-of-concept pilot with an industry leading partner. The innovative nature of the product gives rise to some judgement as to whether the proof-of-concept will be successful such that it will lead to obtaining commercial contracts with customers. See also Note 2 – Intangible Assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Management bases its estimates on historical experience, assumptions, and information currently available and deemed to be reasonable at the time the financial statements are prepared. However, actual amounts may differ from the estimated amounts as more detailed information becomes available. Estimates and assumptions are reviewed on an ongoing basis and, if necessary, changes are recognized in the period in which the estimate is revised.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial liability at fair value</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of financial liabilities at fair value was estimated by using a Black Scholes model and Monte-Carlo simulation approach, which was aimed to model the value of the Company’s assets over time. The simulation approach was designed to take into account the terms and conditions financial liability, which are described in Note 12 and Note 23, as well as the capital structure of the Company and the volatility of its assets. The valuation was performed based on management’s assumptions and projections.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_806_eifrs-full--DisclosureOfOtherCurrentAssetsExplanatory_zduYWGjo0iVh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_82B_zoWgq32VQpHi">OTHER CURRENT ASSETS</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p id="xdx_894_ecustom--DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory_zhH7gAQNIj48" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span id="xdx_8B8_zTYfW7ccU9Mg" style="display: none">SCHEDULE OF OTHER CURRENT ASSETS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20221231_zCZ64DrfkzRl" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20211231_zmMBk9Gl6pXh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--CurrentPrepaymentsAndOtherCurrentAssets_iI_maTAORzn6p_znbQQGuFqche" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses <span id="xdx_F4C_zQ3ezaJEkwM2">(*)</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,157</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">454</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--CurrentValueAddedTaxReceivables_iI_maTAORzn6p_zpCdi2gvmi66" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax authorities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">358</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_ecustom--ProofOfConceptReceivablesCurrent_iI_maTAORzn6p_zSmWTKUKtmWa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proof of concept receivables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--OtherCurrentFinancialAssets_iI_maTAORzn6p_z1QF5JRZoQ1c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--OtherCurrentAssets_iTI_mtTAORzn6p_zIUYzCFuXYic" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,673</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">920</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F01_zbChPBfjSEPk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1F_zzSbYV4ZkhLb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The prepaid expenses include </span><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9USEVSIFJFQ0VJVkFCTEVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eifrs-full--CurrentPrepaidExpenses_iI_c20221231__ifrs-full--BusinessCombinationsAxis__custom--SpecialPurposeAcquisitionCompanyMember_zeouT5icDO74" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,123 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for December 31, 2022, which related to the anticipated SPAC transaction costs (refer to Note 1).</span></td> </tr></table> <p id="xdx_8AD_zr8rLDO8iQy2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_894_ecustom--DisclosureOfDetailedInformationAboutOtherCurrentAssetsExplanatory_zhH7gAQNIj48" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span id="xdx_8B8_zTYfW7ccU9Mg" style="display: none">SCHEDULE OF OTHER CURRENT ASSETS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20221231_zCZ64DrfkzRl" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20211231_zmMBk9Gl6pXh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--CurrentPrepaymentsAndOtherCurrentAssets_iI_maTAORzn6p_znbQQGuFqche" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses <span id="xdx_F4C_zQ3ezaJEkwM2">(*)</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,157</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">454</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--CurrentValueAddedTaxReceivables_iI_maTAORzn6p_zpCdi2gvmi66" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax authorities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">358</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_ecustom--ProofOfConceptReceivablesCurrent_iI_maTAORzn6p_zSmWTKUKtmWa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proof of concept receivables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--OtherCurrentFinancialAssets_iI_maTAORzn6p_z1QF5JRZoQ1c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--OtherCurrentAssets_iTI_mtTAORzn6p_zIUYzCFuXYic" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,673</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">920</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F01_zbChPBfjSEPk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1F_zzSbYV4ZkhLb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The prepaid expenses include </span><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9USEVSIFJFQ0VJVkFCTEVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_901_eifrs-full--CurrentPrepaidExpenses_iI_c20221231__ifrs-full--BusinessCombinationsAxis__custom--SpecialPurposeAcquisitionCompanyMember_zeouT5icDO74" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,123 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for December 31, 2022, which related to the anticipated SPAC transaction costs (refer to Note 1).</span></td> </tr></table> 3157000 454000 358000 280000 86000 116000 72000 70000 3673000 920000 3123000 <p id="xdx_80B_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zu6VIzGL4Flj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_822_zAgNoZzSNmMj">PROPERTY AND EQUIPMENT, NET</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p id="xdx_89A_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_zqbDxA1oHikf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B0_zLb4r9L6d0Oe" style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machines and Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Office Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use assets</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziS8CdRSQNx8" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjP1DwPT0GU9" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,233</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoCFpTc1iGX6" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zG3RiVa12xh3" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTSvjk3XPcS7" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">628</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zr7ZztWwyyFf" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,124</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zW9zpdM9LQy4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0701">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHMEgmyYAi5d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZRbPYRymy05" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0705">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKK4LVU0Dnx3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zd1h2bNCMuGg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEZybKJXepIi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">201</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zV5qv6lfFxMg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPNgr7N18hhg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUojLErkH5tk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVzTFIeaXwr3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">202</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zP3mVwexM7h2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5DywDRcnkD5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxxMG31sM6Ri" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1SU4JfzcoPe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsPLc25Rkngb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zBpt37sCgqJc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(221</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8i3XOipSsi1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8ERyR7FNrR9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zj09UTwJZ78e" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(64</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztRcdW0sDQQi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(335</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQexwA7Lpki9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEvrSPBOGuKl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,147</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzzN7EMRKikf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbyVdjcA8po4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zq0b05ookZU2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">592</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znnstfGYMPdh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,969</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zMjHPRMbRNWi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zqhFWh1zWxl2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">645</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zgvTTKbvSErf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zkmkV01IcaNj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zyB4xT847MRb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zbELHxFCFj6g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">932</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zmA06BV4XMei" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zkgGBG7Rdpnl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">202</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z0dOkxCExL9i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zv12hWsx5wj7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zf7SGdD0T9j4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zSeNu4mic0b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_ziOgXQdENNmh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zGmEJiskmoxj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(148</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zEttMzQdKXi2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zQjgxlXEO5J6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z0X0ZIQBgMgg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zgNV39eklA01" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(203</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zZpbUpWsZXF6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zfDgV5LZeC26" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">699</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z6pJnV9d24y2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zziFVfmi6xzb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z4X3CV0DMEJg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">178</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_znUthABACw9a" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value at December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zd8speBfid16" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zH1wCiu6wNTi" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">448</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zVQ34n5m5Iu6" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z5yMrMCW0ak7" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember_zNnSWt9zmwQ1" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20221231_z2Gdq03JVknj" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">969</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machines and Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Office Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use assets</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="22" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKax7l0M9xNh" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMrXl3q31Iub" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">847</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfrBaFkSH0Oc" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zGPbgbn8TQHl" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNnACa4HN927" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">606</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zddnSGFmdVlh" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,667</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcxTQ4O1ngFd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfFwVikS6oEa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">275</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zE7Z9lRfZ1oj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHzJ1wAnKrKh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjX8uS4toit" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0833">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zncs4VG4WTKa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">297</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zYpkBaq5Jtnb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zSzRfymJaPfe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">187</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zOgAHu32YWme" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEIdhm5IEy04" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzWMgy5lj9I" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zDSIjRdZNfW6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXBHq9RQep8e" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5YvqI1wmqv6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zIcpytqt68tj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvCMYIEoSsz1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMO2kO5rAW29" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1YAhmMLOxi7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcYxRJfeVuyk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMGOmhB59DPi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,233</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ze88tuuZxVW" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRLz1zxalZak" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKDSkCLj0Ci4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">628</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKqZJuVOW0eh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,124</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_znv3t8Aq4TTk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zQMMXsTCp9vb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">399</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zNrfcUzN1gbl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zFfBJToq4mZ2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zK3ilnOmtvsj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zjNt2Fgm32u5" style="margin: 0" title="Property and equipment, beginning balance">569</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zTMP5DiYfsK" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z0muRFKDMtle" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">187</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zdTKrGvDMmWk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zVmO8R7de1E" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z6dbRbQIQBK6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zvaokWi4cmV4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_za9Mksn146ck" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z5NTRjkVn6zk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z4GwrlCQ2je6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zqnW9L3iUtge" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zQ8TcCopWF0g" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zcJG2qUfEiJi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zfAmGIaTeb8e" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zFnSFpqIlrTc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">645</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zybP8D3mpIra" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zeQrDmPhCSVb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z1XBCgCN8v3i" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_ztkqP9bXsN5j" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">932</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zC8epc81NVUd" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_z7BJyWQ0Tc37" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">588</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zyEtWgpiScYk" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zhT8nxZvH7Dd" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember_zdvrCZT78Zld" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20211231_zwFVH6Jc21Tf" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,192</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A1_zkfwnuq6nZO3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89A_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_zqbDxA1oHikf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B0_zLb4r9L6d0Oe" style="display: none">SCHEDULE OF PROPERTY, PLANT AND EQUIPMENT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machines and Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Office Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use assets</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziS8CdRSQNx8" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjP1DwPT0GU9" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,233</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zoCFpTc1iGX6" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zG3RiVa12xh3" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTSvjk3XPcS7" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">628</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zr7ZztWwyyFf" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,124</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zW9zpdM9LQy4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0701">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHMEgmyYAi5d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zZRbPYRymy05" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0705">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKK4LVU0Dnx3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zd1h2bNCMuGg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEZybKJXepIi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">201</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zV5qv6lfFxMg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_ecustom--DeductionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPNgr7N18hhg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deductions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUojLErkH5tk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVzTFIeaXwr3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">202</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zP3mVwexM7h2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5DywDRcnkD5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxxMG31sM6Ri" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1SU4JfzcoPe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsPLc25Rkngb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zBpt37sCgqJc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(221</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8i3XOipSsi1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8ERyR7FNrR9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zj09UTwJZ78e" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(64</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ztRcdW0sDQQi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(335</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQexwA7Lpki9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEvrSPBOGuKl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,147</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzzN7EMRKikf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbyVdjcA8po4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zq0b05ookZU2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">592</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znnstfGYMPdh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,969</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zMjHPRMbRNWi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zqhFWh1zWxl2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">645</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zgvTTKbvSErf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zkmkV01IcaNj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zyB4xT847MRb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zbELHxFCFj6g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">932</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zmA06BV4XMei" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zkgGBG7Rdpnl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">202</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z0dOkxCExL9i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zv12hWsx5wj7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zf7SGdD0T9j4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zSeNu4mic0b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_ziOgXQdENNmh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zGmEJiskmoxj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(148</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zEttMzQdKXi2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zQjgxlXEO5J6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z0X0ZIQBgMgg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zgNV39eklA01" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(203</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zZpbUpWsZXF6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zfDgV5LZeC26" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">699</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z6pJnV9d24y2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zziFVfmi6xzb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z4X3CV0DMEJg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">178</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_znUthABACw9a" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value at December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zd8speBfid16" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_zH1wCiu6wNTi" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">448</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zVQ34n5m5Iu6" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z5yMrMCW0ak7" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember_zNnSWt9zmwQ1" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20221231_z2Gdq03JVknj" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">969</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Leasehold improvements</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machines and Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Office Equipment</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Computers</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right of use assets</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="22" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 40%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKax7l0M9xNh" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">69</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMrXl3q31Iub" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">847</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfrBaFkSH0Oc" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">73</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zGPbgbn8TQHl" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNnACa4HN927" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">606</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zddnSGFmdVlh" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,667</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcxTQ4O1ngFd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfFwVikS6oEa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">275</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zE7Z9lRfZ1oj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHzJ1wAnKrKh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjX8uS4toit" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0833">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zncs4VG4WTKa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">297</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zYpkBaq5Jtnb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zSzRfymJaPfe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">187</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zOgAHu32YWme" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zEIdhm5IEy04" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzWMgy5lj9I" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zDSIjRdZNfW6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXBHq9RQep8e" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5YvqI1wmqv6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zIcpytqt68tj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvCMYIEoSsz1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMO2kO5rAW29" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z1YAhmMLOxi7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">160</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcYxRJfeVuyk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">81</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMGOmhB59DPi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,233</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ze88tuuZxVW" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRLz1zxalZak" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKDSkCLj0Ci4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">628</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKqZJuVOW0eh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,124</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_znv3t8Aq4TTk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zQMMXsTCp9vb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">399</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zNrfcUzN1gbl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zFfBJToq4mZ2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zK3ilnOmtvsj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iS_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zjNt2Fgm32u5" style="margin: 0" title="Property and equipment, beginning balance">569</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zTMP5DiYfsK" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z0muRFKDMtle" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">187</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zdTKrGvDMmWk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zVmO8R7de1E" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z6dbRbQIQBK6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zvaokWi4cmV4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_za9Mksn146ck" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z5NTRjkVn6zk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z4GwrlCQ2je6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zqnW9L3iUtge" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zQ8TcCopWF0g" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zcJG2qUfEiJi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Currency translation adjustments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">76</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zfAmGIaTeb8e" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zFnSFpqIlrTc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">645</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zybP8D3mpIra" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_zeQrDmPhCSVb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_z1XBCgCN8v3i" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">162</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationMember_ztkqP9bXsN5j" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">932</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value at December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zC8epc81NVUd" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MachineryMember_z7BJyWQ0Tc37" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">588</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureAndOfficeEquipmentMember_zyEtWgpiScYk" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zhT8nxZvH7Dd" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--RightofuseAssetsMember_zdvrCZT78Zld" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iE_pn3n3_c20211231_zwFVH6Jc21Tf" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Property and equipment, ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,192</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 81000 1233000 83000 99000 628000 2124000 135000 17000 49000 201000 -21000 -21000 4000 202000 7000 19000 39000 271000 -18000 -221000 -18000 -14000 -64000 -335000 63000 1147000 65000 102000 592000 1969000 20000 645000 33000 72000 162000 932000 4000 202000 7000 19000 39000 271000 -6000 -148000 -9000 -17000 -23000 -203000 18000 699000 31000 74000 178000 1000000 45000 448000 34000 28000 414000 969000 69000 847000 73000 72000 606000 1667000 3000 275000 1000 18000 297000 5000 187000 7000 16000 72000 287000 9000 111000 9000 9000 22000 160000 81000 1233000 83000 99000 628000 2124000 13000 399000 23000 49000 85000 569000 5000 187000 7000 16000 72000 287000 2000 59000 3000 7000 5000 76000 20000 645000 33000 72000 162000 932000 61000 588000 50000 27000 466000 1192000 <p id="xdx_804_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_z1myXPWy1z05" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – <span>CONVERTIBLE NOTE</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_82A_zt2nIPeYCBPh">CONVERTIBLE NOTES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2022, the Company issued <span id="xdx_902_ecustom--NumberOfConvertibleNotesIssued_c20220501__20220531_zEtOAG3r6pYb">828,240</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">convertible notes (the “Convertible Notes”), with a face value of AUD <span id="xdx_901_ecustom--FaceValueOfConvertibleNotes_iI_pn3n3_uAUD_c20220531_zR4xuoxVdUZe">1</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(USD <span id="xdx_90C_ecustom--FaceValueOfConvertibleNotes_iI_pn2n3_c20220531_zusPMUlES8Ug">0.7</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) per each Convertible Note, for an aggregate amount of AUD <span id="xdx_909_eifrs-full--IssueOfConvertibleInstruments_pn3n3_uAUD_c20220501__20220531_zrQYrhVAjWy1">828 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">thousand (<span id="xdx_906_eifrs-full--IssueOfConvertibleInstruments_pn3n3_uUSD_c20220501__20220531_z4cS7nJN70V5">569</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">). The Convertible Notes have a maturity date of <span id="xdx_90A_ecustom--ConvertibleNotesMaturityPeriod_dxL_c20220501__20220531_zmiRHQyBpbF6" title="::XDX::P6M"><span style="-sec-ix-hidden: xdx2ixbrl0939">six months</span></span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">from issuance date. The conversion price is as follows: <span id="xdx_906_ecustom--ConvertibleNoteConversionPriceDescription_c20220501__20220531_zLoqUHmKcK78">(i) if the Company executes a binding agreement for an M&amp;A transaction or receives USD $20 million or more in return for the issuance of shares on or before December 31, 2022, the principal amount of each Convertible Note will automatically be converted into shares in the Company. The issuance price per share will be calculated at a 20% discount to the higher of the offer price or price paid by the investors participating in the qualified transaction, as such term is defined in the Convertible Notes agreement, subject to a floor cap of no lower than AUD 0.15 (USD 0.11) per share. In July 2022, the Company entered into a Business Combination Agreement that will be subject to de-listing of the Company’s ordinary share capital from the Australian Stock Exchange following receiving an Australian court approval of the future merger (ii) if the Company has not executed a binding agreement for a qualified transaction until December 31, 2022, the Convertible Notes balance will automatically convert into ordinary shares at that date. The issuance price per share will be calculated at a 20% discount to the 5-21 day volume weighted average price to December 31, 2022, as such term is defined in the Convertible Notes agreement, subject to a cap of no lower than AUD 0.15 (USD 0.11) per share, and on December 31, 2022 the investors will also be issued unlisted two year options on a 1:2 basis with an exercise price of AUD 0.45 (USD 0.32) per share</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. As of December 31, 2022, the Convertible Note amounted to <span id="xdx_90F_ecustom--ConvertibleNote_iI_pn3n3_c20221231_zc6tLPY3oemk" title="Convertible note">563</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2022, an amendment to the Convertible Notes agreements was signed between the Company and the investors which prescribes a cancellation of the Convertible Notes and replacing them with the issuance of <span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pid_c20220731__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNotesAgreementsMember_zfiOnQSCsg49">1,000,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares of the Company (with the occurrence of the Business Combination).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 7, 2023, the Convertible Notes were converted to <span id="xdx_90B_ecustom--ConvertibleNotesConveredIntoOrdinaryShares_iI_pid_c20230307__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__ifrs-full--MajorOrdinaryShareTransactionsMember_ziBzfy47kqvf">1,000,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 828240 1000 700 828000 569000 (i) if the Company executes a binding agreement for an M&A transaction or receives USD $20 million or more in return for the issuance of shares on or before December 31, 2022, the principal amount of each Convertible Note will automatically be converted into shares in the Company. The issuance price per share will be calculated at a 20% discount to the higher of the offer price or price paid by the investors participating in the qualified transaction, as such term is defined in the Convertible Notes agreement, subject to a floor cap of no lower than AUD 0.15 (USD 0.11) per share. In July 2022, the Company entered into a Business Combination Agreement that will be subject to de-listing of the Company’s ordinary share capital from the Australian Stock Exchange following receiving an Australian court approval of the future merger (ii) if the Company has not executed a binding agreement for a qualified transaction until December 31, 2022, the Convertible Notes balance will automatically convert into ordinary shares at that date. The issuance price per share will be calculated at a 20% discount to the 5-21 day volume weighted average price to December 31, 2022, as such term is defined in the Convertible Notes agreement, subject to a cap of no lower than AUD 0.15 (USD 0.11) per share, and on December 31, 2022 the investors will also be issued unlisted two year options on a 1:2 basis with an exercise price of AUD 0.45 (USD 0.32) per share 563000 1000000 1000000 <p id="xdx_80C_ecustom--DisclosureOfInvestmentInAssociatedCompaniesExplanatory_z6K7AxEl4yl4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_823_zs2EqcxrfZ3d">INVESTMENTS IN ASSOCIATED COMPANIES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zOOfpf1o2og7">SCHEDULE OF INVESTMENTS IN ASSOCIATED COMPANIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entity </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Incorporation</b></p></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0; text-align: center"><b>December 31, 2022</b></p></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 22%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0; text-align: center"><b>December 31, 2021</b></p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yahaloma Technologies Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eifrs-full--CountryOfIncorporation_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zjKDRLeONoD6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zNCWZc6pUSG6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--YahalomaTechnologiesIncMember_zLlMfxeFJJqc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">True Gold Consortium Pty Ltd</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_eifrs-full--CountryOfIncorporation_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--TrueGoldConsortiumPtyLtdMember_z7BvsUIRtRkj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--TrueGoldConsortiumPtyLtdMember_zEKIdfSMAqdg" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44.4</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--TrueGoldConsortiumPtyLtdMember_zamWfnUdx9Uh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45.5</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX Beverages Pty Ltd</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90C_eifrs-full--CountryOfIncorporation_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--SMXBeveragesPtyLtdMember_zLOnVxn8Fnej" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--SMXBeveragesPtyLtdMember_zmiH7OvFPSBh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInAssociatesAxis__custom--SMXBeveragesPtyLtdMember_z5r5KfFjoLM8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> <p id="xdx_8A8_zfqjHVKbJRvf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The proportion of ownership interest is equal to the proportion of voting power held.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – INVESTMENTS IN ASSOCIATED COMPANIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Yahaloma Technologies Inc</span><b>.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2019, Security Matters Ltd. Signed an agreement with Trifecta Industries Inc. (“Trifecta”) for the commercialization of Security Matters Ltd.’s trace technology in the diamonds and precious stone industry.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of the agreement, Security Matters Ltd. And Trifecta established a new entity – Yahaloma Technologies Inc. (“Yahaloma”), which is equally held by Security Matters Limited and Trifecta.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yahaloma will have the exclusive rights and responsibility to commercialize the Group’s intellectual property in the area of diamonds or precious stone. Management has assessed the transaction and reached the conclusion that the new entity is jointly controlled by Security Matters Limited and Trifecta. Management has further determined that the contractual arrangement provides the parties to the joint arrangement with rights to the net assets of the arrangement. The contractual arrangement establishes each party’s share in the profit or loss relating to the activities of the arrangement. The arrangement is a joint venture and the Company’s interests in this joint venture is accounted for using the equity method of accounting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">SMX Beverages Pty Ltd</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 10, 2020, the Company signed an agreement with Global BevCo Pty Ltd. (“Global BevCo”), an Australian company for the commercialization of Group’s trace technology in the alcoholic beverages industry. Under the terms of the agreement, the Company and Global BevCo established a new private entity, SMX Beverages Pty Ltd (“SMX-B”), which is equally held by the above two-mentioned entities. The Company has the exclusive rights and responsibility to commercialize the Group’s intellectual property in the area of alcoholic beverages.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The joint arrangement is a joint venture and the Company’s interests in its associate is accounted for using the equity method of accounting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 24, 2021, the Company signed an agreement with Global BevCo to acquire the remaining <span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInJointVenture_dp_uPure_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zqk5gTdNWmD6">50</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% shares in SMX-B in exchange for <span id="xdx_902_ecustom--SharesIssuedForExerciseOfStockOptionsShares_pid_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zYOk3SDJS5vi" title="Exercise of stock options shares">8,000,001 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options of the Company at exercise price of AUD <span id="xdx_90B_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_uAUDPShares_c20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zpZuSqN0lgLh">0.4</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, with an expiration date of <span id="xdx_908_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zyPOLiba4fGh" title="Weighted average remaining contractual life of outstanding share options">March 25, 2027</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. Total fair value is AUD <span id="xdx_90E_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_uAUD_c20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zPY1Ad7MqBp3">960,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(USD <span id="xdx_906_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_uUSD_c20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_z79yoLoeQ6Qf">721,424</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">), and the acquisition was settled on March 25, 2022. The Company assigned the consideration to technology license intellectual property. The total fair value of the options was determined according to Black &amp; Scholes model, free rate interest of <span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zgqSPlNhgoM9" title="Description of risk free interest rate percentage">2.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, expected life <span id="xdx_900_ecustom--OptionsExpectedLife_dtY_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zc34bL9KVdcl" title="Options expected life">5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years. The acquisition agreement also provides a five-year consulting agreement to Global BevCo including AUD <span id="xdx_901_ecustom--ConsultingFees_uAUD_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--GlobalBevCoPtyLtdMember__ifrs-full--TypesOfContractsAxis__custom--ConsultingAgreementMember_z1R1lLJairJ3" title="Consulting fees">13,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per month and a <span id="xdx_901_eifrs-full--PercentageOfEntitysRevenue_pid_dp_uPure_c20211223__20211224__ifrs-full--JointVenturesAxis__custom--GlobalBevCoPtyLtdMember__ifrs-full--TypesOfContractsAxis__custom--ConsultingAgreementMember_zsMRKFlzYt7j" title="Percentage of entitys revenue">5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% revenue share for referred clients.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">True Gold Consortium Pty Ltd</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 29, 2020, the Company signed a shareholders’ agreement with W.A. Mint Pty Ltd. And True Gold Consortium Pty Ltd. (“True Gold”). The purpose of the agreement is to set the framework for True Gold’s activity. True Gold’s goal is to establish an industry standard with the development of an innovative system that can mark (at a molecular level), track and trace gold bars and gold through every stage of the supply chain with blockchain technology. Under the terms of the agreement, True Gold will be equally held by the above two-mentioned entities, with the goal of adding other shareholders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s management has assessed the transaction and reached the conclusion that the new entity is jointly controlled by Security Matters Limited, and W.A. Mint Pty Ltd. The Company’s management has further determined that the contractual arrangement provides the parties to the joint arrangement with rights to the net assets of the arrangement. The contractual arrangement establishes each party’s share in the profit or loss relating to the activities of the arrangement. The arrangement is a joint venture and the Company’s interests in this joint venture is accounted for using the equity method of accounting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – INVESTMENTS IN ASSOCIATED COMPANIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eifrs-full--DisclosureOfInformationAboutConsolidatedStructuredEntitiesExplanatory_zPLFprd2JqNc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reconciliation of the consolidated entity’s carrying amount</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 35.45pt 0pt 7.1pt; text-align: justify; text-indent: 0in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BA_zBLZ0bQiWA88">SCHEDULE OF INFORMATION ABOUT CONSOLIDATED STRUCTURED ENTITIES</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20221231_zDZ7037mctvb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20211231_z7ts5vDUBwVb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20201231_zsFWmlCqyy2f" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--InvestmentsInSubsidiariesJointVenturesAndAssociates_iI_pn3n3_hifrs-full--CategoriesOfFinancialAssetsAxis__custom--SecurityMattersLimitedsShareOfNetAssetsMember_zTtQnNFCBNH3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters Limited’s share of net assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">248</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">249</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_ecustom--InvestmentInSubsidiariesJointVenturesAndAssociates_iNI_di_hifrs-full--CategoriesOfFinancialAssetsAxis__custom--CompanysShareInNetProfitsLossesOfAssociatedCompaniesMember_ztuLXCgFV8S4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company’s share in net profits (losses) of associated companies</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(101</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_406_eifrs-full--InvestmentsInSubsidiariesJointVenturesAndAssociates_iI_zrndMwt4fpTj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing carrying amount</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Closing carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">221</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">147</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">248</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_z1l2FUAS2kP5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> Canada 0.50 0.50 Australia 0.444 0.455 Australia 1 0.50 0.50 8000001 0.4 2027-03-25 960000 721424 0.025 P5Y 13500 0.05 <p id="xdx_899_eifrs-full--DisclosureOfInformationAboutConsolidatedStructuredEntitiesExplanatory_zPLFprd2JqNc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reconciliation of the consolidated entity’s carrying amount</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 35.45pt 0pt 7.1pt; text-align: justify; text-indent: 0in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BA_zBLZ0bQiWA88">SCHEDULE OF INFORMATION ABOUT CONSOLIDATED STRUCTURED ENTITIES</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20221231_zDZ7037mctvb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49F_20211231_z7ts5vDUBwVb" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20201231_zsFWmlCqyy2f" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--InvestmentsInSubsidiariesJointVenturesAndAssociates_iI_pn3n3_hifrs-full--CategoriesOfFinancialAssetsAxis__custom--SecurityMattersLimitedsShareOfNetAssetsMember_zTtQnNFCBNH3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters Limited’s share of net assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">248</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">249</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_ecustom--InvestmentInSubsidiariesJointVenturesAndAssociates_iNI_di_hifrs-full--CategoriesOfFinancialAssetsAxis__custom--CompanysShareInNetProfitsLossesOfAssociatedCompaniesMember_ztuLXCgFV8S4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company’s share in net profits (losses) of associated companies</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(101</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_406_eifrs-full--InvestmentsInSubsidiariesJointVenturesAndAssociates_iI_zrndMwt4fpTj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing carrying amount</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Closing carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">221</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">147</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">248</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 115000 248000 249000 -106000 101000 1000 221000 147000 248000 <p id="xdx_806_eifrs-full--DisclosureOfIntangibleAssetsExplanatory_zmLUm508z5ih" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span id="xdx_825_zRR1i2gWvH0l" style="text-transform: uppercase">INTANGIBLE ASSETS, NET</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></b></p> <p id="xdx_89A_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_zY2vByxMzivf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B0_zeXYNGHKxFy">SUMMARY OF INTANGIBLE ASSETS NET</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_4BC_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--CapitalisedDevelopmentExpenditureMember_z5uVJXry63ug" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_4B2_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--LicencesMember_zjRJRlX0j4db" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_4B1_znkIKiO7JtG6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization of</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">development cost</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">license</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COST</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43A_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_z8UFwrPNq4ij" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0992">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_436_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_zU2EolsH9gFh" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cost, beginning balance</td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0996">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkMQqW99HDt4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized development cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">975</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">721</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,696</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2nYBjwWJ0Wg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(66</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(566</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_430_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_z7Z99YPosW2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,499</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,154</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_435_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_zAVz9oRyXqr2" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cost, ending balance</td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,499</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,154</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43B_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zyOvVsdmRXrf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1016">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_438_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zF7HcStoF8ki" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1020">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zYk9iRfk6yW4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1024">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zAmcpOk8VWg9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1028">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_43A_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_z4fTmsYRRWvh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1032">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43F_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zqXa4lMrJVxi" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, ending balances</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1036">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_430_c20220101__20221231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zO3yaP1GTMV5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value as of December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,372</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,027</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20220101__20221231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zSY7vXOPHvu2" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,372</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,027</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span style="text-transform: uppercase">Intangible assets, NET</span> (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_4B6_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--CapitalisedDevelopmentExpenditureMember_zNQOfYKTykG8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization of development cost</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COST</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_zcMePQLSSl9f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,332</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43D_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_zzJvfa44SSTg" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,332</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxeT4x1D9aj3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized development cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,468</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR8teRkWOmBa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">224</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43D_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_z7dLTY8FG4Y7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43E_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_zZcb7KxF4Dm1" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_435_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zxBjCzROn3Ca" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_z6wpRYC5ynnd" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_z5PTq1RbtDre" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_430_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zJCWlkmr1zDb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43F_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_z7aWDChDAufe" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_438_c20210101__20211231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zofeFBRpO2b8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value as of December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,908</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43C_c20210101__20211231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_ziZAEoK5TFH" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,908</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A8_zS7FCFfebMi2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An intangible asset at the amount of <span id="xdx_904_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_c20220101__20221231_zBrsdHUvTjn6">145 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">is being amortized, the amortization completed by December 31, 2022. The rest of the intangible asset balance has not yet been amortized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets as of December 31, 2022, consist of capitalized technology development costs of the Group’s core technology as well as the cost of the exclusive license intellectual property (<span id="xdx_901_eifrs-full--IntangibleAssetsUnderDevelopment_iI_c20221231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--OtherIntangibleAssetsMember__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_zNeJreh4gHRb">721</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) which includes the addition amount as a result of the acquisition of additional <span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInJointVenture_dp_c20220101__20221231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--OtherIntangibleAssetsMember__ifrs-full--JointVenturesAxis__custom--SMXBeveragesPtyLtdMember_znQmNsYXQw5k">50</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% interest in SMX Beverages Pty Ltd (Note 7). The acquired rights have not yet commenced amortization as the license was not yet commenced usage.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89A_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_zY2vByxMzivf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B0_zeXYNGHKxFy">SUMMARY OF INTANGIBLE ASSETS NET</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_4BC_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--CapitalisedDevelopmentExpenditureMember_z5uVJXry63ug" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_4B2_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--LicencesMember_zjRJRlX0j4db" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_4B1_znkIKiO7JtG6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization of</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">development cost</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">license</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COST</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43A_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_z8UFwrPNq4ij" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0992">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_436_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_zU2EolsH9gFh" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cost, beginning balance</td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0996">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkMQqW99HDt4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized development cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">975</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">721</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,696</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z2nYBjwWJ0Wg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(66</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(566</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_430_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_z7Z99YPosW2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,499</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,154</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_435_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_zAVz9oRyXqr2" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Cost, ending balance</td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,499</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,154</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43B_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zyOvVsdmRXrf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1016">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_438_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zF7HcStoF8ki" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1020">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zYk9iRfk6yW4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1024">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_iN_pn3n3_di_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_zAmcpOk8VWg9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1028">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_43A_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_z4fTmsYRRWvh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1032">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43F_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zqXa4lMrJVxi" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, ending balances</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1036">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_430_c20220101__20221231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zO3yaP1GTMV5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value as of December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,372</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,027</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20220101__20221231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zSY7vXOPHvu2" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,372</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,027</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span style="text-transform: uppercase">Intangible assets, NET</span> (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_4B6_ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis_ifrs-full--CapitalisedDevelopmentExpenditureMember_zNQOfYKTykG8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization of development cost</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COST</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_437_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_zcMePQLSSl9f" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,332</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43D_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iS_pn3n3_zzJvfa44SSTg" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,332</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxeT4x1D9aj3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalized development cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,468</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR8teRkWOmBa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency translation adjustments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">224</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43D_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_z7dLTY8FG4Y7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43E_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ecustom--IntangibleAssetsOtherThanGoodwillGross_iE_pn3n3_zZcb7KxF4Dm1" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,024</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_435_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_zxBjCzROn3Ca" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of January 1, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iS_pn3n3_z6wpRYC5ynnd" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">88</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_pn3n3_hifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_z5PTq1RbtDre" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_430_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_zJCWlkmr1zDb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43F_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--AccumulatedDepreciationAmortisationMember_ecustom--AccumulatedDepreciationOfIntangibleAssetsOtherThanGoodwill_iE_pn3n3_z7aWDChDAufe" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_438_c20210101__20211231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_zofeFBRpO2b8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value as of December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,908</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43C_c20210101__20211231_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn3n3_ziZAEoK5TFH" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net book value</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,908</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 4024000 4024000 4024000 4024000 975000 721000 1696000 500000 66000 566000 4499000 655000 5154000 4499000 655000 5154000 116000 116000 116000 116000 14000 14000 3000 3000 127000 127000 127000 127000 4372000 655000 5027000 4372000 655000 5027000 2332000 2332000 1468000 224000 4024000 4024000 88000 88000 28000 116000 116000 3908000 3908000 145000 721 0.50 <p id="xdx_805_eifrs-full--DisclosureOfLeasesExplanatory_zDGreztaQjKk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – <span id="xdx_82A_zKaPUTvplqGb">LEASES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has lease contracts for office facilities (including a lab) and motor vehicles used in its operations. Leases of office and lab facilities generally have lease term of <span id="xdx_90D_ecustom--LeaseExpiration_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OfficeEquipmentMember_zzFbEvc7TTVg" title="Lease expiration">12 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years, motor vehicles generally have lease terms of <span id="xdx_903_ecustom--LeaseExpiration_dtY_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--MotorVehiclesMember_zPWkJtbMSC53" title="Lease expiration">3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock_zPtctZwWqZX7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set out below are the carrying amounts of right-of-use assets recognized and the movements during the period:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zVq36U0Ac7Y">SCHEDULE OF RIGHT OF USE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--OfficeEquipmentMember_zLMHfdblzY3g" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_4B9_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--MotorVehiclesMember_zuDxkdceQNQh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_4BC_z2v5kpkWCoT8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Office and lab</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>facilities</b></p> </td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Motor</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>vehicles</b></span></p> </td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> </td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_430_c20220101__20221231_eifrs-full--RightofuseAssets_iS_zi9b4Cf1SFni" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">446</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43E_c20220101__20221231_eifrs-full--RightofuseAssets_iS_zx7xuWYJUyoe" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">446</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--AdditionsToRightofuseAssets_zsYnhAg5Njle" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1093">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--RightofuseAssetsEffectofForeignExchange_iN_di_zQy2cCq7iAAh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency translation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(41</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_ecustom--DeductionsToRightofuseAssets_iN_di_zYaPDWh5ysue" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_403_eifrs-full--DepreciationRightofuseAssets_iN_di_z0XVXc0g7dUc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1105">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_435_c20220101__20221231_eifrs-full--RightofuseAssets_iE_zmjBTm0OtbWa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1109">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_439_c20220101__20221231_eifrs-full--RightofuseAssets_iE_zdXHDK7QJpJj" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use </span>assets, ending balance</td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1113">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A9_zDL8McnoKLGi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – LEASES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89A_ecustom--DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities_z9RUANzG19Wc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set out below are the carrying amounts of lease liabilities and the movements during the period:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B5_zg0kWGol41j4">SCHEDULE OF LEASE LIABILITY</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_494_20220101__20221231_zUNwOpZOlHu3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_497_20210101__20211231_z2xB3Aq4mx2k" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--LeaseLiabilities_iS_pn3n3_zB34IwirAA6i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1,</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">503</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">589</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--LeaseLiabilities_iS_pn3n3_z0jCubeYNLZi" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">503</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">589</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--AdditionsOfLeaseLiabilities_pn3n3_z9gremJY7Nk4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1125">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--DeductionsInLeaseLiabilities_iN_pn3n3_di_zazsdKGnaH32" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1128">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--LeaseLiabilitiesAccretionofInterest_pn3n3_zb900fWaS1P7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion of interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--LeaseLiabilitiesExchangeRateDifferences_iN_pn3n3_di_zRrzaWOU5ani" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign exchange differences</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(57</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_iN_pn3n3_di_z9ZmajQHBKbk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease Payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(55</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(98</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_401_eifrs-full--LeaseLiabilities_iE_pn3n3_zNLPnDzASU72" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">470</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">503</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--LeaseLiabilities_iE_pn3n3_zsW0A7k0GOid" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">470</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">503</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20221231_zhCw4ngpVaZh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20211231_z6Izn8npg2v2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20221231_zxDX7Lk3UIIb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non current"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">440</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20211231_zWxOOX6ReDac" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non current"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A3_zGEy3SZz6sOf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89F_eifrs-full--DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_zxqjfLEpFQA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following are the amounts recognized in profit or loss:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zSUwPQ52Dsh1">SCHEDULE OF CARRYING AMOUNTS OF LEASE LIABILITIES RECOGNIZED IN PROFIT OR LOSS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_496_20220101__20221231_zH1YCTRtDXDd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49F_20210101__20211231_zRXHsMFi3wKe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--DepreciationRightofuseAssets_pn3n3_zCzpEFhiAOA1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense of right-of-use assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_z2LffivocoQ6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense on lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--LeaseLiabilitiesForeignExchangeDifferences_iN_pn3n3_di_z8PuEjHeH6Hk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign Exchange different</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_404_eifrs-full--ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_pn3n3_zgtGqwki0r7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense relating to short-term leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1164">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1165">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--LeaseRecognizedInProfitOrLoss_iT_pn3n3_zqJ3bdWs5GU9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total amount recognized in profit or loss</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_zMUiP17xC4b5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> P12Y P3Y <p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutRightofuseAssetsTextBlock_zPtctZwWqZX7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set out below are the carrying amounts of right-of-use assets recognized and the movements during the period:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zVq36U0Ac7Y">SCHEDULE OF RIGHT OF USE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--OfficeEquipmentMember_zLMHfdblzY3g" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_4B9_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--MotorVehiclesMember_zuDxkdceQNQh" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_4BC_z2v5kpkWCoT8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Office and lab</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>facilities</b></p> </td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Motor</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>vehicles</b></span></p> </td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> </td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_430_c20220101__20221231_eifrs-full--RightofuseAssets_iS_zi9b4Cf1SFni" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">446</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_43E_c20220101__20221231_eifrs-full--RightofuseAssets_iS_zx7xuWYJUyoe" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use assets, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">446</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--AdditionsToRightofuseAssets_zsYnhAg5Njle" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1093">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--RightofuseAssetsEffectofForeignExchange_iN_di_zQy2cCq7iAAh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign currency translation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(41</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_ecustom--DeductionsToRightofuseAssets_iN_di_zYaPDWh5ysue" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_403_eifrs-full--DepreciationRightofuseAssets_iN_di_z0XVXc0g7dUc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1105">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_435_c20220101__20221231_eifrs-full--RightofuseAssets_iE_zmjBTm0OtbWa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1109">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_439_c20220101__20221231_eifrs-full--RightofuseAssets_iE_zdXHDK7QJpJj" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right-of-use </span>assets, ending balance</td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1113">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">414</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 446000 20000 466000 446000 20000 466000 49000 49000 35000 6000 41000 7000 14000 21000 39000 39000 414000 414000 414000 414000 <p id="xdx_89A_ecustom--DisclosureOfDetailedInformationAboutOperatingLeaseLiabilities_z9RUANzG19Wc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set out below are the carrying amounts of lease liabilities and the movements during the period:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B5_zg0kWGol41j4">SCHEDULE OF LEASE LIABILITY</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_494_20220101__20221231_zUNwOpZOlHu3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_497_20210101__20211231_z2xB3Aq4mx2k" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--LeaseLiabilities_iS_pn3n3_zB34IwirAA6i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At January 1,</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">503</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">589</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--LeaseLiabilities_iS_pn3n3_z0jCubeYNLZi" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability, beginning balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">503</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">589</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--AdditionsOfLeaseLiabilities_pn3n3_z9gremJY7Nk4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1125">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--DeductionsInLeaseLiabilities_iN_pn3n3_di_zazsdKGnaH32" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deductions</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1128">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--LeaseLiabilitiesAccretionofInterest_pn3n3_zb900fWaS1P7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accretion of interest</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--LeaseLiabilitiesExchangeRateDifferences_iN_pn3n3_di_zRrzaWOU5ani" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign exchange differences</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(57</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_iN_pn3n3_di_z9ZmajQHBKbk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease Payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(55</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(98</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_401_eifrs-full--LeaseLiabilities_iE_pn3n3_zNLPnDzASU72" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As at December 31,</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">470</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">503</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--LeaseLiabilities_iE_pn3n3_zsW0A7k0GOid" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability, ending balance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">470</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">503</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20221231_zhCw4ngpVaZh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--CurrentLeaseLiabilities_iI_pn3n3_c20211231_z6Izn8npg2v2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20221231_zxDX7Lk3UIIb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non current"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">440</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NoncurrentLeaseLiabilities_iI_pn3n3_c20211231_zWxOOX6ReDac" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Non current"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">466</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 503000 589000 503000 589000 49000 21000 51000 47000 57000 35000 55000 98000 470000 503000 470000 503000 30000 37000 440000 466000 <p id="xdx_89F_eifrs-full--DisclosureOfAdditionalInformationAboutLeasingActivitiesForLesseeExplanatory_zxqjfLEpFQA2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following are the amounts recognized in profit or loss:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zSUwPQ52Dsh1">SCHEDULE OF CARRYING AMOUNTS OF LEASE LIABILITIES RECOGNIZED IN PROFIT OR LOSS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_496_20220101__20221231_zH1YCTRtDXDd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49F_20210101__20211231_zRXHsMFi3wKe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eifrs-full--DepreciationRightofuseAssets_pn3n3_zCzpEFhiAOA1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense of right-of-use assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eifrs-full--InterestExpenseOnLeaseLiabilities_pn3n3_z2LffivocoQ6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest expense on lease liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--LeaseLiabilitiesForeignExchangeDifferences_iN_pn3n3_di_z8PuEjHeH6Hk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign Exchange different</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_404_eifrs-full--ExpenseRelatingToShorttermLeasesForWhichRecognitionExemptionHasBeenUsed_pn3n3_zgtGqwki0r7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expense relating to short-term leases</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1164">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1165">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--LeaseRecognizedInProfitOrLoss_iT_pn3n3_zqJ3bdWs5GU9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total amount recognized in profit or loss</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">106</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 39000 72000 51000 47000 -16000 35000 106000 84000 <p id="xdx_80B_eifrs-full--DisclosureOfTradeAndOtherPayablesExplanatory_zabRdysxJB5j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 – <span id="xdx_828_zAPxBneveUp7">OTHER PAYABLES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></b></p> <p id="xdx_891_ecustom--DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_zBiDAueFZev2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B5_zQmkv58RzYqd">SCHEDULE OF OTHER PAYABLES</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_497_20221231_zxFKMFG0eyj2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49C_20211231_z8DzHofxGdtf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--ShorttermEmployeeBenefitsAccruals_iI_maTAOPzSMC_zXq5j2h9Sez6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees, salaries and related liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">392</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--TradeAndOtherCurrentPayablesToRelatedParties_iI_maTAOPzSMC_zxfVsEOVdijf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related party</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--LiabilitiesForGrantsReceived_iI_pn3n3_maTAOPzSMC_zzhrEHWKZmR1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities for grants received (Note 19)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--AccrualsClassifiedAsCurrent_iI_maTAOPzSMC_zqJvSVqpgque" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1183">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--CurrentDerivativeFinancialLiabilities_iI_maTAOPzSMC_zDeomqNAxTme" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative financial liability (Note 13)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1186">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--OtherPayables_iI_maTAOPzSMC_z121m74X7GUd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">152</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--OtherCurrentPayables_iI_pn3n3_mtTAOPzSMC_zNO5t2K4xKd1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">650</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">673</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A2_zgs4dCwjirPk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_891_ecustom--DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory_zBiDAueFZev2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B5_zQmkv58RzYqd">SCHEDULE OF OTHER PAYABLES</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_497_20221231_zxFKMFG0eyj2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49C_20211231_z8DzHofxGdtf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--ShorttermEmployeeBenefitsAccruals_iI_maTAOPzSMC_zXq5j2h9Sez6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employees, salaries and related liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">392</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--TradeAndOtherCurrentPayablesToRelatedParties_iI_maTAOPzSMC_zxfVsEOVdijf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related party</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--LiabilitiesForGrantsReceived_iI_pn3n3_maTAOPzSMC_zzhrEHWKZmR1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities for grants received (Note 19)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--AccrualsClassifiedAsCurrent_iI_maTAOPzSMC_zqJvSVqpgque" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1183">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--CurrentDerivativeFinancialLiabilities_iI_maTAOPzSMC_zDeomqNAxTme" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative financial liability (Note 13)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1186">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--OtherPayables_iI_maTAOPzSMC_z121m74X7GUd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">152</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--OtherCurrentPayables_iI_pn3n3_mtTAOPzSMC_zNO5t2K4xKd1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">650</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">673</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 392000 500000 56000 24000 50000 30000 49000 32000 152000 38000 650000 673000 <p id="xdx_808_eifrs-full--DisclosureOfBorrowingsExplanatory_zcwLybxYlW8h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 </b>– <span id="xdx_82D_zsN20WtCoWz"><b>BORROWINGS FROM RELATED PARTIES</b></span></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">In 2015, the Group signed an agreement to receive a loan of ILS <span id="xdx_901_eifrs-full--CashAdvancesAndLoansFromRelatedParties_pn6n6_uILS_c20150101__20151231_zDzYGa0GQLTa">2 </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">million (approximately <span id="xdx_90B_eifrs-full--CashAdvancesAndLoansFromRelatedParties_pn3n3_c20150101__20151231_zZwTY7Ge0kIk">513</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">) from its shareholders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">These loan bears interest at an annual rate of <span id="xdx_90C_eifrs-full--BorrowingsInterestRate_iI_dp_uPure_c20221231_z3UCvIZZgiw5">4</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">%.</span></p> <p id="xdx_896_eifrs-full--DisclosureOfDetailedInformationAboutBorrowingsExplanatory_zpaTui5uu1If" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zy7uSOzwwtK4" style="display: none">SCHEDULE OF BORROWINGS FROM RELATED PARTIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20220101__20221231_zwvg873p3qNj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49D_20210101__20211231_zhUuiEELBpjk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--ShorttermBorrowings_iS_z6YSG5ILRXW4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at January 1,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--ShorttermBorrowings_iS_zpke7nTMHLRl" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings from related parties, beginning balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--CashRepaymentsOfAdvancesAndLoansFromRelatedParties_iN_di_z2pjqGA1c1dg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment of borrowings</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(172</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(103</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_403_ecustom--ProvisionOfBorrowingToRelatedParties_zkB7JZ6oq4zg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision for bonus (include interest)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">621</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_z0K9sn7FxBS8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange rate differences</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--ShorttermBorrowings_iE_zkbNgh4rtW02" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--ShorttermBorrowings_iE_zDjwyHKrDqr4" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings from related parties, ending balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_zbV5nxPvPrh4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In consideration of providing funding as a seed capitalist, the Company agreed to provide, as additional consideration, a bonus payments (the “Bonus Payments”) on the occurrence of an exit or major liquidity event. In any way, the Bonus Payments are capped at ILS <span id="xdx_90E_ecustom--BonusPayments_pn6n6_uILS_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LenderTwoMember_zsye0YcG1ltj">3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (approximately <span id="xdx_909_ecustom--BonusPayments_pn3n3_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LenderTwoMember_zkAygmBomqGe">965</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) per each of the two lenders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Bonus Payments are intended to operate in one of the two trigger events:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">dividend distributions paid by the Company; or</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the sale of shares by a lender in Security Matters Ltd. (either in the event of a takeover or otherwise)</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only if the aggregate amounts of one of the two trigger events exceeds the investment of the lenders in the Company (in a way of loan or shares), then the lender would be entitled the Bonus Payments based on a formula set forth in the agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount of the Bonus Payments is the amount that exceeds the aggregate sum invested in the Company (in a way of loan or shares) by the lender divided by several factors according to the formula as set forth in the agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is no time limit to pay the Bonus Payments. Once the Company has paid each Bonus Payment in its entirety (i.e., the cap of ILS <span id="xdx_909_ecustom--BonusPayments_pn6n6_uILS_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--LenderTwoMember_z8Yy45ds2z2k">3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million has been paid to each Lender), then the Company has fulfilled its obligations. When the Bonus Payments are not expected to be made, the resulting cash flows will not affect profit and loss until the point in which the Company estimates that the liquidity events will take place. As of December 31, 2021, the Company estimated that is more likely than not that the shareholders will sell their shares in 2022 which will entitle them to the Bonus Payments. The amount of the Bonus Payment is subject to assumptions that were made with the assistance of external appraisal. As a result, the increase in the carrying amount of the liability was charged as expense of $<span id="xdx_90A_ecustom--IncreaseInCarryingAmountOfLiability_pn3n3_c20210101__20211231_zkjJ92rXzrsj" title="Carrying amount of liability">87 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to profit and loss in 2021. In August 2022 the loan from related party has been fully repaid. In August 2022, the Company signed an addendum to the loan agreement that reduces the total amount of the Bonus Payments to ILS <span id="xdx_90A_ecustom--BonusPayments_pn5n6_uILS_c20220801__20220831_zuMVn4jfUROg" title="Bonus payments">2.5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (approximately $<span id="xdx_905_ecustom--BonusPayments_pn3n3_c20220801__20220831_zDA1Qtj0KPLi" title="Bonus payments">710</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">), to be paid upon the completion of the business combination (refer also to Note 24 – Subsequent Events). As of December 31, 2022, the Company estimated that is more likely than not that the business combination will be completed in the foreseeable future, as a result, the Company updated the liability according to the addendum which described above, the carrying amount of the liability was increased to $<span id="xdx_907_eifrs-full--ShorttermBorrowings_iI_pn3n3_c20221231_zwQ8unxXURg">710</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and charged as expense of $<span id="xdx_906_ecustom--IncreaseInCarryingAmountOfLiability_pn3n3_c20220101__20221231_zw1eyOJk3NNh" title="Carrying amount of liability">621</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to profit and loss in 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 2000000 513000 0.04 <p id="xdx_896_eifrs-full--DisclosureOfDetailedInformationAboutBorrowingsExplanatory_zpaTui5uu1If" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span><span id="xdx_8BB_zy7uSOzwwtK4" style="display: none">SCHEDULE OF BORROWINGS FROM RELATED PARTIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_496_20220101__20221231_zwvg873p3qNj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49D_20210101__20211231_zhUuiEELBpjk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--ShorttermBorrowings_iS_z6YSG5ILRXW4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at January 1,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--ShorttermBorrowings_iS_zpke7nTMHLRl" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings from related parties, beginning balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--CashRepaymentsOfAdvancesAndLoansFromRelatedParties_iN_di_z2pjqGA1c1dg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment of borrowings</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(172</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(103</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_403_ecustom--ProvisionOfBorrowingToRelatedParties_zkB7JZ6oq4zg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision for bonus (include interest)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">621</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">89</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--GainsLossesOnExchangeDifferencesOnTranslationNetOfTax_z0K9sn7FxBS8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange rate differences</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--ShorttermBorrowings_iE_zkbNgh4rtW02" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance at December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--ShorttermBorrowings_iE_zDjwyHKrDqr4" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings from related parties, ending balance</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 270000 280000 270000 280000 172000 103000 621000 89000 -9000 4000 710000 270000 710000 270000 3000000 965000 3000000 87000 2500000 710000 710000 621000 <p id="xdx_80D_eifrs-full--DisclosureOfDerivativeFinancialInstrumentsExplanatory_zAQF3BtK1Qye" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 – <span id="xdx_824_zqfDAYnU1w7e">BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Between August to December 2022, the Company entered into bridge loan agreements (the “Bridge Loans”) with seven lenders, which lent the Company an aggregate amount of 3,310. The Bridge Loans have a maturity date of up to two years and bears interest rate of 10% per annum. The Bridge Loans were accounted for in accordance with amortized cost method.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 – BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the Bridge Loans agreements, the lenders were granted with three types of warrants:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -17.45pt"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Bonus Warrants – <span id="xdx_902_ecustom--WarrantsToPurchaseShares_pid_c20221001__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--BonusWarrantsMember_zY3nOkYkzrkc" title="Warrants to purchase shares">215,500 </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">warrants to purchase ordinary shares of SMX PLC (refer to Note 1) at an exercise price of USD <span id="xdx_901_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20221001__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--BonusWarrantsMember_z0m6uSFjWgK3">11.50 </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">per share. The Bonus Warrants term is <span id="xdx_907_eifrs-full--BorrowingsMaturity_c20221001__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--BonusWarrantsMember_zBY5AApeOri5">five years</span></span> <span style="font: normal 10pt Times New Roman, Times, Serif">commencing upon the Business Combination (refer to Note 1).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in">Management utilized a third-party appraiser to assist them in valuing the Bonus Warrants. <span style="font: normal 10pt Times New Roman, Times, Serif">The fair value of the Bonus Warrants was calculated using the Black and Scholes model. As of December 31, 2022, the fair value of the Bonus Warrants was <span id="xdx_903_ecustom--FairValueOfWarrants_pn3n3_c20220101__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--BonusWarrantsMember__ifrs-full--MeasurementAxis__custom--BlackAndScholesModelMember_zN1uImYC4VE9" title="Fair value of warrants">24</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -17.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable Warrants Type 1 – <span id="xdx_900_ecustom--WarrantsToPurchaseShares_pid_c20221001__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_zqTyasn73Wq" title="Warrants to purchase shares">342,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants to purchase ordinary shares of SMX PLC (refer to Note 1<b>)</b> at a purchase price of USD <span id="xdx_90B_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20221001__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_zWpWfskMnqPg">11.50 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. The Redeemable Warrants Type 1 term is <span id="xdx_906_eifrs-full--BorrowingsMaturity_c20221001__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_ztGAmyXlVw4f">five years</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencing upon the Business Combination (refer to Note 1<b>)</b>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.45pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_909_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_zsHx5CoQXSal" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.00</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the Business Combination for USD <span id="xdx_904_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20220101__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_zrYBHpmxkvej">5.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 53.45pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_909_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--CreationDateAxis__custom--ThirdAnniversaryMember_zlGstQlP3Di3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.00</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder for the 30 days following the third anniversary of the Business Combination for USD <span id="xdx_90C_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20220101__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--CreationDateAxis__custom--ThirdAnniversaryMember_zBf1UhSlTyke">5.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 53.45pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--CreationDateAxis__custom--FourthAnniversaryMember_zCgk3uEQtGbl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.00</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Redeemable Warrants Type 1 shall be redeemable on a non-cumulative basis at the option of the holder for the 30 days following the fourth anniversary of the Business Combination for USD <span id="xdx_90B_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20220101__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--CreationDateAxis__custom--FourthAnniversaryMember_zhrWFQEIdv1d">5.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span id="xdx_90B_eifrs-full--DescriptionOfApproachUsedToDetermineDiscountRates_c20220101__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember_zVo7CClpkW06" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of SMX PLC based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify">Management utilized a third-party appraiser to assist them in valuing the Redeemable Warrants Type 1. The fair value of the Redeemable Warrants Type 1 was calculated using Monte-Carlo simulation model. As of December 31, 2022, the fair value of the Redeemable Warrants Type 1 was <span id="xdx_904_ecustom--FairValueOfWarrants_pn3n3_c20220101__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeOneMember__ifrs-full--MeasurementAxis__custom--MonteCarloSimulationModelMember_zSde6GZm4cq2" title="Fair value of warrants">1,973</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -17.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable Warrants Type 2 – <span id="xdx_90D_ecustom--WarrantsToPurchaseShares_pid_c20221001__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember_zWX0loOAmi3k">120,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants to purchase ordinary shares of SMX PLC (refer to Note 1<b>)</b> at a purchase price of USD <span id="xdx_90F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20221001__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember_zgAz0x9JvYNa">11.50 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per share. The Redeemable Warrants Type 2 term is <span id="xdx_904_eifrs-full--BorrowingsMaturity_c20221001__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember_zg1ekXGu4sab">five years</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencing upon the Business Combination (refer to Note 1<b>)</b>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.45pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 53.45pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_906_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--CreationDateAxis__custom--FirstAnniversaryMember_zH8FsMnK3dQ3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.00</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Redeemable Warrants Type 2 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the first anniversary of the Business Combination for USD <span id="xdx_90C_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20220101__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--CreationDateAxis__custom--FirstAnniversaryMember_zHTB8ZoqBqpi">5.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 53.45pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--CreationDateAxis__custom--SecondAnniversaryMember_z01u9MvH13bd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50.00</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the Redeemable Warrants Type 2 shall be redeemable on a non-cumulative basis at the option of the holder, during the 30 days following the second anniversary of the Business Combination for USD <span id="xdx_904_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20220101__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--CreationDateAxis__custom--SecondAnniversaryMember_z4qFlDXzJEC3">5.00 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per warrant.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span id="xdx_90F_eifrs-full--DescriptionOfApproachUsedToDetermineDiscountRates_c20220101__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember_zd7SfSg5ify2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of SMX PLC based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Management utilized a third-party appraiser to assist them in valuing the Redeemable Warrants Type 2. The fair value of the Redeemable Warrants Type 2 was calculated using Monte-Carlo simulation model. As of December 31, 2022, the fair value of the Redeemable Warrants Type 1 was <span id="xdx_90B_ecustom--FairValueOfWarrants_pn3n3_c20220101__20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsTypeTwoMember__ifrs-full--MeasurementAxis__custom--MonteCarloSimulationModelMember_zXINdbs8qix4" title="Fair value of warrants">696</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The main assumptions used in the three valuation models described above were: (1) risk free rate <span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20220101__20221231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zLYMVA47dTug">3.99</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%; (2) volatility of assets <span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20220101__20221231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zr69I6SDA323">81.03</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%; and (3) excepted terms of the warrants -<span id="xdx_906_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20220101__20221231__ifrs-full--MeasurementAxis__custom--ThreeValuationModelsMember_zgpm0Nyaf8p" title="Term warrants">5.18 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event that the Business Combination shall not be consummated, the Bonus Warrants and the Redeemable Warrants type 1 and 2 shall be exchanged for such number of warrants for the Company’s ordinary shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 215500 11.50 five years 24000 342000 11.50 five years 0.5000 5.00 0.2500 5.00 0.2500 5.00 Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of SMX PLC based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary 1973000 120000 11.50 five years 0.5000 5.00 0.5000 5.00 Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of SMX PLC based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary 696000 0.0399 0.8103 P5Y2M4D <p id="xdx_808_eifrs-full--DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_zxO6zptd68Pk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 – <span id="xdx_82F_zSVTJ3IJfAh5">SHAREHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ordinary shares in the Company confer upon their holders the right to receive notice to participate and vote in general meetings of the Company, and the right to receive dividends, if and when declared.</span></td></tr></table> <p id="xdx_89A_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_zgfD9yoe4vP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_ztVkUt6yzX7j">SCHEDULE OF ORDINARY SHARES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued and</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued and</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 27%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231_zrMbrCDXyjki" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">167,854,581</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231_zeNY2qw9L47h" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">167,854,581</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20211231_zseKOs9HtkAh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,532,264</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20211231_zlGd54QNwdA4" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,532,264</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A9_zXn8vAfr5r0c" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have <span id="xdx_901_eifrs-full--ParValuePerShare_iI_pid_do_c20221231_zcisE0ypfwsl">no </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">par value and the company does not have a limited amount of authorised capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Increase in issued share capital:</b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2022, the Company raised capital, in consideration of an aggregate of <span id="xdx_909_eifrs-full--ProceedsFromIssuingOtherEquityInstruments_pn3n3_c20220801__20220831_zZdkmJnHmvU4">254 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">net proceeds. An amount of <span id="xdx_90E_eifrs-full--PaymentsForShareIssueCosts_pn3n3_c20220801__20220831_zW7hVHCvZYB6">22 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">capital raise fee was paid in cash to the financial advisor. The Company issued <span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pid_c20220831_zBUuGIHHBF41">2,000,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.05pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2021, the Company raised capital, in consideration of an aggregate of <span id="xdx_90C_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20211001__20211031_zci9l39ErPCh">1,890 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">net proceeds. An amount of <span id="xdx_909_eifrs-full--PaymentsForShareIssueCosts_pn3n3_c20211001__20211031_zKdsyD9AkVNe">115 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">capital raise fee was paid in cash to the financial advisor. The Company issued <span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20211031_zwPt9brdPXGj">8,938,666 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares and <span id="xdx_900_ecustom--NumberOfSharesIssuedWarrants_iI_pid_c20211031_zzH5ISd3Hkx7" title="Number of shares issued warrants">4,469,333 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants. The terms of the warrants specify that each warrant has an exercise price of AUD <span id="xdx_901_ecustom--WarrantsExercisePrice_iI_pid_uAUDPShares_c20211031_zqgUmh4Y7b34" title="Warrants exercise price">0.4 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and expires in <span id="xdx_90D_ecustom--WarrantsExpirationDate_c20211001__20211031_z7qnSwqotM5b" title="Warrants expiration date">March 2022</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. <span id="xdx_901_ecustom--WarrantsToPurchaseSharesInConvertedSharesDescription_c20211001__20211031_zyDVOiApi8Yj" title="Converted shares description">Upon exercise the holder would receive one ordinary share and another unlisted warrant that bears an exercise price of AUD 0.7, converted to one ordinary share and expired on January 20, 2023</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The warrants were considered to be a derivative financial liability and measured at fair value. The fair value of the warrant derivative is not material.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41.05pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the Company issued <span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_pid_c20210531_ztx76NjpkPaa">15,270,249 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares in consideration of an aggregate of <span id="xdx_901_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20210501__20210531_zGACqBB8PTm4">4,034 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">net proceeds.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: justify; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2021, <span id="xdx_901_ecustom--NumberOfSharesIssuedWarrants_iI_pid_c20211231_zOddbvQqAlNf">1,774,744 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants were exercised to <span id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_pid_c20211231_zpDG28Jpku6b">1,774,744 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares, for aggregate net proceeds of <span id="xdx_90D_eifrs-full--ProceedsFromExerciseOfWarrants_pn3n3_c20210101__20211231_zcNwmJ0MC3Ba">395</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 – SHAREHOLDERS’ EQUITY (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options granted to employees and service providers:</b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2018, the Company has adopted a Share Option Plan (the “Plan”) to provide an incentive to retain, in the employment or service or directorship of the Company and provide the ability to attract new employees, directors or consultants whose services are considered valuable. The persons eligible to participate in the Share Option Plan include employees, directors and consultants of the Company or any subsidiary of the Company.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.7pt; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A summary of the status of the Company’s Share Option Plan granted to employees (including performance-based awards) and changes during the relevant period ended on that date is presented below:</span></td></tr></table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p id="xdx_89C_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_zSv5CdGKFznc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_ziIEQnTOvNo3">SCHEDULE OF SHARE OPTION GRANTED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31, 2022</b></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31, 2021</b></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options (in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise price (AUD)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise price (AUD)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of year</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20220101__20221231_zKMkf3p9v77b" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,280</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uAUDPShares_c20220101__20221231_zzQB1GlJgdPc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.27</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20210101__20211231_zKM76wSOWeH" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,530</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uAUDPShares_c20210101__20211231_ztE6BG8xsdQi" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.23</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of options</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20220101__20221231_zQNRmlNZRetg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of issue of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uAUDPShares_c20220101__20221231_zB6xV9CDa9bc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, issued of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.27</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20210101__20211231_z0yVikpolww6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of issue of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,850</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uAUDPShares_c20210101__20211231_z5Ql5vxR63Jb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, issued of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.45</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20221231_z2TNaSVpQw8h" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,600</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_uAUDPShares_c20220101__20221231_zH1aeZ9ihPn4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.22</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20210101__20211231_zBSUgtMV8tg1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_uAUDPShares_c20210101__20211231_z3phG45z8YTc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.34</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at end of year</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20220101__20221231_z99e7a1Sn1Mk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,680</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_uAUDPShares_c20220101__20221231_zkSiEYztXdsk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20210101__20211231_zRg5DoA4wv96" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,280</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_uAUDPShares_c20210101__20211231_zNrHmvOdytwl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.27</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable options</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20220101__20221231_zIkOqQBDXmN8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,835</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_uAUDPShares_c20220101__20221231_z8117JDAHkue" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.28</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20210101__20211231_zFfwuiJAcST8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,318</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_uAUDPShares_c20210101__20211231_zoirs19J2bYi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.27</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AE_zM9ssRRYV9J2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_891_eifrs-full--DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_zu0yIzEygIf9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The options to employees outstanding as of December 31, 2022, are comprised, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zor8oxlIYAf">SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price (AUD)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 37%; text-align: center"><span id="xdx_900_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGMD81VoZzT3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.12</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_908_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zFZmbJZGw5uc">0.2</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zEZyiF70IG6k" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">800</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zaVNZMjX3HT4" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.59</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zy1q2GLAwKnf" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zgIp7fb98jZd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.64</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zieaVcyBMxee" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.2</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_z3yv7qAgkRvb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">955</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zcDT4qnY2km6" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.67</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_z9E23ZxyFCfe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">878</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_znW7MFTEpzyh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.67</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zHe3cJzbJHd4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.31</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_907_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z6Q446xewBi4">0.357</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zPOIK6Oaapo1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2075</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zZfBaUlmNY9e" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zwlLQoOuLAxh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1432</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_znlDF9xrCzR1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zUiKi3fQEGV7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.6</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zqO8uO1hVNYb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_z2K3ernmRzi" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.24</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zJGRNeeaQ0u2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zOd6Hs8Qs8O5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.24</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_ztjxoK4nIKa9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zS6LXLXQY4ti" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">750</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zazoFWDfdAMb" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.97</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zrkUxEI5CXn2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zbz5qPHYrMaa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20221231_zrpBQ0oH4QF" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,680</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20221231_zkw7nOagDij2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,835</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_z6HOi7wk9mhe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-indent: -28.35pt"><span style="font: normal 10pt Times New Roman, Times, Serif"><i> </i></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2022, the Company granted <span id="xdx_905_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_zDwwf1X5l2fc">600,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options to employees and <span id="xdx_902_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ConsultantsMember_zLKHqaRz4vE3">1,600,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options to consultants. These grants carry an exercise price of between AUD <span id="xdx_90D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uAUDPShares_c20220101__20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z3aKQyAnx7Ei">0.03</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_902_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uAUDPShares_c20220101__20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zpodKxgaJQBj">0.14</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_90B_eifrs-full--DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_c20220101__20221231_zxadn9BSo2Ua">vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The fair value at grant date is <span id="xdx_90D_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20221231_zMxHDnRJdS3c">154</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2021, the Company granted <span id="xdx_90A_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_zcrvQ123rNFl">250,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options to employees and <span id="xdx_906_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ConsultantsMember_ziQ5yFzVeYy4">5,400,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options to consultants. These grants carry an exercise price of between AUD <span id="xdx_90A_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uAUDPShares_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z9SLU1xA3GGl">0.35</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_907_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uAUDPShares_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zgrkpDzsXMki">0.70</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_906_eifrs-full--DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_c20210101__20211231_zURE5tvQeW1i">vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The fair value at grant date is <span id="xdx_90F_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20211231_z4YDQe15MYs">622</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 – SHAREHOLDERS’ EQUITY (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options granted to employees and service providers (cont.):</b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2020, the Company granted <span id="xdx_900_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_zGTUDzhnufOe">1,055,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options to employees, <span id="xdx_907_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ConsultantsMember_zKyqFPnj9Yzj">750,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options to consultants and <span id="xdx_90E_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BoardMembersMember_zUKrWy1B0KNe">2,500,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options to a board member. These grants carry an exercise price of between AUD <span id="xdx_90A_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uAUDPShares_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_ziTTnfNSevgk">0.20</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_903_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uAUDPShares_c20200101__20201231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zzLZjDYJCkh7">0.70</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_905_eifrs-full--DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_c20200101__20201231_zqckeS1Ia9vl">vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The fair value at grant date is <span id="xdx_903_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20201231_z8A7b0JgCLye">533</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted <span id="xdx_909_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BoardMembersMember_zCSAjduXV3H2">322,317 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares in 2022 and <span id="xdx_909_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BoardMembersMember_zc979hIq0zf9">257,562 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares in 2021 to its Board members in lieu of cash remuneration. The fair value at grant date is <span id="xdx_90E_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BoardMembersMember_zCrc4DwS4Vl4">54 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in 2022 and <span id="xdx_90C_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BoardMembersMember_z4KDTl2Vs3Hh">53 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in 2021.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expenses for the options that were not recognized as of December 31, 2022, amount to <span id="xdx_907_ecustom--ExpensesOfOptions_pn3n3_c20220101__20221231_zOzo7PiJ6vM2" title="Expenses of options">152</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The options issued in 2022 and 2021, were valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: <span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20210101__20211231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zBmIj5VkdlD3">0.11</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_90F_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20210101__20211231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zEyNyNOV2T7e">3.55</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%; (2) expected volatility: <span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20210101__20211231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGdqUUfl5TG5">64</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20210101__20211231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zYEe7HGNwS9l">118</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%: (3) expected term: up to <span id="xdx_901_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20210101__20211231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_zP9ss0wxVwrl" title="Term warrants">5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years; and (4) expected dividend yield: <span id="xdx_906_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_dp_uPure_c20210101__20211231__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember_z4pIHtnXg156">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Performance options:</b></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify; text-indent: -20.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2018, two Executive Directors were granted <span id="xdx_90C_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20180801__20180831__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TwoExecutiveDirectorMember_zCcADLcmZe49">10,000,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance Options with an exercise price of AUD <span id="xdx_905_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uAUDPShares_c20180801__20180831__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TwoExecutiveDirectorMember_zmPBAmDa6ca9">0.2</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, for which their remuneration will be dependent on the Company satisfying several commercial and technological milestones. <span id="xdx_90E_eifrs-full--DateOfGrantOfSharebasedPaymentArrangement_c20180801__20180831__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TwoExecutiveDirectorMember_zDY9B1KgWyrg">These milestones are reviewed by the Board of Directors and need to be achieved in 4 years since the date it was granted. If the milestones are not reached in 4 years, the options will expire</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. As of December 31, 2022, the Company did not reach the milestones. The Performance Options were expired.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2021, Executive Director was granted <span id="xdx_908_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20210801__20210831__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ExecutiveDirectorMember_zSib6Ce6J9Pf">167,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options and a key management was granted <span id="xdx_907_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20210801__20210831__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--KeyManagementPersonnelOfEntityOrParentMember_zMQ8mqGenK62">500,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options based on a non-market condition for which if <span id="xdx_903_eifrs-full--DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_c20210801__20210831_zJ46ZKQxKyV9">the Company raises an aggregated amount of at least 10 million in one raise (including by way of a merger with a company with such amount in its treasury) 80% of the options will become vested. If an amount of 20 million or more is raised in one raise all options will become vested. </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The exercise price is AUD <span id="xdx_906_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uAUDPShares_c20210801__20210831_zdddJhYUqyJ6">0.7 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and the expiration date is <span id="xdx_90D_eifrs-full--DateOfGrantOfSharebasedPaymentArrangement_c20210801__20210831_zFt4IOacVRt5">December 6, 2026</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company believes it is probable that the milestone will be reached. The fair value at grant date is <span id="xdx_906_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20220831_z8K24yq0vZ4j">98</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2021, several employees were granted <span id="xdx_902_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20210701__20210731_zCiRa8K1EHF9">1,100,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options based on a non-market condition for which the options shall vest upon meeting the following conditions: <span id="xdx_901_eifrs-full--DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_c20210701__20210731_zvpQt5Y5mAOc">(1) Company raised an aggregated amount of at least 20 million (including by way of a merger with a company with such amount in its treasury) (2) 25% of the options shall vest after one year and thereafter 6.25% at the end of every three months (3) the employees must continue to provide services to Company</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The exercise price is AUD <span id="xdx_909_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uAUDPShares_c20210701__20210731_zX5ko3ANKGD5">0.351 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and the expiration date is by <span id="xdx_90F_eifrs-full--DateOfGrantOfSharebasedPaymentArrangement_c20210701__20210731_zFp034WkYO48">July – September 2026</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The Company believes it is probable that the milestone will be reached. The fair value at grant date is <span id="xdx_905_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20210731_z2YIXNAriLtk">214</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In July 2022, several employees were granted <span id="xdx_900_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20220701__20220731_zaF8lyhOZcRh">200,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options based on a non-market condition for which the options shall vest upon meeting the following conditions: <span id="xdx_906_eifrs-full--DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_c20220701__20220731_zqvwYaUyx5N1">25% on the first anniversary of the Vesting Commencement Date and additional 6.25% at the end of each three months of continuous services thereafter. However, if Company or a parent thereof commences trading on NASDAQ, all options shall become fully vested</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The exercise price is AUD <span id="xdx_90E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uAUDPShares_c20220601__20220630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zBXzaouUn1lk">0.7</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_90B_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uAUDPShares_c20220601__20220630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zH2bQLyuoKw2">0.8 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and the expiration date is by <span id="xdx_901_eifrs-full--DateOfGrantOfSharebasedPaymentArrangement_c20220701__20220731_zc2ZQlC5Qj82">July 2027</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The options became fully vested on the consummation of the Business Combination in 2023. The fair value at grant date is <span id="xdx_904_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20220731_zuvAYNWJERmj">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 – SHAREHOLDERS’ EQUITY (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E. Performance options (cont.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2022, a key management was granted <span id="xdx_90F_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20220601__20220630_z2U2JskeFol7">200,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options based on a non-market condition for which the options shall vest upon meeting the following conditions: The options will vest upon successful listing on NASDAQ/merger with SPAC. The exercise price is AUD <span id="xdx_905_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uAUDPShares_c20220601__20220630_zqELdQF2Tzp2">0.4 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and the expiration date is by <span id="xdx_902_eifrs-full--DateOfGrantOfSharebasedPaymentArrangement_c20220601__20220630_zMtbZF32T0y9">June 2027</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The options became fully vested on the consummation of the Business Combination in 2023. The fair value at grant date is <span id="xdx_906_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20220630_z23zRVcLaeL1">5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2022, a consultant was granted <span id="xdx_901_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20220501__20220531_zMiLxcRwpEG3">250,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options based on a non-market condition for which if the options will vest upon successful IPO of the Company on NASDAQ. The exercise price is AUD <span id="xdx_905_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_uAUDPShares_c20220501__20220531_zhCalJ6KLksh">0.11 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and the expiration date is <span id="xdx_903_eifrs-full--DateOfGrantOfSharebasedPaymentArrangement_c20220501__20220531_zHNHyauICLBh">May 26, 2027</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The options became fully vested on the consummation of the Business Combination in 2023. The fair value at grant date is <span id="xdx_90F_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20220531_zHGxY6YYflF3">19</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89A_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_zgfD9yoe4vP3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_ztVkUt6yzX7j">SCHEDULE OF ORDINARY SHARES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued and</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Authorized</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued and</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">outstanding</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 27%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231_zrMbrCDXyjki" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">167,854,581</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231_zeNY2qw9L47h" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">167,854,581</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20211231_zseKOs9HtkAh" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,532,264</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20211231_zlGd54QNwdA4" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,532,264</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 167854581 167854581 165532264 165532264 0 254000 22000 2000000 1890000 115000 8938666 4469333 0.4 March 2022 Upon exercise the holder would receive one ordinary share and another unlisted warrant that bears an exercise price of AUD 0.7, converted to one ordinary share and expired on January 20, 2023 15270249 4034000 1774744 1774744 395000 <p id="xdx_89C_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_zSv5CdGKFznc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_ziIEQnTOvNo3">SCHEDULE OF SHARE OPTION GRANTED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31, 2022</b></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>December 31, 2021</b></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options (in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise price (AUD)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise price (AUD)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of year</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20220101__20221231_zKMkf3p9v77b" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,280</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uAUDPShares_c20220101__20221231_zzQB1GlJgdPc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.27</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20210101__20211231_zKM76wSOWeH" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,530</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uAUDPShares_c20210101__20211231_ztE6BG8xsdQi" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.23</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue of options</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20220101__20221231_zQNRmlNZRetg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of issue of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uAUDPShares_c20220101__20221231_zB6xV9CDa9bc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, issued of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.27</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20210101__20211231_z0yVikpolww6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of issue of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,850</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uAUDPShares_c20210101__20211231_z5Ql5vxR63Jb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, issued of options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.45</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20221231_z2TNaSVpQw8h" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,600</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_uAUDPShares_c20220101__20221231_zH1aeZ9ihPn4" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.22</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20210101__20211231_zBSUgtMV8tg1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_uAUDPShares_c20210101__20211231_z3phG45z8YTc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.34</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at end of year</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20220101__20221231_z99e7a1Sn1Mk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,680</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_uAUDPShares_c20220101__20221231_zkSiEYztXdsk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20210101__20211231_zRg5DoA4wv96" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,280</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_uAUDPShares_c20210101__20211231_zNrHmvOdytwl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.27</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable options</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20220101__20221231_zIkOqQBDXmN8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,835</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_uAUDPShares_c20220101__20221231_z8117JDAHkue" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.28</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20210101__20211231_zFfwuiJAcST8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,318</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_uAUDPShares_c20210101__20211231_zoirs19J2bYi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.27</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 11280000 0.27 9530000 0.23 1000000 0.27 1850000 0.45 7600000 0.22 100000 0.34 4680000 0.35 11280000 0.27 2835000 0.28 4318000 0.27 <p id="xdx_891_eifrs-full--DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_zu0yIzEygIf9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The options to employees outstanding as of December 31, 2022, are comprised, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zor8oxlIYAf">SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 97%; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercise price (AUD)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>as of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(years)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 37%; text-align: center"><span id="xdx_900_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGMD81VoZzT3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.12</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_908_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zFZmbJZGw5uc">0.2</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zEZyiF70IG6k" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">800</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zaVNZMjX3HT4" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.59</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zy1q2GLAwKnf" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zgIp7fb98jZd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.64</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zieaVcyBMxee" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.2</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_z3yv7qAgkRvb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">955</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zcDT4qnY2km6" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.67</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_z9E23ZxyFCfe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">878</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_znW7MFTEpzyh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.67</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zHe3cJzbJHd4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.31</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<span id="xdx_907_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z6Q446xewBi4">0.357</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zPOIK6Oaapo1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2075</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zZfBaUlmNY9e" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zwlLQoOuLAxh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1432</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_znlDF9xrCzR1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.15</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zUiKi3fQEGV7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.6</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zqO8uO1hVNYb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_z2K3ernmRzi" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.24</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zJGRNeeaQ0u2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zOd6Hs8Qs8O5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.24</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_ztjxoK4nIKa9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zS6LXLXQY4ti" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">750</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zazoFWDfdAMb" style="font: 10pt Times New Roman, Times, Serif; text-align: center" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.97</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zrkUxEI5CXn2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20220101__20221231__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zbz5qPHYrMaa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20221231_zrpBQ0oH4QF" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,680</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20221231_zkw7nOagDij2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,835</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 0.12 0.2 800000 P4Y7M2D 400000 P4Y7M20D 0.2 955000 P0Y8M1D 878000 P0Y8M1D 0.31 0.357 2075000 P2Y6M21D 1432000 P2Y1M24D 0.6 100000 P2Y2M26D 100000 P2Y2M26D 0.7 750000 P3Y11M19D 25000 P3Y8M26D 4680000 2835000 600000 1600000 0.03 0.14 vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years 154000 250000 5400000 0.35 0.70 vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years 622000 1055000 750000 2500000 0.20 0.70 vesting period up to 4 years from the grant date, contractual life of the options under the Plan is 5 years 533000 322317 257562 54000 53000 152000 0.0011 0.0355 0.64 1.18 P5Y 0 10000000 0.2 These milestones are reviewed by the Board of Directors and need to be achieved in 4 years since the date it was granted. If the milestones are not reached in 4 years, the options will expire 167000 500000 the Company raises an aggregated amount of at least 10 million in one raise (including by way of a merger with a company with such amount in its treasury) 80% of the options will become vested. If an amount of 20 million or more is raised in one raise all options will become vested. 0.7 December 6, 2026 98000 1100000 (1) Company raised an aggregated amount of at least 20 million (including by way of a merger with a company with such amount in its treasury) (2) 25% of the options shall vest after one year and thereafter 6.25% at the end of every three months (3) the employees must continue to provide services to Company 0.351 July – September 2026 214000 200000 25% on the first anniversary of the Vesting Commencement Date and additional 6.25% at the end of each three months of continuous services thereafter. However, if Company or a parent thereof commences trading on NASDAQ, all options shall become fully vested 0.7 0.8 July 2027 10000 200000 0.4 June 2027 5000 250000 0.11 May 26, 2027 19000 <p id="xdx_80F_eifrs-full--DisclosureOfResearchAndDevelopmentExpenseExplanatory_z1wb03jaFr4j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 – <span id="xdx_822_zs1k8d2wqbS9">RESEARCH AND DEVELOPMENT EXPENSES, NET</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory_zHjvHr4nyZR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BF_zvpnVgj1kMsi">SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20220101__20221231_zEzLd8Qxe9c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20210101__20211231_zdRXAEvbqyM" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20200101__20201231_zujfrDPthAT5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--EmployeeBenefitsExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zAcKlTRiIOv3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries and related expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,795</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,186</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--SubcontractorsAndConsultants_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_z0CYtS5Sh8yc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subcontractors and consultants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">374</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">631</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">509</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_ecustom--ResearchExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zhwpNuwdknxi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">316</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">252</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">155</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_z3HXBwvWFsGb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">243</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--AdjustmentsForSharebasedPayments_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zSsmwlvCnfee" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zkJriKCXiExh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--FreightExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zk3C16rXZ3hk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Freight</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zN5zSFdRa3c3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1490">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_ecustom--ReimbursementFromPaidPilotsAndProofOfConceptProjects_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zUzI5S9zd4N9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimbursement from paid pilots and proof of concept projects</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,426</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,091</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(548</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_eifrs-full--ResearchAndDevelopmentExpense_iT_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_mtRADEzLMx_zugfu84o1Oue" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,898</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,039</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,689</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A4_zQ3UCnM71yYi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_892_ecustom--DisclosureOfDetailedInformationAboutResearchAndDevelopmentExpenseExplanatory_zHjvHr4nyZR" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BF_zvpnVgj1kMsi">SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSE</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20220101__20221231_zEzLd8Qxe9c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20210101__20211231_zdRXAEvbqyM" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_494_20200101__20201231_zujfrDPthAT5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--EmployeeBenefitsExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zAcKlTRiIOv3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salaries and related expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,166</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,795</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,186</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--SubcontractorsAndConsultants_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_z0CYtS5Sh8yc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subcontractors and consultants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">374</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">631</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">509</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_ecustom--ResearchExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zhwpNuwdknxi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Research expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">316</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">252</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">155</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_z3HXBwvWFsGb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">287</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">243</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--AdjustmentsForSharebasedPayments_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zSsmwlvCnfee" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">127</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zkJriKCXiExh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--FreightExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zk3C16rXZ3hk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Freight</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zN5zSFdRa3c3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1490">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_ecustom--ReimbursementFromPaidPilotsAndProofOfConceptProjects_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_maRADEzLMx_zUzI5S9zd4N9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimbursement from paid pilots and proof of concept projects</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,426</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,091</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(548</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_eifrs-full--ResearchAndDevelopmentExpense_iT_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--ResearchAndDevelopmentExpensesMember_mtRADEzLMx_zugfu84o1Oue" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,898</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,039</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,689</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2166000 1795000 1186000 374000 631000 509000 316000 252000 155000 255000 287000 243000 127000 100000 47000 50000 42000 11000 30000 23000 33000 6000 53000 -1426000 -1091000 -548000 1898000 2039000 1689000 <p id="xdx_808_eifrs-full--DisclosureOfGeneralAndAdministrativeExpenseExplanatory_zByTP7dA3uH9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15 – <span id="xdx_829_znDXOJPCK8Wl">GENERAL AND ADMINISTRATIVE EXPENSES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></b></p> <p id="xdx_895_ecustom--DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_zKPlbuQp0sZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BD_zSb3PTXKxUXa">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20220101__20221231_zk2E5prz6fEj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20210101__20211231_zJdu9ni8eNdl" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20200101__20201231_z3a1EfagIlv3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--TransactionCost_maGAAEz4rn_zml8RBUxyvSk" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Transaction cost</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eifrs-full--AdvertisingExpense_maGAAEz4rn_zT7WUQeJoiJ4" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Advertising, Public and Investors Relations</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_maGAAEz4rn_z61iL1dydxvl" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Share based compensation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_404_eifrs-full--ProfessionalFeesExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zhFAsF3RVmkh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional services</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,105</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,089</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,257</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--WagesAndSalaries_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_z7YWvHXypide" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wages and salaries related</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">935</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">752</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">409</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zTFbx97M2Xsd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">223</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1526">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--RepairsAndMaintenanceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zbzHtaa7iHrd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office and maintenance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">145</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zLkaFrB2uN43" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">331</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">436</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--InsuranceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zM26Cqw2mZg9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zGin7z9LOm9e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zOnvEnr3o8mc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--GeneralAndAdministrativeExpense_iT_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_mtGAAEz4rn_zt3KAkduEeqh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,723</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,482</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,447</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A9_zpYuJBPo5EKl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_895_ecustom--DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_zKPlbuQp0sZ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BD_zSb3PTXKxUXa">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20220101__20221231_zk2E5prz6fEj" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_497_20210101__20211231_zJdu9ni8eNdl" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20200101__20201231_z3a1EfagIlv3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--TransactionCost_maGAAEz4rn_zml8RBUxyvSk" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Transaction cost</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eifrs-full--AdvertisingExpense_maGAAEz4rn_zT7WUQeJoiJ4" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Advertising, Public and Investors Relations</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_maGAAEz4rn_z61iL1dydxvl" style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Share based compensation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_404_eifrs-full--ProfessionalFeesExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zhFAsF3RVmkh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional services</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,105</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,089</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,257</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--WagesAndSalaries_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_z7YWvHXypide" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wages and salaries related</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">935</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">752</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">409</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zTFbx97M2Xsd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel expenses</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">223</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1526">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--RepairsAndMaintenanceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zbzHtaa7iHrd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office and maintenance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">145</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">116</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zLkaFrB2uN43" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based compensation</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">331</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">436</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--InsuranceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zM26Cqw2mZg9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">102</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zGin7z9LOm9e" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zOnvEnr3o8mc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">83</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--GeneralAndAdministrativeExpense_iT_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_mtGAAEz4rn_zt3KAkduEeqh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,723</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,482</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,447</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1105000 1089000 1257000 935000 752000 409000 223000 65000 145000 116000 120000 137000 331000 436000 60000 102000 101000 35000 28000 16000 83000 64000 43000 2723000 2482000 2447000 <p id="xdx_801_eifrs-full--DisclosureOfIncomeTaxExplanatory_zOvKjd9nPLJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 – <span id="xdx_825_z3UW0ZxNPSWe">TAXES ON INCOME</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify; text-indent: -56.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">The Company is incorporated and domiciled in Australia where the applicable tax rate is <span id="xdx_902_eifrs-full--ApplicableTaxRate_pid_dp_c20220101__20221231_zSPdVVjreeEh">27.5</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">%.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: normal 10pt Times New Roman, Times, Serif">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">Theoretical tax: </span></td></tr></table> <p id="xdx_89F_ecustom--DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory_znKMW0MF2kD9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_8BA_z1sZM8Sv7Ggg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20220101__20221231_zfvWsBZE39Pf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20210101__20211231_zkpcWkpPHiH9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_491_20200101__20201231_zf1Dz3iAQ9Rh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reconciliation of income tax at the statutory rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--ProfitLossBeforeTax_iN_pn3n3_di_zmWCmCzeWnIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss before income tax</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,184</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,939</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,573</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pn3n3_maITECOzgxM_zpvvrZl5h3ra" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Theoretical tax rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTVBPTkVOVFMgT0YgSU5DT01FIFRBWCBFWFBFTlNFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eifrs-full--ApplicableTaxRate_pid_dp_c20200101__20201231_zxYykdiqI518">27.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,701</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,358</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,257</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--TaxEffectAmountsWhichAreNotDeductibletaxableInCalculatingTaxableIncomeAbstract_iB_zovYufQFsEWg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax effect amounts which are not deductible/(taxable) in calculating taxable income:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_pn3n3_maITECOzgxM_ztQExy6ALOt" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-deductible expenditure and others</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">118</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">132</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense_pn3n3_msITECOzgxM_zmiIh1HBtFxl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrecognized temporary differences and tax losses for which deferred tax weren’t recognized</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,366</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,240</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,125</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_mtITECOzgxM_zhVkL69JBQla" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax / (benefit)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1579">—</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1580">—</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1581">—</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_zRAH00Q5M9Gj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: normal 10pt Times New Roman, Times, Serif">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: normal 10pt Times New Roman, Times, Serif">As of December 31, 2022, the Group has estimated carry forward tax losses of approximately <span id="xdx_908_eifrs-full--TaxEffectOfTaxLosses_pn3n3_c20220101__20221231_zKsdEKODgMWf">24,106 </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">(2021: <span id="xdx_903_eifrs-full--TaxEffectOfTaxLosses_pn3n3_c20210101__20211231_zPlgxqcuSecl">17,659 </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">2020:<span id="xdx_909_eifrs-full--TaxEffectOfTaxLosses_pn3n3_c20200101__20201231_zb2883ZH2wRl">13,151</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">) which may be carried forward and offset against taxable income for an indefinite period in the future. The Group did not recognize deferred tax assets relating to carry forward losses in the financial statements because their utilization in the foreseeable future is not probable. </span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 0.275 <p id="xdx_89F_ecustom--DisclosureOfDetailedInformationAboutComponentsOfIncomeTaxExpenseExplanatory_znKMW0MF2kD9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="xdx_8BA_z1sZM8Sv7Ggg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20220101__20221231_zfvWsBZE39Pf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49B_20210101__20211231_zkpcWkpPHiH9" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_491_20200101__20201231_zf1Dz3iAQ9Rh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reconciliation of income tax at the statutory rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--ProfitLossBeforeTax_iN_pn3n3_di_zmWCmCzeWnIe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss before income tax</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,184</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,939</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,573</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pn3n3_maITECOzgxM_zpvvrZl5h3ra" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Theoretical tax rate of <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIENPTVBPTkVOVFMgT0YgSU5DT01FIFRBWCBFWFBFTlNFIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_90E_eifrs-full--ApplicableTaxRate_pid_dp_c20200101__20201231_zxYykdiqI518">27.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,701</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,358</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,257</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--TaxEffectAmountsWhichAreNotDeductibletaxableInCalculatingTaxableIncomeAbstract_iB_zovYufQFsEWg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax effect amounts which are not deductible/(taxable) in calculating taxable income:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_pn3n3_maITECOzgxM_ztQExy6ALOt" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-deductible expenditure and others</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">118</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">132</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_eifrs-full--TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense_pn3n3_msITECOzgxM_zmiIh1HBtFxl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unrecognized temporary differences and tax losses for which deferred tax weren’t recognized</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,366</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,240</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,125</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--IncomeTaxExpenseContinuingOperations_pn3n3_mtITECOzgxM_zhVkL69JBQla" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax / (benefit)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1579">—</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1580">—</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1581">—</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 6184000 4939000 4573000 0.275 -1701000 -1358000 -1257000 335000 118000 132000 1366000 1240000 1125000 24106000 17659000 13151000 <p id="xdx_806_eifrs-full--EarningsPerShareExplanatory_z1tTRq0LFFc4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 17 – <span id="xdx_82D_zjmBBiZvqLVg">LOSS PER SHARE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span> </span></b></span></p> <p id="xdx_894_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zke2pO0iCSM7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_ze2tDpshiGzf">SCHEDULE OF LOSS PER SHARE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20220101__20221231_z2IiQtT3FEhd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20210101__20211231_zjAmVvP1fwOl" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20200101__20201231_zXZqsZSdjz08" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--ProfitLoss_pn3n3_z1gIJhAgsSC8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss attributable to the owners of the company</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,184</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,939</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,573</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--BasicEarningsLossPerShare_pid_z75HaFDd46x2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted loss per share</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.04</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.03</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.04</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_ecustom--WeightedAverageNumberOfOrdinarySharesAbstract_iB_pid_zOCcE7pa0L66" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average number of ordinary shares</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--WeightedAverageShares_pid_z5HmuoPkQO9d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average number of ordinary shares used in calculating basic and diluted loss per share</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">167,855</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">151,850</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,960</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <p id="xdx_8A0_z6E1JxJA8noh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_894_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zke2pO0iCSM7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_ze2tDpshiGzf">SCHEDULE OF LOSS PER SHARE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20220101__20221231_z2IiQtT3FEhd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20210101__20211231_zjAmVvP1fwOl" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20200101__20201231_zXZqsZSdjz08" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--ProfitLoss_pn3n3_z1gIJhAgsSC8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss attributable to the owners of the company</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,184</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,939</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,573</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--BasicEarningsLossPerShare_pid_z75HaFDd46x2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted loss per share</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.04</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.03</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.04</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_ecustom--WeightedAverageNumberOfOrdinarySharesAbstract_iB_pid_zOCcE7pa0L66" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average number of ordinary shares</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eifrs-full--WeightedAverageShares_pid_z5HmuoPkQO9d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average number of ordinary shares used in calculating basic and diluted loss per share</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">167,855</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">151,850</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">125,960</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> -6184000 -4939000 -4573000 -0.04 -0.03 -0.04 167855 151850 125960 <p id="xdx_803_eifrs-full--DisclosureOfRelatedPartyExplanatory_zVB7loTLt9Xl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 18 – <span id="xdx_824_ztu4n48YPZml">RELATED PARTIES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">: </span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-indent: -28.35pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key Management Personnel Compensation and other related party transactions and balances:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The key management personnel, among others includes board members, CEO and CFO.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_zlZd82nEZPW3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The totals of remuneration paid to Key Management Personnel and related parties during the years are as follows<b>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zrJ6tkaM5HBi">SCHEDULE OF KEY MANAGEMENT PERSONNEL</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Transactions with related parties:</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20220101__20221231_zmiaYVUihHUh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20210101__20211231_zXIjffazi1C7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--KeyManagementIssuanceOfOptionsToRelatedParty_maKMPCzriq_zYeIyt4Nz2e8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Issuance of options to related party</p></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">721</p></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1611">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_406_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_maKMPCzriq_zMYohT9xKkc1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term salary and fees</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">508</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">475</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--KeyManagementPersonnelCompensationLoanRepayment_pn3n3_maKMPCzriq_zhLL7tzjLqdg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan repayment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">172</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_pn3n3_maKMPCzriq_zyLL2QEpTuv" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">105</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationPostemploymentBenefits_pn3n3_maKMPCzriq_zF3j1iZpIP3c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-employment retirement benefits</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--KeyManagementPersonnelCompensationPaymentForAdministrativeServices_pn3n3_maKMPCzriq_zBw8OgwAOOqc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment for Administrative services</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--KeyManagementPersonnelCompensationNonmonetaryBenefits_pn3n3_maKMPCzriq_zm5SggvWpKSa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-monetary benefits</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_ecustom--ProofOfConceptProjectsPaidByAffiliatedCompanies_pn3n3_maKMPCzriq_zPOXYusIFl9c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proof of Concept projects paid by affiliated companies</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,064</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(695</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_401_eifrs-full--KeyManagementPersonnelCompensation_iNT_pn3n3_di_mtKMPCzriq_zZeGAmT33qi9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(594</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A9_z5K2Gin0otTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> </p> <p id="xdx_89F_ecustom--DisclosureOfDetailedInformationAboutBalanceWithRelatedPartiesExplanatory_zSzKvnjgZmed" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span id="xdx_8BD_zCQF4URDZkrg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF BALANCE WITH RELATED PARTIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Balance with related parties:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary and related</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--KeyManagementPersonnelOfEntityOrParentMember_zrosKEyTosXg" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(99</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--KeyManagementPersonnelOfEntityOrParentMember_zxjpEEXXR0qc" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(86</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary and related</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zfgiDRUarMr4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(82</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zdUQ3U2rJmug" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings from related parties</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--TradeAndOtherReceivablesDueFromRelatedParties_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zD3K0h5oG2p8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Borrowings from related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(710</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--TradeAndOtherReceivablesDueFromRelatedParties_iNI_pn3n3_di_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zdZFWfMPWi9h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Borrowings from related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(270</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounts payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--OtherPayables_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_z0UnXJIfaqoi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other accounts payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--OtherPayables_iNI_pn3n3_di_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zIqgyyAaTzu2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other accounts payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint Ventures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other receivables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--OtherReceivables_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_z8BBw40jUaD8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--OtherReceivables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_z5353PhWbFpk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint Ventures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in subsidiary</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--InvestmentsInSubsidiaries_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zRAgcGhYtUZd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Investment in subsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">221</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--InvestmentsInSubsidiaries_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zMOXGUfKPaI" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Investment in subsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">147</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--BalanceWithRelatedParties_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zwB2VIUZCorh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(667</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--BalanceWithRelatedParties_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zKz67CwCLLN4" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(170</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> <p id="xdx_8AE_zEkDJg2ObCsj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89B_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_zlZd82nEZPW3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The totals of remuneration paid to Key Management Personnel and related parties during the years are as follows<b>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zrJ6tkaM5HBi">SCHEDULE OF KEY MANAGEMENT PERSONNEL</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Transactions with related parties:</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49A_20220101__20221231_zmiaYVUihHUh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20210101__20211231_zXIjffazi1C7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--KeyManagementIssuanceOfOptionsToRelatedParty_maKMPCzriq_zYeIyt4Nz2e8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Issuance of options to related party</p></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">721</p></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1611">-</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_406_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_maKMPCzriq_zMYohT9xKkc1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short-term salary and fees</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">508</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">475</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--KeyManagementPersonnelCompensationLoanRepayment_pn3n3_maKMPCzriq_zhLL7tzjLqdg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loan repayment</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">172</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">103</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_pn3n3_maKMPCzriq_zyLL2QEpTuv" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based payments</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">98</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">105</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--KeyManagementPersonnelCompensationPostemploymentBenefits_pn3n3_maKMPCzriq_zF3j1iZpIP3c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Post-employment retirement benefits</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">94</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--KeyManagementPersonnelCompensationPaymentForAdministrativeServices_pn3n3_maKMPCzriq_zBw8OgwAOOqc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment for Administrative services</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_ecustom--KeyManagementPersonnelCompensationNonmonetaryBenefits_pn3n3_maKMPCzriq_zm5SggvWpKSa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-monetary benefits</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_ecustom--ProofOfConceptProjectsPaidByAffiliatedCompanies_pn3n3_maKMPCzriq_zPOXYusIFl9c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proof of Concept projects paid by affiliated companies</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,064</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(695</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_401_eifrs-full--KeyManagementPersonnelCompensation_iNT_pn3n3_di_mtKMPCzriq_zZeGAmT33qi9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(594</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">130</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 721000 508000 475000 172000 103000 98000 105000 94000 92000 36000 39000 29000 11000 -1064000 -695000 594000 -130000 <p id="xdx_89F_ecustom--DisclosureOfDetailedInformationAboutBalanceWithRelatedPartiesExplanatory_zSzKvnjgZmed" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span id="xdx_8BD_zCQF4URDZkrg" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF BALANCE WITH RELATED PARTIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Balance with related parties:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Key management</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary and related</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--KeyManagementPersonnelOfEntityOrParentMember_zrosKEyTosXg" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(99</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--KeyManagementPersonnelOfEntityOrParentMember_zxjpEEXXR0qc" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(86</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Salary and related</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zfgiDRUarMr4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(82</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--AmountsPayableRelatedPartyTransactions_iNI_pn3n3_di_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--DirectorsMember_zdUQ3U2rJmug" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Salary and related"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings from related parties</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--TradeAndOtherReceivablesDueFromRelatedParties_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zD3K0h5oG2p8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Borrowings from related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(710</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--TradeAndOtherReceivablesDueFromRelatedParties_iNI_pn3n3_di_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zdZFWfMPWi9h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Borrowings from related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(270</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other accounts payable</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--OtherPayables_iNI_pn3n3_di_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_z0UnXJIfaqoi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other accounts payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(56</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--OtherPayables_iNI_pn3n3_di_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zIqgyyAaTzu2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other accounts payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(24</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint Ventures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other receivables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--OtherReceivables_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_z8BBw40jUaD8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--OtherReceivables_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_z5353PhWbFpk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joint Ventures</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment in subsidiary</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--InvestmentsInSubsidiaries_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zRAgcGhYtUZd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Investment in subsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">221</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--InvestmentsInSubsidiaries_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--JointVenturesMember_zMOXGUfKPaI" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Investment in subsidiary"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">147</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_ecustom--BalanceWithRelatedParties_iI_pn3n3_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zwB2VIUZCorh" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(667</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_ecustom--BalanceWithRelatedParties_iI_pn3n3_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--RelatedPartiesMember_zKz67CwCLLN4" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(170</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> 99000 86000 82000 11000 710000 270000 56000 24000 59000 74000 221000 147000 -667000 -170000 <p id="xdx_804_eifrs-full--DisclosureOfGovernmentGrantsExplanatory_zobXxrLB93D2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 19 – <span id="xdx_821_ziPqbNxIkKc8">GOVERNMENT GRANTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">The Government of Israel encourages research and development projects oriented towards products for export or projects which will otherwise benefit the Israeli economy. This is conducted via the Israel Innovation Authority (IIA), which replaced the former Office of the Chief Scientist (OCS).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group has an approved project with the IIA under which it received a total of <span id="xdx_908_ecustom--ProceedsFromGovernmentGrantsReceived_pn3n3_c20210101__20211231_z1uxCSULEGU3" title="Government grants received">162 </span></span><span style="font: normal 10pt Times New Roman, Times, Serif">in prior years. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">The Group is subject to paying <span id="xdx_90D_ecustom--PercentageOfRevenue_pid_dp_c20220101__20221231_zYTvfUb9Mw0a" title="Percentage of revenue">3</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">% of its relevant revenues until repayment of the entire grant. As of December 31, 2022, the Group paid an amount of <span id="xdx_904_ecustom--PaymentsForGovernmentGrants_pn3n3_c20220101__20221231_zlNh7me98yT7" title="Government grants">3</span></span><span style="font: normal 10pt Times New Roman, Times, Serif">. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif">The difference between the consideration received and the liability recognized at inception (present value) was treated as a government grant according to IAS 20 and recognized as a reimbursement of research expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <p id="xdx_899_ecustom--DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory_zQ3eQH6dE4pi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif; display: none"> <span id="xdx_8B6_zMawydLsUd6d">SCHEDULE OF GOVERNMENT GRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20221231_zpnU3rnWit7b" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20211231_zeraznsaRkC2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--CurrentGovernmentGrants_iI_pn3n3_maGGzTVv_zjTyrSZD7FLf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short term liability at year end</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--NoncurrentGovernmentGrants_iI_pn3n3_maGGzTVv_zv6Hfq1vqg03" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long term liability at year end</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--GovernmentGrants_iTI_pn3n3_mtGGzTVv_z6kGax9zSVah" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AC_zOvo94bjcbs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 162000 0.03 3000 <p id="xdx_899_ecustom--DisclosureOfDetailedInformationAboutGovernmentGrantsExplanatory_zQ3eQH6dE4pi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><span style="font: normal 10pt Times New Roman, Times, Serif; display: none"> <span id="xdx_8B6_zMawydLsUd6d">SCHEDULE OF GOVERNMENT GRANTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_498_20221231_zpnU3rnWit7b" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20211231_zeraznsaRkC2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eifrs-full--CurrentGovernmentGrants_iI_pn3n3_maGGzTVv_zjTyrSZD7FLf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short term liability at year end</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--NoncurrentGovernmentGrants_iI_pn3n3_maGGzTVv_zv6Hfq1vqg03" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long term liability at year end</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">85</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eifrs-full--GovernmentGrants_iTI_pn3n3_mtGGzTVv_z6kGax9zSVah" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 50000 30000 85000 85000 135000 115000 <p id="xdx_804_ecustom--DisclosureOfControlledEntitiesExplanatory_z7UAlYcD0kLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 20 – <span id="xdx_82E_zmHb6HzEanI8">CONTROLLED ENTITIES </span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ultimate legal parent entity of the Group is Security Matters Limited, incorporated and domiciled in Australia. The consolidated financial statements incorporate the assets, liabilities and results of the following subsidiaries in accordance with the accounting policies described in Note 2.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutControlledEntitiesAssetsAndLiabilitiesExplanatory_z16ztPE9jmn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span id="xdx_8B5_zs0VwROBVMN4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF ASSETS AND LIABILITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Controlled entity</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Incorporation</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>December 31, 2022</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>December 31, 2021</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: left"><span id="xdx_909_eifrs-full--CountryOfIncorporation_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersLtdMember_zpsTogo1AGql" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersLtdMember_zjMWWuO0QFbl" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20210101__20211231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersLtdMember_zASXrSN8DtZa" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters Canada Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_eifrs-full--CountryOfIncorporation_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersCanadaLtdMember_zC50O3MzPXMj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersCanadaLtdMember_zPQ2mrgXLFd3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20210101__20211231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersCanadaLtdMember_zijjKLILu0a1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters France Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90E_eifrs-full--CountryOfIncorporation_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersFranceLtdMember_z5gPRCCpYsJ6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">France</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersFranceLtdMember_ziQPoPRJZdAi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20210101__20211231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersFranceLtdMember_zCKLDlIETeme" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX Beverages Pty Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_903_eifrs-full--CountryOfIncorporation_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SMXBeveragesPtyLtdMember_zDq14wuMGBG" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SMXBeveragesPtyLtdMember_zHFkr2G6IHyb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20210101__20211231__ifrs-full--CounterpartiesAxis__custom--SMXBeveragesPtyLtdMember_zINkDwfButK5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> <p id="xdx_8A0_zKKgQFPlNAp5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Security Matters Canada</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters Canada was founded in March 2021 for commercializing the group’s activity in Canada. During the period Security Matters Canada has not yet started its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Security Matters France</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters France was founded in June 2021 for commercializing the group’s activity in EU. During the period Security Matters France has not yet started its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">SMX Beverages Pty Ltd</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX Beverages Pty Ltd was founded in February 2020 as a joint venture for commercializing the group’s alcoholic beverages activity. Since March 2022, SMX Beverages Pty Ltd has been a wholly owned subsidiary (Note 7). During the period SMX Beverages Pty Ltd has not yet started its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_ecustom--DisclosureOfDetailedInformationAboutControlledEntitiesAssetsAndLiabilitiesExplanatory_z16ztPE9jmn8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span id="xdx_8B5_zs0VwROBVMN4" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF ASSETS AND LIABILITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Controlled entity</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Incorporation</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>December 31, 2022</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>December 31, 2021</b></p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: left"><span id="xdx_909_eifrs-full--CountryOfIncorporation_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersLtdMember_zpsTogo1AGql" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersLtdMember_zjMWWuO0QFbl" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20210101__20211231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersLtdMember_zASXrSN8DtZa" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters Canada Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_908_eifrs-full--CountryOfIncorporation_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersCanadaLtdMember_zC50O3MzPXMj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canada</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersCanadaLtdMember_zPQ2mrgXLFd3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20210101__20211231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersCanadaLtdMember_zijjKLILu0a1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters France Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_90E_eifrs-full--CountryOfIncorporation_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersFranceLtdMember_z5gPRCCpYsJ6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">France</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersFranceLtdMember_ziQPoPRJZdAi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20210101__20211231__ifrs-full--CounterpartiesAxis__custom--SecurityMattersFranceLtdMember_zCKLDlIETeme" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX Beverages Pty Ltd.</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span id="xdx_903_eifrs-full--CountryOfIncorporation_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SMXBeveragesPtyLtdMember_zDq14wuMGBG" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Australia</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20220101__20221231__ifrs-full--CounterpartiesAxis__custom--SMXBeveragesPtyLtdMember_zHFkr2G6IHyb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--ProportionOfOwnershipInterestInAssociate_pid_dp_c20210101__20211231__ifrs-full--CounterpartiesAxis__custom--SMXBeveragesPtyLtdMember_zINkDwfButK5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ownership percentage"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> Israel 1 1 Canada 1 1 France 1 1 Australia 1 0.50 <p id="xdx_80F_eifrs-full--DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_zkUQjkECiTI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 21 – <span id="xdx_829_zrRFDEZosLe8">COMMITMENTS AND CONTINGENT LIABILITIES</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the Board’s ongoing regulatory compliance process, the Board continues to monitor legal and regulatory developments and their potential impact on the Company. Management is not aware of any contingencies that may have a significant impact on the financial position of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 18.9pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2015, the Company entered an agreement with Isorad Ltd. (a company wholly owned by the State of Israel with rights to exclusively commercialize the Soreq Research Center technology for civilian uses), according to which the Company was granted technological license in return for future royalties based on <span id="xdx_90F_ecustom--PercentageOfRoyalty_iI_pid_dp_c20150131_zl1Lr10iZWJl" title="Percentage of royalty">2.2</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of Gross sales by the Company and its affiliates and after 25 years the license becomes royalty-free. Upon the occurrence of an M&amp;A event (as such event is defined in the agreement to include mergers, sale of all or substantially all the assets of ours and similar event), in the first M&amp;A event, the Company is to pay a consideration equal to <span id="xdx_900_ecustom--ContingentOfConsiderationPercentage_iI_pid_dp_c20150131_zHhKZgMcsPIj" title="Consideration percentage">1</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the amount received or transferred and in the second M&amp;A event, a consideration equal to <span id="xdx_902_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20150131_zFzR63I3rPH">2</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 14.2pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 2023, the Company signed an amendment to the agreement that determine the following: (1) for the BCA with Lionheart, Isorad was issued (a) <span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pid_c20230130__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z8hurFGHARJa">864,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options to purchase shares of the Company, the options were issued in January 2023 and valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: <span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230129__20230130__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zDRGD2lPwBJ3">3.42</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%; (2) expected volatility: <span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230129__20230130__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zPalOOrwatdj">81.92</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%: (3) expected term: up to <span id="xdx_909_ecustom--DescriptionOfExpectedExpectedTermOptionsGranted_dtY_c20230129__20230130__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zjKBDpS8LYdh" title="Granted">3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years; and (4) expected dividend yield: <span id="xdx_90E_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_uPure_c20230129__20230130__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zEF9VLWp8tgf">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%; (b) Additionally, Isorad will be entitled to <span id="xdx_909_ecustom--AddtionalEquityFundOfConvertiblePercent_iI_pid_dp_uPure_c20230130__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zYmCWGA4MC9e" title="Convertible percentage">1</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of <span id="xdx_90E_eifrs-full--ConsiderationPaidReceived_pn6n6_c20230129__20230130__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zw0eTTSzHtyg">27 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, or at the end of such 13 months, the earlier thereof). (2) Exit fee - in the occurrence of the first M&amp;A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA with SPAC, the Company is to pay a cash amount equal to <span id="xdx_903_ecustom--PaymentOfCashPercent_iI_pid_dp_c20230130__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zHb1YzdS8Vt5" title="Payment of cash percent">1.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 21 – COMMITMENTS AND CONTINGENT LIABILITIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 18.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group leases its offices and laboratory under an operating lease agreement, as well as two company cars which are all recognized within lease balances in the financial statements.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 14.2pt; text-align: justify; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As Described in Note 11 borrowings from related parties, the Company is committed to pay a bonus payment upon achieving certain goals. The Bonus Payments were examined by an external valuator and based on management’s projections and insights it has estimated that the value of the Lender’s Bonus is estimated at the amount of <span id="xdx_901_ecustom--IncreaseInCarryingAmountOfLiability_pn3n3_c20210101__20211231_zHvb7fQEgRP3" title="Carrying amount of liability">87 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2021. In August 2022, the Company signed an addendum to the loan agreement that reduces the maximum total amount of the Bonus Payments to ILS <span id="xdx_901_ecustom--BonusPayments_pn5n6_uILS_c20220801__20220831_zreJuqveumJj" title="Bonus payments">2.5 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million (approximately <span id="xdx_90B_ecustom--BonusPayments_pn3n3_c20220801__20220831_zGHQpYGTGYSd" title="Bonus payments">710</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">), to be paid upon the completion of the business combination. As of December 31, 2022, the bonus was recorded in the amount of <span id="xdx_908_eifrs-full--ShorttermBorrowings_c20221231_pn3n3">710</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 14.2pt; text-align: justify; text-indent: -14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As Described in Note 19 Government grants, the Company has a contingent liability of <span id="xdx_900_ecustom--UnpaidContingentLiabilityGovernance_pn3n3_c20220101__20221231_zkG7kvfUh9nf" title="Unpaid contingent liability governance">166 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(unpaid governance grant dependent on the Company’s future revenues) for the Israel Innovation Authority (IIA), which replaced the former Office of the Chief Scientist (OCS) for grants received to fund an approved research and development project.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.022 0.01 0.02 864000 0.0342 0.8192 P3Y 0 0.01 27000000 0.015 87000 2500000 710000 710000 166000 <p id="xdx_807_ecustom--DisclosureOfFinancialInstrumentAndRiskManagementExplanatory_zr8mjguA9euk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 22 - <span id="xdx_82A_zz80cm6JqAXl">FINANCIAL INSTRUMENTS AND RISK MANAGEMENT</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial risk management objectives</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group’s activities expose it to a variety of financial risks: foreign currency risk, credit risk and liquidity risk. The Group’s overall risk management program focuses on the unpredictability of financial markets and seeks to minimize potential adverse effects on the financial performance of the Group. The Group uses different methods to measure different types of risk to which it is exposed. These methods include sensitivity analysis in the case of interest rate, foreign exchange and other price risks, ageing analysis for credit risk and beta analysis in respect of investment portfolios to determine market risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Foreign currency risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currency risk is the risk that the value of financial instruments will fluctuate due to changes in foreign exchange rates. Currency risk arises when future commercial transactions and recognized assets and liabilities are denominated in a currency that is not the Group’s functional currency. The Group is exposed to foreign exchange risk arising from currency exposure primarily with respect to the USD and Euro. The Group’s policy is not to enter into any currency hedging transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutFinancialInstrumentAndRiskManagementForeignCurrencyExplanatory_zKdInUFVYtz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of the Group foreign currency denominated monetary liability at the reporting date are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zqhjTrbmjfq">SCHEDULE OF FOREIGN CURRENCY RISK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--Assets_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesDollarMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zYnNJnzAwqSc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,214</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--Assets_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesDollarMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zJAjZzHJHl7i" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">481</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--Liabilities_iNI_pn3n3_di_c20221231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesDollarMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zXcrw1QSuxZ2" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(99</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--Liabilities_iNI_pn3n3_di_c20211231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesDollarMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zFDGr392mQ8f" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1747">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EUR</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--Assets_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--EURMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zqpj86iXiJA7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--Assets_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--EURMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zqmbYW2FIYh5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--Liabilities_iNI_pn3n3_di_c20221231__ifrs-full--GeographicalAreasAxis__custom--EURMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_z4li0Y0omQ24" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(73</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--Liabilities_iNI_pn3n3_di_c20211231__ifrs-full--GeographicalAreasAxis__custom--EURMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zcqaFxSTJWt8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1755">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--Assets_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zGGo1kN4Li4c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,242</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--Assets_iI_pn3n3_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zCLeSpmfQKc7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">616</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--Liabilities_iNI_pn3n3_di_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_z99GunVJQOQ6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(172</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--Liabilities_iNI_pn3n3_di_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zacINhmJjrLe" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1763">—</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zaUDxoxPToMf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sensitivity analysis</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A 10% strengthening of the United States Dollar against the following currencies would have increased (decreased) equity and the income statement by the amounts shown below. This analysis assumes that all other variables, in particular interest rates, remain constant. For a 10% weakening of the United States Dollar against the relevant currency, there would be an equal and opposite impact on the profit and other equity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_ecustom--DisclosureOfDetailedInformationAboutSensitivityAnalysisProfitAndOtherEquityExplanatory_z4q6iykKI8R" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span id="xdx_8BD_zLf5T4X5vzEf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF SENSITIVITY ANALYSIS PROFIT AND OTHER EQUITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets less liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--AssetsLessCurrentLiabilities_iI_pn3n3_c20221231_zeJ0FiuOvNPi" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,115</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--AssetsLessCurrentLiabilities_iI_pn3n3_c20211231_zLhaA6bnpwF5" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">481</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--PercentageOfFinancialRiskManagement_iI_pid_dp_c20221231_ziU8tZrir0Uj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Percentage of financial risk management">10</span></td><td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--PercentageOfFinancialRiskManagement_iI_pid_dp_c20211231_zgxpxrpa7Hbe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Percentage of financial risk management">10</span></td><td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--AmountOfFinancialImpactOfFinancialInstrument_iI_pn3n3_c20221231_zeqnqW26Bt2c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Amount of financial impact of financial instrument"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--AmountOfFinancialImpactOfFinancialInstrument_iI_pn3n3_c20211231_zqsGdAYbK19c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Amount of financial impact of financial instrument"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A2_zevrxRZngkV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Price risk</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated entity is not exposed to any significant price risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest rate risk</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated entity is not exposed to any significant interest rate risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Credit risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit risk arises when a failure by counterparties to discharge their obligations could reduce the amount of future cash inflows from financial assets on hand at the balance sheet date. The Group closely monitors the activities of its counterparties and controls the access to its intellectual property which enables it to ensure the prompt collection. The Group’s main financial assets are cash and cash equivalents as well as other receivables and represent the Group’s maximum exposure to credit risk in connection with its financial assets. Wherever possible and commercially practical, the Group holds cash with major financial institutions in Israel and Australia.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eifrs-full--DisclosureOfCreditRiskExposureExplanatory_zByv5zPOfK8c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amount of financial assets represents the maximum credit exposure. The maximum exposure to credit risk at the reporting date was:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B1_zLo97Ct8hRic">SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20221231_zVy4dIf5R8fk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20211231_zqtlZBxo4vj3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_maCAz4SB_zkbF3SgCDlL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,398</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,171</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--CurrentTradeReceivables_iI_pn3n3_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_maCAz4SB_zcQM0tG28qp8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other receivables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">158</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">920</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--CurrentAssets_iTI_pn3n3_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_mtCAz4SB_zmgpJgNrkj86" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,556</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,091</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AD_zD4HiwBljBJa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 22 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Liquidity risk</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liquidity risk is the risk that arises when the maturity of assets and the maturity of liabilities do not match. An unmatched position potentially enhances profitability but can also increase the risk of loss. The Group has procedures to minimize such loss by maintaining sufficient cash and other highly liquid current assets and by having available an adequate amount of committed credit facilities. As of the balance sheet date, the Group has a positive working capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables detail the Group’s remaining contractual maturity for its financial liabilities. The tables have been drawn up based on the undiscounted cash flows of financial liabilities based on the earliest date on which the Group can be required to pay.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"> </p> <p id="xdx_89E_eifrs-full--DisclosureOfFinancialLiabilitiesExplanatory_zTDXYx1pZYAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zV4QiYKdQ172">SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">year</span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-5 years</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over 5 years</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities at amortized cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade and other payables</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zvJLlVNpZIYg" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,622</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--FinancialLiabilities_iI_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zV8toD4fM9t9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1794">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--FinancialLiabilities_iI_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zru0oOXYiIyc" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1796">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridge loans (Note 23)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_z8smcvVDKGU" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1798">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zjk44zp4Lonh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">989</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zFzi1WKX4jE6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1802">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zLyUvC0jgAz4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zcsVJnDFflL5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zFmp5TgrwYc9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1808">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zTZOsfi1xSW4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zTPJqy1lZKYj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">371</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zOUYRBUK1oZa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zxPwhgwzzde3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--FinancialLiabilities_iI_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zm93inrlfIZg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1818">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zoks2RfR7BBf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1820">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zSUnPjy0sjR3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,479</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zg1LcFyc5iB2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,444</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zFlq2Y8RcqBd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">year</span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-5 years</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over 5 years</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities at amortized cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade and other payables</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zrYVQLk3Npoi" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,589</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zyuDyKq1OKba" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1830">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zwvTAXXNXpih" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1832">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_ziX9vhMUbTrk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zBnVItfzwXTa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">272</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zWUffTwPp5k6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">193</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zkkaM7s6vz9f" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_z2umVQQEaav6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1842">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zRKxHNyx2jof" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1844">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zhSqD1Q4Lxe6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,896</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_z7yoRqHTeyA1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">272</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zfBldqqU1S1g" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">193</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><br/></b></span></p> <p id="xdx_8A7_zSQivWjpUP8c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 15%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 70%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITY MATTERS LIMITED</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands, except per share data)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <img alt="" src="fin1_001.jpg" style="height: 29.25pt; width: 77.65pt"/></span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89C_ecustom--DisclosureOfDetailedInformationAboutFinancialInstrumentAndRiskManagementForeignCurrencyExplanatory_zKdInUFVYtz1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of the Group foreign currency denominated monetary liability at the reporting date are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zqhjTrbmjfq">SCHEDULE OF FOREIGN CURRENCY RISK</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 36%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USD</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--Assets_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesDollarMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zYnNJnzAwqSc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,214</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--Assets_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesDollarMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zJAjZzHJHl7i" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">481</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--Liabilities_iNI_pn3n3_di_c20221231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesDollarMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zXcrw1QSuxZ2" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(99</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--Liabilities_iNI_pn3n3_di_c20211231__ifrs-full--GeographicalAreasAxis__custom--UnitedStatesDollarMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zFDGr392mQ8f" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1747">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">EUR</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--Assets_iI_pn3n3_c20221231__ifrs-full--GeographicalAreasAxis__custom--EURMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zqpj86iXiJA7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--Assets_iI_pn3n3_c20211231__ifrs-full--GeographicalAreasAxis__custom--EURMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zqmbYW2FIYh5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">135</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--Liabilities_iNI_pn3n3_di_c20221231__ifrs-full--GeographicalAreasAxis__custom--EURMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_z4li0Y0omQ24" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(73</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--Liabilities_iNI_pn3n3_di_c20211231__ifrs-full--GeographicalAreasAxis__custom--EURMember__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zcqaFxSTJWt8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1755">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--Assets_iI_pn3n3_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zGGo1kN4Li4c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,242</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--Assets_iI_pn3n3_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zCLeSpmfQKc7" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">616</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--Liabilities_iNI_pn3n3_di_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_z99GunVJQOQ6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(172</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--Liabilities_iNI_pn3n3_di_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zacINhmJjrLe" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1763">—</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1214000 481000 99000 28000 135000 73000 1242000 616000 172000 <p id="xdx_891_ecustom--DisclosureOfDetailedInformationAboutSensitivityAnalysisProfitAndOtherEquityExplanatory_z4q6iykKI8R" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span id="xdx_8BD_zLf5T4X5vzEf" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> SCHEDULE OF SENSITIVITY ANALYSIS PROFIT AND OTHER EQUITY</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets less liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--AssetsLessCurrentLiabilities_iI_pn3n3_c20221231_zeJ0FiuOvNPi" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,115</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--AssetsLessCurrentLiabilities_iI_pn3n3_c20211231_zLhaA6bnpwF5" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">481</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_ecustom--PercentageOfFinancialRiskManagement_iI_pid_dp_c20221231_ziU8tZrir0Uj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Percentage of financial risk management">10</span></td><td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td><td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: italic 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--PercentageOfFinancialRiskManagement_iI_pid_dp_c20211231_zgxpxrpa7Hbe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt" title="Percentage of financial risk management">10</span></td><td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_ecustom--AmountOfFinancialImpactOfFinancialInstrument_iI_pn3n3_c20221231_zeqnqW26Bt2c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Amount of financial impact of financial instrument"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">112</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_ecustom--AmountOfFinancialImpactOfFinancialInstrument_iI_pn3n3_c20211231_zqsGdAYbK19c" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Amount of financial impact of financial instrument"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1115000 481000 0.10 0.10 112000 48000 <p id="xdx_896_eifrs-full--DisclosureOfCreditRiskExposureExplanatory_zByv5zPOfK8c" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amount of financial assets represents the maximum credit exposure. The maximum exposure to credit risk at the reporting date was:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B1_zLo97Ct8hRic">SCHEDULE OF FINANCIAL ASSETS AND IMPACT OF CREDIT EXPOSURE</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_490_20221231_zVy4dIf5R8fk" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20211231_zqtlZBxo4vj3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--CashAndCashEquivalents_iI_pn3n3_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_maCAz4SB_zkbF3SgCDlL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash and cash equivalents</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,398</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,171</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eifrs-full--CurrentTradeReceivables_iI_pn3n3_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_maCAz4SB_zcQM0tG28qp8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other receivables</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">158</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">920</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--CurrentAssets_iTI_pn3n3_hifrs-full--TypesOfRisksAxis__ifrs-full--CreditRiskMember_mtCAz4SB_zmgpJgNrkj86" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,556</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,091</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1398000 4171000 158000 920000 1556000 5091000 <p id="xdx_89E_eifrs-full--DisclosureOfFinancialLiabilitiesExplanatory_zTDXYx1pZYAj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zV4QiYKdQ172">SCHEDULE OF UNDISCOUNTED FINANCIAL LIABILITIES</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">year</span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-5 years</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over 5 years</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities at amortized cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade and other payables</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zvJLlVNpZIYg" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,622</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--FinancialLiabilities_iI_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zV8toD4fM9t9" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1794">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--FinancialLiabilities_iI_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zru0oOXYiIyc" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1796">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bridge loans (Note 23)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_z8smcvVDKGU" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1798">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zjk44zp4Lonh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">989</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BridgeLoansMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zFzi1WKX4jE6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1802">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government grants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zLyUvC0jgAz4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zcsVJnDFflL5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">84</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--GovernmentGrantsMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zFmp5TgrwYc9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1808">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zTZOsfi1xSW4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zTPJqy1lZKYj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">371</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zOUYRBUK1oZa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zxPwhgwzzde3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">710</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--FinancialLiabilities_iI_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zm93inrlfIZg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1818">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zoks2RfR7BBf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1820">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zSUnPjy0sjR3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,479</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zg1LcFyc5iB2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,444</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--FinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zFlq2Y8RcqBd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1</span></p> <p style="margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">year</span></p></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-5 years</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over 5 years</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: italic 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial liabilities at amortized cost</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 58%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trade and other payables</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zrYVQLk3Npoi" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,589</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zyuDyKq1OKba" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1830">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradeAndOtherPayablesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zwvTAXXNXpih" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1832">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_ziX9vhMUbTrk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_zBnVItfzwXTa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">272</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zWUffTwPp5k6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">193</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrowings</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zkkaM7s6vz9f" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">270</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_z2umVQQEaav6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1842">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zRKxHNyx2jof" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1844">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zhSqD1Q4Lxe6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,896</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanFiveYearsMember_z7yoRqHTeyA1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">272</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eifrs-full--FinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--BorrowingMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zfBldqqU1S1g" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Financial liabilities at amortized cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">193</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><br/></b></span></p> 3622000 989000 75000 84000 72000 371000 270000 710000 4479000 1444000 270000 1589000 37000 272000 193000 270000 1896000 272000 193000 <p id="xdx_802_eifrs-full--DisclosureOfFairValueMeasurementExplanatory_z3GOHavSmTb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 23 – <span id="xdx_82B_zTqMtcCxg7dj">FAIR VALUE MEASUREMENT</span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fair value hierarchy</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables detail the consolidated entity’s assets and liabilities, measured or disclosed at fair value, using a three-level hierarchy, based on the lowest level of input that is significant to the entire fair value measurement, being:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3: Unobservable inputs for the asset or liability</span></p> <p id="xdx_895_eifrs-full--DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_z1Avs7FHMtpf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B7_zGSmfi3uLoT" style="display: none">SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative financial liabilities (Note 22)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zUaaWKtMlare" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1856">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zWDN5JZ8a129" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1858">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_z2aWkUeJPzQl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,693</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zYnxL0G3wLz6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,693</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zA93umJMesW9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1864">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z6BaHoWudtBc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1866">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zXPGJJ9HeF2d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,693</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231_zkzKzBk1KVbf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,693</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative financial liability</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--DerivativeFinancialLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zGh5SLeuJG33" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1872">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_z5JjV6BPYWa2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--DerivativeFinancialLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zpq8S91J0CAe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1876">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_z62wvfpemKIb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--DerivativeFinancialLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_znPRKGzuzR8k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1880">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zIZfnnBVPvUh" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--DerivativeFinancialLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zN4crBA1GgUe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1884">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20211231_zyIsb8WwVqN9" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_zoqLy5zQzGH9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_895_eifrs-full--DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_z1Avs7FHMtpf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B7_zGSmfi3uLoT" style="display: none">SCHEDULE OF UNOBSERVABLE FOR ASSETS OR LIABILITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative financial liabilities (Note 22)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zUaaWKtMlare" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1856">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zWDN5JZ8a129" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1858">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_z2aWkUeJPzQl" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,693</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_986_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zYnxL0G3wLz6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,693</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zA93umJMesW9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1864">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z6BaHoWudtBc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1866">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zXPGJJ9HeF2d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,693</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--DerivativeFinancialLiabilities_iI_c20221231_zkzKzBk1KVbf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,693</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">US$ in thousands</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative financial liability</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eifrs-full--DerivativeFinancialLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zGh5SLeuJG33" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1872">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_z5JjV6BPYWa2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--DerivativeFinancialLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_zpq8S91J0CAe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1876">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--DerivativesMember_z62wvfpemKIb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--DerivativeFinancialLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_znPRKGzuzR8k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1880">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zIZfnnBVPvUh" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--DerivativeFinancialLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zN4crBA1GgUe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1884">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eifrs-full--DerivativeFinancialLiabilities_iI_pn3n3_c20211231_zyIsb8WwVqN9" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Derivative financial liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2693000 2693000 2693000 2693000 32000 32000 32000 32000 <p id="xdx_806_eifrs-full--DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_zFjsAVYrd5s6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 24 – <span id="xdx_821_zzrbwWQrUnB6">SUBSEQUENT EVENTS</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the reporting date the following significant events have occurred:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.55pt 0pt 0.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 25, 2023, the Company issued <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pid_c20230125__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zyuSJxPoB51g" title="Number of shares issued">250,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in principal amount of</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> convertible notes for an aggregate amount of <span id="xdx_90C_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20230124__20230125__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zX6faJEEOqz7">250</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. These convertible notes have a maturity date of the earlier between <span id="xdx_900_eifrs-full--BorrowingsMaturity_pid_c20230124__20230125__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zzirA7QwOJvd">December 31, 2024</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and the date of any change in control (excluding the Business Combination). The convertible notes has an interest rate of <span id="xdx_90C_ecustom--PercentageOfConvertibleNotes_pid_uPure_c20230124__20230125__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zwLrPNR8v7zh">15% </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">per annum. The convertible notes shall be converted into common shares at a conversion price of USD 10.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2023, the Company signed an amendment to the agreement with Isorad that determine the following: (1) for the BCA with Lionheart, Isorad was issued (a) <span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pid_c20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IsoradLtdMember_zGJBJjJ6pyA7">864,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">options to purchase shares of the Company, the options were issued in January 2023 and valued using the Black-Scholes pricing model. The main parameters which were used are: (1) risk-free rate: <span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230101__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IsoradLtdMember_zwGqGwKpusqf">3.42</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%; (2) expected volatility: <span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230101__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IsoradLtdMember_zRYseArubzh1">81.92</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%: (3) expected term: up to <span id="xdx_90A_ecustom--DescriptionOfExpectedTermWarrants_dtY_c20230101__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IsoradLtdMember_z0UvH6DepoQ7" title="Description of expected term warrants">3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years; and (4) expected dividend yield: <span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_dp_uPure_c20230101__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--MeasurementAxis__custom--BlackScholesPricingModelMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IsoradLtdMember_zrRW6pjBnJeg">0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%; (b) <span id="xdx_902_ecustom--DescriptionForEquityOrOtherFundingConvertible_pn6n6_c20230101__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IsoradLtdMember_z0ctRhWQF6nl" title="Description for equity or other funding convertible">Additionally, Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(to be paid after reaching an aggregated received amount of <span id="xdx_903_ecustom--PaymentsForProceedFromReceivingEquityOrOtherFundingConvertibleIntoEquity_pn6n6_c20230101__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IsoradLtdMember_zT5zawfGBei6" title="Payments for proceed from receiving equity or other funding convertible into equity">27 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million, or at the end of such 13 months, the earlier thereof). (2) Exit fee - in the occurrence of the first M&amp;A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA with SPAC, the Company is to pay a cash amount equal to <span id="xdx_909_ecustom--PercentageOfCashOnExitFee_pid_dp_uPure_c20230101__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IsoradLtdMember_z9lkuyp7m58i" title="Percentage of cash on exit fee">1.5</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 2, 2023, the Group signed an amendment that postponed the Bonus payment from borrowing from related party to March 31, 2024 (see Note 11).</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2023, SMX PLC entered a Standby Equity Facility to raise up to USD $<span id="xdx_90C_eifrs-full--IssuedCapitalOrdinaryShares_iI_pn3n3_c20230228__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SMXPublicLimitedCompanyMember_z1Sm5g5HNVig" title="Issued capital ordinary shares">25,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of common stock over the course of 36 months. SMX PLC will issue to the investor the common stock at a purchase price as one of two options (i) equal to <span id="xdx_90A_ecustom--PercentageOfWeightedAveragePriceOfCommonStock_pid_dp_uPure_c20230201__20230228__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SMXPublicLimitedCompanyMember_zYdOtY2xSErl" title="Percentage of weighted average price of common stock">96</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period (ii) equal to <span id="xdx_90D_ecustom--PercentageOfCommonStock_pid_dp_uPure_c20230201__20230228__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SMXPublicLimitedCompanyMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zomTvU93ATQ" title="Percentage of common stock">97</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period. SMX PLC issued in advance part of the common stocks for proceeds of $<span id="xdx_907_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20230201__20230228__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SMXPublicLimitedCompanyMember_zzuPpFbzQCa5" title="Proceeds from issuing shares">3,500 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as follows <span id="xdx_90A_ecustom--DescriptionForCommonStockReceivedAndEffectivenessOfResgistration_pn3n3_c20230201__20230228__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--SMXPublicLimitedCompanyMember_zXKvp4qouMRd" title="Description for common stock received and effectiveness of resgistration">(i) $1,500 at the initial closing (was received on March 2023) (ii) $2,000 upon effectiveness of a registration statement that was initially filed in March 2023.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2023, the Company entered into an additional bridge loan agreement (the “Additional Bridge Loans”), in which the Company raised an aggregate amount of $<span id="xdx_90C_eifrs-full--ProceedsFromBorrowingsClassifiedAsFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_znSoLSCYS2L2" title="Proceeds from borrowings, classified as financing activities">550</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Additional Bridge Loans have a maturity date of up to two years and bears interest rate of <span id="xdx_90D_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20231231__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zt4Ujs4hMAja" title="Borrowings, interest rate">10</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2023, the Group signed an addendum to the Bridge Loans agreements (see also Note 12) which converted $<span id="xdx_90A_ecustom--NumberOfValueConverted_pn3n3_c20230301__20230331__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zgsHyb08Z6B9" title="Number of value converted">1,350</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">into common shares and deferred</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> the remaining cash payments to March 31, 2024.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 7, 2023, certain of the Company’s Convertible Notes (see also Note 6) were converted to <span id="xdx_907_ecustom--NumberOfSharesConverted_pid_c20230306__20230307__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zwR4THnkLUii" title="Number of shares converted">1,000,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary shares of the Company.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements were authorized for issuance on April 25, 2023.</span></td></tr></table> <p style="margin-top: 0; margin-bottom: 0"></p> <p id="xdx_89A_ecustom--DisclosureOfWeightedAverageLossPerShareExplanatory_zpCWLs04hLc6" style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_8B3_zh5kEGrEXHb3" style="display: none">SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE</span></span></p> <p style="margin-top: 0; margin-bottom: 0"></p> 250000 250000 December 31, 2024 0.15 864000 0.0342 0.8192 P3Y 0 Additionally, Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter 27000000 0.015 25000000 0.96 0.97 3500000 (i) $1,500 at the initial closing (was received on March 2023) (ii) $2,000 upon effectiveness of a registration statement that was initially filed in March 2023. 550000 0.10 1350000 1000000 <p id="xdx_89A_ecustom--DisclosureOfWeightedAverageLossPerShareExplanatory_zpCWLs04hLc6" style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_8B3_zh5kEGrEXHb3" style="display: none">SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE</span></span></p> <p style="margin-top: 0; margin-bottom: 0"></p> 25000 25000 25000 25000 <p id="xdx_800_eifrs-full--DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_zEgy5UAoG8D4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="link_003"></span>NOTE 1 – <span id="xdx_820_zW4lHsh6S2f9">GENERAL</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX (Security Matters) Public Limited Company (the “Company”) was incorporated in July 1, 2022 under the laws of Ireland with registered number 722009 and its registered office at Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">B.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Corporation has not engaged in any activities except in connection with its formation.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On July 26, 2022, Security Matters Limited and Lionheart III Corp (“Lionheart”), a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (“BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders receiving Security Matters Limited shares and warrants in exchange for their existing Lionheart shares and warrants and all shares in Security Matters Limited being cancelled in return for the Company’s shares and resulting in that Security Matters Limited becoming a wholly owned subsidiary of the Company.</p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On March 7, 2023 a business combination (the “Business Combination”) with Lionheart III Corp (“Lionheart”) was completed, following that the Company, which is newly-formed parent company – SMX (Security Matters) Public Limited Company, (formerly called Empatan Public Limited Company) was listed in the NASDAQ stock exchange under the ticker SMX.</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 21.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80C_eifrs-full--DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_zhxM6lSnmqq4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – <span id="xdx_82C_zkizsk8TcFc">SIGNIFICANT ACCOUNTING POLICIES</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The significant accounting policies followed in the preparation of the financial statements, on a consistent basis, are:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84E_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zoPy7qtLmuWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zBT8H6FKlYla">Basis of preparation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). Separate statements of comprehensive income, changes in equity, and cash flows have not been presented because the Corporation has not engaged in any activities except in connection with its formation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_ziENOiWmLac4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zjs4kA6ctQi8">Cash and cash equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash equivalents are considered by the Company to be highly liquid investments, including, inter alia, short-term deposits with banks and the maturity of which do not exceed three months at the time of deposit, and which are not restricted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zvucCa9rT5Uh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zGOOZZku0nHg">Foreign currency</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements are prepared in EURO which is the presentation and functional currency of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84E_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zoPy7qtLmuWb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zBT8H6FKlYla">Basis of preparation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) as issued by the International Accounting Standards Board (“IASB”). Separate statements of comprehensive income, changes in equity, and cash flows have not been presented because the Corporation has not engaged in any activities except in connection with its formation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_ziENOiWmLac4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zjs4kA6ctQi8">Cash and cash equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash equivalents are considered by the Company to be highly liquid investments, including, inter alia, short-term deposits with banks and the maturity of which do not exceed three months at the time of deposit, and which are not restricted.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zvucCa9rT5Uh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zGOOZZku0nHg">Foreign currency</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements are prepared in EURO which is the presentation and functional currency of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_80F_eifrs-full--DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_zxSCCgawaxp2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_828_z10SYcPEQz89">SHAREHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The ordinary shares in the Company confer upon their holders the right to receive notice to participate and vote in general meetings of the Company, and the right to receive dividends, if and when declared.</span></td></tr></table> <p id="xdx_893_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_zRwteFxlE4Jj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_z0WsxWYxhjU7" style="display: none">SCHEDULE OF ORDINARY SHARES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of shares</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 1, 2022</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized</b></span></p></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued and outstanding</b></span></p></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized</b></span></p></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued and outstanding</b></span></p></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%"><p style="margin-top: 0pt; margin-bottom: 0pt">Ordinary shares</p> <p style="margin-top: 0pt; margin-bottom: 0pt">USD <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9SRElOQVJZIFNIQVJFUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eifrs-full--ParValuePerShare_iI_c20221231_zo6EUjEUWWdb">0.0001</span> par value</p></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: center"><span id="xdx_908_eifrs-full--NumberOfSharesAuthorised_iI_c20221231_ze1xBXp5nAJf" title="Number of shares authorized">500,000,000</span></td><td style="width: 1%; text-align: center"> </td><td style="text-align: center; width: 2%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 12%; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_90C_ecustom--NumberOfSharesIssuedAndOutstanding_iI_c20221231_ziM3dh1pFIQg" title="Number of shares issued and outstanding">1</span></p></td><td style="width: 1%; text-align: center"> </td><td style="text-align: center; width: 2%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 12%; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_90E_eifrs-full--NumberOfSharesAuthorised_iI_c20220701_zR1h6m3YVkjd" title="Number of shares authorized">500,000,000</span></p></td><td style="width: 1%; text-align: center"> </td><td style="text-align: center; width: 2%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 12%; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_90D_ecustom--NumberOfSharesIssuedAndOutstanding_iI_c20220701_z6hr5L698oua" title="Number of shares issued and outstanding">1</span></p></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Deferred Shares<br/> EURO <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9SRElOQVJZIFNIQVJFUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eifrs-full--ParValuePerShare_iI_uEuroPerShare_c20221231_zvYuquYmDm64">1</span> par value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_909_eifrs-full--NumberOfSharesAuthorised_iI_c20221231__ifrs-full--ComponentsOfEquityAxis__custom--DeferredSharesMember_zWPjzwMaF3xl" title="Number of shares authorized">25,000</span></p></td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_906_ecustom--NumberOfSharesIssuedAndOutstanding_iI_c20221231__ifrs-full--ComponentsOfEquityAxis__custom--DeferredSharesMember_z4pNpo1uB4ca" title="Number of shares issued and outstanding">25,000</span></p></td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-</p></td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-</p></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AA_zDUnO6NE1RRk" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have no par value and the company does not have a limited amount of authorised capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Deferred shares</i></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 20pt; text-align: justify">Deferred Ordinary Shares are non-voting shares and do not convey upon the holder the right to be paid a dividend or to receive notice of or to attend, vote or speak at a general meeting. The Deferred Shares confer the right on a return of capital, on a winding-up or otherwise, only to the repayment of the nominal value paid up on the Deferred Shares after repayment of the nominal value of the Ordinary Shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_zRwteFxlE4Jj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_z0WsxWYxhjU7" style="display: none">SCHEDULE OF ORDINARY SHARES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of shares</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">July 1, 2022</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized</b></span></p></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued and outstanding</b></span></p></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized</b></span></p></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued and outstanding</b></span></p></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%"><p style="margin-top: 0pt; margin-bottom: 0pt">Ordinary shares</p> <p style="margin-top: 0pt; margin-bottom: 0pt">USD <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9SRElOQVJZIFNIQVJFUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eifrs-full--ParValuePerShare_iI_c20221231_zo6EUjEUWWdb">0.0001</span> par value</p></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: center"><span id="xdx_908_eifrs-full--NumberOfSharesAuthorised_iI_c20221231_ze1xBXp5nAJf" title="Number of shares authorized">500,000,000</span></td><td style="width: 1%; text-align: center"> </td><td style="text-align: center; width: 2%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 12%; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_90C_ecustom--NumberOfSharesIssuedAndOutstanding_iI_c20221231_ziM3dh1pFIQg" title="Number of shares issued and outstanding">1</span></p></td><td style="width: 1%; text-align: center"> </td><td style="text-align: center; width: 2%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 12%; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_90E_eifrs-full--NumberOfSharesAuthorised_iI_c20220701_zR1h6m3YVkjd" title="Number of shares authorized">500,000,000</span></p></td><td style="width: 1%; text-align: center"> </td><td style="text-align: center; width: 2%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 12%; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_90D_ecustom--NumberOfSharesIssuedAndOutstanding_iI_c20220701_z6hr5L698oua" title="Number of shares issued and outstanding">1</span></p></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Deferred Shares<br/> EURO <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE9SRElOQVJZIFNIQVJFUyAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eifrs-full--ParValuePerShare_iI_uEuroPerShare_c20221231_zvYuquYmDm64">1</span> par value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_909_eifrs-full--NumberOfSharesAuthorised_iI_c20221231__ifrs-full--ComponentsOfEquityAxis__custom--DeferredSharesMember_zWPjzwMaF3xl" title="Number of shares authorized">25,000</span></p></td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_906_ecustom--NumberOfSharesIssuedAndOutstanding_iI_c20221231__ifrs-full--ComponentsOfEquityAxis__custom--DeferredSharesMember_z4pNpo1uB4ca" title="Number of shares issued and outstanding">25,000</span></p></td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-</p></td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">-</p></td><td style="text-align: left"> </td></tr> </table> 0.0001 500000000 1 500000000 1 1 25000 25000 <p id="xdx_804_eifrs-full--DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_z37G2Z4DLXc9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_82B_zkv63d49jrh9">SUBSEQUENT EVENTS</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 20pt; text-indent: -0.25in; color: #231F20"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">1.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #231F20">In February 2023, the Company entered a Standby Equity Facility to raise up to USD <span id="xdx_901_eifrs-full--IssuedCapitalOrdinaryShares_iI_pid_c20230228__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zDm0P7JlSm2d" title="Issued capital, ordinary shares">25,000</span> thousand of common stock over the course of 36 months. the Company will issue to the investor the common stock at a purchase price as one of two options (i) equal to <span id="xdx_906_ecustom--PercentageOfWeightedAveragePriceOfCommonStock_pid_dp_uPure_c20230201__20230228__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_z0m3g5dKC43e" title="Percentage of weighted average price of common stock">96</span>% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period (ii) equal to <span id="xdx_907_ecustom--PercentageOfCommonStock_pid_dp_uPure_c20230201__20230228__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4DTXsEYRHw" title="Percentage of common stock">97</span>% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period. the Company issued in advance part of the common stocks for proceeds of USD <span id="xdx_901_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20230201__20230228__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zNiF2CeHROx7" title="Proceeds from common stock">3,500</span> thousand as follows <span id="xdx_90E_ecustom--DescriptionForCommonStockReceivedAndEffectivenessOfResgistration_c20230201__20230228__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zngz6YLKc268" title="Description for common stock received and effectiveness of resgistration">(i) USD 1,500 thousand at the initial closing (was received on March 2023) (ii) USD 2,000 thousand upon effectiveness of a registration statement that was filed on March 2023</span>.</p></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #231F20">2.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #231F20">On January 25, 2023, Security Matters Limited issued <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pid_c20230125__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zvcHbxhNqQLh" title="Number of shares issued">250,000</span> convertible notes for an aggregate amount of USD <span id="xdx_90C_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20230124__20230125__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zGDZIpsVeVZj" title="Aggregate amount of convertible instruments issued">250</span> thousand. These convertible notes have a maturity date of the earlier between <span id="xdx_907_eifrs-full--BorrowingsMaturity_pid_c20230124__20230125__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zDfZtY0UznH" title="Convertible instrument, maturity date">December 31, 2024</span> and the date of any change in control (excluding the Business Combination). The convertible notes have an interest rate of <span id="xdx_90C_ecustom--PercentageOfConvertibleNotes_pid_uPure_c20230124__20230125__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zszpQ3sI2FX" title="Percentage of convertible notes">15</span>% per annum. The convertible notes shall be converted into common shares of the Company at a conversion price of USD <span id="xdx_903_ecustom--ConversionPrice_pid_c20230124__20230125__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zPXCojt23JA7" title="Conversion price">10</span>.</p></td></tr> </table> <p style="margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; color: #231F20"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – SUBSEQUENT EVENTS (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Between August 2022 to January 2023, Security Matters Limited entered into bridge loan agreements (the “Bridge Loans”) with eleven lenders, which lent Security Matters Limited an aggregate amount of USD <span id="xdx_909_ecustom--ProceedsFromLoansAndWarrants_pn3n3_c20220801__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ElevenLendersMember_zKCiQhX6sJa9" title="Proceeds from loans and warrants">3,860</span> thousand. The Bridge Loans have a maturity date of up to <span id="xdx_90A_eifrs-full--BorrowingsMaturity_c20220801__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zcjoSqQir4Gl">two years</span> and bear interest rate of <span id="xdx_90B_eifrs-full--BorrowingsInterestRate_iI_dp_uPure_c20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zGQQoz6rYsi1">10</span>% per annum. The Bridge Loans were accounted for in accordance with amortized cost method.</p></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 18.5pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 18.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the Bridge Loans agreements, the lenders were granted with two types of warrants:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 18.5pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 40pt"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Bonus Warrants – <span id="xdx_902_ecustom--WarrantsToPurchaseShares_pid_c20220801__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--BonusWarrantsMember_z7WgzEVrw28f" title="Warrants to purchase, shares">243,000</span> warrants to purchase ordinary shares of the Company at an exercise price of USD <span id="xdx_90F_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20220801__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--BonusWarrantsMember_zui8rlZ1Go1" title="Exercise price of share">11.50</span> per share. The Bonus Warrants term is <span id="xdx_90D_eifrs-full--BorrowingsMaturity_c20220801__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--BonusWarrantsMember_zIWFaOh8sr6a" title="Loans maturity date">five years</span> commencing upon the Business Combination.</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify; text-indent: -16.95pt; color: #231F20"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 40pt"></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Redeemable Warrants – <span id="xdx_905_ecustom--WarrantsToPurchaseShares_pid_c20220801__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsMember_zqwnYMhlT2se" title="Warrants to purchase, shares">597,000</span> warrants to purchase ordinary shares of the Company at a purchase price of USD <span id="xdx_909_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_pid_c20220801__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsMember_zbH0QA7KeEme" title="Exercise price of share warrants">11.50</span> per share. The Redeemable Warrants term is <span id="xdx_90C_eifrs-full--BorrowingsMaturity_c20220801__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsMember_zHLi98p3Wnig" title="Loans maturity date">five years</span> commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD <span id="xdx_90F_eifrs-full--ParValuePerShare_iI_pid_c20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--BusinessCombinationsAxis__custom--RedeemableWarrantsMember_zv0VCmRqXW1h" title="Per shares">5.00</span> per warrant.</p></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 35.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eifrs-full--DescriptionOfApproachUsedToDetermineDiscountRates_c20220801__20230131__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zyy4NFxpcm26">Each investor has the option to decide that Security Matters Limited will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 18.2pt; text-align: justify; text-indent: 0.3pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 18.2pt; text-align: justify; text-indent: 0.3pt">In March 2023, Security Matters Limited signed an addendum to the Bridge Loans agreements which convert USD <span id="xdx_90E_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20230301__20230331__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zmBixl3dMqsi" title="Aggregate amount of convertible instruments issued">1,350</span> thousand into common shares and defer the payments to March 31, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 18.2pt; text-align: justify; text-indent: 0.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="color: #231F20"> </span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">4.</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-right: 0; margin-left: 0">The Company’s board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan, which was subsequently amended on April 25, 2023, which reserved for grant a number of Ordinary Shares equal to <span id="xdx_905_ecustom--NumberOfIssuedAndOutstandingOrdinarySharesPercentage_pid_dp_c20230425__20230425__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zBvD4Rfl8Wfj" title="Number of issued and outstanding ordinary shares percentage">15</span>% of the number of issued and outstanding Ordinary Shares on a fully diluted basis immediately after the closing of the Business Combination, or <span id="xdx_907_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230425__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zghH2EUlTMX" title="Number of shares authorized">5,082,417</span> authorized ordinary shares.<span style="color: #231F20"> </span></p> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements were authorized for issuance on April 25, 2023.</span></td></tr></table> 25000 0.96 0.97 3500000 (i) USD 1,500 thousand at the initial closing (was received on March 2023) (ii) USD 2,000 thousand upon effectiveness of a registration statement that was filed on March 2023 250000 250000 December 31, 2024 15 10 3860000 two years 0.10 243000 11.50 five years 597000 11.50 five years 5.00 Each investor has the option to decide that Security Matters Limited will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20 trading day VWAP preceding each such anniversary 1350000 0.15 5082417 3020000 1398000 1037000 3673000 4057000 5071000 820000 969000 5269000 5027000 112000 221000 6201000 6217000 10258000 11288000 7281000 2972000 30000 30000 2415000 650000 304000 563000 856000 3050000 2363000 3682000 689000 710000 16988000 4925000 403000 440000 938000 3930000 85000 5271000 4207000 22259000 9132000 51730000 32711000 -702000 -537000 -63029000 -30020000 -12001000 2156000 10258000 11288000 1172000 933000 228000 378000 13350000 1200000 16802000 -31552000 -2511000 1143000 105000 2496000 36000 104000 -33009000 -2442000 -33009000 -2442000 -165000 -639000 -165000 -639000 -33174000 -3081000 -39.46 -39.46 -3.36 -3.36 32713000 -537000 -30020000 2156000 -33009000 -33009000 -165000 -165000 -165000 -33009000 -33174000 170000 170000 11460000 11460000 2092000 2092000 175000 175000 2983000 2983000 10000 10000 290000 290000 1837000 1837000 51730000 -702000 -63029000 -12001000 31504000 223000 -23836000 7891000 -2442000 -2442000 -639000 -639000 -639000 -2442000 -3081000 721000 721000 219000 219000 32444000 -416000 -26278000 5750000 -33009000 -2442000 2052000 165000 114000 176000 2575000 -1727000 2545000 831000 70000 110000 13000 32000 -41000 1421000 -7000 -28000 14000 -89000 382000 -104000 -40000 -54000 16802000 -7675000 -2862000 10000 183000 383000 783000 -393000 -966000 21000 39000 250000 581000 914000 923000 974000 550000 30000 3220000 2923000 9703000 542000 1635000 -3286000 1398000 4171000 -13000 -26000 3020000 859000 450000 290000 2983000 2229000 175000 <p id="xdx_801_eifrs-full--DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_zRLByVZFMHx6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_006"></span>NOTE 1 - <span id="xdx_826_z5ROAjDEnwG3">GENERAL</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX (Security Matters) Public Limited Company (“Security Matters” or the “Company” and together with its subsidiaries, the “Group”) was incorporated in July 1, 2022 under the laws of Ireland with registered number 722009 and its registered office at Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6. The Company was incorporated in 2022 as part of the Business Combination (see Note 1.B).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer. Its proprietary marker system embeds a permanent or removable (depending on the needs of the customer) mark on solid, liquid or gaseous objects or materials. Each marker is comprised of a combination of marker codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with an innovative patented reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers or on a blockchain ledger, to protect data integrity and custody.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Business Combination - the SPAC transaction (“Business Combination”):</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 7, 2023 (the “Closing Date”) the Company completed its Business Combination with Lionheart III Corp (“Lionheart”), following that Lionheart and Security Matters PTY Ltd. (formerly named Security Matters Limited, which was incorporated in May 2018 under Australian law) became the Company’s wholly-owned subsidiaries and the Company listed its ordinary shares and public warrants on the NASDAQ stock market under the tickers SMX and SMXWW, respectively. On July 26, 2022, Security Matters PTY Ltd. and Lionheart, a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (the “BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders received the Company’s shares and warrants in exchange for their existing Lionheart shares and warrants and all shares existed in Security Matters PTY Ltd were cancelled in return for the Company’s shares and resulting in Security Matters PTY Ltd. becoming a wholly owned subsidiary of the Company. Security Matters PTY Ltd. shareholders received consideration of <span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_c20220726__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__srt--ConsolidatedEntitiesAxis__custom--SecurityMattersPTYLtdMember_zzuAgVGkpaSc" title="Number of shares issued">1</span> ordinary share per <span id="xdx_900_ecustom--ShareIssuedPricePerShare_iI_pid_c20220726__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__srt--ConsolidatedEntitiesAxis__custom--SecurityMattersPTYLtdMember_zxLUSBkgRh69" title="Share price">10.3624</span> Security Matters PTY Ltd. shares, having an implied value of $<span id="xdx_906_eifrs-full--ParValuePerShare_iI_pid_c20220726__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__srt--ConsolidatedEntitiesAxis__custom--SecurityMattersPTYLtdMember_z4RthgpPmVL6" title="Implied value">10.00</span> per ordinary share and the Company became the holder of all of the issued shares in Security Matters PTY Ltd. and Lionheart, with Security Matters PTY Ltd. being delisted from the Australian Stock Exchange.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Business Combination resulted in <span id="xdx_90A_ecustom--RedemptionPercentageOfBusinessCombination_pid_dp_uPure_c20220726__20220726__ifrs-full--BusinessCombinationsAxis__custom--LionheartMember__ifrs-full--TypesOfContractsAxis__custom--BusinessCombinationAgreementMember_z47kPVrBix7d" title="Redemption percentage of business combination">97.58</span>% redemption by Lionheart’s public shareholders which resulted in leaving $<span id="xdx_907_ecustom--RemainingFundsInTrustAccount_pn3n3_c20220726__20220726__ifrs-full--BusinessCombinationsAxis__custom--LionheartMember__ifrs-full--TypesOfContractsAxis__custom--BusinessCombinationAgreementMember_zwsjzEyRebSl" title="Remaining funds in trust account">3,061</span> of funds remaining in the trust account (See also Note 6 and Note 2.E as for the accounting treatment of the transaction in these financial statements).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – GENERAL (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates primarily through 8 wholly owned subsidiaries, all of which have been consolidated in these consolidated financial statements.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_zCD82EFXsLo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF COMPANIES SUBSIDIARIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 97%; border-collapse: collapse; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Controlled entity</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 51%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters PTY Ltd. <br/> (Formerly - Security Matters Limited)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zXmxpdjTM1c3" title="Country of Incorporation">Australia</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_z8GZCYtFMXDk" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zOcLCs4Eq3Lc" title="Proportion of ownership interest in subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl2425">-</span></span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lionheart III Corp</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_z9H25GN9t7Ja" title="Country of Incorporation">USA</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zbN9Z7rTX3mc" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_fKio___zKwo20GBVko3" title="Proportion of ownership interest in subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl2431">-</span></span></span>**</td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX Circular Economy Platform PTE, Ltd.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_zZQfP3mpzsj4" title="Country of Incorporation">Singapore</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_zeUshpG1WiB2" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_fKg_____z2LrNki8Ul23" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2436">-</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX (Security Matters) Ireland Limited</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_zkVNAtU9rvW1" title="Country of Incorporation">Ireland</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_z94zcRewKbE" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_fKg_____zhcAlhvK87ec" style="display: none" title="Proportion of ownership interest in subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl2442">-</span></span>*</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX (Security Matters) Israel Ltd. <br/> (Formerly - Security Matters Ltd.)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zJOFQTfal3of" title="Country of Incorporation">Israel</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zZJiOYecCY3l" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_fKioq_znLUdXuxe9P3" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%***</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters Canada Ltd.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_zOdhxMdMhMm4" title="Country of Incorporation">Canada</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_zrV6Q7Kq12x4" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_fKioq_zxLlaCQSsXN8" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%***</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters France Ltd.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersFranceLtdMember_zdKQ1xY3J30b" title="Country of Incorporation">France</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersFranceLtdMember_znNCQIO89Fhd" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersFranceLtdMember_fKioq_zd3uBNj4ZaMg" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%***</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX Beverages Pty Ltd.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zXUXOJGmdkAd" title="Country of Incorporation">Australia</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zaMbju0MHOQa" title="Percentage Owned">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_fKioq_z9VNsU9ZOZy8" title="Percentage Owned">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%***</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, the Company’s has the following investments in associated companies:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 97%; border-collapse: collapse; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entity</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 51%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yahaloma Technologies Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_z9ZCyJ3JWdlg" title="Country of Incorporation">Canada</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zL33ROkVpkZ3" title="Proportion of ownership interest in subsidiary">50</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_fKioq_zkzfLu7DH374" title="Proportion of ownership interest in subsidiary">50</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%***</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">True Gold Consortium Pty Ltd</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_zvEmLLQm0GG9" title="Country of Incorporation">Australia</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_z2bkqj0Yb0vh" title="Percentage Owned">44.4</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_fKioq_zXTwlGxjWVq7" title="Percentage Owned">44.4</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%***</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The proportion of ownership interest is equal to the proportion of voting power held.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 20px; padding-bottom: 6pt; text-align: right"><span id="xdx_F0D_zjDbUZyarnU4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; text-align: justify"><span id="xdx_F1F_zxIeEdU501bk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated in 2023.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; text-align: right"><span id="xdx_F0C_z10SIfEmMrzj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; text-align: justify"><span id="xdx_F1F_z9ihww6sHDyj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger occurred in March 2023.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; text-align: right"><span id="xdx_F06_z87zvtfV2Dif" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; text-align: justify"><span id="xdx_F17_zNRJBq90Og7h" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2022.</span></td></tr> </table> <p id="xdx_8A5_zjUHmHGB8Oy4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months ended June 30, 2023, the Company incurred operating losses and negative cash flows from operating activities. The Company has not yet generated revenues. As discussed in Note 4, during the period, the Company entered into binding loan agreements with existing shareholders. As discussed in Note 5.1, the Company executed an equity line agreement to raise up to $<span id="xdx_90B_ecustom--StockIssuedDuringPeriodValueConsiderationOfIssuanceOfCommonStock_pn3n3_c20230101__20230630__ifrs-full--TypesOfContractsAxis__custom--EquityLineAgreementMember_z28nLAIqYZF" title="Consideration of issuance of common stock">25,000</span> in consideration of the issuance of common stock over the course of 36 months with YA II PN, LTD (“Yorkville”). As discussed in Notes 4 and 9.4, the Company signed agreements to convert indebtedness by issuance of shares. As discussed in Note 9.3 the Company is continuing with additional capital raising, and post balance sheet date it received an additional $<span id="xdx_90C_ecustom--AdditionalPaidInCapitalinFunding_iI_pn3n3_c20230630__ifrs-full--TypesOfContractsAxis__custom--EquityLineAgreementMember_zp6dAzSgiFYc" title="Additional capital raising">2,500</span> in funding. The Company has also the ability to decrease its expenses in order to meet its existing cash flow streams. Management believes that the proceeds from the recent funding agreements, combined with its cash on hand, equity line and the Company’s plans, are sufficient to meet the Company’s obligations as they come due in the foreseeable future. There are no assurances, however, that the Company will be able to obtain an adequate level of financial resources that are required for its long-term business plan.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 1 10.3624 10.00 0.9758 3061000 <p id="xdx_89F_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_zCD82EFXsLo4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; display: none"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF COMPANIES SUBSIDIARIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 97%; border-collapse: collapse; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Controlled entity</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 51%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters PTY Ltd. <br/> (Formerly - Security Matters Limited)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zXmxpdjTM1c3" title="Country of Incorporation">Australia</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_z8GZCYtFMXDk" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zOcLCs4Eq3Lc" title="Proportion of ownership interest in subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl2425">-</span></span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lionheart III Corp</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_z9H25GN9t7Ja" title="Country of Incorporation">USA</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zbN9Z7rTX3mc" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_fKio___zKwo20GBVko3" title="Proportion of ownership interest in subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl2431">-</span></span></span>**</td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX Circular Economy Platform PTE, Ltd.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_zZQfP3mpzsj4" title="Country of Incorporation">Singapore</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_zeUshpG1WiB2" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_fKg_____z2LrNki8Ul23" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2436">-</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX (Security Matters) Ireland Limited</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_zkVNAtU9rvW1" title="Country of Incorporation">Ireland</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_z94zcRewKbE" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_fKg_____zhcAlhvK87ec" style="display: none" title="Proportion of ownership interest in subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl2442">-</span></span>*</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX (Security Matters) Israel Ltd. <br/> (Formerly - Security Matters Ltd.)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zJOFQTfal3of" title="Country of Incorporation">Israel</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zZJiOYecCY3l" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_fKioq_znLUdXuxe9P3" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%***</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters Canada Ltd.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_zOdhxMdMhMm4" title="Country of Incorporation">Canada</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_zrV6Q7Kq12x4" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_fKioq_zxLlaCQSsXN8" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%***</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters France Ltd.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersFranceLtdMember_zdKQ1xY3J30b" title="Country of Incorporation">France</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersFranceLtdMember_znNCQIO89Fhd" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersFranceLtdMember_fKioq_zd3uBNj4ZaMg" title="Proportion of ownership interest in subsidiary">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%***</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX Beverages Pty Ltd.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zXUXOJGmdkAd" title="Country of Incorporation">Australia</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zaMbju0MHOQa" title="Percentage Owned">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_fKioq_z9VNsU9ZOZy8" title="Percentage Owned">100</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%***</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, the Company’s has the following investments in associated companies:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 97%; border-collapse: collapse; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entity</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 51%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yahaloma Technologies Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_z9ZCyJ3JWdlg" title="Country of Incorporation">Canada</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zL33ROkVpkZ3" title="Proportion of ownership interest in subsidiary">50</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_fKioq_zkzfLu7DH374" title="Proportion of ownership interest in subsidiary">50</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%***</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">True Gold Consortium Pty Ltd</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_zvEmLLQm0GG9" title="Country of Incorporation">Australia</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_z2bkqj0Yb0vh" title="Percentage Owned">44.4</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_fKioq_zXTwlGxjWVq7" title="Percentage Owned">44.4</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%***</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The proportion of ownership interest is equal to the proportion of voting power held.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 20px; padding-bottom: 6pt; text-align: right"><span id="xdx_F0D_zjDbUZyarnU4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; text-align: justify"><span id="xdx_F1F_zxIeEdU501bk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated in 2023.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; text-align: right"><span id="xdx_F0C_z10SIfEmMrzj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; text-align: justify"><span id="xdx_F1F_z9ihww6sHDyj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger occurred in March 2023.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; text-align: right"><span id="xdx_F06_z87zvtfV2Dif" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 6pt; text-align: justify"><span id="xdx_F17_zNRJBq90Og7h" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2022.</span></td></tr> </table> Australia 1 USA 1 Singapore 1 Ireland 1 Israel 1 1 Canada 1 1 France 1 1 Australia 1 1 Canada 0.50 0.50 Australia 0.444 0.444 25000000 2500000 <p id="xdx_801_ecustom--DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_zOE1l5DlVoXl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - <span id="xdx_82C_zULBab3HZJj4">SIGNIFICANT ACCOUNTING POLICIES</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_844_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_z01EZEidF1Lc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A. <span id="xdx_869_zPYRXVYqWe9j">Basis of preparation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These interim consolidated financial statements have been prepared in a condensed format in accordance with IAS 34 Interim Financial Reporting. They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the annual consolidated financial statements as of December 31, 2022 of the Company and of Security Matters PTY Ltd. (formerly - Security Matters Limited).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_ziUHR3NV3k0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B. <span id="xdx_861_ze1U5dIoDcr9">Functional currency</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements are prepared in US Dollars, which is the functional and presentation currency of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--DescriptionOfAccountingPolicyForApplicationOfAccountingPoliciesExplanatory_znNZ0fqpUUab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C. <span id="xdx_86A_zyxp3yhD2Csa">Application of accounting policies</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has applied the same accounting policies and methods of computation in its interim condensed consolidated financial statements as in its 2022 annual financial statements and as in the 2022 annual financial statements of Security Matters PTY Ltd, except as stated below in note 2D and 2E.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Several amendments to IFRS Standards apply for the first time in 2023, but do not have an impact on the interim condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84E_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_z09CDDLXYKob" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D. <span id="xdx_861_zrpsoeyGOkO5">Issue of a unit of financial instruments</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_ecustom--DescriptionOfAccountingPolicyForReverseAcquisitionTransactionExplanatory_zFAlkTJ6CBf8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E. <span id="xdx_862_zeZNbWcUUb3a">Reverse acquisition transaction</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($<span id="xdx_903_ecustom--FairValueBasedOnQuotedOpeningSharePrice_iN_pn3n3_di_c20230101__20230630_zJlKT2N35IIa" title="Fair value based on the quoted opening share price">11,599</span>), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $<span id="xdx_900_ecustom--FairValueOfEquityTransaction_pn3n3_c20230101__20230630_z8CIaXkrbbk6" title="Fair value of the shares">16,802</span>, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reverse acquisition transaction (Cont.)</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is initially consolidated in the financial statements from the Closing Date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($<span id="xdx_90A_ecustom--MarketableSecuritiesHeldInTrustAccount_iNI_pn3n3_di_c20230630_zjYIaBDUwvba" title="Marketable securities held in a trust account">4,921</span>) and trade and other payables and warrants ($<span id="xdx_90E_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20230630_zhf4g4LNckL3" title="Trade, other payables and warrants">10,127</span>) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_ecustom--DescriptionOfAccountingPolicyForReverseStockSplitExplanatory_z3O1zqRjisfb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F. <span id="xdx_861_zeBCo9zhBrmd">Reverse stock split</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The presentation of loss per share amounts has been retrospectively adjusted to give effect to the reverse share split which occurred on August 8, 2023. Except otherwise specifically provided, no other adjustments have been made in these notes to reflect the reverse share split. See also Note 9.1.</span></p> <p id="xdx_85A_z1UIvoZ1i6k3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_z01EZEidF1Lc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A. <span id="xdx_869_zPYRXVYqWe9j">Basis of preparation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These interim consolidated financial statements have been prepared in a condensed format in accordance with IAS 34 Interim Financial Reporting. They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the annual consolidated financial statements as of December 31, 2022 of the Company and of Security Matters PTY Ltd. (formerly - Security Matters Limited).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_ziUHR3NV3k0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B. <span id="xdx_861_ze1U5dIoDcr9">Functional currency</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements are prepared in US Dollars, which is the functional and presentation currency of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_ecustom--DescriptionOfAccountingPolicyForApplicationOfAccountingPoliciesExplanatory_znNZ0fqpUUab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C. <span id="xdx_86A_zyxp3yhD2Csa">Application of accounting policies</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has applied the same accounting policies and methods of computation in its interim condensed consolidated financial statements as in its 2022 annual financial statements and as in the 2022 annual financial statements of Security Matters PTY Ltd, except as stated below in note 2D and 2E.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Several amendments to IFRS Standards apply for the first time in 2023, but do not have an impact on the interim condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84E_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_z09CDDLXYKob" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D. <span id="xdx_861_zrpsoeyGOkO5">Issue of a unit of financial instruments</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_ecustom--DescriptionOfAccountingPolicyForReverseAcquisitionTransactionExplanatory_zFAlkTJ6CBf8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E. <span id="xdx_862_zeZNbWcUUb3a">Reverse acquisition transaction</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($<span id="xdx_903_ecustom--FairValueBasedOnQuotedOpeningSharePrice_iN_pn3n3_di_c20230101__20230630_zJlKT2N35IIa" title="Fair value based on the quoted opening share price">11,599</span>), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $<span id="xdx_900_ecustom--FairValueOfEquityTransaction_pn3n3_c20230101__20230630_z8CIaXkrbbk6" title="Fair value of the shares">16,802</span>, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reverse acquisition transaction (Cont.)</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is initially consolidated in the financial statements from the Closing Date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($<span id="xdx_90A_ecustom--MarketableSecuritiesHeldInTrustAccount_iNI_pn3n3_di_c20230630_zjYIaBDUwvba" title="Marketable securities held in a trust account">4,921</span>) and trade and other payables and warrants ($<span id="xdx_90E_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20230630_zhf4g4LNckL3" title="Trade, other payables and warrants">10,127</span>) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -11599000 16802000 -4921000 10127000 <p id="xdx_842_ecustom--DescriptionOfAccountingPolicyForReverseStockSplitExplanatory_z3O1zqRjisfb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F. <span id="xdx_861_zeBCo9zhBrmd">Reverse stock split</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The presentation of loss per share amounts has been retrospectively adjusted to give effect to the reverse share split which occurred on August 8, 2023. Except otherwise specifically provided, no other adjustments have been made in these notes to reflect the reverse share split. See also Note 9.1.</span></p> <p id="xdx_80E_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zAXbjCKsKkGi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span style="text-transform: uppercase"><span id="xdx_82D_zBBbjwWI6Clh">CONVERTIBLE NOTES</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 20pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 25, 2023, the Company received an amount of $<span id="xdx_90A_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20230124__20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zhgFHdefGiGi" title="Proceeds from borrowings">250</span> in consideration for issuance of convertible notes (the “Convertible Notes”) and two types of warrants. The Convertible Notes principal amount is $<span id="xdx_903_eifrs-full--NotionalAmount_iI_pn3n3_c20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zpALnFgQ1Bf5" title="Principal amount">250</span> and maturity date is the earlier between <span id="xdx_90A_eifrs-full--BorrowingsMaturity_c20230124__20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zVjMgIQENUp5" title="Maturity date">December 31, 2024</span>, and the date of any change in control (excluding the Business Combination). The Convertible Notes have an interest rate of <span id="xdx_907_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zaixE948hdWc" title="Interest rate">15</span>% per annum and shall be converted into ordinary shares: (1) at the note holder’s discretion, at a fixed conversion price of USD <span id="xdx_906_ecustom--FixedConversionPrice_iI_pid_c20230125__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z6JePO7DUpxb" title="Fixed conversion price">10</span> per ordinary share, or (2) through issuance of the Company’s ordinary shares at a <span id="xdx_90F_ecustom--DiscountRate_pid_dp_uPure_c20230124__20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zFQ0eCMRbgK8" title="Discount rate">20</span>% discount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the Convertible Note agreements, the investor was granted two types of warrants:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bonus Warrants – <span id="xdx_903_ecustom--WarrantsToPurchaseOrdinaryShares_pid_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zxFwiE4zpRd1" title="Warrants to purchase ordinary shares">12,500</span> warrants to purchase ordinary shares of the Company at an exercise price of USD <span id="xdx_90A_ecustom--ExercisePriceOfWarrants_pid_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zBgu5iyWgTKi" title="Exercise price">11.50</span> per share. The Bonus Warrants term is <span id="xdx_907_ecustom--WarrantsTerm_dc_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zC4hjULhlXe4" title="Warrants term">five years</span> commencing upon the Business Combination.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable Warrants – <span id="xdx_909_ecustom--WarrantsToPurchaseOrdinaryShares_pid_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zQpcpZcfgLPl" title="Warrants to purchase ordinary shares">12,500</span> warrants to purchase ordinary shares of the Company at a purchase price of USD <span id="xdx_903_ecustom--SharePurchasePrice_pid_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zF33ND456qXl" title="Share purchase price">11.50</span> per share. The Redeemable Warrants term is <span id="xdx_90F_ecustom--WarrantsTerm_dc_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zsAluHZI1THh" title="Warrants term">five years</span> commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD <span id="xdx_90B_eifrs-full--ParValuePerShare_iI_pid_c20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zn5Hii6H9EFh">5.00</span> per warrant. <span id="xdx_908_eifrs-full--DescriptionOfApproachUsedToDetermineDiscountRates_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_ztFGuKVb9f2" title="Description of approach used to determine discount rates">The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a <span id="xdx_906_ecustom--DiscountRate_pid_dp_uPure_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertibleNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_ztStVOvghp31" title="Discount rate">20</span>% discount to the 20-trading day VWAP preceding each such anniversary.</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Convertible Notes are recorded in accordance with their fair value. The Redeemable Warrants are accounted for as a derivative financial liability. Management utilized a third-party appraiser to assist them in valuing the Convertible Notes and Redeemable Warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to calculate the fair value of the Convertible Notes, the Company discounted the payment schedule by a discount rate of <span id="xdx_909_ecustom--DiscountRate_pid_dp_uPure_c20230101__20230630__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zJamosccxeTf" title="Discount rate">30.7</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model with expected volatility of <span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zaeDriF0MXF5" title="Volatility rate">71.54</span>% and the risk-free interest rate used is <span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zYGovinIWy61" title="Risk-free interest rate">4.19</span>%. As of June 30, 2023, the fair value of the Convertible Notes was $<span id="xdx_907_ecustom--FairValueOfConvertibleNotes_iI_pn3n3_c20230630_zvWnpC3WmWbi" title="Fair value of convertible notes">218</span> and the fair value of the Redeemable Warrants was $<span id="xdx_902_ecustom--FairValueOfRedeemableWarrants_iI_pn3n3_c20230630_zrdJqEaQ2kp2" title="Fair value of the redeemable warrants">71</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 250000 250000 December 31, 2024 0.15 10 0.20 12500 11.50 P5Y 12500 11.50 P5Y 5.00 The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary. 0.20 0.307 0.7154 0.0419 218000 71000 <p id="xdx_806_eifrs-full--DisclosureOfDerivativeFinancialInstrumentsExplanatory_zXLbsmeIgSCg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_823_zll3816G8ta">BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between August 2022 to January 2023, Security Matters PTY Ltd. entered into bridge loan agreements (the “Bridge Loans”) with eleven lenders, which lent Security Matters PTY Ltd. an aggregate amount of $<span id="xdx_904_ecustom--ProceedsFromLoansAndWarrants_pn3n3_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ElevenLendersMember_zVWoB6UIT4h5" title="Proceeds from loans and warrants">3,860</span>. The Bridge Loans have a maturity date of up to <span id="xdx_90D_eifrs-full--BorrowingsMaturity_c20220801__20230131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_z9XoQksS8DTj" title="Borrowings maturity">two years</span> and bear an interest rate of <span id="xdx_902_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_z7rWBLVldlF1" title="Interest rate">10</span>% per annum. The Bridge Loans were accounted for in accordance with the amortized cost method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the Bridge Loans agreements, the lenders were granted two types of warrants:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bonus Warrants – <span id="xdx_905_ecustom--WarrantsToPurchaseOrdinaryShares_pid_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zAouq1X524hc" title="Warrants to purchase ordinary shares">243,000</span> warrants to purchase ordinary shares of the Company at an exercise price of USD <span id="xdx_902_ecustom--SharePurchasePrice_pid_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zAGju8jDof7k">11.50</span> per share. The Bonus Warrants term is <span id="xdx_909_ecustom--WarrantsTerm_dc_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zvTQ8E3RrLSe" title="Warrants term">five years</span> commencing upon the Business Combination.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable Warrants – <span id="xdx_909_ecustom--WarrantsToPurchaseOrdinaryShares_pid_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zynk6oa0ei55" title="Warrants to purchase ordinary shares">572,000</span> warrants to purchase ordinary shares of the Company at a purchase price of USD <span id="xdx_908_ecustom--SharePurchasePrice_pid_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zFjk2gMtoRb3" title="Exercise price of warrants">11.50</span> per share. The Redeemable Warrants term is <span id="xdx_90B_ecustom--WarrantsTerm_dc_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zIyhtdRg8az3" title="Warrants term">five years</span> commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD <span id="xdx_901_eifrs-full--ParValuePerShare_iI_pid_c20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_z9WVuFDGxUT4" title="Par value">5.00</span> per warrant.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--DescriptionOfApproachUsedToDetermineDiscountRates_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_ztZvO3Jp76Zd">Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management with the assistance of a third-party appraiser valued the Bonus and the Redeemable Warrants. The fair value of the Bonus Warrants was calculated using the Black-Scholes model. As of June 30, 2023, the fair value of the Bonus Warrants was less than $<span id="xdx_90F_ecustom--FairValueOfBonusWarrants_iI_pn3n3_c20230630__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zpVL5GPGfU7e" title="Fair value of the bonus Warrants">1</span> (December 31, 2022 - the fair value of the Bonus Warrants was $<span id="xdx_908_ecustom--FairValueOfBonusWarrants_iI_pn3n3_c20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zEmYxDTpdGSg" title="Fair value of the bonus Warrants">24</span>).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model. As of June 30, 2023, the fair value of the Redeemable Warrants was <span id="xdx_906_ecustom--FairValueOfRedeemableWarrants_iI_pn3n3_c20230630__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zvY8x1r2yM2e" title="Fair value of redeemable warrants">2,133</span> (December 31, 2022, the fair value of the Redeemable Warrants was $<span id="xdx_905_ecustom--FairValueOfRedeemableWarrants_iI_pn3n3_c20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zQBTIwyTt5P3" title="Fair value of redeemable warrants">2,669</span>).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The main assumptions used in the three valuation models described above were: (1) risk free rate <span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230101__20230630__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_z1C8SeFwgjO7" title="Risk-free interest rate">3.99</span>%; (2) volatility of assets <span id="xdx_90B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230101__20230630__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zGWTo9zFBkOj" title="Volatility rate">81.03</span>%; and (3) excepted terms of the warrants -<span id="xdx_908_ecustom--WarrantsTerm_dtY_c20230101__20230630__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zZpxcP9wEIIe" title="Excepted terms">5.18</span> years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2023, the Company entered into an additional bridge loan agreement (the “Additional Bridge Loans”), in which the Company raised an aggregate amount of $<span id="xdx_90C_eifrs-full--ProceedsFromBorrowingsClassifiedAsFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zjzqtUcYpfOa" title="Proceeds from borrowings, classified as financing activities">550</span>. The Additional Bridge Loans have a maturity date of up to <span id="xdx_900_eifrs-full--BorrowingsMaturity_dxL_c20230101__20231231__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zDxCu94rXF2h" title="Borrowings maturity::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl2588">two years</span></span> and bear interest rate of <span id="xdx_90A_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20231231__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_z9ri6zuDuZoh" title="Borrowings, interest rate">10</span>% per annum. In March 2023, the Company signed an addendum to the Bridge Loans agreements which convert principal amount of $<span id="xdx_900_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20230301__20230331__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zM3yBB4egm3i" title="Aggregate amount of convertible instruments issued">1,350</span> and redeemable warrants at the amount of $<span id="xdx_901_ecustom--RedeemableWarrants_iI_pn3n3_c20230331__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zoFBgphQ6k82" title="Redeemable warrants">1,000</span> into <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_c20230331__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zu5E6S9EF8y5" title="Number of shares">872,418</span> ordinary shares and defer the remaining cash payments to March 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> 3860000 two years 0.10 243000 11.50 P5Y 572000 11.50 P5Y 5.00 Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary. 1000 24000 2133000 2669000 0.0399 0.8103 P5Y2M4D 550000 0.10 1350000 1000000 872418 <p id="xdx_800_ecustom--DisclosureOfMaterialEventsDuringPeriodExplanatory_zoMSvxx9hYNk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_827_z5O3E1QS1m1b">MATERIAL EVENTS DURING THE PERIOD</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered in February 2023 into a Standby Equity Purchase Agreement (“SEPA”) to raise up to $<span id="xdx_905_eifrs-full--IssuedCapitalOrdinaryShares_iI_pn3n3_c20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zApuOlSUiRmd" title="Issued capital, ordinary shares">25,000</span> in consideration of the issuance of ordinary shares over the course of 36 months with Yorkville. According to the SEPA, the Company may issue Yorkville the ordinary shares at a purchase price as one of two options <span id="xdx_900_eifrs-full--ExplanationOfShareOptionsInSharebasedPaymentArrangement_c20230201__20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_znkT89z43VPk" title="Description of share-based payment arrangement">(i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period.</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville advanced to the Company an aggregate principal amount of $<span id="xdx_905_eifrs-full--NotionalAmount_iI_pn3n3_c20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zbUU02mT9vQ6" title="Notional amount">3,500</span> (the “Pre-Paid Advance”). The Pre-Paid Advance was disbursed in two separate installments evidenced as convertible loans, the first for $<span id="xdx_90C_eifrs-full--NotionalAmount_iI_pn3n3_c20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember__ifrs-full--BorrowingsByNameAxis__custom--FirstInstallmentMember_zhrzEq8IAVU2" title="Notional amount">1,500</span> at the closing of the Business Combination, and the second, as subsequently amended, for $<span id="xdx_905_eifrs-full--NotionalAmount_iI_pn3n3_c20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember__ifrs-full--BorrowingsByNameAxis__custom--SecondInstallmentMember_zn2uQmlqKAC9" title="Notional amount">2,000</span> upon the effectiveness of the Initial Yorkville Registration Statement. The purchase price for the Pre-Paid Advance is <span id="xdx_90F_ecustom--PrepaidAdvancePercentage_iI_pid_dp_c20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember__ifrs-full--BorrowingsByNameAxis__custom--SecondInstallmentMember_zlp6zyJAr5kl" title="Prepaid advance percentage">92.0</span>% of the Pre-Paid Advance. Such Pre-Paid Advances will be offset upon the issuance of ordinary shares to Yorkville at a price per share equal to the lower of (a) 100% of the daily VWAP of the Ordinary Shares on The Nasdaq Stock Market as of the trading day immediately prior to the date of the disbursement of the Pre-Paid Advance (the “Fixed Price”) (in the case of the first Pre-Paid Advance, $<span id="xdx_909_eifrs-full--ParValuePerShare_iI_c20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zYJXmqBLnuZi" title="Ordinary shares">3.65</span>), or (b) 93.0% of the lowest daily VWAP of the Ordinary Shares on Nasdaq during the seven trading days immediately prior to each purchase (the “Variable Price” and the lower of the Fixed Price and the Variable Price shall be referred to as the “Purchase Price”); however, in no event shall the Purchase Price be less than $<span id="xdx_901_ecustom--PurchasePriceOfPerShare_c20230201__20230228__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zLJOhP5xSrAl" title="Purchase price of per share">1.10</span> (the “Floor Price”). On July 27, 2023, the Company amended the promissory note evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $<span id="xdx_902_ecustom--FloorPricePricePerShare_iI_pid_c20230727_zk0Y73h3xWI7" title="Floor price per share">1.10</span> (as adjusted for reverse stock split which occurred on August 21, 2023, see also Note 9.1), after the Company was required to repay in cash $<span id="xdx_909_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_pn3n3_c20230727__20230727__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zmDKJyb2yPl3" title="Repayments of borrowings">500</span> of principal amount as a result of the Company’s share price being below the original Floor Price. The maturity date will be 12-months after the initial closing of <span style="background-color: white">each </span>Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $<span id="xdx_90F_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_pn3n3_c20230701__20230731__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_zI9lP3oJi9Z7" title="Repayments of borrowings">1,500</span>. In the period, the Company issued ordinary shares in consideration of $<span id="xdx_901_eifrs-full--IssuedCapitalOrdinaryShares_iI_pn3n3_c20230731__ifrs-full--TypesOfContractsAxis__custom--StandbyEquityPurchaseAgreementMember_ztlN2FHQq3Fj" title="Ordinary shares">450</span> in accordance with the terms of the SEPA.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 22, 2023, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with EF Hutton, LLC (the “Underwriter”) relating to the public offering of (i) <span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--CounterpartiesAxis__custom--EFHuttonLLCMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zFJkMzGpjF83" title="Number of shares issued">13,333,333</span> ordinary shares of the Company, at a subscription price per share of $<span id="xdx_90A_eifrs-full--ParValuePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--CounterpartiesAxis__custom--EFHuttonLLCMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_ziLenRvqvB6f" title="Warrants exercise price per share">0.24</span> (the “Firm Shares”), (ii) <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember__ifrs-full--CounterpartiesAxis__custom--EFHuttonLLCMember_zCweUJ1K5wV4" title="Number of shares issued">13,333,333</span> warrants in the form of Warrant A to subscribe for <span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CounterpartiesAxis__custom--EFHuttonLLCMember_zukvjndx5UIb" title="Number of shares issued">13,333,333</span> ordinary shares, at an exercise price of $<span id="xdx_909_ecustom--WarrantsExercisePricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember__ifrs-full--CounterpartiesAxis__custom--EFHuttonLLCMember_ze8cvUhcwxQj" title="Warrants exercise price per share">0.24</span> per share (“Warrant A”), and (iii) <span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember__ifrs-full--CounterpartiesAxis__custom--EFHuttonLLCMember_zmsbkyLkwYHf" title="Number of shares issued">13,333,333</span> warrants in the form of Warrant B to subscribe for <span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zhpQ4sivbl4g" title="Number of shares issued">13,333,333</span> ordinary shares, at an exercise price of $<span id="xdx_90B_ecustom--WarrantsExercisePricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember__ifrs-full--CounterpartiesAxis__custom--EFHuttonLLCMember_zrNFNbmsOnRk" title="Warrants exercise price per share">0.24</span> per share (“Warrant B” and together with Warrant A, the “Firm Warrants” and, collectively with the Firm Shares, the “Firm Securities”).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also granted the Underwriter a 45-day option to subscribe for, in the aggregate, <span id="xdx_90E_eifrs-full--ExplanationOfShareOptionsInSharebasedPaymentArrangement_pp0d_c20230622__20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zoJKWh76tLa6" title="Description of share-based payment arrangement">(a) up to <span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zypLGoaEzH21" title="Number of shares issued">1,999,999</span> additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $<span id="xdx_90F_eifrs-full--ParValuePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zJGJUNScOLv3" title="Par value per share">0.24</span> (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to <span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zM7tbI4lQjq5" title="Number of shares issued">1,999,999</span> ordinary shares at a price per share of $<span id="xdx_903_ecustom--WarrantsPricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zaLWkTOpYRgi" title="Warrants price per share">0.2399</span> (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $<span id="xdx_90A_ecustom--WarrantsExercisePricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--PrefundedWarrantMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zqJR1ce7R0nd" title="Warrants exercise price per share">0.0001</span> per share, and/or (b) <span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantAMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zqBQVJlQ1wIj" title="Number of shares issued">1,999,999</span> warrants in the form of Warrant A to subscribe for an aggregate of <span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zVbNhiilqFS" title="Number of shares issued">1,999,999</span> ordinary shares (15% of the Firm Warrants) at an exercise price of $<span id="xdx_90C_ecustom--WarrantsExercisePricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantAMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_z2IUtaWYchRc" title="Warrants exercise price per share">0.24</span> per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) <span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantBMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zZgDIkSyg1Ma" title="Number of shares issued">1,999,999</span> warrants in the form of Warrant B to purchase an aggregate of <span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zCVBbSdcI5fh" title="Number of shares issued">1,999,999</span> ordinary shares (15% of the Firm Warrants) at a purchase price of $<span id="xdx_907_ecustom--WarrantsPricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantBMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicOfferingMember_zIAfxkp2M8Ki" title="Warrants price per share">0.24</span> per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants.</span> The Option Shares and the Option Warrants are referred to as the “Option Securities”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The offering closed on June 27, 2023. The Company delivered the Firm Shares (or Firm Share equivalents in the form of Pre-Funded Warrants), the Firm Warrants and the Option Warrants to the Underwriter on the same day.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Warrant A terms specify that the warrants may be exercised at any time on or before June 27, 2028. On or after the earlier of <span id="xdx_90E_ecustom--WarrantTermDescription_pp0d_c20230622__20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember_zqZrTi4BTAD9" title="Warrant term description">(i) the thirty day anniversary of the date of the Underwriting Agreement and (ii) the date on which the aggregate composite trading volume of the Company’s ordinary shares as reported by Bloomberg LP beginning on the date of the Underwriting Agreement exceeds 15,000,000 ordinary shares, a holder of Warrant A warrants may also provide notice and elect a “cashless exercise” pursuant to which the holder would receive an aggregate number of ordinary shares equal to the product of (x) the aggregate number of ordinary shares that would be issuable upon a cash exercise and (y) $0.50. As of the date of publication of these financial statements, an aggregate of <span id="xdx_90D_ecustom--WarrantCashlessExercised_pid_c20230622__20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantAMember_zDJrPUzBSaMl" title="Warrant cashless exercised">15,195,332</span> Warrant A warrants were cashless exercised into an aggregate of <span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zdecP22W4PNg" title="Warrant cashless exercised">7,597,665</span> ordinary shares.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – MATERIAL EVENTS DURING THE PERIOD (CONT.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Warrant B terms specify that the warrants may be exercised at any time on or before June 27, 2028. All of such Warrant B warrants remain outstanding as of the end of period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--WarrantExerciseDescription_c20230101__20230630_zt8FTnEJNu0l" title="Warrant exercise description">Warrant A was valued at $0.0635 which is half of the share market price at the end of the period, assuming cashless exercise. Warrants A were considered to be a derivative financial liability. The terms of warrants B specify that each warrant has a cash exercise price of $<span id="xdx_909_ecustom--WarrantCashExercisePrice_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantBMember_zRQPNgwwUl7l" title="Warrant cash exercise price">0.24</span>. Warrant B was valued at $<span id="xdx_904_ecustom--WarrantsExercisePrice_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__custom--WarrantBMember_zodrxgtHoA3d" title="Warrant exercise price">0.0602</span> by using the Black-Scholes option-pricing</span> model, with expected volatility of <span id="xdx_90A_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zZ7xOkAkBRH7" title="Expected volatility">70.39</span>% and the risk-free interest rate used is <span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_zbylZwbRSjA9" title="Risk-free interest rate">4.13</span>%. Warrants A and B expire in June 2028.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The net proceeds to the Company upon the closing of this offering were approximately $<span id="xdx_901_eifrs-full--ProceedsFromExerciseOfOptions_pn3n3_c20230101__20230630_zvYfY1psChW5" title="Net proceeds from offering">2,580</span>. The capital raise fee amounted to $<span id="xdx_902_ecustom--CapitalRaiseFee_iI_pn3n3_c20230630_zcaY9JowqYe9" title="Capital raise fee">660</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also granted to the Underwriter, <span id="xdx_908_ecustom--WarrantsIssued_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__custom--UnderwriterWarrantMember_ziHF27dnaA1e" title="Warrants issued">666,667</span> warrants at an exercise price of $<span id="xdx_902_ecustom--WarrantsExercisePrice_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__custom--UnderwriterWarrantMember_z5NCiXKf6A44" title="Warrant exercise price">0.264</span> per share, which expires after 5 years. The Underwriter’s warrants were valued at $<span id="xdx_90C_ecustom--WarrantsPricePerShare_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__custom--UnderwriterWarrantMember_zYUme89qZZZ5" title="Warrants price per share">0.0575</span> per option by using the Black &amp; Scholes option-pricing, with expected volatility of <span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20230630__ifrs-full--ClassesOfShareCapitalAxis__custom--UnderwriterWarrantMember_zujXVKsB5kr9" title="Expected volatility">70.39</span>% and the risk-free interest rate used is <span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20230630__ifrs-full--ClassesOfShareCapitalAxis__custom--UnderwriterWarrantMember_zl7ncmAVpU93" title="Risk-free interest rate">4.13</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2023, the Company signed an amendment to the agreement with Isorad that determine the following: (1) for the BCA with Lionheart, (a) Isorad was issued <span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_c20230131_zyC1co2GkNSf" title="Number of shares issued">864,000</span> options to purchase shares of the Company, which options were issued in January 2023 and valued using the Black-Scholes pricing model, with the main parameters used are: (1) risk-free rate: <span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20230101__20230131_zVJ928MVXlUe" title="Risk-free rate">3.42</span>%; (2) expected volatility: <span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20230101__20230131_zKoFrRENULja" title="Expected volatility">81.92</span>%: (3) expected term: up to <span id="xdx_902_ecustom--DescriptionOfExpectedTerm_pp0d_dtYp_c20230101__20230131_zqjyDB9BIEab" title="Expected term">3</span> years; and (4) expected dividend yield: <span id="xdx_90C_eifrs-full--ExpectedDividendShareOptionsGranted_pid_dp_c20230101__20230131_zY4dNOuAaUgd" title="Expected dividend">0</span>%; and (b) Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of $<span id="xdx_907_ecustom--ProceedsFromIssuingEquity_pn6n6_c20230101__20230131_zpqQyG1Nlnr" title="Proceeds from issuing equity">27</span> million, or at the end of such 13 months, the earlier thereof). In the period, based on the funds the Company actually received, the Company recognized a technology license intellectual property at the amount of $<span id="xdx_90C_eifrs-full--InvestmentProperty_iI_pn3n3_c20230131__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zzVptPCa6Kz7" title="Investment property">101</span> against a liability that reflects the due amount; and</span></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Exit fee - in the occurrence of the first M&amp;A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA, the Company is to pay a cash amount equal to 1.5% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 2, 2023, the Company amended its loan agreement dated September 7, 2015, between the Company, its Shareholders and Kamea Fund that postponed the repayment of the borrowings from related party (Bonus Payment) to March 31, 2024 (refer also to Note 9.4 – Subsequent Events).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 25000000 (i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period. 3500000 1500000 2000000 0.920 3.65 1.10 1.10 500000 1500000 450000 13333333 0.24 13333333 13333333 0.24 13333333 13333333 0.24 (a) up to 1,999,999 additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $0.24 (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to 1,999,999 ordinary shares at a price per share of $0.2399 (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $0.0001 per share, and/or (b) 1,999,999 warrants in the form of Warrant A to subscribe for an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at an exercise price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) 1,999,999 warrants in the form of Warrant B to purchase an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at a purchase price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants. 1999999 0.24 1999999 0.2399 0.0001 1999999 1999999 0.24 1999999 1999999 0.24 (i) the thirty day anniversary of the date of the Underwriting Agreement and (ii) the date on which the aggregate composite trading volume of the Company’s ordinary shares as reported by Bloomberg LP beginning on the date of the Underwriting Agreement exceeds 15,000,000 ordinary shares, a holder of Warrant A warrants may also provide notice and elect a “cashless exercise” pursuant to which the holder would receive an aggregate number of ordinary shares equal to the product of (x) the aggregate number of ordinary shares that would be issuable upon a cash exercise and (y) $0.50. As of the date of publication of these financial statements, an aggregate of 15,195,332 Warrant A warrants were cashless exercised into an aggregate of 7,597,665 ordinary shares. 15195332 7597665 Warrant A was valued at $0.0635 which is half of the share market price at the end of the period, assuming cashless exercise. Warrants A were considered to be a derivative financial liability. The terms of warrants B specify that each warrant has a cash exercise price of $0.24. Warrant B was valued at $0.0602 by using the Black-Scholes option-pricing 0.24 0.0602 0.7039 0.0413 2580000 660000 666667 0.264 0.0575 0.7039 0.0413 864000 0.0342 0.8192 P3Y 0 27000000 101000 <p id="xdx_802_eifrs-full--DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_zQ73Ud9veBA3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 - <span id="xdx_820_zj1McFsGQIBl">SHAREHOLDERS’ EQUITY</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A. Share capital:</b></span></p> <p id="xdx_891_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_z7f9GJT8Dtt3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zWoECEuUevX1" style="display: none">SCHEDULE OF SHARE CAPITAL</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of shares</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued and outstanding</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued and outstanding</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares <br/> USD <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eifrs-full--ParValuePerShare_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zgA34sa9xtI3" title="Par value per share">0.0001</span> par value</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zCx4liW9AgVl" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">800,000,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zIv4EyaoyeEl" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,364,447</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zpFhHWkB6IF7" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zrI8hrZlIOV4" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred shares <br/> USD <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eifrs-full--ParValuePerShare_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zYxFeKB741e4" title="Par value per share">0.0001</span> par value</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zlmrvKRoiMag" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_znSZBvnfikfd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2726">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zqBxdCCm4nm" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2728">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zzbIQzKpEy2c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2730">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred shares <br/> Euro <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eifrs-full--ParValuePerShare_iI_uEuroPerShare_c20230630_zgTHgsYTac65" title="Par value per share">1</span> par value</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zkKOjdFmQG11" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zmgifcW0EVf3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zNHtmhvquhNe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_z3NATPaXyBy9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A6_zreqK0Wub9Sg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Ordinary shares</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the Company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have a par value per share of $<span id="xdx_902_ecustom--ParValuePerShareBeforeReverseSplit_iI_c20230630_zwXoPuTVet0d" title="Par value per share before reserve split">0.0001</span> (before the reverse split) and par value per share of $<span id="xdx_906_ecustom--ParValuePerSharePostReverseSplit_iI_c20230630_z80rZCwBxOYe" title="Par value per share, post reserve split">0.0022</span> (post reverse split) and the Company does not have a limited amount of authorised capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Preferred shares</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">preferred shares with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deferred shares</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred Ordinary Shares are non-voting shares and do not convey upon the holder the right to be paid a dividend or to receive notice of or to attend, vote or speak at a general meeting. The Deferred Shares confer the right on a return of capital, on a winding-up or otherwise, only to the repayment of the nominal value paid up on the Deferred Shares after repayment of the nominal value of the Ordinary Shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Changes in Share capital </span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 7, 2023 (the “Closing Date”), the Company consummated the Business Combination pursuant the BCA, dated July 26, 2022, and also consummated the SID, dated July 26, 2022.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning on the day immediately prior to the Closing Date and ending on the day immediately after the Closing Date, the following transactions occurred:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The AUD <span id="xdx_909_eifrs-full--NotesAndDebenturesIssued_iI_uAUD_c20230307_zqWjGhAPeFef" title="Convertible notes">828,240</span> of the 2022 Convertible Notes have been cancelled in consideration for the issuance of <span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307_zI53LjZAkjKb">1,000,000</span> ordinary shares in Security Matters PTY Ltd.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters PTY Ltd. performed acceleration of vesting for all unvested warrants and options, the expense for the acceleration amounted to $<span id="xdx_904_eifrs-full--ShareIssueRelatedCost_pn3n3_c20230307__20230307_zFl2UF9JATd1" title="Stock expense">186</span>.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_uShares_c20230307__20230307__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zPkdt69Dszn9" title="Warrants exercised">32,211,716</span> warrants have been exercised on cashless basis to <span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zHuTCebTsYWf">24,568,773</span> shares in Security Matters PTY Ltd.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eifrs-full--NumberOfInstrumentsGrantedInSharebasedPaymentArrangement_pid_uShares_c20230307__20230307_zpgeuJ2MYfS6" title="Number of shares issued">18,673,253</span> ordinary shares of the Company have been issued to Security Matters PTY Ltd.’s shareholders in return for their <span id="xdx_907_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_pid_uShares_c20230307__20230307_z75orlOZ89pd" title="Number of shares cancelled">193,500,379</span> ordinary shares in Security Matters PTY Ltd. that were cancelled. <span id="xdx_90F_eifrs-full--DescriptionOfConversionOfDebtToEquity_uShares_c20230307__20230307_ziZZ5JFe8lO9" title="Conversion of stock, description">Security Matters PTY Ltd.’s shareholders received as consideration 1 ordinary share of the Company per 10.3624 Security Matters PTY Ltd.’s ordinary shares.</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z6H4FDSnkqVl" title="Number of shares issued">3,525,000</span> ordinary shares, <span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pid_c20230703__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--PrivateWarrantsMember_zVtaKhQWiWFb" title="Number of shares issued">2,200,000</span> private warrants and <span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--PublicWarrantsMember_zrKiKk8PZqJ" title="Number of shares issued">6,250,000</span> public warrants to Lionheart’s stockholders, in exchange for their existing Lionheart shares and warrants. The warrants exercise price is $<span id="xdx_906_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_pid_c20230307__20230307__ifrs-full--ComponentsOfEquityAxis__ifrs-full--WarrantsMember_zvEXK7rgZpSb" title="Warrants exercise price">11.5</span> per share, expiring in March 2028. The warrants are considered to be a derivative financial liability and measured at fair value, which is the market price as of the end of the period, amounted to $<span id="xdx_909_ecustom--WarrantsExercisePricePerShare_iI_pid_c20230627__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--WarrantsMember_z5JGNbx828gb" title="Warrants exercise price per share">0.0204</span> per warrant.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – SHAREHOLDERS’ EQUITY (CONT.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesTwoMember_zkeisaAJ3aP9" title="Number of shares issued">303,053</span> ordinary shares for an aggregate of $<span id="xdx_90E_eifrs-full--ProceedsFromIssueOfOrdinaryShares_pn3n3_c20230307__20230307__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesTwoMember_zY8efCManAkf" title="Proceeds from ordinary shares">3,110</span> net proceeds.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20230307__ifrs-full--TypesOfContractsAxis__custom--BridgeLoansMember_zeYnWahpS89a">872,418</span> ordinary shares for the conversion of bridge loan at principal amount of $<span id="xdx_90F_eifrs-full--DebtInstrumentsHeld_iI_pn3n3_c20230307__ifrs-full--TypesOfContractsAxis__custom--BridgeLoansMember_zBeZ3NExQvPc" title="Debt principal amount">1,350</span> and <span id="xdx_90D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_pid_uShares_c20230307__20230307__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zlPLnVxQK2Ki" title="Warrants exercised">200,000</span> redeemable warrants ($<span id="xdx_902_ecustom--WarrantPricePerShare_iI_pid_c20230307__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zH0MK2u4CcXf" title="Warrants price per share">5</span> per warrant, <span id="xdx_905_ecustom--WarrantsTerm_pid_dtY_c20230307__20230307__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zN0yK1RlvFC2" title="Warrants term">5</span> years, exercise price of $<span id="xdx_901_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_pid_c20230307__20230307__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_z8kroUQrEkKg" title="Warrants exercise price">11.5</span> per share).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May and June 2023, the Company issued <span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20230531__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--YorkvilleMember_z6zQJDXSTwx"><span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--YorkvilleMember_zOVzbzNNOA8a">675,168</span></span> ordinary shares to Yorkville, for an aggregate of $<span id="xdx_90D_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20230501__20230531__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--YorkvilleMember_zOZ0XR40zvw1"><span id="xdx_90B_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20230601__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--YorkvilleMember_zeWtwBbxZX5j">450</span></span> net proceeds (see also Note 5.1).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023, the Company raised capital as part of issuance of a unit of financial instruments in consideration of an aggregate of $<span id="xdx_904_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20230601__20230630_zz5yYNIxGH4k">2,580</span> net proceeds. As part of this issuance, the Company issued <span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pid_c20230630__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember_zSMOs1kcWbu3" title="Number of shares issued">13,333,333</span> shares, <span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20230630__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--WarrantAMember_zZJVZqjR8Knf" title="Number of shares issued">15,333,332</span> warrants A and <span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pid_c20230630__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__custom--WarrantBMember_z7DttOVkucI" title="Number of shares issued">15,333,332</span> warrants B (see also Note 5.2).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After the balance sheet date, on August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis, after consolidating every twenty-two ordinary shares of the Company into one ordinary share (see also Note 9.1).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Incentive Equity Plan</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 25, 2023, the Company’s board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan, which was subsequently amended the Company’s board of directors, subject to applicable Nasdaq requirements, which reserved for grant a number of ordinary shares equal to <span id="xdx_905_ecustom--SharesIssuedAndOutstandingPercent_iI_pid_dp_c20230425__ifrs-full--ComponentsOfEquityAxis__custom--IncentiveEquityPlanMember_z7tLiShZNyd2" title="Shares issued percent">15</span>% of the number of issued and outstanding ordinary shares on a fully diluted basis immediately after the closing of the Business Combination, or <span id="xdx_906_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230425__ifrs-full--ComponentsOfEquityAxis__custom--IncentiveEquityPlanMember_zQNRZfSM9sp" title="Number of shares authorized">5,082,417</span> authorized ordinary shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six-month period ended June 30, 2023, the Company granted <span id="xdx_90F_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pid_uShares_c20230101__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_ziNDcuf3X0Qf" title="Number of shares granted">4,334,000</span> RSUs to employees, directors and service providers. The fair value at grant date of RSUs granted in the period were $<span id="xdx_903_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zX1XsyezGkIh" title="Fair value grant">1</span>-$<span id="xdx_903_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zf0x2g2iUM56" title="Fair value grant">1.09</span>. The related share-based expenses that were recognized in the period amounted to $<span id="xdx_904_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20230101__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zS7xJxCYzUTb" title="Share based expenses">1,738</span>.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RSUs granted to employees, directors and service providers:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_898_ecustom--DisclosureOfRestrictedStockUnitExplanatory_z5DlE6rGNoj4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zLzX2uHKL3Md">SCHEDULE OF RESTRICTED STOCK UNIT</span></span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022<br/> (in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pn3n3_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zsApcO5dOaw3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2810">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pn3n3_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zTajTzM7YUia" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2812">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pn3n3_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zJNYkflGqqPk" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,334</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pn3n3_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_ztjDQ6CRTN52" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2816">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zN8Tm8HWL4ad" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(945</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_z5iU9khXCqzg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2820">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zP4qf2YjOpqj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,389</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zAhLAe2OuYxl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2824">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A1_zfOPbb41xyKf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six-month period ended June 30, 2023, the Company granted <span id="xdx_904_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20230101__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_z68rMwjeGy4d">790,408</span> options to employees and service providers. These grants carry an exercise price of between $<span id="xdx_900_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_zcemaEgmUIy5" title="Exercise price">1.04</span> - $<span id="xdx_900_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_zH1DmxrQlZq7" title="Exercise price">4.0</span>, vesting period up to <span id="xdx_901_ecustom--StockOptionVestingPeriod_dtY_c20230101__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_zPvYMWpBolt5" title="Stock option vesting period">4</span> years from the grant date, contractual life of the options under the plan is <span id="xdx_906_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630_z414g392Izfe" title="Exercise price">5</span> years. The fair value of the grant at grant date is $<span id="xdx_907_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_zRlAH6trISof">185</span>. The related share based expenses that were recognized in the six months period ended June 30, 2023 amounted to $<span id="xdx_908_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_c20230101__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesMember_zqVscBeH1Dd6" title="Share based expenses">168</span>.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 - SHAREHOLDERS’ EQUITY (CONT.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options granted to employees and service providers:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89B_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_zo3UWhwtr8N6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zhzuszGnJwdl">SCHEDULE OF SHARE OPTION GRANTED</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span> </span></span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise price per share (US$)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20230101__20230630_zVZ1R4p9ho53" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,251</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uUSDPShares_c20230101__20230630_z3vOKlfK5jA7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20230101__20230630_z67VMmKvxJp4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">790</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20230101__20230630_zE7vvLA0D3fe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.47</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20230630_zULm142cpe37" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20230101__20230630_z09V0LPh8Q0g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.39</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pn3n3_uShares_c20230101__20230630_zaZyX2De5Nz8" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2852">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20230101__20230630_zYDHRnIsiYtk" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2854">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at June 30, 2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20230101__20230630_zDjygwcp4j09" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,034</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_uUSDPShares_c20230101__20230630_zaGBZ2EMMeEe" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.58</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable options at June 30, 2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20230101__20230630_zFpLczPXJWX5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,825</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_uUSDPShares_c20230101__20230630_zdLjwPH5XXLf" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.48</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022 </b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise price per share (US$)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20220101__20220630_zaqkq0uAmts7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,346</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uUSDPShares_c20220101__20220630_zrCcoKS2j8O4" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.02</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20220101__20220630_z6coSKSimqef" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">989</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20220101__20220630_zLAdMhGwWRGk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.86</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20220630_zpM1QMTl1Zm3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2872">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20220630_zSJ3yHHyHDBa" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(375</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20220101__20220630_z2QkFVACItk" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.16</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at June 30, 2022</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20220101__20220630_zI97e1SA24Ib" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,960</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_uUSDPShares_c20220101__20220630_zISYnkIAMm3b" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable options at June 30, 2022</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20220101__20220630_zKigOASmULQ9" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,703</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_uUSDPShares_c20220101__20220630_z41oMdFJrU54" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.33</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_zaFZPW7h1dK8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eifrs-full--DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_zWrsY5l1yGLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 23.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The options to employees and service providers outstanding as of June 30, 2023, are comprised, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 23.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 23.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zYKDAVEUCuW7">SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 97%; border-collapse: collapse; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise price (US$)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding as of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercisable as of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023 </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(years)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(years)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLy9BtxvLGkc">0.84</span>-<span id="xdx_903_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLzLOXFgNrKd">1.39</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zD9ST4XUlBve" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">845</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_z7K2LJkm0gra" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zUvH3Nj05Re4" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">845</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zA1SyDwJMqEi" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zh0UwbLT5aDl">1.81</span>-<span id="xdx_904_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zmUE1wpuCdI4">2.51</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zGLR3ovoeQoa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_z0lGcQS19rW8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.59</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zVE1EjizmuJ1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zlwexmz38IZe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.59</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zOW7RGkphmIc">3.57</span>-<span id="xdx_900_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zzxBecO5MBXc">4.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_z1tmh2MBHXC6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">707</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_z6rHXhEnTJBi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.89</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zAFYA9WxJ8V5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">498</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zD8PAGkQnfN9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.86</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zIodhyfKphU1">4.18</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zX15kFur7Aeg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zyfZxNvj9gCb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.74</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zLNprFjKjI61" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zqt04zk5VUQh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.74</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zhYvLfcMi0p1">4.87</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zyuqTnHj8aff" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zZ53erng6Qab" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.51</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zbe3ryLa5M57" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zJbQQ5RyAfni" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.51</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630_zOakxU9x3D56" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,034</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630_zTd1QHf28JSg" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,825</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A7_zAAovI1IrUU5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_891_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_z7f9GJT8Dtt3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zWoECEuUevX1" style="display: none">SCHEDULE OF SHARE CAPITAL</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="14" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of shares</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued and outstanding</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issued and outstanding</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares <br/> USD <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eifrs-full--ParValuePerShare_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zgA34sa9xtI3" title="Par value per share">0.0001</span> par value</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zCx4liW9AgVl" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">800,000,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zIv4EyaoyeEl" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,364,447</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zpFhHWkB6IF7" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zrI8hrZlIOV4" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred shares <br/> USD <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90C_eifrs-full--ParValuePerShare_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zYxFeKB741e4" title="Par value per share">0.0001</span> par value</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zlmrvKRoiMag" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_znSZBvnfikfd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2726">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zqBxdCCm4nm" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2728">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zzbIQzKpEy2c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2730">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred shares <br/> Euro <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90E_eifrs-full--ParValuePerShare_iI_uEuroPerShare_c20230630_zgTHgsYTac65" title="Par value per share">1</span> par value</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zkKOjdFmQG11" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zmgifcW0EVf3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_zNHtmhvquhNe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares authorized"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__custom--DeferredSharesMember_z3NATPaXyBy9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of shares issued and outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 0.0001 800000000000 38364447 500000000 1 0.0001 200000000000 1000 25000 25000 25000 25000 0.0001 0.0022 828240000 1000000 186000 32211716 24568773 18673253 193500379 Security Matters PTY Ltd.’s shareholders received as consideration 1 ordinary share of the Company per 10.3624 Security Matters PTY Ltd.’s ordinary shares. 3525000 2200000 6250000 11.5 0.0204 303053 3110000 872418 1350000 200000 5 P5Y 11.5 675168 675168 450000 450000 2580000 13333333 15333332 15333332 0.15 5082417 4334000 1 1.09 1738000 <p id="xdx_898_ecustom--DisclosureOfRestrictedStockUnitExplanatory_z5DlE6rGNoj4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zLzX2uHKL3Md">SCHEDULE OF RESTRICTED STOCK UNIT</span></span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022<br/> (in thousands)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pn3n3_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zsApcO5dOaw3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2810">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_984_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pn3n3_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zTajTzM7YUia" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2812">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pn3n3_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zJNYkflGqqPk" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,334</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pn3n3_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_ztjDQ6CRTN52" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of outstanding, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2816">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vested</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zN8Tm8HWL4ad" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(945</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_z5iU9khXCqzg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2820">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at June 30, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zP4qf2YjOpqj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,389</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceMember_zAhLAe2OuYxl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding, Ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2824">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 4334000 945000 3389000 790408 1.04 4.0 P4Y P5Y 185000 168000 <p id="xdx_89B_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_zo3UWhwtr8N6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zhzuszGnJwdl">SCHEDULE OF SHARE OPTION GRANTED</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span> </span></span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise price per share (US$)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20230101__20230630_zVZ1R4p9ho53" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,251</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uUSDPShares_c20230101__20230630_z3vOKlfK5jA7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20230101__20230630_z67VMmKvxJp4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">790</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20230101__20230630_zE7vvLA0D3fe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.47</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20230630_zULm142cpe37" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20230101__20230630_z09V0LPh8Q0g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.39</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_pn3n3_uShares_c20230101__20230630_zaZyX2De5Nz8" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2852">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20230101__20230630_zYDHRnIsiYtk" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2854">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at June 30, 2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20230101__20230630_zDjygwcp4j09" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,034</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_uUSDPShares_c20230101__20230630_zaGBZ2EMMeEe" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.58</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable options at June 30, 2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20230101__20230630_zFpLczPXJWX5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,825</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_uUSDPShares_c20230101__20230630_zdLjwPH5XXLf" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.48</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022 </b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise price per share (US$)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at beginning of period</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20220101__20220630_zaqkq0uAmts7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,346</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uUSDPShares_c20220101__20220630_zrCcoKS2j8O4" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.02</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20220101__20220630_z6coSKSimqef" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">989</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20220101__20220630_zLAdMhGwWRGk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Granted"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.86</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20220630_zpM1QMTl1Zm3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercised"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2872">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20220630_zSJ3yHHyHDBa" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(375</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_uUSDPShares_c20220101__20220630_z2QkFVACItk" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Expired"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.16</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding at June 30, 2022</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20220101__20220630_zI97e1SA24Ib" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options outstanding Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,960</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_uUSDPShares_c20220101__20220630_zISYnkIAMm3b" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.21</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercisable options at June 30, 2022</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20220101__20220630_zKigOASmULQ9" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,703</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_uUSDPShares_c20220101__20220630_z41oMdFJrU54" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.33</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1251000 2.01 790000 3.47 7000 1.39 2034000 2.58 1825000 2.48 3346000 2.02 989000 2.86 375000 2.16 3960000 2.21 2703000 2.33 <p id="xdx_891_eifrs-full--DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_zWrsY5l1yGLe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 23.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The options to employees and service providers outstanding as of June 30, 2023, are comprised, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 23.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 23.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BB_zYKDAVEUCuW7">SCHEDULE OF OPTIONS TO EMPLOYEES OUTSTANDING</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 97%; border-collapse: collapse; margin-left: 0.25in"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise price (US$)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding as of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercisable as of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023 </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(years)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(years)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 21%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zLy9BtxvLGkc">0.84</span>-<span id="xdx_903_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLzLOXFgNrKd">1.39</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zD9ST4XUlBve" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">845</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_z7K2LJkm0gra" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zUvH3Nj05Re4" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">845</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zA1SyDwJMqEi" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.18</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zh0UwbLT5aDl">1.81</span>-<span id="xdx_904_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zmUE1wpuCdI4">2.51</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zGLR3ovoeQoa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_z0lGcQS19rW8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.59</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zVE1EjizmuJ1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">335</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zlwexmz38IZe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.59</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zOW7RGkphmIc">3.57</span>-<span id="xdx_900_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zzxBecO5MBXc">4.0</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_z1tmh2MBHXC6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">707</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_z6rHXhEnTJBi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.89</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zAFYA9WxJ8V5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">498</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zD8PAGkQnfN9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.86</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zIodhyfKphU1">4.18</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zX15kFur7Aeg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zyfZxNvj9gCb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.74</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zLNprFjKjI61" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zqt04zk5VUQh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.74</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zhYvLfcMi0p1">4.87</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zyuqTnHj8aff" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zZ53erng6Qab" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.51</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zbe3ryLa5M57" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">137</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zJbQQ5RyAfni" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.51</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630_zOakxU9x3D56" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,034</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630_zTd1QHf28JSg" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,825</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 0.84 1.39 845000 P1Y2M4D 845000 P1Y2M4D 1.81 2.51 335000 P2Y7M2D 335000 P2Y7M2D 3.57 4.0 707000 P4Y10M20D 498000 P4Y10M9D 4.18 10000 P1Y8M26D 10000 P1Y8M26D 4.87 137000 P3Y6M3D 137000 P3Y6M3D 2034000 1825000 <p id="xdx_80C_eifrs-full--DisclosureOfGeneralAndAdministrativeExpenseExplanatory_zfajOLqGV8c6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_825_zcqcrPzzmd8d">GENERAL AND ADMINISTRATIVE EXPENSES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span> </span></b></span></p> <p id="xdx_894_ecustom--DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_zXv8iBirP0S9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BB_zJtNrdra01c1">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</span></b></span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20230101__20230630_zfFz8t7Icmy6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20220101__20220630_ze72NPucuAP7" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$ in thousands</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$ in thousands</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_ecustom--TransactionCost_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zpQexyvjMLxb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction cost</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,792</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2945">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--AdvertisingExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_z1VQtO5qPv9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising, Public and Investors Relations</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,526</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2948">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zOa85JOg3FVe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based compensation</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,805</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--ProfessionalFeesExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zEYhfAmzsRQ7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional services</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">718</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">545</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--WagesAndSalaries_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zE5MXhJC6WX1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wages and salaries related</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">664</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">429</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zsqJvOhkCXj1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel expenses</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">379</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--InsuranceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zp5fmRcp8k0l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">329</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--RepairsAndMaintenanceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zYY9DaaZmbJ7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office and maintenance</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zMr1yoPTW4J1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zjjyLh6bFMl5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--GeneralAndAdministrativeExpense_iT_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_mtGAAEz4rn_zrVx7TG5qpBh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13,350</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,200</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A4_zx1f4KYOv9Nk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_ecustom--DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_zXv8iBirP0S9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BB_zJtNrdra01c1">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</span></b></span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20230101__20230630_zfFz8t7Icmy6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_495_20220101__20220630_ze72NPucuAP7" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six Months Ended</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$ in thousands</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>US$ in thousands</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_ecustom--TransactionCost_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zpQexyvjMLxb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction cost</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,792</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2945">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--AdvertisingExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_z1VQtO5qPv9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising, Public and Investors Relations</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,526</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2948">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zOa85JOg3FVe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Share based compensation</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,805</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">82</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--ProfessionalFeesExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zEYhfAmzsRQ7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Professional services</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">718</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">545</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eifrs-full--WagesAndSalaries_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zE5MXhJC6WX1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wages and salaries related</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">664</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">429</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zsqJvOhkCXj1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Travel expenses</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">379</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eifrs-full--InsuranceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zp5fmRcp8k0l" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insurance</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">329</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eifrs-full--RepairsAndMaintenanceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zYY9DaaZmbJ7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office and maintenance</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">80</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zMr1yoPTW4J1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zjjyLh6bFMl5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Others</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">86</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eifrs-full--GeneralAndAdministrativeExpense_iT_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_mtGAAEz4rn_zrVx7TG5qpBh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13,350</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,200</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 7792000 1526000 1805000 82000 718000 545000 664000 429000 379000 4000 329000 19000 37000 80000 15000 15000 86000 26000 13350000 1200000 <p id="xdx_801_eifrs-full--EarningsPerShareExplanatory_z9m3h5iJ0U1h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 - <span id="xdx_826_z0rRE9DfCEl7">LOSS PER SHARE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span> </span></b></span></p> <p id="xdx_89E_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zKgpft3aWSUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zBZlGZfU64n3">SCHEDULE OF LOSS PER SHARE</span></span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20230101__20230630_zccuxDTuNcCj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20220101__20220630_ziLvzxyOseCi" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months ended</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--ProfitLoss_pn3n3_zediOc3d31r8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss attributable to the owners of the Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(33,009</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(2,442</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted loss per share</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_904_eifrs-full--BasicEarningsLossPerShare_pid_c20230101__20230630_zQeuT29rlaZg" title="Basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_90D_eifrs-full--DilutedEarningsLossPerShare_pid_c20230101__20230630_zXWbgP5Vdpl" title="Diluted loss per share">(39.46</span></span></b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>*<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_90C_eifrs-full--BasicEarningsLossPerShare_pid_c20220101__20220630_fKg_____z4zXzM8iGfMf" title="Basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_90A_eifrs-full--DilutedEarningsLossPerShare_pid_c20220101__20220630_fKg_____zFENM663kyy8" title="Diluted loss per share">(3.36</span>)</span></b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--WeightedAverageNumberOfOrdinarySharesAbstract_iB_pid_zVTPSdA1A11c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Weighted average number of ordinary shares</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average number of ordinary shares used in calculating basic and diluted loss per share (in thousands)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_90E_eifrs-full--WeightedAverageShares_pid_c20230101__20230630_zznZjDyy506d" title="Weighted average number of ordinary shares used in calculating basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_90A_eifrs-full--AdjustedWeightedAverageShares_pid_c20230101__20230630_z0JrEr7b64vd" title="Weighted average number of ordinary shares used in calculating diluted loss per share">837</span></span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_903_eifrs-full--WeightedAverageShares_pid_c20220101__20220630_fKg_____zgP5axXfiyyf" title="Weighted average number of ordinary shares used in calculating basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_904_eifrs-full--AdjustedWeightedAverageShares_pid_c20220101__20220630_fKg_____z6NC7KnAtiM1" title="Weighted average number of ordinary shares used in calculating diluted loss per share">727</span></span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the reverse share split described in Note 9.1, the calculation of the basic and diluted loss per share for all periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 20px; text-align: right"><span id="xdx_F08_zTpQz5wyHjy7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_zUrGotoBUm0h" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restated as a result of the SPAC transaction</span></td></tr> </table> <p id="xdx_8AA_zuZimmYHTXGk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89E_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zKgpft3aWSUc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zBZlGZfU64n3">SCHEDULE OF LOSS PER SHARE</span></span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_49C_20230101__20230630_zccuxDTuNcCj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20220101__20220630_ziLvzxyOseCi" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months ended</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eifrs-full--ProfitLoss_pn3n3_zediOc3d31r8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss attributable to the owners of the Company</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(33,009</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(2,442</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Basic and diluted loss per share</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_904_eifrs-full--BasicEarningsLossPerShare_pid_c20230101__20230630_zQeuT29rlaZg" title="Basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_90D_eifrs-full--DilutedEarningsLossPerShare_pid_c20230101__20230630_zXWbgP5Vdpl" title="Diluted loss per share">(39.46</span></span></b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>*<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_90C_eifrs-full--BasicEarningsLossPerShare_pid_c20220101__20220630_fKg_____z4zXzM8iGfMf" title="Basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_90A_eifrs-full--DilutedEarningsLossPerShare_pid_c20220101__20220630_fKg_____zFENM663kyy8" title="Diluted loss per share">(3.36</span>)</span></b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_ecustom--WeightedAverageNumberOfOrdinarySharesAbstract_iB_pid_zVTPSdA1A11c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Weighted average number of ordinary shares</i></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average number of ordinary shares used in calculating basic and diluted loss per share (in thousands)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_90E_eifrs-full--WeightedAverageShares_pid_c20230101__20230630_zznZjDyy506d" title="Weighted average number of ordinary shares used in calculating basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_90A_eifrs-full--AdjustedWeightedAverageShares_pid_c20230101__20230630_z0JrEr7b64vd" title="Weighted average number of ordinary shares used in calculating diluted loss per share">837</span></span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_903_eifrs-full--WeightedAverageShares_pid_c20220101__20220630_fKg_____zgP5axXfiyyf" title="Weighted average number of ordinary shares used in calculating basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIExPU1MgUEVSIFNIQVJFIChEZXRhaWxzKQA_" id="xdx_904_eifrs-full--AdjustedWeightedAverageShares_pid_c20220101__20220630_fKg_____z6NC7KnAtiM1" title="Weighted average number of ordinary shares used in calculating diluted loss per share">727</span></span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the reverse share split described in Note 9.1, the calculation of the basic and diluted loss per share for all periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 20px; text-align: right"><span id="xdx_F08_zTpQz5wyHjy7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1D_zUrGotoBUm0h" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restated as a result of the SPAC transaction</span></td></tr> </table> -33009000 -2442000 -39.46 -39.46 -3.36 -3.36 837 837 727 727 <p id="xdx_80C_eifrs-full--DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_zL0MNUvhYtnk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – <span id="xdx_822_zfiD8bOvaSrf">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the reporting date, the following significant events have occurred:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reverse Stock Split - On August 8, 2023, at the Extraordinary General Meeting of Shareholders of the Company, the Company’s shareholders voted in favor of consolidating every twenty-two ordinary shares in the authorized but unissued and in the authorized and issued share capital of the Company into one ordinary share (the “Reverse Stock Split”).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis under the current symbol “SMX”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following is a table which presents the loss per share before the change (see also Note 8).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_ecustom--DisclosureOfWeightedAverageLossPerShareExplanatory_zUa6YJhYncxj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss per share have been calculated using the weighted average number of shares in issue during the relevant financial periods, the weighted average number of equity shares in issue and loss for the period as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zm6jx4sBUpY4">SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.25in; width: 97%" summary="xdx: Disclosure - SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE (Details)"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20230101__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zOVD8dk71ZFi" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20220101__20220630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zi6n0U4m3skd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Six months ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--ProfitLoss_pn3n3_zD3gmorMjvDj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss attributable to the owners of the Company</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(33,009</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,442</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted loss per share</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eifrs-full--BasicEarningsLossPerShare_pid_c20230101__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zsT6CAe1yiz9" title="Basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eifrs-full--DilutedEarningsLossPerShare_pid_c20230101__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_ziOXprHoJLo9" title="Diluted loss per share">(1.79</span></span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90B_eifrs-full--BasicEarningsLossPerShare_pid_c20220101__20220630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zMZJboS8SFVb" title="Basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_908_eifrs-full--DilutedEarningsLossPerShare_pid_c20220101__20220630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zouEFITe3Lpg" title="Diluted loss per share">(0.15</span></span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_ecustom--WeightedAverageNumberOfOrdinarySharesAbstract_iB_pid_zs5jb1q81UO3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average number of ordinary shares</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average number of ordinary shares used in calculating basic and diluted loss per share</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eifrs-full--WeightedAverageShares_pid_c20230101__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zE7DjPrL0ER1" title="Weighted average number of ordinary shares used in calculating basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eifrs-full--AdjustedWeightedAverageShares_pid_c20230101__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zADUo1U5KT75" title="Weighted average number of ordinary shares used in calculating diluted loss per share">18,404</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eifrs-full--WeightedAverageShares_pid_c20220101__20220630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zm4QZRLzE3wg" title="Weighted average number of ordinary shares used in calculating basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90A_eifrs-full--AdjustedWeightedAverageShares_pid_c20220101__20220630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z2EgdxrIc1R8" title="Weighted average number of ordinary shares used in calculating diluted loss per share">15,984</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_zZKNj877nQLa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 27, 2023, the Company amended <span style="background-color: white">its </span>Pre-Paid Advance agreement with Yorkville (see also Note 5.1) evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $<span id="xdx_906_ecustom--PrepaidAdvanceToDecreasePricePerShares_iI_pid_c20230727__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zHwuyt4S9IIe" title="Pre-Paid Advance to decrease price per shares">1.10</span> (as adjusted for the Reverse <span style="background-color: white">S</span>tock <span style="background-color: white">S</span>plit which occurred on August 21, 2023, see also Note 9.1), after the Company was required to repay in cash $<span id="xdx_906_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_pn3n3_c20230727__20230727__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zW8ed1WzIOc6" title="Repayment of debt">500</span> of principal amount as a result of the Company’s share price being below the original Floor Price. The maturity date will be 12-months after the initial closing of the Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $<span id="xdx_907_eifrs-full--CurrentPrepaidExpenses_iI_pn3n3_c20230727__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--PrePaidAdvanceAgreementMember_zLW0yd678gYe" title="Prepaid advance amount">1,500</span>. In the period, the Company repaid approximately $<span id="xdx_90D_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_pn3n3_c20230727__20230727__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--PrePaidAdvanceAgreementMember_zXD1g4rxaUNk" title="Repayment amount">450</span> principal amount by ordinary share issuance in accordance with the terms of the SEPA and subsequent to the period, the Company repaid approximately $<span id="xdx_900_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_c20230930__20230930__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--PrePaidAdvanceAgreementMember_zpX1vKcVdA2k" title="Repayment amount">1,350</span> through September 30, 2023.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 6, 2023, the Company consummated the transactions pursuant to a Securities Purchase Agreement dated as of September 5, 2023 and issued and sold to an institutional investor a promissory note with a fixed conversion price of $<span id="xdx_902_ecustom--ConversionPrice_pid_c20230906__20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_z9668pvvQCV1" title="Conversion price">1.6378</span> and warrants, for gross proceeds to SMX of approximately $<span id="xdx_901_eifrs-full--ProceedsFromIssuingShares_pn3n3_c20230906__20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zjx7aZ7rQEXh" title="Proceeds from offering">2,500</span>, before deducting fees and other offering expenses payable by the Company to their service providers. The note is in the principal amount of $<span id="xdx_905_eifrs-full--NetDebt_iI_pn3n3_c20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_znk8GpHaQWrj" title="Principal debt">4,290</span>. The actual amount loaned by the investor pursuant to the Note is $<span id="xdx_90E_eifrs-full--BorrowingCostsIncurred_pn3n3_c20230906__20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zSBqjPskoaai" title="Loan borrowing">2,574</span> after a <span id="xdx_904_ecustom--OriginalIssueDiscount_iI_pid_dp_c20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_z7gHCidDRDUb" title="Original issue discount">40</span>% original issue discount. The maturity date of the note is the 12-month anniversary of the Effective Date, and is the date upon which the principal amount, as well as any accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of <span id="xdx_90B_ecustom--InterestAccruedPercent_iI_pid_dp_c20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zhYmeMd6juM8" title="Interest accrued percent">12</span>% per year and shall be payable on the maturity date. The investor has the right, at any time, to convert all or any portion of the then outstanding and unpaid principal amount and interest (including any costs, fees and charges) into the Company’s ordinary shares, at a fixed conversion price of $<span id="xdx_90A_ecustom--ConversionPrice_pid_c20230906__20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_znCrQiYKJSs2" title="Conversion price">1.6378</span> per share. <span id="xdx_90C_eifrs-full--DescriptionOfConversionOfDebtToEquity_pid_c20230906__20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zaT1JxfXjymh" title="Conversion of shares, description">Any such conversion is subject to customary conversion limitations set forth in the Purchase Agreement so the investor beneficially owns less than 4.99% of the Company’s ordinary shares. Additionally, the Company has the right to convert in whole or in part the note into ordinary shares; provided that in no case shall the Company so convert the note if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of 4.99%</span>.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 15, 2023, the Company paid $<span id="xdx_90D_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_pn3n3_c20230915__20230915__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--CounterpartiesAxis__custom--BenchmarkInvestmentsLLCMember_zXMjCxzgbtIc" title="Payment of debt">250</span> to EF Hutton, division of Benchmark Investments, LLC, pursuant to a Satisfaction and Discharge of Indebtedness Pursuant to Promissory Note Dated March 7, 2023. Upon paying such amount, the promissory note dated March 7, 2023 in the principal sum of $<span id="xdx_901_eifrs-full--NetDebt_iI_pn3n3_c20230915__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--CounterpartiesAxis__custom--BenchmarkInvestmentsLLCMember_zph6NXPx4NNc" title="Debt principal amount">900</span> was deemed fully paid and satisfied and the Note was thereafter canceled, discharged and no longer of any further force or effect.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund (the “Loan Agreements”). Pursuant to the amendment to the Loan Agreements, Kamea agreed to convert $<span id="xdx_906_eifrs-full--DebtSecurities_iI_pn3n3_c20230919__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementMember_zj1JTW6HMOY8" title="Debt conversion amount">657</span> of indebtedness under the Loan Agreements (the “Indebtedness Amount”) into <span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_pid_c20230919__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--LoanAgreementsMember_zofibEHWl1si" title="Ordinary shares">487,281</span> ordinary shares (post Reverse Stock Split) of the Company, as payment in full for the Indebtedness Amount; provided however, that in the event the proceeds received from Kamea with respect to any sales of such shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">6.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 3, 2023, the Company has signed an agreement with True Gold Consortium Pty Ltd (“TrueGold”) (see also Note 1C) shareholders to acquire an additional <span id="xdx_90E_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20231003__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TrueGoldConsortiumPtyLtdMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zQjYh5SELQm2" title="Percentage of interests acquired additional">7.5</span>% which will increase the Company’s holdings to <span id="xdx_901_ecustom--PercentageOfInterestsAcquiredIncrease_iI_pid_dp_c20231003__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TrueGoldConsortiumPtyLtdMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zuW8spoTz0Ia" title="Percentage of interests acquired increase">51.9</span>% in TrueGold and result in the Company’s gain control over TrueGold. As part of the agreement and in consideration for the additional <span id="xdx_90D_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_c20231003__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TrueGoldConsortiumPtyLtdMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zIO154q7kLY5" title="Percentage of interests acquired additional">7.5</span>%, it was agreed that the outstanding payables from TrueGold to the Company which amounted to AU$ <span id="xdx_907_eifrs-full--OtherPayables_iI_pn3n3_uAUD_c20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TrueGoldConsortiumPtyLtdMember_zdg2PlQzEyzc" title="Outstanding payables">475</span> as of June 30, 2023 (approximately $<span id="xdx_904_eifrs-full--OtherPayables_iI_pn3n3_c20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TrueGoldConsortiumPtyLtdMember_zJeR1S2QJR5h" title="Outstanding payables">307</span>) would be forgiven in full.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The transaction is based on past valuation, which was prepared in October 2021, which evaluates TrueGold’s fair value in the range of $<span id="xdx_90E_eifrs-full--GainRecognisedInBargainPurchaseTransaction_pn5n6_c20211001__20211031__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TrueGoldConsortiumPtyLtdMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zwwizWa8llD6" title="Fair value">78.5</span> million to $<span id="xdx_90C_eifrs-full--GainRecognisedInBargainPurchaseTransaction_pn6n6_c20211001__20211031__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TrueGoldConsortiumPtyLtdMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zaR2QLuVW8f" title="Fair value">90</span> million and at a mean of $<span id="xdx_905_eifrs-full--GainRecognisedInBargainPurchaseTransaction_pn5n6_c20211001__20211031__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TrueGoldConsortiumPtyLtdMember_zzJts6dlvFBi" title="Fair value">84.3</span> million. This past valuation was not audited or reviewed.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="margin: 0">As of the agreement’s closing date, both parties agreed to engage an independent third party appraiser to prepare an updated TrueGold valuation as of closing date by November 30, 2023. Accordingly, the Company will recognize in its financial statements the fair value of TrueGold’s assets &amp; liabilities at closing date as will be valued by the independent third party appraiser. Once this valuation will be completed, there may be material differences between TrueGold’s past valuation from October 2021 to the updated valuation.</p> </td></tr> </table> <p id="xdx_89D_ecustom--DisclosureOfWeightedAverageLossPerShareExplanatory_zUa6YJhYncxj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss per share have been calculated using the weighted average number of shares in issue during the relevant financial periods, the weighted average number of equity shares in issue and loss for the period as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zm6jx4sBUpY4">SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.25in; width: 97%" summary="xdx: Disclosure - SCHEDULE OF WEIGHTED AVERAGE LOSS PER SHARE (Details)"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_492_20230101__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zOVD8dk71ZFi" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_499_20220101__20220630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zi6n0U4m3skd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Six months ended</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2023</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 30, 2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eifrs-full--ProfitLoss_pn3n3_zD3gmorMjvDj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss attributable to the owners of the Company</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(33,009</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,442</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted loss per share</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eifrs-full--BasicEarningsLossPerShare_pid_c20230101__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zsT6CAe1yiz9" title="Basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eifrs-full--DilutedEarningsLossPerShare_pid_c20230101__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_ziOXprHoJLo9" title="Diluted loss per share">(1.79</span></span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90B_eifrs-full--BasicEarningsLossPerShare_pid_c20220101__20220630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zMZJboS8SFVb" title="Basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_908_eifrs-full--DilutedEarningsLossPerShare_pid_c20220101__20220630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zouEFITe3Lpg" title="Diluted loss per share">(0.15</span></span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_ecustom--WeightedAverageNumberOfOrdinarySharesAbstract_iB_pid_zs5jb1q81UO3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: italic 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average number of ordinary shares</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted average number of ordinary shares used in calculating basic and diluted loss per share</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eifrs-full--WeightedAverageShares_pid_c20230101__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zE7DjPrL0ER1" title="Weighted average number of ordinary shares used in calculating basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90C_eifrs-full--AdjustedWeightedAverageShares_pid_c20230101__20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zADUo1U5KT75" title="Weighted average number of ordinary shares used in calculating diluted loss per share">18,404</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_905_eifrs-full--WeightedAverageShares_pid_c20220101__20220630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zm4QZRLzE3wg" title="Weighted average number of ordinary shares used in calculating basic loss per share"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFdFSUdIVEVEIEFWRVJBR0UgTE9TUyBQRVIgU0hBUkUgKERldGFpbHMpAA__" id="xdx_90A_eifrs-full--AdjustedWeightedAverageShares_pid_c20220101__20220630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z2EgdxrIc1R8" title="Weighted average number of ordinary shares used in calculating diluted loss per share">15,984</span></span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> -33009000 -2442000 -1.79 -1.79 -0.15 -0.15 18404 18404 15984 15984 1.10 500000 1500000 450000 1350000 1.6378 2500000 4290000 2574000 0.40 0.12 1.6378 Any such conversion is subject to customary conversion limitations set forth in the Purchase Agreement so the investor beneficially owns less than 4.99% of the Company’s ordinary shares. Additionally, the Company has the right to convert in whole or in part the note into ordinary shares; provided that in no case shall the Company so convert the note if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of 4.99% 250000 900000 657000 487281 0.075 0.519 0.075 475000 307000 78500000 90000000 84300000 The prepaid expenses include Less than 1 thousand. After giving effect to the reverse stock split (see also Note 9.1) Restated as a result of the SPAC transaction and after giving effect to the reverse stock split (see also Note 1 and 9.1) Incorporated in 2023. Merger occurred in March 2023. Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2022. Restated as a result of the SPAC transaction
  •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